Clustering O 0 5.098963811178692e-06
of O 0 9.831020406636526e-07
missense O 0 4.972275291947881e-06
mutations O 0 6.011006092876414e-08
in O 0 8.381999094808634e-09
the O 0 3.5055009561801853e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 4.339422503107926e-06
in O 0 3.904822687417209e-09
a O 0 3.3904210550161906e-09
sporadic B-Disease 0 8.970782232609054e-07
T I-Disease 0 0.10342000424861908
- I-Disease 0 0.023844044655561447
cell I-Disease 0 0.0003317511291243136
leukaemia I-Disease 1 0.9946476817131042
. O 0 2.2413520639474882e-07

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9382769465446472
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 7.3009598366979844e-09
is O 0 1.5674740672100285e-10
a O 0 6.486177706044316e-10
recessive B-Disease 0 4.2424650814609777e-07
multi I-Disease 1 0.9999998807907104
- I-Disease 1 1.0
system I-Disease 1 0.9974383115768433
disorder I-Disease 0 0.00011455795902293175
caused O 0 4.452588520109657e-09
by O 0 2.7065124447167577e-11
mutations O 0 5.389939536359911e-11
in O 0 1.1982990988368414e-10
the O 0 3.1157443292073594e-09
ATM O 0 2.095167559446054e-07
gene O 0 5.066437491763054e-09
at O 0 6.73286448815702e-09
11q22 O 0 1.3161512413262244e-07
- O 0 1.270601757141776e-07
q23 O 0 1.089787815544696e-06
( O 0 8.549079666408943e-09
ref O 0 8.213427463488188e-06
. O 0 3.662760095224371e-09
3 O 0 2.3988654618278815e-08
) O 0 2.532285048317817e-09
. O 0 4.0978132886948515e-08

The O 0 2.0580674231496232e-07
risk O 0 2.0834777103573288e-07
of O 0 1.9217576152641414e-07
cancer B-Disease 0 0.00017632197705097497
, O 0 2.5409407911070048e-09
especially O 0 1.662114712530638e-08
lymphoid B-Disease 0 0.40834563970565796
neoplasias I-Disease 1 0.9905562996864319
, O 0 1.1722971482441835e-09
is O 0 7.315169997523796e-11
substantially O 0 2.836933798988639e-09
elevated O 0 1.7770232716429746e-06
in O 0 2.5906112810503146e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 0.0036757453344762325
and O 0 1.4247793167498912e-08
has O 0 5.472461928057726e-10
long O 0 3.429174444402605e-10
been O 0 1.0227878960433756e-10
associated O 0 9.289957136893179e-10
with O 0 1.9686055008349967e-09
chromosomal O 1 1.0
instability O 1 1.0
. O 0 1.634259933780413e-05

By O 0 4.326073721472312e-08
analysing O 0 5.00831220051623e-07
tumour B-Disease 1 0.7730749249458313
DNA O 0 9.607373385733808e-08
from O 0 2.103883733894918e-09
patients O 0 4.716369517154817e-10
with O 0 1.3785368679908316e-10
sporadic B-Disease 0 5.434770855572424e-07
T I-Disease 0 0.00015216818428598344
- I-Disease 0 2.7439957193564624e-05
cell I-Disease 0 3.7439376683323644e-06
prolymphocytic I-Disease 0 8.279653229692485e-06
leukaemia I-Disease 0 5.592160232481547e-05
( O 0 3.415370430914777e-09
T B-Disease 0 4.371520105905802e-07
- I-Disease 0 2.730339758727496e-07
PLL I-Disease 0 6.739085620210972e-06
) O 0 5.930814173105148e-10
, O 0 5.050965548591968e-11
a O 0 3.1502644937120294e-10
rare O 0 4.209864901127958e-09
clonal B-Disease 0 1.813873637956931e-07
malignancy I-Disease 0 2.6268564852216514e-06
with O 0 8.457436834197196e-11
similarities O 0 2.313910396622987e-09
to O 0 1.4411886128939955e-09
a O 0 1.2748615496604998e-08
mature B-Disease 0 1.3004431309582287e-07
T I-Disease 0 8.924007852328941e-05
- I-Disease 0 4.9496604333398864e-05
cell I-Disease 0 4.9288787522527855e-06
leukaemia I-Disease 0 0.00012308468285482377
seen O 0 3.1512215059592563e-09
in O 0 3.4435479467909147e-10
A B-Disease 1 0.6839534640312195
- I-Disease 1 0.8819248080253601
T I-Disease 1 1.0
, O 0 4.630039018849175e-09
we O 0 3.1945682210654525e-10
demonstrate O 0 6.660363927046831e-10
a O 0 3.870488651802617e-10
high O 0 1.7769677951307017e-09
frequency O 0 2.9250231126098925e-09
of O 0 4.7748258680258004e-09
ATM O 0 2.5476492737652734e-07
mutations O 0 6.05543348797255e-09
in O 0 8.745640656115938e-09
T B-Disease 0 2.6767798772198148e-05
- I-Disease 0 3.343978096381761e-05
PLL I-Disease 0 0.0021601179614663124
. O 0 1.2093893246856169e-06

In O 0 1.7656648765296268e-07
marked O 0 1.2476824906570982e-07
contrast O 0 4.2771254982199025e-08
to O 0 5.525704782627372e-09
the O 0 2.3386165892702593e-08
ATM O 0 5.978584454169322e-07
mutation O 0 2.6751978410288757e-09
pattern O 0 4.015924037759078e-09
in O 0 2.4935011833093768e-09
A B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 2.608973481699195e-09
the O 0 5.272802194866699e-10
most O 0 4.562653380113524e-11
frequent O 0 3.4255577541220106e-11
nucleotide O 0 2.1139630324018555e-10
changes O 0 1.6056949173059998e-11
in O 0 9.701674359707813e-12
this O 0 5.720449114399173e-11
leukaemia B-Disease 0 4.918135527987033e-05
were O 0 1.419081208098305e-08
missense O 0 1.6209992281801533e-06
mutations O 0 7.299792770254498e-08
. O 0 1.0539225314687428e-07

These O 0 1.217166527567315e-07
clustered O 0 2.596468107185501e-07
in O 0 1.009961003717308e-09
the O 0 1.0277476647502226e-09
region O 0 8.470775747504433e-10
corresponding O 0 9.348846141676859e-10
to O 0 9.350487051307255e-10
the O 0 1.0577100972852804e-08
kinase O 0 1.1322606496833032e-07
domain O 0 3.819172089691847e-09
, O 0 7.222061837452998e-11
which O 0 2.7572314223456296e-11
is O 0 5.3635217794889556e-11
highly O 0 9.82571024543688e-10
conserved O 0 2.122379605395963e-09
in O 0 2.917922847789356e-10
ATM O 0 1.446389177317542e-07
- O 0 1.14611617973992e-08
related O 0 8.55844006775186e-10
proteins O 0 3.387127731069306e-11
in O 0 9.89529222450436e-11
mouse O 0 5.048601092738636e-09
, O 0 8.144676599819434e-11
yeast O 0 5.760091781326082e-08
and O 0 6.6533076825692206e-09
Drosophila O 0 6.113082804404257e-07
. O 0 1.034162906421443e-07

The O 0 4.311041266191751e-07
resulting O 0 2.0505054010300228e-07
amino O 0 1.124094453075486e-07
- O 0 8.563984010834247e-08
acid O 0 7.828544923427216e-09
substitutions O 0 1.2589207898372479e-08
are O 0 1.3168624524162453e-10
predicted O 0 1.1267471400344675e-08
to O 0 6.038821109832782e-10
interfere O 0 1.0809192652061483e-08
with O 0 6.958838505433107e-10
ATP O 0 7.235873908939539e-07
binding O 0 1.3635671258782622e-08
or O 0 3.662159242523444e-09
substrate O 0 2.7880992092832457e-07
recognition O 0 4.979964174367524e-08
. O 0 4.570212297494436e-08

Two O 0 7.05353500052297e-07
of O 0 4.822338723897701e-07
seventeen O 0 2.5462722419433703e-07
mutated O 0 3.0574236120628484e-07
T B-Disease 0 2.1404650851764018e-06
- I-Disease 0 9.179087214761239e-07
PLL I-Disease 0 5.679525656887563e-06
samples O 0 7.0038495003643675e-09
had O 0 2.781701757825772e-09
a O 0 1.2594485454542337e-09
previously O 0 6.3517551218694734e-09
reported O 0 1.5378880391381244e-08
A B-Disease 1 0.9999786615371704
- I-Disease 1 0.9999749660491943
T I-Disease 1 1.0
allele O 0 8.1196594692301e-06
. O 0 7.238427315314766e-07

In O 0 5.7307122602878735e-08
contrast O 0 4.4734974835591856e-08
, O 0 3.2806852789946106e-09
no O 0 1.1238296959703575e-09
mutations O 0 8.729554856756749e-10
were O 0 9.348865015468277e-10
detected O 0 5.2067052891402454e-09
in O 0 1.2983716879411134e-10
the O 0 8.140192964134485e-10
p53 O 0 5.003075176368554e-10
gene O 0 5.869280617076811e-10
, O 0 4.503668965538665e-11
suggesting O 0 2.280722138925384e-10
that O 0 5.212622694594771e-11
this O 0 1.9368397996544218e-09
tumour B-Disease 1 1.0
suppressor O 0 7.394525164272636e-05
is O 0 3.4982827745722034e-10
not O 0 2.95451371701283e-11
frequently O 0 5.6614435361979076e-11
altered O 0 6.202330316007476e-10
in O 0 5.999531427214322e-11
this O 0 7.38763716867652e-10
leukaemia B-Disease 0 0.09579625725746155
. O 0 3.722117583038198e-07

Occasional O 0 4.304002231947379e-06
missense O 0 7.048907718854025e-06
mutations O 0 5.5736371962211706e-08
in O 0 7.60986029746391e-09
ATM O 0 4.666235781769501e-06
were O 0 1.0908151715227632e-08
also O 0 8.289684494400262e-10
found O 0 3.5038255630226445e-10
in O 0 2.69247818485141e-10
tumour B-Disease 1 0.9986321330070496
DNA O 0 3.9084756764395934e-08
from O 0 5.230781363607662e-10
patients O 0 1.7985614386706317e-10
with O 0 1.4468147513380103e-10
B B-Disease 0 1.7470822513132589e-06
- I-Disease 0 1.874377267085947e-05
cell I-Disease 0 0.00021760270465165377
non I-Disease 0 0.00014862064563203603
- I-Disease 0 0.0003552172565832734
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 0 9.295419658883475e-06
( O 0 1.5171406353431394e-09
B B-Disease 0 2.959932920987285e-08
- I-Disease 0 7.813000912904045e-09
NHL I-Disease 0 4.402403774861341e-08
) O 0 1.2381543013084695e-10
and O 0 1.495431695142102e-10
a O 0 2.5700150896312834e-09
B B-Disease 0 7.164031217143929e-07
- I-Disease 0 3.496590124996146e-06
NHL I-Disease 0 0.00012805446749553084
cell O 0 5.887303632334806e-05
line O 0 8.01334681455046e-06
. O 0 3.9503981952293543e-07

The O 0 1.9832071984637878e-07
evidence O 0 1.0610121137233364e-07
of O 0 2.7898485299715503e-08
a O 0 2.237873220067854e-09
significant O 0 1.3443017810033098e-09
proportion O 0 1.4794147018548642e-09
of O 0 5.074135334126595e-09
loss O 0 3.404523241101742e-08
- O 0 2.416140887362417e-07
of O 0 2.2003912647505786e-07
- O 0 1.3700800138849445e-07
function O 0 1.3406191434750525e-10
mutations O 0 6.087504805796229e-11
and O 0 2.213351897595306e-11
a O 0 8.64128629762817e-11
complete O 0 1.10171249900759e-09
absence O 0 1.8156834258320487e-08
of O 0 7.967645210271712e-09
the O 0 1.0060120514410187e-09
normal O 0 1.785365050244181e-10
copy O 0 8.517142546793366e-10
of O 0 1.0125474902977771e-09
ATM O 0 7.77616406821835e-08
in O 0 9.983559812187792e-11
the O 0 2.760042472349511e-10
majority O 0 1.3716885960413094e-10
of O 0 4.004596210194222e-09
mutated O 0 8.146224104166322e-07
tumours B-Disease 1 0.9999994039535522
establishes O 0 2.839306887381099e-07
somatic O 0 2.075907019616352e-07
inactivation O 0 2.4963392775134707e-07
of O 0 1.4318318752870596e-09
this O 0 3.873847076452108e-11
gene O 0 1.0912884484959307e-10
in O 0 3.714126228793191e-11
the O 0 3.153847460968251e-10
pathogenesis O 0 5.041462827648502e-06
of O 0 7.459117767893986e-08
sporadic B-Disease 0 8.325426279043313e-06
T I-Disease 0 0.007563620340079069
- I-Disease 0 2.8972597192478133e-06
PLL I-Disease 0 6.704317911498947e-06
and O 0 7.487991338095412e-10
suggests O 0 2.9780683474811553e-10
that O 0 1.131030338830108e-11
ATM O 0 1.5281074183803867e-08
acts O 0 6.030165811132804e-10
as O 0 2.100800200466324e-09
a O 0 1.7591696988006333e-08
tumour B-Disease 1 1.0
suppressor O 0 0.0003323963319417089
. O 0 5.43574458333751e-07

As O 0 2.7304935201755143e-07
constitutional O 0 1.943472653920253e-07
DNA O 0 1.6935341307089402e-07
was O 0 1.621454792655186e-08
not O 0 4.078438281540642e-11
available O 0 3.798291958734268e-10
, O 0 1.251629078158345e-10
a O 0 2.0431640823659336e-09
putative O 0 0.003428578842431307
hereditary O 1 1.0
predisposition O 1 1.0
to O 0 0.0005877373623661697
T B-Disease 1 1.0
- I-Disease 1 0.999845027923584
PLL I-Disease 0 0.08345071226358414
will O 0 2.1418222750924087e-09
require O 0 1.8240713106632e-10
further O 0 5.129247027113593e-10
investigation O 0 2.94594104666146e-09
. O 0 1.208578348510514e-09
. O 0 8.53057535721291e-09

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 2.163763747375924e-05
kinase O 0 1.2023913313896628e-06
is O 0 2.23341165006552e-10
involved O 0 5.1912509013707364e-11
in O 0 1.0878339895548095e-11
the O 0 1.0645195142044983e-10
modulation O 0 7.491338216425447e-09
of O 0 1.3733804093973845e-09
the O 0 3.2834521768165814e-09
Ca2 O 0 1.9672557982630678e-07
+ O 0 1.0853781162722953e-07
homeostasis O 0 7.843583205158211e-08
in O 0 5.991072637989703e-10
skeletal O 0 4.18011040892452e-07
muscle O 0 5.7298709776887335e-08
cells O 0 2.671097831807856e-07
. O 0 7.447815875138986e-08

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9993178844451904
DM B-Disease 1 1.0
) O 0 1.1003233169049054e-07
, O 0 8.698324838185556e-10
the O 0 1.8124716172351896e-09
most O 0 3.0056206412609754e-09
prevalent O 1 0.9707550406455994
muscular B-Disease 1 1.0
disorder I-Disease 1 0.9999988079071045
in O 0 4.324504310204702e-09
adults O 0 7.814338620626415e-10
, O 0 3.831601355641645e-11
is O 0 2.2432554078188893e-11
caused O 0 1.8576556959359891e-09
by O 0 7.317308425847102e-10
( O 0 3.70852348829942e-09
CTG O 0 5.951096682110801e-06
) O 0 5.927285884332889e-10
n O 0 1.6506708222507882e-09
- O 0 4.359053118463407e-09
repeat O 0 9.375400455979843e-10
expansion O 0 2.1650821135921205e-09
in O 0 2.2972502372597958e-11
a O 0 3.008858440178841e-11
gene O 0 1.9373993728755146e-11
encoding O 0 5.66254820810741e-10
a O 0 1.2049370390343483e-09
protein O 0 3.2464433363799117e-09
kinase O 0 6.986507372630513e-08
( O 0 9.033572112571164e-09
DM B-Disease 1 0.9999997615814209
protein O 0 9.23262675200931e-08
kinase O 0 4.07721572059927e-08
; O 0 7.182119343696058e-10
DMPK O 0 3.963151812058641e-06
) O 0 1.5052213642174905e-10
and O 0 2.524653229529772e-11
involves O 0 1.4839979245451218e-10
changes O 0 1.3929574160798097e-10
in O 0 1.815460004550573e-10
cytoarchitecture O 0 2.8261939633011934e-07
and O 0 3.0840943132659504e-09
ion O 0 8.686012051839498e-07
homeostasis O 0 8.739924851397518e-06
. O 0 3.83440749374131e-07

To O 0 1.0048047727195808e-07
obtain O 0 4.1297568031950505e-07
clues O 0 7.690656502745696e-07
to O 0 3.038944873523519e-09
the O 0 2.70415201342189e-09
normal O 0 1.8862043038581078e-09
biological O 0 3.432454320773104e-09
role O 0 3.5710672197097892e-09
of O 0 1.567122787093922e-08
DMPK O 0 0.06669016182422638
in O 0 4.1295256103524025e-09
cellular O 0 3.473857645985845e-08
ion O 0 1.1956410617131041e-07
homeostasis O 0 1.490953991378774e-07
, O 0 4.5394099590367887e-10
we O 0 1.4832678141285527e-10
have O 0 3.833728820512583e-11
compared O 0 6.181402611993292e-10
the O 0 1.437600372078407e-09
resting O 0 4.756612170808694e-08
[ O 0 6.335856284067631e-09
Ca2 O 0 5.924553736491589e-09
+ O 0 5.315944573425213e-09
] O 0 1.4044858609452149e-09
i O 0 4.886675508686267e-10
, O 0 1.8373602986287985e-11
the O 0 5.879990244705979e-11
amplitude O 0 8.709613585899945e-10
and O 0 9.548425938810112e-11
shape O 0 1.2385042991169826e-09
of O 0 6.6812084753564704e-09
depolarization O 0 1.7067058877273666e-07
- O 0 1.2416205663612345e-07
induced O 0 1.1200111060816198e-07
Ca2 O 0 5.122330293261257e-08
+ O 0 1.0652660087373533e-08
transients O 0 1.015964468109587e-08
, O 0 1.8440414126241755e-11
and O 0 1.5475488945870808e-11
the O 0 2.9473221085929424e-10
content O 0 1.095652235605371e-09
of O 0 7.018064351882458e-09
ATP O 0 1.7095254634114099e-06
- O 0 3.543117088611325e-07
driven O 0 2.45762095119062e-07
ion O 0 3.834897768228984e-07
pumps O 0 2.2438031521687662e-07
in O 0 8.760733472001903e-09
cultured O 0 8.379338964914496e-07
skeletal O 0 5.3210095529721e-07
muscle O 0 4.672711995112877e-09
cells O 0 3.5981282398012127e-09
of O 0 8.351454638955147e-09
wild O 0 7.768008458697295e-09
- O 0 2.2614039529855745e-09
type O 0 3.742903320613777e-09
and O 0 6.059719837026023e-09
DMPK O 0 4.4442585931392387e-05
[ O 0 7.558179504485452e-08
- O 0 3.9131754192567314e-07
/ O 0 3.888591891154647e-06
- O 0 3.710347982632811e-06
] O 0 4.803763431482366e-07
knockout O 0 2.32839556701947e-05
mice O 0 2.5316472829217673e-07
. O 0 2.4354386951586093e-08

In O 0 6.849755322946294e-07
vitro O 0 4.364165761217009e-06
- O 0 9.04189903394581e-07
differentiated O 0 2.2155109036248177e-06
DMPK O 0 0.0002620826126076281
[ O 0 3.5948036725130805e-07
- O 0 9.851771665125852e-07
/ O 0 4.294891368772369e-06
- O 0 2.0236084310454316e-06
] O 0 1.1543656341927999e-07
myotubes O 0 2.912383081365988e-07
exhibit O 0 6.666019403134271e-10
a O 0 4.224550431697338e-10
higher O 0 5.446120443508562e-09
resting O 0 1.9212555457670533e-07
[ O 0 1.6488025167404885e-08
Ca2 O 0 3.889422828251554e-08
+ O 0 3.027843931135976e-08
] O 0 1.147555384051202e-08
i O 0 1.641665914320356e-09
than O 0 8.096320835981885e-11
do O 0 1.2952501571295016e-10
wild O 0 4.5974437590246e-09
- O 0 8.496022552151317e-09
type O 0 1.4724958141698608e-08
myotubes O 0 5.743800102209207e-06
because O 0 5.272500769315513e-10
of O 0 1.4423683358799622e-09
an O 0 5.2869389421950075e-11
altered O 0 1.671712435147299e-09
open O 0 2.6603803604530185e-09
probability O 0 9.041342119431306e-10
of O 0 2.354679118354852e-09
voltage O 0 1.8416932334730518e-07
- O 0 4.690501853588103e-08
dependent O 0 1.1446830150418918e-08
l O 0 3.1757125817932774e-09
- O 0 2.45319542457878e-09
type O 0 2.011230959553245e-09
Ca2 O 0 1.1993590121051056e-08
+ O 0 5.594466667702136e-09
and O 0 1.3506654683581587e-09
Na O 0 8.511879059369676e-07
+ O 0 3.7028144106443506e-08
channels O 0 2.050105685214021e-08
. O 0 5.509193101715937e-09

The O 0 7.382498552033212e-06
mutant O 0 4.830108082387596e-06
myotubes O 0 4.627936505130492e-06
exhibit O 0 8.91929019530835e-09
smaller O 0 5.646803913350595e-09
and O 0 2.688907319026157e-09
slower O 0 1.8952106017877668e-07
Ca2 O 0 2.3670439475154126e-07
+ O 0 1.579245356708725e-08
responses O 0 1.8249865507691254e-10
upon O 0 5.186730489548097e-10
triggering O 0 3.98200539208915e-09
by O 0 2.6820103429803233e-11
acetylcholine O 0 2.391157716274961e-09
or O 0 5.667820657251355e-10
high O 0 7.270484658761234e-09
external O 0 6.822530451700004e-08
K O 0 1.5769222727612942e-07
+ O 0 1.2553246619972924e-07
. O 0 1.939099014691692e-08

In O 0 1.4137320647478191e-08
addition O 0 4.614522097767804e-09
, O 0 7.619674891046202e-10
we O 0 9.659874983247718e-11
observed O 0 3.3197861126765815e-10
that O 0 1.7883838507315453e-11
these O 0 4.260917174647716e-10
Ca2 O 0 6.695574938930804e-07
+ O 0 7.193572173491702e-07
transients O 0 3.35236222781532e-07
partially O 0 9.434457659551754e-09
result O 0 1.3684847699479974e-10
from O 0 9.301903691749658e-11
an O 0 3.0412731361062484e-11
influx O 0 7.957223213672648e-10
of O 0 3.5079463778231457e-09
extracellular O 0 5.063490959855699e-09
Ca2 O 0 1.5413943899034166e-08
+ O 0 2.2494448526089172e-09
through O 0 1.5885363857659485e-10
the O 0 2.2186111281463639e-10
l O 0 1.7936053753331294e-09
- O 0 6.847231670548126e-09
type O 0 2.0118340771091425e-08
Ca2 O 0 4.49242008926376e-07
+ O 0 4.146995991050062e-07
channel O 0 5.798036681881058e-07
. O 0 3.445298801807439e-08

Neither O 0 5.1109445848851465e-06
the O 0 1.16328415344924e-07
content O 0 1.8633485865393595e-08
nor O 0 2.662777909279157e-08
the O 0 1.385340508974764e-09
activity O 0 8.171943122192715e-10
of O 0 6.529575991010006e-09
Na O 0 8.827240662867553e-07
+ O 0 2.389649900180757e-08
/ O 0 2.827411549333192e-08
K O 0 3.422101713113079e-08
+ O 0 2.2410436173458947e-08
ATPase O 0 2.5000650438755656e-08
and O 0 1.3207771543122249e-09
sarcoplasmic O 0 2.305667976543191e-06
reticulum O 0 1.7666363874013769e-06
Ca2 O 0 1.3136632048826868e-07
+ O 0 4.3103096203367386e-08
- O 0 2.3202666454835708e-08
ATPase O 0 8.537917040030152e-09
are O 0 2.2312136513380487e-11
affected O 0 3.4586744579456763e-10
by O 0 5.476534226112051e-10
DMPK O 0 0.00047309522051364183
absence O 0 1.6676736777299084e-05
. O 0 9.039761152962456e-07

In O 0 1.070521449264561e-07
conclusion O 0 1.790981372096212e-07
, O 0 6.299513355401132e-09
our O 0 9.23723852963576e-09
data O 0 2.190774672783391e-09
suggest O 0 7.995592521403694e-10
that O 0 4.251078933315e-10
DMPK O 0 0.002265175338834524
is O 0 1.1703892299763652e-09
involved O 0 4.5956530247970306e-10
in O 0 1.5721149382308397e-10
modulating O 0 1.638597879605186e-08
the O 0 1.8600666562562651e-09
initial O 0 1.5723916613197275e-09
events O 0 6.120639411966167e-11
of O 0 3.312979612868361e-10
excitation O 0 4.0950831703412405e-07
- O 0 7.718842311987828e-07
contraction O 0 2.2376225317088938e-08
coupling O 0 2.8125395346023652e-08
in O 0 2.9431554970926754e-09
skeletal O 0 1.3403337106865365e-06
muscle O 0 4.8181007628045336e-08
. O 0 1.5987145829399196e-08
. O 0 9.909489762094381e-08

Constitutional O 0 7.288213237188756e-05
RB1 O 0 0.015057430602610111
- O 0 1.4277861737355124e-05
gene O 0 8.136517237744556e-09
mutations O 0 7.067184060183251e-10
in O 0 7.45293549098136e-11
patients O 0 1.5202371583811214e-09
with O 0 9.972715986350522e-10
isolated O 0 2.012392542383168e-06
unilateral B-Disease 0 6.827803736086935e-05
retinoblastoma I-Disease 1 1.0
. O 0 2.8784888854715973e-05

In O 0 6.469108626561137e-08
most O 0 4.733260006162254e-09
patients O 0 2.0811263823361514e-09
with O 0 4.23859447540309e-10
isolated O 0 1.0038833408998471e-07
unilateral B-Disease 0 2.2474896468338557e-06
retinoblastoma I-Disease 1 0.9999998807907104
, O 0 3.6368099642913876e-08
tumor B-Disease 0 4.229194701110828e-07
development O 0 3.949555349436196e-09
is O 0 2.6623876714371164e-11
initiated O 0 2.8750196667814976e-10
by O 0 9.741409935648537e-12
somatic O 0 8.447771371322688e-09
inactivation O 0 4.541215758990802e-08
of O 0 5.146985615489541e-10
both O 0 4.998780209208853e-11
alleles O 0 1.353351736232966e-10
of O 0 1.2042615793461664e-09
the O 0 1.377870439966955e-08
RB1 O 0 4.762802200275473e-05
gene O 0 9.154559421631348e-08
. O 0 1.599340464508714e-07

However O 0 9.51066994048233e-08
, O 0 8.173143828393847e-10
some O 0 2.868095171082441e-11
of O 0 4.293746469485882e-10
these O 0 1.18093909651229e-10
patients O 0 1.9402970341531045e-09
can O 0 1.8052194183937331e-09
transmit O 0 1.0575607802820741e-06
retinoblastoma B-Disease 0 0.032405655831098557
predisposition O 0 5.622789467452094e-05
to O 0 2.9118490729729274e-08
their O 0 1.124028088383966e-07
offspring O 0 9.529782801109832e-06
. O 0 2.3740498988900072e-07

To O 0 4.532614283903058e-08
determine O 0 9.840606551847486e-09
the O 0 3.0195201894400725e-09
frequency O 0 7.274590707595507e-09
and O 0 2.1856481902116087e-10
nature O 0 5.599246621912357e-10
of O 0 2.843103530381086e-09
constitutional O 0 2.2957146939006634e-07
RB1 O 0 0.0003640374925453216
- O 0 1.9612164692262013e-07
gene O 0 5.950791526210253e-10
mutations O 0 1.2200562782282987e-10
in O 0 2.1661745314149883e-11
patients O 0 4.69964900329245e-10
with O 0 2.601215909336929e-10
isolated O 0 1.332646348828348e-07
unilateral B-Disease 0 1.4455550854108878e-06
retinoblastoma I-Disease 1 0.9994402527809143
, O 0 4.623614380250274e-09
we O 0 1.03433907272521e-10
analyzed O 0 8.44966457913543e-11
DNA O 0 9.42718569874046e-10
from O 0 3.174778218095753e-10
peripheral O 0 8.752300573178218e-07
blood O 0 3.6028410477229045e-08
and O 0 1.4564959016638568e-08
from O 0 5.805888747545396e-08
tumor B-Disease 0 5.4343443480320275e-05
tissue O 0 8.332480319950264e-06
. O 0 2.728884567204659e-07

The O 0 4.1120247828985157e-07
analysis O 0 8.704771659040489e-08
of O 0 3.060311541958072e-07
tumors B-Disease 1 1.0
from O 0 1.329041765529837e-07
54 O 0 1.7116416017870506e-07
( O 0 1.3328740333662381e-09
71 O 0 3.126145387000179e-08
% O 0 9.29825327844469e-10
) O 0 1.5582450607620757e-10
of O 0 4.02539512833755e-09
76 O 0 7.020650514277804e-07
informative O 0 2.3614493471768583e-08
patients O 0 7.315708039357105e-09
showed O 0 1.43556988518867e-09
loss O 0 1.3854311475824943e-08
of O 0 6.002573371688413e-08
constitutional O 0 8.468561281915754e-05
heterozygosity O 1 1.0
( O 0 0.00018352767801843584
LOH O 1 1.0
) O 0 1.5452181756359096e-08
at O 0 3.902464129623695e-08
intragenic O 0 4.884564987150952e-06
loci O 0 9.315157853961864e-07
. O 0 3.5407526866038097e-07

Three O 0 1.9867243850058003e-07
of O 0 1.8260091394495248e-07
13 O 0 4.378805158467003e-07
uninformative O 0 0.033622533082962036
patients O 0 2.7719372610590653e-06
had O 0 2.5238080070266733e-07
constitutional O 0 2.68558801508334e-06
deletions O 0 1.387921474815812e-05
. O 0 1.105162596104492e-06

For O 0 4.1439517417529714e-07
39 O 0 3.2771728797342803e-07
randomly O 0 7.439479254855996e-09
selected O 0 1.195407293153039e-07
tumors B-Disease 1 1.0
, O 0 5.9441269684157305e-08
SSCP O 1 0.9999922513961792
, O 0 8.286988162353737e-08
hetero O 0 9.691880222817417e-06
- O 0 6.20553123553691e-07
duplex O 0 1.2242399805018067e-07
analysis O 0 2.1295597230075458e-10
, O 0 1.549876720019494e-11
sequencing O 0 7.343622931976768e-10
, O 0 3.587516395064938e-11
and O 0 1.6965705229576855e-10
Southern O 0 1.966714968659744e-08
blot O 0 2.8998974244132114e-07
analysis O 0 4.088284710768164e-10
were O 0 5.756897389352922e-11
used O 0 1.2093316625882977e-10
to O 0 2.2527582577147598e-10
identify O 0 9.65675273079114e-09
mutations O 0 1.335715325012643e-07
. O 0 3.6426001770450966e-07

Mutations O 0 2.42119938320684e-07
were O 0 2.981145996727719e-08
detected O 0 3.547417293248145e-08
in O 0 7.754059061504393e-10
21 O 0 1.0900643054867487e-08
( O 0 9.925920085862572e-10
91 O 0 5.640585243327223e-08
% O 0 2.5742832310271524e-09
) O 0 6.712319589041726e-10
of O 0 9.170795323143466e-08
23 O 0 0.00031182399834506214
tumors B-Disease 1 1.0
with O 0 0.464469850063324
LOH O 1 1.0
. O 0 5.415353371063247e-05

In O 0 6.191698389557132e-07
6 O 0 3.977756932727061e-07
( O 0 1.682774697364664e-09
38 O 0 9.606141659901368e-09
% O 0 7.458371142909925e-10
) O 0 9.218295571322699e-10
of O 0 6.627788451396555e-08
16 O 0 2.8305006708251312e-05
tumors B-Disease 1 1.0
without O 1 0.9745168685913086
LOH O 1 1.0
, O 0 2.1892456736338772e-09
one O 0 1.3030605761077396e-10
mutation O 0 6.505899291520123e-11
was O 0 8.818130670107394e-10
detected O 0 4.0780437360332655e-10
, O 0 2.4658169603397617e-11
and O 0 1.1830424140324425e-10
in O 0 4.131792130657175e-10
9 O 0 3.256050717936887e-08
( O 0 3.8907099764173836e-10
56 O 0 3.850360030810407e-09
% O 0 2.064433901605156e-10
) O 0 1.1227087315379691e-10
of O 0 1.0634795266639685e-08
the O 0 4.00261569666327e-06
tumors B-Disease 1 1.0
without O 1 0.9978087544441223
LOH O 1 1.0
, O 0 1.6250362167014032e-09
both O 0 1.0891549467872963e-10
mutations O 0 4.069131698258843e-10
were O 0 2.393799825028964e-09
found O 0 5.414757531241321e-09
. O 0 5.7700212607869616e-08

Thus O 0 6.725878165525501e-07
, O 0 7.493352605081327e-09
a O 0 1.2999680221170706e-09
total O 0 1.2604621513201408e-10
of O 0 7.608260133018518e-10
45 O 0 1.3588514757856274e-09
mutations O 0 1.9302041909252665e-10
were O 0 4.5272355309045054e-10
identified O 0 4.389765884127428e-09
in O 0 5.961836802015341e-09
tumors B-Disease 1 1.0
of O 0 2.2726600946043618e-05
36 O 0 3.454838861216558e-06
patients O 0 1.013112182590703e-06
. O 0 3.5115036212118866e-07

Thirty O 0 9.555301403452177e-06
- O 0 9.107516234507784e-07
nine O 0 1.7104920146948643e-08
of O 0 3.0510372006631314e-09
the O 0 9.7878127824913e-10
mutations O 0 9.06831887359516e-10
- O 0 2.043562652431774e-08
including O 0 1.2236855972957983e-09
34 O 0 1.2519144831912854e-08
small O 0 9.678856605077613e-10
mutations O 0 1.7848552635868487e-09
, O 0 8.495142922448906e-10
2 O 0 1.3595261805221526e-08
large O 0 3.888397603901694e-09
structural O 0 1.934498186528799e-06
alterations O 0 1.3590392882179003e-05
, O 0 6.2365810293840696e-09
and O 0 4.092484129358809e-09
hypermethylation O 0 0.034317631274461746
in O 0 3.916452939733972e-08
3 O 0 3.0861874620313756e-06
tumors O 1 1.0
- O 0 2.6467776024219347e-06
were O 0 2.207493965400431e-09
not O 0 1.320167031249042e-10
detected O 0 1.9237291759566233e-09
in O 0 2.169556895248448e-11
the O 0 6.163540511305854e-11
corresponding O 0 1.6743353370429759e-09
peripheral O 0 5.329324721969897e-06
blood O 0 2.0045456494699465e-07
DNA O 0 1.7969915688809124e-06
. O 0 1.7540075702981994e-07

In O 0 6.247602186704171e-07
6 O 0 1.2363263977022143e-06
( O 0 4.818153431784822e-09
17 O 0 5.734656305378394e-09
% O 0 3.9041356258984194e-10
) O 0 9.613152635035149e-11
of O 0 1.6259570356780273e-09
the O 0 5.946323877736859e-09
36 O 0 2.350511785209619e-08
patients O 0 8.295777398359405e-09
, O 0 3.862995756609422e-10
a O 0 1.3201147952557335e-09
mutation O 0 1.4322742991623727e-09
was O 0 1.2592473730421716e-08
detected O 0 1.918291747671219e-09
in O 0 3.146923693853054e-11
constitutional O 0 1.4078868071365491e-09
DNA O 0 8.941791307393032e-09
, O 0 1.246319020209441e-10
and O 0 1.4556307548208025e-10
1 O 0 4.156566646429383e-09
of O 0 1.2171980090514012e-09
these O 0 2.3596999354502657e-10
mutations O 0 6.664048757265562e-10
is O 0 2.8149075084749065e-11
known O 0 1.6186503526416374e-10
to O 0 3.8340282337845366e-11
be O 0 5.3964614027401936e-11
associated O 0 1.1205656402779596e-09
with O 0 3.052327557373502e-10
reduced O 0 2.458453138842742e-07
expressivity O 0 0.00030362282996065915
. O 0 2.5742360776348505e-07

The O 0 3.4643036883608147e-07
presence O 0 2.608935290027148e-08
of O 0 3.3120603148972805e-08
a O 0 6.577889344328014e-09
constitutional O 0 4.226601646450945e-08
mutation O 0 5.384643397832178e-09
was O 0 4.477686665893543e-09
not O 0 2.385302025342817e-11
associated O 0 2.313953195720586e-10
with O 0 2.6746695136470322e-11
an O 0 6.466138735561344e-11
early O 0 2.1447911890959404e-08
age O 0 9.972416670223083e-09
at O 0 1.0990895304985315e-08
treatment O 0 3.7500154803637997e-07
. O 0 2.721306202602136e-07

In O 0 2.9646008670169977e-07
1 O 0 5.120709261063894e-07
patient O 0 2.2687804346332996e-07
, O 0 9.841131465293529e-09
somatic O 0 0.000113971225800924
mosaicism O 1 0.9999388456344604
was O 0 5.545937256101752e-07
demonstrated O 0 2.032995105594182e-09
by O 0 1.2657133154070355e-11
molecular O 0 2.6406526965061516e-10
analysis O 0 4.6806551690092846e-11
of O 0 1.4562610839430334e-10
DNA O 0 1.873897481630138e-09
and O 0 1.9528077765951224e-10
RNA O 0 2.9149607172485048e-08
from O 0 2.0213142271074958e-09
peripheral O 0 4.200701368972659e-06
blood O 0 2.1623020529659698e-07
. O 0 1.9914894267003547e-07

In O 0 4.710512939709588e-07
2 O 0 7.337321221712045e-07
patients O 0 1.7489188763875063e-08
without O 0 3.787969937718572e-09
a O 0 4.401797149000686e-09
detectable O 0 1.0437640440841278e-07
mutation O 0 3.023819639125236e-09
in O 0 3.646286883540739e-10
peripheral O 0 4.2292895159334876e-06
blood O 0 2.3568196638734662e-07
, O 0 4.368241768304415e-09
mosaicism O 0 7.217185338959098e-05
was O 0 3.007313864600292e-08
suggested O 0 4.97641761132428e-10
because O 0 1.7652750095020764e-10
1 O 0 2.7277946568204925e-09
of O 0 1.9132966322388256e-09
the O 0 1.403602922778191e-08
patients O 0 3.3664363741081615e-07
showed O 0 6.978123678891279e-07
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 7.270030266681715e-08
the O 0 7.577533267522085e-09
other O 0 3.485129684843713e-10
later O 0 1.7282532738249756e-08
developed O 0 2.2755932604923146e-07
bilateral B-Disease 0 6.371004474203801e-06
retinoblastoma I-Disease 1 0.996048629283905
. O 0 2.6397699457447743e-06

In O 0 9.054707561517716e-08
conclusion O 0 1.5679576392813033e-07
, O 0 3.8030205651296e-09
our O 0 3.831517325636469e-09
results O 0 5.151984949769428e-10
emphasize O 0 4.180482626736648e-09
that O 0 6.579249645088936e-11
the O 0 1.6650266720930063e-09
manifestation O 0 1.1644756341411266e-06
and O 0 1.1465097315976891e-08
transmissibility O 0 0.00014015365741215646
of O 0 1.4719796581630362e-07
retinoblastoma B-Disease 0 3.7233759940136224e-05
depend O 0 6.483981707106068e-08
on O 0 7.159610238005598e-09
the O 0 2.0958323965203363e-10
nature O 0 1.9325765987510124e-10
of O 0 2.9202054663279853e-10
the O 0 1.6226782417749774e-10
first O 0 8.05550209870276e-11
mutation O 0 6.367930488471174e-11
, O 0 2.2151256523494922e-11
its O 0 5.087329169040089e-11
time O 0 1.509450481274044e-10
in O 0 4.876356610172827e-11
development O 0 9.097284592307631e-10
, O 0 3.085479788333956e-11
and O 0 7.785235650592526e-11
the O 0 3.5294073219560573e-10
number O 0 1.7200097249259194e-11
and O 0 5.381433840212502e-11
types O 0 3.5094571693150556e-10
of O 0 1.3311234337010092e-09
cells O 0 4.716810275695593e-10
that O 0 2.4062855874529276e-11
are O 0 2.482498755174145e-11
affected O 0 5.934435720611475e-10
. O 0 4.156273103461672e-09
. O 0 5.684966097874167e-08

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 0 0.4076356291770935
the I-Disease 0 6.1493792600231245e-06
fifth I-Disease 0 1.8664593426365172e-06
component I-Disease 0 1.3594411996109557e-07
of I-Disease 0 1.8522646527685538e-08
complement I-Disease 0 1.2424402484612074e-07
in O 0 6.802481067325061e-08
man O 0 6.332938028208446e-06
. O 0 7.636609211658651e-07

I O 0 0.00512591702863574
. O 0 1.5796595107531175e-05

Clinical O 0 3.2703359465813264e-05
, O 0 1.5318902057970263e-07
immunochemical O 0 0.0003960340400226414
, O 0 1.2583734054771867e-08
and O 0 6.937769914117098e-09
family O 0 3.292321437697865e-08
studies O 0 1.0319045173901031e-08
. O 0 4.96232814839459e-08

The O 0 5.016840987082105e-07
first O 0 3.630087519468361e-08
recognized O 0 1.7989165712606336e-08
human O 0 2.683457545060719e-08
kindred O 0 0.07059277594089508
with O 0 6.16946493892101e-08
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9999969005584717
the I-Disease 0 7.512653974117711e-05
fifth I-Disease 0 1.463039893678797e-06
component I-Disease 0 4.50656294503915e-08
of I-Disease 0 7.49159578816716e-09
complement I-Disease 0 1.2490146161781013e-07
( O 0 1.9906728709884192e-07
C5 O 1 0.9990909099578857
) O 0 2.3009973926235716e-09
is O 0 1.0176239850778757e-09
described O 0 2.467321280619217e-08
. O 0 5.86914126188276e-08

The O 0 4.4116518438386265e-06
proband O 0 6.897078856127337e-05
, O 0 1.1327008664352434e-08
a O 0 1.0310230891263927e-08
20 O 0 9.611016871247102e-09
- O 0 5.75317429252209e-08
year O 0 1.881591593644316e-08
- O 0 3.7019924548076233e-06
old O 0 7.419256689900067e-06
black O 0 1.4928170699590737e-08
female O 0 7.649789690589159e-10
with O 0 9.905229969575657e-10
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9999988079071045
age O 0 6.160781822472927e-07
11 O 0 9.831019553985243e-09
, O 0 1.4923230706731516e-10
lacked O 0 6.142611397308428e-08
serum O 0 2.8698650567093864e-07
hemolytic O 0 0.14685136079788208
complement O 0 8.630625814021187e-08
activity O 0 2.301695278816851e-09
, O 0 9.926349325839467e-11
even O 0 1.881934053038492e-10
during O 0 5.720804274744751e-09
remission O 0 8.543506169189641e-07
. O 0 7.478078600797744e-08

C5 O 1 0.9981688261032104
was O 0 6.992524959059665e-06
undetectable O 0 2.1416246909211623e-06
in O 0 1.9090935499121997e-09
her O 0 5.190372021068868e-10
serum O 0 6.947250774658187e-09
by O 0 2.185423231271244e-10
both O 0 2.2815063172032524e-09
immunodiffusion O 0 2.0990060875192285e-05
and O 0 1.1702228874810316e-07
hemolytic O 1 1.0
assays O 0 0.036186154931783676
. O 0 5.397202585299965e-06

Other O 0 3.767759793049663e-08
complement O 0 3.025240147280783e-08
components O 0 3.4129367776358777e-08
were O 0 9.131009282015157e-10
normal O 0 8.1839846011178e-10
during O 0 9.169247583429296e-10
remission O 0 3.7442831057887815e-08
of O 0 9.903571296376867e-09
lupus O 0 0.004025534261018038
, O 0 3.0759050861917103e-09
but O 0 1.6406015435066479e-09
C1 O 0 6.061693511583144e-07
, O 0 1.435298879748359e-09
C4 O 0 1.927967332449043e-06
, O 0 8.982830590475999e-10
C2 O 0 1.606911439466785e-07
, O 0 1.0619303214554066e-09
and O 0 1.12567963839183e-08
C3 O 1 0.8505990505218506
levels O 0 3.499138188090001e-07
fell O 0 4.4463577069109306e-05
during O 0 3.2231295676865557e-07
exacerbations O 1 0.995890200138092
. O 0 1.5551164551652619e-06

A O 0 1.703017005638685e-05
younger O 0 3.449755467954674e-06
half O 0 4.5346203592089296e-07
- O 0 2.913810249083326e-06
sister O 0 3.3476831049483735e-06
, O 0 3.1580627002369965e-09
who O 0 3.599995634928632e-09
had O 0 4.7695833949035205e-09
no O 0 2.6155704269115176e-09
underlying O 0 0.024815047159790993
disease O 1 0.9879159927368164
, O 0 2.154334710624539e-09
was O 0 7.721921235770424e-08
also O 0 8.696798281526696e-10
found O 0 7.887668296291395e-10
to O 0 2.470937010556895e-09
lack O 0 2.208898513345048e-05
immunochemically O 1 0.9996687173843384
detectable O 0 0.3886392116546631
C5 O 1 0.9998364448547363
. O 0 1.7065477777578053e-06

By O 0 1.8299525095244462e-07
hemolytic O 1 0.999996542930603
assay O 0 0.002255868399515748
, O 0 1.0399546113148972e-07
she O 0 2.4373938423138952e-09
exhibited O 0 2.2901434082456262e-09
1 O 0 2.2060007154323102e-08
- O 0 6.67130422016271e-08
2 O 0 3.5590471014756986e-08
% O 0 4.505578965474655e-10
of O 0 1.302425167715171e-09
the O 0 1.524211867831582e-09
normal O 0 7.262210832692517e-09
serum O 0 3.488632103199052e-07
C5 O 0 8.416946002398618e-06
level O 0 3.7616545434104864e-09
and O 0 7.535440327277598e-11
normal O 0 1.0386289744923616e-10
concentrations O 0 4.0905623333031826e-10
of O 0 1.49496970358598e-10
other O 0 5.392109328483663e-11
complement O 0 1.1897327567567118e-08
components O 0 2.450962256261846e-06
. O 0 3.521426776842418e-07

C5 O 1 0.9601682424545288
levels O 0 1.1719640014007382e-07
of O 0 2.1411779016489163e-08
other O 0 6.487996251358652e-10
family O 0 2.1499917401968105e-09
members O 0 7.824237785447608e-11
were O 0 1.2347017852576414e-10
either O 0 2.456865544342435e-10
normal O 0 1.6608843189658273e-09
or O 0 5.587468820955621e-10
approximately O 0 8.792028216575432e-11
half O 0 3.2075486711136136e-10
- O 0 3.7930232288374555e-09
normal O 0 7.016495162659453e-10
, O 0 3.641871526571805e-11
consistent O 0 4.897854344321217e-10
with O 0 2.5749152809950715e-10
autosomal O 0 1.3644365992604435e-07
codominant O 0 4.708115284302039e-06
inheritance O 0 5.449978601745897e-08
of O 0 7.3403074729583295e-09
the O 0 4.637330075496493e-09
gene O 0 2.6618840465175708e-08
determining O 0 7.267361183949106e-07
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.0653111530700698e-05

Normal O 0 1.4919090972398408e-05
hemolytic O 1 0.9998478889465332
titers O 0 0.005598803050816059
were O 0 4.159345508014667e-07
restored O 0 2.03127683562343e-06
to O 0 3.801091441602011e-09
both O 0 1.0822375884345092e-08
homozygous O 0 5.784295808552997e-06
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 1.3217490959505085e-05
C5D B-Disease 1 1.0
) O 0 1.751656242277022e-08
sera O 0 3.057178332710464e-08
by O 0 2.3718551428464352e-11
addition O 0 1.0738615552341457e-10
of O 0 4.514820073353576e-09
highly O 0 5.927178747811013e-08
purified O 0 5.574614760917029e-07
human O 0 1.4245870261220261e-07
C5 O 0 0.001209816662594676
. O 0 7.546503297817253e-07

In O 0 1.10616689141807e-07
specific O 0 6.20419342567402e-08
C5 O 0 0.0007137191714718938
titrations O 0 7.2163002187153324e-06
, O 0 1.951230288455008e-09
however O 0 1.7159350607087731e-09
, O 0 3.5726868685692637e-10
it O 0 9.592455302298575e-11
was O 0 5.28710586422676e-09
noted O 0 3.833291739585576e-10
that O 0 1.0320801505092625e-11
when O 0 1.9137008644420916e-10
limited O 0 2.4406118792619225e-10
amounts O 0 1.1887522077813628e-09
of O 0 1.0766518343530151e-08
C5 O 0 4.308495044824667e-05
were O 0 4.7220249932422576e-09
assayed O 0 1.2602374255266113e-08
in O 0 3.460170691638176e-11
the O 0 9.609852497094451e-11
presence O 0 1.7986266642733284e-10
of O 0 3.6080864962428905e-09
low O 0 1.9905762371763558e-07
dilutions O 0 2.2283595171757042e-05
of O 0 3.4083637245885257e-08
either O 0 7.328265638761877e-08
C5D B-Disease 1 1.0
serum O 0 5.756060659223294e-07
, O 0 3.3310759706139947e-10
curving O 0 3.1356508500834934e-09
rather O 0 1.0984597259566797e-10
than O 0 1.7761696627371926e-11
linear O 0 4.3396888860236515e-10
dose O 0 6.08476256047652e-08
- O 0 1.7403966268147997e-08
response O 0 5.647339818004582e-10
plots O 0 8.022666087015295e-09
were O 0 2.588294023553317e-10
consistently O 0 2.734820980787589e-10
obtained O 0 4.5279585636492925e-11
, O 0 1.8102309581879972e-11
suggesting O 0 3.179274621345485e-10
some O 0 1.3059268944015656e-10
inhibitory O 0 3.609251209013564e-08
effect O 0 2.8616080172128022e-08
. O 0 8.066707124498862e-08

Further O 0 1.0410283124429043e-07
studies O 0 4.279946619334396e-09
suggested O 0 2.3551014471934195e-09
that O 0 8.810745188991831e-11
low O 0 1.1408146605162983e-07
dilutions O 0 0.02550421468913555
of O 0 7.787184586049989e-06
C5D B-Disease 1 1.0
serum O 0 1.7748773188941414e-06
contain O 0 5.441821659957213e-09
a O 0 1.95505989175615e-09
factor O 0 7.302933813235768e-10
( O 0 9.111276316753347e-11
or O 0 1.0649033044263234e-10
factors O 0 4.306878187421148e-10
) O 0 2.3945842531070127e-10
interfering O 0 3.625352906766466e-09
at O 0 1.0350698076422304e-09
some O 0 3.6333516056918924e-11
step O 0 1.9794190730948458e-09
in O 0 1.6622207776872955e-10
the O 0 2.371549845392451e-09
hemolytic O 0 0.007515003439038992
assay O 0 3.753336568479426e-05
of O 0 4.379994425107725e-05
C5 O 1 0.9996007084846497
, O 0 5.126332136562439e-10
rather O 0 2.2586611747588137e-10
than O 0 7.560186504607103e-11
a O 0 1.329395593607785e-09
true O 0 8.336402856912173e-08
C5 O 0 0.0010646136943250895
inhibitor O 0 8.234479196289612e-07
or O 0 1.6183527407065412e-08
inactivator O 0 3.19858850161836e-06
. O 0 4.007685561191465e-08

Of O 0 2.09900440495403e-06
clinical O 0 3.928231762984069e-06
interest O 0 3.4303553775316686e-08
are O 0 2.5548527182728265e-10
( O 0 2.9606753160216215e-10
a O 0 6.129427521095465e-10
) O 0 7.299322951626053e-11
the O 0 3.7387987150694357e-10
documentation O 0 3.909847379190978e-08
of O 0 1.6498083255100937e-07
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 0 9.757101224749931e-07
vasculitis B-Disease 1 1.0
, O 0 1.5006827425168012e-07
and O 0 3.415109858906362e-06
arthritis B-Disease 1 1.0
in O 0 3.16804943167881e-07
an O 0 7.040867333607537e-10
individual O 0 2.0633945940762288e-10
lacking O 0 5.248163233773084e-06
C5 O 1 0.9805755615234375
( O 0 1.3077920968385115e-09
and O 0 2.027425588524423e-10
its O 0 4.343332360434715e-10
biologic O 0 3.0122654948172567e-07
functions O 0 1.7460406731562017e-10
) O 0 1.099666625120621e-11
, O 0 7.909505515824033e-12
and O 0 7.375497435013756e-11
( O 0 2.6886498583067464e-10
b O 0 1.478033517798849e-08
) O 0 2.1325269328187346e-10
a O 0 5.266621028177099e-10
remarkable O 0 1.3603503878911738e-09
propensity O 0 1.1077968764539037e-07
to O 0 3.457014230434652e-09
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 1.7561850862435335e-09
the O 0 1.359240275888851e-09
proband O 0 1.3569000145707832e-07
, O 0 4.216868174089505e-11
even O 0 4.945030496195102e-11
during O 0 3.5192973535380645e-10
periods O 0 1.849299380296543e-08
of O 0 4.086680771564488e-09
low O 0 4.42261125499499e-08
- O 0 2.710307089870412e-09
dose O 0 8.748076929521176e-09
or O 0 5.675924175108094e-10
alternate O 0 1.149557693480574e-08
- O 0 7.993130424210904e-08
day O 0 1.3134423326732758e-08
corticosteroid O 0 9.316622708865907e-06
therapy O 0 6.456378287111875e-06
. O 0 1.284787458644132e-07

Other O 0 4.6497500960640537e-08
observations O 0 2.251115560625294e-08
indicate O 0 1.3153294009526917e-09
that O 0 3.7265318608703524e-10
the O 0 1.650394665375643e-08
C5D B-Disease 1 1.0
state O 0 3.2127240867652063e-09
is O 0 1.7089771264799936e-10
compatible O 0 1.3284128463908473e-08
with O 0 1.1589130349820564e-10
normal O 0 3.6186653673553337e-09
coagulation O 0 4.8588169931917946e-08
function O 0 2.243688845826597e-10
and O 0 5.147807527472459e-11
the O 0 1.753412970373347e-10
capacity O 0 8.619299163292737e-10
to O 0 7.995378803471453e-10
mount O 0 2.786974391710828e-06
a O 0 1.4331816089452332e-07
neutrophilic O 0 0.012354356236755848
leukocytosis O 0 0.0005793587770313025
during O 0 1.7680572454992216e-06
pyogenic B-Disease 0 0.0008162883459590375
infection I-Disease 0 3.111908881692216e-06
. O 0 7.882423602723065e-09
. O 0 5.749477693939298e-08

Susceptibility O 0 0.00017609044152777642
to O 0 4.554301995085552e-06
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 0.0005908672465011477
twins O 0 0.00010444144572829828
: O 0 4.133234865477675e-10
the O 0 6.471373437122452e-10
role O 0 2.1712893705228e-09
of O 0 2.835840895443198e-09
genes O 0 1.4789182101182519e-09
, O 0 8.918554228465325e-10
HLA O 0 8.056577826209832e-06
, O 0 6.370509675335256e-10
and O 0 1.354483636362147e-09
the O 0 1.99445011617172e-08
environment O 0 2.8432063459149504e-07
. O 0 9.977405568406539e-08

OBJECTIVE O 0 9.326605322712567e-06
To O 0 7.887025255115532e-09
determine O 0 5.1476849449727524e-09
the O 0 1.295858642613723e-09
relative O 0 3.420065652903759e-08
effects O 0 1.4559549299519858e-07
of O 0 2.0588913685060106e-08
genetic O 0 9.836180936417804e-08
and O 0 3.92823218398064e-10
environmental O 0 1.6196828322989631e-09
factors O 0 4.262540667654413e-11
in O 0 1.7671877849956275e-11
susceptibility O 0 4.4687389788578e-08
to O 0 6.585285916571593e-08
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.999998927116394
AS B-Disease 1 1.0
) O 0 1.8714693794663617e-08
. O 0 2.6069754355262376e-08

METHODS O 0 1.115707891585771e-05
Twins O 0 4.621567131835036e-05
with O 0 1.2162563400863746e-08
AS B-Disease 1 0.9999158382415771
were O 0 4.220807259258663e-09
identified O 0 1.3405865306737041e-09
from O 0 1.9643811577374493e-10
the O 0 1.050826425874618e-09
Royal O 0 2.1056077059711242e-07
National O 0 1.237272595489003e-08
Hospital O 0 6.320662464531779e-07
for O 0 1.6258019375214872e-09
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 0 1.0834749446075875e-05
. O 0 1.9826220523100346e-06

Clinical O 0 1.830565270211082e-05
and O 0 6.894045156968787e-08
radiographic O 0 2.3020686057861894e-05
examinations O 0 1.0303369890607428e-06
were O 0 1.0140381867529413e-08
performed O 0 3.318304520050219e-10
to O 0 3.793923855632819e-11
establish O 0 3.2943359151715867e-09
diagnoses O 1 0.8929044008255005
, O 0 2.0387934895893522e-08
and O 0 2.0654402632658275e-08
disease O 0 0.0012577867601066828
severity O 1 0.9399123787879944
was O 0 1.0672874850570224e-06
assessed O 0 7.5548607370024e-09
using O 0 1.732135823662162e-10
a O 0 2.124902059863487e-10
combination O 0 7.227333398418523e-09
of O 0 4.6533699560313835e-08
validated O 0 4.840857741328364e-07
scoring O 0 1.7658939555076358e-07
systems O 0 1.7492946426500566e-05
. O 0 3.7299562904991035e-07

HLA O 0 0.0005032053450122476
typing O 0 5.445850092655746e-06
for O 0 9.612981699547163e-08
HLA O 0 4.829159024666296e-06
- O 0 9.121040989157336e-07
B27 O 0 3.83901806344511e-06
, O 0 1.0383288895354781e-08
HLA O 0 6.881629133204115e-07
- O 0 1.5436312139627262e-07
B60 O 0 4.523597567640536e-07
, O 0 1.165846419404204e-09
and O 0 2.1435548891446388e-09
HLA O 0 2.7941150619881228e-05
- O 0 6.232448868104257e-06
DR1 O 0 0.0027142995968461037
was O 0 8.762522263339179e-09
performed O 0 1.2467375742897246e-10
by O 0 2.195892946643685e-11
polymerase O 0 4.690036803367548e-08
chain O 0 3.213012078617794e-09
reaction O 0 1.501135882264748e-10
with O 0 3.064249201600866e-11
sequence O 0 1.6830274673917955e-10
- O 0 6.579253808425278e-10
specific O 0 5.313942341711453e-11
primers O 0 1.767635460225847e-08
, O 0 1.206840738454673e-10
and O 0 5.401324942866381e-10
zygosity O 0 9.874430588752148e-07
was O 0 3.4664839887454946e-08
assessed O 0 3.9646224081479886e-08
using O 0 3.182390173606109e-08
microsatellite O 0 1.094792241929099e-05
markers O 0 7.924074907350587e-07
. O 0 4.3729087906285713e-07

Genetic O 0 6.0690849750244524e-06
and O 0 3.590664121588816e-08
environmental O 0 2.84824519525273e-08
variance O 0 8.3058626643151e-09
components O 0 2.7117096124129603e-08
were O 0 1.6949931458398737e-09
assessed O 0 1.2726022013964666e-08
with O 0 2.065158460906602e-10
the O 0 6.0895084530443455e-09
program O 0 1.2957778849909118e-08
Mx O 0 1.220921745925807e-07
, O 0 1.7676899874419227e-11
using O 0 1.0874356970447252e-11
data O 0 3.700732775779869e-11
from O 0 1.458932107067934e-11
this O 0 1.0675628783762825e-11
and O 0 3.7487436765903936e-11
previous O 0 3.51474266357954e-10
studies O 0 8.653392585822317e-11
of O 0 1.1636026586714365e-09
twins O 0 2.0678533019236056e-07
with O 0 4.3839172292337025e-09
AS B-Disease 1 1.0
. O 0 3.6344845284475014e-06

RESULTS O 0 1.0408491561975097e-06
Six O 0 2.5690516736176505e-07
of O 0 1.8259918022067723e-07
8 O 0 6.646270662713505e-07
monozygotic O 0 0.00016489178233314306
( O 0 2.068504301178109e-07
MZ O 1 0.8925116658210754
) O 0 5.165171845789018e-09
twin O 0 1.9903768588847015e-07
pairs O 0 6.000209773482368e-10
were O 0 8.459908884539402e-10
disease O 0 8.571157650294481e-08
concordant O 0 5.599899395747343e-06
, O 0 8.749991842194049e-10
compared O 0 1.1460761228931915e-09
with O 0 4.089875937918208e-10
4 O 0 6.163877941389728e-08
of O 0 8.030340126197189e-08
15 O 0 6.115688933050478e-08
B27 O 0 5.384655423767981e-07
- O 0 6.722293477423591e-08
positive O 0 1.7623391634913332e-09
dizygotic O 0 2.1944408672425197e-06
( O 0 1.9550085994524125e-08
DZ O 0 1.0312874110240955e-05
) O 0 1.6931125390584612e-09
twin O 0 6.373845451435045e-08
pairs O 0 3.4500299839201887e-10
( O 0 4.860147284624361e-10
27 O 0 3.268730397465447e-09
% O 0 3.275044402339944e-10
) O 0 9.863108246799257e-11
and O 0 6.416213671478488e-10
4 O 0 5.8599017194183034e-08
of O 0 6.848763689504267e-08
32 O 0 6.984814717725385e-07
DZ O 0 0.0001652925566304475
twin O 0 4.5996873154763307e-07
pairs O 0 7.684125558071742e-10
overall O 0 5.589987139842378e-09
( O 0 4.986536183970713e-10
12 O 0 2.6846949108261242e-09
. O 0 5.480526032997091e-10
5 O 0 7.251788058937336e-09
% O 0 1.0697285279803737e-09
) O 0 1.6644742251159528e-09
. O 0 4.149463705971357e-08

Nonsignificant O 0 0.000267744850134477
increases O 0 6.376192374091261e-08
in O 0 1.1911966968369825e-09
similarity O 0 8.809628582184814e-09
with O 0 1.3912342111677134e-10
regard O 0 9.682555202061849e-09
to O 0 6.666998064730478e-10
age O 0 1.1747712136411792e-08
at O 0 5.321118212719966e-09
disease O 0 5.006029724086147e-08
onset O 0 0.0035846498794853687
and O 0 1.3775413032490746e-09
all O 0 7.472635704663944e-11
of O 0 9.193782957162e-10
the O 0 1.2162604257071052e-09
disease O 0 2.7419217119017958e-08
severity O 0 1.7171514343772287e-07
scores O 0 2.3127324499938595e-09
assessed O 0 3.1655407184416617e-09
were O 0 2.685784650235945e-10
noted O 0 1.0603273814524528e-09
in O 0 4.962285582443826e-10
disease O 0 5.508438789547654e-07
- O 0 2.059309736068826e-06
concordant O 0 0.0034147934056818485
MZ O 1 0.9999353885650635
twins O 0 3.0421067549468717e-06
compared O 0 1.885356404329741e-08
with O 0 3.8405900681937055e-09
concordant O 0 0.00045813401811756194
DZ O 1 0.9999971389770508
twins O 0 0.0007946580881252885
. O 0 2.7364783363736933e-06

HLA O 0 0.007859108038246632
- O 0 2.643234984134324e-05
B27 O 0 5.315422185958596e-06
and O 0 6.4347847050783e-09
B60 O 0 1.666413425027713e-07
were O 0 4.647714713090778e-10
associated O 0 5.171902350831203e-10
with O 0 6.619289144582652e-11
the O 0 3.504488921279858e-09
disease O 0 1.4898723748046905e-06
in O 0 6.972151189721387e-10
probands O 0 2.477024645486381e-05
, O 0 1.1580379710718347e-10
and O 0 6.87643691987816e-11
the O 0 2.717459313128501e-10
rate O 0 1.6426681126446852e-09
of O 0 5.904225552910702e-09
disease O 0 6.204909368534572e-07
concordance O 0 1.5631532050974783e-06
was O 0 2.1489847767952597e-07
significantly O 0 1.0834293462380629e-08
increased O 0 6.132073515630054e-09
among O 0 4.878157433552133e-09
DZ O 0 1.780889397196006e-05
twin O 0 1.2930971138302993e-07
pairs O 0 1.2652312531002963e-10
in O 0 6.937895397074456e-11
which O 0 1.1161389174008107e-10
the O 0 2.4005029075624407e-09
co O 0 8.399446471685224e-08
- O 0 9.668717382282921e-08
twin O 0 7.00365148986748e-07
was O 0 1.3185577962815387e-08
positive O 0 5.926061724670362e-11
for O 0 1.0478577033845582e-10
both O 0 1.6699309712819854e-09
B27 O 0 2.6398404315841617e-06
and O 0 1.8389798128737311e-07
DR1 O 0 0.008503153920173645
. O 0 4.436069502844475e-07

Additive O 0 1.3552617019740865e-06
genetic O 0 1.9028132669518527e-07
effects O 0 8.169519816192405e-08
were O 0 2.851624714139689e-09
estimated O 0 3.3542066346647914e-10
to O 0 1.9795537431477328e-10
contribute O 0 7.897318354821437e-10
97 O 0 5.112550383046255e-08
% O 0 4.681237619763579e-10
of O 0 3.018199856708037e-10
the O 0 3.9738545787315616e-10
population O 0 6.833144727130813e-12
variance O 0 8.308267407386438e-10
. O 0 9.358342545340292e-09

CONCLUSION O 0 4.150530912738759e-06
Susceptibility O 0 6.510747334687039e-05
to O 0 3.672591049053153e-07
AS B-Disease 1 1.0
is O 0 8.965683306882966e-09
largely O 0 6.2738529926775755e-09
genetically O 0 6.965810150916241e-10
determined O 0 1.1702643298860949e-09
, O 0 8.450518756975001e-11
and O 0 1.0780521614295324e-10
the O 0 5.274462533400026e-10
environmental O 0 4.298386535595e-09
trigger O 0 1.3301794110631704e-09
for O 0 8.692813829869195e-11
the O 0 3.477024446141286e-09
disease O 0 1.0304794159310404e-05
is O 0 1.7438317456708319e-09
probably O 0 9.822008451010333e-08
ubiquitous O 0 1.3328717614058405e-06
. O 0 9.449372839753778e-08

HLA O 0 0.0013534808531403542
- O 0 5.066448011348257e-06
B27 O 0 5.584863060903444e-07
accounts O 0 1.1786691622717171e-09
for O 0 8.848149296580843e-11
a O 0 5.914975731435845e-10
minority O 0 5.887377252378201e-10
of O 0 1.8465985407445373e-09
the O 0 2.730126569261415e-09
overall O 0 2.535508691892119e-09
genetic O 0 1.725921094930527e-08
susceptibility O 0 3.1443312309420435e-07
to O 0 1.9852123500641028e-08
AS B-Disease 1 1.0
. O 0 2.2654473923466867e-06

Cell O 0 1.5358633390860632e-05
cycle O 0 4.358561227491009e-07
- O 0 3.0991597554930195e-07
dependent O 0 7.541115820686173e-08
colocalization O 0 2.6429336230648914e-06
of O 0 3.8035011584725e-08
BARD1 O 0 0.000562317727599293
and O 0 5.948830761326462e-09
BRCA1 O 0 2.33771446644937e-09
proteins O 0 2.6553335918944043e-11
in O 0 3.1430844038560224e-11
discrete O 0 5.091158605807777e-09
nuclear O 0 3.924971281321632e-07
domains O 0 4.1060204125642485e-08
. O 0 4.746316761838898e-08

Germ O 0 0.028039133176207542
- O 0 4.946272019878961e-05
line O 0 3.9803222762202495e-07
mutations O 0 9.655665600405428e-09
of O 0 1.5682292797691844e-08
the O 0 3.106329060642565e-08
BRCA1 O 0 2.9746935581442813e-08
gene O 0 2.4819899469008533e-09
predispose O 0 2.714384983448781e-08
women O 0 1.920229947272034e-11
to O 0 1.115949485597234e-10
early O 0 5.022959044254094e-07
- O 0 0.0002060822444036603
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9999995231628418
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
by O 0 1.3620632399735655e-10
compromising O 0 2.978547186671676e-09
the O 0 3.6239269918247885e-10
genes O 0 3.2327304722024053e-10
presumptive O 0 5.816722818963171e-07
function O 0 2.3736484999759e-10
as O 0 3.1391919619316866e-10
a O 0 2.512521524167255e-09
tumor B-Disease 0 3.1764614050189266e-06
suppressor O 0 0.00010069248673971742
. O 0 9.475874662712158e-07

Although O 0 5.969395147076284e-07
the O 0 1.5447385237621347e-07
biochemical O 0 2.2722890662407735e-06
properties O 0 2.43537442656816e-07
of O 0 4.6972527201205594e-08
BRCA1 O 0 3.831490147376826e-08
polypeptides O 0 2.087631756353403e-08
are O 0 4.07414622871638e-11
not O 0 4.721254637241046e-11
understood O 0 3.5889027305557875e-09
, O 0 6.914657735279661e-11
their O 0 4.461076300033007e-11
expression O 0 5.313772200032929e-10
pattern O 0 1.513972502920069e-09
and O 0 7.546662739166266e-10
subcellular O 0 2.11557903639914e-07
localization O 0 3.610587384628161e-07
suggest O 0 1.8225073672439862e-09
a O 0 9.303859349607535e-10
role O 0 6.035346888921822e-09
in O 0 1.7275273433980942e-09
cell O 0 4.2551801016088575e-07
- O 0 4.576671699396684e-07
cycle O 0 5.2273460227070245e-08
regulation O 0 3.293942256732407e-07
. O 0 6.539961106000192e-08

When O 0 2.115342113029328e-06
resting O 0 2.561195105954539e-05
cells O 0 1.3307591473221692e-07
are O 0 1.1642219410745724e-09
induced O 0 2.018832674366422e-07
to O 0 4.302906031483644e-09
proliferate O 0 8.227596737242493e-08
, O 0 9.131357892044889e-10
the O 0 1.9934982553593272e-09
steady O 0 1.5229108640824052e-08
- O 0 1.0154375118531789e-08
state O 0 1.5269636943759934e-10
levels O 0 4.230533701132799e-10
of O 0 6.808640873323668e-10
BRCA1 O 0 6.559581211540433e-10
increase O 0 5.844991157744062e-11
in O 0 2.2156086687541432e-10
late O 0 2.1489314860900777e-07
G1 O 0 3.3679935995678534e-07
and O 0 1.2804292071066925e-09
reach O 0 1.1210659067728557e-09
a O 0 2.347136096592095e-10
maximum O 0 1.0449224818742664e-09
during O 0 7.0170207422393105e-09
S O 0 1.1132972304039868e-06
phase O 0 1.3914552710048156e-06
. O 0 1.270037159883941e-07

Moreover O 0 3.1490112633036915e-06
, O 0 3.104250367869099e-08
in O 0 6.698331667109869e-09
S O 0 1.5834021951377508e-06
phase O 0 6.802532652727677e-07
cells O 0 4.0504122722495595e-08
, O 0 6.320861611897044e-10
BRCA1 O 0 1.793317938592054e-09
polypeptides O 0 5.1916915211336345e-09
are O 0 5.346546469442437e-11
hyperphosphorylated O 0 7.387926359569974e-08
and O 0 6.937846408483495e-10
accumulate O 0 2.320235914510249e-08
into O 0 1.4364088585239188e-08
discrete O 0 6.634441263031476e-08
subnuclear O 0 1.5830926258786349e-06
foci O 0 7.326043487410061e-07
termed O 0 4.689821935244254e-07
" O 0 8.881928437176612e-08
BRCA1 O 0 8.269035589592022e-08
nuclear O 0 2.0527390915958676e-06
dots O 0 5.97055645812361e-07
. O 0 9.918699106492568e-08

" O 0 1.4389185707841534e-05
BRCA1 O 0 2.8071699489373714e-06
associates O 0 7.058662276904215e-07
in O 0 3.446526175565623e-09
vivo O 0 4.467605307922895e-08
with O 0 2.614412020207624e-10
a O 0 4.168356770861692e-09
structurally O 0 6.679324542346876e-07
related O 0 6.723755774373785e-08
protein O 0 3.328904369936936e-07
termed O 0 2.014731308008777e-06
BARD1 O 0 0.018147418275475502
. O 0 2.4918153940234333e-07

Here O 0 2.076819100693683e-06
we O 0 2.2910489505534315e-08
show O 0 2.0044024218179857e-09
that O 0 6.423729603799444e-11
the O 0 1.115613712521224e-09
steady O 0 3.9959385134125114e-08
- O 0 2.1230567526231425e-08
state O 0 1.9439037879376286e-10
levels O 0 4.5977924245654833e-10
of O 0 1.5324995716881062e-09
BARD1 O 0 8.539111149730161e-05
, O 0 1.4648691981644646e-10
unlike O 0 2.2459882564884737e-10
those O 0 4.223613819798189e-11
of O 0 2.2982691305628578e-09
BRCA1 O 0 7.073930774481596e-09
, O 0 1.308460007010126e-10
remain O 0 8.833971887334258e-10
relatively O 0 7.324751916115702e-10
constant O 0 2.4500437234564743e-09
during O 0 6.673681607338722e-09
cell O 0 1.2234742996497516e-07
cycle O 0 1.2001208915535244e-08
progression O 0 4.4403783761026716e-08
. O 0 2.049996261632714e-08

However O 0 1.0119573516931268e-06
, O 0 6.557860388056724e-08
immunostaining O 0 1.6124473404488526e-05
revealed O 0 4.1341306200592953e-07
that O 0 5.780449896519713e-09
BARD1 O 1 0.9078893661499023
resides O 0 9.95890331978444e-07
within O 0 3.235595968931193e-08
BRCA1 O 0 4.859372992882527e-08
nuclear O 0 6.376484407155658e-07
dots O 0 1.5450414281303892e-08
during O 0 8.588795452624254e-09
S O 0 1.797593114361007e-07
phase O 0 8.274984253375806e-08
of O 0 3.787536062560548e-09
the O 0 1.18799059478647e-09
cell O 0 2.6656934437596647e-09
cycle O 0 8.628555508982672e-11
, O 0 3.887412527298073e-12
but O 0 3.6145899641459867e-12
not O 0 1.9409463619668443e-11
during O 0 1.512113878554544e-09
the O 0 4.1547276730113936e-09
G1 O 0 4.920416358800139e-07
phase O 0 4.225473730912199e-07
. O 0 7.270043766993695e-08

Nevertheless O 0 4.4768759835278615e-05
, O 0 3.6056670182915695e-07
BARD1 O 0 0.0002691715199034661
polypeptides O 0 4.2428695223861723e-07
are O 0 9.559638636247314e-10
found O 0 9.325108463187348e-10
exclusively O 0 1.226913126650686e-09
in O 0 2.1558463347837176e-10
the O 0 1.2752962019746406e-09
nuclear O 0 1.6601953234385292e-07
fractions O 0 2.3952352989908832e-08
of O 0 1.4776078138822868e-08
both O 0 2.2733617210946022e-09
G1 O 0 1.408535297287017e-07
- O 0 3.969850936869079e-08
and O 0 1.9355435032508694e-09
S O 0 1.9502770101098577e-06
- O 0 2.147460520518507e-07
phase O 0 3.389712333046191e-07
cells O 0 1.064927133143101e-07
. O 0 3.5727723002310086e-08

Therefore O 0 7.652509452782397e-07
, O 0 1.5930101682215536e-08
progression O 0 4.169670830833638e-08
to O 0 6.1754548141834675e-09
S O 0 1.6631760217933333e-06
phase O 0 3.8000897006895684e-07
is O 0 3.9671751994596605e-10
accompanied O 0 4.2827208446283294e-10
by O 0 1.4658524394306482e-11
the O 0 2.302761314965096e-10
aggregation O 0 3.1668270228379924e-09
of O 0 3.3141696054173053e-09
nuclear O 0 1.4400388863577973e-06
BARD1 O 0 5.816455086460337e-05
polypeptides O 0 1.8179156313635758e-07
into O 0 8.91880063136341e-08
BRCA1 O 0 1.1812966960178528e-07
nuclear O 0 1.596344532117655e-06
dots O 0 1.4869284541418892e-06
. O 0 2.202450986033e-07

This O 0 1.3105562857163022e-07
cell O 0 3.49148137956945e-07
cycle O 0 3.1590282389970525e-08
- O 0 2.802686260849896e-08
dependent O 0 1.7132869345459767e-08
colocalization O 0 1.3268752354633762e-06
of O 0 5.727117269316295e-08
BARD1 O 0 0.08837069571018219
and O 0 1.4568126260883218e-08
BRCA1 O 0 6.192628632106789e-09
indicates O 0 9.419349744632655e-10
a O 0 4.41605724210703e-10
role O 0 1.454679487977728e-09
for O 0 2.5934641101343914e-09
BARD1 O 0 0.24698498845100403
in O 0 4.848615375863119e-08
BRCA1 O 0 5.748215698986314e-07
- O 0 1.8927156588688376e-06
mediated O 0 9.904858598019928e-05
tumor B-Disease 0 0.005024131387472153
suppression O 0 0.0012199896154925227
. O 0 9.221878940479655e-07

Ethnic O 0 1.0723326795414323e-06
differences O 0 5.552229822569643e-07
in O 0 1.5901324701417252e-08
the O 0 5.396119462375282e-08
HFE O 0 0.0009182202047668397
codon O 0 1.5605777434757329e-06
282 O 0 4.113783688808326e-06
( O 0 1.9853833066463267e-07
Cys O 0 0.18410862982273102
/ O 0 0.00018054696556646377
Tyr O 0 0.00033357663778588176
) O 0 6.256718876329614e-08
polymorphism O 0 1.343720214208588e-06
. O 0 1.3486844352428307e-07

Recent O 0 9.946813150918388e-08
studies O 0 5.702142757968431e-09
have O 0 3.962123684697616e-10
shown O 0 1.4104831747019375e-09
that O 0 1.3011693944520175e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 1 0.9882420897483826
HH B-Disease 1 1.0
) O 0 1.5432174427232326e-09
is O 0 2.5416216006823866e-11
likely O 0 1.9957761832056775e-10
to O 0 1.8845562610447786e-10
be O 0 2.72629502306998e-10
caused O 0 5.230664346100866e-09
by O 0 1.708866242955409e-10
homozygosity O 0 1.87288407005326e-07
for O 0 2.7679714076356277e-10
a O 0 8.169932508295119e-10
Cys282Tyr O 0 1.6944936476193107e-07
mutation O 0 2.505858021084606e-10
in O 0 1.2960756079483104e-10
the O 0 1.5010248599622855e-09
HFE O 0 0.0001782101026037708
gene O 0 5.333395591833323e-08
located O 0 3.098045198157706e-08
4 O 0 5.6943203929904485e-08
. O 0 3.495085110216678e-08

5 O 0 5.801121733384207e-05
Mb O 0 0.00024310323351528496
telomeric O 0 6.721891259076074e-05
to O 0 2.6067868930113036e-07
HLA O 0 0.00022731628268957138
- O 0 7.671445018786471e-06
A O 0 2.0362458599265665e-06
. O 0 4.2609869410625834e-07

Population O 0 3.2820810513811693e-09
studies O 0 7.872488216875695e-10
of O 0 8.88188689263103e-10
this O 0 9.731813271907086e-11
polymorphism O 0 1.2315959807551735e-08
are O 0 4.172703849114612e-11
facilitated O 0 4.790715046887328e-10
by O 0 4.8890599901874054e-11
the O 0 5.385091816911824e-10
fact O 0 4.769398764814525e-10
that O 0 8.046595334487705e-11
the O 0 3.1027744817890834e-09
Cys282Tyr O 0 2.1480700524989516e-06
mutation O 0 1.0508971470812867e-08
creates O 0 2.683682787107955e-08
a O 0 2.1945021799751885e-08
Rsal O 0 1.0375813872087747e-05
restriction O 0 1.1945468259000336e-07
site O 0 3.4480015642657236e-07
. O 0 5.0607997792440074e-08

We O 0 1.701773157947173e-07
have O 0 3.5839777812185503e-09
studied O 0 2.1981424680461714e-08
the O 0 4.895783334291082e-09
codon O 0 4.8269033214864976e-08
282 O 0 5.407400749390945e-07
( O 0 7.359530229678057e-08
Cys O 1 0.7639500498771667
/ O 0 0.00049218611093238
Tyr O 0 0.00011686740617733449
) O 0 2.4883890503701878e-09
polymorphism O 0 8.04608113469385e-09
in O 0 5.1873508960520454e-11
different O 0 5.5301697249321435e-11
ethnic O 0 5.866617192040735e-10
groups O 0 5.592181162583643e-10
. O 0 2.488722650184627e-08

In O 0 5.1478743046118325e-08
agreement O 0 8.175333476856395e-08
with O 0 1.2570918750398619e-09
previous O 0 2.023602618805853e-08
observations O 0 2.332290982565155e-08
the O 0 9.019472280158425e-09
Tyr O 0 4.901784450339619e-06
allele O 0 4.001605091730198e-08
appeared O 0 1.3972189627509124e-08
to O 0 3.261965142442591e-10
be O 0 6.238968786043131e-10
rare O 0 8.508574289578519e-09
or O 0 6.003624708483812e-09
absent O 0 4.155753288159758e-07
in O 0 2.665917042676824e-09
Asiatic O 0 7.84160931743827e-08
( O 0 1.6352461051916123e-10
Indian O 0 3.6964755700807927e-09
, O 0 1.8793228084845737e-10
Chinese O 0 3.8127963009060295e-09
) O 0 6.299750721083797e-10
populations O 0 3.6575520390158545e-09
. O 0 8.425890030139271e-08

The O 0 5.181614142202307e-07
highest O 0 2.320282845857946e-07
allele O 0 1.49809409322188e-08
frequency O 0 4.373193362994243e-09
( O 0 3.3353483863685085e-10
7 O 0 2.47443177059381e-09
. O 0 1.7203254099040777e-10
5 O 0 2.366669527020804e-09
% O 0 3.269271242611893e-10
) O 0 1.7624289527784498e-10
was O 0 2.897310613647619e-09
found O 0 1.010043826354945e-09
in O 0 2.4956519073526806e-09
Swedes O 0 1.4250601452658884e-05
. O 0 7.580577516819176e-07

Saamis O 0 0.00047412177082151175
( O 0 2.264228413650926e-07
2 O 0 1.4272251291913562e-07
% O 0 3.5130554021378657e-09
) O 0 7.963660841880937e-10
and O 0 2.2872010951857646e-09
Mordvinians O 0 1.1487748452054802e-05
( O 0 5.000492020457159e-09
1 O 0 1.3552698518992656e-08
. O 0 6.732733259795509e-10
8 O 0 6.9108807565498864e-09
% O 0 3.2697888840971245e-10
) O 0 1.003146940514732e-10
had O 0 3.7301156607938424e-10
significantly O 0 2.6460185154064675e-09
lower O 0 9.159205660580483e-08
frequencies O 0 3.0570731723855715e-08
of O 0 8.750746793850794e-09
the O 0 1.0311352660608009e-08
Tyr O 0 1.5411174899782054e-05
allele O 0 5.546751822294027e-07
. O 0 8.280051844167247e-08

Comparisons O 0 3.550298117716011e-07
with O 0 4.415840582083774e-09
allele O 0 3.2261489479878946e-08
frequencies O 0 1.19629524064635e-08
based O 0 1.2172165497759124e-09
on O 0 1.2686923733795652e-09
prevalence O 0 4.3040309094521945e-09
estimates O 0 1.6056199703129437e-09
of O 0 2.5005800097233077e-08
HH B-Disease 1 1.0
showed O 0 4.023555177923299e-08
some O 0 2.121083586548167e-10
disagreements O 0 1.4964719241561397e-08
with O 0 7.377945476783054e-11
the O 0 7.587797612451652e-10
RFLP O 0 6.735101720778403e-08
data O 0 1.5585015500363397e-09
, O 0 1.2737155774544817e-10
particularly O 0 1.9823849228828294e-09
in O 0 4.176267331956751e-09
Finns O 0 5.105999662191607e-06
. O 0 4.343962416442082e-07

The O 0 5.0947787713084836e-06
newly O 0 9.933682122209575e-06
described O 0 1.3816860473525594e-06
HFE O 1 0.5428068041801453
marker O 0 4.302988600102253e-06
provides O 0 6.706743604922849e-09
a O 0 7.625562958857302e-10
new O 0 5.057108620754036e-10
approach O 0 1.6045056394631274e-09
to O 0 1.1580578856973389e-10
the O 0 2.523806996723721e-10
screening O 0 1.7558769993542e-09
of O 0 3.962420613845552e-09
HH B-Disease 1 0.9997677206993103
as O 0 6.221812398621296e-09
well O 0 6.97083391010267e-10
as O 0 5.5095764756041277e-11
studies O 0 2.009897977217623e-11
of O 0 6.824212722689182e-11
the O 0 2.143733662807179e-10
relationship O 0 7.547238944916046e-10
between O 0 5.182181905816208e-10
the O 0 2.5926529811926002e-09
HFE O 0 0.0012749703601002693
Tyr O 0 1.0328966709494125e-05
allele O 0 9.940475109715408e-09
and O 0 2.8722133005310013e-10
different O 0 7.095074527896372e-10
disorders O 0 7.276519318111241e-05
including O 0 3.0260602557063976e-07
cancer B-Disease 1 0.999994158744812

Autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999628067016602
associated O 0 1.8670775148166285e-07
with O 0 1.6127714719260666e-09
a O 0 1.0871926470201743e-08
missense O 0 1.4816342286394502e-07
mutation O 0 5.865523622361479e-09
encoding O 0 1.6148352699474344e-07
Gly23 O 0 1.9893263015546836e-05
- O 0 2.6754958071251167e-06
- O 0 3.8319180930557195e-06
> O 0 6.296221727097873e-06
Val O 0 3.9798624129616655e-06
in O 0 1.1606950955922457e-08
neurophysin O 0 2.6933881599688902e-05
II O 1 0.9999998807907104
. O 0 5.031966793467291e-06

Autosomal B-Disease 1 0.9999983310699463
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 7.68575830534246e-07
ADNDI B-Disease 1 0.9999998807907104
) O 0 2.463313997225214e-09
is O 0 1.502854785062624e-10
an O 0 4.18036910643238e-10
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 0.9876540303230286
by O 0 2.736373438949613e-08
progressive O 0 0.21882863342761993
degeneration O 1 1.0
of O 0 6.641760592174251e-06
the O 0 6.983282219152898e-07
magnocellular O 0 0.00021657459728885442
neurons O 0 3.830394135206916e-08
of O 0 1.020454476474697e-08
the O 0 9.454778293616073e-09
hypothalamus O 0 1.1412150513478991e-07
leading O 0 2.105956475872972e-08
to O 0 4.241117457226551e-10
decreased O 0 4.6481778426255005e-09
ability O 0 3.2456819454296237e-09
to O 0 1.020734274881363e-09
produce O 0 9.035140635660355e-09
the O 0 2.136771826144468e-08
hormone O 0 2.941501264785984e-08
arginine O 0 1.6395300406202296e-07
vasopressin O 0 3.9234069504345825e-07
( O 0 7.3755326290836365e-09
AVP O 0 1.752831394696841e-06
) O 0 3.2702895946812305e-09
. O 0 2.1550921047719385e-08

Affected O 0 2.5433064365643077e-07
individuals O 0 3.810685933469671e-10
are O 0 5.184096901755808e-11
not O 0 1.7135533270096204e-10
symptomatic O 0 3.09289462165907e-05
at O 0 5.104080269546785e-09
birth O 0 3.3349429884310666e-09
, O 0 6.042390199301195e-11
but O 0 1.008616801190243e-10
usually O 0 3.2094349400324518e-09
develop O 0 5.042338216298958e-06
diabetes B-Disease 1 1.0
insipidus I-Disease 1 0.9999996423721313
at O 0 3.535209543770179e-06
1 O 0 7.096758736224729e-07
- O 0 4.288511263439432e-06
6 O 0 3.6575793274096213e-06
yr O 0 0.0002061421691905707
of O 0 4.125111274788651e-08
age O 0 5.1217831753547216e-08
. O 0 7.29648093056312e-08

The O 0 6.266141667765623e-07
genetic O 0 6.188794259287533e-07
locus O 0 4.3836479335368495e-07
of O 0 2.9427638992274296e-08
the O 0 3.961402228469524e-08
disease O 0 9.095988389162812e-06
is O 0 4.610580806030384e-09
the O 0 7.441156668619442e-08
AVP O 0 0.0005103632574900985
- O 0 9.084978955797851e-06
neurophysin O 0 0.0016073917504400015
II O 1 1.0
( O 0 8.128269257667853e-08
NPII O 0 4.853531572734937e-05
) O 0 2.694348077980635e-10
gene O 0 1.8745255347951684e-10
, O 0 3.130377207449797e-11
and O 0 1.1205565642047333e-10
mutations O 0 5.735091290759442e-10
that O 0 1.1841938540868568e-10
cause O 0 4.1319077581647434e-07
ADNDI B-Disease 1 0.9999995231628418
have O 0 1.7239460969875608e-09
been O 0 2.9626467945575996e-10
found O 0 4.782012286153048e-11
in O 0 6.613317532488949e-12
both O 0 3.706992351970584e-11
the O 0 7.014220315681996e-10
signal O 0 3.550835714349887e-08
peptide O 0 1.009362549098114e-08
of O 0 2.1417251971911355e-08
the O 0 8.643227289439892e-08
prepro O 0 5.933317152084783e-05
- O 0 1.6823103578644805e-05
AVP O 0 0.00034188086283393204
- O 0 5.238322501099901e-06
NPII O 0 0.0002752825093921274
precursor O 0 3.141315971788572e-07
and O 0 4.2774659370081736e-09
within O 0 1.5656111074235923e-08
NPII O 0 0.0002122036094078794
itself O 0 1.519596395382905e-07
. O 0 6.870114788171122e-08

An O 0 1.4691103444874898e-07
affected O 0 1.5888780069417408e-07
girl O 0 1.7914733518864523e-07
who O 0 7.826827186363516e-09
presented O 0 3.3568017698826225e-08
at O 0 3.46920963067987e-08
9 O 0 8.042767341009949e-09
months O 0 1.281189043744746e-09
of O 0 2.187542813558707e-09
age O 0 4.064882652698998e-09
and O 0 7.689652803399838e-10
her O 0 2.3521465331022284e-10
similarly O 0 4.892644067666652e-10
affected O 0 3.3325886494850465e-10
younger O 0 1.7024200715809457e-08
brother O 0 9.341222835246299e-07
and O 0 2.8740232416168965e-09
father O 0 6.25893903816177e-07
were O 0 1.268205984672477e-09
all O 0 5.6576111850947797e-11
found O 0 1.1615022138533604e-10
to O 0 1.3190218361991413e-10
have O 0 3.572053486333715e-10
a O 0 3.663912950813142e-09
novel O 0 4.928982377805369e-08
missense O 0 1.5276884823833825e-07
mutation O 0 4.236171413651846e-09
( O 0 4.377481432893404e-10
G1758 O 0 1.0047300236237788e-07
- O 0 9.05099497572337e-08
- O 0 1.609346753639329e-07
> O 0 1.2537213933683233e-07
T O 0 2.4316557656334226e-08
) O 0 2.7733497789950157e-11
encoding O 0 2.3260424142357294e-10
the O 0 1.5711437706400488e-10
amino O 0 1.0081147722162953e-10
acid O 0 1.6993817464339145e-10
substitution O 0 3.2361127111357746e-09
Gly23 O 0 8.519926950611989e-07
- O 0 3.666949339731218e-07
- O 0 1.3857847989129368e-06
> O 0 5.0524508878879715e-06
Val O 0 5.18097976964782e-06
within O 0 8.471155155120869e-08
NPII O 0 0.00023985646839719266
. O 0 1.8198029749783018e-07

The O 0 3.8980795125098666e-07
mutation O 0 9.38589295174097e-08
was O 0 8.12716862697016e-08
confirmed O 0 7.98773136523323e-09
by O 0 5.980363981805681e-10
restriction O 0 2.6981975764783783e-08
endonuclease O 0 1.908346348500345e-06
analysis O 0 8.905711723627974e-08
. O 0 1.6103324185223755e-07

A O 0 5.192744720261544e-05
T1 O 0 0.00175809720531106
- O 0 2.753195076365955e-06
weighted O 0 8.63989768618012e-08
magnetic O 0 7.014815395223195e-08
resonance O 0 6.466777335845109e-08
imaging O 0 5.815186909785552e-07
of O 0 5.70933913479621e-08
the O 0 4.4961663547837816e-07
fathers O 0 5.965816308162175e-05
pituitary O 0 0.000582102220505476
gland O 0 3.4022466479655122e-06
demonstrates O 0 2.411655941614299e-08
an O 0 9.615431784126827e-10
attenuated O 0 1.8713341205511824e-06
posterior O 0 3.998216925538145e-06
pituitary O 0 5.2211918955435976e-05
bright O 0 4.6179375203792006e-05
spot O 0 4.7683282900834456e-05
. O 0 5.602531132353761e-07

This O 0 2.424116907207008e-08
mutation O 0 3.069582987791364e-08
may O 0 4.34595293086204e-09
be O 0 4.483769466823162e-10
valuable O 0 1.7740495295015535e-08
for O 0 1.625239942626422e-10
developing O 0 2.1831161323149217e-09
models O 0 1.1303543656637771e-09
of O 0 3.860355235474344e-08
dominantly B-Disease 1 0.9999799728393555
inherited I-Disease 1 1.0
neurodegeneration I-Disease 1 1.0
, O 0 6.948894792913052e-09
as O 0 1.3466390502703263e-10
the O 0 7.581167638104347e-11
early O 0 7.061928819496188e-10
age O 0 9.944598616806744e-11
of O 0 5.315201612177134e-10
onset O 0 0.040327683091163635
of O 0 2.456646086557157e-07
symptoms O 0 4.997718860977329e-06
suggests O 0 2.255304609732889e-09
that O 0 7.92548231903778e-12
this O 0 8.324945767468339e-12
mutation O 0 1.2879236566121222e-10
may O 0 1.0563904612181929e-10
be O 0 2.1517916615199084e-10
particularly O 0 5.175812667346236e-09
deleterious O 0 7.694443127093109e-08
to O 0 2.9282831714994018e-09
the O 0 2.807555077311008e-08
magnocellular O 0 3.436778933973983e-05
neuron O 0 7.28639008684695e-07
. O 0 9.168640069390221e-09
. O 0 3.7671274100148366e-08

Frequent O 0 2.8392630611051572e-06
inactivation O 0 8.473439811496064e-05
of O 0 5.265770596452057e-06
PTEN O 1 0.9999998807907104
/ O 1 0.9999821186065674
MMAC1 O 1 0.9999982118606567
in O 0 5.729564378498253e-08
primary O 0 0.013865186832845211
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.785468718182528e-06

Sporadic B-Disease 1 0.9999990463256836
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 1.4868589914840413e-06
the O 0 2.9553975267049282e-08
most O 0 1.9394892636359629e-10
common O 0 1.4776388113091343e-08
male B-Disease 0 9.824253410783967e-09
cancer I-Disease 0 1.980816080049408e-07
in O 0 2.1499824143234036e-10
the O 0 4.538979414547839e-09
Western O 0 1.9941530808864627e-06
world O 0 6.656430517892886e-09
, O 0 4.041439058410923e-11
yet O 0 4.2795014060237335e-11
many O 0 3.4683421499398515e-12
of O 0 6.84047679611055e-11
the O 0 1.2882897526544923e-10
major O 0 6.297588006631827e-10
genetic O 0 7.696534520817977e-10
events O 0 4.424180206213935e-12
involved O 0 1.4997014047279933e-11
in O 0 9.561251096412704e-12
the O 0 9.69734917366516e-11
progression O 0 3.3312175240496344e-09
of O 0 9.517303611872308e-10
this O 0 8.286265423818051e-11
often O 0 2.5191626562559577e-09
fatal O 0 3.27674497384578e-05
cancer B-Disease 0 4.493965025176294e-05
remain O 0 6.398902030468889e-08
to O 0 4.4248111841227455e-09
be O 0 4.848171286653269e-08
elucidated O 0 0.04946880042552948
. O 0 1.5497481626880472e-06

Numerous O 0 1.4814196447332506e-06
cytogenetic O 0 0.0001644580770516768
and O 0 5.7772339800976624e-08
allelotype O 0 7.168177489802474e-06
studies O 0 2.9793822964307992e-09
have O 0 1.948321087796856e-10
reported O 0 8.852508726064912e-10
frequent O 0 4.021627031391972e-09
loss O 0 1.2518373182501819e-07
of O 0 7.07664526089502e-07
heterozygosity O 1 1.0
on O 0 1.1584053027036134e-05
chromosomal O 0 8.343945410160813e-06
arm O 0 1.2852563486376312e-05
10q O 0 1.8725032759903115e-06
in O 0 3.1729396887669736e-09
sporadic B-Disease 0 0.32930469512939453
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.945044449617853e-06

Deletion O 0 1.3622144251712598e-05
mapping O 0 4.823875201509509e-07
studies O 0 1.0285600815507223e-08
have O 0 9.364427011604448e-10
unambiguously O 0 1.4253148883369704e-08
identified O 0 4.7641099953921184e-09
a O 0 1.2175322972041158e-09
region O 0 7.58800400291193e-09
of O 0 5.5950248878389175e-08
chromosome O 0 3.732987963189771e-08
10q23 O 0 1.1456554460664847e-07
to O 0 1.8296709980436532e-10
be O 0 2.1973102504180275e-10
the O 0 1.1092358143116599e-09
minimal O 0 9.96015927512417e-08
area O 0 2.7740680863530542e-08
of O 0 9.701873082690327e-09
loss O 0 3.2402840588474646e-07
. O 0 4.999274096917361e-07

A O 0 4.286070179659873e-06
new O 0 1.6092255350486084e-07
tumor B-Disease 0 7.383459887932986e-07
suppressor O 0 1.3516913668354391e-06
gene O 0 1.8330190698634397e-08
, O 0 5.287871918113751e-09
PTEN O 0 0.2928318977355957
/ O 0 0.03375440090894699
MMAC1 O 1 0.9999973773956299
, O 0 1.7460724421880514e-08
was O 0 2.0684963430994685e-07
isolated O 0 7.409290958548809e-08
recently O 0 1.2611558908304232e-08
at O 0 7.966167725470541e-10
this O 0 3.882939109134398e-11
region O 0 9.115192489694834e-10
of O 0 4.15136147680073e-09
chromosome O 0 2.2231288809848593e-08
10q23 O 0 8.965840692098936e-08
and O 0 2.0174346915258212e-10
found O 0 5.360330929127244e-11
to O 0 1.5851093007612782e-11
be O 0 1.8998469464293066e-11
inactivated O 0 2.463873105540415e-09
by O 0 2.0941292103171527e-11
mutation O 0 2.2042362379792735e-10
in O 0 1.7905622817782074e-10
three O 0 2.451353964261216e-08
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 0.035011015832424164
lines O 0 2.178824871634788e-07
. O 0 5.341335906905442e-08

We O 0 3.231937398595619e-06
screened O 0 2.684684659470804e-05
80 O 0 7.305138296942459e-06
prostate B-Disease 1 0.9999995231628418
tumors I-Disease 1 1.0
by O 0 1.0042124465314828e-08
microsatellite O 0 3.4476177006581565e-06
analysis O 0 5.194544350217711e-09
and O 0 7.063195028855773e-10
found O 0 3.25398596956461e-10
chromosome O 0 1.7928939444189496e-09
10q23 O 0 2.431734458241408e-08
to O 0 2.0054226335108893e-10
be O 0 3.158314165752074e-10
deleted O 0 1.7694738119189424e-08
in O 0 3.4693514727734964e-10
23 O 0 3.852901553358379e-09
cases O 0 2.2681772016142077e-09
. O 0 6.795517037971877e-08

We O 0 1.233508726272703e-07
then O 0 8.202444945482057e-09
proceeded O 0 1.2187411080333277e-08
with O 0 1.9953297694663696e-11
sequence O 0 4.4431923418297714e-11
analysis O 0 1.3540592258554085e-10
of O 0 1.8829762193917077e-09
the O 0 1.6208579367571474e-08
entire O 0 1.0015575071520288e-06
PTEN O 1 0.9997584223747253
/ O 0 0.0010935445316135883
MMAC1 O 0 0.0019449013052508235
coding O 0 8.715435342310229e-07
region O 0 8.658833650088127e-09
and O 0 5.909112088531288e-10
tested O 0 2.8685467334810255e-09
for O 0 1.3977667634446078e-10
homozygous O 0 3.160967487758626e-09
deletion O 0 5.3023958557218975e-09
with O 0 7.452424094500643e-11
new O 0 1.910390290404962e-09
intragenic O 0 2.6094585336977616e-06
markers O 0 2.9576796567454267e-09
in O 0 3.494853365038075e-11
these O 0 2.8760273676486925e-11
23 O 0 4.1028458408476354e-10
cases O 0 8.465473461116702e-11
with O 0 2.7534960422848087e-10
10q23 O 0 2.11547126127698e-06
loss O 0 4.243480589138926e-07
of O 0 1.8517473563406384e-06
heterozygosity O 1 0.9999871253967285
. O 0 9.197688996209763e-06

The O 0 9.801384948104896e-08
identification O 0 7.152474523763885e-08
of O 0 3.6579933748726035e-08
the O 0 2.494634721017519e-08
second O 0 1.8604849572056992e-07
mutational O 0 8.20107561594341e-06
event O 0 8.678243901272253e-09
in O 0 7.105475097191061e-10
10 O 0 1.2246498259926852e-09
( O 0 7.877850594084634e-10
43 O 0 2.1026172802862675e-08
% O 0 1.6538704628032974e-08
) O 0 6.235370619833702e-08
tumors B-Disease 1 1.0
establishes O 0 0.00010410208778921515
PTEN O 1 1.0
/ O 0 0.4172992706298828
MMAC1 O 0 0.002524405950680375
as O 0 4.9544195412920544e-09
a O 0 9.63331081571539e-10
main O 0 2.9240079246761752e-09
inactivation O 0 2.8927564343916856e-08
target O 0 6.232201976708041e-10
of O 0 9.868306172222674e-10
10q O 0 3.218203232790984e-07
loss O 0 2.423506728632674e-08
in O 0 4.839096234832141e-09
sporadic B-Disease 1 0.9966006875038147
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.0728271604421025e-07
. O 0 6.950461539645403e-08

Risk O 0 7.954095963214058e-06
reversals O 0 7.262916824402055e-06
in O 0 7.273744717650743e-09
predictive O 0 7.882968589001393e-08
testing O 0 4.886820548222204e-08
for O 0 7.257312262254345e-08
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 5.9039293773821555e-06

The O 0 3.3421025591451325e-07
first O 0 1.9056676237028114e-08
predictive O 0 6.545164410454163e-08
testing O 0 4.752767068794128e-08
for O 0 8.083988234375283e-08
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 9.46613099017668e-08
HD B-Disease 0 0.20276802778244019
) O 0 4.723066937550868e-10
was O 0 1.3048370162138667e-09
based O 0 7.77805181373381e-11
on O 0 1.8617907215912055e-10
analysis O 0 6.914143563241382e-11
of O 0 3.0523392147152606e-10
linked O 0 6.849883771309351e-09
polymorphic O 0 6.241604921797261e-08
DNA O 0 5.599497754360527e-08
markers O 0 1.5416730114736765e-09
to O 0 9.842773818213857e-11
estimate O 0 7.321287465167359e-10
the O 0 6.257370177564781e-10
likelihood O 0 2.8538462260030428e-08
of O 0 4.963265354263058e-08
inheriting O 0 2.2682654332584207e-07
the O 0 1.4626567512721067e-08
mutation O 0 3.815487925606931e-09
for O 0 4.613448734147596e-09
HD B-Disease 0 0.00024563021725043654
. O 0 1.0568287507339846e-06

Limits O 0 5.900130304326012e-07
to O 0 1.1772632646511738e-08
accuracy O 0 9.34528898710596e-08
included O 0 7.88720644351315e-09
recombination O 0 1.2123145154419035e-08
between O 0 1.981050656851835e-09
the O 0 1.2148925199184646e-09
DNA O 0 2.383577601960951e-08
markers O 0 5.364919175576688e-09
and O 0 4.150844667982767e-10
the O 0 9.731354611020038e-10
mutation O 0 2.5065525210976602e-09
, O 0 3.0619839996859355e-10
pedigree O 0 6.139376562686039e-09
structure O 0 6.068174851492358e-09
, O 0 1.537819038777144e-10
and O 0 4.706231238049696e-11
whether O 0 6.16525719365768e-11
DNA O 0 1.7706073274226242e-09
samples O 0 7.566346854614991e-11
were O 0 3.1811352163568785e-11
available O 0 1.1976455938089714e-10
from O 0 3.742558762898085e-10
family O 0 9.427406411077754e-09
members O 0 1.393383297632056e-09
. O 0 7.308737792754982e-08

With O 0 6.894475657048815e-09
direct O 0 1.544222172356058e-08
tests O 0 1.316873166068433e-09
for O 0 2.1310550546438378e-10
the O 0 1.6766362742615115e-09
HD B-Disease 0 1.2546233847388066e-05
mutation O 0 2.893681960713934e-09
, O 0 2.8767419002484473e-10
we O 0 1.6404787250845487e-10
have O 0 4.272829659535127e-11
assessed O 0 3.170628648518914e-09
the O 0 2.9806199175475e-10
accuracy O 0 2.988585379171127e-09
of O 0 6.576719169260059e-10
results O 0 4.609802123356488e-11
obtained O 0 2.699821477492037e-10
by O 0 3.008272797533351e-11
linkage O 0 4.8286779019690584e-09
approaches O 0 3.2857951914877503e-09
when O 0 1.55239210375413e-10
requested O 0 1.5789493046369785e-09
to O 0 2.190397585533077e-10
do O 0 5.7272832310051314e-11
so O 0 4.877231257749415e-11
by O 0 3.356175753976842e-11
the O 0 6.054529655408203e-10
test O 0 1.1823212409112216e-09
individuals O 0 2.10635606179288e-10
. O 0 5.112238099513888e-08

For O 0 2.0017369095626236e-08
six O 0 2.0416059953731747e-09
such O 0 1.2028514295714388e-10
individuals O 0 4.602844147494345e-11
, O 0 1.0268575573180172e-10
there O 0 1.078488201522454e-10
was O 0 5.3180135850539045e-09
significant O 0 5.533021263381954e-10
disparity O 0 1.2645233304908743e-08
between O 0 1.4381323909518073e-09
the O 0 4.341462744861246e-09
tests O 0 1.270107041762003e-08
. O 0 4.224667193852838e-08

Three O 0 6.328273798317241e-07
went O 0 1.792560198055071e-07
from O 0 1.5850867285394088e-09
a O 0 2.2989752324065194e-09
decreased O 0 4.383239993188681e-09
risk O 0 3.2569309471597307e-09
to O 0 3.661200786986285e-10
an O 0 3.865661610258364e-11
increased O 0 2.1947049733128665e-10
risk O 0 2.1697741381387914e-09
, O 0 5.2505007286374195e-11
while O 0 2.767959472738113e-11
in O 0 1.2145622181602977e-11
another O 0 8.818328012250021e-11
three O 0 6.631686866320763e-11
the O 0 6.647342676302515e-10
risk O 0 9.246916121696813e-09
was O 0 8.446389898608686e-08
decreased O 0 6.077710423824101e-08
. O 0 5.5961560718742476e-08

Knowledge O 0 1.0324071809009183e-05
of O 0 6.403297447832301e-07
the O 0 1.6784834855343433e-08
potential O 0 6.003818775468517e-09
reasons O 0 1.201524324478953e-09
for O 0 3.749008395392828e-11
these O 0 1.4872984788194543e-11
changes O 0 1.1747992856303568e-10
in O 0 1.1783043984969765e-10
results O 0 1.4050477448179777e-10
and O 0 1.7229327686774099e-10
impact O 0 3.3939926424864097e-09
of O 0 1.0669043426503322e-09
these O 0 1.329298615626584e-10
risk O 0 3.0965194852683453e-09
reversals O 0 4.356636651436929e-08
on O 0 1.6883882070217737e-09
both O 0 1.1802432642316063e-10
patients O 0 5.044969997314297e-10
and O 0 6.016999676283774e-10
the O 0 2.2501054353085692e-09
counseling O 0 1.080301004208195e-08
team O 0 1.771173901987666e-10
can O 0 7.467078344536304e-11
assist O 0 2.880729654819447e-09
in O 0 1.6992390827752502e-10
the O 0 9.861683691880785e-10
development O 0 1.5061497604662577e-09
of O 0 3.9561734443971375e-10
strategies O 0 2.2585762149418542e-09
for O 0 5.800102065300905e-11
the O 0 3.091006617328418e-10
prevention O 0 1.8769316767475175e-08
and O 0 8.504639353867915e-11
, O 0 1.0640906558667673e-11
where O 0 1.2083696890319295e-11
necessary O 0 9.331370121046234e-10
, O 0 8.126738171299053e-11
management O 0 8.269879780975486e-10
of O 0 5.123116375571612e-10
a O 0 8.255207628593553e-10
risk O 0 5.766992217104416e-09
reversal O 0 1.585323516906101e-08
in O 0 1.3942252907739316e-10
any O 0 1.412059774663632e-10
predictive O 0 5.733562957743743e-09
testing O 0 3.2474776201496525e-09
program O 0 2.151509637116078e-09
. O 0 4.4908562979451006e-10
. O 0 8.089197756078192e-09

A O 0 4.432662535691634e-06
novel O 0 1.2155511512901285e-06
common O 0 4.541224427612178e-07
missense O 0 2.1187340735195903e-06
mutation O 0 7.579212280006686e-08
G301C O 0 6.581863658539078e-07
in O 0 1.229079726883242e-09
the O 0 3.862739905713397e-09
N O 0 5.805733849229e-08
- O 0 1.1358534379724006e-07
acetylgalactosamine O 0 2.508943907741923e-06
- O 0 2.4887944505280757e-07
6 O 0 1.1555486167935669e-07
- O 0 9.879143192392803e-08
sulfate O 0 9.8079738108936e-07
sulfatase O 0 1.87830319191562e-05
gene O 0 3.640154844219978e-08
in O 0 9.044934579094388e-09
mucopolysaccharidosis B-Disease 0 3.362451752764173e-05
IVA I-Disease 1 0.9999483823776245
. O 0 3.2418681712442776e-06

Mucopolysaccharidosis B-Disease 1 0.9915756583213806
IVA I-Disease 1 1.0
( O 0 0.0003589692641980946
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 6.371292471385459e-08
is O 0 7.836398752125717e-10
an O 0 6.617285608356838e-10
autosomal B-Disease 1 0.937544584274292
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 0.02703314647078514
by O 0 7.796030487838834e-09
a O 0 2.1076890277527127e-07
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 2.2305515301468404e-07
N O 0 2.0441336801013676e-06
- O 0 7.618271524734155e-07
acetylgalactosamine O 0 1.035492641676683e-05
- O 0 8.031501579353062e-07
6 O 0 4.157259354542475e-07
- O 0 3.383769069387199e-07
sulfate O 0 2.607120040920563e-05
sulfatase O 0 0.0020040704403072596
( O 0 9.676263346136693e-08
GALNS O 0 0.00042319713975302875
) O 0 1.3715591329344079e-08
. O 0 6.404311392316231e-08

In O 0 5.299435912320405e-08
previous O 0 2.5750360066467692e-08
studies O 0 3.319490238240519e-09
, O 0 4.287019905735434e-10
we O 0 1.5165553535201326e-10
have O 0 4.698732375407744e-11
found O 0 2.009462179985988e-10
two O 0 9.604684408914821e-11
common O 0 2.8918833994140414e-09
mutations O 0 1.2741049326692178e-09
in O 0 2.1268806160712472e-10
Caucasians O 0 5.4920423764315274e-08
and O 0 2.2622064221877736e-09
Japanese O 0 1.3587635976364254e-06
, O 0 1.920385628295662e-09
respectively O 0 2.4849660107406635e-08
. O 0 1.0720948040443545e-07

To O 0 3.702137121308624e-07
characterize O 0 5.7302586355945095e-06
the O 0 5.319872684594884e-07
mutational O 0 0.0004552215395960957
spectrum O 0 1.4391546301339986e-06
in O 0 1.630058171775417e-10
various O 0 2.3844650212656582e-11
ethnic O 0 2.877519923727423e-11
groups O 0 1.579157811459897e-12
, O 0 9.224670506624566e-12
mutations O 0 4.197128755656365e-11
in O 0 7.959010533964417e-11
the O 0 1.662798787549491e-09
GALNS O 0 1.6142243111971766e-05
gene O 0 1.954228556755311e-09
in O 0 2.7296148674693654e-10
Colombian O 0 1.7205460380864679e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 0.00014031692990101874
were O 0 1.4511440937781117e-08
investigated O 0 1.016704942458091e-08
, O 0 1.7160978194041832e-10
and O 0 1.0979402109700942e-10
genetic O 0 1.761982892922731e-09
backgrounds O 0 7.378483934949998e-10
were O 0 3.206203080807768e-10
extensively O 0 3.699168193982416e-10
analyzed O 0 3.341422971647745e-10
to O 0 3.898671663282727e-11
identify O 0 2.4418783661772636e-10
racial O 0 2.0527213262511168e-10
origin O 0 3.761035372029653e-10
, O 0 7.113987871010252e-11
based O 0 1.5501788741545397e-10
on O 0 5.970425265289236e-10
mitochondrial O 0 1.267608795707531e-09
DNA O 0 3.2194593657663972e-09
( O 0 2.075591643002639e-10
mtDNA O 0 8.08388800344062e-10
) O 0 6.001686370105119e-10
lineages O 0 2.8967757970121966e-08
. O 0 8.715238664080971e-08

Three O 0 8.188519018403895e-07
novel O 0 1.0027023336078855e-06
missense O 0 3.720226459336118e-06
mutations O 0 2.8118208206251438e-08
never O 0 3.4681907123967903e-08
identified O 0 1.9469261758331413e-08
previously O 0 1.824389883609001e-08
in O 0 3.888217248171344e-10
other O 0 6.72749217445201e-11
populations O 0 1.2279004202309096e-10
and O 0 9.663339572973939e-11
found O 0 1.956655532042717e-10
in O 0 1.0377142201090095e-10
16 O 0 2.0567236802548905e-09
out O 0 3.3025759904603547e-10
of O 0 4.1561230013087425e-09
19 O 0 4.733695746494959e-08
Colombian O 0 7.661501513211988e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
unrelated O 0 2.2692695722525968e-07
alleles O 0 1.6614292164263134e-09
account O 0 2.2297257096237644e-10
for O 0 1.1915943787244032e-09
84 O 0 6.115071187196008e-07
. O 0 3.74408358538858e-07

2 O 0 1.7241529803868616e-06
% O 0 7.512213962002079e-09
of O 0 6.133220153969887e-09
the O 0 1.742664679227346e-09
alleles O 0 2.416673750005316e-09
in O 0 3.184178198889498e-10
this O 0 1.7227290427523911e-10
study O 0 9.293394942488931e-10
. O 0 3.079933819094549e-08

The O 0 2.6488760340726003e-06
G301C O 0 1.7231834135600366e-05
and O 0 6.581116451798152e-08
S162F O 0 8.789716048340779e-07
mutations O 0 2.780386143541591e-09
account O 0 4.808493048180651e-10
for O 0 2.7310587125128905e-09
68 O 0 1.9337346657266608e-06
. O 0 6.610870286749559e-07

4 O 0 7.896624083514325e-06
% O 0 1.1637190766577987e-07
and O 0 2.4646027441121987e-08
10 O 0 1.462810814700788e-07
. O 0 2.7225627263760543e-07

5 O 0 4.002094442512316e-07
% O 0 2.8693620812703102e-09
of O 0 2.010413835407121e-09
mutations O 0 7.753083175465747e-10
, O 0 1.5886818249821744e-10
respectively O 0 1.1624735618553927e-09
, O 0 1.0899280089571306e-10
whereas O 0 1.2762794154852486e-09
the O 0 1.3278858901344393e-08
remaining O 0 7.413913181153475e-07
F69V O 0 0.00015764565614517778
is O 0 6.323357393256401e-10
limited O 0 5.250743173590422e-10
to O 0 5.408974379506049e-10
a O 0 3.413729299239776e-09
single O 0 1.922776426965811e-08
allele O 0 1.4644410839537159e-07
. O 0 1.0563375241190442e-07

The O 0 3.782308510835719e-07
skewed O 0 2.078974006280987e-07
prevalence O 0 2.727323362705647e-07
of O 0 4.1751619050955924e-08
G301C O 0 6.923112323420355e-07
in O 0 3.546872517912192e-10
only O 0 1.392171239400497e-10
Colombian O 0 1.5209572268304328e-08
patients O 0 3.750664223645117e-09
and O 0 8.009115592955141e-10
haplotype O 0 8.34629929613584e-08
analysis O 0 5.068145902953347e-10
by O 0 1.523187478924548e-11
restriction O 0 1.1628321916479223e-10
fragment O 0 1.775395830350135e-09
length O 0 3.426121331084886e-10
polymorphisms O 0 1.1983682934868511e-09
in O 0 6.650510003813892e-11
the O 0 1.7092746107394419e-09
GALNS O 0 1.4350322089740075e-05
gene O 0 2.8325541912010976e-09
suggest O 0 2.9763136399907353e-10
that O 0 7.263893653242093e-11
G301C O 0 7.597232354328298e-08
originated O 0 6.260094664867211e-09
from O 0 3.653729263586314e-10
a O 0 1.0057261690121777e-09
common O 0 1.629543611159079e-08
ancestor O 0 1.3177730579627678e-05
. O 0 7.857416903789272e-07

Investigation O 0 1.9433814486546908e-06
of O 0 1.6618935205769958e-07
the O 0 9.229876418714866e-09
genetic O 0 1.2062805865298287e-08
background O 0 5.921308443568307e-10
by O 0 4.9023476250686926e-11
means O 0 2.5649953272477433e-09
of O 0 3.999443887181542e-09
mtDNA O 0 2.5425259675415646e-09
lineages O 0 3.05121566901434e-10
indicate O 0 2.4066160522751012e-11
that O 0 6.305538556572454e-12
all O 0 8.638205428734835e-11
our O 0 3.693572114826793e-09
patients O 0 2.612708493998639e-09
are O 0 2.794546885565019e-11
probably O 0 7.17784987003256e-09
of O 0 1.4955245930536876e-08
native O 0 6.092577820027145e-08
American O 0 1.2412463945565833e-07
descent O 0 2.306410897290334e-05

Low O 0 2.0663308077928377e-06
frequency O 0 1.0223641311313258e-07
of O 0 3.05322735982827e-08
BRCA1 O 0 2.647145436185383e-08
germline O 0 4.139961262694669e-08
mutations O 0 1.0768355651613604e-10
in O 0 5.0385917660378254e-11
45 O 0 2.768162810085073e-09
German O 1 0.9954628348350525
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.113298987500457e-07
. O 0 5.923155299569771e-08

In O 0 4.547213450223353e-08
this O 0 7.750865504974058e-10
study O 0 3.6884029164241383e-10
we O 0 5.5711310564809935e-11
investigated O 0 1.3276573174181294e-09
45 O 0 4.969277878075218e-09
German O 1 0.8280746936798096
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.645853784486121e-10
for O 0 1.923346620857913e-10
germline O 0 1.405451310887429e-08
mutations O 0 1.993839537917097e-10
in O 0 1.0610997497328967e-10
the O 0 3.648410684675696e-09
BRCA1 O 0 4.57490401117866e-08
gene O 0 4.699922939721546e-08
. O 0 4.529934827246507e-08

We O 0 6.972010879735535e-08
identified O 0 6.522731865743481e-08
four O 0 8.691546149464102e-09
germline O 0 3.4104647284038947e-07
mutations O 0 4.144597109956294e-09
in O 0 7.163676318810985e-10
three O 0 5.406996628209981e-09
breast B-Disease 0 0.011934405192732811
cancer I-Disease 0 0.0019750744104385376
families O 0 2.6911959327691193e-09
and O 0 5.700128147267947e-10
in O 0 1.246044045721817e-09
one O 0 5.826333904224157e-07
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 4.603237258038462e-08
. O 0 2.991884517911103e-11
among O 0 3.521522917021569e-12
these O 0 2.3620977136068477e-12
were O 0 1.1454222292872629e-10
one O 0 1.590155090935852e-10
frameshift O 0 6.81235956534465e-09
mutation O 0 2.562436651754041e-10
, O 0 6.790674966783428e-11
one O 0 1.604572169577878e-10
nonsense O 0 2.4617744287525056e-08
mutation O 0 1.1646172914936415e-09
, O 0 1.180256864463658e-10
one O 0 1.36273881068405e-10
novel O 0 7.996832529499898e-09
splice O 0 5.658947088704736e-07
site O 0 7.474153740361089e-09
mutation O 0 2.1312990261534992e-10
, O 0 4.562496908055991e-11
and O 0 1.924836678934838e-10
one O 0 3.0362452552168406e-09
missense O 0 2.4049875264609e-06
mutation O 0 2.563085104156926e-07
. O 0 4.4131232357358385e-07

The O 0 4.6659636154799955e-07
missense O 0 4.3945569814241026e-06
mutation O 0 7.005936453197137e-08
was O 0 1.1862187676570102e-07
also O 0 7.519908029607336e-10
found O 0 8.650344329730331e-10
in O 0 1.6502049726696555e-09
2 O 0 1.1909403383469908e-06
. O 0 6.596448542950384e-07

8 O 0 1.5103670421012794e-06
% O 0 7.178643901539772e-09
of O 0 4.010283216615562e-09
the O 0 1.2193682730199384e-09
general O 0 4.608259995819708e-09
population O 0 2.3279453018054674e-11
, O 0 2.2359936818761028e-11
suggesting O 0 9.39562316837339e-11
that O 0 7.259706724660475e-12
it O 0 6.126865681466143e-11
is O 0 6.833929949712214e-11
not O 0 1.8126780632066186e-10
disease O 0 1.050572819849549e-07
associated O 0 3.07836074853185e-07
. O 0 3.089147639911971e-07

The O 0 1.8593959794088732e-07
average O 0 5.0918096405894175e-09
age O 0 2.443957702880084e-09
of O 0 3.808449999809227e-09
disease O 0 8.753054316912312e-06
onset O 1 0.9999969005584717
in O 0 5.631337618439147e-09
those O 0 1.1216860773544113e-09
families O 0 6.828955734228259e-10
harbouring O 0 7.51852411440268e-08
causative O 0 2.7622675702332344e-08
mutations O 0 1.5688805810043505e-09
was O 0 2.1943220573916733e-08
between O 0 6.059927670776233e-09
32 O 0 1.9547742624581588e-07
. O 0 1.9351999469563452e-07

3 O 0 9.463995411351789e-06
and O 0 2.1515461412491277e-07
37 O 0 3.3417563827242702e-06
. O 0 8.871784302755259e-07

4 O 0 3.0280225473688915e-06
years O 0 3.3859635095723206e-08
, O 0 7.691838832535325e-10
whereas O 0 2.237360963164292e-09
the O 0 3.495176814638512e-09
family O 0 8.308777665888556e-09
harbouring O 0 4.4496448481368134e-07
the O 0 9.709574477767546e-09
missense O 0 1.2506619384566875e-07
mutation O 0 2.7262965218710633e-09
had O 0 3.6799163716239036e-09
an O 0 2.5406957787632578e-11
average O 0 8.33558083668251e-11
age O 0 2.6966823218899094e-10
of O 0 5.852203166512027e-09
onset O 1 0.9994725584983826
of O 0 0.00016025520744733512
51 O 0 8.323077054228634e-06
. O 0 3.9119294115153025e-07

2 O 0 2.7150350433657877e-05
years O 0 1.1370427728252253e-06
. O 0 1.0307339834980667e-06

These O 0 3.009517257623884e-08
findings O 0 2.1264447980229306e-08
show O 0 1.4913990042941805e-09
that O 0 2.3124002712648917e-10
BRCA1 O 0 1.186503428840524e-08
is O 0 6.220776671561623e-10
implicated O 0 2.2556841727805477e-08
in O 0 4.394111186023508e-10
a O 0 4.334593239896378e-10
small O 0 1.1528809851224509e-10
fraction O 0 6.257644402651863e-10
of O 0 1.1717752101958467e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.1498992869007907e-09
suggesting O 0 8.580960247916991e-11
the O 0 1.6768681929124618e-11
involvement O 0 1.5143586384880336e-10
of O 0 1.102123947660516e-10
another O 0 2.5859450691889663e-10
susceptibility O 0 1.7477450597880306e-08
gene O 0 5.3594675364365685e-09
( O 0 1.2545438465849656e-08
s O 0 8.762842298892792e-06
) O 0 1.057402414517128e-06

Paternal O 0 0.0012372237397357821
transmission O 0 0.0024439264088869095
of O 0 0.0011952889617532492
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9999663829803467

We O 0 7.639517463076118e-08
report O 0 2.1568511421321546e-09
a O 0 6.632980276144451e-10
rare O 0 4.454261848252372e-09
case O 0 2.1070333033890165e-08
of O 0 2.3561635487112653e-07
paternally O 1 0.9999994039535522
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999988079071045
DM B-Disease 1 1.0
) O 0 8.394223414143198e-07
. O 0 2.8123579909333785e-07

The O 0 3.7887919006607262e-06
proband O 0 2.6436129701323807e-05
is O 0 7.583373928810033e-09
a O 0 4.114744545091753e-09
23 O 0 1.2730707155128584e-08
year O 0 2.1331383326383957e-09
old O 0 5.7130739151034504e-05
, O 0 2.1929347440163838e-06
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 6.615300662815571e-05
who O 0 5.161510898687993e-07
suffers O 1 0.9999223947525024
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9999749660491943

He O 0 9.376802978522392e-08
presented O 0 8.297553222291754e-08
with O 0 1.2561623741191852e-08
respiratory O 1 1.0
and O 0 4.0454406757817196e-07
feeding O 0 1.2561764606289216e-06
difficulties O 0 2.96518805953383e-06
at O 0 1.207266109304328e-07
birth O 0 7.891835025475302e-07
. O 0 5.242202973931853e-07

His O 0 1.202307794301305e-05
two O 0 1.658332735132717e-06
sibs O 1 0.9980102181434631
suffer O 0 3.5671998830366647e-06
from O 0 2.6378521056358295e-07
childhood O 0 0.0010810663225129247
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 0.001344306510873139

Their O 0 1.3096602913265087e-07
late O 0 1.6403684639954008e-05
father O 0 5.094375410408247e-06
had O 0 2.871252391400958e-08
the O 0 1.4444881957231814e-09
adult O 0 1.0029537617084472e-10
type O 0 4.963979782779404e-10
of O 0 6.5614109701073176e-09
DM B-Disease 1 1.0
, O 0 1.7767916027366937e-09
with O 0 2.9186464356456554e-10
onset O 1 0.9999884366989136
around O 0 1.1076464190296065e-08
30 O 0 7.015374503538396e-09
years O 0 4.881740789386413e-09
. O 0 2.4436513257342085e-08

Only O 0 3.3568724688848306e-08
six O 0 2.368259144347462e-09
other O 0 1.19447854385335e-11
cases O 0 4.066103703737056e-11
of O 0 1.14927212191418e-09
paternal O 0 3.5849820960720535e-06
transmission O 0 0.0001256074319826439
of O 0 1.990339660551399e-05
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 4.053854809171753e-06
been O 0 2.4042613233632437e-08
reported O 0 4.603111669609916e-09
recently O 0 1.9053439714866727e-08
. O 0 3.743069498796103e-08

We O 0 6.919482586908998e-08
review O 0 4.4779284280593856e-08
the O 0 1.130884830224943e-09
sex O 0 2.3267569815299538e-10
related O 0 1.609004596225816e-09
effects O 0 2.0354246288434297e-08
on O 0 1.9067801559913278e-08
transmission O 0 9.616592251404654e-07
of O 0 1.4851258356429753e-06
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.887753963470459

Decreased O 0 1.0974514452755102e-06
fertility O 0 3.3244376140828535e-07
of O 0 1.731135790272731e-09
males O 0 1.8304868037999356e-11
with O 0 2.6137625050437485e-11
adult O 0 2.4724455816027557e-09
onset O 1 0.9665231108665466
DM B-Disease 1 1.0
and O 0 4.644440920742454e-08
contraction O 0 1.3659879449789969e-08
of O 0 5.257039248363071e-09
the O 0 1.8248901278994367e-09
repeat O 0 2.411576494054657e-09
upon O 0 1.1373677555326367e-09
male O 0 1.6799389657151664e-10
transmission O 0 1.516263226086778e-10
contribute O 0 7.691244342800108e-12
to O 0 3.236936760298015e-11
the O 0 1.9927216821091776e-10
almost O 0 9.365529879401535e-11
absent O 0 1.5681684839563559e-09
occurrence O 0 3.1230612540511515e-10
of O 0 4.332824099506638e-10
paternal O 0 2.3124914605432423e-07
transmission O 0 4.707804919235059e-07
of O 0 6.547062412209925e-07
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.005375588778406382

Also O 0 3.2699423968551855e-07
the O 0 2.2696974966152084e-08
fathers O 0 8.03593209752762e-08
of O 0 2.4942922394188827e-08
the O 0 1.8538409918278376e-08
reported O 0 4.289985255923057e-08
congenitally O 0 0.036266885697841644
affected O 0 2.6026182098348727e-08
children O 0 2.179887381714707e-09
showed O 0 1.534942173364584e-09
, O 0 3.7066688607367837e-10
on O 0 3.539453841128193e-09
average O 0 8.402916140681782e-10
, O 0 1.1176947145585814e-09
shorter O 0 8.217839422286488e-07
CTG O 0 0.006791166961193085
repeat O 0 5.43412738807092e-07
lengths O 0 7.11914140083536e-07
and O 0 4.915148843487316e-10
hence O 0 3.925148206462836e-09
less O 0 1.2289085304928449e-09
severe O 0 3.285471734670864e-07
clinical O 0 5.123386017658049e-07
symptoms O 0 2.255483650515089e-06
than O 0 5.58267487793529e-10
the O 0 1.1432510493847303e-09
mothers O 0 1.774562163880944e-10
of O 0 1.1553332596170307e-10
children O 0 1.1425071305692924e-10
with O 0 4.113551277384886e-09
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9993765950202942

We O 0 3.088180733357149e-08
conclude O 0 2.00483949441832e-08
that O 0 1.0478737322294762e-10
paternal O 0 6.112447294981393e-07
transmission O 0 7.4757203947228845e-06
of O 0 9.337454685010016e-06
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 5.251820880403102e-07
rare O 0 6.378269912232781e-09
and O 0 1.88834142766936e-10
preferentially O 0 3.6565736549754035e-10
occurs O 0 2.6135132252802507e-11
with O 0 6.141850049379283e-12
onset O 0 3.104652250840445e-06
of O 0 1.5971310858731158e-05
DM B-Disease 1 1.0
past O 0 1.351156470263959e-06
30 O 0 3.1306068848380164e-09
years O 0 1.1209370237574845e-10
in O 0 2.806057296245168e-11
the O 0 2.1560273011367315e-10
father O 0 1.6969057270443955e-08
. O 0 2.5891244703757366e-09
. O 0 2.281098510081847e-08

The O 0 9.84777898338507e-07
RB1 O 0 4.019173138658516e-05
gene O 0 1.763086387995827e-08
mutation O 0 5.944747361041891e-09
in O 0 2.623173067650697e-10
a O 0 5.048534035267949e-09
child O 0 8.068199264243958e-08
with O 0 2.094338498181969e-07
ectopic B-Disease 1 0.9999995231628418
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 2.6483723559067585e-05

The O 0 3.204120503141894e-06
RB1 O 0 0.00011303921928629279
gene O 0 5.44433724769533e-08
mutation O 0 1.2064209187201413e-08
was O 0 2.169932500351024e-08
investigated O 0 9.435879633201694e-09
in O 0 2.87574880575292e-10
a O 0 2.3584367792039984e-09
child O 0 4.961997035479726e-08
with O 0 2.5709869788670403e-08
ectopic B-Disease 1 0.9944297671318054
intracranial I-Disease 1 0.9999619722366333
retinoblastoma I-Disease 0 5.650309049087809e-06
using O 0 1.0668880223718702e-09
DNA O 0 1.1345663297746e-09
obtained O 0 1.28946478494818e-10
from O 0 7.52896078815013e-11
both O 0 1.3037268487003928e-10
the O 0 6.313177980388218e-09
pineal B-Disease 1 0.952115535736084
and I-Disease 0 2.764519138054311e-07
retinal I-Disease 1 1.0
tumours I-Disease 1 1.0
of O 0 6.391758506651968e-05
the O 0 7.364591851910518e-07
patient O 0 7.539211310358951e-06
. O 0 2.2200255500592903e-07

A O 0 5.7145416576531716e-06
nonsense O 0 3.790060418396024e-06
mutation O 0 9.34241981553896e-08
in O 0 1.8025090753326367e-08
exon O 0 5.875514261788339e-07
17 O 0 3.6824456373096837e-08
( O 0 6.415002418158622e-10
codon O 0 2.8752678016275013e-09
556 O 0 2.3344005839476267e-08
) O 0 2.8975133403719155e-10
of O 0 3.2659883686392277e-09
the O 0 1.84642328093787e-08
RB1 O 0 5.0955728511326015e-05
gene O 0 7.265286594559939e-09
was O 0 6.3674638894895e-09
found O 0 1.6927306778491413e-10
to O 0 5.013666218300905e-11
be O 0 1.0310850090400336e-10
present O 0 2.406884913597196e-09
homozygously O 0 0.00019576074555516243
in O 0 6.704616861696877e-10
both O 0 8.108719806720899e-10
the O 0 5.531272329051262e-09
retinal B-Disease 0 6.467659113695845e-05
and I-Disease 0 1.934777316137115e-07
the I-Disease 0 3.958633897127584e-06
pineal I-Disease 1 0.9999998807907104
tumours I-Disease 1 1.0
. O 0 6.082910658733454e-06

The O 0 2.2953929601499112e-07
same O 0 1.1925862963835243e-08
mutation O 0 2.358109618683102e-08
was O 0 2.738529758516961e-08
present O 0 4.608839976327772e-09
heterozygously O 0 1.8394655398878967e-06
in O 0 7.654284428504354e-10
the O 0 4.0710107507280213e-10
DNA O 0 4.1053214161479445e-09
from O 0 4.0404779522162926e-10
the O 0 4.630230920898981e-10
constitutional O 0 3.169709605899129e-09
cells O 0 1.1111583875234032e-09
of O 0 1.8421028036286202e-09
the O 0 1.2900681634064881e-09
patient O 0 1.609435074101384e-08
, O 0 2.012511546300999e-10
proving O 0 2.9892653685692494e-08
it O 0 8.073159502020033e-11
to O 0 7.826984199654774e-11
be O 0 1.0800650651621169e-10
of O 0 5.964680305226011e-09
germline O 0 1.289919623559399e-06
origin O 0 1.2324517228989862e-07
. O 0 2.2987576642208296e-07

The O 0 1.3347629135296302e-07
initial O 0 3.195754061380285e-08
mutation O 0 1.863675613833493e-08
was O 0 3.4776498125665967e-08
shown O 0 1.1083326478811273e-09
to O 0 8.202847845417693e-10
have O 0 3.098916678823116e-10
occurred O 0 1.9078859381238544e-08
in O 0 3.0162894404384133e-10
the O 0 3.130398162909387e-09
paternally O 0 6.593228363271919e-07
derived O 0 3.2198670396610396e-07
RB1 O 0 0.0002697639574762434
allele O 0 1.0592050330160419e-06
. O 0 1.8873429041832424e-07

The O 0 3.0819265361969883e-07
mutation O 0 2.9284857205880144e-08
is O 0 8.004427676233661e-10
in O 0 1.992136455797322e-10
an O 0 8.881678725813913e-11
area O 0 1.289347517641204e-09
of O 0 1.4019566618728163e-09
the O 0 7.386256606345398e-10
gene O 0 3.707008311426563e-10
that O 0 3.198932438386315e-11
encodes O 0 4.3495665402737416e-10
the O 0 2.6480062587097564e-10
protein O 0 4.7444476125591e-10
- O 0 2.048189617909202e-09
binding O 0 1.6212282627492414e-09
region O 0 1.4554517591136573e-08
known O 0 1.0414309414841227e-08
as O 0 1.4349703647553724e-09
the O 0 2.5482402854493102e-09
pocket O 0 2.934020449174568e-05
region O 0 9.094499375805754e-08
and O 0 1.715569375448922e-08
has O 0 8.43424330376763e-10
been O 0 1.9771841108795485e-10
detected O 0 7.298560644741769e-10
in O 0 5.023063128634098e-12
other O 0 2.0737060072578695e-12
cases O 0 5.3730443705379827e-11
of O 0 6.464567103847685e-09
retinoblastoma B-Disease 0 0.23699475824832916
. O 0 1.491172838541388e-07
. O 0 1.9475191948004067e-07

Low O 0 3.7931160932203056e-06
levels O 0 4.767448302800403e-08
of O 0 1.5985316181854614e-08
beta O 0 7.166416082782234e-08
hexosaminidase O 0 7.807475981280732e-07
A O 0 2.6710335276902697e-08
in O 0 1.4992644625788643e-10
healthy O 0 2.851590907848589e-10
individuals O 0 1.8564769947021498e-12
with O 0 6.015114101254326e-11
apparent O 0 3.1381856388179585e-05
deficiency O 1 1.0
of O 0 4.298169369576499e-05
this O 0 1.5817112952731804e-08
enzyme O 0 7.95390775465421e-08
. O 0 2.5147567583871933e-08

Appreciable O 0 3.663604729808867e-05
beta O 0 5.164158210391179e-06
hexosaminidase O 0 1.2619816516235005e-05
A O 0 9.502978741693369e-07
( O 0 2.1088908397359774e-08
hex O 0 9.817134696277208e-07
A O 0 2.65128960563743e-07
) O 0 1.0317898757605803e-09
activity O 0 1.1028941093726985e-09
has O 0 2.4891047556430124e-10
been O 0 9.861175209735507e-10
detected O 0 1.1187040627191891e-08
in O 0 6.826508247570473e-10
cultured O 0 2.399580125711509e-07
skin O 0 1.8627091549205943e-06
fibroblasts O 0 1.2755738225678215e-06
and O 0 9.354634045166677e-08
melanoma B-Disease 1 1.0
tissue O 0 4.28230305260513e-06
from O 0 8.715650423596344e-09
healthy O 0 8.791093408788697e-10
individuals O 0 1.05632134983491e-11
previously O 0 5.499122823771074e-10
reported O 0 2.5788718382990794e-10
as O 0 2.1101359548580945e-10
having O 0 3.4870397680464293e-09
deficiency B-Disease 1 0.632176399230957
of I-Disease 0 0.0002381894300924614
hex I-Disease 0 2.866550858016126e-05
A I-Disease 0 5.3918398634777986e-08
activity O 0 3.2338834388134785e-10
indistinguishable O 0 4.353268301393598e-10
from O 0 9.743509818416207e-12
that O 0 1.346974073078433e-12
of O 0 1.1709201663823166e-10
patients O 0 8.78422168337778e-10
with O 0 1.2277628513857053e-07
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.4782330026719137e-06
TSD B-Disease 1 0.999983549118042
) O 0 8.776073912031279e-08
. O 0 1.3392191533512232e-07

Identification O 0 1.0984335858665872e-06
and O 0 8.22242043341248e-08
quantitation O 0 0.07915659248828888
of O 0 2.312074684596155e-05
hex O 0 4.972923488821834e-05
A O 0 5.655548420691048e-07
, O 0 4.175287227070612e-09
amounting O 0 3.192415221064948e-08
to O 0 2.296627066300516e-08
3 O 0 1.3522728750103852e-06
. O 0 7.31139948584314e-07

5 O 0 3.686104037115001e-06
% O 0 2.832578047673451e-07
- O 0 2.4534551812394056e-06
6 O 0 1.4898580502631376e-06
. O 0 3.8644003552690265e-07

9 O 0 2.2801691557106096e-06
% O 0 1.6006824310466072e-08
of O 0 1.0058168520288291e-08
total O 0 1.2489373979462925e-09
beta O 0 3.7865483193399996e-08
hexosaminidase O 0 4.874959813605528e-07
activity O 0 2.6202242597861414e-09
, O 0 2.0493921837339002e-10
has O 0 6.853065337431019e-11
been O 0 8.12069508859814e-11
obtained O 0 4.369706263496198e-10
by O 0 3.8740485819310777e-10
cellulose O 0 3.4172405776189407e-06
acetate O 0 1.8246772697239066e-06
gel O 0 5.514630743164162e-07
electrophoresis O 0 3.8087938492026296e-07
, O 0 1.4486717603290344e-08
DEAE O 0 2.2946996978134848e-05
- O 0 2.516681547604094e-07
cellulose O 0 2.1144144284335198e-06
ion O 0 1.0117414461774388e-07
- O 0 5.9194398716044816e-08
exchange O 0 1.2093583912076156e-08
chromatography O 0 3.279698645997087e-08
, O 0 4.953056298440117e-10
radial O 0 2.999488657451366e-08
immunodiffusion O 0 2.1096445834700717e-06
, O 0 2.0791031118960746e-09
and O 0 1.3416231681162571e-08
radioimmunoassay O 0 0.00011110982450190932
. O 0 8.384710667996842e-07

Previous O 0 5.1567171794886235e-06
family O 0 6.155559617582185e-08
studies O 0 6.927637352660554e-10
suggested O 0 5.15063880435207e-10
that O 0 5.567930665140164e-12
these O 0 6.705326398293021e-12
individuals O 0 7.445060193345121e-12
may O 0 3.4279515337409805e-10
be O 0 1.47397524741244e-10
compound O 0 2.506233443000383e-08
heterozygotes O 0 5.268542935255027e-09
for O 0 4.3627917251098935e-11
the O 0 2.3289192796482894e-10
common O 0 9.160250336037734e-09
mutant O 0 3.4868349985117675e-08
TSD B-Disease 0 2.1168959847273072e-06
gene O 0 1.0945973016873722e-09
and O 0 2.725182857155062e-10
a O 0 7.05120184463226e-10
rare O 0 3.101922274595381e-09
( O 0 9.851192084298077e-10
allelic O 0 3.0128776984383876e-07
) O 0 3.4070943844000112e-09
mutant O 0 1.891493894845553e-08
gene O 0 1.472565980265017e-08
. O 0 2.6783235185234844e-08

Thus O 0 4.98913436786097e-07
, O 0 7.700488247053272e-09
the O 0 5.28521004738991e-09
postulated O 0 3.9060691392478475e-07
rate O 0 1.2348749578450224e-08
mutant O 0 1.4797315373016318e-08
gene O 0 8.010002106040304e-10
appears O 0 1.61313140623065e-09
to O 0 1.3944487231576375e-10
code O 0 3.0974156572938227e-10
for O 0 9.511418042063013e-11
the O 0 2.5647201029599387e-10
expression O 0 3.2105906822010866e-10
of O 0 8.272688090116276e-10
low O 0 1.0801485039735326e-08
amounts O 0 7.221431785886523e-10
of O 0 6.64288446472483e-09
hex O 0 9.85303017841943e-07
A O 0 4.4681510757982323e-07
. O 0 1.9583046650950564e-07

Heterozygotes O 0 4.3577001633821055e-05
for O 0 1.764641410773038e-07
the O 0 9.75950484871646e-08
rare O 0 3.3686779943309375e-07
mutant O 0 1.7336122937194887e-07
may O 0 7.325872797281363e-09
be O 0 3.052851582641125e-10
indistinguishable O 0 2.1757927015642053e-08
from O 0 2.4138807619422664e-10
heterozygotes O 0 3.026891093327322e-08
for O 0 4.657449426126448e-10
the O 0 9.707629367028403e-09
common O 0 2.3601221528224414e-06
TSD B-Disease 1 0.9909952282905579
mutant O 0 4.594010533764958e-06
. O 0 1.430484672937382e-07

However O 0 2.221347017439257e-07
, O 0 2.853572711458696e-09
direct O 0 1.2200715104881965e-08
visualization O 0 6.577220119652338e-07
and O 0 2.1242477998839604e-08
quantitation O 1 0.9987267851829529
of O 0 9.181501809507608e-06
hex O 0 8.255361535702832e-06
A O 0 3.5823802591039566e-08
by O 0 8.158265035751455e-11
the O 0 2.3810847737948393e-10
methods O 0 4.595076763536099e-09
described O 0 1.8345152064114245e-09
may O 0 2.4210924931544753e-10
prevent O 0 9.542805434747947e-10
false O 0 8.972937060036656e-09
- O 0 1.3667906806347219e-08
positive O 0 2.3607171772965785e-10
prenatal O 0 5.7287451227239217e-08
diagnosis O 0 1.1255227718720562e-06
of O 0 1.0353786450423286e-07
TSD B-Disease 1 0.955269992351532
in O 0 1.21134142716528e-08
fetuses O 0 3.97269133145528e-08
having O 0 7.519262990030029e-10
the O 0 1.588264408880491e-09
incomplete O 0 2.5287590688094497e-07
hex B-Disease 0 2.997333103849087e-05
A I-Disease 0 2.057844994851621e-06
deficiency I-Disease 1 0.9962706565856934
of O 0 1.9576937120291404e-05
the O 0 6.844310007636523e-08
type O 0 2.0327793492924684e-07
described O 0 3.706488627130966e-08
in O 0 6.025153709288134e-10
the O 0 3.13897796644369e-09
four O 0 4.043864798575214e-09
healthy O 0 2.4531594533527823e-08
individuals O 0 8.590532729613187e-09

The O 0 2.0158076949883252e-06
tumor B-Disease 0 8.017114851099905e-06
suppressor O 0 9.09456593944924e-06
gene O 0 7.513893507393732e-08
Smad4 O 0 3.999520777142607e-05
/ O 0 3.6533820093609393e-06
Dpc4 O 0 1.4460762258750037e-06
is O 0 5.880472497832301e-11
required O 0 3.071060072912246e-11
for O 0 3.639246889952652e-11
gastrulation O 0 8.883063884468356e-08
and O 0 4.794024066612224e-10
later O 0 5.12035436273095e-09
for O 0 2.193759202073764e-10
anterior O 0 9.370827669386017e-09
development O 0 1.701017815491923e-08
of O 0 1.8449343386350847e-08
the O 0 3.4394751935451495e-08
mouse O 0 6.018824478815077e-07
embryo O 0 1.487987901782617e-07
. O 0 4.459296576442284e-08

Mutations O 0 7.799379204698198e-07
in O 0 3.526503888906518e-08
the O 0 1.0526608917871272e-07
SMAD4 O 1 0.9832556247711182
/ O 0 0.001974343555048108
DPC4 O 0 0.021963102743029594
tumor B-Disease 0 8.935068080972997e-07
suppressor O 0 1.230678208230529e-07
gene O 0 5.192243301976873e-10
, O 0 5.7983326473554087e-11
a O 0 1.178718567196313e-09
key O 0 4.6167872369551333e-07
signal O 0 3.986905539932195e-06
transducer O 0 2.5887020456139e-06
in O 0 4.0146836965959665e-09
most O 0 1.1964680357579027e-09
TGFbeta O 0 6.008363016007934e-06
- O 0 9.5949566514264e-08
related O 0 1.3510319085696665e-08
pathways O 0 1.8254757705449265e-08
, O 0 1.98627746195168e-11
are O 0 5.054044747813957e-13
involved O 0 4.2096738421537605e-12
in O 0 1.292416521025963e-11
50 O 0 1.466238935821096e-10
% O 0 3.9554789998952344e-10
of O 0 2.2296562462997827e-07
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 8.24044764158316e-06

Homozygous O 0 0.00011793967132689431
Smad4 O 0 0.0015887945191934705
mutant O 0 1.0172024303756189e-05
mice O 0 3.1203882144836825e-07
die O 0 2.390393660789414e-07
before O 0 7.652759137499743e-08
day O 0 2.41727690308835e-07
7 O 0 7.653568445675774e-07
. O 0 2.323101284673612e-07

5 O 0 9.913240319292527e-06
of O 0 2.207235411333386e-06
embryogenesis O 0 0.000182997333467938
. O 0 3.1609861252945848e-06

Mutant O 0 7.1364738687407225e-06
embryos O 0 2.878150837659632e-07
have O 0 8.258467798505364e-10
reduced O 0 6.474512925791487e-09
size O 0 2.54757437367914e-09
, O 0 4.786102625331523e-10
fail O 0 2.7053348006234046e-08
to O 0 3.508709545130273e-09
gastrulate O 0 2.4317463612533174e-05
or O 0 1.3464015680142438e-08
express O 0 3.321149133483914e-09
a O 0 8.028692710659868e-10
mesodermal O 0 5.871178814231826e-07
marker O 0 2.0718486837267847e-07
, O 0 1.5397040309395038e-09
and O 0 3.056739528162211e-09
show O 0 6.136543273527195e-09
abnormal O 0 1.2018917416867225e-08
visceral O 0 5.1409160732873715e-06
endoderm O 1 0.9172347784042358
development O 0 3.313126853754511e-06
. O 0 1.870752726063074e-07

Growth B-Disease 1 0.9999998807907104
retardation I-Disease 1 1.0
of O 0 7.056777394609526e-05
the O 0 1.488332941335102e-06
Smad4 O 1 0.997403085231781
- O 0 2.659488018252887e-05
deficient O 0 1.0880306717808708e-06
embryos O 0 4.9785464639739985e-09
results O 0 7.478823810247448e-11
from O 0 9.684872348536544e-11
reduced O 0 3.746102983370747e-09
cell O 0 8.802742534896879e-09
proliferation O 0 8.566479969829288e-09
rather O 0 1.0929924326719131e-10
than O 0 5.403846120577427e-11
increased O 0 1.7376395877732875e-09
apoptosis O 0 1.1574913969525369e-06
. O 0 1.0967779928705568e-07

Aggregation O 0 9.420286005479284e-06
of O 0 1.3815251804771833e-06
mutant O 0 1.5980733678588877e-06
Smad4 O 0 2.4206981834140606e-05
ES O 0 3.6186097531754058e-06
cells O 0 2.4545061538816526e-09
with O 0 2.0173884784924212e-10
wild O 0 1.507912550380297e-08
- O 0 1.7103158000963958e-08
type O 0 1.3716226021642797e-07
tetraploid O 0 0.00011358259507687762
morulae O 0 0.0001637470704736188
rescues O 0 3.010984300999553e-06
the O 0 4.577033863029101e-08
gastrulation B-Disease 0 0.0001031241481541656
defect I-Disease 0 2.9171549613238312e-05
. O 0 5.505823423845868e-07

These O 0 5.043166240170649e-08
results O 0 6.663582130528312e-09
indicate O 0 6.4429022117451495e-09
that O 0 4.4278650190854307e-10
Smad4 O 0 2.799086132654338e-06
is O 0 2.0105585252228053e-10
initially O 0 1.6059897856024463e-10
required O 0 3.8617411352026565e-11
for O 0 1.500190423275871e-11
the O 0 1.3153587941072686e-10
differentiation O 0 1.883270872582443e-09
of O 0 4.7348764908861085e-09
the O 0 2.282185329605113e-09
visceral O 0 3.0299122499855e-07
endoderm O 0 6.957926962058991e-05
and O 0 1.3783824082125307e-09
that O 0 4.859421545710951e-11
the O 0 1.841400143476335e-09
gastrulation B-Disease 0 3.2596663004369475e-06
defect I-Disease 0 3.6419783100427594e-07
in O 0 2.114726171953407e-09
the O 0 1.269162552830494e-08
epiblast O 0 5.688480086973868e-05
is O 0 1.6972737659770587e-09
secondary O 0 2.3596394171931934e-08
and O 0 2.3368182944238924e-09
non O 0 1.9626122593763284e-07
- O 0 4.351726602180861e-06
cell O 0 4.498097041505389e-06
autonomous O 0 1.8090106834733888e-07
. O 0 9.510288379033227e-08

Rescued O 0 0.0009276695200242102
embryos O 0 5.245111424301285e-06
show O 0 7.50761941503697e-08
severe O 0 2.0019217572553316e-06
anterior O 0 1.5040718608361203e-05
truncations O 1 0.9999892711639404
, O 0 3.836126083456293e-08
indicating O 0 5.00638286382582e-08
a O 0 1.5575245981835906e-08
second O 0 5.5409689281304964e-08
important O 0 1.4606021281338144e-08
role O 0 2.2608270811019793e-08
for O 0 5.590029772406524e-09
Smad4 O 0 0.01230577565729618
in O 0 1.4604349729552268e-08
anterior O 0 1.8677129673960735e-06
patterning O 0 2.2931944840820506e-05
during O 0 9.077738241103361e-07
embryogenesis O 0 1.1321346391923726e-05
. O 0 2.1325114119008504e-07

Prevalence O 0 1.0796667993417941e-05
of O 0 7.878562087171304e-07
p16 O 0 1.5525054095633095e-06
and O 0 5.801648939041115e-08
CDK4 O 0 0.005972868297249079
germline O 0 1.4817679584666621e-05
mutations O 0 7.360610965179148e-08
in O 0 7.814565883279556e-09
48 O 0 8.021443136385642e-07
melanoma B-Disease 1 1.0
- O 1 0.994731068611145
prone O 0 0.0003966366348322481
families O 0 3.495531686326103e-08
in O 0 3.2365077284879362e-09
France O 0 1.581811233108965e-07
. O 0 2.554783122832305e-07

The O 0 4.06787830797839e-06
French O 0 2.3478412913391367e-05
Familial B-Disease 1 0.9819639921188354
Melanoma I-Disease 1 1.0
Study O 0 2.9564586156993755e-07
Group O 0 1.492315959694679e-08
. O 0 3.037694895624554e-08

Germline O 0 0.0001780806778697297
mutations O 0 4.174381729171728e-07
in O 0 1.6445500961026482e-08
the O 0 2.755989392255742e-08
p16 O 0 1.3057220371592848e-07
and O 0 1.3046933311500197e-08
CDK4 O 0 0.01372209470719099
genes O 0 1.0595515576028447e-08
have O 0 6.234698868290423e-10
been O 0 7.138565849551526e-10
reported O 0 2.6401389408015064e-10
in O 0 8.07737973729239e-11
a O 0 6.764422910698897e-10
subset O 0 1.444502828462646e-08
of O 0 2.7158558069118044e-08
melanoma B-Disease 1 0.9999911785125732
pedigrees O 0 4.6611336301793926e-07
, O 0 2.4446697444169274e-10
but O 0 3.388491223721424e-11
their O 0 4.164156866548474e-11
prevalence O 0 2.210894356480253e-09
is O 0 1.726761268694421e-11
not O 0 1.8049423067267867e-11
well O 0 5.262594804378296e-10
known O 0 1.5761155935933857e-08
. O 0 6.376058081514202e-08

We O 0 2.4794866249067127e-07
searched O 0 1.9760801706070197e-07
for O 0 3.670101167418949e-10
such O 0 4.90357754401316e-09
germline O 0 6.059230145183392e-06
mutations O 0 7.213577646325575e-08
in O 0 1.306780461618473e-08
48 O 0 6.14997475167911e-07
French O 0 0.00018047606863547117
melanoma B-Disease 1 1.0
- O 1 0.9999517202377319
prone O 0 7.78910907683894e-06
families O 0 1.5688985666173494e-09
selected O 0 2.0248401566558272e-10
according O 0 3.140705404081068e-11
to O 0 4.6491841626528085e-11
two O 0 7.767984866458022e-11
major O 0 1.1107303965474102e-09
criteria O 0 1.830488649545714e-09
families O 0 1.7631922311078796e-10
with O 0 6.894784743138871e-11
at O 0 1.9204078327561547e-09
least O 0 5.835378014129589e-11
three O 0 1.0078302775662351e-10
affected O 0 1.8476262186872816e-10
members O 0 2.3450641428723884e-10
( O 0 3.1988178772479614e-10
n O 0 5.081282949959132e-09
= O 0 5.452835072361495e-09
20 O 0 4.931413055686562e-10
) O 0 3.2137320582492634e-11
or O 0 1.3755976913110146e-10
families O 0 1.0621709067848428e-10
with O 0 3.6889217375213335e-11
two O 0 1.8857142236594626e-10
affected O 0 4.741479986414276e-10
members O 0 8.776747384420247e-11
, O 0 5.6714841156768614e-11
one O 0 6.19890944131285e-11
of O 0 5.114670909023289e-10
them O 0 1.088378345781571e-10
affected O 0 3.25818427793223e-10
before O 0 9.111454923882434e-10
the O 0 2.5115615143178616e-10
age O 0 3.0496855041306503e-10
of O 0 1.3427284839551135e-09
50 O 0 8.202049039951476e-10
( O 0 1.464422333397053e-10
n O 0 2.6147823906086387e-09
= O 0 4.2555425849855055e-09
28 O 0 3.1487159546372823e-09
) O 0 6.697456478299557e-11
, O 0 6.233435295710521e-11
and O 0 1.1264279786704634e-10
one O 0 1.7788252815176264e-10
additional O 0 1.4682602911264553e-09
minor O 0 1.326405651980167e-07
criterion O 0 4.480284405872226e-05
. O 0 5.288117108648294e-07

Sixteen O 0 4.3388554331613705e-06
different O 0 2.6333623281971086e-08
p16 O 0 4.0852069105312694e-07
germline O 0 4.4427039824768144e-07
mutations O 0 9.930426481119525e-10
were O 0 4.4595471759834027e-10
found O 0 3.4277813920624567e-10
in O 0 2.479206839822723e-10
21 O 0 3.128863834689355e-09
families O 0 4.5656506353353166e-10
, O 0 1.652708248034429e-10
while O 0 3.910604617907154e-10
one O 0 4.917924401048879e-10
germline O 0 1.1869520477603146e-07
mutation O 0 4.102785222670491e-09
, O 0 7.508298982550343e-10
Arg24His O 0 3.120342626061756e-06
, O 0 2.3235515733688317e-09
was O 0 4.317632473771482e-08
detected O 0 1.7837058052805332e-08
in O 0 6.553578235646285e-10
the O 0 2.464833137594269e-08
CDK4 O 0 0.0024265293031930923
gene O 0 6.99286601957283e-07
. O 0 4.0938064671536267e-07

The O 0 1.7015898379213468e-07
frequency O 0 7.981551419788957e-08
of O 0 1.5610696735279816e-08
p16 O 0 1.3924993602643099e-08
gene O 0 6.870082835952473e-10
mutation O 0 1.5658006835561622e-10
in O 0 7.974220589401781e-11
our O 0 6.769637628245562e-10
sample O 0 8.009050367352444e-11
( O 0 5.778404491008082e-11
44 O 0 7.760095899200792e-10
% O 0 2.625691053470547e-10
) O 0 7.047770006485266e-11
is O 0 3.1296607666542187e-11
among O 0 5.7885755216924295e-11
the O 0 3.2707742070314794e-10
highest O 0 1.2447856967412463e-08
rates O 0 5.889331244901541e-10
yet O 0 1.1046914771828398e-10
reported O 0 1.47910364511894e-10
and O 0 7.089862030795757e-11
the O 0 7.481324448832538e-10
CDK4 O 0 1.4091925777393044e-06
mutation O 0 3.3544178545952263e-10
is O 0 3.190182493173488e-11
the O 0 1.7614644465258067e-10
second O 0 1.4930697789239389e-09
mutation O 0 4.854300850176685e-10
detected O 0 2.409319188600989e-09
in O 0 7.312687261284978e-11
this O 0 1.7898554860451554e-10
gene O 0 8.742972568143159e-09
worldwide O 0 1.4221810396009005e-08
. O 0 1.2061221354997542e-07

In O 0 1.823830189096043e-07
summary O 0 5.044494173489511e-07
, O 0 7.959367387400107e-09
our O 0 7.509535215888263e-09
results O 0 1.800501636672891e-09
show O 0 5.333145591812638e-10
frequent O 0 1.111209235737931e-09
involvement O 0 4.228365657610311e-09
of O 0 2.4311073154592577e-09
the O 0 4.171482270720617e-09
p16 O 0 8.60755644538358e-09
gene O 0 1.284475192875334e-09
in O 0 4.829384669946535e-10
familial B-Disease 0 1.0909836873906897e-06
melanoma I-Disease 1 0.9999936819076538
and O 0 2.927506903560584e-09
confirm O 0 2.0469672623590895e-09
the O 0 1.7088150894295495e-09
role O 0 2.1417609907814494e-09
of O 0 4.9622590481135376e-09
the O 0 9.941631518017857e-09
CDK4 O 0 0.00048498730757273734
gene O 0 4.156344601824458e-09
as O 0 1.5224946858793942e-09
a O 0 8.875439050370915e-09
melanoma B-Disease 1 0.9999274015426636
- O 0 4.3420863221399486e-05
predisposing O 0 2.273483551107347e-05
gene O 0 6.477998937270968e-08
. O 0 1.818712824785962e-08
. O 0 8.434363962805946e-08

Progression O 0 2.4249404305010103e-05
of O 0 3.174078301526606e-06
somatic O 0 0.00010737679258454591
CTG O 0 8.97221834748052e-05
repeat O 0 3.9562674913895535e-08
length O 0 2.776437968421419e-09
heterogeneity O 0 1.6500296240451462e-08
in O 0 5.443331896337611e-11
the O 0 2.421314260203644e-10
blood O 0 1.1565465252161289e-09
cells O 0 1.3092252615365396e-08
of O 0 1.524323778312464e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9998032450675964
. O 0 3.5471443879941944e-06

The O 0 1.4518369084726146e-07
genetic O 0 4.0388403732549705e-08
basis O 0 3.8473665142646496e-08
of O 0 6.550696980411885e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9954620003700256
DM B-Disease 1 1.0
) O 0 7.519295408542348e-09
is O 0 1.1570400887395138e-10
the O 0 2.9942953672090766e-10
expansion O 0 7.3807395750691285e-09
of O 0 7.083583941636107e-09
an O 0 1.3761888295604763e-09
unstable O 0 1.918818043122883e-06
CTG O 0 1.9366787455510348e-05
repeat O 0 3.989784502778093e-08
in O 0 5.666243030333362e-10
the O 0 3.776535528743352e-09
34 O 0 9.588879912314496e-09
UTR O 0 0.000388401240343228
of O 0 4.808598674799214e-08
the O 0 1.2001535765193694e-07
DM B-Disease 1 1.0
protein O 0 4.470350134511136e-08
kinase O 0 4.128267505620897e-08
gene O 0 1.0192791055629868e-09
on O 0 3.2109228609300544e-09
chromosome O 0 1.82917379021319e-08
19 O 0 4.765221106595163e-08
. O 0 1.2204746724364668e-07

One O 0 7.037879612425968e-08
of O 0 2.0082380203234607e-08
the O 0 5.496126664894518e-09
principal O 0 3.5066641146386246e-08
features O 0 1.5194688840480808e-09
of O 0 6.571330590787738e-09
the O 0 6.907101379738378e-08
DM B-Disease 1 1.0
mutation O 0 6.104407646034815e-08
is O 0 8.892853675668277e-10
an O 0 1.713898814537096e-11
extraordinarily O 0 7.626163700535926e-09
high O 0 5.860044449690349e-09
level O 0 4.629067351658023e-09
of O 0 3.127992753704234e-09
somatic O 0 5.666204856424883e-07
mosaicism O 0 8.304506991407834e-06
, O 0 9.889952051755913e-11
due O 0 2.2001378496838697e-09
to O 0 2.8339200430771427e-10
an O 0 5.8123283963595895e-11
extremely O 0 2.259903375545491e-09
high O 0 4.4637533669344975e-09
degree O 0 1.4430185046876431e-08
of O 0 5.7264148978219964e-09
somatic O 0 4.107987479073927e-07
instability O 0 1.0096460556496822e-07
both O 0 5.715674600281773e-10
within O 0 6.988459810841618e-10
and O 0 1.8198768880761662e-10
between O 0 2.1347895673429207e-10
different O 0 5.960640314661703e-10
tissues O 0 1.7425531950721052e-07
. O 0 6.744949132553302e-08

This O 0 2.822778526478942e-07
instability O 0 1.0376624231867027e-05
appears O 0 6.988666712004488e-08
to O 0 1.0205278844210852e-09
be O 0 2.5326027386363137e-10
biased O 0 1.029896878890213e-08
towards O 0 6.6148664323861794e-09
further O 0 6.830727650175561e-10
expansion O 0 3.6840388517589417e-09
and O 0 1.7343142200143546e-10
continuous O 0 1.3742241788960996e-09
throughout O 0 1.1565613050601442e-10
the O 0 2.433416523839327e-10
life O 0 3.844751461645757e-10
of O 0 2.5630916833385697e-10
an O 0 1.163941078935471e-11
individual O 0 1.8128838274317216e-12
, O 0 9.41079245780907e-12
features O 0 4.531051575606959e-11
that O 0 4.907837157508421e-12
could O 0 1.6682683012803068e-10
be O 0 1.0357703583707689e-10
associated O 0 8.145550900451326e-10
with O 0 1.9946307106000205e-10
the O 0 1.0580531117909686e-08
progressive O 0 1.3882398661735351e-06
nature O 0 3.031523254648505e-09
of O 0 6.61607790775065e-09
the O 0 1.8034926441146126e-08
disease O 0 4.458685907593463e-06
. O 0 1.1457908755119206e-07

Although O 0 1.4267133963130618e-07
increasing O 0 2.0716937498832522e-08
measured O 0 2.0707060954805456e-08
allele O 0 5.914527534400804e-09
size O 0 5.92954740863405e-10
between O 0 5.445826567473944e-10
patients O 0 2.8391424766738282e-09
clearly O 0 5.649236078930642e-10
correlates O 0 1.1673972899473029e-09
with O 0 1.3163846748764918e-11
an O 0 2.909206079163007e-12
increased O 0 7.964203602162101e-11
severity O 0 4.1042048337658343e-07
of O 0 2.7805361568766784e-08
symptoms O 0 1.7361517166136764e-06
and O 0 7.789041633898819e-10
an O 0 1.3745636573414544e-11
earlier O 0 1.026395426984017e-10
age O 0 4.36945410409173e-11
of O 0 1.7192987311620556e-10
onset O 0 9.212816394210677e-07
, O 0 4.0556936281577194e-11
this O 0 6.477837797419506e-12
correlation O 0 2.5365754635631177e-11
is O 0 6.4748484351895286e-12
not O 0 6.359431210800626e-12
precise O 0 2.0733490480040473e-09
and O 0 3.335233755841216e-10
measured O 0 1.2557976880600563e-09
allele O 0 6.403010344158133e-10
length O 0 4.832047539871098e-10
cannot O 0 2.9093977227390155e-10
be O 0 3.2983754616466854e-11
used O 0 3.900570422210592e-10
as O 0 1.2700766827133947e-10
an O 0 7.96198176833407e-12
accurate O 0 2.5300352923807168e-09
predictor O 0 1.499519726166909e-07
of O 0 9.059920813569988e-09
age O 0 1.629341639386439e-08
of O 0 2.5594596664291203e-08
onset O 1 0.9935181736946106
. O 0 9.239546443495783e-07

In O 0 4.088670735313826e-08
order O 0 2.3550891015133857e-08
to O 0 1.5911691964021202e-09
further O 0 3.1088998042605454e-09
characterize O 0 6.256826168282714e-08
the O 0 1.4143065385496811e-08
dynamics O 0 4.049779533943365e-07
of O 0 1.4600292388422531e-06
DM B-Disease 1 1.0
CTG O 1 0.8544837832450867
repeat O 0 3.360575817623612e-07
somatic O 0 7.453286343661603e-07
instability O 0 1.3473474780312245e-07
, O 0 2.655400621609516e-10
we O 0 2.3280698549510426e-11
have O 0 1.586179972090651e-11
studied O 0 1.5766732364141944e-10
repeat O 0 1.2542937521953235e-10
length O 0 1.439651436258016e-11
changes O 0 1.0229863831034969e-11
over O 0 1.5008830983598287e-11
time O 0 3.3285593031839866e-11
in O 0 8.025596853755701e-11
111 O 0 5.042310249336879e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 6.18427463905391e-07
with O 0 3.7361520127676684e-11
varying O 0 9.69313851406639e-10
clinical O 0 3.316030117161972e-08
severity O 0 1.580366188136395e-05
and O 0 1.0300387742745443e-07
CTG O 0 1.3067029613011982e-05
repeat O 0 5.664495539292602e-09
size O 0 1.5959068788706787e-10
over O 0 6.652006029339574e-11
time O 0 3.218455363329653e-11
intervals O 0 1.1408412409208424e-10
of O 0 5.218912524362906e-10
1 O 0 1.9523257677178663e-08
- O 0 7.107040289611177e-08
7 O 0 7.996637663154615e-08
years O 0 2.29944099316981e-08
. O 0 9.150631541388066e-08

We O 0 2.685598587959248e-07
have O 0 4.903839112557762e-09
found O 0 1.5667096509019984e-09
a O 0 8.51607062646309e-10
direct O 0 5.749309917035816e-09
progression O 0 5.426215921033872e-08
of O 0 2.9017693137234346e-08
the O 0 9.618260854438176e-09
size O 0 4.358438054907765e-09
heterogeneity O 0 3.3546960764851974e-08
over O 0 3.2963332063928874e-10
time O 0 1.7642821925623053e-10
related O 0 6.894209647612115e-10
to O 0 5.271193481704017e-10
initial O 0 5.620245602244722e-08
CTG O 0 7.68724930821918e-06
repeat O 0 5.731791485885651e-09
size O 0 2.9785285349248625e-10
and O 0 6.506618854817958e-11
the O 0 1.9514526106156893e-10
time O 0 1.8657188294302074e-10
interval O 0 1.963513129865646e-09
and O 0 3.507483192777272e-10
always O 0 8.731569356434932e-10
biased O 0 6.579758515812273e-09
towards O 0 6.369710980891341e-09
further O 0 4.831330890908703e-09
expansion O 0 3.544083710949053e-07
. O 0 1.244672205302777e-07

Attempts O 0 6.871753157611238e-06
to O 0 5.303652628185773e-08
mathematically O 0 1.5819833265595662e-07
model O 0 3.9772405813209843e-08
the O 0 3.277666138501445e-08
dynamics O 0 1.6727219076528854e-07
have O 0 3.765322276194638e-09
proved O 0 7.995460578058555e-07
only O 0 4.5542136728471405e-10
partially O 0 1.1396245724881737e-08
successful O 0 1.9916817084464356e-09
suggesting O 0 1.8156608161401522e-10
that O 0 2.7796397995827338e-12
individual O 0 1.1973245745561245e-12
specific O 0 1.6174461076046143e-11
genetic O 0 1.0860272681156857e-09
and O 0 3.006977999930882e-10
/ O 0 4.820876711164601e-07
or O 0 1.2764790335850762e-09
environmental O 0 3.2089944035362805e-09
factors O 0 1.811181621347302e-10
also O 0 1.475198574407699e-10
play O 0 4.2612910422512584e-10
a O 0 9.874576711865757e-10
role O 0 7.736572271710429e-09
in O 0 1.9990040733830483e-09
somatic O 0 3.1317845241574105e-06
mosaicism O 0 0.0003057561407331377
. O 0 3.540623794151543e-08
. O 0 1.1990701409558824e-07

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 4.2868606442425516e-07
Palestinian O 0 4.952417384629371e-06
Arabs O 0 4.9795739869296085e-06
. O 0 4.6882118454050214e-07

Aspartylglucosaminuria B-Disease 1 1.0
( O 0 0.42294490337371826
AGU B-Disease 1 1.0
) O 0 1.2616581557267637e-07
is O 0 2.335628579430704e-09
a O 0 1.1039111846855576e-08
rare O 0 6.942762865946861e-06
disorder B-Disease 1 1.0
of I-Disease 1 0.9997853636741638
glycoprotein I-Disease 1 0.9998749494552612
metabolism I-Disease 0 5.882045115868095e-06
caused O 0 3.4412253047122476e-09
by O 0 6.262560608982781e-11
the O 0 1.855892106661372e-09
deficiency B-Disease 0 0.011342192068696022
of I-Disease 0 3.2576306239207042e-06
the I-Disease 0 1.1202091627637856e-06
lysosomal I-Disease 0 8.594088285462931e-05
enzyme I-Disease 0 7.906655241640692e-08
aspartylglucosaminidase I-Disease 0 1.178886464003881e-06
( O 0 2.8611208957585177e-09
AGA O 0 7.015806477284059e-05
) O 0 1.298605845079237e-08
. O 0 9.492745789430046e-08

AGU B-Disease 1 1.0
is O 0 1.2602898777913651e-06
inherited O 1 0.942767322063446
as O 0 7.347874486640649e-08
an O 0 2.343853333641732e-09
autosomal O 0 4.773424006998539e-05
recessive O 0 0.00031956101884134114
trait O 0 4.718084528576583e-05
and O 0 1.1476780414909626e-08
occurs O 0 2.6663732333176426e-10
with O 0 1.8401379378585325e-11
a O 0 8.633959658332913e-10
high O 0 3.253964564464695e-08
frequency O 0 1.4512188784010505e-08
in O 0 3.52938039904771e-10
Finland O 0 3.040574236834459e-09
because O 0 3.3794564369138413e-10
of O 0 7.599591178575338e-09
a O 0 2.096698104026018e-08
founder O 0 1.8318362435820745e-06
effect O 0 9.484710261631335e-08
. O 0 1.1097593954900731e-07

While O 0 3.589596246911242e-07
very O 0 1.4529748071367976e-08
few O 0 1.5156025767737447e-08
patients O 0 3.7657624574194415e-08
with O 0 2.0589974170093228e-08
AGU B-Disease 1 1.0
have O 0 3.4500672541071253e-07
been O 0 5.650251821975871e-09
reported O 0 7.850850525237263e-10
from O 0 1.9723854494113624e-10
non O 0 5.472078790091928e-09
- O 0 1.4701890371782156e-08
Finnish O 0 3.5907399364987214e-07
origin O 0 6.891688553167796e-09
, O 0 1.064347388002318e-09
we O 0 6.578488309649799e-10
diagnosed O 0 1.2897196029371116e-05
the O 0 5.533364699772392e-08
disorder O 0 5.0578593800310045e-05
in O 0 7.145231073479863e-09
8 O 0 1.1523457743578547e-08
patients O 0 6.04223171496443e-10
originating O 0 1.5926661101062223e-09
from O 0 1.6535698366126894e-09
3 O 0 5.313714801502556e-09
unrelated O 0 1.8981138882878668e-09
families O 0 3.541748005986278e-10
, O 0 6.90067863962085e-11
all O 0 3.5410844395622476e-11
Palestinian O 0 7.1503296616981515e-09
Arabs O 0 3.868557030273223e-09
from O 0 1.7273847630061567e-10
the O 0 2.2469821836512693e-10
region O 0 1.4373316981064477e-09
of O 0 1.3296397760598211e-08
Jerusalem O 0 7.2157154136220925e-06
. O 0 3.359915865530638e-07

The O 0 2.856662604244775e-07
clinical O 0 2.9171801543270703e-06
diagnosis O 1 1.0
of O 1 0.9999991655349731
AGU B-Disease 1 1.0
is O 0 2.3577213426051458e-07
often O 0 1.7658586815016974e-09
difficult O 0 5.5469513426942285e-09
, O 0 8.319458316696782e-11
in O 0 3.082450614200205e-11
particular O 0 3.5699893041751807e-10
early O 0 2.1255688764654224e-08
in O 0 1.3780977747845924e-10
the O 0 3.5898867212225127e-10
course O 0 6.322308232498131e-10
of O 0 2.5553253957255606e-10
the O 0 2.834563417319913e-10
disease O 0 1.0227523006278716e-07
, O 0 3.482649238439883e-11
and O 0 2.5510777518222838e-11
most O 0 8.825630504194493e-11
of O 0 4.686260712816193e-09
the O 0 9.383777310745245e-09
patients O 0 5.6337654541493976e-09
are O 0 9.987025789692794e-11
diagnosed O 0 1.9676009799241e-07
after O 0 1.4858461128142153e-08
the O 0 2.94009172563392e-09
age O 0 2.4825959066276937e-09
of O 0 1.1548233480596082e-08
5 O 0 2.3898369505559458e-08
years O 0 2.467575654918619e-08
. O 0 8.531003459211206e-08

However O 0 4.2809327283066523e-07
, O 0 5.21065945946475e-09
since O 0 1.7633848825582277e-09
these O 0 6.711756705968241e-10
patients O 0 1.125134385659976e-08
excrete O 0 1.4662438729828864e-07
early O 0 2.1576010311719074e-08
large O 0 2.771394502776303e-10
amounts O 0 6.528875218236863e-10
of O 0 7.967615012205442e-09
aspartylglucosamine O 0 2.1675350581062958e-06
in O 0 6.05145877852209e-10
urine O 0 1.779925651312908e-09
, O 0 2.8347619390745038e-11
biochemical O 0 2.185049030600794e-09
screening O 0 7.152867187443235e-09
is O 0 2.9643482113428377e-10
easy O 0 1.5228286409652014e-09
by O 0 3.0075805734774974e-10
urine O 0 8.097086556801969e-09
chromatography O 0 1.9027842768082337e-07
. O 0 1.5401747432974844e-08
. O 0 1.6103554401070141e-07

Detection O 0 3.5452849260764197e-05
of O 0 3.803784522915521e-07
heterozygous O 0 2.2333500382387683e-08
carriers O 0 2.096977036458725e-09
of O 0 5.401852742892288e-09
the O 0 1.3706471690966282e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.2016729417373426e-06
ATM O 0 1.5325082358685904e-06
) O 0 2.803410559248931e-10
gene O 0 1.631196427931414e-10
by O 0 9.44705286221037e-11
G2 O 0 1.7937297798198415e-06
phase O 0 3.462229472006584e-07
chromosomal O 0 2.954569993107725e-07
radiosensitivity O 0 2.893496230171877e-06
of O 0 5.5196192505491126e-08
peripheral O 0 0.00015108428488019854
blood O 0 1.4547101727657719e-06
lymphocytes O 0 1.823024831537623e-06
. O 0 2.939477496965992e-07

In O 0 1.8564773199614137e-05
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9830198884010315
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 8.163908660208108e-09
patients O 0 9.728148953058735e-09
, O 0 7.025355991396864e-11
mutations O 0 5.345383857768837e-11
in O 0 4.9945297897480145e-11
a O 0 2.207762167527605e-10
single O 0 1.3124742959114144e-10
gene O 0 5.017473936330674e-11
, O 0 2.0889710100613357e-11
ATM O 0 2.74579470271874e-08
, O 0 1.622510459320381e-11
result O 0 1.1477118561087352e-10
in O 0 3.131059300720551e-10
an O 0 7.028741588754883e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 5.172065442593521e-08
embraces O 0 2.8222123304999513e-08
a O 0 2.8658164730188673e-10
variety O 0 3.0575017517797676e-10
of O 0 9.693322811088478e-10
clinical O 0 7.338910279486299e-08
features O 0 3.571906859178853e-08
and O 0 4.346035975544282e-09
manifests O 0 3.733215692136582e-08
extreme O 0 9.165669325739145e-07
radiosensitivity O 0 5.745383532484993e-06
and O 0 1.9514831972600177e-09
a O 0 3.5425740119165994e-09
strong O 0 1.8568419690723204e-08
pre O 0 0.0007483187946490943
- O 0 5.031568434787914e-05
disposition O 0 6.592226418433711e-05
to O 0 7.245527910981764e-08
malignancy B-Disease 1 0.99456387758255
. O 0 3.028973480923014e-07

Heterozygotes O 0 1.4386249858944211e-05
for O 0 4.89350782117981e-08
the O 0 3.832118622426606e-08
ATM O 0 4.3874328525816964e-07
gene O 0 2.500659679327555e-09
have O 0 1.2602649479553918e-10
no O 0 2.428348633287669e-10
clinical O 0 4.312379342508166e-09
expression O 0 3.406899207192282e-09
of O 0 9.871609307765539e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 2.6708948386300335e-09
may O 0 2.9935660617042004e-09
be O 0 6.963193910358711e-10
cancer B-Disease 0 5.744795998907648e-07
prone O 0 1.2671935500918607e-08
with O 0 9.013151336390024e-11
a O 0 3.333899822877129e-09
moderate O 0 1.286972803882236e-07
increase O 0 8.245309990329019e-10
in O 0 1.223764978242059e-09
in O 0 1.882157762977954e-09
vitro O 0 3.930833543108747e-07
radiosensitivity O 0 5.194044661038788e-06
. O 0 5.5024855782903614e-08

We O 0 8.586110880060005e-07
performed O 0 3.7185199630584975e-07
a O 0 8.152350972068234e-08
blind O 0 7.347930477408227e-07
chromosomal O 0 1.8576642446532787e-07
analysis O 0 3.138608306585411e-08
on O 0 5.839628514081596e-08
G2 O 0 2.4163398393284297e-06
- O 0 3.974510320858826e-08
phase O 0 4.834818412291497e-08
lymphocytes O 0 5.97635274601771e-09
from O 0 1.3617988958714022e-09
7 O 0 5.729517749131219e-09
unrelated O 0 1.0321722143658008e-08
A B-Disease 1 0.999997615814209
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
patients O 0 3.6940787140338216e-06
, O 0 4.24477741844953e-09
13 O 0 6.736487367930977e-09
obligate O 0 3.2167726260468044e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 3.894043038599193e-05
( O 0 2.4778983309658997e-09
parents O 0 2.1038908115667e-10
of O 0 5.14045139787811e-10
the O 0 4.273744969029991e-10
patients O 0 1.9474145906972495e-10
) O 0 2.3257484479954904e-11
, O 0 5.116327500553908e-11
and O 0 7.735948548415195e-10
14 O 0 3.1551368184778994e-09
normal O 0 4.122882923951465e-09
controls O 0 1.2251551773090341e-08
following O 0 2.366227214167793e-09
X O 0 5.907371587454691e-07
- O 0 5.8486467224838634e-08
irradiation O 0 2.2853953396406723e-07
with O 0 1.0129685978910175e-09
1 O 0 8.445004340273954e-08
Gy O 0 1.4701893633173313e-05
in O 0 1.404174415631232e-10
order O 0 4.3561587670382096e-10
to O 0 3.7517855488999885e-10
evaluate O 0 2.9119693323309548e-09
this O 0 1.3799968112682137e-10
cytogenetic O 0 1.7664127938132879e-07
method O 0 1.3871338744309014e-08
as O 0 5.743892583787158e-10
a O 0 2.0363080666108146e-10
tool O 0 5.383164136674168e-09
for O 0 2.0562952729452633e-10
detection O 0 4.628028023034858e-07
of O 0 1.0502743208462562e-07
ATM O 0 1.6302192307193764e-05
carriers O 0 2.484014203218976e-07
. O 0 1.889486043182842e-07

Both O 0 4.389962214190746e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 1 0.9952706694602966
and O 0 1.0992178545166098e-07
heterozygotes O 0 1.0946970405711909e-06
showed O 0 3.0630835645695242e-09
significantly O 0 1.3911711782554903e-09
increased O 0 3.593956243719276e-10
levels O 0 8.237764359542155e-10
of O 0 1.878313282688282e-09
radiation O 0 0.07863114774227142
- O 0 5.294705260894261e-06
induced O 0 1.2160091500845738e-05
chromatid O 0 0.00013664555444847792
damage O 0 2.217848759755725e-06
relative O 0 7.83074298738029e-08
to O 0 4.2310580039561785e-10
that O 0 6.475087133139823e-11
of O 0 6.675043628945332e-09
normal O 0 1.1073743166889471e-07
controls O 0 4.725567919194873e-07
. O 0 1.027438898404398e-07

These O 0 8.8845212076194e-08
results O 0 1.6363896904181274e-08
show O 0 1.4591866603907988e-09
that O 0 1.7402920771125707e-10
the O 0 5.69865266086822e-09
G2 O 0 4.7255100071197376e-05
- O 0 7.560124686278868e-07
phase O 0 9.333040225101286e-07
chromosomal O 0 8.58842042816832e-07
radiosensitivity O 0 7.474626499970327e-07
assay O 0 1.8513850008616828e-08
can O 0 1.8147667396606337e-11
be O 0 9.601347494836432e-12
used O 0 3.325120040420515e-11
for O 0 1.442449371752419e-11
the O 0 1.4060612396615824e-10
detection O 0 3.344283072692633e-07
of O 0 3.779221913191577e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 8.747813262743875e-05
. O 0 5.773355837845884e-07

In O 0 4.1757513002949054e-08
combination O 0 9.159345637499428e-08
with O 0 7.184311479058181e-10
molecular O 0 1.8033688320429064e-08
genetic O 0 9.093715114261158e-09
analyses O 0 3.3525451303972886e-09
, O 0 6.833539289985424e-11
this O 0 2.2845218772271636e-11
test O 0 5.612932896248424e-10
may O 0 2.3206804533604242e-10
be O 0 3.472885173883e-11
of O 0 2.351495942409798e-10
value O 0 1.2693428252941175e-10
in O 0 8.904589739178181e-12
studies O 0 1.1016987669365541e-11
of O 0 6.668063323722606e-11
familial B-Disease 0 2.1446686204740217e-08
and I-Disease 0 2.46553244487302e-09
sporadic I-Disease 0 2.5221405053343915e-07
cancers I-Disease 0 2.9820679628755897e-05
aimed O 0 1.2393178927538884e-08
at O 0 7.847826832829696e-10
determination O 0 8.891633540564214e-10
of O 0 7.143469149539783e-10
the O 0 4.1299252906412676e-10
potential O 0 5.45672340646064e-10
involvement O 0 2.1610182532327826e-09
of O 0 4.04817068755392e-09
ATM O 0 7.176120675467246e-07
mutations O 0 1.9474526435914186e-09
in O 0 3.4628461209607053e-10
tumor B-Disease 0 3.3428290180381737e-07
risk O 0 7.644134214501719e-09
or O 0 1.797372473077985e-09
development O 0 7.0120300676990155e-09
. O 0 2.3853954367325514e-09
. O 0 4.886941695758651e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 5.023725080377517e-08
identification O 0 1.89709421505313e-08
and O 0 5.686120463366251e-10
detection O 0 1.2596685792232165e-06
of O 0 1.3884660177154728e-07
founder O 0 0.00014412622840609401
- O 0 5.047468221164308e-07
effect O 0 1.2069249599733212e-08
mutations O 0 8.179506516547974e-10
in O 0 9.170624676313466e-11
the O 0 1.8482193553381876e-09
ATM O 0 1.0790225957180155e-07
gene O 0 9.91668525074374e-10
in O 0 9.444135057323777e-11
ethnic O 0 5.431335381445024e-10
populations O 0 1.0215430279458815e-08
. O 0 7.049016659266272e-08

To O 0 3.722138330886082e-08
facilitate O 0 2.398517828794411e-08
the O 0 3.4394340708843174e-09
evaluation O 0 3.526127301256565e-08
of O 0 4.3188848053432594e-08
ATM O 0 1.0939844287349842e-05
heterozygotes O 0 8.908837401122582e-08
for O 0 1.6776272038221407e-10
susceptibility O 0 4.334382452952923e-08
to O 0 2.7689958659316005e-10
other O 0 1.8046403260640886e-10
diseases O 0 0.0536101870238781
, O 0 1.2782129521493601e-10
such O 0 1.1830612045571343e-09
as O 0 1.8794578693359654e-07
breast B-Disease 1 0.9833557605743408
cancer I-Disease 0 0.03435688465833664
, O 0 4.734648229032246e-10
we O 0 1.3049060443304228e-10
have O 0 6.047970457778717e-11
attempted O 0 7.237762389422642e-09
to O 0 1.17649889830318e-10
define O 0 7.321790396197514e-10
the O 0 7.064973606141223e-10
most O 0 4.256699506766104e-11
common O 0 3.55337953505952e-10
mutations O 0 7.204671581551025e-11
and O 0 6.588680989683127e-11
their O 0 6.761130544319371e-11
frequencies O 0 6.787638451299927e-09
in O 0 2.1866832788930424e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.0006412632064893842
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 7.695555304110258e-09
homozygotes O 0 4.0989709759742254e-07
from O 0 6.647951633631521e-10
10 O 0 1.2502958668392239e-09
ethnic O 0 7.929558121233526e-10
populations O 0 4.653180951663671e-09
. O 0 6.32297769698198e-08

Both O 0 1.497343333767276e-07
genomic O 0 4.138462088576489e-07
mutations O 0 1.1238324937323796e-08
and O 0 8.214731117561769e-10
their O 0 4.255264751673593e-10
effects O 0 6.158718690585374e-08
on O 0 3.5125143682535054e-08
cDNA O 0 1.9244903626258747e-07
were O 0 3.216077626433389e-09
characterized O 0 7.815329183813446e-08
. O 0 1.673660108281183e-07

Protein O 0 1.8784521671477705e-06
- O 0 7.013851472947863e-07
truncation O 0 1.5007071851869114e-06
testing O 0 3.377139989879652e-08
of O 0 2.0214386609040957e-08
the O 0 5.253611323752239e-09
entire O 0 1.8758008479835553e-08
ATM O 0 2.858183165699302e-07
cDNA O 0 7.625774145481046e-08
detected O 0 7.876382213112265e-09
92 O 0 1.4534876413563325e-08
( O 0 4.18587442485574e-10
66 O 0 1.2423188699983712e-08
% O 0 5.93957605321549e-10
) O 0 4.783145546305434e-10
truncating O 0 1.2843990759847657e-07
mutations O 0 3.409798665643393e-09
in O 0 2.212645178190087e-09
140 O 0 3.1826814961277705e-08
mutant O 0 6.000512797754709e-08
alleles O 0 1.6786435352855733e-08
screened O 0 3.227802096716914e-07
. O 0 7.036738480792337e-08

The O 0 8.53279061630019e-07
haplotyping O 0 7.098257628967986e-05
of O 0 9.984925242179088e-08
patients O 0 1.3434079626506445e-08
with O 0 1.4651319046876665e-10
identical O 0 3.0630619818339255e-08
mutations O 0 7.613955688157148e-09
indicates O 0 3.566846817903979e-09
that O 0 9.012619123227594e-11
almost O 0 1.9033190301609437e-10
all O 0 2.2609790775729444e-11
of O 0 6.953819464694533e-11
these O 0 6.104779876059396e-12
represent O 0 5.3032573991973475e-12
common O 0 4.5055273401040097e-10
ancestry O 0 5.937028091373975e-10
and O 0 3.847573648574354e-11
that O 0 2.8771670376043224e-12
very O 0 1.4260694014556208e-10
few O 0 5.463148822215658e-10
spontaneously O 0 2.904348095356113e-09
recurring O 0 4.344745363482616e-08
ATM O 0 2.031009444181109e-06
mutations O 0 9.627695085612231e-09
exist O 0 2.095874584995272e-08
. O 0 1.1721239445705578e-07

Assays O 0 5.710335699404823e-06
requiring O 0 6.292790999395947e-08
minimal O 0 2.339357507707973e-07
amounts O 0 7.189743467250764e-09
of O 0 3.1678359935227718e-09
genomic O 0 9.354898189428695e-09
DNA O 0 6.057050860874824e-09
were O 0 3.2836447450002026e-10
designed O 0 1.5375735129552481e-09
to O 0 1.5412958409566357e-10
allow O 0 5.852300866138194e-10
rapid O 0 6.9900503163466965e-09
screening O 0 1.1606861249902067e-08
for O 0 1.09671799419786e-10
common O 0 1.454679487977728e-09
ethnic O 0 1.4491962074814069e-09
mutations O 0 5.172970496403195e-09
. O 0 2.1812857298186827e-08

These O 0 2.4643584950467812e-08
rapid O 0 1.7849147582182923e-07
assays O 0 4.743258159578545e-07
detected O 0 1.5319690760406957e-07
mutations O 0 1.6506519484593696e-09
in O 0 4.484231597157162e-10
76 O 0 2.182476066536765e-08
% O 0 6.844578237519272e-10
of O 0 5.908507016982867e-09
Costa O 0 2.7753128506446956e-07
Rican O 0 4.6184607072063955e-07
patients O 0 1.5676011599907724e-08
( O 0 1.2010042960142187e-09
3 O 0 6.589366829956589e-09
) O 0 1.0173557135617628e-10
, O 0 3.213523544487451e-11
50 O 0 1.298193358367783e-10
% O 0 9.910968573612067e-11
of O 0 1.1528287213735666e-09
Norwegian O 0 5.877739113202551e-07
patients O 0 5.500174538042302e-09
( O 0 1.0248094595155521e-09
1 O 0 1.5659933794154313e-08
) O 0 1.5655916840717765e-10
, O 0 7.11164044320256e-11
25 O 0 4.274641751678132e-10
% O 0 1.3739090420905598e-10
of O 0 1.5838417244395941e-09
Polish O 0 3.230113361496478e-05
patients O 0 5.918265699733638e-08
( O 0 1.4379457624613678e-09
4 O 0 4.994191726837016e-09
) O 0 6.001099617236605e-11
, O 0 4.7800333136116535e-11
and O 0 1.515774589178065e-10
14 O 0 8.964379794029753e-10
% O 0 1.510789826575376e-10
of O 0 1.3389817032916085e-09
Italian O 0 1.0892993032030063e-06
patients O 0 2.8124915729677014e-08
( O 0 8.945318374919964e-10
1 O 0 1.4278835003267432e-08
) O 0 1.1599258359362707e-10
, O 0 8.713828963946568e-11
as O 0 2.4839494350281655e-10
well O 0 4.3185835463255273e-10
as O 0 6.111240402617568e-10
in O 0 1.483369677091062e-10
patients O 0 9.231984066104815e-10
of O 0 2.712501157020597e-08
Amish O 0 2.5039457796083298e-06
/ O 0 9.077600225282367e-06
Mennonite O 0 2.336628995180945e-06
and O 0 2.486170203042093e-08
Irish O 0 4.534568347480672e-07
English O 0 3.758744924198254e-07
backgrounds O 0 4.7598888386346516e-07
. O 0 2.220637611571874e-07

Additional O 0 7.569071414081918e-08
mutations O 0 1.3859543734895396e-08
were O 0 1.7947072716850698e-09
observed O 0 2.204044058373711e-09
in O 0 5.306459716081235e-10
Japanese O 0 4.736577352559834e-07
, O 0 1.0109419967818667e-09
Utah O 0 8.194754741452925e-08
Mormon O 0 2.173320723386496e-08
, O 0 1.029132057350779e-10
and O 0 3.0686256313749993e-10
African O 0 2.1326258536902287e-09
American O 0 2.1969102093066795e-08
patients O 0 6.696546250850588e-08
. O 0 2.226702520147228e-07

These O 0 3.757138600235521e-08
assays O 0 1.2618542655218334e-07
should O 0 2.0450745541467086e-09
facilitate O 0 1.026419393923561e-09
screening O 0 7.785986078090446e-09
for O 0 2.3644226576635674e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 1.6024310752982274e-05
in O 0 1.3993786129873342e-09
the O 0 4.5044790120130074e-10
populations O 0 5.2847812931355875e-11
studied O 0 3.588654651220935e-10
. O 0 3.2567057384191855e-10
. O 0 1.2755110745388265e-08

The O 0 5.736995262850542e-06
von B-Disease 1 0.9998712539672852
Hippel I-Disease 1 1.0
- I-Disease 1 0.9999973773956299
Lindau I-Disease 1 0.9999723434448242
tumor I-Disease 0 4.663164145313203e-05
suppressor O 0 5.438648713607108e-07
gene O 0 2.1914589587446187e-10
is O 0 8.857295973052626e-12
required O 0 2.320086310569902e-11
for O 0 5.3544859518472876e-11
cell O 0 9.554047331050697e-09
cycle O 0 2.037777724339662e-09
exit O 0 6.62792531969103e-09
upon O 0 1.3811456422985202e-09
serum O 0 3.794183101035742e-08
withdrawal O 0 5.948527714849661e-08
. O 0 1.1354158857557195e-07

The O 0 9.594140237823012e-07
inactivation O 0 1.819730459828861e-05
of O 0 3.4504290624681744e-07
the O 0 8.13700253843308e-08
von B-Disease 1 0.9990562796592712
Hippel I-Disease 1 1.0
- I-Disease 1 0.9999881982803345
Lindau I-Disease 1 0.9999991655349731
( I-Disease 0 8.804305480225594e-07
VHL I-Disease 1 1.0
) I-Disease 0 2.583611546924658e-07
tumor I-Disease 0 0.00013695313828065991
suppressor O 0 0.0001710229116724804
gene O 0 3.906701806499768e-08
predisposes O 0 1.859589247033e-07
affected O 0 8.451538913156753e-10
individuals O 0 6.7789337511448e-12
to O 0 5.720317969304389e-11
the O 0 2.019391320828845e-09
human O 0 1.0685243069019634e-05
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 5.58233403946673e-10
is O 0 1.2019196402035526e-11
associated O 0 4.228417616047864e-11
with O 0 6.602279833956004e-11
sporadic B-Disease 0 8.747946594667155e-06
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 7.854213635027918e-08
RCC B-Disease 1 0.9998868703842163
) O 0 1.565390128632771e-08
and O 0 8.777447391139503e-08
brain B-Disease 1 0.7528671026229858
hemangioblastomas I-Disease 0 0.040122419595718384
. O 0 2.4723485125832667e-07

VHL O 1 0.8816176056861877
- O 0 0.00010738313721958548
negative O 0 1.1332797384966398e-06
786 O 0 7.523364183725789e-05
- O 0 3.186223329976201e-05
0 O 0 5.113632823849912e-07
RCC B-Disease 0 0.001120054512284696
cells O 0 9.310240045579121e-08
are O 0 1.3861546355187215e-09
tumorigenic O 0 1.9345616237842478e-05
in O 0 3.2102800417987964e-09
nude O 0 9.944267631567527e-09
mice O 0 2.071767868372376e-09
which O 0 4.8876982322587637e-11
is O 0 5.522738516505754e-11
suppressed O 0 7.102430199523724e-09
by O 0 2.292226686240184e-10
the O 0 3.6268053005272805e-09
reintroduction O 0 1.7224717794306343e-06
of O 0 1.3547250432566216e-07
VHL B-Disease 1 0.9998272061347961
. O 0 3.7974014048813842e-06

Remarkably O 0 1.74543874891242e-05
, O 0 2.1497539304249358e-09
this O 0 6.70991040507829e-11
occurs O 0 3.3652863828947943e-10
without O 0 3.015512839432688e-10
affecting O 0 7.306524829608918e-11
the O 0 7.898037085452003e-11
growth O 0 7.41287101146959e-11
rate O 0 7.519994627003257e-10
and O 0 3.140281645830356e-10
cell O 0 4.861801983224723e-08
cycle O 0 1.3395258235959773e-09
profile O 0 3.5276712107013e-10
of O 0 2.350204753032159e-10
these O 0 6.368149757518538e-11
cells O 0 1.567513674416432e-09
in O 0 5.489648735590436e-10
culture O 0 1.2930003734368256e-08
. O 0 3.5458615599281984e-08

The O 0 4.307591098040575e-06
786 O 0 2.3721680918242782e-05
- O 0 3.245505922677694e-06
0 O 0 1.2173894958777964e-07
cell O 0 1.322015918958641e-07
line O 0 3.202337950369838e-07
, O 0 1.1600503890818459e-09
like O 0 8.725641875706458e-10
many O 0 4.378040430186303e-10
cancer B-Disease 0 1.2640537079278147e-06
cells O 0 2.0548192480873695e-08
, O 0 9.019777147400987e-10
fails O 0 2.1101902447639986e-08
to O 0 2.658391951015915e-09
exit O 0 1.0630722613313992e-07
the O 0 4.79422723742573e-09
cell O 0 1.207316380202883e-08
cycle O 0 1.53596135810119e-09
upon O 0 9.772628262183503e-10
serum O 0 4.6568057854301514e-08
withdrawal O 0 7.936056078960974e-08
. O 0 1.2246520952885476e-07

Here O 0 2.86382572767252e-07
, O 0 3.4110474445014916e-09
it O 0 2.107103519444209e-10
is O 0 6.563732890541019e-11
shown O 0 4.162338529400955e-11
that O 0 3.25451818272704e-11
reintroduction O 0 1.2867469934008113e-07
of O 0 6.859742107678812e-09
the O 0 6.2484879492785694e-09
wild O 0 2.3259161707755993e-08
- O 0 1.7292160592319306e-08
type O 0 5.489026122518226e-08
VHL B-Disease 1 0.9989345669746399
gene O 0 1.3394426900958933e-07
restores O 0 1.2774802371495753e-06
the O 0 5.887234255652629e-09
ability O 0 4.668988307088284e-09
of O 0 9.414705459676043e-08
VHL O 1 1.0
- O 0 0.414789617061615
negative O 0 4.7406712155861896e-07
RCC B-Disease 1 0.9999722242355347
cancer I-Disease 0 2.3537811557616806e-06
cells O 0 3.664493153365811e-09
to O 0 3.625254541006484e-10
exit O 0 1.6338074004806913e-08
the O 0 1.9194337230743486e-09
cell O 0 7.009930858004054e-09
cycle O 0 6.238350391818415e-10
and O 0 2.3262554382785794e-10
enter O 0 2.151986677745299e-08
G0 O 0 0.0007773730321787298
/ O 0 2.4629762265249155e-05
quiescence O 0 5.209934897720814e-06
in O 0 4.825492450066804e-09
low O 0 2.55029902973547e-07
serum O 0 7.973195579324965e-07
. O 0 1.6891546295028093e-07

Both O 0 6.555836534971604e-06
VHL O 1 0.9999302625656128
- O 0 0.0002743455988820642
positive O 0 8.129571682502501e-08
and O 0 7.117865408190482e-08
VHL O 1 1.0
- O 1 0.5870843529701233
negative O 0 3.8515523215210123e-07
RCC B-Disease 1 0.9696753621101379
cells O 0 1.592148208828803e-07
exit O 0 5.0469768808625304e-08
the O 0 7.524958989257868e-10
cell O 0 2.540024857111689e-09
cycle O 0 2.9527352785052585e-10
by O 0 2.611963423326813e-11
contact O 0 4.824700639005641e-09
inhibition O 0 8.656176078147837e-07
. O 0 4.693652044807095e-07

The O 0 4.3853010538441595e-06
cyclin O 0 9.548323760100175e-06
- O 0 2.361982069487567e-06
dependent O 0 3.5296002920404135e-07
kinase O 0 7.144149662963173e-07
inhibitor O 0 1.203679289574211e-07
, O 0 8.447477162221162e-10
p27 O 0 7.242763899739657e-07
, O 0 3.98549859781383e-10
accumulates O 0 2.4793118669208525e-09
upon O 0 5.117637424945087e-10
serum O 0 3.0224014402335797e-09
withdrawal O 0 2.8309177224628e-09
, O 0 6.630396925944027e-11
only O 0 1.343234204420618e-11
in O 0 1.80074375549788e-11
the O 0 1.301704299905282e-10
presence O 0 5.079304199462342e-10
of O 0 1.425967521839766e-08
VHL B-Disease 1 1.0
, O 0 1.3171301382897127e-08
as O 0 9.640772624663896e-10
a O 0 3.3253375053554635e-10
result O 0 3.8268266333574275e-10
of O 0 2.230981621664796e-09
the O 0 2.0394925748234982e-09
stabilization O 0 2.743445008945855e-07
of O 0 1.2302615459702793e-07
the O 0 5.051387574894761e-08
protein O 0 1.03918928573421e-07
. O 0 3.432587192264691e-08

We O 0 1.2842166086102225e-07
propose O 0 2.939498955356612e-08
that O 0 4.1365869063447747e-10
the O 0 5.2591149213299104e-09
loss O 0 3.0712929088849705e-08
of O 0 1.511400142817365e-07
wild O 0 2.9842641424693284e-07
- O 0 9.723848393150547e-08
type O 0 5.471079589369765e-08
VHL B-Disease 1 0.9999542236328125
gene O 0 1.6227851062922127e-08
results O 0 3.5024225186752744e-10
in O 0 8.362317088783655e-11
a O 0 3.7100003624779276e-10
specific O 0 1.4795106251241918e-09
cellular O 0 6.659734452796329e-08
defect O 0 2.4188608449549065e-08
in O 0 1.8762784381731734e-10
serum O 0 1.1496448593106834e-07
- O 0 2.2586834802496014e-07
dependent O 0 7.4475998701473145e-09
growth O 0 7.501127496922777e-10
control O 0 1.2482330724594703e-08
, O 0 1.1737957827939738e-10
which O 0 6.174483146992316e-11
may O 0 3.0242004456226823e-09
initiate O 0 7.133849777574142e-08
tumor B-Disease 0 1.3938379197497852e-06
formation O 0 2.8372770088935795e-07
. O 0 2.0716075255222677e-07

This O 0 3.3184218040105407e-08
is O 0 2.3372062063486965e-09
corrected O 0 4.495316829888907e-08
by O 0 4.5187464881024653e-10
the O 0 3.538603188246725e-09
reintroduction O 0 4.996862230655097e-07
of O 0 5.997389251888308e-08
wild O 0 1.219857921341827e-07
- O 0 1.0293494057123098e-07
type O 0 3.7417134990391787e-07
VHL B-Disease 1 1.0
, O 0 4.601578140750462e-08
implicating O 0 4.203125354251824e-05
VHL B-Disease 1 1.0
as O 0 3.352227793129714e-07
the O 0 4.4285282996270325e-08
first O 0 8.190704114952041e-09
tumor B-Disease 0 1.0057480892555759e-07
suppressor O 0 1.5129344888009655e-07
involved O 0 3.019386130009849e-10
in O 0 1.0654802734544333e-10
the O 0 5.561631155615032e-10
regulation O 0 6.116421591428889e-09
of O 0 3.057269992723377e-09
cell O 0 1.7496763149438266e-08
cycle O 0 6.47767173234115e-10
exit O 0 2.111409269645037e-09
, O 0 1.3059860484720964e-11
which O 0 4.4312908377419635e-12
is O 0 1.5303569175784126e-11
consistent O 0 2.854823322184785e-10
with O 0 2.8421086664676132e-11
its O 0 1.2829692863647324e-09
gatekeeper O 0 4.7291385385506146e-07
function O 0 2.942996679689003e-10
in O 0 6.165044863504221e-11
the O 0 1.6684982284687067e-09
kidney O 0 4.613125838659471e-06
. O 0 7.249091549255127e-09
. O 0 7.285786551847195e-08

Piebaldism B-Disease 1 1.0
with O 0 0.000290070689516142
deafness B-Disease 1 1.0
: O 0 1.901477553190034e-08
molecular O 0 1.2204159460793562e-08
evidence O 0 6.2205667283876664e-09
for O 0 3.264379877521151e-10
an O 0 3.19760412592629e-10
expanded O 0 1.121218133448565e-06
syndrome O 1 1.0
. O 0 3.1239630970958387e-06

In O 0 3.226740261652594e-07
a O 0 7.508650412546558e-08
South O 0 7.17099695179968e-08
African O 0 1.1127411880806903e-08
girl O 0 1.3537403198427e-08
of O 0 1.392733040006533e-08
Xhosa O 0 0.005435456521809101
stock O 0 1.1521238185707716e-08
with O 0 1.05083192147859e-10
severe O 0 6.513981588796014e-06
piebaldism B-Disease 1 0.959089457988739
and O 0 2.756831349870481e-07
profound O 1 0.9999969005584717
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 4.06328467761341e-07
identified O 0 1.8027317416624555e-09
a O 0 1.8149511060716605e-10
novel O 0 2.070598581482841e-09
missense O 0 3.552793614858274e-08
substitution O 0 6.498864024706563e-08
at O 0 1.5988273815992216e-08
a O 0 1.4213613619418197e-09
highly O 0 3.3497074003463467e-09
conserved O 0 5.56566659426494e-09
residue O 0 1.4121017244406175e-08
in O 0 1.2525246118055833e-10
the O 0 8.089162673030614e-10
intracellular O 0 1.2034929497417579e-08
kinase O 0 2.892734407566877e-08
domain O 0 1.6064102270618719e-09
of O 0 2.838124402160247e-09
the O 0 1.4276711368665929e-08
KIT O 0 3.6902005376759917e-05
proto O 0 0.00018546113278716803
- O 0 1.392089052387746e-05
oncogene O 0 1.5133174201764632e-05
, O 0 1.8462685602571582e-08
R796G O 0 2.855299953807844e-06
. O 0 2.885885237446928e-07

Though O 0 3.516675178616424e-06
auditory B-Disease 0 0.0016202464466914535
anomalies I-Disease 0 2.676450640137773e-05
have O 0 4.5175938545582994e-09
been O 0 2.706577184596881e-09
observed O 0 4.0679077883964965e-09
in O 0 6.699938381871107e-10
mice O 0 5.62644197898976e-09
with O 0 5.508003497745051e-10
dominant O 0 7.013030699454248e-05
white O 0 3.4434840472385986e-06
spotting O 0 2.9215063932497287e-06
( O 0 2.3829775486206017e-08
W O 0 2.9745685878879158e-06
) O 0 3.7989730805598754e-10
due O 0 1.0332949607061437e-08
to O 0 2.865790493800091e-09
KIT O 1 0.8434434533119202
mutations O 0 6.298951689132082e-07
, O 0 1.8174459626152384e-07
deafness B-Disease 1 1.0
is O 0 3.5865352909780768e-09
not O 0 1.2607313804036124e-10
typical O 0 5.238182332334418e-09
in O 0 3.285179628331747e-10
human O 0 8.026462161581094e-09
piebaldism B-Disease 0 1.3826344002154656e-05
. O 0 2.467929220983933e-07

Thus O 0 2.839047112956905e-07
, O 0 2.8269624419152706e-09
the O 0 8.943049634169142e-10
occurrence O 0 1.9987037802593477e-08
of O 0 7.541711966041476e-07
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 2.2513137309942977e-07
this O 0 1.3559492417769548e-09
patient O 0 6.8470654923658e-08
extends O 0 1.870420440752696e-08
considerably O 0 2.370131113593743e-08
the O 0 1.3532801546034534e-09
phenotypic O 0 2.698633538855688e-09
range O 0 2.9251125965856772e-09
of O 0 2.528077081009883e-09
piebaldism B-Disease 0 5.198600661060482e-07
due O 0 2.2319063930353877e-08
to O 0 1.144346284398523e-09
KIT O 0 2.3550901460112073e-06
gene O 0 1.3562776457476389e-09
mutation O 0 1.777410996162132e-10
in O 0 1.2952692737822069e-11
humans O 0 6.28472496266852e-10
and O 0 5.460679686208891e-10
tightens O 0 6.685570497211302e-08
the O 0 5.776490397124689e-10
clinical O 0 1.0208204059836135e-08
similarity O 0 9.306632797745351e-09
between O 0 4.051893931489303e-09
piebaldism B-Disease 0 1.2254540706635453e-06
and O 0 1.653468195694785e-10
the O 0 4.247850682315146e-11
various O 0 1.9353643687658462e-11
forms O 0 9.026385749955068e-10
of O 0 9.940156786569787e-08
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 3.025747830065484e-08
. O 0 5.985744166991935e-08

Cycloheximide O 0 8.27107869554311e-05
facilitates O 0 3.6212605891705607e-07
the O 0 1.0982010856253055e-08
identification O 0 2.0268899447728472e-08
of O 0 2.4444810620138924e-08
aberrant O 0 1.7829923137924197e-07
transcripts O 0 1.0183919130213326e-07
resulting O 0 1.625994983101009e-08
from O 0 2.833245860145439e-09
a O 0 3.7088208060254146e-09
novel O 0 4.181489998700272e-08
splice O 0 1.435711146768881e-05
- O 0 6.681261766061652e-07
site O 0 9.378212872945824e-09
mutation O 0 3.227739742150959e-10
in O 0 1.4426097816322425e-10
COL17A1 O 0 2.0534756913548335e-05
in O 0 2.1500973224064523e-10
a O 0 9.282695168089106e-10
patient O 0 1.0627455360179283e-08
with O 0 2.225418738177609e-09
generalized O 0 0.1700577586889267
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999997615814209
. O 0 8.007938049559016e-06

Patients O 0 3.500537559375516e-06
with O 0 6.268735575076789e-08
generalized O 0 0.3497718572616577
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
often O 0 9.916825405298368e-08
show O 0 2.7497448762403565e-09
decreased O 0 8.663586514856547e-10
expression O 0 4.07939737545604e-10
of O 0 8.266568540804542e-10
type O 0 5.132041636102258e-08
XVII O 1 0.9910081028938293
collagen O 0 1.2587627679749858e-05
, O 0 1.5959420451849837e-08
a O 0 2.1201513433766195e-08
transmembrane O 0 2.988079472743266e-08
hemidesmosomal O 0 6.940843633174154e-08
protein O 0 4.4567413648444187e-10
encoded O 0 3.778832247114394e-10
by O 0 3.3189248571652286e-10
COL17A1 O 0 8.991585491457954e-05
. O 0 4.6759996052969655e-07

This O 0 8.626346215123704e-08
report O 0 6.105616456864027e-09
documents O 0 2.8788855743755448e-08
a O 0 7.475152052904832e-09
novel O 0 1.5302460099064774e-07
splice O 0 3.120173278148286e-05
- O 0 1.4019861964698066e-06
site O 0 1.9956678087851287e-08
mutation O 0 8.45137737570667e-10
in O 0 2.576929780673254e-10
COL17A1 O 0 0.0009378059767186642
in O 0 8.482254343356033e-10
a O 0 1.3988289415678423e-09
patient O 0 2.272621557608545e-08
with O 0 1.937028093479398e-09
generalized O 0 0.034485116600990295
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999996423721313
, O 0 7.508904609210276e-09
and O 0 5.102860911598839e-10
applies O 0 1.0612843936996796e-09
a O 0 3.7244285433502e-10
new O 0 5.202017705485673e-10
methodology O 0 2.5222586241824274e-09
to O 0 1.7355750170366946e-10
define O 0 1.3571885837393438e-09
and O 0 6.755887516085579e-10
characterize O 0 2.6438000233497405e-08
the O 0 2.7290385506972825e-09
resulting O 0 1.9796539518779355e-08
mRNA O 0 7.56749756192221e-08
splice O 0 8.193259759536886e-07
variants O 0 9.02166092942025e-08
. O 0 5.967151395225301e-08

Mutational O 0 0.00018837327661458403
analysis O 0 3.133832251478452e-07
of O 0 4.825080850423547e-07
COL17A1 O 0 0.004678967874497175
identified O 0 3.598487410272355e-07
a O 0 6.534050811524139e-08
maternally O 0 4.861199727201893e-07
inherited O 0 1.0707071851356886e-05
G O 0 3.431944423937239e-05
- O 0 4.269027340342291e-05
to O 0 3.2209663913818076e-07
- O 0 9.332312038168311e-05
T O 0 3.209372516721487e-05
transversion O 0 4.3869877117685974e-05
at O 0 7.057193052162347e-09
the O 0 1.0750383916402484e-09
- O 0 4.615508419902881e-09
1 O 0 6.3600955613196675e-09
position O 0 1.8718194993994075e-08
of O 0 2.9371898691010756e-08
exon O 0 1.2601252592503442e-06
32 O 0 3.380230850780208e-07
. O 0 1.1489137818898598e-07

This O 0 2.3919847436104646e-08
acceptor O 0 2.971812662622142e-08
splice O 0 1.4268226550484542e-05
- O 0 4.653734038129187e-07
site O 0 1.4611761578464666e-08
mutation O 0 3.8065745000537277e-10
led O 0 9.7385033370756e-10
to O 0 2.0870841166420462e-10
the O 0 2.0513564180646426e-09
formation O 0 2.884849692463831e-08
of O 0 8.456900957298785e-08
aberrant O 0 5.761476273846711e-08
transcripts O 0 1.3115497132787368e-08
present O 0 1.815682493244708e-09
at O 0 1.2563942108911874e-09
extremely O 0 4.39956426845356e-09
low O 0 9.56177999000829e-08
levels O 0 2.916512364947721e-08
. O 0 4.4295589418652526e-08

Based O 0 1.1624240414676024e-06
on O 0 2.2007061772910674e-07
our O 0 1.0160846386497724e-08
recent O 0 1.0511250758682422e-09
finding O 0 1.936193427809485e-09
that O 0 3.2979619035700125e-10
cycloheximide O 0 4.297128270991379e-06
stabilized O 0 3.1659994419896975e-05
mutant O 0 1.1854796184707084e-06
COL17A1 O 0 6.343206041492522e-05
transcripts O 0 6.627864479469281e-08
in O 0 5.440407568890748e-10
keratinocytes O 0 7.786390199271409e-08
homozygous O 0 4.9179176286884285e-09
for O 0 3.2977290342905974e-10
a O 0 2.270960752781548e-09
frameshift O 0 4.6943236498009355e-07
mutation O 0 1.589665465928647e-08
, O 0 8.001848073035944e-10
the O 0 1.8730399453659174e-09
effects O 0 1.3886514693695062e-07
of O 0 2.4001499809855886e-07
the O 0 9.855805416236763e-08
splice O 0 7.572631602670299e-06
- O 0 9.040418547101581e-08
site O 0 3.3679914412942935e-09
mutation O 0 1.0532558852860419e-10
on O 0 3.033442108613116e-10
splicing O 0 4.950338805542742e-09
of O 0 1.08539988108447e-09
COL17A1 O 0 1.2037947271892335e-05
transcripts O 0 1.6858113127682373e-08
were O 0 1.9467534528860853e-10
determined O 0 3.4171931950766066e-10
using O 0 6.203454416819909e-10
reverse O 0 1.1641426489461537e-08
transcriptase O 0 3.6445317874722605e-08
polymerase O 0 7.425065007282683e-08
chain O 0 1.0568725894444242e-09
reaction O 0 1.2502023027938236e-10
of O 0 3.159109362993462e-10
total O 0 3.192276304408992e-11
RNA O 0 2.5327488994975056e-09
from O 0 2.174753294115206e-10
keratinocytes O 0 4.7115282342247156e-08
incubated O 0 3.757669020387766e-08
for O 0 9.689976598892258e-10
2 O 0 1.0377591763699456e-07
. O 0 8.324946065840777e-08

5 O 0 1.414146822753537e-06
h O 0 6.586303129552107e-07
in O 0 2.4247259755583173e-09
the O 0 2.0899733055301795e-09
presence O 0 8.731369516290499e-10
or O 0 2.688655964533382e-09
absence O 0 1.401968461323122e-07
of O 0 1.8162000969823566e-07
10 O 0 2.4099545470335215e-08
microg O 0 1.5310328080886393e-06
cycloheximide O 0 8.977200423032627e-07
per O 0 2.4869763137758127e-08
ml O 0 3.7598204016831005e-07
. O 0 6.149293341195516e-08

Using O 0 4.128267505620897e-08
this O 0 1.96680405295524e-09
approach O 0 5.020669036071013e-08
, O 0 8.95129192990396e-10
an O 0 1.3728035375137893e-10
abnormally O 0 1.390840331794152e-08
spliced O 0 2.3984588892744796e-07
transcript O 0 2.3050779418554157e-07
was O 0 2.0622557883598347e-08
identified O 0 5.922957124759876e-10
that O 0 2.3525265069324064e-11
contains O 0 1.414521000331348e-10
an O 0 1.4091003364136157e-10
extra O 0 9.543156487268334e-09
264 O 0 1.9940165074672223e-08
bases O 0 1.8436397297705298e-08
upstream O 0 2.3943218963040636e-08
from O 0 7.907899335357627e-10
exon O 0 3.089424183144729e-08
32 O 0 2.9072910745497893e-09
, O 0 3.713290439022465e-11
resulting O 0 9.878946549690681e-10
in O 0 3.4294295181425127e-10
a O 0 3.3964664414298795e-09
premature O 0 3.9267828100264524e-08
termination O 0 1.8195232769357972e-06
codon O 0 3.671190427212423e-07
27 O 0 5.108358891448006e-07
bp O 0 6.679846933366207e-07
downstream O 0 8.47888230737226e-08
from O 0 3.2267628569115914e-09
the O 0 1.4228024092233227e-08
cryptic O 0 5.047177637607092e-06
splice O 0 7.031733548501506e-05
site O 0 2.1161492895771516e-06
. O 0 1.7157306331228028e-07

Three O 0 1.8100236331974884e-07
other O 0 7.17388060067492e-09
splice O 0 1.4245478041630122e-06
variants O 0 5.5633986306702354e-08
, O 0 5.752663900793209e-10
including O 0 8.176802984705134e-11
one O 0 8.831828324229463e-11
derived O 0 3.0172808695994036e-09
from O 0 2.831711753970012e-09
the O 0 2.8426425657812615e-09
skipping O 0 1.392887138962351e-08
of O 0 4.110422224812282e-09
exon O 0 5.4814830008353965e-08
32 O 0 4.792115593232893e-09
, O 0 1.5909802641989046e-10
were O 0 7.390174028287788e-10
also O 0 1.0457936738816898e-09
identified O 0 1.4328817243836056e-08
. O 0 6.4006229649749e-08

These O 0 9.961641467270965e-08
results O 0 1.9123453043334848e-08
indicate O 0 1.6072323916205278e-08
the O 0 7.210686270298083e-09
usefulness O 0 4.1447341914135905e-07
of O 0 2.677777111159685e-08
cycloheximide O 0 1.8300936517334776e-06
treatment O 0 1.2485109834869945e-07
in O 0 5.241188039128986e-10
evaluating O 0 1.863913023925079e-09
the O 0 4.0009676127716887e-10
abnormal O 0 1.6044129913517224e-10
processing O 0 1.0170113640128875e-08
of O 0 3.5600773440336297e-09
mRNA O 0 9.966142577866322e-09
due O 0 1.7139537789034875e-08
to O 0 2.6886715076557266e-09
splice O 0 1.215533757203957e-06
- O 0 8.934311779285053e-08
site O 0 1.7837321619751378e-09
mutations O 0 9.001194234414811e-11
, O 0 2.944219174016993e-11
because O 0 2.1319739029745932e-10
( O 0 2.377301466793824e-09
i O 0 1.9375278270672425e-08
) O 0 7.547554803366552e-10
aberrant O 0 1.2437580743096532e-08
splicing O 0 3.310752916263482e-08
often O 0 1.4136390669161614e-10
generates O 0 1.1459269644298331e-10
a O 0 1.460032511557685e-10
premature O 0 2.06278172321106e-09
termination O 0 9.464235972700408e-08
codon O 0 1.4404061943196211e-08
, O 0 9.475353834886846e-10
( O 0 2.466434279035923e-10
ii O 0 0.00014403472596313804
) O 0 2.844530166967729e-09
transcripts O 0 7.941897806063025e-09
with O 0 2.552875133510213e-10
premature O 0 3.544563043078597e-08
termination O 0 1.0291780654370086e-06
codons O 0 1.0002289485555593e-07
can O 0 6.039558297921133e-10
occur O 0 1.3905107065781408e-09
at O 0 2.6968225430579196e-09
low O 0 1.264103666187566e-08
or O 0 1.3950666177819926e-09
undetectable O 0 6.858973478074404e-08
levels O 0 1.3516009422787079e-09
due O 0 5.093868882255492e-09
to O 0 6.233176752523661e-10
nonsense O 0 6.193977242219262e-08
- O 0 2.356989980967228e-08
mediated O 0 3.824539263064253e-08
mRNA O 0 4.96681362704976e-09
decay O 0 6.849361078309357e-09
, O 0 2.5253082611143007e-11
and O 0 4.2403872080321037e-11
( O 0 1.774738134230347e-10
iii O 1 0.99313884973526
) O 0 1.919909564662703e-09
the O 0 7.00682567522648e-10
levels O 0 5.960799076554224e-10
of O 0 3.702895490231839e-10
these O 0 2.5088410515738957e-11
transcripts O 0 5.759294707807783e-10
can O 0 9.488184543604561e-12
be O 0 1.3545415657179039e-11
increased O 0 4.254453178642592e-10
by O 0 7.70602415212096e-10
cycloheximide O 0 1.4906844626239035e-05
. O 0 3.456838442161825e-07

A O 0 3.605691745178774e-06
deletion O 0 1.0629439657350304e-06
mutation O 0 2.6773939509894262e-08
in O 0 4.464826286465495e-09
COL17A1 O 0 0.000247451476752758
in O 0 6.572195676568526e-09
five O 0 9.669986589244672e-09
Austrian O 0 7.138381192817178e-07
families O 0 1.4368747081050515e-08
with O 0 6.48877929165792e-09
generalized O 0 0.01209411583840847
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999915361404419
represents O 0 2.124904625588897e-07
propagation O 0 4.123617429740989e-07
of O 0 1.912104607981746e-08
an O 0 1.075325606336719e-09
ancestral O 0 7.794798762006394e-07
allele O 0 3.7026066479484143e-07
. O 0 9.508438836292044e-08

Patients O 0 2.557857669671648e-06
with O 0 5.4635400204006146e-08
generalized O 0 0.009976583532989025
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 5.5830000178502814e-08
a O 0 2.9653506317117717e-09
usually O 0 1.9384844840431015e-09
nonlethal O 0 5.55494693799119e-07
form O 0 3.008690896422195e-08
of O 0 9.421866707270965e-06
junctional B-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.999767005443573
, O 0 3.146818805532803e-09
have O 0 2.0386320409571113e-10
generalized O 0 7.823800984851914e-08
blistering B-Disease 0 5.7135284805553965e-06
, O 0 1.2575001484549375e-08
nail B-Disease 1 0.9999966621398926
dystrophy I-Disease 1 1.0
, O 0 4.7291254645642766e-07
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 0 2.82917653748882e-07
and O 0 7.921596534288255e-07
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 0 4.773915497935377e-05

Skin B-Disease 1 1.0
fragility I-Disease 1 0.9999998807907104
in O 0 1.1301737323776706e-08
most O 0 3.5884353821735715e-10
cases O 0 9.823399732544758e-11
is O 0 1.24803119228023e-11
due O 0 5.377394085570586e-10
to O 0 1.2351775158236933e-10
mutations O 0 2.2850503433868852e-10
in O 0 1.881237943202052e-10
the O 0 6.711782241097808e-10
gene O 0 3.39632849621907e-10
encoding O 0 8.957649733076778e-09
type O 0 1.0678743933567603e-07
XVII O 1 0.9702145457267761
collagen O 0 4.052711301483214e-05
( O 0 1.9773186465954495e-07
COL17A1 O 0 0.0006306018331088126
) O 0 2.4622346828095942e-08
. O 0 4.938411279908905e-08

Recently O 0 7.92139326222241e-06
, O 0 1.822838591181153e-08
we O 0 2.5089681443546397e-09
reported O 0 3.9829624043363765e-09
five O 0 9.451310845065564e-10
Austrian O 0 1.5703071198913676e-07
families O 0 3.201804599228808e-09
with O 0 2.0365034103519974e-09
generalized O 0 0.002099343342706561
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
who O 0 1.1939492878809688e-06
share O 0 4.168803613424643e-08
the O 0 2.452167713329345e-08
same O 0 1.533506122086692e-08
COL17A1 O 0 0.022749867290258408
mutation O 0 2.744502296536666e-07
. O 0 1.6865101315488573e-07

Affected O 0 1.398643405536859e-07
individuals O 0 4.296941413794997e-10
in O 0 4.486986060481257e-10
three O 0 2.3256256642678608e-10
families O 0 1.2586506836775868e-10
are O 0 2.410180735545886e-11
homozygous O 0 9.333933626010094e-10
for O 0 1.7373635863293657e-10
4003delTC O 0 4.280838794556985e-08
, O 0 5.738480177153171e-11
whereas O 0 7.05282943158636e-10
those O 0 2.754352301792551e-10
in O 0 3.386257385606939e-10
two O 0 3.004644588688876e-10
others O 0 8.577266119580429e-10
are O 0 1.0529747213050555e-10
compound O 0 3.4420813221913704e-07
heterozygotes O 0 2.149067995560472e-06
. O 0 3.869939746437012e-07

To O 0 9.6678327565769e-08
determine O 0 1.7465254131820984e-08
if O 0 2.2115564934921395e-09
the O 0 1.5448520240823882e-09
occurrence O 0 4.7165071848098705e-09
of O 0 4.659415520080756e-09
4003delTC O 0 1.0791440274715569e-07
in O 0 4.700982658700781e-11
these O 0 1.6338454894571086e-11
unrelated O 0 6.63391619415421e-10
families O 0 3.829891612183722e-11
signifies O 0 5.787971213422338e-10
propagation O 0 1.3702780243818324e-08
of O 0 3.0863658295743335e-09
an O 0 1.307881164480662e-10
ancestral O 0 2.4261057163244004e-08
allele O 0 2.2580075587086412e-09
or O 0 1.3871332971149286e-09
a O 0 1.0615744727715537e-08
mutational O 0 1.2298080036998726e-05
hot O 0 8.017000254767481e-06
spot O 0 2.5961685423681047e-07
, O 0 2.0658637300829952e-10
haplotypes O 0 1.2080442424178273e-08
were O 0 5.228816268854075e-10
determined O 0 6.924414375220067e-10
for O 0 5.438042238736784e-10
polymorphisms O 0 3.673704540574363e-08
both O 0 1.1214635886602764e-09
within O 0 1.102968294475204e-08
and O 0 5.242922895831725e-08
flanking O 0 0.00035953897167928517
COL17A1 O 1 0.999987006187439
. O 0 2.2493359210784547e-06

Five O 0 1.9038093341805506e-06
intragenic O 0 1.9912244169972837e-05
polymorphisms O 0 1.0598870403555338e-06
were O 0 7.592840134407197e-09
chosen O 0 6.549158548807554e-09
based O 0 8.916773097666919e-09
on O 0 1.5932199559642868e-08
their O 0 1.2258283277333248e-08
informativeness O 0 0.00020335889712441713
. O 0 8.921359153646335e-07

One O 0 1.0121583926547828e-07
of O 0 1.3955622435446458e-08
these O 0 5.016260740120515e-10
, O 0 2.4865279280028574e-10
not O 0 9.950443247142005e-11
previously O 0 5.492709842513932e-09
reported O 0 1.9869159650909296e-09
, O 0 6.482664960394402e-10
was O 0 1.3697970757675648e-08
2988 O 0 4.250264566962869e-07
A O 0 4.279002041585045e-08
or O 0 2.5321691410340463e-09
C O 0 7.382066087302519e-07
that O 0 3.8459835316473345e-10
introduces O 0 9.237572484721568e-09
a O 0 7.099636434304557e-10
new O 0 1.1110694586591308e-09
restriction O 0 1.535457538892615e-09
site O 0 2.2305179925297125e-09
for O 0 2.4750537730433564e-10
Eco0109 O 0 7.718312531324045e-07
I O 0 1.3314869420355535e-06
. O 0 2.108400565248303e-07

All O 0 8.391808847818538e-08
the O 0 1.933382343111134e-08
4003delTC O 0 2.7804307478618284e-07
alleles O 0 2.508173668758218e-09
showed O 0 4.0655945277023875e-10
the O 0 2.7235821931093085e-10
same O 0 3.744300980379478e-10
haplotype O 0 8.278156826690974e-08
for O 0 4.730225100502139e-10
these O 0 4.099474371077605e-10
five O 0 8.275311991212675e-09
polymorphic O 0 4.452489008599514e-07
markers O 0 3.875298659750115e-07
. O 0 2.727448418227141e-07

Fourteen O 0 2.033717646554578e-05
microsatellite O 0 4.5704982767347246e-05
polymorphisms O 0 1.2035500276397215e-06
were O 0 7.440472238329221e-09
selected O 0 3.5642218065845555e-09
based O 0 2.7739344155008894e-09
on O 0 1.3551457733740335e-08
their O 0 8.548635133109883e-10
high O 0 1.4887118027218094e-07
heterozygosity O 0 7.088138227118179e-05
and O 0 4.410579457214681e-09
their O 0 6.363757298899486e-10
location O 0 7.880984043140415e-08
within O 0 2.300954626832663e-08
10q23 O 0 2.224059016953106e-06
- O 0 6.814661901444197e-07
q25 O 0 5.071195118944161e-06
near O 0 2.2923527467355598e-06
COL17A1 O 0 0.0017792109865695238
. O 0 7.595202760057873e-07

Three O 0 5.153150368641946e-07
families O 0 6.656622986156435e-08
shared O 0 9.342829088154758e-08
microsatellite O 0 1.9005885405931622e-05
polymorphisms O 0 1.1425146340116044e-06
covering O 0 2.0109791876166128e-07
at O 0 1.9742429913094384e-08
most O 0 1.0924010585000588e-09
19 O 0 4.0497458719812585e-09
cM O 0 1.2298189133730375e-08
, O 0 1.448963171668538e-10
whereas O 0 4.238709383486139e-09
the O 0 1.2068329446890402e-08
others O 0 6.2860943117470924e-09
shared O 0 1.7881443881151426e-08
smaller O 0 2.0962973579230493e-09
regions O 0 1.126995941014286e-09
consistent O 0 3.4993126174498457e-09
with O 0 3.191024111615093e-10
cross O 0 4.361284311471536e-08
- O 0 2.7911053734896996e-07
over O 0 7.044789196442025e-10
events O 0 9.113461721388383e-12
during O 0 1.0845301740003421e-10
passage O 0 4.6521494989626433e-10
of O 0 4.5540286819356623e-11
this O 0 3.996258185479107e-12
mutation O 0 3.300722889454377e-11
through O 0 9.232120623536844e-11
several O 0 5.36653332883219e-10
generations O 0 4.111027962494518e-08
. O 0 5.3818116185766485e-08

These O 0 2.123789855090763e-08
results O 0 3.3783498221140462e-09
indicate O 0 1.6005260450313585e-09
that O 0 2.513037833384857e-10
4003delTC O 0 1.4231733302949579e-07
occurs O 0 2.9131250744995896e-09
on O 0 2.8614537406213003e-09
a O 0 2.7257648915757215e-10
single O 0 9.58119583671646e-10
ancestral O 0 1.5094728667008894e-07
allele O 0 3.75149618037085e-08
. O 0 9.61004609223437e-09
. O 0 1.2303144103498198e-07

The O 0 5.341822088666959e-06
haptoglobin O 0 0.00019133841851726174
- O 0 6.976405984460143e-06
gene O 0 4.2863781857249705e-08
deletion O 0 1.256889134992889e-07
responsible O 0 8.710880017304135e-09
for O 0 6.4340848204835766e-09
anhaptoglobinemia B-Disease 0 0.00012258654169272631
. O 0 5.432500529423123e-07

We O 0 1.9564454589726665e-07
have O 0 3.264157610871621e-09
found O 0 2.414756838930998e-09
an O 0 2.777813812304686e-10
allelic O 0 1.4498776579330297e-07
deletion O 0 1.4135223125322227e-07
of O 0 5.618444731680938e-08
the O 0 5.521093626725815e-08
haptoglobin O 0 4.788204387295991e-05
( O 0 1.0232590774705841e-08
Hp O 0 2.5615506160647783e-07
) O 0 7.971320270527826e-10
gene O 0 7.064920315436041e-10
from O 0 8.621781621975799e-10
an O 0 5.725535323630737e-11
individual O 0 6.305998778710631e-11
with O 0 8.821293140393038e-10
anhaptoglobinemia B-Disease 0 7.544817344751209e-05
. O 0 4.901149281977268e-07

The O 0 2.1187884158280212e-06
Hp O 0 2.0623874661396258e-06
gene O 0 2.753083983009219e-08
cluster O 0 2.8280318531415105e-08
consists O 0 3.809227600015674e-09
of O 0 9.160563863019888e-09
coding O 0 1.3402119236616272e-07
regions O 0 4.00362631935991e-09
of O 0 2.6184370227610998e-08
the O 0 1.593295984037013e-08
alpha O 0 2.198741988479469e-08
chain O 0 1.5506704809098437e-09
and O 0 1.4387900593160197e-10
beta O 0 3.5665135289519867e-09
chain O 0 2.5580186857609988e-09
of O 0 2.7365443244775634e-09
the O 0 4.792782615226088e-09
haptoglobin O 0 5.14335965817736e-07
gene O 0 2.856436864817624e-09
( O 0 2.166216789278863e-10
Hp O 0 1.5512719997445856e-08
) O 0 7.725563244687095e-11
and O 0 9.29718455000561e-11
of O 0 4.883472737304828e-09
the O 0 8.243333127211372e-09
alpha O 0 1.9714283538974087e-08
chain O 0 1.7950050335002743e-09
and O 0 2.541225563312821e-10
beta O 0 4.2742525074856985e-09
chain O 0 2.3274193683420208e-09
of O 0 7.358835762971694e-10
the O 0 2.377763985705883e-09
haptoglobin O 0 6.001623660267796e-07
- O 0 1.6270654157324316e-08
related O 0 2.545252897334649e-09
gene O 0 3.1753977225434937e-09
( O 0 8.040247911900167e-10
Hpr O 0 4.444475223408517e-07
) O 0 1.012034012148888e-09
, O 0 2.1471792399641032e-10
in O 0 4.601020675565337e-10
tandem O 0 1.3301614387728478e-07
from O 0 1.7197498536347666e-08
the O 0 3.545266480386999e-08
5 O 0 1.7238919269857433e-07
side O 0 2.953082685053232e-07
. O 0 3.108166879428609e-07

Southern O 0 5.522650826605968e-05
blot O 0 9.899213182507083e-05
and O 0 6.79753924259785e-08
PCR O 0 8.126995680868276e-07
analyses O 0 1.932029292106563e-08
have O 0 3.171752027686381e-10
indicated O 0 1.026826734751296e-09
that O 0 2.8081132905088957e-11
the O 0 1.7546374075916304e-10
individual O 0 9.122209931877734e-12
with O 0 4.339835782407597e-11
anhaptoglobinemia B-Disease 0 5.012192332287668e-07
was O 0 1.1689219370225601e-08
homozygous O 0 9.071086659595551e-10
for O 0 9.291051261683947e-11
the O 0 5.239458866768132e-10
gene O 0 6.896418991431119e-10
deletion O 0 5.709663408737242e-09
and O 0 6.734887647574794e-11
that O 0 1.3872800477821023e-11
the O 0 4.679015508379791e-10
gene O 0 4.2013917345151697e-10
deletion O 0 5.076710607454515e-09
was O 0 2.6940718544921083e-09
included O 0 5.659276380853839e-10
at O 0 7.252973777127636e-10
least O 0 1.9013913707399688e-11
from O 0 3.5264668962753376e-10
the O 0 4.069257819594441e-09
promoter O 0 1.5897145431154058e-06
region O 0 1.339330282235096e-07
of O 0 2.0398559286149975e-07
Hp O 0 7.449104487022851e-06
to O 0 3.060281983380264e-08
Hpr O 0 4.527509190666024e-06
alpha O 0 4.497092476185571e-08
but O 0 2.3226022494160503e-10
not O 0 8.004712864773111e-11
to O 0 6.934975371741814e-10
Hpr O 0 2.8300366921030218e-06
beta O 0 1.625992638309981e-07
( O 0 4.17304235611482e-09
Hpdel O 0 1.4364246680997894e-06
) O 0 5.797343494151619e-09
. O 0 3.8886959430328716e-08

In O 0 5.442198514060692e-08
addition O 0 9.315406224175149e-09
, O 0 2.800194964791558e-09
we O 0 2.8658328488084805e-10
found O 0 4.806393061329572e-10
seven O 0 2.431616297204897e-10
individuals O 0 7.232369651083426e-12
with O 0 1.1237285407750264e-10
hypohaptoglobinemia B-Disease 0 8.803848322713748e-05
in O 0 8.806734230759616e-10
three O 0 2.460744108478963e-10
families O 0 1.539051525112356e-10
, O 0 4.0840428261468276e-11
and O 0 1.2376254188151137e-10
the O 0 1.114346281916312e-09
genotypes O 0 1.2966066265107656e-07
of O 0 2.794401865457985e-08
six O 0 5.095802890764389e-09
of O 0 8.375382165581868e-09
the O 0 4.853016655204101e-09
seven O 0 1.0847417408754723e-09
individuals O 0 6.016098209882248e-12
were O 0 3.124878411586707e-10
found O 0 2.7596422369491336e-10
to O 0 3.319811370250392e-10
be O 0 1.308483899009616e-08
Hp2 O 1 0.9917343854904175
/ O 1 0.9704106450080872
Hpdel O 0 0.06669015437364578
. O 0 6.671036203442782e-07

The O 0 9.097116731027199e-07
phenotypes O 0 2.861373332052608e-06
and O 0 2.4536648268735917e-08
genotypes O 0 1.83579936674505e-06
in O 0 3.7950784737006416e-09
one O 0 5.275196945930816e-10
of O 0 7.641856036855188e-10
these O 0 8.100630582985602e-11
three O 0 4.5801293313552094e-10
families O 0 2.074467542190206e-10
showed O 0 2.3422211392620795e-10
the O 0 5.334326313999327e-10
father O 0 4.980135059895474e-08
to O 0 2.1258355076270163e-09
be O 0 1.6107525979691673e-08
hypohaptoglobinemic B-Disease 0 2.7605679861153476e-05
( O 0 7.711938643240046e-09
Hp2 O 0 5.127597432874609e-06
) O 0 1.1761763785145263e-09
and O 0 2.488892203444948e-09
Hp2 O 0 5.792696902062744e-05
/ O 0 7.386513061646838e-06
Hpdel O 0 2.0703031623270363e-05
, O 0 1.1549196043958432e-09
the O 0 9.907497044991942e-10
mother O 0 2.541701737968083e-09
to O 0 5.686749404709701e-10
be O 0 1.9458894495727463e-09
Hp2 O 0 9.282220162276644e-06
- O 0 4.4896535200678045e-07
1 O 0 5.3659245935477884e-08
and O 0 5.0634234582958015e-09
Hp1 O 0 4.0223563701147214e-05
/ O 0 4.042728050990263e-06
Hp2 O 0 1.6080217392300256e-05
, O 0 6.430486698683069e-10
one O 0 1.37388808663097e-10
of O 0 9.444499626809488e-10
the O 0 2.002079613205865e-09
two O 0 2.857786784993266e-10
children O 0 9.24932283541402e-11
to O 0 9.831328806608752e-11
be O 0 1.681985439816458e-09
hypohaptoglobinemic B-Disease 0 1.6086138202808797e-05
( O 0 7.233222021341135e-09
Hp2 O 0 6.8107647166471e-06
) O 0 1.3446146418516491e-09
and O 0 3.4661848946626606e-09
Hp2 O 0 0.0001824561768444255
/ O 0 6.138942262623459e-05
Hpdel O 0 0.00022778667334932834
, O 0 7.147599734302901e-10
and O 0 2.681781463564903e-10
the O 0 1.1135474764500941e-09
other O 0 1.3777114171720228e-10
child O 0 6.132140906167649e-10
to O 0 2.2947202471534922e-10
be O 0 7.040437122185494e-10
Hp1 O 0 1.5890665963524953e-05
and O 0 3.890773214720866e-08
Hp1 O 0 0.009804034605622292
/ O 0 0.0019706522580236197
Hpdel O 0 0.00017861380183603615
, O 0 6.968322030509455e-10
showing O 0 2.432358481296859e-10
an O 0 3.3445458208491985e-11
anomalous O 0 2.2850395353657404e-08
inheritance O 0 3.7816625990672037e-06
of O 0 9.958095688489266e-06
Hp O 0 0.00011066350270994008
phenotypes O 0 7.50883543787495e-07
in O 0 9.416242230386729e-10
the O 0 3.6317893137294277e-09
child O 0 5.000711400526825e-09
with O 0 2.0699628677789406e-09
Hp1 O 0 0.00044262013398110867
. O 0 1.1252973308728542e-06

The O 0 6.740930984960869e-06
Hp2 O 0 0.017892658710479736
/ O 0 0.0006990192923694849
Hpdel O 0 5.7551565987523645e-05
individuals O 0 1.4029650774460833e-09
had O 0 1.9575198351162726e-08
an O 0 2.724574454937567e-10
extremely O 0 2.2819950373786924e-08
low O 0 2.6896969984591124e-07
level O 0 9.763824948549882e-08
of O 0 2.7292220039498716e-08
Hp O 0 2.649712200764043e-07
( O 0 1.698131968375094e-09
mean O 0 7.366254273222239e-09
+ O 0 9.46482714425656e-09
/ O 0 2.780218011366742e-08
- O 0 3.0476069667884076e-08
SD O 0 4.1998978872470616e-07
= O 0 1.0135855710302621e-08
0 O 0 1.9215069535505336e-09
. O 0 1.3830614431498134e-10
049 O 0 1.401943166001729e-07
+ O 0 3.979180984714503e-09
/ O 0 1.880816391519602e-08
- O 0 2.6584999091028294e-08
0 O 0 3.673730653019902e-09
. O 0 1.1873427796516012e-09
043 O 0 9.641854603614775e-07
mg O 0 1.0328481181431926e-07
/ O 0 2.361521289628854e-08
ml O 0 1.136732930007156e-08
; O 0 4.793639374334191e-10
n O 0 2.3545354554954656e-09
= O 0 4.539515874313338e-09
6 O 0 2.960947931285318e-09
) O 0 4.580817322685782e-11
, O 0 1.9247622592977187e-11
compared O 0 1.504747854097488e-10
with O 0 4.5489764732842275e-11
the O 0 2.588625758193075e-09
level O 0 1.71954983585465e-08
( O 0 3.786515823112069e-10
1 O 0 2.5368100953215844e-09
. O 0 2.1208003408990095e-10
64 O 0 6.2430793867918055e-09
+ O 0 6.86069689947999e-09
/ O 0 2.9081633101668558e-08
- O 0 1.7053579881576297e-08
1 O 0 5.579037232195105e-09
. O 0 2.737801096941439e-10
07 O 0 1.4069533094129838e-08
mg O 0 2.8584004496678972e-08
/ O 0 2.7077815545339945e-08
ml O 0 4.322953550683906e-09
) O 0 2.0398367023277686e-11
obtained O 0 2.0066930062068167e-10
from O 0 1.5201819802967975e-09
52 O 0 3.682024285467378e-08
healthy O 0 4.703274658623968e-09
volunteers O 0 3.855754382442456e-09
having O 0 2.625026418456855e-09
phenotype O 0 1.171840011693348e-07
Hp2 O 0 1.7080815268855076e-06
, O 0 3.4082495159459825e-10
whereas O 0 8.037380760939072e-10
the O 0 2.0352450835758873e-09
serum O 0 1.873648756145485e-07
Hp O 0 2.628806328175415e-07
level O 0 1.3173763413476536e-08
of O 0 1.919349568169082e-09
an O 0 4.469414421892637e-11
individual O 0 1.685693078179451e-11
with O 0 1.2811175731375357e-10
Hp1 O 0 1.1383033779566176e-05
/ O 0 2.430539552733535e-06
Hpdel O 0 2.2067551981308497e-05
was O 0 4.270384010851558e-07
0 O 0 1.1628981155809015e-07
. O 0 8.486033209464949e-08

50 O 0 1.1719600934156915e-06
mg O 0 3.494729980957345e-06
/ O 0 1.3753008261119248e-06
ml O 0 2.4026783762565174e-07
, O 0 4.228960237551149e-10
which O 0 5.595870294916594e-11
was O 0 2.458554249074041e-09
approximately O 0 2.720507152886853e-11
half O 0 1.5467617464626215e-10
the O 0 3.267313641863723e-10
level O 0 4.156725186277299e-09
of O 0 5.024537230724491e-09
Hp O 0 3.376348729489109e-07
in O 0 2.603544935197988e-09
control O 0 1.1454807236077613e-07
sera O 0 3.018977849933435e-07
from O 0 1.505368496523829e-09
the O 0 4.1217980140118016e-09
Hp1 O 0 8.28325710244826e-07
phenotype O 0 3.057143160845044e-08
( O 0 3.333020803797382e-10
1 O 0 2.5043591644902108e-09
. O 0 3.7001843256057043e-10
26 O 0 5.241950429279996e-09
+ O 0 3.8770742172289374e-09
/ O 0 2.0910270848162327e-08
- O 0 1.6754864162749072e-08
0 O 0 2.329053616634269e-09
. O 0 1.7178532207839936e-10
33 O 0 7.839781268614843e-09
mg O 0 3.966966843904629e-08
/ O 0 1.500152713163061e-08
ml O 0 4.961227428879056e-09
; O 0 5.353681942210642e-10
n O 0 3.690684868828953e-09
= O 0 5.038663708489821e-09
9 O 0 3.4626366218759586e-09
) O 0 7.161814891132323e-11
, O 0 5.1242669829587584e-11
showing O 0 1.8256654521486837e-10
a O 0 1.5299498334897521e-09
gene O 0 4.50814274799427e-09
- O 0 9.62777164659201e-08
dosage O 0 1.7650096424404182e-06
effect O 0 3.703436561863782e-07
. O 0 1.655307073633594e-07

The O 0 6.084054575694609e-07
other O 0 9.674745449217426e-09
allele O 0 8.684871488640056e-08
( O 0 4.706038225776865e-09
Hp2 O 0 5.22367099620169e-06
) O 0 7.653146449904114e-10
of O 0 1.1583853876118155e-09
individuals O 0 7.448416189381746e-11
with O 0 2.434169532605779e-09
Hp2 O 0 0.2843514680862427
/ O 0 0.0004199824179522693
Hpdel O 0 0.0001667171309236437
was O 0 3.355937749915938e-08
found O 0 1.7722823208998761e-10
to O 0 3.5411857474132447e-11
have O 0 2.999221010435704e-11
, O 0 2.59407495484254e-11
in O 0 5.6972884743267116e-11
all O 0 1.427108847762426e-10
exons O 0 7.46098223203262e-08
, O 0 7.67925723010876e-11
no O 0 3.778188872871624e-11
mutation O 0 1.1851293557629816e-10
, O 0 1.0997945609769744e-11
by O 0 2.269538203203414e-11
DNA O 0 3.2200691890693633e-08
sequencing O 0 9.73901023826329e-07
. O 0 2.0465628836063843e-07

On O 0 7.69792848132056e-07
the O 0 4.019564237012219e-09
basis O 0 4.173631218407081e-09
of O 0 3.446795959760607e-09
the O 0 5.281791115585577e-10
present O 0 5.394498181487961e-10
study O 0 1.0785787540879e-10
, O 0 1.895608323088105e-11
the O 0 2.9308114962711684e-11
mechanism O 0 6.583374290158872e-09
of O 0 1.076738076477568e-08
anhaptoglobinemia B-Disease 0 6.986652351770317e-06
and O 0 1.2186383013812474e-09
the O 0 1.8889836361779544e-09
mechanism O 0 1.763510226737708e-08
of O 0 3.357037314799527e-09
anomalous O 0 5.691681792541203e-08
inheritance O 0 1.4168693951432942e-07
of O 0 3.943039317277908e-08
Hp O 0 7.512345518989605e-07
phenotypes O 0 1.1803754773609398e-07
were O 0 5.747599729488684e-09
well O 0 3.5454472691043293e-09
explained O 0 3.2422679652199804e-08
. O 0 6.761139559330331e-08

However O 0 3.903469689703343e-07
, O 0 7.368137211472003e-09
the O 0 4.2481707041019945e-09
mechanism O 0 2.2101835384091828e-07
of O 0 4.0098919384945475e-07
hypohaptoglobinemia B-Disease 0 0.05837159976363182
remains O 0 3.564251528587192e-05
unknown O 0 2.4312734240083955e-05

ATM O 0 3.477427890175022e-05
mutations O 0 9.562327818457561e-08
and O 0 1.5784502593874095e-08
phenotypes O 0 1.126248548644071e-06
in O 0 1.233254636190395e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 2.3324668291024864e-05
in O 0 5.708113981484075e-10
the O 0 1.2342101785023374e-09
British O 0 8.852547139781564e-09
Isles O 0 6.777550964898182e-08
: O 0 9.311790921673335e-11
expression O 0 7.042236793708412e-10
of O 0 2.2533181986972295e-09
mutant O 0 9.58321155763997e-09
ATM O 0 4.8771362060051615e-08
and O 0 1.3633809359259175e-10
the O 0 1.194372101220864e-10
risk O 0 3.8459394002821057e-10
of O 0 5.9830367327151635e-09
leukemia B-Disease 1 1.0
, O 0 6.822018622187898e-05
lymphoma B-Disease 1 1.0
, O 0 2.685621802811511e-05
and O 0 3.074620690313168e-05
breast B-Disease 1 0.999998927116394
cancer I-Disease 1 0.9740741848945618
. O 0 7.345309427364555e-07

We O 0 8.691864650245407e-08
report O 0 1.738680532881176e-09
the O 0 1.2334360199872663e-09
spectrum O 0 7.1521469635627e-08
of O 0 1.4645969770299416e-08
59 O 0 6.280763642507736e-08
ATM O 0 2.3460601994429453e-07
mutations O 0 8.028264164572363e-10
observed O 0 8.612002777574901e-10
in O 0 2.4807451648456436e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9915579557418823
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 7.730922568782717e-09
patients O 0 5.397496227743659e-09
in O 0 3.72958941508017e-10
the O 0 4.198221770224109e-09
British O 0 3.4593583109199244e-07
Isles O 0 8.48679610498948e-06
. O 0 1.3654910446803115e-07

Of O 0 5.3483317969948985e-06
51 O 0 2.0864747511950554e-06
ATM O 0 6.123806087998673e-06
mutations O 0 1.050167774963029e-08
identified O 0 7.649472166804117e-09
in O 0 8.403508999776932e-10
families O 0 9.165785908038515e-10
native O 0 9.123871658189842e-10
to O 0 1.7613703551244697e-10
the O 0 3.2553535422863433e-09
British O 0 9.49596952182219e-08
Isles O 0 3.935273525712546e-06
, O 0 7.702717352842114e-10
11 O 0 1.0664404914706438e-09
were O 0 1.0036411701719317e-09
founder O 0 1.5368449624020286e-07
mutations O 0 9.626789365668742e-10
, O 0 2.5233642952926516e-10
and O 0 1.0365317493210569e-09
2 O 0 2.016121136705351e-08
of O 0 2.228238926704762e-09
these O 0 2.6595875501911337e-10
11 O 0 1.7726077272683938e-09
conferred O 0 6.21626083940896e-09
a O 0 1.973981117453505e-10
milder O 0 2.0726550076233252e-07
clinical O 0 1.9558591191071173e-08
phenotype O 0 4.51335635531791e-09
with O 0 1.0364002191176613e-11
respect O 0 3.3097080631705467e-10
to O 0 3.2523603255008027e-10
both O 0 5.857496709893439e-09
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 0 3.843803278869018e-05
cellular O 0 9.7537247256696e-07
features O 0 4.096851924373368e-08
. O 0 2.740300963921527e-08

We O 0 8.294372833006491e-08
report O 0 3.151083172170388e-09
, O 0 5.8988197659815e-10
in O 0 6.019834630777154e-10
two O 0 3.0735591849406774e-09
A B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999991655349731
T I-Disease 1 1.0
families O 0 5.5503718954241776e-08
, O 0 7.187271888753344e-10
an O 0 1.5729427482735758e-10
ATM O 0 2.4858572089669906e-08
mutation O 0 1.0428178320864845e-09
( O 0 4.548111054436532e-10
7271T O 0 1.4117439661731623e-07
- O 0 1.9274678209058038e-07
- O 0 4.0024838199315127e-07
> O 0 9.697554332888103e-07
G O 0 4.771218868881988e-07
) O 0 9.615719331890205e-11
that O 0 2.1825800715358223e-12
may O 0 9.061087297146386e-11
be O 0 2.3539985932741203e-11
associated O 0 5.1074741658219125e-11
with O 0 2.6678917321859563e-12
an O 0 1.2625974484675728e-12
increased O 0 1.806843737128805e-11
risk O 0 2.0586548021839235e-09
of O 0 5.4969259366544065e-08
breast B-Disease 1 0.9617212414741516
cancer I-Disease 0 1.6817137293401174e-05
in O 0 4.500270989193922e-10
both O 0 8.782177762789445e-10
homozygotes O 0 1.6765451960054634e-07
and O 0 8.856190225614569e-10
heterozygotes O 0 1.6956374082610637e-08
( O 0 2.8611302216319245e-10
relative O 0 2.0911786080546335e-08
risk O 0 6.1949911867031915e-09
12 O 0 1.882157762977954e-09
. O 0 1.750585787441139e-10
7 O 0 1.5439005629502844e-09
; O 0 3.962274952584721e-10
P O 0 5.440308541437844e-07
= O 0 1.4167635065120976e-08
. O 0 5.479146580888994e-10
0025 O 0 4.7068218123058614e-07
) O 0 6.347098541192864e-11
, O 0 5.292081876884236e-12
although O 0 5.454046242414634e-11
there O 0 4.994834407190396e-11
is O 0 5.0300551918125436e-11
a O 0 1.6554246862199307e-10
less O 0 2.2824029333179396e-09
severe O 0 0.09371602535247803
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 1.8639356369476445e-07
in O 0 3.6669715874904085e-11
terms O 0 7.761261078265136e-11
of O 0 1.1857556603267483e-10
the O 0 1.9649244731301252e-10
degree O 0 2.5572784778660207e-08
of O 0 3.6673196035508226e-08
cerebellar B-Disease 1 0.9999992847442627
degeneration I-Disease 1 1.0
. O 0 1.3843932720192242e-05

This O 0 1.8450086258781084e-07
mutation O 0 8.809363549744376e-08
( O 0 1.228060853009083e-08
7271T O 0 6.696487844237708e-07
- O 0 4.597893621394178e-07
- O 0 2.81236339105817e-07
> O 0 3.727339219494752e-07
G O 0 2.721752707657288e-07
) O 0 4.0445874427419426e-10
also O 0 9.517461124763926e-11
allows O 0 8.24623355710763e-11
expression O 0 1.649474029585818e-10
of O 0 7.47275297197092e-10
full O 0 2.027960244177507e-09
- O 0 6.396910556816238e-09
length O 0 5.411347481221185e-10
ATM O 0 1.0754983570393506e-08
protein O 0 2.4923207941895953e-10
at O 0 1.3935180787072454e-10
a O 0 4.123523744681279e-11
level O 0 3.1219474228016963e-10
comparable O 0 1.4586970520369391e-09
with O 0 1.0831223418161784e-10
that O 0 1.390114828803135e-10
in O 0 8.177930554964519e-10
unaffected O 0 2.711182958137215e-07
individuals O 0 7.571114846172122e-10
. O 0 5.151449755658177e-08

In O 0 7.401042978472105e-08
addition O 0 1.7021148934759367e-08
, O 0 2.2109492014976695e-09
we O 0 2.5673388415192733e-10
have O 0 7.741110530368189e-11
studied O 0 4.391658592339809e-09
18 O 0 1.2452558095787936e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 0.00010451226989971474
, O 0 9.204064177481541e-10
in O 0 1.4624851329969601e-10
15 O 0 3.921285240959804e-10
families O 0 1.1265031962803818e-10
, O 0 4.407934087180543e-11
who O 0 2.1000740035859167e-10
developed O 0 3.834261690371932e-07
leukemia B-Disease 1 1.0
, O 0 8.549100311938673e-05
lymphoma B-Disease 1 1.0
, O 0 2.317680809937883e-06
preleukemic O 0 0.0003735665522981435
T O 0 1.5707544662291184e-05
- O 0 8.219987535085238e-07
cell O 0 9.808603351757483e-08
proliferation O 0 5.829134863688523e-08
, O 0 5.874743747025235e-11
or O 0 1.7426387444174907e-08
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 2.3229827093018685e-06
mostly O 0 9.51645429125847e-09
in O 0 2.8571289778511755e-09
childhood O 0 1.8406376511848066e-06
. O 0 3.1038655379234115e-07

A O 0 4.735331003757892e-06
wide O 0 5.368483471102081e-07
variety O 0 2.3185016573279427e-08
of O 0 1.511647340635136e-08
ATM O 0 5.932579369982705e-07
mutation O 0 1.4138689108378344e-09
types O 0 9.488193564166636e-10
, O 0 1.6918268175292184e-10
including O 0 3.5317374025289894e-10
missense O 0 3.413836111576529e-07
mutations O 0 1.1022659229809051e-08
and O 0 4.837269251822818e-09
in O 0 1.9801100759053725e-09
- O 0 4.9145349123591586e-08
frame O 0 5.6009188398320475e-08
deletions O 0 8.097953951846648e-08
, O 0 2.88003593196251e-10
were O 0 2.6974125710843566e-10
seen O 0 5.534436242626839e-10
in O 0 7.90104995318508e-11
these O 0 4.995332480994819e-10
patients O 0 6.475232083857918e-08
. O 0 1.6450432838155393e-07

We O 0 7.783240789649426e-07
also O 0 3.105843404682673e-08
show O 0 8.703037179813577e-10
that O 0 2.3125931725154203e-11
25 O 0 3.623256694673671e-10
% O 0 9.797147121348715e-11
of O 0 1.1800728172417507e-09
all O 0 4.734126868299882e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 5.313768269843422e-07
carried O 0 1.7044465838722545e-09
in O 0 4.400905195822702e-10
- O 0 1.4637478784607083e-08
frame O 0 2.8953836661571586e-08
deletions O 0 2.9085461150657466e-08
or O 0 2.8586060185631368e-09
missense O 0 4.784948259839439e-08
mutations O 0 8.245750193758283e-10
, O 0 3.281620808426311e-11
many O 0 8.149085573005976e-12
of O 0 2.7736898888797157e-10
which O 0 2.949536448415557e-11
were O 0 1.3036920154529952e-10
also O 0 2.1408970082847922e-11
associated O 0 4.279681123375845e-11
with O 0 3.046684085572515e-11
expression O 0 1.6681640513382945e-09
of O 0 3.157209249593507e-08
mutant O 0 1.410417098668404e-07
ATM O 0 8.517895366821904e-07
protein O 0 5.42718829876776e-08
. O 0 2.224868111966316e-08

The O 0 1.2962964319740422e-06
DMPK O 0 0.001154133235104382
gene O 0 2.0632990072044777e-07
of O 0 1.7194489032590354e-07
severely O 0 0.19821223616600037
affected O 0 0.00046919670421630144
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999080896377563
is O 0 4.4575784841072164e-08
hypermethylated O 0 6.414594736270374e-06
proximal O 0 4.8137611884158105e-05
to O 0 1.638813351689805e-08
the O 0 4.686272347953491e-08
largely O 0 7.031827919945499e-08
expanded O 0 6.787835360455574e-08
CTG O 0 1.662173781369347e-05
repeat O 0 2.456756362789747e-07
. O 0 1.1961816426264704e-07

Using O 0 6.230906137716374e-07
methylation O 0 1.2536906979221385e-06
- O 0 1.449680098630779e-06
sensitive O 0 4.2895189267255773e-07
restriction O 0 6.044378775271753e-09
enzymes O 0 2.1433506081081077e-09
, O 0 1.6855847273511415e-10
we O 0 3.1367124175840644e-11
characterized O 0 1.187741460739744e-09
the O 0 1.38255318304914e-09
methylation O 0 3.392025327286774e-09
pattern O 0 1.9256600758410514e-09
on O 0 1.4937791004143719e-09
the O 0 5.241477807338413e-10
5 O 0 9.399176992275216e-10
side O 0 2.0761745656017183e-09
of O 0 8.907491633181053e-09
the O 0 4.354975047249354e-08
CTG O 0 7.903600817371625e-06
repeat O 0 8.823721309170196e-09
in O 0 1.3475100202331447e-10
the O 0 2.816095689972542e-10
DMPK O 0 1.6285451920339256e-06
gene O 0 2.2136147082019164e-10
of O 0 7.252873301943907e-11
normal O 0 6.448046957485687e-11
individuals O 0 9.075884033031556e-13
and O 0 3.620346383792494e-11
of O 0 1.1321170667599745e-09
patients O 0 1.3980320900941479e-08
affected O 0 7.009649749534219e-09
with O 0 1.1094520857568568e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 1.4595493702529438e-08
showing O 0 7.401233514947592e-10
expansions O 0 1.9304639664596834e-08
of O 0 7.2602164280510806e-09
the O 0 8.653104011102641e-09
repetitive O 0 1.176186330553719e-07
sequence O 0 2.736900484023863e-08
. O 0 4.173649159611159e-08

The O 0 1.948830458786688e-06
gene O 0 1.1763838614342603e-07
segment O 0 7.471919616364175e-08
analyzed O 0 4.777595652427635e-09
corresponds O 0 3.941202475488126e-09
to O 0 1.8149070024620073e-09
the O 0 1.6078395503882348e-08
genomic O 0 1.1791507859015837e-06
SacI O 0 8.93164542503655e-05
- O 0 5.024127744945872e-07
HindIII O 0 1.3358177284317208e-06
fragment O 0 5.0325194678180196e-08
carrying O 0 8.849643684527564e-09
exons O 0 4.706058689407655e-07
11 O 0 4.3599204246902445e-08
- O 0 3.4766026146826334e-07
15 O 0 1.0781112536051296e-07
. O 0 3.691046401854692e-07

There O 0 8.259908668151184e-08
is O 0 6.915298111920265e-09
constitutive O 0 6.019869260853739e-07
methylation O 0 2.715012215048773e-07
in O 0 2.82370908877283e-08
intron O 0 3.1266761652659625e-05
12 O 0 1.4765801381599886e-07
at O 0 6.8060996838426036e-09
restriction O 0 6.942730279568821e-10
sites O 0 9.209578655244854e-10
of O 0 1.6992983686847651e-09
SacII O 0 6.358436621667352e-07
and O 0 2.5068394027272234e-09
HhaI O 0 1.8909727259597275e-06
, O 0 7.584729511123101e-10
localized O 0 2.692141976012863e-08
1 O 0 3.3031774648861756e-08
, O 0 3.9852932065542745e-10
159 O 0 8.522655470244445e-09
- O 0 1.0746231993152833e-07
1 O 0 1.087269865251983e-07
, O 0 2.169434853982466e-09
232 O 0 4.7045240592069604e-08
bp O 0 3.561309256383538e-07
upstream O 0 4.057092439779808e-08
of O 0 8.770932424795319e-09
the O 0 1.887281264600915e-08
CTG O 0 9.007911103253718e-06
repeat O 0 2.9867237572034355e-08
, O 0 2.966407119942005e-10
whereas O 0 3.221552469234723e-10
most O 0 1.1613205536109561e-10
, O 0 1.3608836280099013e-11
if O 0 9.282969358481719e-12
not O 0 1.5245766454841103e-11
all O 0 1.997408835552328e-11
, O 0 1.834268500977565e-11
of O 0 2.8192934098392186e-10
the O 0 4.1366501890571783e-10
other O 0 9.769195175035605e-11
sites O 0 3.6056974073161996e-10
of O 0 1.8660080147725466e-09
SacII O 0 1.3644641967403004e-06
, O 0 8.996925426885127e-10
HhaI O 0 1.6273854726023274e-06
, O 0 1.0311327347523047e-09
and O 0 1.4769421241567215e-09
HpaII O 0 1.2478527423809282e-05
in O 0 1.0149877605059032e-09
this O 0 2.396484954925171e-10
region O 0 7.005358959588648e-09
are O 0 1.8576937210745825e-10
unmethylated O 0 1.3047949778410839e-06
, O 0 1.175588237867231e-10
in O 0 1.7720548986521756e-11
normal O 0 1.148049086352465e-10
individuals O 0 1.2451392998255595e-12
and O 0 4.7889945481438545e-11
most O 0 7.721556727346979e-11
of O 0 3.226153566515677e-09
the O 0 1.8345895469451534e-08
patients O 0 9.84124781666651e-08
. O 0 1.4052803010144999e-07

In O 0 5.0860752054404657e-08
a O 0 5.307879913374336e-09
number O 0 1.6612604347709947e-10
of O 0 3.2053608656212873e-09
young O 0 6.194187829322573e-09
and O 0 5.488018484101076e-09
severely O 0 6.335056968964636e-05
affected O 0 2.2153319179096798e-08
patients O 0 1.2560523288129843e-08
, O 0 6.278299408135624e-11
however O 0 2.66872385301653e-10
, O 0 4.767558917095904e-11
complete O 0 1.0958988161391403e-09
methylation O 0 5.336099562214258e-09
of O 0 1.166573726507636e-09
these O 0 1.0051427051793738e-10
restriction O 0 4.743759829395344e-10
sites O 0 2.2772489449707223e-10
was O 0 4.346697168866598e-10
found O 0 2.3238064250641344e-11
in O 0 5.320057241964271e-11
the O 0 1.0574876530000665e-09
mutated O 0 5.56097958792634e-08
allele O 0 6.116120516708179e-07
. O 0 4.7287599613810016e-07

In O 0 2.9856870753519615e-08
most O 0 1.1087493145822691e-09
of O 0 1.3519335650968856e-09
these O 0 5.0772479970317974e-11
patients O 0 8.114166005768197e-10
, O 0 1.69799417581995e-11
the O 0 1.1079749617781687e-10
onset O 0 0.0027398301754146814
of O 0 2.1443908337914763e-07
the O 0 7.885314801114873e-08
disease O 1 0.9811047911643982
was O 0 0.00035697314888238907
congenital O 1 1.0
. O 0 1.0404726708657108e-05

Preliminary O 0 1.3935282368038315e-06
in O 0 1.3506510754268675e-07
vivo O 0 4.289709522709018e-06
footprinting O 0 0.00014185176405590028
data O 0 2.4931221531687697e-08
gave O 0 9.214151219794076e-09
evidence O 0 2.1794259730256726e-09
for O 0 4.84139284218088e-10
protein O 0 1.134163762905871e-09
- O 0 6.2459140082182785e-09
DNA O 0 9.283035673490758e-09
contact O 0 9.32497012939848e-09
in O 0 2.874602778035751e-10
normal O 0 2.4952757637919376e-09
genes O 0 1.4059331476801162e-09
at O 0 1.8048339489595833e-09
an O 0 1.6345662323669075e-10
Sp1 O 0 4.229892454077344e-07
consensus O 0 5.507273570515281e-08
binding O 0 3.374641721620719e-08
site O 0 4.5940801385313534e-08
upstream O 0 4.12251344172887e-09
of O 0 4.3093351109746436e-10
the O 0 1.9353736391281018e-09
CTG O 0 1.7187682033181773e-06
repeat O 0 6.200547186807626e-09
and O 0 1.408745620157248e-10
for O 0 1.1035600384901034e-11
a O 0 2.2750813385985502e-11
significant O 0 4.4512678265551386e-11
reduction O 0 2.0609884909816856e-09
of O 0 5.334783725885472e-10
this O 0 1.7289497958317135e-11
interaction O 0 7.334281793003328e-11
in O 0 8.14165922180532e-12
cells O 0 7.953714770136955e-11
with O 0 1.5238440717602053e-11
a O 0 1.8223926812055424e-09
hypermethylated O 0 1.2903946071674e-06
DMPK O 0 6.080591265344992e-05
gene O 0 1.7790780404425277e-08
. O 0 2.8258304585193628e-09
. O 0 2.7073632224983157e-08

The O 0 2.022581065830309e-05
hemochromatosis B-Disease 1 1.0
gene O 0 1.1867189186887117e-07
product O 0 7.55758478021562e-09
complexes O 0 6.599718105348984e-09
with O 0 1.2479128841391685e-10
the O 0 2.9773941090383005e-09
transferrin O 0 5.598329607892083e-06
receptor O 0 2.338848403837801e-08
and O 0 4.447926194028895e-10
lowers O 0 9.263455780228469e-09
its O 0 3.6318548862768196e-11
affinity O 0 5.031237648722708e-10
for O 0 5.7666892094854205e-11
ligand O 0 2.535597154462721e-08
binding O 0 2.0044380377726156e-08
. O 0 7.962970016706095e-08

We O 0 2.9767204523523105e-07
recently O 0 7.70917694126183e-08
reported O 0 2.3753254918545963e-09
the O 0 1.1561407387006284e-09
positional O 0 8.678022140884423e-07
cloning O 0 9.132759259955492e-08
of O 0 7.191554018959323e-09
a O 0 1.9736359213595733e-09
candidate O 0 9.414666379825576e-09
gene O 0 2.2106465991100777e-08
for O 0 3.0279881713113355e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.999998927116394
HFE O 1 0.9999997615814209
. O 0 1.4943047972337808e-06

The O 0 2.3451542574548512e-07
gene O 0 7.601418161584661e-09
product O 0 1.0685850426739307e-08
, O 0 5.782255230180056e-10
a O 0 1.5492367388958428e-09
member O 0 2.380868169282735e-09
of O 0 3.2802738303416845e-08
the O 0 1.2613729438726295e-07
major O 0 6.564893624272372e-07
histocompatibility O 1 0.5795300602912903
complex O 0 2.6893710582953645e-06
class O 0 7.662088741255957e-09
I O 0 5.74550895748871e-08
- O 0 1.8353629727130283e-08
like O 0 2.858790149051771e-10
family O 0 2.8672886287495203e-09
, O 0 1.8277106217379213e-10
was O 0 4.633891048655414e-09
found O 0 2.757101214001523e-10
to O 0 4.0925135502689614e-10
have O 0 7.213475372580547e-10
a O 0 7.36409067059185e-09
mutation O 0 7.927748235658783e-09
, O 0 3.625989064559576e-09
Cys O 0 2.861978100554552e-05
- O 0 2.650869873832562e-06
282 O 0 1.093693185794109e-06
- O 0 1.2062641872034874e-06
- O 0 1.0172276461162255e-06
> O 0 1.0629146345308982e-06
Tyr O 0 1.0393203410785645e-05
( O 0 1.358675172369317e-09
C282Y O 0 2.813816735169894e-08
) O 0 3.800768380579633e-11
, O 0 2.1872569727632296e-11
in O 0 3.981667426322666e-11
85 O 0 1.6154005910706815e-09
% O 0 3.6449449014597235e-10
of O 0 2.3001065496686124e-09
patient O 0 6.778765992976332e-08
chromosomes O 0 7.558857362255367e-08
. O 0 1.6662734481087682e-07

This O 0 3.5204084980478e-08
mutation O 0 6.376033923061186e-08
eliminates O 0 3.6563966432368034e-07
the O 0 1.370670066336288e-08
ability O 0 8.971807297086798e-09
of O 0 7.777114063856061e-08
HFE O 1 0.992715060710907
to O 0 3.586249519571538e-08
associate O 0 1.9465814204977505e-07
with O 0 2.91470891866652e-09
beta2 O 0 3.951855978812091e-05
- O 0 6.323354682535864e-06
microglobulin O 0 0.0001112651516450569
( O 0 5.344900522175067e-09
beta2m O 0 2.0194017906760564e-06
) O 0 4.3715739361793737e-10
and O 0 3.68598374045348e-10
prevents O 0 3.6843268436115295e-09
cell O 0 2.4726361402827024e-07
- O 0 8.41634957282622e-08
surface O 0 1.0854753895728209e-07
expression O 0 5.895777377418199e-08
. O 0 5.2097082203772516e-08

A O 0 5.507033620233415e-06
second O 0 4.304402523302997e-07
mutation O 0 5.4957385309251094e-09
that O 0 1.8535208090586508e-10
has O 0 2.556354294913632e-10
no O 0 1.4026273198464168e-10
effect O 0 3.094523748359279e-09
on O 0 9.045900917215022e-09
beta2m O 0 1.1567310593818547e-06
association O 0 1.1067167182687854e-09
, O 0 6.387957385278753e-10
H63D O 0 0.0007023675134405494
, O 0 1.4476492227188942e-09
was O 0 1.1089739793135323e-08
found O 0 1.3103881868481437e-10
in O 0 5.0194650519364004e-11
eight O 0 2.2855298209556452e-10
out O 0 1.4217077515255028e-10
of O 0 3.323956665468586e-09
nine O 0 1.755077505549707e-08
patients O 0 2.3751802746829753e-09
heterozygous O 0 1.0671465933143054e-09
for O 0 5.252075441219972e-10
the O 0 2.1666735960934602e-08
C282Y O 0 6.5859912865562364e-06
mutant O 0 1.384354163747048e-06
. O 0 5.362609840631194e-07

In O 0 4.206110659765727e-08
this O 0 1.1235661290243115e-09
report O 0 3.739806242464283e-09
, O 0 1.7920324113518404e-09
we O 0 9.837448633476242e-10
demonstrate O 0 1.9027982745001282e-08
in O 0 4.454720592406147e-09
cultured O 0 6.770663389943365e-07
293 O 0 7.990736605734128e-08
cells O 0 1.762810697414352e-08
overexpressing O 0 2.270010554639157e-06
wild O 0 4.847505508109862e-08
- O 0 3.616045418652902e-08
type O 0 4.26864943392502e-08
or O 0 6.913744243775e-08
mutant O 0 1.0424588481328101e-07
HFE O 0 2.003868303290801e-06
proteins O 0 3.199871964620904e-11
that O 0 7.472175655998115e-12
both O 0 5.755448201361091e-11
the O 0 1.3046130842297998e-09
wild O 0 1.184552012034601e-08
- O 0 2.00405185779573e-08
type O 0 2.985208524819427e-08
and O 0 2.8049322864376336e-08
H63D O 0 0.0004178360104560852
HFE O 0 2.8260341423447244e-05
proteins O 0 1.847527686393846e-10
form O 0 1.3529335984863167e-10
stable O 0 1.8506605137247334e-09
complexes O 0 8.373461923838477e-10
with O 0 1.8961363729141922e-11
the O 0 1.2460866782859625e-09
transferrin O 0 2.0903567019558977e-06
receptor O 0 1.4724509611596659e-08
( O 0 5.602397989967756e-10
TfR O 0 2.191221284419953e-07
) O 0 1.387167714028692e-09
. O 0 1.1981768466284848e-08

The O 0 3.0533376502717147e-06
C282Y O 0 1.225159485329641e-05
mutation O 0 9.905237874363593e-08
nearly O 0 7.0181580547057365e-09
completely O 0 8.920226335362713e-09
prevents O 0 1.7651514694350112e-09
the O 0 1.905150481817941e-09
association O 0 8.827554243140412e-10
of O 0 6.114601713846923e-09
the O 0 1.1337426997215516e-08
mutant O 0 1.1451376025206628e-07
HFE O 0 3.2617859687888995e-05
protein O 0 7.501776089213763e-09
with O 0 3.8571645877283345e-10
the O 0 1.2560211537504529e-08
TfR O 0 0.0001688574266154319
. O 0 6.169642006170761e-07

Studies O 0 3.8131696555865346e-07
on O 0 1.342478697097249e-07
cell O 0 1.958584761041493e-07
- O 0 9.309103177201905e-08
associated O 0 3.230237410889458e-08
transferrin O 0 4.172545959590934e-05
at O 0 4.1580040743838254e-08
37 O 0 5.24481080788064e-09
degrees O 0 4.145357834772767e-08
C O 0 5.498960220506888e-08
suggest O 0 1.26929988741864e-09
that O 0 1.2480651234714202e-10
the O 0 7.005666713411074e-09
overexpressed O 0 1.8046097238766379e-06
wild O 0 1.263348536895137e-07
- O 0 9.158699043609886e-08
type O 0 6.524411588770818e-08
HFE O 0 0.0006481010350398719
protein O 0 5.175447626015739e-09
decreases O 0 4.3141049066441894e-10
the O 0 6.755575265859903e-11
affinity O 0 4.2772924091494247e-10
of O 0 6.467695823353381e-10
the O 0 2.5991986341011852e-09
TfR O 0 1.4764985962756327e-06
for O 0 6.647320471842022e-09
transferrin O 0 2.5966588509618305e-05
. O 0 2.7619998377304e-07

The O 0 1.288828207179904e-05
overexpressed O 0 0.00025133482995443046
H63D O 0 0.0022450427059084177
protein O 0 3.2765598234618665e-08
does O 0 3.131584991322711e-10
not O 0 2.367461955643524e-11
have O 0 7.0495003064163786e-12
this O 0 2.8650046744738145e-12
effect O 0 1.166900326365905e-10
, O 0 3.4319404956795196e-11
providing O 0 8.539000062590674e-11
the O 0 9.313620014106405e-11
first O 0 4.931890312809273e-11
direct O 0 6.876057362381616e-11
evidence O 0 4.190123803482493e-10
for O 0 5.306356049006311e-11
a O 0 3.4248667790670595e-10
functional O 0 7.839033422385455e-09
consequence O 0 2.578638635952757e-08
of O 0 2.1887711199042315e-08
the O 0 5.027856886385962e-08
H63D O 0 0.0001318366703344509
mutation O 0 1.41789001872894e-07
. O 0 8.240412086024662e-08

Addition O 0 3.1259520483217784e-07
of O 0 7.486897857233998e-07
soluble O 0 4.097093551536091e-06
wild O 0 9.433837817596213e-07
- O 0 3.8026166748750256e-07
type O 0 1.2222420764373965e-06
HFE O 1 1.0
/ O 1 0.9993640780448914
beta2m O 0 2.2867041479912587e-05
heterodimers O 0 2.632780706335325e-06
to O 0 6.722945311565809e-09
cultured O 0 1.148656352256694e-07
cells O 0 3.116202185182715e-09
also O 0 2.1832233243479493e-10
decreased O 0 4.766361749730663e-10
the O 0 2.714366509337651e-10
apparent O 0 1.2673241123195567e-08
affinity O 0 9.447656879046917e-09
of O 0 8.293135067560797e-09
the O 0 2.6730453406287324e-09
TfR O 0 2.5775818812689977e-07
for O 0 1.333320814866923e-10
its O 0 1.0450275367279716e-10
ligand O 0 8.21301160414123e-09
under O 0 1.5099011818620056e-08
steady O 0 4.486049576257756e-08
- O 0 8.962537378920388e-09
state O 0 1.3463127834789645e-10
conditions O 0 5.8464015850745454e-09
, O 0 9.492442942793389e-11
both O 0 7.223357328944857e-11
in O 0 1.5981031775691434e-10
293 O 0 2.0440060755078093e-09
cells O 0 7.694244685829688e-10
and O 0 1.335202171048877e-09
in O 0 3.550678417951758e-09
HeLa O 0 7.722972077317536e-05
cells O 0 2.2280961786691478e-07
. O 0 1.0517717896618706e-07

Furthermore O 0 1.4192430626280839e-06
, O 0 6.5845071617332e-08
at O 0 6.772239657948376e-08
4 O 0 2.4416852539843603e-08
degrees O 0 1.7769525584299117e-07
C O 0 5.33664660906652e-07
, O 0 1.703595042812367e-09
the O 0 4.066526670953863e-09
added O 0 1.0234797009900376e-08
soluble O 0 2.837904844454897e-07
complex O 0 2.1792466498027352e-07
of O 0 8.348942515112867e-08
HFE O 1 0.9988760352134705
/ O 0 4.486651232582517e-05
beta2m O 0 1.6667565887473756e-06
inhibited O 0 5.238182332334418e-09
binding O 0 1.2965509776918793e-09
of O 0 3.86646226147036e-09
transferrin O 0 1.639922516005754e-06
to O 0 1.5077601389634765e-08
HeLa O 0 2.9042559617664665e-05
cell O 0 1.5515951190536725e-07
TfR O 0 6.098053972891648e-07
in O 0 5.982827566697324e-10
a O 0 3.3498734897108307e-09
concentration O 0 6.051798777662043e-07
- O 0 2.449013152272528e-07
dependent O 0 3.0368028092198074e-08
manner O 0 2.4965464717752184e-07
. O 0 1.2891618439425656e-07

Scatchard O 0 0.0006553008570335805
plots O 0 3.59871819455293e-06
of O 0 1.2305208940688317e-07
these O 0 1.4909183887468203e-09
data O 0 2.887628136605258e-09
indicate O 0 9.648278842533387e-10
that O 0 1.6062869090394116e-10
the O 0 7.1564696391135385e-09
added O 0 1.665275206619299e-08
heterodimer O 0 8.639170232527249e-07
substantially O 0 5.534272418117325e-08
reduced O 0 6.500274984944099e-09
the O 0 1.119224157797305e-09
affinity O 0 4.410032783397355e-09
of O 0 1.5858194757356614e-08
TfR O 0 4.204974175081588e-06
for O 0 3.1185106053044365e-08
transferrin O 0 7.653923239558935e-05
. O 0 1.1707223848134163e-06

These O 0 4.5164590289914486e-08
results O 0 2.493654704949222e-08
establish O 0 4.494288674550262e-08
a O 0 6.211745784412415e-09
molecular O 0 2.5692418859080135e-08
link O 0 8.088136382866651e-08
between O 0 1.5225564808929448e-08
HFE O 1 0.9999996423721313
and O 0 1.5905183659015165e-07
a O 0 2.3509510782560028e-08
key O 0 1.6836430916100653e-07
protein O 0 1.6360330867826178e-09
involved O 0 2.076264715711318e-10
in O 0 1.5533488384456007e-10
iron O 0 1.07342675619293e-05
transport O 0 7.730070450406856e-08
, O 0 3.7876574099371396e-10
the O 0 1.3817463839771449e-09
TfR O 0 2.0520817997748964e-05
, O 0 3.237049239768197e-10
and O 0 1.670930616093358e-10
raise O 0 6.095605686873284e-10
the O 0 2.668622267609777e-10
possibility O 0 2.0466117689466046e-09
that O 0 2.7522921441924808e-11
alterations O 0 9.123250599429866e-09
in O 0 3.351250527083849e-11
this O 0 9.194860151051643e-12
regulatory O 0 1.7477576053082089e-09
mechanism O 0 4.52428539077232e-09
may O 0 5.130832425592757e-10
play O 0 8.884750157811538e-10
a O 0 6.897102888814288e-10
role O 0 1.1027005974995063e-09
in O 0 7.763482218203777e-11
the O 0 1.1040727221356406e-09
pathogenesis O 1 0.9999597072601318
of O 0 0.33697381615638733
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 9.239227438229136e-06
. O 0 1.0007995854266483e-07

Genomic O 0 7.578267286589835e-06
organization O 0 8.839795384574245e-08
of O 0 2.1792737925352412e-07
the O 0 4.5313174723560223e-07
UBE3A O 1 0.9997938275337219
/ O 0 0.07582566142082214
E6 O 0 0.001309752929955721
- O 0 2.6206812435702886e-06
AP O 0 3.490693188723526e-06
gene O 0 3.963924743999314e-09
and O 0 5.935748559338094e-10
related O 0 5.631018140661581e-08
pseudogenes O 0 6.024576214258559e-05
. O 0 6.655365609731234e-07

The O 0 9.101212526729796e-06
UBE3A O 0 0.0007188718882389367
gene O 0 4.708716403456492e-07
encodes O 0 1.1404861055552828e-07
the O 0 5.007996861650099e-08
E6 O 0 1.590903048054315e-05
- O 0 1.7516600792077952e-06
AP O 0 1.7650163499638438e-05
ubiquitin O 0 3.6638034544012044e-06
- O 0 4.0392728806182276e-07
protein O 0 4.486098603706523e-09
ligase O 0 1.7879294489375752e-08
and O 0 1.6795074220254946e-09
has O 0 3.0140753781715546e-10
recently O 0 1.1705857394517238e-09
been O 0 1.1260413435021377e-10
shown O 0 2.343810735772056e-11
to O 0 2.8498274920463196e-11
be O 0 6.524514956085525e-11
mutated O 0 1.2614233924068685e-07
in O 0 3.42135820119438e-07
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9983410835266113
who O 0 1.6212753806144065e-08
lack O 0 2.142428456863854e-07
15q11 O 0 7.1845415732241236e-06
- O 0 5.310110395839729e-07
q13 O 0 8.310650514431472e-07
deletions O 0 8.931959882829688e-08
or O 0 1.0457064547608752e-08
chromosome O 0 5.6600484299451637e-08
15 O 0 8.256397165951057e-08
paternal O 0 9.654385939938948e-05
uniparental B-Disease 1 0.9999977350234985
disomy I-Disease 1 0.9863974452018738
. O 0 1.727599919831846e-05

Previous O 0 1.8457196347299032e-05
UBE3A O 0 0.000785565993282944
cDNA O 0 2.8271042538108304e-06
analysis O 0 1.9618445534774764e-08
has O 0 8.049976796264957e-10
shown O 0 1.4595591402155605e-10
a O 0 1.6894351473339952e-09
coding O 0 8.857499267378444e-08
region O 0 1.553421569155944e-08
of O 0 1.9545462137671166e-08
approximately O 0 3.874804477277394e-09
2 O 0 1.187540874525439e-07
. O 0 2.4802684350788695e-08

6 O 0 5.0076156185241416e-05
kb O 0 4.869090116699226e-05
and O 0 1.3192664027883438e-07
a O 0 2.7214281317355926e-07
3 O 0 2.7763819616666296e-06
- O 0 1.0840175491466653e-05
untranslated O 1 1.0
region O 0 4.308322331780801e-06
( O 0 3.3042113045667065e-08
UTR O 1 0.9990179538726807
) O 0 1.7920187556086375e-09
of O 0 4.817611198859595e-09
< O 0 2.2764007212572324e-07
50 O 0 7.728357509506623e-09
bp O 0 3.7297638755262597e-08
, O 0 1.4172674145385145e-10
whereas O 0 1.0464601407633722e-09
Northern O 0 7.888966813140996e-09
analysis O 0 6.490087911537046e-10
has O 0 1.6710771655326084e-10
indicated O 0 1.097961235818623e-10
mRNA O 0 7.378512245637125e-10
sizes O 0 5.258962154641722e-10
of O 0 4.935320152554823e-09
5 O 0 7.759673792406829e-08
- O 0 4.910000370728085e-07
8 O 0 6.667117986580706e-07
kb O 0 5.570051507675089e-05
. O 0 8.358101695193909e-07

We O 0 2.7848307126987493e-07
have O 0 2.3568313967103904e-09
analyzed O 0 4.173185352840392e-09
additional O 0 1.3102539053733153e-09
cDNA O 0 1.6492246857069404e-07
clones O 0 1.997176184431737e-07
and O 0 1.706338959017728e-10
provide O 0 3.31601898717615e-11
evidence O 0 4.5390116665267044e-10
for O 0 5.667580293966523e-11
an O 0 3.472447676622359e-11
additional O 0 2.5122146585232485e-09
0 O 0 6.738417113183459e-08
. O 0 6.265914720415822e-08

5 O 0 6.69140217723907e-06
kb O 0 1.7130363630712964e-05
of O 0 8.322166422658483e-07
5 O 0 3.998744659838849e-07
- O 0 6.088448571972549e-07
UTR O 1 0.9997319579124451
and O 0 5.05119501781337e-08
> O 0 4.5276848936737224e-07
2 O 0 1.189814824442692e-07
kb O 0 5.129389251123939e-07
of O 0 8.799422346328356e-08
3 O 0 7.207813268905738e-06
- O 0 2.913585376518313e-05
UTR O 1 1.0
. O 0 4.896242899121717e-06

We O 0 1.8071362717364536e-07
have O 0 3.752138599821819e-09
established O 0 6.558633636188915e-09
the O 0 6.302129929025568e-10
genomic O 0 6.946403008356583e-09
organization O 0 1.681904338024509e-10
of O 0 6.444635491931194e-09
UBE3A O 0 0.0001445725793018937
and O 0 1.5917345663751803e-08
the O 0 2.731334936001417e-09
sequence O 0 8.195059630899948e-10
of O 0 7.961478587503734e-09
intron O 0 4.613482360582566e-06
- O 0 3.3888695725181606e-06
exon O 0 3.967863904108526e-06
borders O 0 8.47589092245471e-08
. O 0 1.1899011553850869e-07

We O 0 3.751582653421792e-07
have O 0 1.6151673776221287e-08
also O 0 1.0284227691670367e-08
mapped O 0 4.05215843102269e-08
two O 0 1.40837286277673e-09
highly O 0 9.812791468277737e-09
homologous O 0 2.1745396594496924e-08
processed O 0 5.3558835588773945e-08
pseudogenes O 0 4.771464432451467e-07
, O 0 2.0267654221584053e-09
UBE3AP1 O 0 5.835589035996236e-05
and O 0 3.080656441056817e-08
UBE3AP2 O 0 0.0017657768912613392
, O 0 8.923182748254987e-10
to O 0 1.872363791788345e-10
chromosomes O 0 3.365588086001736e-10
2 O 0 4.0352889918437995e-09
and O 0 2.5971405581692864e-10
21 O 0 4.466325531637949e-09
, O 0 1.3534343090704226e-10
respectively O 0 2.1170791786317977e-09
, O 0 2.2023871615317603e-10
and O 0 3.280402338656785e-10
determined O 0 3.348353150300909e-09
their O 0 1.082643752425838e-09
genomic O 0 4.1047677257211035e-08
organization O 0 3.303478601779375e-09
. O 0 2.2749505390606828e-08

These O 0 2.275136878893136e-08
results O 0 3.1086033747129704e-09
will O 0 1.635557939083654e-10
form O 0 2.6812443931767405e-10
the O 0 4.686491195116105e-10
basis O 0 2.1575492781256145e-10
for O 0 1.1936449224869694e-11
studies O 0 2.7666608587439967e-11
of O 0 1.4885451204982303e-10
mutation O 0 1.302682961501489e-10
and O 0 1.0486900237083319e-09
imprinting O 0 9.27800897443376e-07
of O 0 6.857925995973346e-07
UBE3A O 1 0.9971634745597839
. O 0 1.515529561402218e-06

Mutation O 0 2.0296483853599057e-06
spectrum O 0 4.263777555024717e-06
and O 0 2.888114458698965e-08
genotype O 0 1.7460828303228482e-06
- O 0 3.13694499709527e-07
phenotype O 0 1.1623636453350628e-07
analyses O 0 9.647032506165942e-09
in O 0 9.854199678471787e-10
Cowden B-Disease 0 0.04758285731077194
disease I-Disease 0 3.829744400718482e-06
and O 0 5.889426901717343e-08
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.0059051369637473e-08
two O 0 1.3313298907746685e-08
hamartoma B-Disease 1 0.9999997615814209
syndromes I-Disease 1 0.999997615814209
with O 0 1.7690068716547103e-06
germline O 1 0.9999531507492065
PTEN O 1 0.9999994039535522
mutation O 0 4.97378823638428e-06
. O 0 5.158637463864579e-07

The O 0 2.0336634406703524e-05
tumour B-Disease 1 1.0
suppressor O 0 0.0009572200942784548
gene O 0 1.8203789977633278e-06
PTEN O 0 0.0018698659259825945
, O 0 6.989090195475001e-09
which O 0 9.533436262643136e-10
maps O 0 1.9401277029373887e-08
to O 0 7.741059349086754e-09
10q23 O 0 2.0879619114566594e-05
. O 0 7.478761858692451e-07

3 O 0 2.131091378032579e-06
and O 0 2.2174413416564676e-08
encodes O 0 9.511754939239836e-09
a O 0 9.214744522978435e-10
403 O 0 7.86351428416765e-10
amino O 0 3.428840822383705e-10
acid O 0 1.0112120030214555e-09
dual O 0 3.862806075005665e-09
specificity O 0 8.36142035609555e-08
phosphatase O 0 6.71598991175415e-06
( O 0 1.8935359946681274e-09
protein O 0 2.072831017940757e-09
tyrosine O 0 1.382008019135128e-08
phosphatase O 0 6.221518589200059e-08
; O 0 1.535163940413753e-10
PTPase O 0 8.148899866000647e-08
) O 0 1.0411598666548727e-10
, O 0 5.170084846350953e-11
was O 0 1.6951255954467115e-09
shown O 0 2.3847254726483413e-10
recently O 0 1.729921206283791e-09
to O 0 3.070967924401202e-10
play O 0 5.774521305568214e-09
a O 0 6.415495246159253e-09
broad O 0 7.72833033124698e-08
role O 0 3.0543514384362425e-08
in O 0 4.522576979582027e-09
human O 0 3.054625352660878e-08
malignancy B-Disease 1 0.7371513843536377
. O 0 5.177286652724433e-07

Somatic O 0 0.0009656671318225563
PTEN O 0 0.00484120799228549
deletions O 0 2.880819238271215e-06
and O 0 1.1567676594381737e-08
mutations O 0 2.306789204098436e-09
were O 0 5.400284108780795e-10
observed O 0 4.670927533645397e-10
in O 0 1.8136638024746077e-10
sporadic B-Disease 0 3.5340329418431793e-07
breast I-Disease 1 0.9998435974121094
, I-Disease 0 1.3263823817055709e-08
brain I-Disease 0 0.00013212863996159285
, I-Disease 0 1.0545193163125077e-08
prostate I-Disease 1 1.0
and I-Disease 0 0.07211245596408844
kidney I-Disease 1 1.0
cancer I-Disease 1 0.9999990463256836
cell O 0 7.831367111066356e-05
lines O 0 7.422768621978548e-09
and O 0 3.243315893630694e-10
in O 0 6.931678842025946e-11
several O 0 2.1710935826924072e-10
primary O 0 4.874188164194493e-08
tumours B-Disease 1 0.9998626708984375
such O 0 1.0033656128172197e-09
as O 0 1.731563514795198e-07
endometrial B-Disease 1 0.9999997615814209
carcinomas I-Disease 1 1.0
, O 0 0.017390461638569832
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 0.0009935104753822088

In O 0 3.39152244066554e-08
addition O 0 1.7431506904586058e-08
, O 0 1.0603643296747123e-08
PTEN O 0 0.0026756892912089825
was O 0 2.514695154332003e-07
identified O 0 4.454431934419745e-09
as O 0 2.1068061184514875e-10
the O 0 3.3363917184559e-10
susceptibility O 0 1.4098598732914525e-08
gene O 0 4.079708793014447e-10
for O 0 1.7346252212391278e-10
two O 0 5.061231433955982e-09
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 0.9999916553497314
( O 0 1.3770849349725722e-08
CD B-Disease 0 7.170010121626547e-06
; O 0 1.3948643129424454e-07
MIM O 1 0.6462314128875732
158350 O 0 2.4633491193526424e-06
) O 0 5.038603423379584e-10
and O 0 4.155472854705522e-09
Bannayan B-Disease 0 0.0001066500335582532
- I-Disease 0 4.2001291149063036e-05
Zonana I-Disease 1 0.9971741437911987
( I-Disease 0 1.295602913842231e-07
BZS I-Disease 0 0.000720847281627357
) I-Disease 0 5.429567462300611e-09
or I-Disease 0 5.458288043769244e-09
Ruvalcaba I-Disease 0 2.4185983420466073e-05
- I-Disease 0 1.9255014649388613e-06
Riley I-Disease 0 1.0179263881582301e-05
- I-Disease 0 0.2162495255470276
Smith I-Disease 1 0.9994926452636719
syndrome I-Disease 1 1.0
( O 0 1.4937363630451728e-06
MIM O 1 0.9999943971633911
153480 O 0 5.379478170652874e-05
) O 0 1.669075189170144e-08
. O 0 7.78683570956673e-08

Constitutive O 0 5.618429895548616e-06
DNA O 0 6.772755227757443e-07
from O 0 4.259702635067697e-08
37 O 0 7.936284163179153e-08
CD B-Disease 0 6.445338840421755e-07
families O 0 4.21806278794179e-09
and O 0 7.976191263026067e-09
seven O 0 7.428209869431157e-08
BZS B-Disease 1 0.8719621300697327
families O 0 2.017013400745782e-08
was O 0 6.945279551473504e-08
screened O 0 3.679145876844814e-08
for O 0 4.735291714297318e-09
germline O 0 2.470494837325532e-05
PTEN O 0 0.0038865008391439915
mutations O 0 6.633978841819044e-07
. O 0 3.164266217936529e-07

PTEN O 0 0.0016888612881302834
mutations O 0 2.1095912927648897e-07
were O 0 1.5041582202002246e-08
identified O 0 2.843689284048878e-09
in O 0 2.857318270876874e-10
30 O 0 1.6224656063101861e-09
of O 0 6.2892127061786596e-09
37 O 0 2.895566098004565e-08
( O 0 8.160261910639122e-10
81 O 0 5.2024397234617936e-08
% O 0 1.1362381036050806e-09
) O 0 4.134614872697284e-10
CD B-Disease 0 1.7604661195491644e-07
families O 0 1.7197883117603396e-09
, O 0 1.816239242335982e-10
including O 0 2.895176598460836e-10
missense O 0 1.3445466606754053e-07
and O 0 9.769800080050572e-09
nonsense O 0 3.598618150135735e-07
point O 0 1.4832694184008233e-08
mutations O 0 1.4227304057090606e-10
, O 0 6.845383981879394e-11
deletions O 0 3.845031848470626e-09
, O 0 4.137912512636177e-10
insertions O 0 4.448881085750145e-08
, O 0 1.2530557702561396e-09
a O 0 5.318236961926459e-09
deletion O 0 6.036270860931836e-07
/ O 0 2.072727511404082e-06
insertion O 0 2.8271645646782417e-07
and O 0 3.030854145436024e-08
splice O 0 1.0625614777381998e-05
site O 0 2.4210584115280653e-07
mutations O 0 9.314553572892237e-09
. O 0 2.5518165358562328e-08

These O 0 6.009068442835996e-08
mutations O 0 6.752363646000958e-08
were O 0 1.432433460735183e-08
scattered O 0 2.0366597297538647e-08
over O 0 3.816252203137083e-09
the O 0 1.8296090198433035e-09
entire O 0 3.3382521191782644e-09
length O 0 1.8373444987673793e-09
of O 0 5.383841816808399e-09
PTEN O 0 3.768582973862067e-05
, O 0 3.49028500545856e-10
with O 0 3.5935979886270175e-11
the O 0 8.201298529186829e-10
exception O 0 2.419205502590671e-09
of O 0 2.4289752431627676e-09
the O 0 1.353120171465605e-09
first O 0 1.3322232206292028e-09
, O 0 1.6158217819306486e-10
fourth O 0 4.273309173186135e-08
and O 0 1.2271641480765538e-08
last O 0 5.37597372840537e-07
exons O 0 0.00011476340296212584
. O 0 9.984350981540047e-07

A O 0 4.230599370202981e-05
hot O 0 5.8061694289790466e-05
spot O 0 1.6503117876709439e-06
for O 0 6.691640574985058e-09
PTEN O 0 1.3451315680867992e-05
mutation O 0 9.077234963683622e-09
in O 0 1.6671685143521131e-09
CD B-Disease 0 7.521184102188272e-07
was O 0 1.3209017879489693e-07
identified O 0 2.6553310661370233e-09
in O 0 3.9579242661069713e-10
exon O 0 2.084560080106712e-08
5 O 0 1.4218168864488234e-09
that O 0 2.030450634016301e-11
contains O 0 5.622534104965382e-10
the O 0 3.834631723265147e-09
PTPase O 0 1.7076418998840381e-06
core O 0 6.146115794081197e-08
motif O 0 4.138940745690434e-09
, O 0 1.6409129263705857e-11
with O 0 1.2328396116478846e-11
13 O 0 1.4012268012564277e-09
of O 0 9.505370712759031e-09
30 O 0 1.0198221822577125e-08
( O 0 5.88755710850819e-10
43 O 0 6.559284226881346e-09
% O 0 3.1844210601761347e-10
) O 0 1.2344261723917782e-10
CD B-Disease 0 5.2939903127935395e-08
mutations O 0 1.4863158481759342e-09
identified O 0 2.074084903824769e-09
in O 0 4.0423586700200076e-10
this O 0 2.035361656993473e-09
exon O 0 8.225900387515139e-07
. O 0 5.462831609293062e-08

Seven O 0 1.020635409076931e-06
of O 0 2.649949806254881e-07
30 O 0 6.756473425184595e-08
( O 0 2.280236222063081e-09
23 O 0 1.1088427953609425e-08
% O 0 1.0996907828797475e-09
) O 0 2.265555937297492e-10
were O 0 8.120296657310178e-10
within O 0 3.307147666831156e-09
the O 0 5.230404998002314e-09
core O 0 4.552263987989136e-08
motif O 0 6.270623131854336e-09
, O 0 2.9670790130387203e-11
the O 0 1.1325721610555561e-10
majority O 0 7.089673292881571e-11
( O 0 7.766014220589312e-11
five O 0 3.1725627680501134e-10
of O 0 2.4069490844880193e-09
seven O 0 1.0370162506490033e-09
) O 0 5.0379669186417786e-11
of O 0 4.036310730093362e-10
which O 0 2.5961552352349315e-10
were O 0 2.348673033836235e-09
missense O 0 9.775098419595452e-08
mutations O 0 1.834690066537803e-09
, O 0 2.3140944716004697e-10
possibly O 0 8.621227287619604e-09
pointing O 0 2.7716829720247915e-08
to O 0 1.3552691191520694e-09
the O 0 2.9119195943394516e-09
functional O 0 5.537609126804455e-08
significance O 0 1.3086960848340823e-08
of O 0 5.551926030022969e-09
this O 0 4.6419915133988354e-10
region O 0 2.8485329650607127e-08
. O 0 1.109990179770648e-07

Germline O 0 0.0018688116688281298
PTEN O 0 0.0003666256961878389
mutations O 0 6.786812889458815e-08
were O 0 5.72208058713386e-09
identified O 0 4.318964741401032e-09
in O 0 4.268628506221006e-10
four O 0 8.23422996454326e-10
of O 0 9.497070685426934e-09
seven O 0 1.1383905373918424e-08
( O 0 2.2691377665751133e-09
57 O 0 8.982289756431783e-08
% O 0 1.8551922664755693e-08
) O 0 2.2441492220082182e-08
BZS B-Disease 1 0.9822516441345215
families O 0 6.886619274837358e-08
studied O 0 4.6818141186122375e-07
. O 0 1.493079793135621e-07

Interestingly O 0 1.7966008272196632e-06
, O 0 4.399077990768774e-09
none O 0 2.6270801090078066e-09
of O 0 1.8627615006039377e-09
these O 0 2.252904390820376e-10
mutations O 0 1.8349455288557692e-09
was O 0 7.430842607902832e-09
observed O 0 6.068310298701363e-10
in O 0 2.6663121710512883e-10
the O 0 8.921638539050036e-09
PTPase O 0 6.718379881931469e-05
core O 0 1.4165077118377667e-05
motif O 0 1.4211933603291982e-06
. O 0 8.760670766605472e-08

It O 0 5.054683782645952e-08
is O 0 2.7296787052932814e-09
also O 0 4.285368448986304e-10
worthy O 0 1.5214766335702734e-08
of O 0 3.8854026662704655e-09
note O 0 1.169099705933263e-09
that O 0 5.2916202669672785e-11
a O 0 8.70967964416991e-10
single O 0 1.7079774261574698e-09
nonsense O 0 7.315013306197216e-08
point O 0 1.160732665539399e-08
mutation O 0 1.609832406268552e-10
, O 0 1.4342829701696758e-10
R233X O 0 7.912809962817846e-08
, O 0 8.790791428125999e-10
was O 0 1.7173308108908714e-08
observed O 0 2.303087498489731e-09
in O 0 3.0848987253584426e-10
the O 0 3.179943197650914e-09
germline O 0 5.2491866853188185e-08
DNA O 0 1.8713837590667026e-08
from O 0 9.289373159582226e-10
two O 0 2.6089325144695863e-10
unrelated O 0 8.700269837902397e-09
CD B-Disease 0 2.407132797088707e-06
families O 0 4.1899501646014414e-09
and O 0 1.2180067621159196e-08
one O 0 6.689282372462912e-08
BZS B-Disease 1 0.9999945163726807
family O 0 2.289453504999983e-06
. O 0 3.852250358704623e-07

Genotype O 0 0.00012520277232397348
- O 0 3.7794452509842813e-06
phenotype O 0 7.190116235733512e-08
studies O 0 5.046817408427273e-10
were O 0 1.2547818339925243e-10
not O 0 3.914550281147733e-11
performed O 0 5.949157277918005e-10
on O 0 8.193309364301626e-10
this O 0 5.199396468924533e-11
small O 0 5.738045039116457e-10
group O 0 3.5593830660651804e-10
of O 0 3.9346399915984875e-08
BZS B-Disease 1 1.0
families O 0 2.2253489078138955e-06
. O 0 8.121060659505019e-07

However O 0 4.877574042438937e-07
, O 0 2.7641755551144342e-08
genotype O 0 1.7236401390618994e-06
- O 0 3.7886226778027776e-07
phenotype O 0 5.5757315209348235e-08
analysis O 0 2.8867030987811404e-09
inthe O 0 1.9226852998599497e-07
group O 0 2.3193971743218356e-10
of O 0 5.968527005961732e-09
CD B-Disease 0 3.7570462154690176e-05
families O 0 9.223329655583257e-09
revealed O 0 1.852151498837884e-08
two O 0 1.7790457995658926e-10
possible O 0 6.193097701334693e-10
associations O 0 1.2259346315879327e-10
worthy O 0 3.8835370474998854e-08
of O 0 4.9790500611379684e-09
follow O 0 6.129489804607147e-09
- O 0 1.419081741005357e-07
up O 0 1.8421940639612444e-09
in O 0 2.8705812726848023e-10
independent O 0 1.7861970791344106e-09
analyses O 0 1.598171728289799e-08
. O 0 3.200176124096288e-08

The O 0 9.116971000366902e-07
first O 0 1.2769488932917739e-07
was O 0 1.6099546940040455e-07
an O 0 1.9949426832699402e-10
association O 0 3.502876599892346e-10
noted O 0 8.415218522017653e-10
in O 0 1.592787013393604e-10
the O 0 1.0883186574162096e-09
group O 0 8.75833572333562e-11
of O 0 2.221915318401102e-09
CD B-Disease 0 0.002797159366309643
families O 0 3.472618814726047e-08
with O 0 4.386395247024666e-08
breast B-Disease 1 0.9999691247940063
disease I-Disease 1 0.9540432095527649
. O 0 2.1842351998202503e-06

A O 0 1.1479559134386363e-06
correlation O 0 9.071008122418789e-08
was O 0 2.999282955329363e-08
observed O 0 1.0723004706392203e-09
between O 0 3.956731609022768e-10
the O 0 9.210456841657333e-10
presence O 0 3.0926594618563286e-09
/ O 0 3.4686947856243933e-06
absence O 0 4.0478104779140267e-07
of O 0 1.2301971707984194e-07
a O 0 2.1391450388819067e-08
PTEN O 0 2.192208967244369e-06
mutation O 0 3.641470458504159e-10
and O 0 8.488319769295316e-11
the O 0 7.928464829110027e-11
type O 0 1.815097294688428e-09
of O 0 4.036961342990253e-08
breast O 0 8.205394806282129e-06
involvement O 0 4.618399316314026e-07
( O 0 2.1826759066811974e-08
unaffected O 0 7.242008450702997e-06
versus O 0 0.00021584113710559905
benign O 1 0.7480050325393677
versus O 0 0.00969064049422741
malignant O 1 0.9917342662811279
) O 0 3.5622523597567124e-08
. O 0 6.321735668279871e-08

Specifically O 0 1.2912190072711383e-07
and O 0 5.781971346152659e-09
more O 0 8.051001532116686e-11
directly O 0 3.4987501784655706e-10
, O 0 6.476729569326878e-11
an O 0 1.6584893181015303e-11
association O 0 2.4054147562679873e-10
was O 0 1.8174851845742523e-08
also O 0 2.250550995563927e-10
observed O 0 1.1129098337336885e-10
between O 0 1.3002897369940314e-10
the O 0 3.220188560248971e-10
presence O 0 6.230347349145404e-10
of O 0 8.568408205178457e-09
a O 0 6.396656004881152e-08
PTEN O 1 0.9957951307296753
mutation O 0 7.196879892035213e-07
and O 0 6.069919322726491e-07
malignant B-Disease 1 1.0
breast I-Disease 1 0.9999998807907104
disease I-Disease 1 0.979947566986084
. O 0 7.976040592438949e-07

Secondly O 0 7.54340726416558e-05
, O 0 7.57869216272411e-08
there O 0 5.101793210116057e-09
appeared O 0 3.5124337216529966e-08
to O 0 8.805726703364769e-10
be O 0 6.096618210271743e-10
an O 0 4.978857326420894e-10
interdependent O 0 5.631532644656545e-07
association O 0 2.206794968984127e-09
between O 0 5.048302664789617e-09
mutations O 0 9.451929017245675e-09
upstream O 0 6.019576659355153e-08
and O 0 5.054052176767243e-10
within O 0 1.0274459061321295e-09
the O 0 6.111173345146881e-09
PTPase O 0 2.720771362874075e-06
core O 0 2.0841871162247116e-07
motif O 0 1.6610814057571588e-08
, O 0 7.566000603809186e-11
the O 0 2.4328458692046695e-10
core O 0 1.2338037258530221e-08
motif O 0 1.869830956735541e-09
containing O 0 4.8245855227557755e-11
the O 0 6.070437208460788e-11
majority O 0 4.8924180678922013e-11
of O 0 1.2776871782804733e-09
missense O 0 5.8977683181637985e-08
mutations O 0 5.383612999843024e-10
, O 0 3.805701240255921e-11
and O 0 5.691216942160793e-11
the O 0 3.958392225111851e-10
involvement O 0 3.1660478683193105e-09
of O 0 9.38026545327375e-10
all O 0 1.014770420471045e-10
major O 0 2.3311068630960108e-09
organ O 0 9.283284043704043e-07
systems O 0 0.002238959539681673
( O 0 1.423522206778216e-07
central O 0 2.056917037407402e-05
nervous O 0 5.3680460041505285e-06
system O 0 9.514752309769392e-05
, O 0 1.1747783901228104e-07
thyroid O 1 1.0
, O 0 6.559749294865469e-07
breast O 1 1.0
, O 0 5.108456093694258e-07
skin O 1 1.0
and O 1 0.9436286687850952
gastrointestinal O 1 1.0
tract O 1 0.999993085861206
) O 0 9.121548316670669e-08
. O 0 2.5671118919490254e-07

However O 0 2.1342795264445158e-07
, O 0 1.5106984552204494e-09
these O 0 9.828141078749297e-11
observations O 0 1.7128156670764838e-09
would O 0 1.448242081814044e-10
need O 0 3.752866073458705e-10
to O 0 1.7494942994300544e-10
be O 0 7.670884066834915e-11
confirmed O 0 6.068611169141036e-10
by O 0 1.5981082776561628e-11
studying O 0 1.0981560105705057e-10
a O 0 2.6139319875273515e-11
larger O 0 8.974057608135411e-11
number O 0 3.092915853986078e-11
of O 0 3.196118036896678e-09
CD B-Disease 0 5.234617674432229e-06
families O 0 8.048955635331367e-08
. O 0 1.5389480267913314e-07

Molecular O 0 0.0006385980523191392
defects O 1 0.9951390027999878
leading O 0 6.879017746541649e-07
to O 0 8.45386427528183e-09
human O 0 3.528589687107342e-08
complement B-Disease 0 0.0002028257877100259
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 4.384268503798694e-09
an O 0 1.1093197194167459e-10
African O 0 1.0827180263461855e-09
- O 0 3.3257911979944765e-08
American O 0 1.4067171427711855e-08
family O 0 7.621063247142956e-08
. O 0 6.151686449129556e-08

Complement B-Disease 0 6.198402115842327e-05
component I-Disease 1 0.9994862079620361
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 2.358654569434293e-07
C6D B-Disease 0 0.29571959376335144
) O 0 1.1084389406335049e-08
was O 0 1.911288478595452e-07
diagnosed O 0 1.142901510320371e-06
in O 0 5.5817408473046726e-09
a O 0 2.1101380198729203e-08
16 O 0 2.2530270982201728e-08
- O 0 2.6837644995225673e-08
year O 0 4.668613939884381e-09
- O 0 1.1271109201516083e-07
old O 0 1.9327501377119916e-06
African O 0 1.2506308166848612e-07
- O 0 1.9443940857399866e-07
American O 0 3.2993980880746676e-09
male O 0 4.118487495485823e-10
with O 0 2.3257852588276506e-10
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 6.907614988449495e-06

The O 0 3.4270536275471386e-07
patients O 0 1.1436490865435189e-07
father O 0 8.21537184947374e-07
and O 0 1.735153176696258e-08
two O 0 1.2046113440078443e-08
brothers O 0 2.325430978089571e-05
also O 0 3.514672286542009e-08
had O 0 2.1166930253002647e-07
C6D B-Disease 1 0.9999909400939941
, O 0 1.924162162936227e-09
but O 0 3.003240989229994e-10
gave O 0 2.209279870157843e-09
no O 0 2.2144848454974664e-10
history O 0 8.874029289174246e-10
of O 0 2.1920285586674026e-09
meningitis B-Disease 1 0.9999990463256836
or O 0 3.14778709764596e-08
other O 0 2.8704183474559386e-09
neisserial B-Disease 0 5.634335320792161e-05
infection I-Disease 0 0.00024320618831552565
. O 0 7.983185810189752e-07

By O 0 4.83395155015387e-08
using O 0 4.976830680902822e-08
exon O 0 2.844228674803162e-07
- O 0 2.162862600130211e-08
specific O 0 1.154827122817892e-09
polymerase O 0 2.128311962223961e-07
chain O 0 1.1471352756586839e-08
reaction O 0 1.4218548560762656e-09
( O 0 3.617083299545243e-10
PCR O 0 5.917317480452766e-08
) O 0 9.618292828861286e-10
/ O 0 1.60668065518621e-08
single O 0 5.424143356691502e-09
- O 0 1.925080894693565e-08
strand O 0 1.0379407555660691e-08
conformation O 0 1.5048282064888951e-10
polymorphism O 0 5.859482898884494e-10
as O 0 1.9242702917199317e-11
a O 0 4.428335823036811e-11
screening O 0 1.0816983975203698e-09
step O 0 1.4347678600756808e-09
and O 0 1.287864676013939e-10
nucleotide O 0 5.959457927140477e-10
sequencing O 0 1.875363420111853e-09
of O 0 9.796815580997986e-10
target O 0 5.984634565692204e-09
exons O 0 1.1447947656506585e-07
, O 0 3.5805594600368806e-10
we O 0 1.2105340341239668e-10
determined O 0 5.356041721249483e-10
that O 0 3.3258049092488307e-11
the O 0 1.6010511805220062e-09
proband O 0 5.024999722991197e-07
was O 0 1.1596926086099302e-08
a O 0 9.47571465736985e-10
compound O 0 1.5345447579306892e-08
heterozygote O 0 2.4701992629161396e-07
for O 0 9.710107162774761e-10
two O 0 4.497870520481229e-09
C6 O 0 0.00022026500664651394
gene O 0 1.2369308421966707e-07
mutations O 0 8.64415099499638e-08
. O 0 8.523846162233895e-08

The O 0 6.568927233274735e-07
first O 0 5.613967246631546e-08
, O 0 5.0740385226788476e-09
1195delC O 0 7.467786531378806e-07
located O 0 1.610515987238159e-08
in O 0 5.472326480848722e-10
exon O 0 6.86589700649165e-08
7 O 0 1.932467874610211e-08
, O 0 9.68141886104057e-11
is O 0 3.74887967891091e-11
a O 0 2.0947053813724636e-10
novel O 0 1.800628646186908e-09
mutation O 0 3.255289648951276e-10
, O 0 7.095679599444793e-11
while O 0 6.272171670929083e-11
the O 0 7.233784127258502e-10
second O 0 2.2298980439927618e-08
, O 0 5.910149036836287e-10
1936delG O 0 8.131432593927457e-08
in O 0 1.024584750375368e-09
exon O 0 3.2778096681340685e-08
12 O 0 3.478795473910168e-09
, O 0 1.3837844758946005e-10
has O 0 6.862509172034237e-11
been O 0 2.2303807412082932e-10
described O 0 1.7820318554129244e-09
before O 0 2.9500737408483246e-09
to O 0 6.479302649964325e-10
cause O 0 7.081749799908721e-07
C6D B-Disease 1 0.9999997615814209
in O 0 5.548824066892166e-09
an O 0 1.2011182326521208e-10
unrelated O 0 6.541243102731187e-09
African O 0 8.116769478760943e-09
- O 0 1.2036426255690458e-07
American O 0 1.374046654234462e-08
individual O 0 1.4852672425291757e-09
. O 0 1.0423435981010698e-07

Both O 0 9.834774061800999e-08
mutations O 0 3.297738970786668e-08
result O 0 5.858345808462673e-09
in O 0 4.614258308777153e-09
premature O 0 1.652852432698637e-07
termination O 0 4.2046171984111425e-06
codons O 0 1.0945551593977143e-06
and O 0 1.0595864097240337e-07
C6 O 0 0.00018913924577645957
null O 0 3.5868836221197853e-06
alleles O 0 1.264889277763359e-07
. O 0 9.881537010869579e-08

Allele O 0 1.0507868637432694e-06
- O 0 1.0096941593928932e-07
specific O 0 1.0401083327948868e-09
PCR O 0 6.161127430459601e-08
indicated O 0 2.313746971793762e-09
that O 0 4.055508359690485e-11
the O 0 1.0407275041757202e-09
probands O 0 1.017574959405465e-06
two O 0 4.563032618420948e-09
brothers O 0 1.1584101002881653e-06
also O 0 2.5278648063675746e-09
inherited O 0 7.334127985814121e-06
the O 0 7.321294503981335e-08
1195delC O 0 9.888060503726592e-08
mutation O 0 4.176017864843118e-10
from O 0 1.1884274120355087e-10
their O 0 2.709819590940299e-10
heterozygous O 0 1.1214785766711088e-09
mother O 0 1.0884764201080088e-09
and O 0 3.11991155133029e-10
the O 0 1.2070532351415864e-09
1936delG O 0 2.9107884103041215e-08
mutation O 0 2.704181600865496e-10
from O 0 1.119343159827757e-10
their O 0 3.330834774661895e-10
homozygous O 0 2.5816159876512756e-08
father O 0 7.930442080805733e-08
. O 0 1.034016516854308e-08
. O 0 1.3672502063855063e-07

PAX6 O 0 0.35656729340553284
mutations O 0 2.6060908567160368e-05
reviewed O 0 1.58127677423181e-05
. O 0 2.2966264623391908e-06

Mutations O 0 1.2145684422648628e-06
in O 0 2.7235227406663398e-08
PAX6 O 0 0.002167772501707077
are O 0 3.498832112924788e-09
responsible O 0 8.901275272421572e-09
for O 0 1.0864354971218404e-09
human O 0 8.975096932317683e-08
aniridia B-Disease 1 1.0
and O 0 1.3318840785814245e-07
have O 0 2.195613552080644e-10
also O 0 8.793235584114711e-11
been O 0 2.311772821783631e-11
found O 0 1.6715162240443782e-11
in O 0 5.642360276919556e-12
patients O 0 5.283975340608649e-11
with O 0 1.3954171151908668e-10
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.630538548624827e-08
with O 0 1.2392255257509532e-06
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 0.0007051931461319327
with O 0 6.831351697655919e-07
autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 1.0
keratitis I-Disease 1 1.0
, O 0 2.3568865969991748e-08
and O 0 4.985587942485381e-09
with O 0 1.5316324208924925e-08
isolated B-Disease 1 0.9999737739562988
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 0.0007878018077462912

No O 0 1.069376139639644e-06
locus O 0 1.0381703532402753e-06
other O 0 2.467113180415481e-09
than O 0 8.321351385731646e-10
chromosome O 0 1.9265391060230286e-08
11p13 O 0 4.766257291066722e-07
has O 0 1.1158542978506603e-09
been O 0 6.871000435282326e-10
implicated O 0 1.1466540605908904e-08
in O 0 1.378926639539202e-09
aniridia B-Disease 1 1.0
, O 0 6.011633857383458e-09
and O 0 1.465259114041828e-08
PAX6 O 1 0.998968243598938
is O 0 2.6426896226894314e-09
clearly O 0 1.4054934993623647e-09
the O 0 6.167765187470309e-10
major O 0 4.097874040098759e-09
, O 0 4.9308650912349705e-11
if O 0 1.782726917476385e-11
not O 0 2.5312203721927773e-11
only O 0 6.564634252859136e-11
, O 0 6.403862162773777e-11
gene O 0 5.08341313487648e-10
responsible O 0 9.096005726405565e-09
. O 0 1.4585009466827614e-07

Twenty O 0 1.735562545945868e-05
- O 0 3.3466808417870197e-06
eight O 0 2.4840797863134867e-08
percent O 0 4.59933824359382e-09
of O 0 5.314018558522093e-09
identified O 0 2.959639466837416e-08
PAX6 O 0 5.5799930123612285e-05
mutations O 0 8.878926927025077e-09
are O 0 5.768331368116719e-10
C O 0 4.991736204829067e-06
- O 0 1.216963937622495e-05
T O 0 9.295243899032357e-07
changes O 0 1.2046963426826096e-08
at O 0 1.5316675927579126e-08
CpG O 0 1.7480259373314766e-07
dinucleotides O 0 1.056236840213387e-07
, O 0 1.8119694633611516e-10
20 O 0 2.029205137255019e-10
% O 0 1.919896706892299e-11
are O 0 2.829062071413313e-12
splicing O 0 8.558869168950878e-09
errors O 0 1.7271526431272832e-08
, O 0 3.697954997772257e-10
and O 0 3.3125563403402225e-10
more O 0 5.1552553892442177e-11
than O 0 1.2596929055419537e-10
30 O 0 1.2254584014215197e-09
% O 0 2.4541210730255614e-10
are O 0 3.0158795599755095e-11
deletion O 0 8.392013306490753e-09
or O 0 2.10202677486393e-09
insertion O 0 7.213770203406966e-08
events O 0 2.675789589901001e-09
. O 0 2.7689827319932192e-08

There O 0 1.569381993249408e-07
is O 0 9.977534354277395e-09
a O 0 1.656993120491279e-08
noticeably O 0 3.213616537323105e-06
elevated O 0 2.400656376266852e-05
level O 0 2.5728610353326076e-08
of O 0 3.066333631451812e-09
mutation O 0 3.8112166200754416e-10
in O 0 1.0039854364540801e-10
the O 0 3.8694258908122947e-10
paired O 0 5.334834796144605e-10
domain O 0 7.739194840539199e-10
compared O 0 2.1844219141864407e-11
with O 0 3.2734234160086695e-12
the O 0 2.380331209916875e-10
rest O 0 4.424001165403979e-09
of O 0 5.265729630110627e-09
the O 0 1.0183080156878077e-08
gene O 0 2.639809260074344e-08
. O 0 2.97761140188868e-08

Increased O 0 1.422713467036374e-07
mutation O 0 3.869747189355621e-08
in O 0 2.773500540342866e-09
the O 0 5.61015323086167e-09
homeodomain O 0 1.3249659787106793e-06
is O 0 5.545995884759236e-10
accounted O 0 5.381703971352181e-10
for O 0 8.472807178083741e-11
by O 0 2.4099613971095835e-10
the O 0 3.168744200365836e-08
hypermutable O 0 3.76633761334233e-05
CpG O 0 1.1022764738299884e-05
dinucleotide O 0 7.605533483001636e-06
in O 0 5.552657000862382e-09
codon O 0 4.355315752491151e-08
240 O 0 1.3674535637164809e-07
. O 0 4.8434483090886715e-08

Very O 0 2.4368193862756016e-07
nearly O 0 5.731878971459992e-09
all O 0 3.115677438270126e-10
mutations O 0 3.4613140131867226e-10
appear O 0 1.231581170380025e-09
to O 0 4.933990993549742e-10
cause O 0 1.199682060359919e-07
loss O 0 1.2069868944308837e-06
of O 0 1.714670645469596e-07
function O 0 3.720383334737676e-09
of O 0 8.054004574375995e-09
the O 0 5.745996456418823e-10
mutant O 0 3.8990602413413455e-10
allele O 0 1.1904624508396466e-10
, O 0 1.2893830968196962e-11
and O 0 1.642503494325709e-11
more O 0 8.994788421035071e-12
than O 0 1.7843667515782258e-11
80 O 0 7.8547746085178e-10
% O 0 1.3780820928843696e-10
of O 0 1.3152992028864219e-09
exonic O 0 3.453694716881728e-07
substitutions O 0 9.990046123675711e-09
result O 0 2.5980981810391768e-09
in O 0 1.1872249849886884e-09
nonsense O 0 2.6041729483949894e-07
codons O 0 4.480841653276002e-07
. O 0 1.1554362799870432e-07

In O 0 7.810382385287085e-08
a O 0 7.85320608542861e-09
gene O 0 6.91092960636297e-10
with O 0 6.97682953076928e-11
such O 0 9.465888073378892e-10
extraordinarily O 0 6.495902198366821e-07
high O 0 6.25263893994088e-08
sequence O 0 5.378112399867518e-10
conservation O 0 3.004306525777878e-10
throughout O 0 7.71528153864498e-12
evolution O 0 4.415296947501979e-11
, O 0 8.228993007841634e-12
there O 0 5.302650679661625e-12
are O 0 2.3223088382873236e-11
presumed O 0 7.865206725909957e-07
undiscovered O 0 0.00015595590230077505
missense O 0 3.5534583275875775e-07
mutations O 0 1.7393438911383896e-09
, O 0 8.234429804687693e-11
these O 0 3.1149804957664173e-11
are O 0 3.3974736218800317e-11
hypothesized O 0 1.5545181142329056e-08
to O 0 3.1699132208018455e-10
exist O 0 2.0895589702973894e-09
in O 0 2.985013569656303e-09
as O 0 7.028567061695412e-09
- O 0 7.992840522774713e-08
yet O 0 4.657407348673814e-09
unidentified O 0 3.762108136129427e-08
phenotypes O 0 4.67631622314002e-08
. O 0 4.0230005993180384e-09
. O 0 5.204147157655825e-08

Genetic O 0 4.209805410937406e-06
heterogeneity O 0 2.6121224436792545e-06
and O 0 1.077629807610947e-08
penetrance O 0 1.4345149565997417e-06
analysis O 0 3.1164992808641045e-09
of O 0 7.997396522796407e-09
the O 0 6.01888494600189e-09
BRCA1 O 0 3.087497901788083e-08
and O 0 1.1648844555622873e-08
BRCA2 O 0 2.0245879284175317e-07
genes O 0 1.0363780056366068e-08
in O 0 4.13551592970407e-09
breast B-Disease 0 0.23581638932228088
cancer I-Disease 0 0.009887367486953735
families O 0 6.770315508219937e-08
. O 0 2.4630105599499075e-07

The O 0 0.00021504492906387895
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 0.0012782562989741564
Consortium O 0 1.1225310117879417e-05
. O 0 2.3073586419286585e-07

The O 0 7.615846442377006e-08
contribution O 0 4.1646710968734624e-08
of O 0 6.078162329004044e-08
BRCA1 O 0 7.79362636649239e-08
and O 0 1.2659181258811714e-08
BRCA2 O 0 2.2502413230540697e-06
to O 0 4.4944172827854345e-07
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 1.940009678946808e-05
assessed O 0 1.3468946846728613e-08
by O 0 1.1356568463405381e-10
linkage O 0 1.6708174399582276e-08
and O 0 2.9009086799369754e-10
mutation O 0 1.916118652633969e-10
analysis O 0 1.895059803525001e-10
in O 0 4.825229799054753e-11
237 O 0 4.936871467187132e-10
families O 0 2.497077891683297e-11
, O 0 6.055123850240429e-12
each O 0 5.527380311266816e-13
with O 0 1.0238686634633787e-11
at O 0 5.750798726111839e-10
least O 0 2.1278777351252387e-11
four O 0 7.153023312556073e-11
cases O 0 2.6292440447051035e-10
of O 0 5.585002682551021e-08
breast B-Disease 1 0.949263870716095
cancer I-Disease 0 1.849378918450384e-06
, O 0 4.891746382962303e-11
collected O 0 9.434519832041133e-11
by O 0 4.6873734060870476e-11
the O 0 5.336040942438558e-08
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 3.28776914102491e-05
Consortium O 0 5.020348794460006e-07
. O 0 6.355175230510213e-08

Families O 0 2.8507072258321386e-08
were O 0 1.1840454172684645e-09
included O 0 3.2660241178206206e-10
without O 0 9.745564355512215e-10
regard O 0 9.892848318315828e-09
to O 0 3.045285690284061e-10
the O 0 5.290976545779813e-10
occurrence O 0 1.887716827297936e-08
of O 0 2.050447847068426e-06
ovarian B-Disease 1 1.0
or I-Disease 0 2.0373285281038989e-07
other I-Disease 0 3.976178675202391e-08
cancers I-Disease 0 0.024440905079245567
. O 0 3.868626095027139e-07

Overall O 0 5.335417426977074e-06
, O 0 7.496229414982736e-08
disease O 0 0.00011036526848329231
was O 0 2.2841868485556915e-06
linked O 0 6.775572387596185e-07
to O 0 7.788273137521173e-09
BRCA1 O 0 6.562440546531434e-08
in O 0 5.087118504221166e-10
an O 0 3.2061523574933304e-11
estimated O 0 2.695672851604769e-11
52 O 0 4.140075782199659e-10
% O 0 6.886925058013915e-11
of O 0 8.880040591741079e-10
families O 0 1.2430957374576224e-09
, O 0 2.2055020310052242e-10
to O 0 1.1431812163564814e-09
BRCA2 O 0 3.2544797079481214e-08
in O 0 1.1928040777320348e-09
32 O 0 2.6043993628377393e-09
% O 0 1.2952254546672037e-10
of O 0 2.857618031093523e-10
families O 0 9.067933903761372e-11
, O 0 2.922800890203803e-11
and O 0 5.6531779257795733e-11
to O 0 1.69261452076519e-10
neither O 0 3.1593156979425885e-09
gene O 0 1.2558455386724177e-09
in O 0 3.3062000359684873e-10
16 O 0 1.6237968747390141e-09
% O 0 2.0536260192383082e-10
( O 0 2.693325562574955e-10
95 O 0 3.91687891010406e-08
% O 0 8.748861191065771e-09
confidence O 0 1.6974308891803958e-07
interval O 0 8.132859363740863e-08
[ O 0 1.624560468371783e-07
CI O 0 2.8712470339087304e-06
] O 0 1.3946575450063392e-08
6 O 0 5.359866772636224e-09
% O 0 3.185769703595298e-10
- O 0 3.2662377247305585e-09
28 O 0 2.564638279523024e-09
% O 0 3.559939565356274e-10
) O 0 1.6172495287403166e-10
, O 0 3.883353361100461e-11
suggesting O 0 1.7377322913958437e-09
other O 0 1.5967754896095698e-09
predisposition O 0 1.2843778677051887e-05
genes O 0 6.175893645377073e-07
. O 0 4.690054709044489e-07

The O 0 1.1555105174920755e-06
majority O 0 2.4812242926941508e-08
( O 0 4.343392312478045e-09
81 O 0 4.9568036786240555e-08
% O 0 1.148207307011262e-09
) O 0 2.078222038903732e-10
of O 0 5.130198932334906e-09
the O 0 3.7380793855845695e-06
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.5499845851252303e-09
were O 0 1.0839944913909605e-10
due O 0 1.2670043902929251e-09
to O 0 4.308710610523292e-10
BRCA1 O 0 2.508585117411144e-09
, O 0 7.860076478571898e-11
with O 0 2.6743275996499172e-11
most O 0 7.855943673362731e-10
others O 0 2.6271751440987146e-09
( O 0 2.685082989284382e-10
14 O 0 1.1977786540384727e-09
% O 0 1.808727195795612e-10
) O 0 4.8594770568621826e-11
due O 0 2.5395902270020088e-08
to O 0 4.099885231312328e-08
BRCA2 O 0 3.0980780138634145e-05
. O 0 2.066890601781779e-06

Conversely O 0 1.9681012872752035e-06
, O 0 9.004998524630992e-09
the O 0 1.9995074485024134e-09
majority O 0 3.1778923936798265e-10
of O 0 2.241324681406809e-09
families O 0 3.319064190154819e-10
with O 0 3.447936727796197e-11
male B-Disease 0 2.2529398346904372e-09
and I-Disease 0 8.687762731440785e-10
female I-Disease 0 1.3699722245519297e-08
breast I-Disease 0 2.931975723186042e-05
cancer I-Disease 0 2.3389588932332117e-06
were O 0 4.262041386482451e-09
due O 0 3.48585189158257e-07
to O 0 2.358046558015303e-08
BRCA2 O 0 2.4609136062281323e-07
( O 0 2.5413866566736942e-09
76 O 0 1.4794612468449486e-07
% O 0 3.1010054524216457e-09
) O 0 3.366173784158377e-09
. O 0 5.633714650343791e-08

The O 0 4.023163000965724e-06
largest O 0 4.805802404916903e-07
proportion O 0 1.5117974427880654e-08
( O 0 1.5751352444581812e-09
67 O 0 4.0026890246736e-08
% O 0 8.590888000981067e-10
) O 0 2.1501957159220098e-10
of O 0 1.7721749623333949e-09
families O 0 1.996253162772632e-09
due O 0 7.674348267983078e-08
to O 0 8.017781993885364e-10
other O 0 3.156290784289695e-10
genes O 0 2.441598867530814e-10
was O 0 1.235366586804787e-09
found O 0 9.520711302668516e-11
in O 0 1.1198594135342077e-11
families O 0 1.3227978608310043e-11
with O 0 9.911437122422928e-12
four O 0 2.297172452259133e-10
or O 0 5.450253581784636e-10
five O 0 5.971997341092106e-10
cases O 0 4.496753247540397e-10
of O 0 1.357461627549128e-07
female O 0 8.91616252829408e-07
breast B-Disease 0 0.028396332636475563
cancer I-Disease 0 1.0997187928296626e-05
only O 0 1.1629087026676643e-08
. O 0 1.5690616805841273e-07

These O 0 1.704421492831898e-08
estimates O 0 1.4096985800904349e-08
were O 0 1.1575395086893536e-09
not O 0 2.0724665039661971e-10
substantially O 0 1.991348241858759e-08
affected O 0 1.7191454926290817e-09
either O 0 4.067083614334166e-10
by O 0 7.861560707977944e-11
changing O 0 1.0515300852276255e-09
the O 0 5.170008865462705e-10
assumed O 0 1.0451023157997952e-08
penetrance O 0 7.057411011146542e-08
model O 0 9.651057730764023e-10
for O 0 5.6471646803224473e-11
BRCA1 O 0 3.184366381692172e-10
or O 0 5.384812387654314e-11
by O 0 1.3335947797454839e-11
including O 0 6.862300311327729e-11
or O 0 1.749565381459206e-09
excluding O 0 4.5532715375884436e-08
BRCA1 O 0 2.4771766859998934e-08
mutation O 0 4.887386495511237e-09
data O 0 8.317292632398221e-09
. O 0 4.251545249189803e-08

Among O 0 9.003920098393792e-08
those O 0 2.3779456181927117e-09
families O 0 9.340879181252149e-10
with O 0 4.4779580044007616e-10
disease O 0 5.328399765858194e-06
due O 0 2.5815031676756917e-06
to O 0 1.46645575682669e-08
BRCA1 O 0 1.5876384651392073e-08
that O 0 8.182388794297779e-11
were O 0 1.4436225825864568e-10
tested O 0 1.626399709353521e-10
by O 0 5.9344629904645174e-12
one O 0 2.126076571740132e-11
of O 0 2.8454077982686954e-10
the O 0 2.785384978221117e-10
standard O 0 1.4194649899934575e-09
screening O 0 3.295258232949294e-10
methods O 0 3.4962815975703165e-10
, O 0 2.3667486373502022e-11
mutations O 0 2.9445449550857816e-11
were O 0 7.412616354063317e-11
detected O 0 1.7923810213815727e-09
in O 0 7.826417292022825e-11
the O 0 5.559573912350402e-10
coding O 0 1.6126245228065272e-08
sequence O 0 6.289761489419732e-10
or O 0 1.2235478186184423e-09
splice O 0 1.7356867942908139e-07
sites O 0 1.2340618527062475e-09
in O 0 3.2411129335940814e-11
an O 0 1.7068978175327487e-11
estimated O 0 2.949761268578044e-11
63 O 0 3.905582079966052e-09
% O 0 7.705847626660045e-10
( O 0 1.0079269641138922e-09
95 O 0 1.613203721717582e-07
% O 0 2.540389587579739e-08
CI O 0 3.808152905548923e-05
51 O 0 1.720173798958058e-07
% O 0 6.761537552080199e-09
- O 0 1.7072528635253548e-07
77 O 0 4.6469306624885576e-08
% O 0 4.045083379367043e-09
) O 0 3.865009645664941e-09
. O 0 3.802412962272683e-08

The O 0 3.037011708784121e-07
estimated O 0 7.64060636981867e-09
sensitivity O 0 2.2132034871447104e-08
was O 0 6.025546728238851e-09
identical O 0 7.665417744995295e-10
for O 0 9.803259592988667e-11
direct O 0 1.0215952528369598e-09
sequencing O 0 1.1290921975160018e-08
and O 0 3.752894939257345e-10
other O 0 1.3810633192612443e-10
techniques O 0 2.1899366231536987e-07
. O 0 1.0606033384874536e-07

The O 0 8.295795055346389e-07
penetrance O 0 0.0001153248522314243
of O 0 1.7294390772804036e-06
BRCA2 O 0 4.9403897719457746e-06
was O 0 9.109204057722309e-08
estimated O 0 3.239229440232805e-10
by O 0 9.96535284847333e-11
maximizing O 0 4.2451762993778175e-08
the O 0 1.7488321901737436e-08
LOD O 1 0.7151687145233154
score O 0 1.6979781491954782e-07
in O 0 2.9797460054936664e-09
BRCA2 O 0 1.2306219332458568e-07
- O 0 7.611954089270512e-08
mutation O 0 6.000358543367668e-10
families O 0 2.703346158039466e-10
, O 0 2.913816757321719e-11
over O 0 3.893707231639176e-11
all O 0 4.20884889440476e-11
possible O 0 9.53988088525648e-09
penetrance O 0 1.0527504855417646e-05
functions O 0 4.205974235560461e-08
. O 0 2.5931489844310818e-08

The O 0 9.949299339950812e-08
estimated O 0 1.9344659207831683e-09
cumulative O 0 1.0374539449742315e-08
risk O 0 1.8877097218705785e-08
of O 0 1.1320187098817769e-07
breast B-Disease 1 0.5706561803817749
cancer I-Disease 0 9.184478403767571e-05
reached O 0 3.677371580579347e-07
28 O 0 2.3047322272873316e-08
% O 0 5.764240196270976e-10
( O 0 2.083528488627806e-10
95 O 0 2.7167832428176553e-08
% O 0 8.026140640993162e-09
CI O 0 7.427171112794895e-06
9 O 0 6.115583772725586e-08
% O 0 7.974483295924983e-10
- O 0 7.4334365329775665e-09
44 O 0 1.903080359966225e-09
% O 0 1.9332291323337358e-10
) O 0 1.4003757355107727e-11
by O 0 1.56171950371764e-11
age O 0 5.16001963379864e-10
50 O 0 7.586046235630306e-10
years O 0 3.902489997820169e-10
and O 0 2.400716847539286e-10
84 O 0 1.6101534328072376e-08
% O 0 4.1135023165495e-10
( O 0 3.7805983343908167e-10
95 O 0 2.7010294445517502e-08
% O 0 7.668521817549845e-09
CI O 0 3.067288162128534e-06
43 O 0 4.660893537788979e-08
% O 0 1.873961874565566e-09
- O 0 1.0575648801136595e-08
95 O 0 7.74770647637979e-09
% O 0 2.0490246999127493e-10
) O 0 1.4615475496526642e-11
by O 0 2.321564815388477e-11
age O 0 7.051968453630764e-10
70 O 0 1.3152371636238058e-08
years O 0 1.0623401713871772e-08
. O 0 5.252110923947839e-08

The O 0 6.91263551289012e-07
corresponding O 0 0.0022555573377758265
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 2.8711649520118954e-06
were O 0 2.5520549229440803e-08
0 O 0 7.47478452467476e-08
. O 0 4.8109928485473574e-08

4 O 0 4.831342721445253e-06
% O 0 4.63325697808159e-08
( O 0 5.7380042939314535e-09
95 O 0 1.1571211189220776e-07
% O 0 1.463784204958074e-08
CI O 0 5.285064617055468e-06
0 O 0 2.705123058888148e-08
% O 0 1.0204228573229557e-09
- O 0 8.266667350653734e-09
1 O 0 3.314473140392238e-09
% O 0 9.056923266914652e-11
) O 0 9.608235214397798e-12
by O 0 4.9613720250196724e-12
age O 0 2.546387822821572e-10
50 O 0 4.742909953669994e-10
years O 0 3.356599997950127e-10
and O 0 1.9876730816825727e-10
27 O 0 2.5861632835244563e-09
% O 0 1.4334952669337042e-10
( O 0 8.872857309993876e-11
95 O 0 1.5784804574536793e-08
% O 0 3.1430757996275815e-09
CI O 0 1.4556317182723433e-06
0 O 0 7.886875152962602e-09
% O 0 5.759184795728345e-10
- O 0 7.753737207849554e-09
47 O 0 4.5502477341585745e-09
% O 0 2.0604686012948292e-10
) O 0 2.3170966881314037e-11
by O 0 4.4272717436566467e-11
age O 0 2.0431016878319497e-09
70 O 0 8.314675170595365e-09
years O 0 2.863660952812097e-08
. O 0 1.0055332921865556e-07

The O 0 6.138161552371457e-07
lifetime O 0 2.1178350380068878e-06
risk O 0 1.039055860019289e-06
of O 0 1.9165959201927762e-06
breast B-Disease 1 0.9999372959136963
cancer I-Disease 0 0.0009666805271990597
appears O 0 1.0262867888854998e-08
similar O 0 9.044239801525578e-10
to O 0 8.235282455970605e-10
the O 0 4.51187620598148e-09
risk O 0 2.032011181540838e-08
in O 0 5.656352053406977e-10
BRCA1 O 0 3.0468556566631833e-09
carriers O 0 4.961187571872472e-10
, O 0 3.9622877895384434e-11
but O 0 2.982000063544987e-11
there O 0 2.89472786019207e-11
was O 0 8.850600807797093e-10
some O 0 6.0701331114354495e-12
suggestion O 0 9.766069064554017e-10
of O 0 7.292813575254797e-10
a O 0 1.3214070948563972e-09
lower O 0 7.338644536503125e-08
risk O 0 5.92694959777873e-09
in O 0 4.68251493135341e-10
BRCA2 O 0 8.105538462643835e-09
carriers O 0 1.4793328784179494e-09
< O 0 7.84852218771448e-08
50 O 0 1.4590475494458133e-09
years O 0 8.866770651039246e-10
of O 0 2.3360831047369857e-09
age O 0 1.4374749390810848e-08
. O 0 6.84019951791015e-08

Eye B-Disease 1 0.9999884366989136
movement I-Disease 0 1.3338660210138187e-05
abnormalities I-Disease 0 2.021504769800231e-05
correlate O 0 5.960907145663441e-08
with O 0 2.7352293763271973e-09
genotype O 0 8.780979442235548e-06
in O 0 1.993697118507498e-08
autosomal O 0 0.004622998647391796
dominant O 1 0.9999958276748657
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 1.0
. O 0 4.358163550932659e-06

We O 0 2.5974611617129995e-07
compared O 0 1.6977513439542236e-07
horizontal O 0 3.858813215629198e-06
eye O 0 0.00017795931489672512
movements O 0 1.0489049628858993e-07
( O 0 1.0265256200625572e-08
visually O 0 4.5828603134623336e-08
guided O 0 3.110052659849316e-07
saccades O 0 3.080425813095644e-05
, O 0 4.462169744812172e-09
antisaccades O 0 8.187987532437546e-07
, O 0 4.446568946381291e-10
and O 0 4.287682153769623e-10
smooth O 0 9.34152577514169e-09
pursuit O 0 4.296306954643114e-08
) O 0 1.0392631893951787e-10
in O 0 9.253840749234854e-11
control O 0 2.9520494937429476e-09
subjects O 0 6.2800666889017975e-09
( O 0 1.5899306871069996e-10
n O 0 7.460106976608927e-10
= O 0 1.6948669134819738e-09
14 O 0 4.048454071980956e-10
) O 0 3.637068077266825e-11
and O 0 8.935559930867143e-11
patients O 0 2.9264449197263787e-10
with O 0 2.6138322409274828e-11
three O 0 2.1842772035540747e-10
forms O 0 3.1110709564075023e-09
of O 0 3.8679181102452276e-07
autosomal O 0 3.225074760848656e-05
dominant O 0 0.00027122985920868814
cerebellar B-Disease 1 0.9999796152114868
ataxias I-Disease 0 8.224846533266827e-05
type I-Disease 0 1.7049991356543615e-06
I I-Disease 0 2.871127799153328e-05
spinocerebellar B-Disease 0 0.278356671333313
ataxias I-Disease 0 3.3198364690179005e-05
1 I-Disease 0 9.950228729849186e-08
and I-Disease 0 8.283080887849792e-09
2 I-Disease 0 7.026545034705123e-08
( O 0 6.024742926769022e-09
SCA1 B-Disease 0 8.177945710485801e-05
, O 0 3.861391650872292e-09
n O 0 7.743923724490287e-09
= O 0 7.795733836246654e-09
11 O 0 2.2778365860176564e-09
; O 0 7.554065151182954e-10
SCA2 B-Disease 0 6.1768159866915084e-06
, O 0 3.003815418622935e-09
n O 0 5.0306359078433616e-09
= O 0 5.480717213401931e-09
10 O 0 8.468288292817761e-10
) O 0 2.7506877331440194e-10
and O 0 6.473327207601187e-09
SCA3 B-Disease 1 1.0
/ O 0 8.66898990352638e-05
Machado B-Disease 0 2.5776680558919907e-06
- I-Disease 0 1.3726421457249671e-06
Joseph I-Disease 0 0.0006763444398529828
disease I-Disease 0 0.3616710901260376
( O 0 1.431131408935471e-07
MJD B-Disease 1 1.0
) O 0 2.3602787280196935e-08
( O 0 2.116118169581682e-09
n O 0 1.091962076316122e-08
= O 0 2.7254454693093066e-08
16 O 0 1.479742817167562e-08
) O 0 3.73495900873877e-09
. O 0 9.127273870035424e-08

In O 0 9.98362679638376e-07
SCA1 B-Disease 0 0.0002915267541538924
, O 0 2.1903371560938467e-08
saccade O 0 2.746012569332379e-06
amplitude O 0 1.774409099652985e-07
was O 0 1.3985361313473277e-08
significantly O 0 1.4531874592549343e-09
increased O 0 5.183259377261606e-10
, O 0 1.9935884887356536e-10
resulting O 0 7.341931507198751e-09
in O 0 2.508854457516918e-08
hypermetria B-Disease 0 7.35305220587179e-05
. O 0 4.847699415222451e-07

The O 0 4.148018433625111e-06
smooth O 0 2.6766442715597805e-06
pursuit O 0 2.1051127987448126e-06
gain O 0 7.15961220976169e-07
was O 0 2.1647637993282842e-07
decreased O 0 3.2031323371484177e-07
. O 0 1.3019693767546414e-07

In O 0 1.0838652997335885e-06
SCA2 B-Disease 0 0.0002834811748471111
, O 0 3.366380951774772e-08
saccade O 0 2.2987783268035855e-06
velocity O 0 3.868692317610112e-07
was O 0 1.657910644325966e-07
markedly O 0 5.221775722930033e-07
decreased O 0 1.5892190674549056e-07
. O 0 6.190587953369686e-08

The O 0 6.021000444889069e-07
percentage O 0 1.5739114189727843e-07
of O 0 3.4025113393454376e-08
errors O 0 1.7045683762262342e-06
in O 0 1.701498142381297e-08
antisaccades O 0 0.000657413387671113
was O 0 1.5332376790411217e-07
greatly O 0 9.994391092504884e-09
increased O 0 1.5233400096903438e-09
and O 0 4.772346962056417e-10
was O 0 2.769330098573164e-09
significantly O 0 5.637599831409545e-10
correlated O 0 6.050569489879365e-10
with O 0 3.5729440239773425e-11
age O 0 3.3257578913037378e-09
at O 0 9.466289974113806e-09
disease O 0 3.272244555319048e-07
onset O 0 0.48004409670829773
. O 0 1.891108126983454e-06

In O 0 5.6581271223876684e-08
addition O 0 8.231407555570058e-09
, O 0 5.546525461141982e-10
a O 0 8.758223590810132e-10
correlation O 0 1.2751575351188649e-09
between O 0 4.510361861775891e-09
smooth O 0 1.240590847828571e-07
pursuit O 0 4.5573986540148326e-07
gain O 0 4.3007666761241126e-08
and O 0 4.712188417244079e-10
the O 0 5.646887402122047e-10
number O 0 9.92182586090351e-11
of O 0 4.1796219818479585e-09
trinucleotide O 0 8.873444130585995e-06
repeats O 0 1.1229137442114734e-07
was O 0 4.054261282249172e-08
found O 0 4.596181213400996e-09
. O 0 2.10710560111238e-08

In O 0 8.543493095203303e-06
SCA3 B-Disease 1 1.0
, O 0 1.5986998960215715e-06
gaze B-Disease 0 0.00046686184941791
- I-Disease 0 0.00014736248704139143
evoked I-Disease 0 0.00012110007810406387
nystagmus I-Disease 0 0.04892904311418533
was O 0 4.39954192188452e-07
often O 0 5.32133836994575e-10
present O 0 8.280517937997445e-10
as O 0 1.198176224903591e-09
was O 0 1.6472245789600493e-08
saccade O 0 1.28795409182203e-06
hypometria O 0 4.940502549288794e-06
and O 0 1.2321034859041902e-08
smooth O 0 2.0774162123871065e-07
pursuit O 0 7.462617759301793e-07
gain O 0 2.4431346901110373e-07
was O 0 2.084099577359666e-07
markedly O 0 8.292014399557956e-07
decreased O 0 1.2197857301998738e-07
. O 0 4.7855504448079955e-08

Three O 0 1.5035105604965793e-07
major O 0 8.198038159434873e-08
criteria O 0 3.0034904341391666e-08
, O 0 1.272261740403735e-09
saccade O 0 4.1661579075480404e-07
amplitude O 0 6.297292998169723e-08
, O 0 4.1816769491553885e-10
saccade O 0 8.217559610557146e-08
velocity O 0 1.735494059573739e-08
, O 0 5.014347825849086e-10
and O 0 2.563399770227903e-10
presence O 0 9.406279088963743e-10
of O 0 4.9606153851300405e-08
gaze B-Disease 0 2.7019292247132398e-05
- I-Disease 0 3.6197695862938417e-06
evoked I-Disease 0 9.116553201238276e-07
nystagmus I-Disease 0 2.682419335542363e-06
, O 0 2.912440288938001e-10
permitted O 0 2.695869638635884e-10
the O 0 4.442449186292663e-10
correct O 0 2.205465365889836e-09
assignment O 0 3.270027360002814e-09
of O 0 2.3628086154303674e-09
90 O 0 2.0793013977282726e-09
% O 0 2.805245202797124e-10
of O 0 9.91524751192685e-10
the O 0 3.0403828343850137e-09
SCA1 B-Disease 0 4.4892913138028234e-05
, O 0 6.698583909781064e-10
90 O 0 7.080811492699013e-10
% O 0 8.22018147994541e-11
of O 0 2.1346756307050185e-10
the O 0 1.2728516018967184e-09
SCA2 B-Disease 0 6.245941767701879e-05
, O 0 5.497025057366045e-10
and O 0 4.180321089286565e-10
93 O 0 5.552476700643183e-09
% O 0 1.2607914712248203e-10
of O 0 5.822517468168087e-10
the O 0 2.073542892944147e-09
patients O 0 1.9439456711012326e-09
with O 0 1.1844428771112803e-09
SCA3 B-Disease 1 1.0
to O 0 7.67985053329312e-09
their O 0 1.2718662789623636e-09
genetically O 0 8.356426661748628e-09
confirmed O 0 5.571285210947963e-09
patient O 0 1.521673809179447e-08
group O 0 5.397552890751278e-11
and O 0 8.292115605268435e-11
, O 0 2.7407569269666254e-11
therefore O 0 4.539253972701829e-10
, O 0 3.457830133335449e-10
may O 0 3.745959986645175e-09
help O 0 3.3802269427951614e-08
orient O 0 2.8060403565177694e-06
diagnoses O 0 7.1548865889781155e-06
of O 0 9.87620182968385e-07
SCA1 B-Disease 1 0.9989486336708069
, O 0 1.2486569112013512e-08
SCA2 B-Disease 0 0.0002854624472092837
, O 0 2.75848610620244e-09
and O 0 1.0115288162637626e-08
SCA3 B-Disease 1 1.0
at O 0 4.398274455752471e-08
early O 0 9.437445491755625e-09
clinical O 0 4.605729131412772e-09
stages O 0 6.164181609591424e-09
of O 0 2.2599078164375896e-09
the O 0 8.104951376708414e-09
diseases O 0 0.003120024688541889
. O 0 1.2555156914118015e-08
. O 0 7.204447882713794e-08

Genetic O 0 1.2954323835856485e-07
basis O 0 1.4779996782010585e-08
and O 0 4.41895575686857e-10
molecular O 0 1.2559898898700794e-08
mechanism O 0 1.498949302458641e-07
for O 0 1.5953233400978206e-07
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.804485023021698

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 1.0
causes O 0 5.303356829244876e-06
more O 0 6.215629677619461e-10
than O 0 1.2197910737032913e-10
300 O 0 3.2922864434681287e-10
, O 0 9.205938789058621e-11
000 O 0 7.777076760362434e-10
sudden O 0 3.986405427980344e-09
deaths O 0 1.169059626882074e-09
each O 0 1.195915311225093e-10
year O 0 2.555281541916088e-10
in O 0 3.7394620733266493e-10
the O 0 1.9356404479253797e-08
USA O 0 2.9433431336656213e-07
alone O 0 1.951767103491875e-08
. O 0 6.592197365762331e-08

In O 0 2.3745435839828133e-07
approximately O 0 2.0671231837354753e-08
5 O 0 4.2093851959634776e-08
- O 0 8.938368267763508e-08
12 O 0 1.5959715771174388e-09
% O 0 1.1710407643583665e-10
of O 0 7.14804535006941e-11
these O 0 8.191254098621759e-12
cases O 0 1.3730366843489605e-10
, O 0 1.9527993805334987e-11
there O 0 5.568695244512201e-12
are O 0 6.984868846510173e-12
no O 0 3.2562336160779637e-10
demonstrable O 0 7.623692363267764e-05
cardiac O 1 0.9999834299087524
or O 0 5.203442583479045e-07
non O 1 0.6760786771774292
- O 1 0.9999128580093384
cardiac O 1 0.9850581288337708
causes O 0 9.754122842764446e-09
to O 0 1.3839401846738042e-10
account O 0 4.548160806305823e-11
for O 0 1.1673989552818398e-10
the O 0 1.6454464457638096e-09
episode O 0 9.309402138057976e-09
, O 0 1.92114588126735e-11
which O 0 1.4045640735552145e-12
is O 0 2.2079031311572628e-12
therefore O 0 1.8145797364699234e-11
classified O 0 3.583442431676076e-10
as O 0 2.5935531500209663e-09
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 0.9998127818107605
IVF B-Disease 1 1.0
) O 0 1.4930341762919852e-07
. O 0 7.88499860959746e-08

A O 0 8.043513162192539e-07
distinct O 0 2.887453476319024e-08
group O 0 3.4785234692691347e-09
of O 0 2.2081567863097007e-07
IVF B-Disease 1 1.0
patients O 0 0.0006022576708346605
has O 0 7.234557397595154e-10
been O 0 4.846222381726939e-11
found O 0 2.3571257792842637e-11
to O 0 1.208706225386269e-11
present O 0 3.0787269955645513e-10
with O 0 7.668927715087648e-10
a O 0 3.427824424306891e-08
characteristic O 0 2.9354789603530662e-06
electrocardiographic O 0 0.00019809238438028842
pattern O 0 1.0069099971588003e-06
. O 0 4.969375027030765e-07

Because O 0 2.717087284054287e-07
of O 0 2.1569512398400548e-07
the O 0 2.1912731185125267e-08
small O 0 8.06223865446043e-10
size O 0 2.698899992381598e-10
of O 0 7.644538890794195e-10
most O 0 2.464426440695888e-10
pedigrees O 0 1.1834003110777758e-08
and O 0 1.2334824828208468e-10
the O 0 2.5401497572019593e-10
high O 0 2.353139239019697e-09
incidence O 0 3.6490719335091626e-09
of O 0 1.2159449003235068e-09
sudden B-Disease 0 1.6728199270232835e-08
death I-Disease 0 1.0219079626949679e-07
, O 0 1.4094604650072284e-10
however O 0 2.675604737767401e-10
, O 0 1.5388922774972613e-11
molecular O 0 7.698996995486596e-11
genetic O 0 1.0563844243804965e-10
studies O 0 7.451912004130534e-11
of O 0 3.5603353598645526e-09
IVF B-Disease 1 1.0
have O 0 3.761396083490354e-09
not O 0 5.104389133592235e-10
yet O 0 6.865370494324452e-09
been O 0 6.789736328727258e-09
done O 0 3.3519267361725724e-08
. O 0 8.218171387852635e-08

Because O 0 8.929266186896712e-06
IVF B-Disease 1 1.0
causes O 0 0.004387476481497288
cardiac O 1 1.0
rhythm O 1 0.9999960660934448
disturbance O 1 0.9254949688911438
, O 0 1.603337018707407e-09
we O 0 1.6863178908810283e-10
investigated O 0 2.1136172811964116e-09
whether O 0 3.6143249504405617e-10
malfunction O 0 6.936363661225187e-06
of O 0 8.78920314306697e-09
ion O 0 1.3240186262919451e-06
channels O 0 1.532616380472973e-07
could O 0 1.5172447742628492e-09
cause O 0 6.450821654624406e-09
the O 0 1.6876797737097604e-09
disorder O 0 1.187116893675011e-08
by O 0 3.4568261447764925e-11
studying O 0 1.2481841948908112e-10
mutations O 0 2.47728625807353e-11
in O 0 1.8318908889813912e-11
the O 0 1.3426003642180717e-09
cardiac O 0 1.7055379430530593e-05
sodium O 0 2.654993750184076e-06
channel O 0 8.149122550094035e-07
gene O 0 2.3374436608492033e-08
SCN5A O 0 1.9969482309534214e-05
. O 0 1.1269560928894862e-07

We O 0 3.671022454909689e-07
have O 0 1.1118288512079744e-08
now O 0 3.0221820601639138e-09
identified O 0 7.027186388341988e-09
a O 0 6.240424177406112e-09
missense O 0 2.0822876933834777e-07
mutation O 0 2.147857358636429e-08
, O 0 1.8015802183413143e-09
a O 0 5.798493241115921e-09
splice O 0 3.287924073447357e-06
- O 0 1.537743656854218e-07
donor O 0 4.994058500074061e-09
mutation O 0 1.5066956571274659e-09
, O 0 1.765062956904373e-10
and O 0 3.9957742670182483e-10
a O 0 4.964843647314865e-09
frameshift O 0 2.6489340143598383e-07
mutation O 0 1.4556619243322189e-09
in O 0 2.793082987118112e-10
the O 0 1.3751996208455353e-09
coding O 0 7.215710695618327e-08
region O 0 9.892036523240222e-09
of O 0 4.7830777560875504e-08
SCN5A O 1 0.5489857792854309
in O 0 4.6896406757923614e-09
three O 0 1.0018515794740779e-08
IVF B-Disease 1 1.0
families O 0 2.511698404816798e-08
. O 0 5.793830482048179e-08

We O 0 2.481409637766774e-07
show O 0 4.633449179891613e-09
that O 0 1.6412456116388086e-10
sodium O 0 1.9357178970835776e-08
channels O 0 6.66364563528532e-09
with O 0 4.507656747865241e-11
the O 0 9.47987244259707e-10
missense O 0 7.006791946650992e-08
mutation O 0 7.351123709753438e-09
recover O 0 2.3196412257675547e-07
from O 0 9.92838611324487e-09
inactivation O 0 7.64977539802203e-06
more O 0 2.619568173489739e-10
rapidly O 0 1.4417165239422047e-09
than O 0 1.903761003008153e-11
normal O 0 1.4551672367080215e-10
and O 0 5.540485084609692e-11
that O 0 2.24623115246958e-11
the O 0 1.2135168425686516e-09
frameshift O 0 1.5044285817111813e-07
mutation O 0 8.135365714423415e-10
causes O 0 8.756636526996431e-10
the O 0 1.1191794158094126e-09
sodium O 0 2.2079371220229405e-08
channel O 0 1.8343621732697102e-08
to O 0 2.7906812971600914e-10
be O 0 4.5046336105691864e-10
non O 0 5.797014068775752e-08
- O 0 6.274597694755357e-07
functional O 0 1.5030188933451427e-06
. O 0 2.704545920551027e-07

Our O 0 1.3258128319648677e-06
results O 0 1.2091969203709141e-08
indicate O 0 1.7222567816332912e-09
that O 0 1.0501707142784866e-10
mutations O 0 1.2187055808965397e-09
in O 0 9.34340937952527e-10
cardiac O 0 2.949281906694523e-06
ion O 0 6.527090135932667e-06
- O 0 0.00010648520401446149
channel O 0 9.99380347366241e-08
genes O 0 9.828853703153229e-11
contribute O 0 1.3146433594513063e-11
to O 0 3.770715684137116e-11
the O 0 5.101926658923617e-10
risk O 0 6.129126983722699e-09
of O 0 2.0075486162340894e-08
developing O 0 4.620690560841467e-06
IVF B-Disease 1 1.0
. O 0 3.788036551100049e-08
. O 0 6.883480807573505e-08

Molecular O 0 4.6087816372164525e-06
heterogeneity O 0 1.6187674191314727e-05
in O 0 1.545005261505139e-07
mucopolysaccharidosis B-Disease 0 0.00202875304967165
IVA I-Disease 1 0.9999992847442627
in O 0 2.7300757210468873e-08
Australia O 0 3.3845544145094664e-09
and O 0 9.79782477372737e-10
Northern O 0 3.013595417655779e-08
Ireland O 0 2.290336631460832e-08
: O 0 3.397306880259521e-10
nine O 0 7.170511961973602e-10
novel O 0 1.3222138939283923e-09
mutations O 0 2.063504783711423e-10
including O 0 1.6155229931591464e-10
T312S O 0 1.3340680027340568e-07
, O 0 2.0426760283243084e-10
a O 0 3.3292210654956023e-10
common O 0 6.718907208380642e-09
allele O 0 7.023541304107539e-09
that O 0 1.46230388908819e-10
confers O 0 4.883177240344594e-08
a O 0 1.1151334966541526e-08
mild O 0 6.825805030530319e-06
phenotype O 0 3.54253024852369e-05
. O 0 5.061118599769543e-07

Mucopolysaccharidosis B-Disease 1 0.9505271315574646
IVA I-Disease 1 1.0
( O 0 0.00030881320708431304
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 6.298602528431729e-08
is O 0 1.1971984514858036e-09
an O 0 1.0182666931868312e-09
autosomal B-Disease 1 0.9997614026069641
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.5468192100524902
by O 0 2.366743068193955e-08
a O 0 4.2013562051579356e-07
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 1.3386994623942883e-07
N O 0 9.35509490318509e-07
- O 0 3.597437228108902e-07
acetylgalactosamine O 0 9.020143806992564e-06
- O 0 4.0614676777295244e-07
6 O 0 2.678119983556826e-07
- O 0 2.5307613782388216e-07
sulfate O 0 1.1165274372615386e-05
sulfatase O 0 0.0018982556648552418
( O 0 6.587622181086772e-08
GALNS O 0 0.0006935912533663213
) O 0 3.194876185830253e-08
. O 0 9.490699426351057e-08

Previous O 0 3.640974739482772e-07
studies O 0 5.958869842004333e-09
of O 0 8.528363792947857e-09
patients O 0 6.007919939321482e-09
from O 0 2.8281275099573122e-09
a O 0 5.732851970918773e-09
British O 0 5.553146138481679e-07
- O 0 7.413344064843841e-06
Irish O 0 1.9468970435809752e-07
population O 0 2.4325149533543922e-11
showed O 0 3.821653063451613e-11
that O 0 2.6807356248020886e-12
the O 0 2.0455961924348287e-10
I113F O 0 4.106623663346909e-08
mutation O 0 1.7837890886607255e-10
is O 0 1.675416749780112e-11
the O 0 3.125341999088427e-11
most O 0 1.0855581190905017e-11
common O 0 2.8887064962290765e-10
single O 0 3.3205585503459645e-10
mutation O 0 4.057243430111157e-10
among O 0 1.500506718876693e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 0.0005539067788049579
and O 0 1.4112911728147992e-08
produces O 0 3.3172558033811583e-09
a O 0 1.6712246031502787e-09
severe O 0 1.4618027535107103e-06
clinical O 0 8.104611879389267e-06
phenotype O 0 4.3264128180453554e-05
. O 0 1.5463893987543997e-07

We O 0 1.980655355282579e-07
studied O 0 9.192668670721105e-08
mutations O 0 6.4548828504484845e-09
in O 0 6.946743735802841e-10
the O 0 3.364100553682192e-09
GALNS O 0 1.057551253325073e-05
gene O 0 3.2562974539018796e-09
from O 0 1.7890576797796598e-09
23 O 0 4.876584469570844e-09
additional O 0 9.802352707311002e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 5.978144599794177e-06
( O 0 1.914628899868376e-09
15 O 0 7.032358029235297e-10
from O 0 3.152355876334667e-10
Australia O 0 3.6466904496101904e-10
, O 0 7.490358333583913e-11
8 O 0 8.792703232174404e-10
from O 0 6.052474077478109e-10
Northern O 0 2.7739043062524615e-08
Ireland O 0 1.4051805941051043e-08
) O 0 1.8594130402060927e-10
, O 0 1.501077907806181e-11
with O 0 5.415637556460684e-12
various O 0 4.2986958437296607e-10
clinical O 0 3.9559213860229647e-07
phenotypes O 0 4.1091800085268915e-05
( O 0 3.52530697966813e-08
severe O 0 0.3119170367717743
, O 0 9.699800962437166e-09
16 O 0 2.4197825965188713e-09
cases O 0 8.145142199600386e-11
; O 0 1.823824286040221e-10
intermediate O 0 4.101347528262522e-08
, O 0 5.765150162817534e-11
4 O 0 5.339100273005215e-10
cases O 0 1.1122393284157539e-10
; O 0 1.592292520058436e-09
mild O 0 0.0002373766474192962
, O 0 1.4424130334589336e-08
3 O 0 3.247479085644045e-08
cases O 0 2.3246331526394215e-09
) O 0 8.04273625476526e-09
. O 0 8.436053633431584e-08

We O 0 1.3971821033464948e-07
found O 0 1.0264258776260249e-08
two O 0 3.645668211760267e-10
common O 0 1.8483991004458744e-09
mutations O 0 2.7062763141572077e-10
that O 0 1.7949279215723202e-11
together O 0 5.1609026080479126e-11
accounted O 0 4.782880758114061e-10
for O 0 2.2531020105187594e-10
32 O 0 3.711488449908984e-09
% O 0 4.2753917073312664e-10
of O 0 2.2565824764342324e-09
the O 0 5.870717245670676e-09
44 O 0 6.031572574727306e-09
unrelated O 0 3.5169773759946565e-09
alleles O 0 3.018677807720138e-10
in O 0 3.5773217721413175e-11
these O 0 1.5831341793060005e-10
patients O 0 9.993858185453064e-09
. O 0 5.4350618228227177e-08

One O 0 1.7165358201509662e-07
is O 0 5.293553595464573e-09
the O 0 4.579852053154809e-09
T312S O 0 1.6307818384575512e-07
mutation O 0 1.383072656402362e-09
, O 0 1.6734949537244859e-10
a O 0 2.324915815421491e-10
novel O 0 7.591651751681638e-09
mutation O 0 1.235793134490848e-09
found O 0 4.1949058116053095e-10
exclusively O 0 8.113330007830655e-10
in O 0 1.8074650109944912e-10
milder O 1 0.7341206073760986
patients O 0 0.002745044184848666
. O 0 3.0792050438321894e-06

The O 0 4.537454003639141e-07
other O 0 4.024865329910199e-09
is O 0 6.840153998766141e-10
the O 0 5.255352264477153e-10
previously O 0 2.71776134930235e-09
described O 0 3.281160676493755e-09
I113F O 0 9.584823601471726e-08
that O 0 6.783257289200151e-11
produces O 0 1.3976233503854019e-09
a O 0 6.689241160984238e-09
severe O 0 9.957351721823215e-05
phenotype O 0 0.006810140796005726
. O 0 1.4617581882703234e-06

The O 0 3.0380888347281143e-06
I113F O 0 1.3194468920119107e-05
and O 0 3.074176291306685e-08
T312S O 0 4.2008832679130137e-07
mutations O 0 1.7851480293984423e-09
accounted O 0 6.350858949843996e-09
for O 0 1.6245094158762186e-09
8 O 0 3.809912385577263e-08
( O 0 1.1972441926744182e-09
18 O 0 3.2172433606092454e-09
% O 0 4.4474851579323627e-10
) O 0 1.5503652528447986e-10
and O 0 9.819901558572042e-10
6 O 0 6.868490487477175e-08
( O 0 1.2402584514958903e-09
14 O 0 2.796581410891008e-09
% O 0 2.795507991759649e-10
) O 0 6.720053680187021e-11
of O 0 1.1079459572016503e-09
44 O 0 5.627654342532651e-09
unrelated O 0 6.841083255437752e-09
alleles O 0 1.9401340534130895e-09
, O 0 6.855474521394456e-10
respectively O 0 1.4268380255089141e-08
. O 0 9.563458291950155e-08

The O 0 7.046824634926452e-07
relatively O 0 5.318848366187012e-07
high O 0 8.825928148326057e-07
residual O 0 1.5379753676825203e-05
GALNS O 0 0.0006153645808808506
activity O 0 1.2396205839593222e-08
seen O 0 5.89792303884451e-09
when O 0 1.0245534420860736e-09
the O 0 3.743032106484634e-09
T312S O 0 1.5590649127261713e-07
mutant O 0 2.127637621640588e-08
cDNA O 0 1.2689596928794344e-07
is O 0 8.394026029812096e-10
overexpressed O 0 1.6068561592419428e-07
in O 0 5.146592596538824e-10
mutant O 0 3.934518044701463e-09
cells O 0 4.099748041053175e-10
provides O 0 6.596942436765119e-11
an O 0 1.4758838682432662e-12
explanation O 0 1.1054249876574218e-10
for O 0 5.51611638310856e-11
the O 0 1.5068969405618304e-09
mild O 0 7.446021754731191e-06
phenotype O 0 3.2846082831383683e-06
in O 0 9.943332823780793e-10
patients O 0 4.10904837933046e-10
with O 0 1.66767884224317e-11
this O 0 1.6179281525641187e-10
mutation O 0 9.380395127323027e-09
. O 0 2.7484773568176024e-08

The O 0 4.608271098049954e-08
distribution O 0 2.2536619237456534e-09
and O 0 4.0253936295364667e-10
relative O 0 8.731440459541773e-09
frequencies O 0 7.904556120763573e-09
of O 0 2.328502946014055e-09
the O 0 2.1435224706323197e-09
I113F O 0 1.0275702067019665e-07
and O 0 1.0159503238682532e-09
T312S O 0 8.541211826695871e-08
mutations O 0 4.694704069940769e-10
in O 0 5.06780485631797e-11
Australia O 0 1.3797810116678022e-10
corresponded O 0 2.9241628562992616e-10
to O 0 1.6545313730187416e-10
those O 0 1.601924010108391e-10
observed O 0 8.105070503638956e-10
in O 0 2.3592766629221273e-10
Northern O 0 3.191209785313731e-08
Ireland O 0 2.0512244347514752e-08
and O 0 4.617724813638091e-10
are O 0 6.592260591575805e-12
unique O 0 5.357081098167349e-11
to O 0 2.037421967249209e-11
these O 0 2.5860622671070033e-11
two O 0 8.062665118879764e-11
populations O 0 9.607799972277675e-11
, O 0 3.508772786209313e-11
suggesting O 0 1.4912163170954784e-10
that O 0 2.443107001426359e-11
both O 0 1.838353219651978e-10
mutations O 0 5.864390639764849e-10
were O 0 1.269655824920335e-09
probably O 0 4.656092844612658e-09
introduced O 0 8.454376643207695e-10
to O 0 2.4559845823723947e-10
Australia O 0 2.6141877551566495e-10
by O 0 2.6413767006960853e-11
Irish O 0 8.250285787880784e-09
migrants O 0 2.0970959691002378e-10
during O 0 4.20631501851787e-10
the O 0 6.740107916236582e-10
19th O 0 1.89191666777333e-07
century O 0 1.450331410524086e-06
. O 0 1.373811358007515e-07

Haplotype O 0 4.622571941581555e-05
analysis O 0 1.2798371074040915e-07
using O 0 8.132270323812918e-08
6 O 0 3.4281714533790364e-07
RFLPs O 0 2.5606766484997934e-06
provides O 0 1.2564398410574995e-09
additional O 0 3.2299199426155667e-10
data O 0 1.7922364980993422e-10
that O 0 1.0571921810198504e-11
the O 0 4.2203382455419103e-10
I113F O 0 4.081572768654951e-08
mutation O 0 2.691245837294076e-10
originated O 0 1.5030675593052933e-09
from O 0 7.13291439802255e-11
a O 0 2.183714875592102e-10
common O 0 7.74879982401444e-09
ancestor O 0 2.972074616991449e-05
. O 0 2.6784036322169413e-07

The O 0 4.2732031602099596e-07
other O 0 6.172299116258273e-09
9 O 0 2.7049683382074363e-08
novel O 0 4.645563045357903e-09
mutations O 0 4.678988307915688e-10
identified O 0 1.0459773047699628e-09
in O 0 9.369084674748507e-11
these O 0 1.7835338761429398e-10
23 O 0 8.606834356328363e-09
patients O 0 1.229602530905538e-09
were O 0 3.3438074531488837e-10
each O 0 1.326496638226482e-11
limited O 0 1.689054035525217e-10
to O 0 1.689575979124669e-10
a O 0 4.789876495436829e-09
single O 0 5.012517334535005e-08
family O 0 1.776135860609429e-07
. O 0 1.2818574646189518e-07

These O 0 2.8295533027744568e-08
data O 0 9.836139902574814e-09
provide O 0 7.072389340834206e-10
further O 0 9.348223306560044e-10
evidence O 0 6.02625993550987e-09
for O 0 1.0379700432494587e-09
extensive O 0 4.611304404988914e-08
allelic O 0 1.1033954478989472e-06
heterogeneity O 0 1.668984964453557e-06
in O 0 3.7920340645314354e-08
MPS B-Disease 1 0.9996446371078491
IVA I-Disease 1 1.0
in O 0 3.528589687107342e-08
British O 0 1.7085149011109024e-06
- O 0 7.0206760938162915e-06
Irish O 0 1.0276294233335648e-06
patients O 0 1.0594727761770173e-08
and O 0 3.3781033526025794e-10
provide O 0 2.8651986339056634e-10
evidence O 0 4.175430667885394e-09
for O 0 5.491156973569389e-10
their O 0 9.846722326400936e-10
transmission O 0 2.5324265351400754e-08
to O 0 4.701729561240597e-10
Australia O 0 7.028442827738957e-10
by O 0 1.8148646474536179e-10
British O 0 9.237540865569827e-08
- O 0 1.7196686030729325e-07
Irish O 0 5.5790188469018176e-08
migrants O 0 2.934579246272051e-09
. O 0 7.065000806605326e-10
. O 0 1.6766019683700506e-08

Identification O 0 7.858878348088183e-07
of O 0 6.193930630615796e-07
constitutional O 0 5.832932856719708e-06
WT1 O 1 0.9689781665802002
mutations O 0 1.3010000543545175e-07
, O 0 4.394597463708294e-10
in O 0 6.457770429513232e-11
patients O 0 3.890531785621931e-10
with O 0 5.933473157249125e-10
isolated O 0 0.00010716851829783991
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 1.5978417478024198e-09
and O 0 5.6659808789216726e-11
analysis O 0 2.369495988308046e-10
of O 0 3.3548737121691374e-09
genotype O 0 2.172327640437288e-06
/ O 0 5.809820891045092e-07
phenotype O 0 6.592446144537689e-09
correlations O 0 5.196821306618915e-10
by O 0 1.3314902999606026e-11
use O 0 4.4811190869076256e-10
of O 0 6.221753334756386e-09
a O 0 7.355780429207925e-09
computerized O 0 2.211752274661194e-07
mutation O 0 1.1115298903519033e-08
database O 0 4.9048708206100855e-08
. O 0 9.191143135467428e-08

Constitutional O 0 9.601338206266519e-06
mutations O 0 2.015852516024097e-07
of O 0 1.72926959862707e-07
the O 0 8.335973689099774e-08
WT1 O 0 1.2332869118836243e-05
gene O 0 4.353527760514453e-09
, O 0 2.173616980849502e-10
encoding O 0 3.479505572556718e-09
a O 0 7.549042280174945e-09
zinc O 0 0.0002490500919520855
- O 0 8.621965389465913e-05
finger O 0 5.016285285819322e-05
transcription O 0 2.1027030925324652e-06
factor O 0 1.6377126321742708e-09
involved O 0 1.1133344940406076e-10
in O 0 2.6797775110054545e-10
renal O 1 0.9957807064056396
and O 0 3.822803407160791e-08
gonadal O 0 0.0010303868912160397
development O 0 7.300935322973601e-08
, O 0 4.750548218690476e-11
are O 0 2.0494528383402377e-12
found O 0 2.2087635540013473e-11
in O 0 1.4906353928978433e-11
most O 0 6.574846916906907e-11
patients O 0 9.457293975723147e-11
with O 0 3.330008768731574e-10
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.4840165022178553e-05
DDS B-Disease 1 1.0
) O 0 8.013245178517536e-09
, O 0 1.3864950854092228e-10
or O 0 6.032515820209028e-09
diffuse B-Disease 1 0.9999710321426392
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 1.492551518822438e-06
DMS B-Disease 1 0.7963776588439941
) O 0 4.2290490553931193e-10
associated O 0 1.2170773278086244e-09
with O 0 1.4952157290082368e-09
pseudohermaphroditism B-Disease 1 1.0
and O 0 2.6763098048832035e-06
/ O 1 0.9961187839508057
or O 0 7.682031537115108e-06
Wilms B-Disease 1 1.0
tumor I-Disease 0 0.008452030830085278
( O 0 7.560529979855346e-08
WT B-Disease 1 1.0
) O 0 1.9222555991404988e-08
. O 0 3.4774373602886044e-08

Most O 0 3.306903977318143e-07
mutations O 0 4.027110378501675e-07
in O 0 1.0934506633475394e-07
DDS B-Disease 1 1.0
patients O 0 0.2119983285665512
lie O 0 6.551805199705996e-06
in O 0 1.1459762028209752e-08
exon O 0 2.0915221909945103e-07
8 O 0 1.0192563237865215e-08
or O 0 7.577745653186696e-10
exon O 0 3.6866904196131145e-08
9 O 0 8.614553514973977e-09
, O 0 2.7825280968230004e-10
encoding O 0 1.3238982887742168e-07
zinc O 0 0.002322525018826127
finger O 0 0.00021859964181203395
2 O 0 3.813907824223861e-06
or O 0 1.6169957461897866e-07
zinc O 0 0.0002529105404391885
finger O 0 1.4728064343216829e-05
3 O 0 2.8068117785551294e-07
, O 0 4.706771639106933e-10
respectively O 0 1.2990137854274053e-09
, O 0 1.7983316225045343e-10
with O 0 1.7524633133536582e-10
a O 0 4.5721300523382524e-08
hot O 0 3.6800898669753224e-05
spot O 0 1.9624153537733946e-06
( O 0 3.4637859247510505e-09
R394W O 0 1.7586103240319062e-07
) O 0 5.489230181510152e-10
in O 0 1.2285077399809552e-09
exon O 0 4.34134136639841e-07
9 O 0 2.052927641216229e-07
. O 0 1.0138239048274045e-07

We O 0 9.727205707577014e-08
analyzed O 0 1.8126488754433012e-08
a O 0 3.860802344490821e-09
series O 0 3.2633047375441038e-09
of O 0 3.7032643618317707e-09
24 O 0 1.8097400911187833e-08
patients O 0 1.1981631686808214e-08
, O 0 1.274698124831275e-09
10 O 0 3.190635977645684e-09
with O 0 2.8266606832971775e-09
isolated B-Disease 0 0.0002673912385944277
DMS I-Disease 1 1.0
( O 0 4.983242547496047e-07
IDMS B-Disease 1 0.9987925291061401
) O 0 1.4915981783047982e-09
, O 0 2.631240780814892e-10
10 O 0 3.9728084710866085e-10
with O 0 7.191193751587832e-10
DDS B-Disease 1 1.0
, O 0 3.8105010702338404e-08
and O 0 5.190879281968819e-09
4 O 0 2.441759860971615e-08
with O 0 1.4336244413826194e-09
urogenital B-Disease 1 0.9999908208847046
abnormalities I-Disease 1 0.9999983310699463
and O 0 8.228833030443639e-05
/ O 1 0.9999988079071045
or O 0 0.014459291473031044
WT B-Disease 1 1.0
. O 0 7.626037131558405e-06

We O 0 4.1816016960183333e-07
report O 0 1.1147555056822966e-07
WT1 O 0 0.00011624732724158093
heterozygous O 0 4.4576637492355076e-08
mutations O 0 3.0434348374797082e-09
in O 0 5.336401875943864e-10
16 O 0 8.607310419961323e-09
patients O 0 1.0429158869840194e-08
, O 0 1.0712170039894886e-09
4 O 0 6.820462061796206e-08
of O 0 4.449831436659224e-08
whom O 0 2.569678656527685e-07
presented O 0 4.7506873102065583e-07
with O 0 5.6342628340644296e-08
IDMS B-Disease 1 1.0
. O 0 4.262171387381386e-06

One O 0 2.023916039206597e-07
male O 0 2.2229295737474786e-08
and O 0 2.201061333195753e-09
two O 0 1.4180605578673067e-09
female O 0 1.3534227960576573e-08
IDMS B-Disease 1 0.9999819993972778
patients O 0 8.13958479284338e-07
with O 0 1.0417095097636775e-07
WT1 O 1 1.0
mutations O 0 1.1540541891008615e-05
underwent O 0 0.00014460251259151846
normal O 0 3.375238009084569e-07
puberty O 0 2.030819814535789e-06
. O 0 2.1215548429154296e-08

Two O 0 2.4592432623649074e-07
mutations O 0 7.451083661180746e-08
associated O 0 6.11311108400514e-08
with O 0 9.300900494224607e-09
IDMS B-Disease 1 0.9999994039535522
are O 0 9.053111038603845e-10
different O 0 2.498308226961399e-10
from O 0 3.8981456951248106e-10
those O 0 7.929009532281484e-11
described O 0 4.803435427191971e-09
in O 0 8.479055679799785e-09
DDS B-Disease 1 1.0
patients O 0 0.0063342684879899025
. O 0 3.276469442425878e-07

No O 0 6.196788945089793e-06
WT1 O 0 0.0019237474771216512
mutations O 0 1.6736153440888302e-07
were O 0 1.2815196015480979e-08
detected O 0 2.4434463341549417e-08
in O 0 2.9062030559856566e-10
the O 0 2.3176911501110453e-09
six O 0 5.945768322135336e-09
other O 0 9.355255237153415e-09
IDMS B-Disease 1 1.0
patients O 0 0.00022846570936962962
, O 0 2.497175799476281e-09
suggesting O 0 1.1211990447179687e-08
genetic O 0 3.641411794319538e-08
heterogeneity O 0 1.9693320041369589e-07
of O 0 2.320381753406764e-08
this O 0 6.0672027402119966e-09
disease O 0 0.00030830278410576284
. O 0 3.118683764569141e-07

We O 0 4.1754012158889964e-07
analyzed O 0 2.94524681976327e-07
genotype O 0 7.592786460008938e-06
/ O 0 1.8772666408040095e-06
phenotype O 0 9.600760364492089e-08
correlations O 0 3.7579845013624436e-08
, O 0 4.517643203971744e-10
on O 0 8.029765186101656e-10
the O 0 1.906676205809532e-10
basis O 0 4.482572646402616e-10
of O 0 1.7502596039165041e-09
the O 0 1.3579187774226398e-09
constitution O 0 1.1633829455348632e-09
of O 0 9.218827479173797e-09
a O 0 1.647394221038212e-08
WT1 O 0 5.753784080297919e-06
mutation O 0 2.3409270077934252e-09
database O 0 9.417373547648822e-10
of O 0 2.715833780086996e-09
84 O 0 2.7451559247992918e-08
germ O 1 0.923845112323761
- O 0 0.0010967921698465943
line O 0 6.342484653032443e-07
mutations O 0 1.8887171826520444e-09
, O 0 5.848715955991679e-11
to O 0 1.571991148363594e-11
compare O 0 2.1092184943061199e-10
the O 0 3.062223252747742e-10
distribution O 0 6.649926442836573e-11
and O 0 1.3523963199313371e-11
type O 0 3.757808786364336e-10
of O 0 7.933037005081189e-10
mutations O 0 9.76636271854403e-11
, O 0 4.689973669841363e-12
according O 0 5.917881202438524e-12
to O 0 3.965387740390014e-11
the O 0 8.490315672737836e-10
different O 0 2.980143909425692e-09
symptoms O 0 1.0729744644777384e-05
. O 0 4.027686486551829e-07

This O 0 3.870064446687138e-08
demonstrated O 0 9.084427432526354e-08
( O 0 2.4476711768528503e-09
1 O 0 1.3524525499519768e-08
) O 0 2.569572332689063e-10
the O 0 3.371138923569106e-10
association O 0 1.8843621107933473e-10
between O 0 5.659416824066454e-10
mutations O 0 4.584884139013923e-10
in O 0 1.1914988995442855e-09
exons O 0 2.476298561759904e-07
8 O 0 1.7233551474760134e-08
and O 0 1.1157329504740687e-09
9 O 0 9.352507213122863e-09
and O 0 1.7445536126814432e-09
DMS B-Disease 1 0.9221460819244385
; O 0 3.693412153893405e-08
( O 0 1.5196986780097177e-08
2 O 0 3.821725158559275e-07
) O 0 3.987171426356184e-10
among O 0 2.44380737868255e-10
patients O 0 2.6467654734574353e-09
with O 0 1.6320250706414186e-09
DMS B-Disease 1 0.9354690313339233
, O 0 8.303657206276682e-10
a O 0 4.0242570387150067e-10
higher O 0 1.0970908626006803e-09
frequency O 0 1.9448913590736083e-09
of O 0 7.757372522121386e-10
exon O 0 1.0561578278611705e-08
8 O 0 4.1784559146051947e-10
mutations O 0 2.5898975672400404e-11
among O 0 4.261297217866833e-11
46 O 0 3.1486797613666795e-09
, O 0 1.0676820538790821e-09
XY O 1 0.604960560798645
patients O 0 9.773121689704567e-08
with O 0 4.01308153374913e-10
female O 0 1.8114416633352448e-09
phenotype O 0 3.804972337206891e-09
than O 0 3.6407536707638855e-11
among O 0 7.297680515438998e-11
46 O 0 4.447572088395191e-09
, O 0 8.047090216400932e-10
XY O 0 0.060994572937488556
patients O 0 1.2768546220343069e-08
with O 0 4.9902637577758924e-11
sexual O 0 1.7407038310768286e-10
ambiguity O 0 1.037153207761321e-08
or O 0 2.0992971250244352e-10
male O 0 4.498612246606193e-11
phenotype O 0 6.176096439824974e-11
; O 0 9.00369709344595e-12
and O 0 9.346826784772944e-11
( O 0 3.098515055643958e-10
3 O 0 1.616375300272921e-08
) O 0 1.2079139077858514e-10
statistically O 0 3.8250878159340473e-11
significant O 0 8.908671716989502e-11
evidence O 0 1.3799028586447548e-09
that O 0 9.61876481242463e-11
mutations O 0 4.236525019685189e-10
in O 0 6.787946316144655e-10
exons O 0 3.1839266512179165e-07
8 O 0 2.0003094292064816e-08
and O 0 1.2877720001469584e-09
9 O 0 3.4844866991790013e-09
preferentially O 0 8.105194293506202e-10
affect O 0 2.645633434550376e-10
amino O 0 1.9186859046005367e-10
acids O 0 7.092324644242254e-11
with O 0 2.6872319473791872e-12
different O 0 2.967288220689923e-11
functions O 0 1.2591716558318922e-10
. O 0 7.470288276856252e-10
. O 0 9.91271775774294e-09

The O 0 5.818576482852222e-06
185delAG O 0 2.2862417608848773e-05
BRCA1 O 0 3.5844172430188337e-07
mutation O 0 1.2499627999318363e-08
originated O 0 5.337992714515849e-09
before O 0 9.807379353077295e-10
the O 0 1.0661999755301466e-10
dispersion O 0 6.588247725147767e-09
of O 0 2.5582480578378863e-09
Jews O 0 9.72733271709103e-09
in O 0 4.559228272693616e-10
the O 0 8.840140841570587e-10
diaspora O 0 6.644151451240532e-09
and O 0 6.336843827448035e-10
is O 0 7.015929504028406e-11
not O 0 6.398050839129255e-11
limited O 0 2.6868363089960212e-09
to O 0 9.06752806173472e-09
Ashkenazim O 0 0.0004049923154525459
. O 0 1.6121160797410994e-06

The O 0 5.535021045943722e-07
185delAG O 0 2.8371978260111064e-06
mutation O 0 4.1385952442851703e-08
in O 0 3.5260852015994715e-09
BRCA1 O 0 1.671761040711317e-08
is O 0 1.943577659924145e-10
detected O 0 1.3638681295446986e-09
in O 0 3.55246318473057e-11
Ashkenazi O 0 8.903758441647369e-08
Jews O 0 3.968857686942329e-09
both O 0 3.3902383678174886e-10
in O 0 7.835830873048621e-10
familial B-Disease 1 0.9029073715209961
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 4.821373167374077e-08
in O 0 2.3395288484273635e-10
the O 0 7.994799267052599e-10
general O 0 5.969734040434105e-09
population O 0 2.4679874810473734e-10
. O 0 6.759139026257799e-09

All O 0 1.8160164927394362e-07
tested O 0 1.2633690005259268e-07
Ashkenazi O 0 2.1573309822997544e-06
mutation O 0 8.639696069678848e-09
carriers O 0 4.340320547413512e-09
share O 0 3.950926696916213e-09
the O 0 1.7274186525639834e-09
same O 0 1.7345930247714136e-09
allelic O 0 4.2820556700462475e-07
pattern O 0 1.44888517183972e-07
at O 0 4.755723281846258e-08
the O 0 1.64214579712052e-08
BRCA1 O 0 2.6427596822031774e-07
locus O 0 8.554936812288361e-07
. O 0 9.609480855488073e-08

Our O 0 1.5364653336291667e-06
previous O 0 2.039988231672396e-07
study O 0 1.575201191705844e-09
showed O 0 2.9401969747766543e-10
that O 0 4.44554722894841e-12
this O 0 3.164801060107081e-11
Ashkenazi O 0 1.074841065928922e-06
mutation O 0 3.6925436042167803e-09
also O 0 1.021779813537016e-10
occurs O 0 5.4870292337527715e-11
in O 0 1.757114766187673e-11
Iraqi O 0 8.3909243997482e-09
Jews O 0 4.218755123019946e-09
with O 0 7.392538664552362e-11
a O 0 4.831835487273395e-10
similar O 0 2.7474014174799777e-09
allelic O 0 5.831981866322167e-07
pattern O 0 2.6277683673470165e-07
. O 0 1.5794688579262584e-07

We O 0 3.583074317248247e-07
extended O 0 4.263954451744212e-07
our O 0 1.789952897013336e-08
analysis O 0 1.9762236291853696e-09
to O 0 4.898620398208209e-10
other O 0 6.247721784369276e-10
non O 0 3.955874916528046e-08
- O 0 1.0579041287428481e-07
Ashkenazi O 0 7.00275677445461e-07
subsets O 0 1.8813510749282614e-08
354 O 0 6.614109704372595e-09
of O 0 5.299683469850436e-10
Moroccan O 0 6.3356870860786785e-09
origin O 0 1.959689299724232e-09
, O 0 4.1599912403711414e-10
200 O 0 3.789376867846528e-10
Yemenites O 0 2.4829435574247327e-07
and O 0 3.6519685053804096e-09
150 O 0 6.6913088403453e-09
Iranian O 0 1.859365852396877e-07
Jews O 0 4.620504512331536e-07
. O 0 4.892766014563676e-07

Heteroduplex O 0 9.180766937788576e-05
analysis O 0 1.1261815302532341e-07
complemented O 0 1.5665855812585505e-07
by O 0 4.675089759764717e-10
direct O 0 2.949100741389543e-09
DNA O 0 3.9027618470299785e-08
sequencing O 0 5.8883376397034226e-08
of O 0 8.087038594339901e-09
abnormally O 0 2.2613921402125925e-08
migrating O 0 5.491212373698318e-09
bands O 0 1.4717714158507533e-08
were O 0 3.1773241815358233e-09
employed O 0 7.658044864911062e-08
. O 0 8.478898649855182e-08

Four O 0 2.516494532756042e-07
of O 0 8.09497393561287e-08
Moroccan O 0 1.1006502518284833e-06
origin O 0 1.5966087119068106e-08
( O 0 1.2571758079005235e-09
1 O 0 6.666976304359196e-09
. O 0 2.429548784377289e-10
1 O 0 5.845609774013383e-09
% O 0 2.778412777626471e-10
) O 0 8.108034382781071e-11
and O 0 1.4450744767469104e-10
none O 0 5.262235536207527e-09
of O 0 2.2091166229643022e-08
the O 0 3.190351804960301e-08
Yemenites O 0 1.615717792446958e-06
or O 0 3.5459408742610776e-09
Iranians O 0 7.908280252877375e-09
was O 0 3.3606633031979527e-09
a O 0 2.7112465050826984e-10
carrier O 0 7.30775440160869e-10
of O 0 1.9761294822728814e-09
the O 0 7.145503744254711e-09
185delAG O 0 6.193050694491831e-07
mutation O 0 2.2944425026594217e-08
. O 0 3.2711518826999963e-08

BRCA1 O 0 1.2800834156223573e-05
allelic O 0 3.2746563647378935e-06
patterns O 0 1.3712008417599009e-08
were O 0 2.469222160073059e-09
determined O 0 1.5252588081438034e-09
for O 0 2.2305891855811666e-10
four O 0 1.6753728959706393e-10
of O 0 3.477619581193636e-10
these O 0 3.5508644635751097e-11
individuals O 0 9.916277868282641e-12
and O 0 3.7299879851460105e-10
for O 0 2.403571230935597e-10
12 O 0 9.434705239286245e-10
additional O 0 1.287133621907799e-09
non O 0 1.64944413683088e-08
- O 0 2.590168257654568e-08
Ashkenazi O 0 7.499990317683114e-08
185delAG O 0 6.284655906796388e-09
mutation O 0 4.295005670562624e-11
carriers O 0 8.980496207788846e-11
who O 0 2.969611223591073e-10
had O 0 8.160907327692257e-08
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.377543544047512e-05

Six O 0 4.812663974007592e-06
non O 0 7.942830961837899e-06
- O 0 5.46002593182493e-06
Ashkenazi O 0 5.545283784158528e-06
individuals O 0 4.1227396496701374e-10
shared O 0 6.9318444317900685e-09
the O 0 1.4552455906979844e-09
common O 0 6.356797310758111e-09
Ashkenazi O 0 2.0759914605150698e-06
haplotype O 0 1.3369557336773141e-06
, O 0 1.7359269577355008e-09
four O 0 1.1008134404022485e-09
had O 0 2.7736382079979194e-09
a O 0 9.120026955855565e-10
closely O 0 1.6033421812444715e-10
related O 0 1.8093628817439367e-09
pattern O 0 3.985624275060218e-08
, O 0 1.4396555059192906e-09
and O 0 8.910648330306969e-10
the O 0 6.06586025853062e-09
rest O 0 1.8803286039315026e-08
( O 0 6.291525078694349e-10
n O 0 4.9938679858030355e-09
= O 0 1.329373500169595e-08
6 O 0 8.196767709023334e-09
) O 0 1.701068036430442e-10
displayed O 0 1.2733420984289978e-09
a O 0 3.4030025464204527e-09
distinct O 0 2.253302078258912e-08
BRCA1 O 0 9.403793654882975e-08
allelic O 0 5.79984487103502e-07
pattern O 0 2.0761605412644712e-07
. O 0 1.1435749058819056e-07

We O 0 8.042986365808247e-08
conclude O 0 8.863786149504449e-08
that O 0 6.54758081086726e-10
the O 0 7.17405868044807e-09
185delAG O 0 2.995532781824295e-07
BRCA1 O 0 1.4905751299920666e-08
mutation O 0 7.457774398034189e-10
occurs O 0 1.840054636437216e-10
in O 0 4.6334266284864256e-11
some O 0 4.117786320256833e-11
non O 0 2.0574349335333864e-08
- O 0 3.139321336220746e-07
Ashkenazi O 0 3.2940945402515354e-06
populations O 0 1.4365368894431185e-09
at O 0 2.5973734274487015e-10
rates O 0 3.0171278669888224e-11
comparable O 0 2.987540770327257e-10
with O 0 2.852970984457137e-11
that O 0 1.943963046091568e-10
of O 0 7.44257633300549e-08
Ashkenazim O 0 0.003570432774722576
. O 0 5.41299357337266e-07

The O 0 3.7137994013392017e-07
majority O 0 1.4690004768169729e-08
of O 0 1.2423567952168924e-08
Jewish O 0 4.229150363244116e-08
185delAG O 0 2.46650330382181e-07
mutation O 0 5.1513486809540154e-09
carriers O 0 1.1921035270034963e-09
have O 0 8.545746055244052e-11
a O 0 4.716873558407997e-10
common O 0 5.442299499947012e-09
allelic O 0 2.987686968936032e-07
pattern O 0 2.993555980879137e-08
, O 0 4.4861389603134683e-10
supporting O 0 3.077343047053205e-09
the O 0 5.2235757941332395e-09
founder O 0 1.8573786064735032e-06
effect O 0 4.995401869933858e-09
notion O 0 4.520716601064123e-08
, O 0 1.3996875880550874e-10
but O 0 2.0606011688628634e-11
dating O 0 4.312854240406949e-10
the O 0 1.6257670210073627e-10
mutations O 0 7.702210397253495e-12
origin O 0 4.1384316112891284e-11
to O 0 2.5770611339348548e-11
an O 0 1.837552852934632e-11
earlier O 0 7.390005274388045e-10
date O 0 3.432115747159514e-08
than O 0 1.0144052264848824e-09
currently O 0 1.4700087813679374e-09
estimated O 0 1.7916906847048608e-09
. O 0 2.178429525656611e-08

However O 0 3.904568188772828e-07
, O 0 3.3227458562379297e-09
the O 0 7.998399165209946e-10
different O 0 1.6201300023777065e-10
allelic O 0 1.4034775119853293e-07
pattern O 0 3.811663873420912e-08
at O 0 1.3123004904969093e-08
the O 0 2.4773361140262296e-09
BRCA1 O 0 1.3991764191700895e-08
locus O 0 1.5155679378153764e-08
even O 0 2.193491221991195e-10
in O 0 2.2110143577114272e-11
some O 0 8.61404784308073e-12
Jewish O 0 7.545439273393129e-10
mutation O 0 2.919086083963407e-10
carriers O 0 1.0247195314505575e-09
, O 0 1.3307978330434622e-10
might O 0 4.6153206256782653e-10
suggest O 0 6.611683978086091e-10
that O 0 1.1524303039633921e-10
the O 0 1.1228805663066055e-09
mutation O 0 7.871692742078551e-10
arose O 0 3.701146056300786e-09
independently O 0 7.245770095032356e-10
. O 0 4.603540049163968e-10
. O 0 1.6679836178923324e-08

Crystal O 0 4.174647983745672e-05
structure O 0 1.3731855688092764e-06
of O 0 1.6979778365566744e-06
the O 0 2.0513673462119186e-06
hemochromatosis B-Disease 1 1.0
protein O 0 1.5003665794210974e-06
HFE O 0 0.004568791016936302
and O 0 4.565618105800695e-09
characterization O 0 4.0443907778353605e-08
of O 0 6.868762447709287e-09
its O 0 9.08857822334852e-10
interaction O 0 1.9595398637051176e-09
with O 0 4.238416562163394e-10
transferrin O 0 4.023692326882156e-06
receptor O 0 1.1008039990656471e-07
. O 0 3.1338405648284606e-08

HFE O 0 0.3447257876396179
is O 0 5.432676744021592e-07
an O 0 1.1421183110371658e-08
MHC O 0 1.333649743173737e-05
- O 0 7.995041414687876e-06
related O 0 9.53640935108524e-08
protein O 0 8.635281822932939e-09
that O 0 6.642750932650543e-11
is O 0 4.792649957452433e-11
mutated O 0 1.0276888229299175e-09
in O 0 1.0027605135132234e-10
the O 0 2.203166538095047e-08
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.0003809990594163537

HFE O 0 0.0027814290951937437
binds O 0 1.535458977741655e-06
to O 0 1.5118529006485915e-07
transferrin O 0 3.203296728315763e-05
receptor O 0 1.4078879928547394e-07
( O 0 2.237583007769217e-09
TfR O 0 4.682680412315676e-07
) O 0 3.001568715799152e-10
and O 0 2.184197961385692e-10
reduces O 0 5.579888551210388e-09
its O 0 7.503517251983283e-10
affinity O 0 5.107946510207739e-09
for O 0 2.610108351674967e-09
iron O 0 2.9117076337570325e-05
- O 0 3.37525392524185e-07
loaded O 0 1.3757754402377032e-07
transferrin O 0 1.8031784065897227e-06
, O 0 3.396032344227251e-09
implicating O 0 2.458798235238646e-06
HFE O 1 0.9999997615814209
in O 0 4.116897969197453e-07
iron O 1 0.9999876022338867
metabolism O 0 1.4511530025629327e-05
. O 0 1.703538146102801e-07

The O 0 2.1408082830021158e-05
2 O 0 1.6403904737671837e-05
. O 0 9.24827475046186e-07

6 O 0 3.7285495636751875e-05
A O 0 3.0240344131016172e-06
crystal O 0 2.6013383831013925e-05
structure O 0 2.8419394766387995e-06
of O 0 5.651306764775654e-06
HFE O 1 1.0
reveals O 0 8.797942996352504e-07
the O 0 5.172062778058262e-09
locations O 0 2.730100590042639e-09
of O 0 5.60386794745682e-08
hemochromatosis B-Disease 1 1.0
mutations O 0 1.2873728394424688e-07
and O 0 8.229163128703476e-09
a O 0 8.659724493043086e-09
patch O 0 0.26617515087127686
of O 0 1.1090596672147512e-05
histidines O 0 0.004702787380665541
that O 0 4.771500972111653e-10
could O 0 1.2262298954013318e-09
be O 0 2.3003644822328084e-10
involved O 0 3.201937326391402e-10
in O 0 3.7576938782812874e-10
pH O 0 2.3077336663845927e-06
- O 0 8.692243795849208e-07
dependent O 0 4.5355545097436334e-08
interactions O 0 2.6216552484470412e-08
. O 0 7.383418676454312e-08

We O 0 6.816806603637815e-07
also O 0 2.0202397976731845e-08
demonstrate O 0 7.29519689102176e-09
that O 0 5.583079554227766e-10
soluble O 0 1.0519459010538412e-06
TfR O 0 0.0001025349265546538
and O 0 3.312136342970007e-08
HFE O 0 0.00041268341010436416
bind O 0 8.825055175520902e-08
tightly O 0 6.554746789788624e-08
at O 0 3.974531370687373e-09
the O 0 3.811020388155839e-10
basic O 0 1.792956361157394e-08
pH O 0 1.1000861377397086e-07
of O 0 1.1355194118323197e-08
the O 0 2.1105637237894825e-09
cell O 0 4.163597022710519e-09
surface O 0 1.5548554666011682e-09
, O 0 3.37061004107575e-11
but O 0 1.6112663286937945e-11
not O 0 5.1210331114548424e-11
at O 0 5.481864406853276e-10
the O 0 3.861993780329698e-10
acidic O 0 4.329995419993793e-07
pH O 0 1.8163071899834904e-06
of O 0 2.716781466460816e-07
intracellular O 0 3.845056255613599e-07
vesicles O 0 1.1175458212164813e-06
. O 0 1.3736240589423687e-07

TfR O 0 0.0029457060154527426
HFE O 0 0.0046713328920304775
stoichiometry O 0 4.7088880819501355e-05
( O 0 3.4963960615641554e-07
2 O 0 3.88683531582501e-07
1 O 0 3.134384840564053e-08
) O 0 2.3017512895684433e-10
differs O 0 6.6680194699131334e-09
from O 0 5.949330361687544e-09
TfR O 0 4.684593022830086e-06
transferrin O 0 2.5703552637423854e-06
stoichiometry O 0 2.3917573344078846e-07
( O 0 1.773530988735672e-09
2 O 0 1.184466125181416e-08
2 O 0 8.070058399312074e-09
) O 0 7.466068041583895e-11
, O 0 3.71937237952924e-11
implying O 0 1.5691559163144575e-09
a O 0 2.9436478254929455e-10
different O 0 4.1421824303888855e-11
mode O 0 1.466257248949887e-08
of O 0 3.353515520831962e-10
binding O 0 1.2182570507945911e-09
for O 0 9.913697640584473e-10
HFE O 0 0.00035859932540915906
and O 0 1.92704998625004e-08
transferrin O 0 3.0429832804657053e-06
to O 0 3.9739171953101504e-09
TfR O 0 1.8920478623840609e-06
, O 0 4.704187039905605e-10
consistent O 0 4.1750962687103765e-09
with O 0 5.199815578116329e-10
our O 0 9.300936021361395e-09
demonstration O 0 4.047954416108723e-09
that O 0 7.573609100974821e-11
HFE O 0 8.939493272919208e-05
, O 0 2.3493675893604404e-09
transferrin O 0 1.6998037608573213e-06
, O 0 1.6790684398415578e-09
and O 0 1.1454774906383136e-09
TfR O 0 1.2021390602967585e-06
form O 0 1.1036690672483473e-08
a O 0 3.045230556608658e-08
ternary O 0 3.527241688061622e-06
complex O 0 1.2331716789049096e-05
. O 0 5.308095865075302e-07

Identification O 0 2.983933882205747e-07
of O 0 1.3738612381075654e-07
three O 0 5.257259960700367e-09
novel O 0 1.779166325377446e-08
mutations O 0 1.9000627737852938e-09
and O 0 8.055736633316712e-10
a O 0 1.5867747116260489e-09
high O 0 1.3835879109080906e-08
frequency O 0 5.750341092181088e-09
of O 0 1.0608512956977734e-09
the O 0 7.659776146695663e-10
Arg778Leu O 0 9.306316428592254e-08
mutation O 0 2.9263330647566477e-10
in O 0 1.1062348953538859e-10
Korean O 0 1.3148816435659683e-07
patients O 0 8.677610852103612e-10
with O 0 6.667799645754258e-10
Wilson B-Disease 0 3.663904863060452e-06
disease I-Disease 0 4.507897756411694e-05
. O 0 8.712045769243559e-07

Four O 0 1.2205775874463143e-06
mutations O 0 9.84695560646287e-08
- O 0 8.689806918482645e-07
- O 0 7.565360533590137e-07
R778L O 0 2.6903560410573846e-06
, O 0 4.646502738125946e-09
A874V O 0 2.5244122525691637e-07
, O 0 1.8107784161003337e-09
L1083F O 0 2.053626815268217e-07
, O 0 8.100928816645592e-10
and O 0 9.05155672636937e-10
2304delC O 0 3.966748352013383e-07
- O 0 2.54558017331874e-07
- O 0 1.5279128717793355e-07
in O 0 1.203623201107007e-09
the O 0 6.10243766629992e-09
copper O 0 2.5141051196442277e-07
- O 0 3.51091991035446e-08
transporting O 0 1.3034224366492708e-08
enzyme O 0 5.6270539339209336e-09
, O 0 1.3822313293943012e-09
P O 0 3.666467023322184e-07
- O 0 1.9517341343089356e-07
type O 0 1.7512029160116072e-07
ATPase O 0 3.0727787247997185e-07
( O 0 1.179152553376639e-09
ATP7B O 0 1.0326290293960483e-06
) O 0 1.3185816327698774e-10
, O 0 2.0815611387337007e-11
were O 0 5.4447338998508954e-11
identified O 0 4.377990747705951e-10
in O 0 2.0603979633548875e-10
Korean O 0 9.61906835073023e-07
Patients O 0 5.156322480104336e-09
with O 0 1.1671279498415288e-09
Wilson B-Disease 0 5.978937406325713e-05
disease I-Disease 0 0.016351107507944107
. O 0 1.4567898460882134e-06

Arg778Leu O 0 0.00495121767744422
, O 0 6.059398316438092e-08
the O 0 1.2770933643935223e-08
most O 0 5.683951642687646e-10
frequently O 0 1.9755179436753423e-10
reported O 0 5.14176271004807e-11
mutation O 0 6.068886365673265e-11
of O 0 2.403924281857428e-10
this O 0 6.237395322461481e-11
enzyme O 0 2.138344390445468e-09
, O 0 1.7725527989842504e-10
was O 0 1.0710290432314196e-09
found O 0 3.5709001727779466e-11
in O 0 3.091405950672588e-11
six O 0 2.054726805367224e-10
of O 0 8.958362940347797e-10
eight O 0 1.1753868989217153e-09
unrelated O 0 5.507502010004828e-09
patients O 0 9.919334242880495e-10
studied O 0 1.3277864363558933e-09
, O 0 9.247183747895793e-12
an O 0 7.03965141388152e-12
allele O 0 2.5414484405850146e-10
frequency O 0 2.6985460532813477e-09
of O 0 1.2434425933349758e-08
37 O 0 2.7219186904403614e-07
. O 0 1.2837023177780793e-07

5 O 0 1.3916622947363066e-06
% O 0 2.3330029463863866e-08
, O 0 7.236516386122105e-10
which O 0 9.59333376626681e-11
is O 0 1.6230032595654365e-10
considerably O 0 1.906587421274253e-08
higher O 0 5.8022551208125606e-09
than O 0 3.001945220182378e-11
those O 0 5.567444769094543e-11
in O 0 1.201569538311631e-10
other O 0 2.9856267458328034e-10
Asian O 0 6.816883058036183e-09
populations O 0 1.3230591067170394e-09
. O 0 3.3400372245750987e-08

The O 0 8.358412628695078e-07
novel O 0 2.805826966323366e-07
single O 0 1.7076070335519944e-08
nucleotide O 0 4.5430002870716635e-08
deletion O 0 3.444103313654523e-08
, O 0 4.6440287726490226e-10
2304delC O 0 1.2613753597179311e-07
, O 0 1.1837021363092504e-09
was O 0 1.9265097961351785e-08
found O 0 9.700868996986856e-10
in O 0 4.1203102041365014e-10
one O 0 2.734389381586766e-09
patient O 0 3.4362659562248155e-07
. O 0 1.8037374616142188e-07

Since O 0 1.766899345057027e-06
a O 0 1.5630428151780507e-07
mutation O 0 1.0191633492695473e-07
at O 0 7.035329474547325e-08
cDNA O 0 1.0115637678609346e-06
nucleotide O 0 8.833254128148837e-07
2302 O 0 4.940049984725192e-05
( O 0 6.04643135559968e-09
2302insC O 0 2.8098753546146327e-07
) O 0 1.272608796121233e-09
had O 0 6.558633636188915e-09
been O 0 1.5534651343074302e-09
previously O 0 2.929087639103045e-09
described O 0 2.5825845906268796e-09
, O 0 8.39626354554035e-11
this O 0 4.140989634526804e-11
region O 0 3.284303939921074e-09
of O 0 9.241643894597473e-09
the O 0 2.4743624038592316e-08
ATP7B O 0 0.04306225851178169
gene O 0 8.529209338803412e-09
may O 0 9.042169790696164e-10
be O 0 2.0231376296475645e-10
susceptible O 0 1.255080377404738e-07
to O 0 3.0555444840985047e-09
gene O 0 1.7568400778600335e-07
rearrangements O 0 0.0004938440397381783
causing O 0 1.4243768418964464e-05
Wilson B-Disease 0 0.00018709803407546133
disease I-Disease 0 0.00041437576874159276
. O 0 4.2493729779380374e-07

Disruption O 0 5.681350739905611e-05
of O 0 8.548159371457587e-07
splicing O 0 5.969400262983982e-07
regulated O 0 1.1201772842639457e-08
by O 0 2.636103280106994e-10
a O 0 3.5260314668050796e-09
CUG O 0 8.173118840204552e-05
- O 0 2.8282647690502927e-07
binding O 0 3.8854707895552565e-08
protein O 0 1.3284945055147546e-07
in O 0 2.61347228303066e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.0001014767331071198

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9995346069335938
DM B-Disease 1 1.0
) O 0 1.3731852277487633e-07
is O 0 1.2954534112097349e-09
caused O 0 8.175657484343901e-09
by O 0 8.124386718932897e-10
a O 0 2.7025961912841012e-08
CTG O 0 9.680814400780946e-06
expansion O 0 6.788548034819541e-08
in O 0 7.511665733872519e-10
the O 0 1.6349537279580773e-09
3 O 0 2.022074774288285e-08
untranslated O 0 0.0006176075548864901
region O 0 1.2720416719957939e-08
of O 0 2.9524001021741242e-08
the O 0 2.117314892302602e-07
DM B-Disease 1 1.0
gene O 0 2.5181657292705495e-06
. O 0 2.821343798586895e-07

One O 0 5.781290823847485e-08
model O 0 3.4320766673090475e-08
of O 0 3.189451831531187e-07
DM B-Disease 1 1.0
pathogenesis O 1 0.9999967813491821
suggests O 0 1.2118016456952319e-07
that O 0 8.006626472933931e-10
RNAs O 0 2.750202732215712e-08
from O 0 4.087317984069472e-10
the O 0 6.864830370822972e-10
expanded O 0 2.1240926795229598e-09
allele O 0 1.8096322218497107e-09
create O 0 3.7831229815488143e-10
a O 0 1.0393785832008007e-09
gain O 0 1.6604225550054252e-08
- O 0 4.182638591032628e-08
of O 0 2.8748525338073705e-08
- O 0 5.644825762374239e-08
function O 0 1.7615114922264752e-10
mutation O 0 5.634597996517776e-11
by O 0 3.764691683394439e-12
the O 0 5.5146127247995835e-11
inappropriate O 0 1.4254439295591226e-10
binding O 0 1.818537542774834e-10
of O 0 3.6728181607159627e-10
proteins O 0 2.8446085764688434e-11
to O 0 2.792225339831589e-10
the O 0 2.7107011746352327e-08
CUG O 0 0.0038069237489253283
repeats O 0 3.0095229703874793e-06
. O 0 3.2178411402128404e-07

Data O 0 5.317255613590532e-07
presented O 0 2.6125113095076813e-07
here O 0 6.557357767889016e-09
indicate O 0 2.7531037449790574e-09
that O 0 4.244491702554143e-10
the O 0 3.1670142064399442e-09
conserved O 0 6.848763689504267e-08
heterogeneous O 0 6.50548713565513e-07
nuclear O 0 2.276777377119288e-05
ribonucleoprotein O 0 4.89588055643253e-05
, O 0 1.3615866656380149e-08
CUG O 0 1.3765220501227304e-05
- O 0 1.0847530518276471e-07
binding O 0 1.317250664101266e-08
protein O 0 6.056542378729546e-09
( O 0 9.011076329557e-10
CUG O 0 4.0966435335576534e-05
- O 0 1.581411652296083e-06
BP O 0 8.195993359549902e-06
) O 0 1.1514706965698451e-09
, O 0 4.5994941189064775e-10
may O 0 8.603026735443109e-09
mediate O 0 2.66360643763619e-06
the O 0 5.665351068273594e-07
trans O 0 2.50669813794957e-06
- O 0 3.6883686789224157e-06
dominant O 0 3.5848412949235353e-07
effect O 0 1.065723242987815e-08
of O 0 6.657560280842745e-09
the O 0 1.700440499519118e-08
RNA O 0 5.082032430436811e-07
. O 0 3.043355079057619e-08

CUG O 1 0.9998626708984375
- O 0 0.0528322234749794
BP O 0 0.00021892585209570825
was O 0 1.1635658836439688e-07
found O 0 8.072363333333499e-10
to O 0 1.3154716205221462e-10
bind O 0 6.495388671368119e-10
to O 0 1.3005285737222039e-09
the O 0 1.65163527299228e-08
human O 0 7.475425150005321e-07
cardiac O 1 0.9999794960021973
troponin O 0 0.16001878678798676
T O 0 3.304725032649003e-05
( O 0 8.031025622301513e-09
cTNT O 0 1.6942189517976658e-07
) O 0 2.2832727375465822e-10
pre O 0 7.364009491084289e-08
- O 0 4.295487698868783e-08
messenger O 0 1.4100266731986721e-08
RNA O 0 2.45699922629683e-08
and O 0 2.985114377906939e-10
regulate O 0 8.687194713585811e-11
its O 0 1.64922547840618e-10
alternative O 0 2.804755894203481e-08
splicing O 0 8.016334049898433e-07
. O 0 6.93869921519763e-08

Splicing O 0 9.080613381229341e-06
of O 0 1.643542418605648e-06
cTNT O 0 6.549030513269827e-05
was O 0 2.620966142785619e-06
disrupted O 0 6.6893726398120634e-06
in O 0 2.4123880848492263e-07
DM B-Disease 1 1.0
striated O 1 0.9976289868354797
muscle O 0 7.425867806887254e-06
and O 0 2.0990388094332957e-08
in O 0 3.597906972352405e-10
normal O 0 1.4286782867856118e-09
cells O 0 1.412704397907305e-09
expressing O 0 1.5180610102305536e-09
transcripts O 0 9.072285145350634e-09
that O 0 1.1895545659612594e-10
contain O 0 1.710955466194264e-08
CUG O 0 0.002245513955131173
repeats O 0 5.8390992307977285e-06
. O 0 8.02023521373485e-07

Altered O 0 6.210685569385532e-06
expression O 0 3.633468566022202e-07
of O 0 1.7297709575814224e-07
genes O 0 1.1388205045648192e-08
regulated O 0 1.8342570129448177e-08
posttranscriptionally O 0 2.1371960201577167e-07
by O 0 1.9554178276592893e-09
CUG O 1 0.9980435371398926
- O 0 0.00027033145306631923
BP O 0 1.075932686944725e-05
therefore O 0 4.160984889978181e-09
may O 0 4.337123715725255e-10
contribute O 0 4.455704416539419e-10
to O 0 8.662301986817056e-09
DM B-Disease 1 1.0
pathogenesis O 1 0.9999997615814209
. O 0 1.1763322760316441e-07
. O 0 1.4759733346636494e-07

Identification O 0 7.907278813945595e-07
of O 0 1.7678317476566008e-07
a O 0 2.700215517847937e-08
novel O 0 1.4388167812739994e-07
nonsense O 0 5.240773930381692e-07
mutation O 0 1.1183669990089129e-08
and O 0 1.3696449530087307e-09
a O 0 2.1832078367367558e-09
missense O 0 6.235774208107614e-08
substitution O 0 4.615932880369655e-08
in O 0 3.2251630255331065e-09
the O 0 7.458375250735116e-09
vasopressin O 0 1.5991300017503818e-07
- O 0 8.97422438583817e-08
neurophysin O 0 9.982712754208478e-07
II O 1 0.7567008137702942
gene O 0 3.357556010996632e-09
in O 0 1.5979507994590136e-10
two O 0 1.0742999545509946e-10
Spanish O 0 7.649151534394605e-09
kindreds O 0 3.5261012953924364e-07
with O 0 1.2448420072530553e-09
familial B-Disease 0 0.0006822358700446784
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 0 1.6722429791116156e-05

Familial B-Disease 1 0.9999974966049194
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 0.00019641547987703234
FNDI B-Disease 1 1.0
) O 0 1.3612829086184774e-08
is O 0 2.4314122937241223e-10
an O 0 1.4947330873038567e-10
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 0.25954294204711914
by O 0 1.5413386122986594e-08
deficiency O 1 0.9999955892562866
in O 0 2.5154283989081705e-08
the O 0 1.4092744038407545e-07
antidiuretic O 0 1.5120359648790327e-06
hormone O 0 1.129535842636642e-08
arginine O 0 4.512429185865585e-08
vasopressin O 0 6.846202893484588e-08
( O 0 1.6199980246156542e-09
AVP O 0 1.0813568707135346e-07
) O 0 7.143888258731579e-11
encoded O 0 1.02124010636917e-10
by O 0 1.1944745192948858e-10
the O 0 7.939702229009526e-09
AVP O 0 1.220277317770524e-05
- O 0 3.560915502021089e-06
neurophysin O 0 0.0001371731050312519
II O 1 1.0
( O 0 8.363770689356897e-07
AVP O 0 0.00020058870723005384
- O 0 3.1295037388190394e-06
NPII O 0 6.242083327379078e-05
) O 0 3.6577614270782988e-09
gene O 0 2.8843474275674907e-09
on O 0 1.9304049914126153e-08
chromosome O 0 4.8426905152609834e-08
20p13 O 0 2.15083946386585e-06
. O 0 2.711369120333984e-07

In O 0 6.226267146303144e-08
this O 0 9.142232526571092e-10
study O 0 4.271503983854785e-10
, O 0 8.922344113537761e-11
we O 0 4.498621267168268e-11
analyzed O 0 5.603477681859204e-10
two O 0 1.9973794840311143e-10
families O 0 4.060603520095185e-10
with O 0 7.432922055627955e-10
FNDI B-Disease 1 1.0
using O 0 2.1359404911436286e-08
direct O 0 7.804406898515026e-09
automated O 0 5.6279045423934804e-08
fluorescent O 0 1.3729044567867277e-08
, O 0 1.5375903328340712e-10
solid O 0 1.4135892456579313e-08
phase O 0 1.4099222767072206e-07
, O 0 7.666235979364444e-10
single O 0 2.0960813085224572e-09
- O 0 9.40384481395995e-09
stranded O 0 8.629897685352717e-09
DNA O 0 7.182119343696058e-10
sequencing O 0 2.1559956042693784e-09
of O 0 1.6585859352602483e-09
PCR O 0 8.22393985799863e-07
- O 0 2.612979869809351e-06
amplified O 0 4.0572936086391564e-06
AVP O 0 0.00011795113823609427
- O 0 3.0860785500408383e-06
NPII O 0 0.00010943582310574129
DNA O 0 2.47136836151185e-06
. O 0 4.119121115309099e-07

In O 0 7.578403682373391e-08
one O 0 8.589876365761029e-09
of O 0 6.992050938237071e-09
the O 0 5.032459338139006e-09
families O 0 1.5316550250332739e-09
, O 0 8.580436361427246e-11
affected O 0 1.1273910277553867e-10
individuals O 0 1.0097500093009248e-11
presented O 0 3.058395980914952e-09
a O 0 1.9261596762021327e-09
novel O 0 2.205070970262568e-08
nonsense O 0 7.237544963345499e-08
mutation O 0 1.1943088740196117e-09
in O 0 2.1382944026537842e-10
exon O 0 1.0172752418213804e-08
3 O 0 1.2893401901692414e-09
of O 0 3.165563366991364e-10
the O 0 6.174697975147581e-10
gene O 0 2.1117142756654772e-10
, O 0 4.4880110044998034e-11
consisting O 0 9.940939044161823e-11
in O 0 4.7505121364421754e-11
a O 0 1.0256698823596366e-09
G O 0 1.1040842906595572e-07
to O 0 7.62203367088432e-09
T O 0 1.8340598444410716e-06
transition O 0 1.195509184981347e-06
at O 0 1.2402827209712086e-08
nucleotide O 0 1.6984632367211816e-08
2101 O 0 4.4289851075518527e-07
, O 0 7.171410687512036e-11
which O 0 1.5418066129369024e-11
produces O 0 1.252992987144097e-10
a O 0 7.316052763606251e-10
stop O 0 2.519354724839218e-09
signal O 0 7.487098230285483e-08
in O 0 2.1842989639253574e-09
codon O 0 1.5482392257126776e-08
82 O 0 2.5429838501622726e-07
( O 0 2.3730079234951518e-08
Glu O 0 4.929385977447964e-05
) O 0 1.1026338064823449e-08
of O 0 1.360255623694684e-07
NPII O 1 0.9995742440223694
. O 0 1.5780550484123523e-06

The O 0 1.7162801668746397e-06
premature O 0 3.5572868455346907e-06
termination O 0 1.3008244422962889e-05
eliminates O 0 1.3625073052025982e-06
part O 0 2.5570297879085047e-08
of O 0 1.3952109689796544e-08
the O 0 7.637662946535784e-09
C O 0 9.692496405477868e-07
- O 0 3.664750636289682e-07
terminal O 0 1.5958269727889274e-07
domain O 0 2.6460185154064675e-09
of O 0 1.3005484467143447e-09
NPII O 0 1.7203260540554766e-06
, O 0 1.7821057129996376e-10
including O 0 5.415082618420719e-11
a O 0 7.281805158854127e-10
cysteine O 0 6.332400825925788e-09
residue O 0 1.518024284052899e-08
in O 0 1.1336916821980125e-10
position O 0 3.478709320603457e-09
85 O 0 9.565333414229826e-09
, O 0 1.0499544289555018e-10
which O 0 3.3158541884459325e-11
could O 0 3.177140772692155e-10
be O 0 2.8924995731927083e-10
involved O 0 3.281096783158688e-10
in O 0 1.8300617965483212e-10
the O 0 1.6224223076122257e-09
correct O 0 2.9263638623433508e-08
folding O 0 1.0832023633611243e-07
of O 0 1.783732983540176e-08
the O 0 1.0572586717216836e-07
prohormone O 0 0.01698826253414154
. O 0 1.162995090453478e-06

In O 0 3.069685874379502e-07
the O 0 5.973232930500672e-08
second O 0 3.9812067598177237e-07
family O 0 2.68562843075415e-08
, O 0 6.054552414980208e-10
a O 0 2.220279959885829e-09
G279A O 0 6.124233209447993e-08
substitution O 0 2.916195462887572e-08
at O 0 1.8739054752359152e-08
position O 0 3.726194464093169e-08
- O 0 2.5375952006356783e-08
1 O 0 6.368034544124157e-09
of O 0 1.008082728404247e-09
the O 0 2.749917848987593e-09
signal O 0 3.5686316124383666e-08
peptide O 0 3.4982847729736477e-09
was O 0 1.569407381829535e-09
observed O 0 9.203234702104268e-11
in O 0 1.7513396982637985e-11
all O 0 4.3534238713949236e-11
affected O 0 5.064715313807255e-10
individuals O 0 5.683908343989685e-10
. O 0 9.286971902611185e-08

This O 0 6.171018185341381e-08
missense O 0 2.2961446575209266e-06
mutation O 0 2.480978267271894e-08
, O 0 2.3207258337265557e-09
which O 0 2.3043618124773957e-09
replaces O 0 0.00022902010823599994
Ala O 0 0.0363478921353817
with O 0 9.004895495934306e-09
Thr O 1 0.9265186190605164
, O 0 1.3462313486201083e-09
is O 0 1.5457708724131436e-10
frequent O 0 2.1887613943505357e-09
among O 0 5.211056919307566e-09
FNDI B-Disease 1 1.0
patients O 0 3.8029156712582335e-05
and O 0 1.005636462991788e-08
is O 0 2.904573803697019e-10
thought O 0 7.318565198310978e-10
to O 0 4.4735336962586914e-11
reduce O 0 5.709812622711752e-10
the O 0 1.1508757280509485e-09
efficiency O 0 8.842826915156365e-09
of O 0 8.691193320586876e-10
cleavage O 0 7.440926541590898e-09
by O 0 1.8343708496626476e-10
signal O 0 9.150718938144564e-08
peptidases O 0 7.575446829832799e-07
. O 0 3.894870204135259e-09
. O 0 2.82128667095094e-08

Genetic O 0 9.594528819434345e-06
heterogeneity O 0 1.5043788152979687e-05
of O 0 1.443531164113665e-05
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 2.3608177635026095e-09
due O 0 9.819647317499403e-08
to O 0 3.731327247180616e-09
TWIST O 0 0.0056062787771224976
and O 0 5.941666927355982e-07
FGFR O 1 0.9996579885482788
mutations O 0 3.3733297755134117e-07
. O 0 2.1835758445831743e-07

Thirty O 0 3.091387770837173e-05
- O 0 2.708303782128496e-06
two O 0 2.5122146585232485e-09
unrelated O 0 2.206493121548192e-08
patients O 0 2.0223671626240503e-09
with O 0 4.171303233380108e-11
features O 0 4.890006621849352e-09
of O 0 3.6204835396347335e-07
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 3.098515055643958e-10
a O 0 2.3031346274571263e-10
common O 0 1.1269303001881781e-07
autosomal B-Disease 0 0.001620464725419879
dominant I-Disease 0 0.4202089309692383
condition I-Disease 1 0.696036159992218
of O 0 0.00011684578203130513
craniosynostosis B-Disease 1 1.0
and O 0 2.6283451006747782e-06
limb B-Disease 1 0.9999994039535522
anomalies I-Disease 0 5.9694346418837085e-05
, O 0 1.7264436547037576e-09
were O 0 2.0302979297781576e-09
screened O 0 8.337798007573838e-09
for O 0 2.859433523294541e-10
mutations O 0 1.1812461009341746e-09
in O 0 2.755646377750054e-09
TWIST O 0 0.0006229202845133841
, O 0 3.709147833319548e-08
FGFR2 O 1 0.9259020686149597
, O 0 1.1068502558941873e-08
and O 0 3.793444847133287e-08
FGFR3 O 1 0.9986029267311096
. O 0 1.479231400480785e-06

Nine O 0 1.7808641814553994e-06
novel O 0 4.0904893694460043e-07
and O 0 6.6668999210151014e-09
three O 0 3.5296248146465814e-09
recurrent O 0 1.305993919231696e-06
TWIST O 0 0.0005219140439294279
mutations O 0 2.4800320019835453e-08
were O 0 1.7127272933237236e-09
found O 0 3.742244569782116e-10
in O 0 2.995889092360926e-10
12 O 0 1.4013878946173008e-08
families O 0 8.563294073837824e-09
. O 0 1.2932980553159723e-07

Seven O 0 9.019403819365834e-07
families O 0 1.2957061201746e-08
were O 0 1.4695042960255478e-09
found O 0 6.952921571823367e-10
to O 0 5.073281239553751e-10
have O 0 7.134523527518866e-10
the O 0 2.145224797800438e-08
FGFR3 O 0 0.07323583215475082
P250R O 0 1.251361481990898e-06
mutation O 0 3.1412539236441717e-09
, O 0 1.8292521664076133e-10
and O 0 1.3598774883938347e-10
one O 0 8.452889083132575e-11
individual O 0 5.09851015573215e-11
was O 0 1.579944353125029e-08
found O 0 4.544729315103524e-10
to O 0 7.391358081143551e-10
have O 0 1.2752718880904013e-09
an O 0 1.9707093734666614e-09
FGFR2 O 0 0.0004920064238831401
VV269 O 0 4.07363913836889e-05
- O 0 6.311281140369829e-06
270 O 0 3.9517885852546897e-07
deletion O 0 5.431205636341474e-07
. O 0 1.1672202759882566e-07

To O 0 3.538686144111125e-08
date O 0 4.995499693905003e-07
, O 0 2.292350309573976e-09
our O 0 2.6583311107941654e-09
detection O 0 1.6703370420145802e-07
rate O 0 1.64820745940375e-09
for O 0 1.090285639548938e-10
TWIST O 0 7.681039164708636e-07
or O 0 2.656223863084506e-08
FGFR O 0 0.00015310797607526183
mutations O 0 1.5863207414312797e-09
is O 0 1.26469806849272e-10
68 O 0 2.8355380266020802e-09
% O 0 1.2346640376748041e-10
in O 0 1.1005862193824711e-10
our O 0 1.2753504918805447e-08
Saethre B-Disease 1 0.9995272159576416
- I-Disease 1 0.9585427045822144
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 6.373553418370648e-08
, O 0 2.5116481117137823e-10
including O 0 1.1275092665075093e-10
our O 0 1.3574481982914222e-08
five O 0 4.664964414757833e-09
patients O 0 1.536518023925737e-09
elsewhere O 0 1.0247331871937604e-09
reported O 0 9.237021703079051e-10
with O 0 2.770564888621152e-10
TWIST O 0 3.049780752917286e-05
mutations O 0 2.3645417002171598e-07
. O 0 2.2107926156422764e-07

More O 0 1.1920132436671338e-08
than O 0 8.902578674252482e-10
35 O 0 1.9342223378515655e-09
different O 0 1.8593455941573467e-10
TWIST O 0 7.457659307874565e-07
mutations O 0 1.0889643631273316e-09
are O 0 2.743026812634941e-11
now O 0 2.1076260181551731e-10
known O 0 6.354562986921053e-10
in O 0 9.942020123832052e-11
the O 0 1.1876779559827355e-09
literature O 0 1.3513567154177508e-08
. O 0 3.279861005012208e-08

The O 0 1.4601029079130967e-06
most O 0 1.0577383413590269e-08
common O 0 3.8320749240483565e-08
phenotypic O 0 2.099764060403686e-07
features O 0 3.186524821785497e-09
, O 0 1.2907568069930875e-10
present O 0 4.537245856806038e-10
in O 0 9.65648533357566e-11
more O 0 8.392063953477358e-12
than O 0 6.63818782928316e-12
a O 0 1.0209752487888579e-10
third O 0 2.9281268520975345e-09
of O 0 1.9525259187247457e-09
our O 0 5.60177015884733e-09
patients O 0 3.211564347793683e-10
with O 0 5.746103245996004e-11
TWIST O 0 1.4905273815202236e-07
mutations O 0 6.306651312293354e-10
, O 0 3.9271513124772284e-11
are O 0 3.412267343683162e-11
coronal B-Disease 0 3.133397694909945e-05
synostosis I-Disease 0 0.00013438324094749987
, O 0 3.6339373732374725e-09
brachycephaly B-Disease 0 9.885352483252063e-06
, O 0 5.867023311623143e-09
low B-Disease 0 0.0005407413700595498
frontal I-Disease 1 1.0
hairline I-Disease 1 1.0
, O 0 3.709840967758282e-08
facial B-Disease 0 0.00012491682718973607
asymmetry I-Disease 0 7.764857582515106e-05
, O 0 1.1637030894462441e-08
ptosis B-Disease 1 0.9498719573020935
, O 0 4.9553289471759854e-08
hypertelorism B-Disease 1 0.9999767541885376
, O 0 1.786062426845092e-07
broad B-Disease 1 0.5398246049880981
great I-Disease 1 0.9999998807907104
toes I-Disease 1 0.9999145269393921
, O 0 4.548931187287053e-08
and O 0 1.2329513765507727e-07
clinodactyly B-Disease 0 0.12441783398389816
. O 0 4.6613031372544356e-06

Significant O 0 4.90830507260398e-06
intra O 0 0.0011810038704425097
- O 0 0.0003844954480882734
and O 0 4.823028731948398e-08
interfamilial O 0 1.6751668226788752e-05
phenotypic O 0 5.975717272121983e-07
variability O 0 3.5268612919026054e-07
is O 0 2.1243873327136953e-10
present O 0 3.230486711469638e-10
for O 0 1.3440755453064668e-10
either O 0 3.888620092595829e-09
TWIST O 0 7.53378844819963e-05
mutations O 0 5.1956668301045283e-08
or O 0 3.8951320391333866e-08
FGFR O 0 0.0005950371269136667
mutations O 0 1.2486097489272652e-07
. O 0 5.772399092052183e-08

The O 0 1.4721651098170696e-07
overlap O 0 2.6534843655667828e-08
in O 0 7.520954969919558e-10
clinical O 0 5.819988935229503e-09
features O 0 1.5197325620164293e-09
and O 0 3.3335420535074434e-10
the O 0 3.908464385471433e-10
presence O 0 3.022399552854438e-10
, O 0 5.389425711266327e-11
in O 0 2.0368430900252754e-11
the O 0 5.6405338733078736e-11
same O 0 2.60192423162664e-11
genes O 0 2.9100178863816772e-11
, O 0 5.0665266253246966e-12
of O 0 1.0903771635595305e-10
mutations O 0 1.2400686033586794e-10
for O 0 1.2987728947866373e-10
more O 0 1.4310002835471458e-11
than O 0 3.955620206386179e-11
one O 0 3.423338557073663e-10
craniosynostotic B-Disease 0 1.6035525618462998e-07
condition I-Disease 0 5.3990639514722716e-08
- O 0 3.0818849694469463e-08
such O 0 1.4182173213583837e-09
as O 0 1.0433595321046596e-08
Saethre B-Disease 0 8.092108146229293e-06
- I-Disease 0 2.1119244308920315e-07
Chotzen I-Disease 0 4.8027832235675305e-06
, I-Disease 0 1.1126302101871488e-09
Crouzon I-Disease 0 1.218267971125897e-05
, I-Disease 0 1.834186247329228e-09
and I-Disease 0 5.052483320611145e-09
Pfeiffer I-Disease 1 0.9756850004196167
syndromes I-Disease 1 1.0
- O 1 0.9233296513557434
support O 0 6.840746777925233e-07
the O 0 4.594334157559388e-08
hypothesis O 0 1.857826781304084e-08
that O 0 6.395366874967223e-11
TWIST O 0 2.4664467446200433e-07
and O 0 1.3545919941293505e-09
FGFRs O 0 3.14797944156453e-07
are O 0 2.141003173361522e-11
components O 0 2.6854070078741188e-09
of O 0 8.111132876464922e-10
the O 0 2.49827492027066e-10
same O 0 8.307771831583821e-11
molecular O 0 1.1496207319439122e-09
pathway O 0 4.764616479135952e-10
involved O 0 7.976422473909839e-12
in O 0 2.575281134176155e-12
the O 0 4.763696034859599e-11
modulation O 0 2.8462032730658393e-08
of O 0 9.054842209366143e-09
craniofacial O 1 0.9999998807907104
and O 0 1.3890727359466837e-06
limb O 1 0.9999998807907104
development O 0 1.6701568483767915e-06
in O 0 1.5744262560346556e-09
humans O 0 5.84490766897261e-09
. O 0 1.8227054310315793e-09
. O 0 1.758062673218319e-08

Mutation O 0 7.541820679080047e-08
analysis O 0 1.3264734199935901e-08
of O 0 8.814927099365377e-08
UBE3A O 1 1.0
in O 0 9.826830500969663e-05
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999572038650513
. O 0 1.1610801493588951e-06

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9242514967918396
AS B-Disease 1 1.0
) O 0 4.815619902842627e-08
is O 0 9.301428516295118e-10
caused O 0 1.5098926553491765e-08
by O 0 2.3027888484961068e-09
chromosome O 0 1.5994335456070985e-07
15q11 O 0 1.6543078800168587e-06
- O 0 3.4280864724678395e-07
q13 O 0 4.356836598162772e-07
deletions O 0 1.2335306998068063e-08
of O 0 9.23462584179191e-10
maternal O 0 3.6076390763639665e-09
origin O 0 9.326672767429045e-10
, O 0 9.042958742933038e-11
by O 0 1.411548239405036e-10
paternal O 0 1.2886181139037944e-05
uniparental B-Disease 1 0.9999998807907104
disomy I-Disease 1 0.9999911785125732
( O 0 1.529281803414051e-06
UPD B-Disease 1 1.0
) O 0 2.270845023133461e-08
15 O 0 3.6711109707709966e-09
, O 0 8.185354477552309e-11
by O 0 2.1619983581189217e-10
imprinting O 0 0.00020983064314350486
defects O 1 0.9378396272659302
, O 0 7.956070247061575e-10
and O 0 2.9587557404120446e-10
by O 0 1.790142201141265e-10
mutations O 0 5.937197955496742e-10
in O 0 1.3861203296272606e-09
the O 0 4.617799831407865e-08
UBE3A O 0 0.0007914244779385626
gene O 0 2.26528655389302e-07
. O 0 1.5594129365581466e-07

UBE3A O 0 0.006034669000655413
encodes O 0 3.848655524052447e-06
a O 0 3.6163220329399337e-07
ubiquitin O 0 2.9612485832331004e-06
- O 0 4.57991575331107e-07
protein O 0 8.175283561229207e-09
ligase O 0 8.052855804407955e-08
and O 0 4.726332214488593e-09
shows O 0 7.376602439990165e-09
brain O 0 5.53235111055983e-07
- O 0 6.660636131528008e-08
specific O 0 2.904670992620595e-08
imprinting O 0 1.0906093848461751e-05
. O 0 2.007051449481878e-07

Here O 0 7.839318527658179e-07
we O 0 2.999626147470735e-08
describe O 0 1.7848330458036799e-07
UBE3A O 0 0.0017234078841283917
coding O 0 3.4297718229936436e-05
- O 0 4.351411007519346e-06
region O 0 1.1597235172189357e-08
mutations O 0 1.2131419202532356e-09
detected O 0 1.7564196763686368e-09
by O 0 3.414787203004366e-11
SSCP O 0 1.3251706150185782e-06
analysis O 0 1.6143996139916794e-09
in O 0 4.6517412144453374e-10
13 O 0 1.2680108518736688e-08
AS B-Disease 1 0.9581125974655151
individuals O 0 6.845331940175114e-11
or O 0 4.287806998348742e-09
families O 0 8.431368492267666e-09
. O 0 4.1839467002091624e-08

Two O 0 3.049328824999975e-07
identical O 0 3.9519017036582227e-07
de O 0 7.363008080574218e-06
novo O 0 3.725485294125974e-05
5 O 0 3.107555130554829e-06
- O 0 5.144672741153045e-06
bp O 0 1.913252162921708e-06
duplications O 0 5.021943252359051e-07
in O 0 3.3054323722581103e-09
exon O 0 1.867739882754904e-07
16 O 0 6.5799343751393735e-09
were O 0 1.6898572541279577e-09
found O 0 1.2482568756411183e-08
. O 0 1.2747283051339764e-07

Among O 0 2.2180489622769528e-07
the O 0 1.854215803120951e-08
other O 0 1.5219546734002165e-09
11 O 0 2.0365187314297373e-09
unique O 0 1.1661377419258656e-09
mutations O 0 2.0805153155833978e-09
, O 0 8.734600820403671e-10
8 O 0 1.234340363254205e-08
were O 0 1.9032326825652035e-09
small O 0 1.2462412213309904e-09
deletions O 0 3.113435198542902e-08
or O 0 5.479567466437629e-09
insertions O 0 7.670016799465884e-08
predicted O 0 6.55573444419133e-08
to O 0 1.648657099728723e-09
cause O 0 2.5677093162812525e-07
frameshifts O 1 0.6816049218177795
, O 0 7.379121313988435e-09
1 O 0 2.3822503081305513e-08
was O 0 9.637579623245074e-09
a O 0 2.1068825850623085e-10
mutation O 0 7.629735038205965e-11
to O 0 7.840132709713288e-11
a O 0 6.147904407782789e-10
stop O 0 6.30749286134602e-10
codon O 0 1.4880574550346637e-09
, O 0 5.906633515628812e-10
1 O 0 7.287562109326018e-09
was O 0 5.351306509027154e-09
a O 0 8.005725526949448e-10
missense O 0 1.2217387990176576e-08
mutation O 0 2.995335091071638e-10
, O 0 1.2704012841702195e-10
and O 0 4.649239604415101e-10
1 O 0 3.706361439981265e-08
was O 0 1.1112505404753392e-07
predicted O 0 1.5751298931832025e-08
to O 0 5.216723164558346e-10
cause O 0 1.623574696907326e-08
insertion O 0 3.0792296001891373e-07
of O 0 4.504174100361524e-08
an O 0 7.322502604267811e-10
isoleucine O 0 3.0703034781254246e-07
in O 0 9.587338700711712e-10
the O 0 7.54914264433637e-09
hect O 0 5.224291044214624e-07
domain O 0 4.55411175437348e-09
of O 0 2.1370478719973107e-09
the O 0 4.142636900184016e-09
UBE3A O 0 2.538530679885298e-06
protein O 0 1.12163056620318e-09
, O 0 3.115128988095961e-11
which O 0 1.497043287945754e-11
functions O 0 1.0774046238504198e-10
in O 0 1.800534998874781e-10
E2 O 0 1.7078490088806575e-07
binding O 0 4.4005803445656966e-09
and O 0 1.5465796421310074e-09
ubiquitin O 0 1.686478015017201e-07
transfer O 0 2.928486821929255e-07
. O 0 1.3610393523322273e-07

Eight O 0 1.054099016073451e-06
of O 0 4.464317626684533e-08
the O 0 2.6443836009804045e-09
cases O 0 5.218972476406236e-10
were O 0 7.126988443850735e-10
familial O 0 8.659101524699508e-08
, O 0 1.0631787672465975e-09
and O 0 7.173685534489493e-10
five O 0 1.2469807408876932e-09
were O 0 4.253708496548825e-09
sporadic O 0 1.301701445299841e-06
. O 0 4.2889911355814547e-07

In O 0 9.84346328891661e-08
two O 0 5.3331485894148045e-09
familial O 0 4.4640242435889377e-07
cases O 0 7.325425599447044e-09
and O 0 3.2262152949158462e-09
one O 0 4.905689188205997e-10
sporadic O 0 1.1053164605812071e-08
case O 0 1.3598010717430498e-08
, O 0 7.128457268912314e-10
mosaicism O 0 6.948737791390158e-06
for O 0 6.864217638735681e-09
UBE3A O 0 0.0022478471510112286
mutations O 0 1.3266150844515323e-08
was O 0 9.648927878913582e-09
detected O 0 1.635674262701059e-09
in O 0 4.426815511382465e-11
the O 0 2.863302928091116e-10
mother O 0 2.256311359971619e-09
of O 0 6.580812783596457e-09
three O 0 5.872419439612031e-09
AS B-Disease 1 1.0
sons O 0 0.002540288958698511
, O 0 2.894883777138091e-10
in O 0 8.1819828690044e-11
the O 0 7.203479479578334e-10
maternal O 0 6.151253018060743e-08
grandfather O 0 4.8661995606380515e-06
of O 0 8.942357965224801e-08
two O 0 1.594785636882534e-08
AS B-Disease 1 0.9999998807907104
first O 0 2.2601975402380958e-08
cousins O 0 1.7961518778975005e-06
, O 0 3.0688013241686463e-10
and O 0 3.3244496044915195e-10
in O 0 3.346857513353285e-10
the O 0 3.9460164025229005e-09
mother O 0 1.417550077320584e-08
of O 0 1.2663503135001974e-08
an O 0 2.481104877105622e-09
AS B-Disease 1 1.0
daughter O 0 0.0008998154080472887
. O 0 4.172251010459149e-06

The O 0 1.3257150044410082e-07
frequencies O 0 3.642530188585624e-08
with O 0 1.2593422138440502e-10
which O 0 1.181509057257557e-10
we O 0 9.822406082937718e-11
detected O 0 1.896691692593322e-09
mutations O 0 2.2297257096237644e-10
were O 0 1.0637628555798528e-09
5 O 0 3.342489174329444e-09
( O 0 2.9662711176214884e-10
14 O 0 9.36959065889198e-10
% O 0 2.1343010692120856e-10
) O 0 5.0427353265325436e-11
of O 0 1.9348791457929337e-09
35 O 0 5.861162222231542e-09
in O 0 7.112902628003681e-11
sporadic O 0 3.5053580038635346e-09
cases O 0 6.121623208343863e-10
and O 0 8.643450399858921e-10
8 O 0 8.225066849831819e-09
( O 0 1.2034802321370108e-10
80 O 0 5.752180953777497e-10
% O 0 8.6310736335804e-11
) O 0 4.488541829883452e-11
of O 0 8.887732771967194e-10
10 O 0 1.53694601490173e-09
in O 0 3.4646102653468347e-10
familial O 0 7.926677625391676e-08
cases O 0 1.044175768072364e-08
. O 0 9.938768918971164e-09
. O 0 6.801858631888535e-08

The O 0 7.815490971552208e-05
hemochromatosis B-Disease 1 1.0
845 O 0 9.3775313871447e-05
G O 0 4.460157470020931e-06
- O 0 1.6043188679759623e-06
- O 0 4.303791172333149e-07
> O 0 1.309650343728208e-07
A O 0 4.000322917363519e-08
and O 0 1.1465528526599655e-09
187 O 0 9.909084663917156e-10
C O 0 3.34048948502641e-08
- O 0 5.892427523690458e-08
- O 0 1.0289843288546763e-07
> O 0 5.262269269223907e-07
G O 0 4.2395529931127385e-07
mutations O 0 1.0974968711607858e-09
: O 0 1.0112462256461896e-10
prevalence O 0 4.059195646277658e-09
in O 0 3.362533584905236e-10
non O 0 3.71032236046176e-08
- O 0 3.443400942160224e-07
Caucasian O 0 4.2715819859040494e-07
populations O 0 5.74043781398359e-08
. O 0 1.0291982732724136e-07

Hemochromatosis B-Disease 1 1.0
, O 0 4.1014658336280263e-07
the O 0 1.5955180288074189e-06
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 0 0.12543714046478271
, O 0 7.057327167103722e-09
leads O 0 9.592318939155575e-09
, O 0 1.0998438826348433e-09
if O 0 1.3923505903790101e-08
untreated O 1 0.9999998807907104
, O 0 1.653457282202453e-08
to O 0 1.0480751200248051e-07
progressive O 1 1.0
iron B-Disease 1 1.0
overload I-Disease 1 0.9999992847442627
and O 0 9.537427558825584e-08
premature B-Disease 0 7.695447266087285e-07
death I-Disease 0 2.8929664495080942e-06
. O 0 6.260992222451023e-07

The O 0 1.6544308891752735e-05
hemochromatosis B-Disease 1 1.0
gene O 0 5.383695338423422e-07
, O 0 1.0452279042283408e-08
HFE O 1 0.999968409538269
, O 0 5.164849525840509e-08
recently O 0 3.60043692637646e-08
has O 0 1.7513807071267706e-10
been O 0 9.613299739585912e-11
identified O 0 4.461861435878234e-10
, O 0 3.81282123929072e-11
and O 0 7.932322160231209e-11
characterization O 0 5.2515499504579566e-08
of O 0 2.2860378479094834e-08
this O 0 2.864007642155997e-10
gene O 0 1.3392754683039243e-09
has O 0 4.70610529712534e-11
shown O 0 7.541331274729668e-12
that O 0 2.544326728470825e-12
it O 0 7.730246998072232e-12
contains O 0 1.1644695624424273e-11
two O 0 1.9031727582774494e-11
mutations O 0 1.2576805048791773e-11
that O 0 6.4174798287963686e-12
result O 0 3.7434155775173394e-10
in O 0 3.7565187072097217e-10
amino O 0 3.8970676685678995e-10
acid O 0 1.233421809132551e-09
substitutions O 0 2.8952387154390635e-09
- O 0 6.7821774862864e-09
cDNA O 0 1.212582745324653e-08
nucleotides O 0 1.1549415868117308e-09
845 O 0 6.557683285279836e-09
G O 0 1.0155459584382243e-08
- O 0 2.9086294262015144e-08
- O 0 8.621132252528696e-08
> O 0 1.0110682069353061e-07
A O 0 1.1673693478542191e-07
( O 0 6.809133812346602e-10
C282Y O 0 2.5426825089880367e-08
) O 0 4.1826642843689754e-11
and O 0 8.171751469943089e-11
187 O 0 5.681241588284536e-10
C O 0 2.826392453414428e-08
- O 0 7.873276786085626e-08
- O 0 1.1464139504369086e-07
> O 0 7.594478574901586e-07
G O 0 2.27902546612313e-06
( O 0 2.5059275543526383e-08
H63D O 0 0.00015417950635310262
) O 0 1.695304341353676e-08
. O 0 5.9185932599348234e-08

Although O 0 9.041926386998966e-05
hemochromatosis B-Disease 1 1.0
is O 0 3.8863383622356196e-08
common O 0 3.0523310101671086e-08
in O 0 1.1489346141146939e-09
Caucasians O 0 7.896948517327473e-08
, O 0 4.5099809997672935e-10
affecting O 0 1.3554112276992214e-09
> O 0 1.7118506434599112e-07
= O 0 7.788157319055244e-08
1 O 0 5.106741696181416e-08
/ O 0 2.860832992723772e-08
300 O 0 6.968012972174975e-11
individuals O 0 2.5905287030086876e-12
of O 0 4.619310489673012e-10
northern O 0 3.728823028126271e-09
European O 0 5.528928426201674e-10
origin O 0 9.113957921691451e-10
, O 0 8.906378412554261e-11
it O 0 1.5715475795707867e-11
has O 0 6.232040924980531e-12
not O 0 5.2286916116250914e-12
been O 0 6.630852117384123e-11
recognized O 0 1.5420603682869682e-10
in O 0 8.288066760675505e-11
other O 0 2.346415284293357e-10
populations O 0 4.564451483446419e-09
. O 0 6.250933637375056e-08

The O 0 2.228176754215383e-07
present O 0 1.4809399928594758e-08
study O 0 8.828245356973241e-10
used O 0 9.151688296071825e-10
PCR O 0 1.2581699593283702e-07
and O 0 1.6260531809919598e-09
restriction O 0 4.282723065074379e-09
- O 0 1.0884209089567776e-08
enzyme O 0 3.1717339865622307e-10
digestion O 0 4.156788691034308e-09
to O 0 5.911183348361604e-11
analyze O 0 2.76264428000772e-10
the O 0 3.1076000106544654e-10
frequency O 0 1.9325554490023933e-09
of O 0 8.441614629539629e-10
the O 0 2.6674835673645703e-09
845 O 0 3.1742850126192934e-08
G O 0 4.517992735486587e-08
- O 0 3.989883623489732e-08
- O 0 4.211264226228195e-08
> O 0 3.156438310725207e-08
A O 0 1.1909065733561874e-08
and O 0 6.2536831269e-10
187 O 0 9.70775460018558e-10
C O 0 3.659570779745991e-08
- O 0 9.004865120232353e-08
- O 0 1.4795911340570456e-07
> O 0 3.120278222468187e-07
G O 0 3.2618009981888463e-07
mutations O 0 2.7666744450982605e-09
in O 0 7.613428221198149e-10
HLA O 0 6.34797956422517e-08
- O 0 7.3244055265320185e-09
typed O 0 3.512458990329037e-09
samples O 0 2.8729474355060347e-10
from O 0 2.5279600635030874e-10
non O 0 1.4458396258021367e-08
- O 0 1.4056797681405442e-07
Caucasian O 0 8.845597676554462e-08
populations O 0 1.6201030517137838e-09
, O 0 1.1406062899732561e-10
comprising O 0 8.663582351520205e-11
Australian O 0 2.737525761631332e-09
Aboriginal O 0 4.5878869592286264e-09
, O 0 4.621290849993187e-11
Chinese O 0 5.424120042007985e-10
, O 0 1.5754048066085602e-10
and O 0 3.8837648652645385e-09
Pacific O 0 1.104628381654038e-06
Islanders O 0 1.5555018762825057e-05
. O 0 3.4334982501604827e-07

Results O 0 5.938370009062055e-07
showed O 0 4.724324398353019e-08
that O 0 1.23148491404379e-09
the O 0 1.679956795896942e-08
845 O 0 5.095212713968067e-07
G O 0 1.1336127272443264e-06
- O 0 2.7420376227382803e-06
- O 0 9.065868198376847e-07
> O 0 1.5030919087166694e-07
A O 0 1.0333343070101364e-08
mutation O 0 2.943210120065487e-10
was O 0 4.649984564064624e-10
present O 0 4.3243179870255943e-11
in O 0 8.91172639155835e-12
these O 0 7.339876102741005e-12
populations O 0 3.367577050550352e-11
( O 0 8.74489369806497e-12
allele O 0 7.688256281612738e-11
frequency O 0 5.67504709891864e-10
0 O 0 3.293297856643562e-10
. O 0 1.787916516227117e-11
32 O 0 3.425624506281366e-10
% O 0 4.5737892639952094e-11
) O 0 2.600589708856571e-11
, O 0 2.6920040849254256e-11
and O 0 5.511195319551909e-11
, O 0 3.250609850735664e-11
furthermore O 0 5.699465344122245e-10
, O 0 1.7020417020230383e-10
it O 0 1.2220663370143825e-10
was O 0 1.877318389631455e-08
always O 0 2.105272622898724e-09
seen O 0 1.2501671919906698e-09
in O 0 1.2967134310759576e-10
conjunction O 0 1.3116041586158644e-09
with O 0 5.453747453643132e-10
HLA O 0 9.798141036299057e-06
haplotypes O 0 4.104322215425782e-07
common O 0 7.855906147824498e-08
in O 0 2.8541822238992154e-09
Caucasians O 0 5.2409230733019285e-08
, O 0 1.7101313420919695e-10
suggesting O 0 1.018971906852073e-09
that O 0 1.4906931244951238e-10
845 O 0 6.888485160061464e-08
G O 0 3.520120799294091e-07
- O 0 1.321946911048144e-06
- O 0 3.277805944890133e-06
> O 0 1.6794174371170811e-06
A O 0 1.2330536947047221e-07
may O 0 2.077632288433051e-09
have O 0 6.871966190535872e-11
been O 0 7.503413862464114e-11
introduced O 0 9.827241798099351e-11
into O 0 4.822625979117312e-11
these O 0 5.5882303992560445e-12
populations O 0 8.198197676279051e-11
by O 0 1.586967640632153e-10
Caucasian O 0 7.355236419925859e-08
admixture O 0 1.1827389698737534e-06
. O 0 3.668404815471149e-07

187 O 0 2.1056489458715077e-06
C O 0 1.4055257224754314e-06
- O 0 5.923234311921988e-07
- O 0 1.975867292003386e-07
> O 0 1.9940246431815467e-07
G O 0 1.313984085982156e-07
was O 0 4.974920031486363e-09
present O 0 2.5744339993138965e-10
at O 0 2.0844387327301206e-10
an O 0 1.901452086061628e-12
allele O 0 6.53320661458956e-11
frequency O 0 1.2292273865455172e-09
of O 0 4.509656648110649e-09
2 O 0 1.5864070235238614e-07
. O 0 1.2944617822086002e-07

68 O 0 1.0145382475457154e-05
% O 0 3.58270817457651e-08
in O 0 2.2007926592237936e-09
the O 0 2.0979693537981348e-09
two O 0 8.097869597101237e-10
populations O 0 6.118915374386802e-10
analyzed O 0 3.372581103278094e-09
( O 0 8.288166264414087e-10
Australian O 0 4.637730910417304e-08
Aboriginal O 0 1.1072328476302573e-07
and O 0 2.507480223457037e-09
Chinese O 0 1.2077355115991395e-08
) O 0 3.2551425999116645e-09
. O 0 6.139964625617722e-08

In O 0 8.039548333726998e-07
the O 0 2.0938931299951946e-07
Australian O 0 3.182251191446994e-07
Aboriginal O 0 3.983610241675706e-08
samples O 0 9.939483680554417e-10
, O 0 2.3276136573713302e-10
187 O 0 3.973083639863262e-09
C O 0 2.1493045210263517e-07
- O 0 4.209963151424745e-07
- O 0 9.484019187766535e-07
> O 0 1.5953081629049848e-06
G O 0 9.868405186352902e-07
was O 0 8.328420619818644e-09
found O 0 5.2454554588798885e-11
to O 0 1.171013286338507e-11
be O 0 2.9462977196859086e-11
associated O 0 5.238179889843764e-10
with O 0 9.484575347329383e-10
HLA O 0 0.00018952901882585138
haplotypes O 0 2.8292330966905865e-07
common O 0 2.8631912840637597e-08
in O 0 5.921725887425566e-10
Caucasians O 0 1.8369879839497116e-08
, O 0 4.52166706854662e-11
suggesting O 0 1.0700911684535797e-10
that O 0 8.454173992811231e-12
it O 0 3.475429666277563e-11
was O 0 8.983173094279095e-10
introduced O 0 3.7792574625328257e-10
by O 0 2.8856542155786258e-11
recent O 0 6.349923364901144e-10
admixture O 0 1.6314430695274496e-07
. O 0 1.4814717985700554e-07

In O 0 3.384033675501996e-07
the O 0 8.593813305424192e-08
Chinese O 0 2.8706828913982463e-08
samples O 0 8.485134816993423e-10
analyzed O 0 9.815632751042358e-10
, O 0 5.5352455258228517e-11
187 O 0 7.978073757186621e-10
C O 0 3.606553988788619e-08
- O 0 1.0735210054235722e-07
- O 0 2.2832081469914556e-07
> O 0 3.622473059294862e-07
G O 0 5.750858917963342e-07
was O 0 9.831751413003076e-09
present O 0 1.609292282767072e-10
in O 0 4.714046861198362e-11
association O 0 3.1314041637475754e-11
with O 0 1.4039434545476404e-11
a O 0 5.186008289470578e-10
wide O 0 5.1930779676467864e-09
variety O 0 1.2788233805238747e-09
of O 0 1.1031660029914292e-08
HLA O 0 9.846719876804855e-06
haplotypes O 0 5.328839947082997e-08
, O 0 1.0750337425813328e-10
showing O 0 5.7827378302510724e-11
this O 0 5.841466199640877e-12
mutation O 0 4.653690974243396e-11
to O 0 4.495893241029947e-11
be O 0 6.556925835621286e-11
widespread O 0 7.590001516177836e-09
and O 0 1.16486609247346e-09
likely O 0 2.8685467334810255e-09
to O 0 5.154648374805504e-10
predate O 0 4.732283400699089e-07
the O 0 1.2296007767531592e-08
more O 0 8.078597513172525e-11
genetically O 0 1.0609909617542712e-09
restricted O 0 6.389809237283828e-10
845 O 0 2.3780282631946648e-08
G O 0 1.1588969783815628e-07
- O 0 6.92274284119776e-07
- O 0 1.0591029422357678e-06
> O 0 4.935106403536338e-07
A O 0 1.274843839382811e-07
mutation O 0 2.744778804242287e-08
. O 0 4.382197360541795e-08

Genotype O 0 0.00024403075804002583
- O 0 2.0976052837795578e-05
phenotype O 0 1.0134290278074332e-06
correlations O 0 2.9131052770026145e-07
in O 0 2.9668683509953553e-08
attenuated B-Disease 1 0.9999958276748657
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 0.00010521383956074715

Germ O 0 0.47437524795532227
- O 0 0.0001243705628439784
line O 0 8.08603772384231e-07
mutations O 0 4.893972338493313e-09
of O 0 7.068967189383102e-09
the O 0 9.16556253116596e-09
tumor B-Disease 0 1.3363235211727442e-06
suppressor O 0 3.840713361569215e-06
APC O 0 2.7819259784678252e-08
are O 0 5.059479571412062e-11
implicated O 0 3.4336460341677366e-09
in O 0 1.6306653805031601e-09
attenuated B-Disease 1 0.9927242398262024
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 8.573643754061777e-06
AAPC B-Disease 1 1.0
) O 0 7.97424015708259e-10
, O 0 5.3201890809484453e-11
a O 0 2.2777051078559651e-10
variant O 0 6.240121365408413e-06
of O 0 0.0052498942241072655
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.3032185051997658e-05
FAP B-Disease 0 6.358382961479947e-05
) O 0 2.657561815055942e-08
. O 0 1.4903653777764703e-07

AAPC B-Disease 1 1.0
is O 0 1.2686693651176029e-07
recognized O 0 1.4885380039686424e-08
by O 0 3.388415381611054e-10
the O 0 9.256986843730886e-10
occurrence O 0 5.70463365434648e-09
of O 0 3.734227149720937e-08
< O 0 1.9720148429769324e-06
100 O 0 1.555764050920061e-08
colonic B-Disease 0 1.3970764484838583e-05
adenomas I-Disease 0 1.4907363947713748e-06
and O 0 1.9690062080801596e-10
a O 0 1.4260366498763943e-10
later O 0 3.2302664987327034e-09
onset O 1 0.999476969242096
of O 1 0.9999914169311523
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.325238585536681e-09
age O 0 4.219179450259958e-10
> O 0 6.08075723107504e-09
40 O 0 6.198758728537257e-10
years O 0 4.973466083413314e-10
) O 0 6.132679364334592e-10
. O 0 2.1785002246588192e-08

The O 0 4.977253524884873e-07
aim O 0 1.285964259523098e-07
of O 0 1.592961673679838e-08
this O 0 3.9505329563205294e-10
study O 0 7.116922606797971e-10
was O 0 4.217001414730248e-09
to O 0 3.4955482952625516e-10
assess O 0 7.127647450033692e-08
genotype O 0 9.998749192163814e-06
- O 0 6.275211035244865e-06
phenotype O 0 6.568087087543972e-07
correlations O 0 2.872069160275714e-07
in O 0 2.8179792721516606e-08
AAPC B-Disease 1 1.0
families O 0 2.6135302277907613e-07
. O 0 3.5739725490202545e-07

By O 0 6.388938089685325e-08
protein O 0 1.4491173772057664e-07
- O 0 3.588494337236625e-07
truncation O 0 2.4813627987896325e-06
test O 0 1.800733144818878e-07
( O 0 2.7713868533396635e-08
PTT O 0 6.142541906228871e-07
) O 0 1.4744447329739785e-10
assay O 0 1.27602204358368e-08
, O 0 1.7229394300155576e-10
the O 0 7.574003646482197e-10
entire O 0 8.52628101455366e-09
coding O 0 6.709983324526547e-08
region O 0 4.206445414212112e-09
of O 0 4.985397428214355e-09
the O 0 4.853035306950915e-09
APC B-Disease 0 2.683795230495889e-08
gene O 0 2.284999078838723e-09
was O 0 8.810368434808424e-09
screened O 0 4.076078141679318e-09
in O 0 4.394167668619886e-11
affected O 0 9.879375095778187e-11
individuals O 0 2.952823402457838e-11
from O 0 3.269704862418621e-08
11 O 0 3.7707254705310334e-06
AAPC B-Disease 1 1.0
kindreds O 1 0.9996688365936279
, O 0 1.0421422835804606e-08
and O 0 1.4676806436852985e-09
their O 0 1.3594165793051616e-09
phenotypic O 0 1.1128519616931953e-07
differences O 0 3.948277083054563e-08
were O 0 1.673464566920302e-08
examined O 0 3.03972370829797e-07
. O 0 8.442363252925134e-08

Five O 0 6.53505423997558e-07
novel O 0 4.878448294221016e-07
germ O 0 0.0008081247797235847
- O 0 1.554001573822461e-05
line O 0 7.574341225335957e-07
APC B-Disease 0 6.832193122363606e-08
mutations O 0 4.777319650983713e-10
were O 0 2.991754899372978e-10
identified O 0 2.46927855940271e-09
in O 0 1.424895534896109e-09
seven O 0 5.972206906790234e-08
kindreds O 0 0.00010316878615412861
. O 0 4.2874700056927395e-07

Mutations O 0 4.5910235257906606e-07
were O 0 8.321770650354665e-08
located O 0 1.8231654408396025e-08
in O 0 1.569831764580698e-10
three O 0 1.6471466551815084e-11
different O 0 7.945962464395162e-12
regions O 0 1.6748424869206247e-10
of O 0 3.986686536450179e-09
the O 0 1.0569760178213983e-08
APC B-Disease 0 1.3729620995661662e-08
gene O 0 4.3149608885961754e-10
( O 0 1.4498589828715325e-10
1 O 0 4.056177616007517e-09
) O 0 2.0667818845243602e-10
at O 0 1.1466053662090303e-09
the O 0 1.8518468980488478e-09
5 O 0 5.879928544061386e-09
end O 0 2.5561860184097895e-08
spanning O 0 2.6346683057454356e-08
exons O 0 6.313445055639022e-08
4 O 0 3.541142046259438e-09
and O 0 9.365278691442214e-11
5 O 0 1.2015449746272111e-09
, O 0 1.128118015669699e-10
( O 0 3.874056075936494e-10
2 O 0 2.14612523308233e-08
) O 0 3.6030436967315893e-10
within O 0 2.14359596739655e-09
exon O 0 3.823765837296378e-08
9 O 0 4.9132111712424376e-09
, O 0 5.273755390722279e-11
and O 0 1.930675619377098e-10
( O 0 6.142746866721893e-10
3 O 0 3.440072049443188e-08
) O 0 7.915081923215439e-10
at O 0 4.72871253265339e-09
the O 0 2.9441209470348895e-09
3 O 0 2.7425913984302497e-08
distal O 0 1.2425899740264867e-06
end O 0 7.611307069055329e-07
of O 0 6.561513998804003e-08
the O 0 5.4937185467451854e-08
gene O 0 7.708560190167191e-08
. O 0 6.552183862140737e-08

Variability O 0 1.3079696145723574e-05
in O 0 3.507130363900046e-09
the O 0 1.597445731249536e-09
number O 0 8.405048324000575e-10
of O 0 3.771200226765359e-06
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 1 0.999970555305481
most O 0 1.2942530380755102e-09
apparent O 0 2.7004835700950025e-08
in O 0 2.952451824689284e-11
individuals O 0 2.4153567600854187e-12
with O 0 1.5849401652223705e-11
mutations O 0 5.968581184845334e-10
in O 0 9.150222246567807e-10
region O 0 1.0263811844879456e-07
1 O 0 3.393827910258551e-06
, O 0 2.2730020088346237e-09
and O 0 3.6159764960075336e-08
upper O 1 1.0
- O 1 0.9999912977218628
gastrointestinal O 1 0.979350745677948
manifestations O 0 0.004574863240122795
were O 0 1.609607025443438e-08
more O 0 4.153202781687071e-11
severe O 0 1.0584289356074805e-07
in O 0 1.335347388220498e-09
them O 0 3.5669760478640455e-09
. O 0 1.190227933989263e-07

In O 0 1.2584814967908642e-08
individuals O 0 1.0840814357315764e-10
with O 0 1.0516860299292219e-10
mutations O 0 1.6118304468903943e-09
in O 0 5.694325566629743e-10
either O 0 4.3281844774867295e-09
region O 0 5.3302937175203624e-08
2 O 0 1.448697304340385e-07
or O 0 6.0463158924051186e-09
region O 0 3.81599960519452e-08
3 O 0 5.354943510837984e-08
, O 0 2.0337578843232507e-10
the O 0 3.343131327326887e-10
average O 0 3.7570418998100763e-10
number O 0 1.1269910699107655e-10
of O 0 8.44732017668548e-09
adenomas B-Disease 0 0.004088908899575472
tended O 0 1.0982160603134616e-07
to O 0 1.329730436872012e-09
be O 0 9.64596069685797e-10
lower O 0 4.662600616711643e-08
than O 0 1.7716798514366694e-11
those O 0 1.0226703164861739e-11
in O 0 7.003331508464994e-12
individuals O 0 5.181432539969055e-13
with O 0 2.6334674458478036e-12
mutations O 0 5.97652899392287e-11
in O 0 6.330172497293063e-11
region O 0 3.842715035062838e-09
1 O 0 5.1593751493328455e-08
, O 0 5.4310219516073843e-11
although O 0 2.6815513698430493e-10
age O 0 1.3281309385604345e-09
at O 0 1.3243618424141346e-09
diagnosis O 0 1.2147475558776932e-07
was O 0 4.9550710201629045e-09
similar O 0 5.656182189284209e-09
. O 0 4.273447729019608e-08

In O 0 8.582148325331218e-07
all O 0 7.072738981150906e-07
AAPC B-Disease 1 1.0
kindreds O 0 0.0010067246621474624
, O 0 2.7498302301864896e-08
a O 0 9.595392924666157e-09
predominance O 0 2.803889628921752e-06
of O 0 1.2082435205229558e-05
right O 1 0.9999972581863403
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9997902512550354
rectal B-Disease 1 1.0
polyp I-Disease 1 0.9992528557777405
sparing O 0 1.6293530507027754e-06
was O 0 1.213897604657177e-07
observed O 0 2.156251355245331e-08
. O 0 1.196635679434621e-07

No O 0 9.17224315344356e-05
desmoid B-Disease 1 0.999998927116394
tumors I-Disease 1 1.0
were O 0 4.727235847212796e-08
found O 0 2.2650472608631844e-09
in O 0 9.75906799816073e-10
these O 0 8.657859318361716e-09
kindreds O 0 0.0007175974315032363
. O 0 8.216296123464417e-07

Our O 0 1.38087716550217e-06
data O 0 5.981532780197085e-08
suggest O 0 3.556697381057461e-09
that O 0 2.845288449293548e-10
, O 0 1.9853401145297767e-09
in O 0 8.592138556196005e-09
AAPC B-Disease 1 1.0
families O 0 7.660118939156746e-08
, O 0 4.0071537754649e-10
the O 0 3.1810096223772177e-10
location O 0 3.914352397771381e-09
of O 0 3.733064080080339e-09
the O 0 6.410247888055665e-09
APC B-Disease 0 2.8080674496777647e-07
mutation O 0 6.8829266730574545e-09
may O 0 3.063703069017265e-09
partially O 0 6.206004599107473e-08
predict O 0 5.499859678792518e-09
specific O 0 6.765588533852451e-09
phenotypic O 0 7.136802082641225e-07
expression O 0 9.429820124751132e-08
. O 0 7.237669308324257e-08

This O 0 1.0462395039212424e-07
should O 0 1.6157958526719085e-08
help O 0 6.215632897266232e-09
in O 0 6.77072231614062e-10
the O 0 7.931524326210138e-10
design O 0 2.0516235821332884e-08
of O 0 4.385506180426546e-09
tailored O 0 2.0048052107313197e-08
clinical O 0 1.7716428146741237e-07
- O 0 5.014616704102082e-07
management O 0 6.310119982089191e-09
protocols O 0 9.627918728938312e-08
in O 0 2.8428785367462517e-11
this O 0 4.011791766844741e-12
subset O 0 2.2293174251064585e-10
of O 0 5.567723504462663e-10
FAP B-Disease 0 5.013119448449288e-07
patients O 0 1.284676720558764e-08
. O 0 5.512966971821243e-09
. O 0 6.80645300121796e-08

Wilms B-Disease 1 0.9999992847442627
' I-Disease 0 0.08158960193395615
tumor I-Disease 0 3.313738125143573e-05
1 O 0 7.202579013210197e-07
and O 0 2.9452795757833883e-08
Dax O 0 0.00038381482590921223
- O 0 1.147526859313075e-06
1 O 0 1.8495433096177294e-07
modulate O 0 1.451720521572497e-07
the O 0 4.573604073243587e-08
orphan O 0 6.418864018087334e-07
nuclear O 0 1.8006318214247585e-06
receptor O 0 9.516748633586758e-08
SF O 0 0.0002541680005379021
- O 0 1.6292895566039078e-07
1 O 0 2.446975733150225e-09
in O 0 4.038526457694758e-11
sex O 0 4.590096705503477e-11
- O 0 2.658197828520059e-10
specific O 0 5.618232615245411e-11
gene O 0 1.137187788380345e-09
expression O 0 5.006342451707724e-09
. O 0 1.6601376273683854e-08

Products O 0 2.3469290226785233e-06
of O 0 1.7139689134637592e-06
steroidogenic O 0 0.14555053412914276
factor O 0 9.380207188769418e-07
1 O 0 3.579525582608767e-07
( O 0 5.462735153116682e-09
SF O 0 0.400801420211792
- O 0 1.2420604207363795e-06
1 O 0 7.44293160437337e-08
) O 0 9.610516826796811e-10
and O 0 8.184831479240984e-09
Wilms B-Disease 1 0.9999673366546631
tumor I-Disease 0 1.3095098438498098e-05
1 O 0 2.6998247903975425e-07
( O 0 3.6697040961541916e-09
WT1 O 0 7.695535714447033e-06
) O 0 2.871227422485134e-10
genes O 0 6.56495968698323e-11
are O 0 8.870771305014014e-12
essential O 0 1.6033063765519273e-09
for O 0 6.698226417967135e-10
mammalian O 0 4.822707069251919e-07
gonadogenesis O 0 4.986465569345455e-07
prior O 0 8.754486913176152e-09
to O 0 3.374922008525516e-10
sexual O 0 6.445898259599403e-10
differentiation O 0 1.3668511655851034e-07
. O 0 3.936561654427351e-08

In O 0 7.674596957940594e-08
males O 0 7.567422244392219e-09
, O 0 2.7927503865043946e-08
SF O 1 0.9999997615814209
- O 0 0.0001493646705057472
1 O 0 2.389609505826229e-07
participates O 0 7.802185564287356e-10
in O 0 4.296398653513833e-11
sexual O 0 2.680026166268501e-11
development O 0 1.0721505627753203e-10
by O 0 6.234323821074916e-12
regulating O 0 1.426265217041589e-10
expression O 0 3.1680397194477905e-10
of O 0 2.1185575516113886e-09
the O 0 6.189251777755089e-09
polypeptide O 0 4.885990847469657e-07
hormone O 0 2.2906817775947275e-08
Mullerian O 0 4.991003606846789e-06
inhibiting O 0 1.794215265249477e-08
substance O 0 2.6062295432893734e-08
( O 0 1.3979333246538772e-08
MIS O 0 0.00047369327512569726
) O 0 2.5453221752513855e-08
. O 0 1.2376719382700685e-07

Here O 0 2.757557012955658e-06
, O 0 6.376156136411737e-08
we O 0 7.706968396803404e-09
show O 0 6.107514494146926e-09
that O 0 3.18379100860966e-09
WT1 O 0 0.002044139662757516
- O 0 8.460481330985203e-05
KTS O 0 0.03171893209218979
isoforms O 0 1.5804286022103042e-06
associate O 0 3.709021143549762e-07
and O 0 4.32092583935173e-09
synergize O 0 9.81724838311493e-07
with O 0 1.3077054994425907e-08
SF O 1 1.0
- O 0 9.584798681316897e-05
1 O 0 3.0710035048286954e-07
to O 0 9.734793415816512e-09
promote O 0 1.252642221061251e-07
MIS O 0 0.18765535950660706
expression O 0 1.670904197226264e-07
. O 0 1.1233164798341022e-07

In O 0 1.298110987590917e-07
contrast O 0 4.08056536116419e-07
, O 0 9.878277040797911e-08
WT1 O 0 0.004165195859968662
missense O 0 1.4079785614740103e-05
mutations O 0 3.582502827725875e-08
, O 0 9.092878672234406e-10
associated O 0 2.96751778705584e-09
with O 0 7.246571676056135e-10
male B-Disease 0 2.7789147338808107e-07
pseudohermaphroditism I-Disease 1 1.0
in O 0 4.288111910000225e-08
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 3.829700290225446e-08
fail O 0 3.2282886763823626e-07
to O 0 2.4107315255150752e-08
synergize O 0 5.889629028388299e-05
with O 0 4.427194255640643e-07
SF O 1 1.0
- O 1 0.9465493559837341
1 O 0 5.466966285894159e-06
. O 0 1.4986476060130371e-07

Additionally O 0 7.838571036700159e-07
, O 0 3.108006296770327e-08
the O 0 1.5688454979567723e-08
X O 0 2.0218520148773678e-05
- O 0 1.0373161785537377e-05
linked O 0 1.7401265495209373e-06
, O 0 2.7906295052559926e-09
candidate O 0 9.542246104388141e-09
dosage O 0 5.551885919885535e-07
- O 0 3.772725847284164e-07
sensitive O 0 2.6809053110810055e-07
sex O 0 3.03020519787367e-09
- O 0 1.2903297985644713e-08
reversal O 0 8.709069909684786e-09
gene O 0 1.2746932398499666e-09
, O 0 8.793591965705616e-10
Dax O 0 1.5870526112848893e-05
- O 0 3.3918527719833946e-07
1 O 0 2.2073777472542133e-07
, O 0 2.670283549832675e-09
antagonizes O 0 6.137224772828631e-07
synergy O 0 2.445304971843143e-07
between O 0 2.8766681481329215e-08
SF O 1 0.9945778846740723
- O 0 4.924274890072411e-07
1 O 0 1.6358528753812607e-08
and O 0 1.0739440448048754e-09
WT1 O 0 2.728701292653568e-05
, O 0 5.015036719235866e-10
most O 0 1.5595921776245802e-10
likely O 0 9.42481204191381e-10
through O 0 2.8851437905430544e-10
a O 0 1.443132696676841e-10
direct O 0 2.989524461316506e-10
interaction O 0 2.9958721614598005e-10
with O 0 6.903749238951207e-10
SF O 1 1.0
- O 0 0.00010338092397432774
1 O 0 1.0839066817425191e-06
. O 0 1.4801867109781597e-07

We O 0 2.909162901687523e-07
propose O 0 1.5204791736778134e-07
that O 0 7.708849558696329e-09
WT1 O 0 0.00023605003661941737
and O 0 4.758463774123811e-07
Dax O 1 0.9644569158554077
- O 0 9.471462362853345e-06
1 O 0 1.1185743176156393e-07
functionally O 0 2.0626057306571965e-08
oppose O 0 2.684787281381773e-09
each O 0 7.625224757168425e-11
other O 0 1.9540410955976029e-10
in O 0 5.304011119200425e-10
testis O 0 1.0838823527592467e-07
development O 0 1.8155302816680319e-09
by O 0 4.56699206230482e-10
modulating O 0 5.715358497582201e-07
SF O 1 0.9995600581169128
- O 0 6.737189778505126e-06
1 O 0 3.896547866588662e-07
- O 0 2.87809854171428e-07
mediated O 0 2.1442590423248475e-06
transactivation O 0 3.919399023288861e-05
. O 0 1.6015651027601052e-08
. O 0 5.474994324572435e-08

A O 0 9.98557879938744e-06
mouse O 0 1.2754193221553578e-06
model O 0 2.8333447588124727e-08
for O 0 4.9129980084217095e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 0.9999998807907104
centre O 0 3.290755194029771e-05
mutations O 0 6.47470059789157e-08
. O 0 3.598418274464166e-08

Imprinting O 0 9.041203156812117e-05
in O 0 2.2995996573627053e-07
the O 0 2.037798765286425e-07
15q11 O 0 8.060314030444715e-06
- O 0 1.0996137689289753e-06
q13 O 0 1.4202666989149293e-06
region O 0 1.0937589500770173e-08
involves O 0 2.7966398086221034e-09
an O 0 2.972331270001405e-10
imprinting O 0 2.3604276577771088e-07
centre O 0 1.489613623562036e-07
( O 0 5.526787916210196e-10
IC O 0 2.5566066597093595e-06
) O 0 1.313343878095452e-09
, O 0 1.663533893969671e-10
mapping O 0 4.745825954444172e-09
in O 0 2.704346468984653e-10
part O 0 1.3140956101054257e-09
to O 0 8.057995382060312e-10
the O 0 1.2965640117101884e-08
promoter O 0 1.7005627341859508e-06
and O 0 1.1764103469147358e-08
first O 0 3.309446228172419e-08
exon O 0 5.971945711280569e-07
of O 0 1.866844172582205e-07
SNRPN O 0 0.011375579051673412
. O 0 1.288083126382844e-06

Deletion O 0 1.2111783689761069e-05
of O 0 3.870818261475506e-07
this O 0 6.234749605482648e-09
IC O 0 4.158503725193441e-05
abolishes O 0 1.2959384548594244e-05
local O 0 3.8931414536591546e-08
paternally O 0 1.318928042337575e-07
derived O 0 3.1969227265449263e-09
gene O 0 5.774429823190985e-10
expression O 0 4.69225103216786e-10
and O 0 1.0233928288139182e-10
results O 0 1.7069116953205565e-10
in O 0 1.0699454655593854e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.999997615814209
PWS B-Disease 1 1.0
) O 0 8.434233222942566e-07
. O 0 3.1192161031867727e-07

We O 0 1.4810677839705022e-07
have O 0 2.0804915568106708e-09
created O 0 9.047107951687394e-09
two O 0 1.6548192816046026e-09
deletion O 0 4.9183796591023565e-08
mutations O 0 3.729278219566368e-09
in O 0 4.4213330219200486e-10
mice O 0 9.936305112034916e-09
to O 0 1.4151881888579965e-09
understand O 0 4.4926431996827887e-07
PWS B-Disease 1 1.0
and O 0 5.20333856002253e-07
the O 0 7.091979448148322e-09
mechanism O 0 1.3203748316925612e-08
of O 0 1.6492263110734484e-09
this O 0 9.578529081011311e-10
IC O 0 3.6166791687719524e-05
. O 0 2.030202637115508e-07

Mice O 0 1.4015333363204263e-05
harbouring O 0 4.587843068293296e-05
an O 0 3.0087480951124235e-08
intragenic O 0 2.58871750702383e-05
deletion O 0 1.3442520412354497e-06
in O 0 7.334961082960945e-09
Snrpn O 0 2.5488221581326798e-05
are O 0 1.196023058369633e-09
phenotypically O 0 1.142104792961618e-05
normal O 0 2.4819438948497918e-08
, O 0 1.8350111707921002e-10
suggesting O 0 4.0256542543914975e-10
that O 0 1.550932299254626e-11
mutations O 0 8.416598529237262e-10
of O 0 1.939099014691692e-08
SNRPN O 1 0.8125143051147461
are O 0 1.0925547966333937e-10
not O 0 6.796440493728184e-11
sufficient O 0 1.6335455654825637e-08
to O 0 4.021926347519411e-09
induce O 0 9.939842129824683e-06
PWS B-Disease 1 1.0
. O 0 7.79942492954433e-05

Mice O 0 4.206097401038278e-06
with O 0 6.351197789911112e-09
a O 0 1.3004152421558501e-08
larger O 0 2.1565968566505944e-08
deletion O 0 9.398844724728406e-08
involving O 0 4.366375705444625e-09
both O 0 1.2326364373649312e-09
Snrpn O 0 3.4491238238842925e-06
and O 0 2.362051665372178e-09
the O 0 2.0027144387313456e-08
putative O 0 0.0004139965458307415
PWS O 1 1.0
- O 1 0.9522237181663513
IC O 0 0.012474188581109047
lack O 0 3.97011262975866e-07
expression O 0 6.375837191541223e-09
of O 0 2.503719009894212e-09
the O 0 1.512119651714272e-09
imprinted O 0 7.217773045908871e-09
genes O 0 2.2889554696092773e-09
Zfp127 O 0 1.285173880205548e-06
( O 0 4.886417048766134e-09
mouse O 0 1.9983461641004396e-07
homologue O 0 5.192890512262238e-06
of O 0 1.8121619405064848e-07
ZNF127 O 0 0.09319117665290833
) O 0 1.0990769183649718e-08
, O 0 3.1840825531759265e-09
Ndn O 0 3.825524345302256e-06
and O 0 4.497012540127798e-09
Ipw O 0 5.945010457253375e-07
, O 0 1.0189583621311726e-09
and O 0 1.8358618791847192e-10
manifest O 0 3.925994196407601e-09
several O 0 6.748623326835457e-10
phenotypes O 0 4.6922021823547766e-08
common O 0 1.6319737028425152e-07
to O 0 1.9579105980938039e-07
PWS B-Disease 1 1.0
infants O 1 0.9999994039535522
. O 0 9.421363756700885e-06

These O 0 3.9949931363025826e-08
data O 0 2.689585798520966e-08
demonstrate O 0 4.624655325358162e-09
that O 0 1.1290349904991004e-10
both O 0 3.516492375066349e-10
the O 0 1.8787502664707745e-09
position O 0 1.1329752247490887e-08
of O 0 4.537265674287028e-09
the O 0 3.065860010309507e-09
IC O 0 3.924607426597504e-06
and O 0 4.879392445644726e-10
its O 0 1.2866370469044597e-10
role O 0 4.88027673828384e-10
in O 0 3.1139649886435805e-11
the O 0 8.498120263045195e-11
coordinate O 0 1.753871076148883e-10
expression O 0 5.067053998608628e-10
of O 0 9.88744863761326e-10
genes O 0 1.277511013642041e-10
is O 0 3.648907911935062e-11
conserved O 0 3.150336380652874e-10
between O 0 4.739690306898581e-10
mouse O 0 3.534625392376256e-08
and O 0 1.9186165156614976e-10
human O 0 1.395798587822128e-09
, O 0 1.1536421123947704e-10
and O 0 1.6923433487914252e-10
indicate O 0 3.6585132145994237e-10
that O 0 1.9670282069839118e-10
the O 0 9.939868483854752e-09
mouse O 0 7.796569434503908e-08
is O 0 8.116977923133817e-11
a O 0 2.0342622031321866e-10
suitable O 0 8.351199731748693e-09
model O 0 2.0129502509291797e-09
system O 0 1.0925517379689609e-08
in O 0 2.1910744052444642e-10
which O 0 4.13051363945538e-11
to O 0 1.0581751447302779e-10
investigate O 0 7.125900980398114e-10
the O 0 2.8007596242218824e-10
molecular O 0 1.0047042087180102e-09
mechanisms O 0 7.632537268875694e-09
of O 0 3.594753383850957e-09
imprinting O 0 1.359764070230085e-07
in O 0 1.0682681128582061e-10
this O 0 3.1543032075198596e-11
region O 0 6.965664156588502e-10
of O 0 1.056370879659596e-09
the O 0 4.410770637619521e-10
genome O 0 1.0110288162223924e-09
. O 0 5.145493475744445e-10
. O 0 2.430839529665718e-08

Mutations O 0 3.020190320057736e-07
of O 0 1.7878977587315603e-07
the O 0 4.132947495349981e-08
ATM O 0 1.5573782548017334e-06
gene O 0 8.720272504092463e-09
detected O 0 1.5663488284189953e-08
in O 0 1.7687710185398942e-09
Japanese O 0 0.0005270196124911308
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999997615814209
: O 0 4.3576235952969e-09
possible O 0 6.6844965118662e-09
preponderance O 0 5.994238108542049e-06
of O 0 1.9670563844442768e-08
the O 0 3.5857008473527685e-09
two O 0 1.2004272020860185e-09
founder O 0 3.4923738212455646e-07
mutations O 0 4.86320939074858e-09
4612del165 O 0 9.413356565346476e-07
and O 0 3.551831539994055e-08
7883del5 O 0 1.2469867215259e-05
. O 0 3.8977785266069986e-07

The O 0 2.1277649011608446e-06
ATM O 0 1.6646148651489057e-05
( O 0 1.1766856289341376e-07
A O 1 0.9999986886978149
- O 1 0.9999655485153198
T O 1 0.9999998807907104
, O 0 6.615434422485578e-09
mutated O 0 9.099788478295068e-09
) O 0 2.9112406929598933e-10
gene O 0 7.961352133101229e-10
on O 0 2.606675542082826e-09
human O 0 1.7326620138646831e-09
chromosome O 0 3.772915846411706e-08
11q22 O 0 2.6391053324914537e-06
. O 0 8.917933058683047e-08

3 O 0 1.6593372492934577e-05
has O 0 2.081572070267157e-08
recently O 0 5.763165500383138e-09
been O 0 2.805116694482024e-10
identified O 0 5.6094873190915e-10
as O 0 1.4682202675864175e-10
the O 0 2.0308042747441135e-10
gene O 0 2.1350667067654427e-10
responsible O 0 1.5113056639481925e-10
for O 0 4.206473364076757e-11
the O 0 9.770559916688626e-10
human O 0 1.844614061496941e-08
recessive B-Disease 0 0.007087161298841238
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.6878333687782288
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.482511891026661e-07
. O 0 1.68710528214433e-07

In O 0 1.65172110655476e-07
order O 0 8.283858932145449e-08
to O 0 1.8992221129110476e-09
define O 0 7.0685626241129285e-09
the O 0 9.840094294943924e-10
types O 0 6.892319603934993e-09
of O 0 3.325556363620308e-08
disease O 0 5.546253305510618e-05
- O 0 7.904376388978562e-07
causing O 0 6.876381775100526e-08
ATM O 0 5.840776111654122e-07
mutations O 0 1.0759615420852242e-09
in O 0 2.3129824444634295e-10
Japanese O 0 1.4426160532821086e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 3.7747520309494575e-06
as O 0 5.300150540676896e-09
well O 0 3.7632166827172853e-10
as O 0 2.646017016605384e-10
to O 0 1.2450836195387893e-10
look O 0 5.626503707389929e-10
for O 0 3.109989488159215e-10
possible O 0 4.126645691826525e-08
mutational O 0 7.26336074876599e-05
hotspots O 0 7.261465384544863e-07
, O 0 4.207695303293235e-10
reverse O 0 3.39844929975186e-09
- O 0 3.789667690767828e-09
transcribed O 0 1.2656856673842753e-09
RNA O 0 2.165829515732298e-09
derived O 0 1.3192709424902915e-10
from O 0 1.0169056569031554e-10
ten O 0 4.090305316672982e-10
patients O 0 1.7722620593296767e-10
belonging O 0 1.2469284493832333e-09
to O 0 9.469246498028383e-10
eight O 0 2.1366359792551748e-09
unrelated O 0 6.744254221757728e-08
Japanese O 0 0.00013173687329981476
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 1.6221260779047952e-08
was O 0 6.816700981460144e-09
analyzed O 0 1.1058045451539655e-10
for O 0 9.72939610821566e-12
mutations O 0 4.496725214409025e-11
by O 0 3.326185854524155e-11
the O 0 1.336779464899962e-09
restriction O 0 1.156666140644802e-08
endonuclease O 0 2.0207993145504588e-07
fingerprinting O 0 1.8576141513904076e-08
method O 0 3.068915788162485e-08
. O 0 1.963611495625628e-08

As O 0 1.1273833706582082e-06
has O 0 7.009208324859628e-09
been O 0 7.19964754480884e-10
reported O 0 2.3548621386204616e-10
by O 0 2.765616381739111e-11
others O 0 5.507099776203006e-10
, O 0 1.251559827997184e-10
mutations O 0 1.7143052255530478e-10
that O 0 1.2681740380049433e-10
lead O 0 1.1329839288976018e-08
to O 0 2.189888936854345e-09
exon O 0 2.5673614345578244e-07
skipping O 0 6.6558967226626464e-09
or O 0 2.116036512678221e-10
premature O 0 2.3806683291383024e-09
protein O 0 3.696248307427652e-10
truncation O 0 5.125458102384073e-08
were O 0 2.910964358449064e-09
also O 0 3.5706707035565444e-10
predominant O 0 1.5045476686736947e-07
in O 0 2.7383562084537516e-09
our O 0 7.94376546764397e-08
mutants O 0 1.084661448658153e-06
. O 0 8.439626242306986e-08

Six O 0 7.909807209216524e-08
different O 0 9.083881979954356e-10
mutations O 0 9.331049266592117e-10
were O 0 4.2416511969456394e-10
identified O 0 6.462200108359184e-09
on O 0 5.849569717497616e-09
12 O 0 3.0514910598355982e-09
of O 0 3.525870040377299e-09
the O 0 2.24390088732207e-08
16 O 0 4.048844459703105e-08
alleles O 0 2.9295806669438207e-08
examined O 0 3.5894183270102076e-07
. O 0 1.9763648140269652e-07

Four O 0 4.359554850452696e-07
were O 0 1.0731910471406536e-08
deletions O 0 1.296987477417133e-07
involving O 0 1.2165022766907896e-08
a O 0 1.0202404254755493e-08
loss O 0 7.900323595322334e-08
of O 0 5.548714625547291e-07
a O 0 1.4725414132499282e-07
single O 0 3.70462274190686e-08
exon O 0 1.206628468253257e-07
exon O 0 5.419306248199973e-08
7 O 0 1.488231404778162e-08
, O 0 4.457166302707094e-10
exon O 0 3.709685358899151e-08
16 O 0 1.0241905101793236e-08
, O 0 1.5122234575670745e-09
exon O 0 5.192670187170734e-07
33 O 0 9.618576513048538e-08
or O 0 2.2092640605819724e-08
exon O 0 3.6316780551715055e-06
35 O 0 6.787614665881847e-07
. O 0 2.451565137562284e-07

The O 0 9.836553545028437e-07
others O 0 8.91522944357348e-08
were O 0 2.506864404949738e-08
minute O 0 3.1574444392390433e-07
deletions O 0 2.1849091069725546e-07
, O 0 5.6365170308936285e-09
4649delA O 0 3.1785720011612284e-07
in O 0 4.828236033205258e-09
exon O 0 6.53857000543212e-07
33 O 0 9.307772330657826e-08
and O 0 5.0417785502077095e-09
7883del5 O 0 1.3584605085270596e-06
in O 0 1.9851364996270604e-08
exon O 0 2.8566264518303797e-06
55 O 0 4.394551922359824e-07
. O 0 1.315127349243994e-07

The O 0 1.0088305089084315e-06
mutations O 0 1.887355551843939e-07
4612del165 O 0 1.4292547803052003e-06
and O 0 1.1566265278872834e-08
7883del5 O 0 3.8184538198038354e-07
were O 0 2.8176390109990734e-09
found O 0 2.758905603972295e-10
in O 0 2.6186925891624746e-11
more O 0 2.6689859090184287e-12
than O 0 7.55941836905194e-12
two O 0 1.7074645516923503e-11
unrelated O 0 3.113028168577614e-10
families O 0 4.673010242650655e-11
; O 0 5.4393049092604784e-11
44 O 0 1.0826519680762203e-09
% O 0 6.092584214911767e-10
( O 0 4.895314154040875e-10
7 O 0 1.1505931318822604e-08
of O 0 1.3308144808377165e-08
16 O 0 1.3966861445169343e-08
) O 0 2.8281263442231364e-10
of O 0 2.3317294761682206e-09
the O 0 2.2732273841086226e-09
mutant O 0 1.352671086252144e-09
alleles O 0 5.434120167735479e-11
had O 0 2.597205228660471e-10
one O 0 2.684835513633299e-11
of O 0 4.69918326473362e-10
the O 0 2.007792598845981e-09
two O 0 1.6211354481043827e-09
mutations O 0 1.9941078122087674e-08
. O 0 1.6540698766220885e-07

The O 0 3.06219976664579e-06
4612del165 O 0 1.3842149201082066e-05
mutations O 0 3.9300495302541094e-08
in O 0 1.0451596255123263e-09
three O 0 1.7008863761880377e-10
different O 0 3.271633658430417e-11
families O 0 3.105212198484253e-10
were O 0 2.5053134566910273e-10
all O 0 8.037208398814499e-11
ascribed O 0 1.3981066970814027e-08
to O 0 8.490218528223181e-10
the O 0 3.4432345863422142e-09
same O 0 3.768282574867499e-09
T O 0 1.309872743604501e-07
- O 0 1.4621775790146785e-07
- O 0 6.848554079397218e-08
> O 0 4.0170526460769906e-08
A O 0 6.503896532450426e-09
substitution O 0 8.944981644276595e-09
at O 0 2.0781911747036474e-09
the O 0 2.8594770995482577e-10
splice O 0 1.1938088562146731e-07
donor O 0 3.1584121984451485e-09
site O 0 5.011023596068753e-09
in O 0 4.0155317959644776e-10
intron O 0 4.210255156067433e-06
33 O 0 1.2847621064793202e-06
. O 0 2.598224284611206e-07

Microsatellite O 0 0.0011314679868519306
genotyping O 0 6.461389421019703e-05
around O 0 2.4479431814938835e-08
the O 0 1.7264378371351086e-08
ATM O 0 1.5739369700895622e-06
locus O 0 3.99662418715252e-08
also O 0 6.179561029551195e-11
indicated O 0 7.492401837838614e-11
that O 0 2.7112593854045075e-12
a O 0 7.381520394922347e-11
common O 0 2.2020103518372025e-09
haplotype O 0 1.4982531411078526e-06
was O 0 1.7680568120681528e-08
shared O 0 4.0064582207399724e-10
by O 0 1.9936862924452292e-11
the O 0 5.325237473208233e-10
mutant O 0 1.9654613492292583e-09
alleles O 0 3.3854305470093493e-10
in O 0 1.9904197734454954e-10
both O 0 2.1235457836610294e-09
mutations O 0 4.622805249709927e-08
. O 0 2.33077969369333e-07

This O 0 9.239423448548223e-09
suggests O 0 4.8195136770345925e-09
that O 0 1.8894358300158842e-11
these O 0 3.299206047246983e-11
two O 0 3.289455929866847e-10
founder O 0 6.672200356661051e-07
mutations O 0 1.5065290126514697e-09
may O 0 2.1411481476718563e-09
be O 0 8.394602235561877e-10
predominant O 0 3.7175627198848815e-07
among O 0 1.0059294508479866e-09
Japanese O 0 9.194807404355743e-08
ATM O 0 7.344735308834061e-07
mutant O 0 8.697503517396399e-08
alleles O 0 1.106033487019431e-08
. O 0 3.668131043355061e-08

W474C O 0 1.7854430552688427e-05
amino O 0 9.592852734385815e-08
acid O 0 2.3098634116536232e-08
substitution O 0 1.0387329218985997e-08
affects O 0 1.4985046536963864e-09
early O 0 2.9066922202503065e-09
processing O 0 2.614173988391144e-09
of O 0 8.789282635035534e-10
the O 0 1.4162899741876345e-09
alpha O 0 1.800597893009126e-09
- O 0 6.077345293675762e-10
subunit O 0 7.172919480602502e-10
of O 0 7.323746054055391e-10
beta O 0 1.0635626601640524e-08
- O 0 4.189800506537722e-08
hexosaminidase O 0 8.660852302000421e-08
A O 0 4.017142618550906e-09
and O 0 1.5188654500786214e-10
is O 0 2.0194738242773624e-11
associated O 0 4.519341290087908e-10
with O 0 1.4365532097215805e-09
subacute O 1 0.9999959468841553
G B-Disease 1 0.8691427707672119
( I-Disease 0 2.300503325614045e-07
M2 I-Disease 0 5.0372094847261906e-05
) I-Disease 0 4.019313593062179e-08
gangliosidosis I-Disease 0 2.9203058147686534e-05
. O 0 4.732707736820885e-07

Mutations O 0 9.353470886708237e-07
in O 0 5.371904876483313e-08
the O 0 6.356193438250557e-08
HEXA O 0 3.796549572143704e-05
gene O 0 6.1901603842784425e-09
, O 0 3.5800404307728684e-10
encoding O 0 4.8872181857007035e-09
the O 0 7.513746957954481e-09
alpha O 0 6.152822251692669e-09
- O 0 3.6931917524185565e-09
subunit O 0 2.0934243227799243e-09
of O 0 3.826113204041803e-09
beta O 0 1.9008719931434825e-08
- O 0 7.865996565215028e-08
hexosaminidase O 0 5.034766559219861e-07
A O 0 8.14077480981723e-08
( O 0 1.9822903318811314e-09
Hex O 0 1.0949678852512079e-07
A O 0 1.2803029747487926e-08
) O 0 1.1047926462559587e-10
, O 0 4.736705472296876e-11
that O 0 6.851549189113015e-11
abolish O 0 7.743720686903544e-08
Hex O 0 4.5945185433993174e-07
A O 0 2.738352122833021e-08
enzyme O 0 7.60843832381397e-09
activity O 0 1.8791230793624436e-09
cause O 0 6.9481679929594975e-06
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 0.9999996423721313
( O 0 8.76301058383433e-08
TSD B-Disease 1 0.9999023675918579
) O 0 3.018040484192852e-09
, O 0 1.9425620834123691e-10
the O 0 8.221518466022815e-10
fatal O 0 9.628689667806611e-08
infantile B-Disease 0 2.0521289911812346e-07
form I-Disease 0 5.060092345132716e-09
of I-Disease 0 3.618153527895629e-07
G I-Disease 0 5.9776434682135005e-06
( I-Disease 0 7.55539364405422e-09
M2 I-Disease 0 8.427415423284401e-07
) I-Disease 0 2.346344896153596e-09
gangliosidosis I-Disease 0 2.384655886089604e-07
, I-Disease 0 4.3922340764446233e-10
Type I-Disease 0 5.498949917637219e-08
1 I-Disease 0 5.847754209753475e-07
. O 0 9.67085753700303e-08

Less O 0 1.0494037496755482e-06
severe O 0 0.0007834220305085182
, O 0 1.403523128828965e-07
subacute O 1 1.0
( O 0 9.238031566383142e-07
juvenile O 0 0.09272647649049759
- O 0 1.5784458810230717e-05
onset O 1 1.0
) O 0 1.1547113842880208e-07
and O 0 5.926274582179758e-08
chronic O 1 0.9999996423721313
( O 0 1.3288538269762284e-08
adult O 0 6.134322205753051e-08
- O 0 2.43912126052237e-07
onset O 0 0.00016192607290577143
) O 0 3.2609945299633125e-10
variants O 0 1.567005525338061e-09
are O 0 2.796411756669781e-12
characterized O 0 7.555574221829175e-11
by O 0 1.0296733951586923e-11
a O 0 1.4211194721003295e-10
broad O 0 5.389760193708071e-09
spectrum O 0 6.94455124516935e-08
of O 0 9.627468822159813e-10
clinical O 0 4.774716622080177e-09
manifestations O 0 9.091291275353797e-08
and O 0 1.4754068800026943e-10
are O 0 1.3439869876730182e-12
associated O 0 2.2093113796750607e-11
with O 0 1.1366661084588614e-11
residual O 0 1.5361884209141863e-07
levels O 0 1.3615191640781177e-08
of O 0 1.583202191568489e-08
Hex O 0 3.530249728100898e-07
A O 0 2.662828713084764e-08
enzyme O 0 5.807790692813342e-09
activity O 0 2.0435695358145267e-09
. O 0 8.374215987316802e-09

We O 0 2.62908201875689e-07
identified O 0 1.1900599616865293e-07
a O 0 7.002596902339064e-08
1422 O 0 3.433315941947512e-05
G O 0 5.465767117129872e-06
- O 0 3.552818270691205e-06
- O 0 8.797020427664393e-07
> O 0 1.772923923226699e-07
C O 0 1.795653616909476e-07
( O 0 2.5887678112290757e-10
amino O 0 1.1050624304509427e-10
acid O 0 4.6445955415030937e-10
W474C O 0 2.287445344251182e-09
) O 0 3.6074888735970756e-12
substitution O 0 1.7835066756788365e-10
in O 0 5.792540058724427e-11
the O 0 4.5254050506926546e-10
first O 0 9.401939227160483e-10
position O 0 4.434476785775132e-09
of O 0 8.158242081890421e-09
exon O 0 1.371456477272659e-07
13 O 0 7.346637964644742e-09
of O 0 8.391788597350569e-09
HEXA O 0 0.00021855960949324071
of O 0 7.385869338349949e-08
a O 0 2.338786053712738e-08
non O 0 1.3439594681585731e-07
- O 0 3.618574453412293e-07
Jewish O 0 8.96266101335641e-08
proband O 0 6.616662176384125e-06
who O 0 4.926226093715513e-09
manifested O 0 2.147910826977295e-08
a O 0 6.917289407937233e-09
subacute O 0 0.0001980515953619033
variant O 0 0.0001131624958361499
of O 0 0.0003624773817136884
G B-Disease 0 0.009251699782907963
( I-Disease 0 8.01216373247371e-08
M2 I-Disease 0 8.58521343616303e-06
) I-Disease 0 1.715788755518588e-08
gangliosidosis I-Disease 0 6.438681793952128e-06
. O 0 1.5801316521901754e-07

On O 0 2.6516586331126746e-06
the O 0 4.103154793710928e-08
second O 0 5.073305686664753e-08
maternally O 0 3.432620587773272e-07
inherited O 0 1.0171529538638424e-06
allele O 0 6.576499345101183e-08
, O 0 7.9339301795045e-10
we O 0 1.1292158874631752e-10
identified O 0 9.502393316651592e-10
the O 0 7.20419390809468e-10
common O 0 3.1090650054466096e-07
infantile O 1 0.9954805374145508
disease O 1 0.9568578004837036
- O 0 3.1136246434471104e-06
causing O 0 2.1155831575470074e-07
4 O 0 3.007532143328717e-07
- O 0 1.2345491029464029e-07
bp O 0 9.392196886892634e-08
insertion O 0 2.9572751358841742e-08
, O 0 1.1048016945736094e-09
+ O 0 1.634835911090704e-08
TATC O 0 1.7924996427609585e-05
1278 O 0 1.8749136870610528e-05
, O 0 2.3821491446085474e-09
in O 0 1.8931676226685568e-09
exon O 0 1.4921786259947112e-06
11 O 0 1.778488609716078e-07
. O 0 2.120095103919084e-07

Pulse O 0 9.673534077592194e-05
- O 0 5.6379244597337674e-06
chase O 0 5.6487461819187956e-08
analysis O 0 1.0167199304689234e-09
using O 0 1.5870167402454172e-09
proband O 0 6.252048478927463e-07
fibroblasts O 0 6.097460669707289e-08
revealed O 0 1.9152508912156918e-08
that O 0 9.079945129109035e-11
the O 0 1.394869664217424e-09
W474C O 0 4.971214195848006e-08
- O 0 5.5927174003045366e-09
containing O 0 1.3136395304869097e-09
alpha O 0 6.273912944720905e-09
- O 0 3.6145404447296414e-09
subunit O 0 2.1635091496108316e-09
precursor O 0 5.0405284390819816e-09
was O 0 7.372434884800327e-10
normally O 0 3.738005391329402e-11
synthesized O 0 6.741959213130144e-10
, O 0 1.990631444404034e-11
but O 0 1.4810621479233177e-11
not O 0 1.9846943533075034e-11
phosphorylated O 0 7.201848895022067e-09
or O 0 8.21208379075955e-10
secreted O 0 5.452790996507417e-10
, O 0 1.2980794217298808e-10
and O 0 5.549868897780641e-10
the O 0 7.202562990471506e-09
mature O 0 1.72315797186684e-08
lysosomal O 0 2.3457205315935425e-06
alpha O 0 6.768159011016905e-08
- O 0 1.924280645937415e-08
subunit O 0 3.760406208641598e-09
was O 0 4.076093684801663e-09
not O 0 3.477075849467326e-10
detected O 0 3.994817987518218e-08
. O 0 1.9763453096288686e-08

When O 0 1.0933792964351596e-06
the O 0 3.2993466447805986e-07
W474C O 0 9.97021174953261e-07
- O 0 9.964549718688431e-08
containing O 0 5.868992847268828e-09
alpha O 0 2.837416879231114e-08
- O 0 2.017975297974317e-08
subunit O 0 1.7075452163339833e-08
was O 0 2.0911706144488562e-08
transiently O 0 3.491513922426748e-08
co O 0 1.1304001290568522e-08
- O 0 2.8589985934246442e-09
expressed O 0 2.6798027685792647e-10
with O 0 7.884099623156615e-11
the O 0 1.6812220504647257e-09
beta O 0 4.265505726408492e-09
- O 0 6.320623580080564e-09
subunit O 0 2.2154575951560673e-09
to O 0 2.765122020242927e-10
produce O 0 3.730196151963128e-09
Hex O 0 7.004486519690545e-07
A O 0 2.2253821896356385e-07
( O 0 4.114917295794385e-09
alphabeta O 0 6.026170353834459e-07
) O 0 8.737283674342677e-10
in O 0 1.2843869301448763e-09
COS O 0 2.5945053494069725e-05
- O 0 4.161686604220449e-07
7 O 0 1.9507103488081157e-08
cells O 0 6.669542140791407e-10
, O 0 7.254229161812731e-11
the O 0 3.754262456467927e-10
mature O 0 1.057838705520453e-09
alpha O 0 6.869194990599681e-09
- O 0 1.7665459095539404e-09
subunit O 0 1.2001845073328354e-09
was O 0 1.5639389783217439e-09
present O 0 1.3955396560572098e-10
, O 0 7.890026132439942e-11
but O 0 4.024454727802329e-11
its O 0 1.5595712221649904e-10
level O 0 6.46176845364721e-09
was O 0 5.870336217128624e-09
much O 0 5.520645607326458e-10
lower O 0 2.972105894727406e-09
than O 0 2.133608047183433e-11
that O 0 4.358531330989068e-12
from O 0 8.673899792865924e-11
normal O 0 1.4319847529975505e-09
alpha O 0 8.628711967162417e-09
- O 0 5.5670681398112265e-09
subunit O 0 3.1391695909377404e-09
transfections O 0 8.030922060697776e-08
, O 0 9.461966626878038e-11
although O 0 1.0362228436422427e-10
higher O 0 1.6308301376000145e-09
than O 0 3.080857791104563e-11
in O 0 6.141806507820036e-11
those O 0 3.7965228183445276e-11
cells O 0 6.813941078043229e-10
transfected O 0 3.748585086782441e-08
with O 0 4.0918088362040805e-11
an O 0 4.5443801499622793e-11
alpha O 0 3.0913738235938126e-09
- O 0 3.233249890044476e-09
subunit O 0 1.9632246939238485e-09
associated O 0 1.590010234586714e-09
with O 0 4.509647766326452e-09
infantile O 0 0.0002203070471296087
TSD B-Disease 1 0.7149906754493713
. O 0 2.410562728982768e-06

Furthermore O 0 1.133360910898773e-06
, O 0 1.1303051827837862e-08
the O 0 4.919578078244058e-09
precursor O 0 1.6990570372854563e-07
level O 0 3.244853985506779e-08
of O 0 9.006578594039638e-09
the O 0 6.609329528117769e-09
W474C O 0 1.7141064745374024e-07
alpha O 0 1.0779505288383007e-08
- O 0 5.530966795674885e-09
subunit O 0 2.5475939136043735e-09
was O 0 8.761748548913317e-10
found O 0 6.732716467672262e-11
to O 0 3.037898752000778e-11
accumulate O 0 3.023715944294736e-09
in O 0 3.000870385516663e-10
comparison O 0 1.6338843611407583e-09
to O 0 7.929724099575708e-10
the O 0 5.176977513343672e-09
normal O 0 8.087639891130038e-09
alpha O 0 4.078631121728904e-08
- O 0 2.2157207624218245e-08
subunit O 0 1.4897167943672684e-08
precursor O 0 2.887993133526834e-08
levels O 0 1.5081770499136837e-08
. O 0 2.101534590792653e-08

We O 0 5.05990271904011e-07
conclude O 0 2.9384347044469905e-07
that O 0 2.515945451975199e-09
the O 0 1.9093311820483905e-08
1422 O 0 1.3432816558633931e-05
G O 0 1.3708422557101585e-06
- O 0 1.0550744491411024e-06
- O 0 1.887162994762548e-07
> O 0 4.0726529704215864e-08
C O 0 5.086521781549891e-08
mutation O 0 2.509789875926316e-10
is O 0 1.0953626894405488e-11
the O 0 5.152237317340713e-11
cause O 0 2.036635304847323e-09
of O 0 6.085377179942952e-08
Hex B-Disease 0 8.021976827876642e-05
A I-Disease 0 3.7973240978317335e-05
enzyme I-Disease 1 0.9999996423721313
deficiency I-Disease 1 1.0
in O 0 1.4331823727786741e-08
the O 0 5.8432945593267505e-08
proband O 0 3.09529023070354e-05
. O 0 1.9542561346952425e-07

The O 0 9.826484301811433e-07
resulting O 0 1.0137596291315276e-06
W474C O 0 2.0238401248207083e-06
substitution O 0 2.0617490292806906e-07
clearly O 0 2.4628171502172336e-08
interferes O 0 2.5646444967719617e-08
with O 0 7.617320663122484e-10
alpha O 0 9.177213655675587e-09
- O 0 4.347810556026843e-09
subunit O 0 1.676172645126428e-09
processing O 0 4.1084313728845245e-09
, O 0 2.7414837761030597e-11
but O 0 8.124703167189384e-12
because O 0 2.0394632163633908e-11
the O 0 2.1245454007168263e-10
base O 0 1.2278969840906484e-08
substitution O 0 3.1483214257832515e-08
falls O 0 2.785776302971499e-07
at O 0 2.5105286738380528e-09
the O 0 5.242397627114315e-10
first O 0 5.951937831483178e-10
position O 0 1.2409855365547173e-08
of O 0 1.3253859343365093e-08
exon O 0 2.3117175373954524e-07
13 O 0 6.400840746323411e-09
, O 0 1.0369464314985422e-10
aberrant O 0 3.824800032248277e-09
splicing O 0 3.2546100925401333e-08
may O 0 7.750599051448148e-10
also O 0 1.6301389405004585e-10
contribute O 0 5.265445857105533e-10
to O 0 1.0536346906064864e-08
Hex B-Disease 0 0.02448505163192749
A I-Disease 0 0.0002751838765107095
deficiency I-Disease 1 0.9999996423721313
in O 0 1.2814609817723976e-08
this O 0 3.2469325006445615e-09
proband O 0 4.01437864638865e-06
. O 0 5.421267879057723e-09
. O 0 3.7920486306575185e-08

Two O 0 2.67951492105567e-07
frequent O 0 3.2561194984737085e-07
missense O 0 1.2872571460320614e-05
mutations O 0 3.6247053003535257e-07
in O 0 2.7402811042520625e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0002426010323688388

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 3.280831606389256e-07
an O 0 1.6483033959957538e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 0.11615604907274246
by O 0 1.9060737432852193e-09
early O 0 1.0249222214042675e-05
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.999997615814209
goiter B-Disease 1 1.0
. O 0 0.38194870948791504

A O 0 2.5362680844409624e-06
century O 0 2.5874333005049266e-06
after O 0 2.4321751723732632e-08
its O 0 5.36923616678564e-10
recognition O 0 1.2775586810676032e-08
as O 0 3.3165472590468426e-09
a O 0 4.9747401753563736e-09
syndrome O 0 2.559836730142706e-06
by O 0 3.439543649896848e-10
Vaughan O 0 5.462796707433881e-06
Pendred O 0 0.004689843859523535
, O 0 1.2913582425611025e-09
the O 0 2.545388788632863e-09
disease O 0 1.8004446644681593e-07
gene O 0 8.175205401528274e-09
( O 0 1.2867121590431907e-08
PDS O 0 0.00039674423169344664
) O 0 3.681671412181231e-09
was O 0 7.243496469300226e-08
mapped O 0 1.1890956841398292e-07
to O 0 7.539443735993245e-09
chromosome O 0 4.432119737884932e-07
7q22 O 0 5.0065125833498314e-05
- O 0 2.675136784091592e-05
q31 O 0 3.525073771015741e-05
. O 0 4.615862678747362e-07

1 O 0 2.4977020984806586e-06
and O 0 2.3672306781463703e-08
, O 0 2.0799917344049845e-09
recently O 0 1.566794161078633e-08
, O 0 4.5653719693561357e-10
found O 0 4.1459310984315323e-10
to O 0 7.287182524073899e-10
encode O 0 1.33789477274604e-08
a O 0 2.662188691715528e-08
putative O 0 3.65692721970845e-05
sulfate O 0 0.0018066149204969406
transporter O 0 0.339523047208786
. O 0 2.0383481569297146e-06

We O 0 1.872366084398891e-07
performed O 0 1.15732383676459e-08
mutation O 0 7.947303370947623e-10
analysis O 0 5.331447505696474e-10
of O 0 4.562597410995295e-09
the O 0 1.4031746431442116e-08
PDS B-Disease 0 9.634300658944994e-05
gene O 0 5.330606178688413e-09
in O 0 3.6091926669534757e-10
patients O 0 2.4583479696360655e-09
from O 0 3.634699874410785e-09
14 O 0 1.959473472368245e-08
Pendred B-Disease 0 7.200743766588857e-06
families O 0 1.3799975606687553e-09
originating O 0 2.116441244481848e-09
from O 0 3.6074995768409224e-10
seven O 0 1.3241009677589233e-10
countries O 0 9.80671533562516e-12
and O 0 1.680916655866227e-10
identified O 0 2.6758000259974324e-09
all O 0 1.105722846617141e-09
mutations O 0 1.1969434332570472e-08
. O 0 6.969577981408293e-08

The O 0 4.788440151060058e-07
mutations O 0 3.477344634461588e-08
include O 0 4.993353730498029e-09
three O 0 1.3572714063769808e-09
single O 0 2.874966265054013e-09
base O 0 1.2033740404149285e-07
deletions O 0 2.1098126978813525e-07
, O 0 1.3357804862224043e-09
one O 0 9.08258190879252e-10
splice O 0 5.9867488744203e-07
site O 0 1.0300482244929299e-08
mutation O 0 8.793257233463692e-10
and O 0 1.0943489447967636e-09
10 O 0 1.4713336327076831e-08
missense O 0 2.036234263869119e-06
mutations O 0 1.613308313608286e-07
. O 0 3.286280332304159e-07

One O 0 1.0608861202854314e-06
missense O 0 6.095017852203455e-06
mutation O 0 8.484220614946025e-08
( O 0 5.0566382192585024e-09
L236P O 0 6.307799935711955e-07
) O 0 8.955715058434066e-10
was O 0 7.71382158148981e-09
found O 0 9.583244198196894e-10
in O 0 2.065138893225793e-10
a O 0 6.974810728976877e-10
homozygous O 0 1.8146611990843553e-09
state O 0 2.183981329118012e-10
in O 0 1.255205661632175e-10
two O 0 5.439702022158599e-10
consanguineous O 0 8.014637273845437e-07
families O 0 1.1617907746952483e-09
and O 0 5.424533600084658e-10
in O 0 2.2902077456699033e-10
a O 0 1.604732124960151e-09
heterozygous O 0 2.8872412793923274e-10
state O 0 3.906576798162753e-11
in O 0 4.9064727974945654e-11
five O 0 2.4452059821378214e-10
additional O 0 3.0450719723518205e-09
non O 0 8.608330404058506e-07
- O 0 1.4716341866005678e-05
consanguineous O 0 0.000445155194029212
families O 0 3.0443223408838094e-07
. O 0 2.420702855943091e-07

Another O 0 1.7079398730857065e-06
missense O 0 5.335417426977074e-06
mutation O 0 6.206667535479937e-08
( O 0 4.913014439722474e-09
T416P O 0 3.311543252948468e-07
) O 0 5.982508377577744e-10
was O 0 6.19860784922821e-09
found O 0 6.545882724751095e-10
in O 0 1.4619606913957028e-10
a O 0 1.0674743311511747e-09
homozygous O 0 4.5898387313059175e-09
state O 0 1.6286752502203683e-10
in O 0 1.0372827596860645e-10
one O 0 3.031059014890758e-10
family O 0 1.6030617944196024e-09
and O 0 2.9082880548259027e-10
in O 0 3.2542407657487615e-10
a O 0 1.1388895382324904e-09
heterozygous O 0 1.031176033450265e-09
state O 0 1.1224218082750426e-10
in O 0 3.004237691950351e-10
four O 0 2.6554880516727053e-09
families O 0 1.6630277599460896e-08
. O 0 1.5308502554489678e-07

Pendred B-Disease 0 0.35674142837524414
patients O 0 5.583101938100299e-06
in O 0 3.432063522268436e-08
three O 0 1.8657813072309182e-08
non O 0 1.036698222378618e-06
- O 0 7.013201866357122e-06
consanguineous O 0 0.00028205933631397784
families O 0 6.8340804126876264e-09
were O 0 9.100928899385963e-10
shown O 0 7.789423966952924e-11
to O 0 6.158252380261686e-11
be O 0 4.77435924128855e-10
compound O 0 5.184490703413758e-08
heterozygotes O 0 7.991300776666321e-08
for O 0 1.6128237634305265e-09
L236P O 0 6.664664056188485e-07
and O 0 1.4621351240862168e-08
T416P O 0 6.350368039420573e-06
. O 0 2.0921625321079773e-07

In O 0 5.563249416695726e-08
total O 0 2.0353150276264387e-09
, O 0 7.923858236225101e-10
one O 0 2.5599355968353166e-10
or O 0 4.099200701102035e-10
both O 0 2.990836189820101e-10
of O 0 1.4716752261278998e-09
these O 0 1.5138734710262725e-10
mutations O 0 5.307674300070175e-10
were O 0 3.359322264806508e-10
found O 0 8.812930246682171e-11
in O 0 4.483014653944295e-11
nine O 0 1.0581212572802201e-09
of O 0 2.7921309708744957e-09
the O 0 1.1200085303642027e-08
14 O 0 2.123526599007164e-08
families O 0 2.639515939151238e-09
analyzed O 0 3.280136340322315e-08
. O 0 6.004886188293312e-08

The O 0 8.296350273440112e-08
identification O 0 2.859185599390912e-08
of O 0 2.866305948145964e-08
two O 0 3.919268465324421e-09
frequent O 0 5.727914853537186e-08
PDS B-Disease 0 3.1484316423302516e-05
mutations O 0 3.5054117386579264e-09
will O 0 1.4745038523500398e-10
facilitate O 0 8.151487818075509e-10
the O 0 6.704272137447731e-10
molecular O 0 4.627851879490663e-08
diagnosis O 0 0.020749753341078758
of O 0 0.0024301172234117985
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 5.666276592819486e-06

Insertional O 0 5.9115453041158617e-05
mutation O 0 1.399435944904326e-07
by O 0 3.4001867987853984e-09
transposable O 0 4.752042059408268e-06
element O 0 4.7182911089294066e-07
, O 0 5.5707114476888364e-09
L1 O 0 7.262723102030577e-06
, O 0 5.245108236628937e-10
in O 0 1.7647937278209014e-10
the O 0 1.332015564514677e-08
DMD B-Disease 1 1.0
gene O 0 1.5666925534674192e-08
results O 0 8.687646713134711e-10
in O 0 1.7562319376551727e-09
X B-Disease 1 0.9999879598617554
- I-Disease 1 0.9995585083961487
linked I-Disease 1 0.9970700740814209
dilated I-Disease 1 0.9999996423721313
cardiomyopathy I-Disease 1 1.0
. O 0 4.369243106339127e-05

X B-Disease 1 0.9999467134475708
- I-Disease 1 0.9996015429496765
linked I-Disease 1 0.6958579421043396
dilated I-Disease 1 0.9999994039535522
cardiomyopathy I-Disease 1 1.0
( O 0 5.22385562362615e-06
XLDCM B-Disease 1 0.9999978542327881
) O 0 8.848237698089179e-10
is O 0 5.1323955502224905e-11
a O 0 2.5560908945010397e-10
clinical O 0 2.2692733026019596e-08
phenotype O 0 4.5527505676545843e-07
of O 0 1.7791772677355766e-07
dystrophinopathy B-Disease 0 1.9907307432731614e-05
which O 0 7.898805221007166e-11
is O 0 1.1060191824896481e-11
characterized O 0 7.216995057124365e-11
by O 0 1.532670518278323e-11
preferential O 0 1.1308038239121743e-07
myocardial B-Disease 1 0.9485201835632324
involvement I-Disease 0 1.1393789911551266e-08
without O 0 7.07873204497389e-10
any O 0 1.6116820378275776e-10
overt O 0 3.863542819004806e-09
clinical O 0 1.9939745854458124e-08
signs O 0 2.9575854654240175e-08
of O 0 2.836919065885013e-06
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.9708735942840576

To O 0 2.0314686821620853e-08
date O 0 1.6038707428833732e-07
, O 0 9.311031390346614e-10
several O 0 1.8576476468190606e-10
mutations O 0 1.0553236062804672e-09
in O 0 6.937819208019391e-10
the O 0 1.1039474401286498e-07
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 0 0.006614173762500286
, O 0 2.4674679366398777e-07
DMD O 1 1.0
, O 0 9.645524379209292e-09
have O 0 1.7594230239392772e-10
been O 0 2.8405494623129357e-10
identified O 0 2.797951037525337e-10
in O 0 2.1970827934758574e-11
patients O 0 1.716395775508417e-10
with O 0 1.4185765062624256e-10
XLDCM B-Disease 1 1.0
, O 0 2.894808170950114e-09
but O 0 4.5026407602399843e-10
a O 0 5.199557451263104e-10
pathogenic O 0 1.6201594732478952e-08
correlation O 0 8.41661462747112e-10
of O 0 4.95602392458494e-10
these O 0 2.9226460140918675e-10
cardiospecific O 0 2.5278669113504293e-07
mutations O 0 1.5829144661694272e-09
in O 0 6.515191164346845e-10
DMD O 1 1.0
with O 0 8.048384181336132e-09
the O 0 1.869383083885623e-07
XLDCM B-Disease 1 0.777799129486084
phenotype O 0 2.0008624233014416e-06
has O 0 3.093685752020292e-09
remained O 0 1.8725298644994837e-08
to O 0 3.4479644139828736e-10
be O 0 2.1137303019003184e-09
elucidated O 0 4.821782931685448e-05
. O 0 6.058936605768395e-07

We O 0 9.412586621238006e-08
report O 0 2.957882827558933e-09
here O 0 3.821560290440118e-10
the O 0 1.661960846721655e-10
identification O 0 1.0003273764880305e-09
of O 0 2.908367324749861e-09
a O 0 2.7137108116193076e-09
unique O 0 6.822241438442234e-09
de O 0 5.1668496325874e-07
novo O 0 1.9564281501516234e-06
L1 O 0 7.789814844727516e-06
insertion O 0 1.8936586343443196e-07
in O 0 2.2699906399026304e-09
the O 0 2.140882804368971e-09
muscle O 0 5.67048408228743e-09
exon O 0 1.9207168122648e-07
1 O 0 1.801945437307495e-08
in O 0 1.0389504812025052e-09
DMD O 1 1.0
in O 0 1.531062743254097e-08
three O 0 2.3566437690192288e-08
XLDCM B-Disease 1 0.6895691156387329
patients O 0 2.364189555237317e-08
from O 0 3.3277753885840866e-09
two O 0 4.4827347389642114e-10
unrelated O 0 4.071495851576401e-08
Japanese O 0 2.023905608439236e-06
families O 0 3.280624483181782e-08
. O 0 1.8726841233274172e-07

The O 0 1.5834096984690404e-06
insertion O 0 1.98403290596616e-06
was O 0 5.328890892997151e-07
a O 0 2.983660252198206e-08
5 O 0 2.273154642296049e-08
- O 0 1.4478072074552983e-08
truncated O 0 1.672430727239771e-08
form O 0 4.426305544313891e-09
of O 0 2.758397954494285e-08
human O 0 5.041951744999551e-09
L1 O 0 6.630620532632747e-07
inversely O 0 5.4496876344956036e-08
integrated O 0 5.4931529547275204e-08
in O 0 5.931922730795236e-10
the O 0 3.260200331922647e-09
5 O 0 2.1718786769042708e-08
- O 0 2.5784351009860984e-07
untranslated O 1 0.9999961853027344
region O 0 9.380845966688867e-08
in O 0 2.428206302695912e-09
the O 0 2.0572770154103637e-09
muscle O 0 4.799140196354301e-09
exon O 0 6.346962777570297e-08
1 O 0 5.904879252227602e-09
, O 0 3.5108211476897466e-11
which O 0 1.3559296914433805e-11
affected O 0 8.186030187040672e-10
the O 0 2.4184998448362194e-09
transcription O 0 1.2652692760184436e-07
or O 0 3.1504099329282553e-09
the O 0 6.396178253709195e-09
stability O 0 9.38014522944286e-07
of O 0 1.198264101276436e-07
the O 0 9.175007420481052e-09
muscle O 0 1.5774082040564963e-09
form O 0 3.902038248071449e-09
of O 0 3.5598887393462064e-08
dystrophin O 0 3.9453868794225855e-07
transcripts O 0 1.2849952213400684e-08
but O 0 3.633878267739199e-11
not O 0 5.451069717138379e-12
that O 0 9.624669117247464e-12
of O 0 2.8498956528011377e-09
the O 0 2.130821386003845e-08
brain O 0 2.6808288566826377e-06
or O 0 3.183112440297009e-08
Purkinje O 0 0.00022013630950823426
cell O 0 9.064727350960311e-07
form O 0 8.529502437681913e-09
, O 0 9.879305151727635e-10
probably O 0 1.9909267123807695e-08
due O 0 1.9166694187333633e-07
to O 0 4.476047532619987e-09
its O 0 1.2401802917949567e-09
unique O 0 5.406233238858249e-09
site O 0 1.753006806382018e-08
of O 0 4.492657357246799e-09
integration O 0 3.330218873998092e-07
. O 0 1.9916414828458073e-07

We O 0 1.0280172091370332e-07
speculate O 0 2.5321899244090673e-08
that O 0 1.0869800198820556e-10
this O 0 7.224735393274173e-11
insertion O 0 2.415237432273898e-08
of O 0 6.853072775925284e-09
an O 0 2.5885701915306925e-10
L1 O 0 1.973279921685389e-07
sequence O 0 1.2061096565929574e-09
in O 0 9.757504804142059e-10
DMD O 1 1.0
is O 0 2.508958596436628e-09
responsible O 0 4.89266294145807e-10
for O 0 1.832233323395549e-11
some O 0 7.518924718952213e-12
of O 0 1.3703758960925683e-10
the O 0 7.646342586875576e-11
population O 0 1.1998553192671402e-12
of O 0 6.724824169745958e-11
Japanese O 0 1.2736196985940751e-08
patients O 0 7.552739544891551e-10
with O 0 3.535430559420405e-10
XLDCM B-Disease 0 0.013589094392955303
. O 0 2.900446993692185e-08
. O 0 1.5580155832140008e-07

Severe O 0 0.14365996420383453
early O 1 0.8974350094795227
- O 1 0.9972754120826721
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 4.7304106942647195e-07
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 1.0397990990895778e-05
red O 0 4.2228442907799035e-05
hair O 0 8.722719826437242e-07
pigmentation O 0 0.00012794473150279373
caused O 0 2.2305154345758638e-07
by O 0 2.842691415594345e-09
POMC O 1 0.9999912977218628
mutations O 0 1.7268298790895642e-08
in O 0 9.701203174117268e-10
humans O 0 2.9717785565708255e-08
. O 0 3.525589420405595e-08

Sequential O 0 6.045590453140903e-06
cleavage O 0 9.84138750936836e-06
of O 0 8.514615501553635e-07
the O 0 4.716923385217342e-08
precursor O 0 1.0067672207014766e-07
protein O 0 1.50127483777851e-08
pre O 0 7.271548270182393e-07
- O 0 1.0413922382213059e-06
pro O 0 2.316306336069829e-06
- O 0 6.726116680511041e-06
opiomelanocortin O 0 7.212148193502799e-05
( O 0 2.585681357913927e-08
POMC O 0 9.787068120203912e-05
) O 0 1.458235199258695e-09
generates O 0 1.7256107653906838e-09
the O 0 2.3784445524199782e-09
melanocortin O 0 8.27225812827237e-06
peptides O 0 5.7505413764147306e-08
adrenocorticotrophin O 0 2.3240108930622227e-06
( O 0 1.3902269335730466e-09
ACTH O 0 5.399876954470528e-07
) O 0 3.743174659120996e-09
, O 0 6.87076751049176e-09
melanocyte O 0 5.511770723387599e-05
- O 0 1.1426211131038144e-05
stimulating O 0 1.7234349058981024e-07
hormones O 0 2.4030086809290196e-09
( O 0 5.197772767751019e-10
MSH O 0 1.317754140472971e-06
) O 0 2.7025109927691915e-10
alpha O 0 1.8003162294277786e-09
, O 0 2.32808303884946e-11
beta O 0 5.003895631183752e-10
and O 0 1.108456798570856e-10
gamma O 0 1.5774351824759947e-09
as O 0 2.4192367553688143e-10
well O 0 2.1294135899019295e-10
as O 0 3.900495759712186e-10
the O 0 9.948019075167736e-10
opioid O 0 1.4705176454299362e-07
- O 0 1.2381748604184395e-07
receptor O 0 1.0666608041276504e-08
ligand O 0 1.6798068713796965e-07
beta O 0 2.9943245749564085e-07
- O 0 5.691105684491049e-07
endorphin O 0 2.7979756850982085e-05
. O 0 2.0173909831555648e-07

While O 0 5.817350512415942e-08
a O 0 8.827592878901669e-09
few O 0 2.5145157067640866e-09
cases O 0 2.813343114027589e-09
of O 0 1.3523163033823948e-07
isolated O 0 0.003635081462562084
ACTH B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999998807907104
have O 0 1.7968110554988925e-08
been O 0 6.511070793635554e-09
reported O 0 3.963063210932205e-09
( O 0 2.494110029616081e-09
OMIM O 0 0.0007330095977522433
201400 O 0 9.201101420330815e-06
) O 0 1.7796745188647378e-09
, O 0 3.0195645983610575e-10
an O 0 1.045450725989383e-09
inherited O 1 0.9999991655349731
POMC O 1 1.0
defect O 1 1.0
has O 0 4.672705244956887e-08
not O 0 2.5901508715620025e-10
been O 0 5.289795823593124e-10
described O 0 1.4818801741256493e-09
so O 0 4.381423834853848e-10
far O 0 6.5784533376245236e-09
. O 0 2.6553628629244486e-08

Recent O 0 1.7557513842803019e-07
studies O 0 1.935544524656052e-08
in O 0 7.815337266237066e-10
animal O 0 1.3035111878778594e-09
models O 0 9.670775291681366e-10
elucidated O 0 9.362128139400738e-07
a O 0 9.103434450707937e-09
central O 0 3.056292285918971e-08
role O 0 4.3473978195152085e-08
of O 0 3.507728081331152e-07
alpha O 0 3.1700490126240766e-06
- O 0 1.2961543234268902e-06
MSH O 0 0.0003745946451090276
in O 0 9.020413860305609e-10
the O 0 7.865418871766394e-10
regulation O 0 2.5702404649052824e-09
of O 0 4.272294185092562e-10
food O 0 2.384211716943696e-10
intake O 0 3.546356611150436e-11
by O 0 2.9525292800924863e-12
activation O 0 7.289990833214688e-10
of O 0 8.984410548862343e-09
the O 0 7.152842584901009e-08
brain O 0 1.4968421737648896e-06
melanocortin O 0 9.221020445693284e-05
- O 0 1.3008241239731433e-06
4 O 0 1.6206283248720865e-07
- O 0 6.019599396722697e-08
receptor O 0 1.1486065432109172e-08
( O 0 2.926585862539355e-09
MC4 O 0 4.7259291022783145e-05
- O 0 6.188640782056609e-07
R O 0 3.621485120675061e-07
; O 0 4.175669587880293e-09
refs O 0 3.931759806619084e-07
3 O 0 2.1234619396182097e-08
- O 0 1.655615733398008e-08
5 O 0 1.1574534664049452e-09
) O 0 1.928598773737189e-11
and O 0 2.3245599889420987e-11
the O 0 1.9265261608225615e-10
linkage O 0 6.927855622507195e-08
of O 0 7.174428606759875e-09
human O 0 5.235668254499615e-08
obesity B-Disease 0 0.0550723671913147
to O 0 9.886392815516842e-10
chromosome O 0 3.4153964101335532e-09
2 O 0 1.5150014576192916e-08
in O 0 4.926026253571081e-10
close O 0 2.0596768735003934e-08
proximity O 0 3.9743216007082083e-07
to O 0 4.160461308799768e-09
the O 0 8.582314592331386e-08
POMC O 1 0.7733180522918701
locus O 0 1.2347823030722793e-07
, O 0 9.031857900465567e-11
led O 0 1.825369438934743e-10
to O 0 5.3389445642260114e-11
the O 0 4.2315181913998856e-10
proposal O 0 3.2223528290131753e-09
of O 0 1.723479248205706e-09
an O 0 9.702640774156279e-11
association O 0 3.0996438749042454e-10
of O 0 6.2649081478127755e-09
POMC O 1 0.9993374943733215
with O 0 1.109839420365688e-08
human O 0 3.734430720214732e-06
obesity B-Disease 1 1.0
. O 0 1.2567385283546173e-06

The O 0 4.386830312341772e-07
dual O 0 6.696819809803856e-07
role O 0 2.3477545596506388e-07
of O 0 8.511173064107425e-07
alpha O 0 1.9247054297011346e-05
- O 0 2.7434987714514136e-05
MSH O 0 0.08621380478143692
in O 0 5.673545633300137e-09
regulating O 0 5.633153055129014e-09
food O 0 4.6514774254546865e-09
intake O 0 1.543211558541202e-09
and O 0 3.110879331913452e-10
influencing O 0 2.1963863616747403e-08
hair O 0 7.722495354300918e-08
pigmentation O 0 8.356033504242077e-06
predicts O 0 1.295928608868735e-08
that O 0 4.7140829434466625e-11
the O 0 8.471098822404599e-10
phenotype O 0 6.079226455568687e-09
associated O 0 4.971901224060105e-10
with O 0 1.568328626688764e-11
a O 0 1.6655921086794478e-09
defect O 0 8.228458341363876e-07
in O 0 5.35312372207386e-09
POMC O 1 0.9999340772628784
function O 0 2.219069150655173e-09
would O 0 3.139341564484255e-10
include O 0 4.289491872810913e-09
obesity B-Disease 1 0.9999995231628418
, O 0 2.865373771587798e-10
alteration O 0 5.278523644847155e-07
in O 0 3.986488916751796e-09
pigmentation O 0 0.05250432342290878
and O 0 2.806174848046794e-07
ACTH B-Disease 1 0.9754456281661987
deficiency I-Disease 1 0.9965977072715759
. O 0 7.651342457393184e-07

The O 0 6.050038905414112e-07
observation O 0 2.3441778012056602e-06
of O 0 5.8622383392048505e-08
these O 0 1.7815798836195995e-09
symptoms O 0 5.9884218899242114e-06
in O 0 7.782036348658039e-09
two O 0 5.4889084388776155e-09
probands O 0 4.295247435948113e-06
prompted O 0 2.483444916379085e-08
us O 0 1.2254303127789967e-09
to O 0 3.8165851035110165e-10
search O 0 3.6543583714632177e-09
for O 0 1.2418958916793343e-10
mutations O 0 5.528970059565097e-10
within O 0 4.965715394433801e-09
their O 0 2.009211108600084e-08
POMC O 1 0.7011849284172058
genes O 0 2.435978387893556e-07
. O 0 1.0818190787631465e-07

Patient O 0 9.080809832084924e-05
1 O 0 2.21829509428062e-06
was O 0 9.465156125543217e-08
found O 0 1.3033470969148198e-09
to O 0 2.2288072776266432e-10
be O 0 3.337473630793397e-10
a O 0 1.746224720378109e-09
compound O 0 1.0139979167433921e-07
heterozygote O 0 4.716644355085009e-07
for O 0 8.283235763961727e-10
two O 0 1.8477108731929093e-10
mutations O 0 3.4976024854138643e-10
in O 0 5.652383006093942e-10
exon O 0 1.1357602858197424e-07
3 O 0 2.6184968859865876e-08
( O 0 6.720646816837927e-10
G7013T O 0 2.073066127650236e-07
, O 0 1.0733297584053503e-09
C7133delta O 0 1.9216217879147734e-06
) O 0 3.544613491612836e-10
which O 0 3.802494083493535e-11
interfere O 0 3.1576152803580726e-10
with O 0 2.071501130351816e-11
appropriate O 0 1.1048058023988006e-09
synthesis O 0 1.1596063664853773e-08
of O 0 4.636719896922159e-09
ACTH O 0 9.233055493496067e-07
and O 0 5.2050403098746756e-08
alpha O 0 1.644448616389127e-06
- O 0 5.493977369042113e-06
MSH O 0 0.0006281002424657345
. O 0 4.4701758383780543e-07

Patient O 0 3.371895581949502e-05
2 O 0 2.5530248422001023e-06
was O 0 1.4669656422938715e-07
homozygous O 0 1.2249028458199973e-08
for O 0 6.148115350157468e-10
a O 0 1.645088620882973e-09
mutation O 0 2.494481288195516e-09
in O 0 4.522594299061211e-09
exon O 0 7.533890880040417e-07
2 O 0 3.482973909285647e-07
( O 0 3.514751156785678e-09
C3804A O 0 3.4510014756961027e-07
) O 0 2.1827497587167954e-09
which O 0 4.838856426658822e-09
abolishes O 0 2.3152699213824235e-05
POMC O 0 0.015108234249055386
translation O 0 1.3226518603914883e-05
. O 0 1.0314498695151997e-06

These O 0 2.903435714074476e-08
findings O 0 5.6084417110469076e-09
represent O 0 6.31837859810247e-10
the O 0 1.425227047491262e-09
first O 0 3.047871399708413e-10
examples O 0 1.8452958050474422e-09
of O 0 9.897585862006508e-09
a O 0 2.3974200402676615e-08
genetic B-Disease 1 0.9999998807907104
defect I-Disease 1 0.9999980926513672
within O 0 1.2282905359484175e-08
the O 0 6.243793926330454e-09
POMC O 0 7.523568456235807e-06
gene O 0 6.92864210449784e-10
and O 0 1.2286031914054973e-10
define O 0 6.433725774357413e-10
a O 0 1.6180402573340302e-09
new O 0 9.615182250399812e-08
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 0 0.0034770392812788486
resulting O 0 7.187812656184178e-08
in O 0 1.0830236707448648e-09
early O 0 8.860293405632547e-07
- O 0 5.203797172725899e-06
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 2.446520284138387e-07
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 4.878401341557037e-06
red O 0 4.141881436225958e-05
hair O 0 8.345326136804943e-07
pigmentation O 0 2.320225212315563e-05
. O 0 2.1224860091706432e-08
. O 0 6.552409104187973e-08

A O 0 2.766641955531668e-06
European O 0 2.2251656162097788e-07
multicenter O 0 2.5786128389881924e-05
study O 0 6.669178986840052e-08
of O 0 2.8331227440503426e-05
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 1.0349281431842883e-08
classification O 0 1.509325286974672e-08
of O 0 1.9054784416994153e-08
105 O 0 3.81246358927001e-08
mutations O 0 2.5388804947290566e-10
and O 0 1.55408977353666e-10
a O 0 4.53215992513023e-10
general O 0 4.061302405489187e-09
system O 0 9.15635478548893e-09
for O 0 2.743551219541729e-10
genotype O 0 1.4955672256178332e-08
- O 0 4.837176881267169e-09
based O 0 6.851357259307633e-10
prediction O 0 5.650922929589797e-08
of O 0 4.497950101267634e-08
metabolic O 0 0.0014296869048848748
phenotype O 0 5.286026862449944e-06
. O 0 8.40218703501705e-08

Phenylketonuria B-Disease 1 0.6398850083351135
( O 0 1.219610680891492e-06
PKU B-Disease 0 0.010056521743535995
) O 0 1.788522929757619e-08
and O 0 1.8534379364609777e-08
mild B-Disease 1 1.0
hyperphenylalaninemia I-Disease 1 1.0
( O 1 1.0
MHP B-Disease 1 1.0
) O 0 2.7331299179422786e-07
are O 0 1.6378501888070218e-09
allelic B-Disease 0 0.0004531343001872301
disorders I-Disease 0 0.3403460383415222
caused O 0 3.496352007914538e-08
by O 0 1.848028119422196e-10
mutations O 0 1.403531735277852e-10
in O 0 1.0594333049729343e-10
the O 0 1.064899723957069e-09
gene O 0 2.110918106978943e-09
encoding O 0 1.8562121795184794e-07
phenylalanine O 0 7.882839781814255e-06
hydroxylase O 0 0.0004256100219208747
( O 0 2.531575091779814e-07
PAH O 1 1.0
) O 0 1.9940094375670014e-07
. O 0 1.9803003681317932e-07

Previous O 0 5.295207188282802e-07
studies O 0 1.191888099327798e-08
have O 0 1.936222016052369e-10
suggested O 0 8.092805314774409e-10
that O 0 1.61002825654899e-11
the O 0 2.5928395541718885e-10
highly O 0 8.659229777663313e-09
variable O 0 2.3027642725992337e-07
metabolic O 1 0.9895408749580383
phenotypes O 0 3.478091093711555e-05
of O 0 0.0012386409798637033
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 0 3.2142629606823903e-06
with O 0 2.35645572388421e-07
PAH O 1 1.0
genotypes O 1 0.728981077671051
. O 0 1.5551935348412371e-06

We O 0 3.1141002665435735e-08
identified O 0 5.838612260333775e-09
both O 0 3.4740132992538975e-10
causative O 0 9.847443749322338e-08
mutations O 0 8.795626449398242e-09
in O 0 2.17183626638473e-09
686 O 0 3.6407388961379183e-06
patients O 0 1.5628700111847138e-07
from O 0 2.8371246685310325e-08
seven O 0 2.113408825721308e-08
European O 0 3.8427465653967374e-08
centers O 0 1.4504418288652232e-07
. O 0 1.0880062717433248e-07

On O 0 6.724127388224588e-07
the O 0 1.2879397992549002e-08
basis O 0 1.0794154015059121e-08
of O 0 1.6144959147368354e-08
the O 0 4.686028010070231e-09
phenotypic O 0 9.330862127399087e-08
characteristics O 0 2.838234181012922e-08
of O 0 2.743627192103304e-08
297 O 0 3.630835365697749e-08
functionally O 0 3.5087018090962374e-07
hemizygous O 0 4.191090283711674e-06
patients O 0 6.676749819689576e-09
, O 0 1.4593920516503545e-10
105 O 0 4.478557968923269e-09
of O 0 1.7825757536726883e-09
the O 0 8.723179401037839e-10
mutations O 0 1.9911640392056285e-10
were O 0 1.5493600846738786e-10
assigned O 0 1.4271557269296409e-09
to O 0 1.014294412349237e-10
one O 0 2.1293973528901944e-10
of O 0 1.7552674869136808e-09
four O 0 3.958731953357386e-10
arbitrary O 0 4.281873966505145e-09
phenotype O 0 1.2340888133621775e-07
categories O 0 1.2167390650574816e-08
. O 0 1.5277024090210034e-08

We O 0 1.3310358326634741e-07
proposed O 0 9.654804244974002e-08
and O 0 6.104032390652492e-09
tested O 0 3.846278850971885e-09
a O 0 3.049633323648493e-10
simple O 0 5.742468722758076e-10
model O 0 3.7035874367319366e-10
for O 0 2.6094239616303305e-11
correlation O 0 1.2642036029131276e-10
between O 0 4.383229335047645e-10
genotype O 0 6.343803704567108e-08
and O 0 3.183766583703118e-09
phenotypic O 0 3.0595117550547e-08
outcome O 0 1.3730202397255198e-07
. O 0 9.616026375169895e-08

The O 0 3.5585182445174723e-07
observed O 0 5.614652209828819e-08
phenotype O 0 2.910495027208526e-07
matched O 0 4.819690957447165e-08
the O 0 2.342991933801386e-08
predicted O 0 1.0136885464362422e-07
phenotype O 0 2.5814787818490004e-07
in O 0 8.325367617523227e-10
79 O 0 1.1371687591577029e-08
% O 0 1.1029819418917342e-10
of O 0 3.1257604837797714e-10
the O 0 1.2341225263945432e-10
cases O 0 1.600592436368231e-10
, O 0 6.78851280744297e-11
and O 0 8.61503784976847e-11
in O 0 2.8651752845276768e-11
only O 0 1.6334123290051572e-11
5 O 0 2.772076457269179e-10
of O 0 2.286506400883681e-10
184 O 0 3.4144713723094355e-09
patients O 0 3.380876689718093e-09
was O 0 2.6296781641121925e-08
the O 0 2.274623822628996e-09
observed O 0 6.537074215273719e-10
phenotype O 0 1.967074059194829e-09
more O 0 9.714079367284523e-12
than O 0 1.1882794227757731e-11
one O 0 6.838232757822027e-11
category O 0 2.388280406773191e-10
away O 0 6.816618935978624e-10
from O 0 7.337584012612197e-11
that O 0 7.807704482942768e-11
expected O 0 2.8802586982124012e-08
. O 0 1.7235828408956877e-07

Among O 0 6.787989832446328e-07
the O 0 6.222942516842522e-08
seven O 0 1.127645887777362e-08
contributing O 0 1.921873549193265e-09
centers O 0 2.738580695549331e-09
, O 0 5.1380177890081313e-11
the O 0 1.908604801981184e-10
proportion O 0 3.828038719344562e-10
of O 0 8.517597738233462e-10
patients O 0 1.5572119149709351e-09
for O 0 2.4233748341373484e-10
whom O 0 5.57899459963096e-09
the O 0 8.450893873579446e-10
observed O 0 5.392132296222485e-10
phenotype O 0 2.1515589310183714e-09
did O 0 1.2090527190533606e-10
not O 0 1.9334235601409233e-11
match O 0 1.722427644956781e-09
the O 0 2.719067859757729e-09
predicted O 0 1.5395050567690305e-08
phenotype O 0 2.2553615863785126e-08
was O 0 2.0328640104594342e-08
4 O 0 3.5017628796651934e-09
% O 0 1.5904948191813872e-10
- O 0 5.2260369365342285e-09
23 O 0 6.630668902829484e-09
% O 0 1.3252942077102148e-09
( O 0 1.4760662692125948e-09
P O 0 1.5011595451142057e-06
< O 0 4.468176939553814e-07
. O 0 1.638693958305737e-09
0001 O 0 3.3158977430503e-07
) O 0 6.446362194045818e-11
, O 0 1.7373328470293714e-11
suggesting O 0 7.692333575670673e-11
that O 0 6.691502820593831e-12
differences O 0 2.0122696564595088e-10
in O 0 4.187693247725832e-11
methods O 0 3.280921367920797e-10
used O 0 2.0375513776205167e-10
for O 0 5.406557840315074e-11
mutation O 0 7.035900195795364e-10
detection O 0 6.116435429248668e-07
or O 0 6.516164496872534e-09
phenotype O 0 2.544739707843746e-08
classification O 0 2.5545032755758257e-09
may O 0 1.1843655223220395e-10
account O 0 4.3467944521591306e-11
for O 0 3.8652785833148684e-11
a O 0 1.6764532817514777e-10
considerable O 0 1.5385591689565103e-09
proportion O 0 1.496585189109112e-09
of O 0 8.592793143691324e-09
genotype O 0 2.625303977765725e-06
- O 0 3.0651126508018933e-06
phenotype O 0 1.0132243914995342e-06
inconsistencies O 0 1.5101423969099415e-06
. O 0 2.8425418463484675e-07

Our O 0 1.5952168723742943e-06
data O 0 2.5970246397832852e-08
indicate O 0 3.356870781345833e-09
that O 0 7.597267814851705e-10
the O 0 3.619813426780638e-08
PAH O 1 1.0
- O 0 1.1559686754480936e-05
mutation O 0 3.5972225198577235e-09
genotype O 0 1.3862453407398334e-08
is O 0 5.771542271881813e-11
the O 0 1.1307375175073631e-10
main O 0 4.217644455906111e-09
determinant O 0 3.268152326540985e-08
of O 0 9.316969418193821e-09
metabolic O 0 0.004058117512613535
phenotype O 0 6.818419251430896e-07
in O 0 2.2960160162011078e-10
most O 0 3.2234087621318963e-10
patients O 0 9.223839469996165e-09
with O 0 3.6265205949348456e-07
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.0005688694072887301

In O 0 1.1343108496930654e-07
the O 0 1.3477580829146518e-08
present O 0 1.8378493171766763e-09
study O 0 5.15337050810416e-10
, O 0 1.0161417540732742e-10
the O 0 2.993461589717583e-10
classification O 0 1.4020402616665706e-08
of O 0 3.059278697037371e-07
105 O 0 0.0026106738951057196
PAH O 1 1.0
mutations O 0 8.245947213936233e-08
may O 0 1.1956649004218889e-09
allow O 0 5.708636341417161e-10
the O 0 8.161101794357251e-10
prediction O 0 5.58581234599842e-08
of O 0 2.836057388933e-09
the O 0 1.896413248658746e-09
biochemical O 0 7.278466540583395e-08
phenotype O 0 3.7294650923058725e-08
in O 0 1.831546025954367e-10
> O 0 1.52215005044809e-08
10 O 0 6.724134582469787e-10
, O 0 7.804235729880205e-11
000 O 0 9.41740907478561e-10
genotypes O 0 3.56622287256414e-08
, O 0 2.922110886593998e-10
which O 0 4.0932451872421893e-11
may O 0 1.7877707647606655e-10
be O 0 4.170046252749415e-11
useful O 0 2.750855654376494e-10
for O 0 2.7808182839761386e-11
the O 0 1.3970789802808525e-10
management O 0 4.319244961692448e-09
of O 0 1.3175547763921713e-08
hyperphenylalaninemia B-Disease 1 1.0
in O 0 1.951893757734524e-08
newborns O 0 1.467578414349191e-07
. O 0 8.790967598315547e-08

Somatic O 0 0.0002996708790306002
instability O 0 0.0001190549082821235
of O 0 1.3602754052044475e-06
the O 0 4.1336653566759196e-07
CTG O 0 0.004828117322176695
repeat O 0 4.4154052147860057e-07
in O 0 3.951514671030054e-09
mice O 0 7.1814376667589386e-09
transgenic O 0 1.8444733740352603e-08
for O 0 2.27419749698754e-10
the O 0 1.7452875056278572e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 0.020641585811972618
is O 0 1.7438614996478918e-09
age O 0 2.360636408571537e-10
dependent O 0 1.2638323720892686e-10
but O 0 4.803959747362585e-12
not O 0 2.7824511358159887e-12
correlated O 0 1.5710957534942338e-10
to O 0 8.98078764133281e-11
the O 0 1.570802932171489e-09
relative O 0 3.295079693543812e-07
intertissue O 0 1.2043517017445993e-05
transcription O 0 2.4172194912353007e-07
levels O 0 1.6628122878614704e-08
and O 0 1.2678197158777493e-08
proliferative O 0 0.0013141788076609373
capacities O 0 5.397289896791335e-06
. O 0 3.9188000755530084e-07

A O 0 7.312370871659368e-05
( O 0 1.0859190524570295e-06
CTG O 0 0.00020529191533569247
) O 0 3.573344642404663e-08
nexpansion O 0 2.671852143976139e-06
in O 0 3.2626636947696852e-09
the O 0 1.5362727978640578e-08
3 O 0 2.025302450192612e-07
- O 0 1.1344151289449655e-06
untranslated O 1 0.9999998807907104
region O 0 2.1136602299520746e-06
( O 0 1.1438340052905005e-08
UTR O 1 0.999915599822998
) O 0 1.7235910476642857e-09
of O 0 6.603508406755054e-09
the O 0 4.589490743001079e-08
DM O 1 1.0
protein O 0 1.023925335630338e-07
kinase O 0 4.133404729600443e-08
gene O 0 9.899450148509459e-10
( O 0 1.3896853112704832e-10
DMPK O 0 1.5875252756814007e-06
) O 0 7.596221568428874e-11
is O 0 1.0762600879954398e-11
responsible O 0 1.1750031503332536e-10
for O 0 2.6943119957323347e-10
causing O 0 9.12448626877449e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.5227600336074829
DM B-Disease 1 1.0
) O 0 2.578250644091895e-07
. O 0 1.5171737288710574e-07

Major O 0 3.417798870941624e-05
instability O 0 0.0017358448822051287
, O 0 1.432717677829487e-08
with O 0 1.5337305869778106e-09
very O 0 3.564853967574777e-09
large O 0 3.631394518421871e-09
expansions O 0 3.895867450864898e-08
between O 0 1.6427432747434523e-09
generations O 0 1.7503138494134873e-08
and O 0 3.0716004739694824e-10
high O 0 1.9027173170371725e-09
levels O 0 4.4527986853282187e-10
of O 0 1.4570397111057787e-09
somatic O 0 1.697712548320851e-07
mosaicism O 0 6.913756806170568e-06
, O 0 1.2020395789846816e-10
is O 0 2.6299400157636654e-11
observed O 0 2.5357155264416065e-10
in O 0 3.9130065854209306e-10
patients O 0 4.378170359586875e-08
. O 0 2.1039816999746108e-07

There O 0 1.3791304809274152e-07
is O 0 4.8324926282816705e-09
a O 0 2.2262847121368168e-09
good O 0 4.667821684734008e-09
correlation O 0 1.2283180028660468e-09
between O 0 8.645808513563225e-10
repeat O 0 1.0093836877445028e-08
size O 0 2.7076099140543874e-09
( O 0 3.2510952263642423e-10
at O 0 2.1788262860589214e-10
least O 0 1.121811237653203e-11
in O 0 4.112096080310934e-11
leucocytes O 0 1.4141642168397084e-07
) O 0 1.5815948550823578e-10
, O 0 2.3404425966710996e-11
clinical O 0 2.975577118036199e-09
severity O 0 2.3525715278083226e-06
and O 0 6.489893511485434e-09
age O 0 1.0363701008486714e-08
of O 0 4.2973724134753866e-08
onset O 1 0.9052349925041199
. O 0 1.1598649507504888e-06

The O 0 1.027149392029969e-05
trinucleotide O 0 0.03616248816251755
repeat O 0 5.168814823264256e-06
instability O 0 3.7404115573735908e-06
mechanisms O 0 3.1699474334345723e-07
involved O 0 6.831486487612892e-09
in O 0 7.2473773649051054e-09
DM B-Disease 1 1.0
and O 0 7.314887540132986e-08
other O 0 7.866574613935029e-10
human O 0 4.6595868496979165e-08
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 2.538764198867227e-10
unknown O 0 5.750563758510907e-08
. O 0 2.0742241702009778e-08

We O 0 2.515606638553436e-07
studied O 0 7.12460177965113e-07
somatic O 0 9.219116691383533e-06
instability O 0 1.7125443037002697e-06
by O 0 4.043957169130863e-09
measuring O 0 1.9820896568489843e-07
the O 0 4.689518107170443e-08
CTG O 0 3.711889439728111e-05
repeat O 0 3.2442102337881806e-08
length O 0 2.842631907640225e-09
at O 0 6.104506899973217e-10
several O 0 1.6147395920373953e-11
ages O 0 3.989818753158403e-10
in O 0 3.935324635606641e-11
various O 0 1.8110815624972076e-10
tissues O 0 4.456966351540359e-08
of O 0 4.437228895426415e-08
transgenic O 0 1.6137975933361304e-07
mice O 0 2.567682733101151e-09
carrying O 0 4.3607140121082466e-10
a O 0 1.9995340938550044e-09
( O 0 9.398465117271826e-09
CTG O 0 6.966751243453473e-05
) O 0 8.406719764764148e-09
55expansion O 0 1.349689568996837e-06
surrounded O 0 4.304591172399341e-08
by O 0 3.618463584320608e-10
45 O 0 5.0674811014062016e-09
kb O 0 2.4632359441056906e-07
of O 0 1.0190074561933216e-08
the O 0 2.4891592786957517e-08
human O 0 5.247450189926894e-07
DM B-Disease 1 1.0
region O 0 7.733490861028258e-07
, O 0 1.4930184866202012e-09
using O 0 2.9000581935889613e-09
small O 0 4.897408256709923e-09
- O 0 1.278610994859264e-07
pool O 0 6.55006004990355e-08
PCR O 0 1.6004877352315816e-06
. O 0 1.4348019305998605e-07

These O 0 1.9685845131789392e-07
mice O 0 2.2251698794661934e-07
have O 0 7.150053882298835e-10
been O 0 1.4057240926845793e-09
shown O 0 4.1869924194415375e-10
to O 0 2.1903723279592668e-10
reproduce O 0 6.739159896795854e-09
the O 0 4.158834610024087e-09
intergenerational O 0 7.51225996964422e-08
and O 0 1.929461701521973e-09
somatic O 0 5.523810386875994e-07
instability O 0 1.8391833123132528e-07
of O 0 8.71995631257505e-09
the O 0 1.117492764990402e-08
55 O 0 3.7755363280211895e-08
CTG O 0 1.813311428122688e-06
repeat O 0 2.5091497768414683e-09
suggesting O 0 5.876853448327779e-10
that O 0 4.023426036781075e-11
surrounding O 0 1.57537549672071e-09
sequences O 0 4.169841694157128e-10
and O 0 1.6770865252091482e-10
the O 0 2.5771459966072996e-10
chromatin O 0 8.804320827948686e-09
environment O 0 1.0197379607390644e-09
are O 0 5.333079464153734e-12
involved O 0 1.2535905646871015e-10
in O 0 2.8612065494648675e-10
instability O 0 1.207134232572571e-06
mechanisms O 0 4.3881758756469935e-05
. O 0 8.595614531259343e-07

As O 0 1.243787011162567e-07
observed O 0 1.3312105195950608e-08
in O 0 5.810358305602392e-10
some O 0 5.843921180304079e-11
of O 0 1.2601309995474708e-09
the O 0 6.085209558470694e-10
tissues O 0 5.808037428778334e-08
of O 0 8.209927955249441e-07
DM B-Disease 1 1.0
patients O 0 0.0005711833364330232
, O 0 4.340723613882602e-10
there O 0 5.401486549705403e-11
is O 0 2.622891660808424e-11
a O 0 4.597228500657913e-11
tendency O 0 1.747756661618638e-10
for O 0 6.875086611124459e-11
repeat O 0 1.0602586586472285e-09
length O 0 1.079723643826469e-09
and O 0 1.0874201539223805e-09
somatic O 0 2.26885177312397e-07
mosaicism O 0 1.5040225207485491e-06
to O 0 1.4270326587073612e-10
increase O 0 7.600844259547657e-11
with O 0 3.021037933703674e-11
the O 0 1.0990721666104264e-09
age O 0 1.3819730915187733e-09
of O 0 7.786282729682625e-09
the O 0 2.3120012571098414e-08
mouse O 0 7.712455385444628e-07
. O 0 3.351549437979884e-08

Furthermore O 0 1.8175495597461122e-06
, O 0 1.2122081116672234e-08
we O 0 4.266056674584462e-10
observed O 0 7.322740191995081e-10
no O 0 1.1389323512078775e-10
correlation O 0 2.53391724269747e-10
between O 0 2.0434280656456139e-10
the O 0 4.95930518873422e-10
somatic O 0 5.894147037110997e-08
mutation O 0 2.5703383865760543e-09
rate O 0 1.9344361668061083e-09
and O 0 6.483109604715764e-10
tissue O 0 5.4088765466531186e-08
proliferation O 0 2.357090124860406e-06
capacity O 0 1.1088072682241545e-07
. O 0 6.061282675773327e-08

The O 0 1.370599079564272e-06
somatic O 0 5.712389793188777e-06
mutation O 0 3.8828112280953064e-08
rates O 0 6.987810774461423e-09
in O 0 3.831513925578456e-11
different O 0 4.8312524120186495e-11
tissues O 0 1.9792009808838884e-08
were O 0 1.6591682472366642e-09
also O 0 4.905480882611002e-11
not O 0 5.410723084853242e-12
correlated O 0 4.247528717638005e-10
to O 0 2.6027593968969143e-10
the O 0 7.058835294060373e-09
relative O 0 1.930389043991454e-05
inter O 1 0.9992042183876038
- O 0 0.036120928823947906
tissue O 0 1.1756632147807977e-06
difference O 0 9.28018550894194e-09
in O 0 1.0748041345820525e-10
transcriptional O 0 1.646419667267196e-09
levels O 0 1.1167117924815173e-10
of O 0 2.0756867058491224e-10
the O 0 3.4692521078127925e-10
three O 0 2.0460841354541515e-10
genes O 0 6.487166914759257e-10
( O 0 9.42919964330713e-10
DMAHP O 0 7.96831154730171e-05
, O 0 5.416409987191173e-09
DMPK O 0 0.0007427658420056105
and O 0 2.468733661942224e-08
59 O 0 1.309360584400565e-07
) O 0 9.988554428019825e-10
surrounding O 0 2.4155413669291192e-08
the O 0 1.4367678602411615e-08
repeat O 0 8.974173226761195e-08
. O 0 1.0035805075858661e-08
. O 0 5.395893154513942e-08

A O 0 9.598185215509147e-07
novel O 0 4.105660877939954e-07
missense O 0 1.3209098597144475e-06
mutation O 0 1.7369082172535855e-08
in O 0 1.2267025173429147e-09
patients O 0 8.978038756879414e-09
from O 0 5.683618464757956e-09
a O 0 3.707224038862478e-08
retinoblastoma B-Disease 1 0.9076260924339294
pedigree O 0 1.0002315320889466e-05
showing O 0 2.865757631198562e-09
only O 0 3.137970716604599e-10
mild O 0 2.892437294121919e-07
expression O 0 9.55003898184259e-09
of O 0 1.4062075059939616e-08
the O 0 6.009719388799795e-09
tumor B-Disease 0 1.0495133295762571e-07
phenotype O 0 1.0912005166119343e-07
. O 0 5.101861599854374e-09

We O 0 1.8204363527729583e-07
have O 0 2.5949484783183152e-09
used O 0 2.4307642565446486e-09
single O 0 2.290331257981393e-09
strand O 0 1.0029815200596204e-08
conformation O 0 1.8148921254734773e-10
polymorphism O 0 6.434646149244827e-10
analysis O 0 2.1937915026248866e-11
to O 0 1.875955467356416e-11
study O 0 2.537678747693839e-11
the O 0 7.67437002835436e-10
27 O 0 1.8203785145942675e-08
exons O 0 6.061317776584474e-07
of O 0 2.3267370252710862e-08
the O 0 3.457846986520963e-08
RB1 O 0 7.074856966937659e-06
gene O 0 1.8949595226303018e-09
in O 0 4.8328379492756923e-11
individuals O 0 4.13081114453151e-12
from O 0 3.0091468206094873e-10
a O 0 2.7229083432445123e-09
family O 0 1.1236823915794503e-08
showing O 0 1.53064450003626e-09
mild O 0 1.7656105910646147e-06
expression O 0 4.8055728285589794e-08
of O 0 5.4302638829994976e-08
the O 0 4.7534740588162094e-08
retinoblastoma B-Disease 0 4.004069705842994e-05
phenotype O 0 5.69289250051952e-06
. O 0 1.0921665705154737e-07

In O 0 4.092142802392118e-08
this O 0 2.254341158192119e-09
family O 0 5.778311162885075e-09
affected O 0 2.9889374308922356e-10
individuals O 0 1.513104745665128e-11
developed O 0 9.569826175948037e-08
unilateral B-Disease 0 0.12918990850448608
tumors I-Disease 1 1.0
and O 0 6.773596851417096e-06
, O 0 6.883041359095898e-10
as O 0 1.76471295909586e-10
a O 0 8.649976568353424e-11
result O 0 1.9544772744684025e-10
of O 0 8.637022763657853e-10
linkage O 0 1.5932229757709138e-08
analysis O 0 6.434670574151369e-10
, O 0 4.94269174200479e-11
unaffected O 0 1.9878940715756244e-09
mutation O 0 1.3145085020482838e-10
carriers O 0 3.648408797296554e-10
were O 0 4.1642780890249753e-10
also O 0 3.5845088008912285e-10
identified O 0 9.664228306505152e-10
within O 0 4.253335461612551e-09
the O 0 4.152543198188141e-08
pedigree O 0 2.408117779850727e-06
. O 0 1.8885170049998123e-07

A O 0 4.430908575159265e-06
single O 0 1.5999262359400745e-07
band O 0 1.5489825955228298e-07
shift O 0 3.783220492437067e-08
using O 0 5.7138684894653125e-09
SSCP O 0 1.934067222464364e-05
was O 0 5.526741020389636e-08
identified O 0 5.948172621117465e-09
in O 0 4.5302586682005597e-10
exon O 0 1.5376555495549837e-07
21 O 0 6.233037197489466e-09
which O 0 3.79921753779211e-11
resulted O 0 8.313628896416958e-09
in O 0 9.706755399463418e-10
a O 0 1.1874747407603081e-08
missense O 0 3.1767780228619813e-07
mutation O 0 2.354981454288918e-08
converting O 0 1.4083352084526268e-07
a O 0 4.36556213401218e-08
cys O 0 2.025588219112251e-05
- O 0 3.39465327670041e-06
- O 0 1.8462898196958122e-06
> O 0 1.4889959629726945e-06
arg O 0 8.434313940597349e-07
at O 0 5.362995825208827e-09
nucleotide O 0 2.2267856447655276e-09
position O 0 5.923672219410037e-09
28 O 0 8.345913293794638e-09
in O 0 2.7403612712362246e-10
the O 0 1.4722487229335002e-08
exon O 0 2.5379567887284793e-06
. O 0 1.380788745564132e-07

The O 0 5.400680151979032e-07
mutation O 0 2.4932654696385725e-07
destroyed O 0 2.4837445380399004e-06
an O 0 4.523466046180147e-09
NdeI O 0 3.438515477682813e-06
restriction O 0 7.004413049571667e-08
enzyme O 0 4.64240379471903e-08
site O 0 1.4556967187218106e-07
. O 0 3.986802710187476e-08

Analysis O 0 1.1247744424736084e-07
of O 0 1.4160346495373233e-07
all O 0 7.596026030398662e-09
family O 0 5.5481570448989714e-09
members O 0 2.3321997111303006e-10
demonstrated O 0 9.006539958278381e-10
that O 0 8.431472880987556e-11
the O 0 2.880345295608322e-09
missense O 0 2.7185592443856876e-07
mutation O 0 6.26978788886845e-08
co O 0 1.3174060313758673e-06
- O 0 1.165286562354595e-06
segregated O 0 1.1396767085614101e-08
with O 0 2.7900851073958677e-10
patients O 0 1.9340092194397585e-08
with O 0 1.4987856289394585e-08
tumors B-Disease 1 1.0
or O 0 0.0001773992262315005
who O 0 1.3885295402360498e-07
, O 0 6.068484048604716e-10
as O 0 2.526841791361534e-10
a O 0 3.1412641932071494e-10
result O 0 4.5809681048503137e-10
of O 0 2.7505737687505416e-09
linkage O 0 2.2224419637950632e-08
analysis O 0 4.6271234066530553e-10
had O 0 6.378704231480015e-10
been O 0 1.370595442695688e-10
predicted O 0 1.02848107808029e-09
to O 0 1.1998267657187256e-10
carry O 0 1.5312227041874849e-09
the O 0 1.1943710021000697e-08
predisposing O 0 7.853245733713266e-06
mutation O 0 3.548176152889937e-07
. O 0 3.967308259689162e-07

These O 0 3.7389522589137414e-08
observations O 0 2.2780686492751556e-07
point O 0 7.027040993534683e-08
to O 0 1.0333299771403404e-09
another O 0 2.615809790995627e-09
region O 0 8.73097416587143e-09
of O 0 3.567406281490548e-08
the O 0 5.123405344420462e-08
RB1 O 0 9.865476022241637e-05
gene O 0 4.7386530255266734e-09
where O 0 2.4144103383250126e-10
mutations O 0 2.843127989982097e-11
only O 0 9.993327346191627e-12
modify O 0 5.604236519296535e-10
the O 0 4.121151198077655e-10
function O 0 8.118619665431481e-11
of O 0 4.323223445901192e-10
the O 0 4.2472617090005826e-10
gene O 0 4.279642751292556e-10
and O 0 1.922613040994392e-10
raise O 0 1.8323600969871734e-10
important O 0 3.542031945524826e-10
questions O 0 2.740235816034442e-10
for O 0 3.5066050757537326e-11
genetic O 0 2.11057171739526e-09
counseling O 0 1.3705491186399854e-09
in O 0 2.117182124061756e-11
families O 0 1.6981851688746552e-11
with O 0 4.9430472735811914e-12
these O 0 6.418315878775616e-11
distinctive O 0 2.716239144717747e-08
phenotypes O 0 2.416871325294778e-07
. O 0 7.74720376739424e-09
. O 0 2.5425855199046055e-08

Maternal B-Disease 0 0.0004294765240047127
disomy I-Disease 0 0.002925888868048787
and O 0 3.716146238730289e-05
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 0.0014034369960427284
with O 0 6.245151062955756e-09
gamete O 0 4.717571471246629e-07
complementation O 0 1.2004423979306011e-06
in O 0 5.83899928408016e-10
a O 0 2.0375718889908967e-09
case O 0 5.91761972756899e-09
of O 0 3.114646673907373e-08
familial O 0 1.0281695494995802e-06
translocation O 0 4.0215994090431195e-07
( O 0 1.1916079234453036e-09
3 O 0 6.087975457091943e-09
; O 0 7.701101423229773e-10
15 O 0 1.2577880070807623e-08
) O 0 9.982574766809194e-10
( O 0 1.6720409501402855e-09
p25 O 0 4.5322252617552294e-07
; O 0 1.9614281310254e-09
q11 O 0 1.8962771264341427e-07
. O 0 7.918555255947979e-10
2 O 0 3.05947658318928e-08
) O 0 3.917175472878398e-09
. O 0 7.044446448389863e-08

Maternal B-Disease 0 0.055603913962841034
uniparental I-Disease 1 0.9999969005584717
disomy I-Disease 1 0.9999300241470337
( I-Disease 0 1.6876660083653405e-05
UPD I-Disease 1 1.0
) I-Disease 0 2.957139777493012e-08
for I-Disease 0 2.734869442022614e-09
chromosome I-Disease 0 7.922063893772702e-09
15 I-Disease 0 2.58662691265954e-09
is O 0 9.120421778918697e-11
responsible O 0 3.524187608405782e-10
for O 0 8.1636197801771e-11
an O 0 2.476549347540935e-11
estimated O 0 4.332127712114442e-11
30 O 0 2.1525550786272163e-10
% O 0 3.1828404495337637e-11
of O 0 1.5097038896794146e-10
cases O 0 7.493406450898021e-10
of O 0 1.2144781749157119e-06
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9741991758346558
PWS B-Disease 1 1.0
) O 0 4.284604528947966e-07
. O 0 2.3373462454401306e-07

We O 0 2.798301750317478e-07
report O 0 1.4422536054325974e-08
on O 0 7.575422955596878e-09
an O 0 5.019857446386666e-11
unusual O 0 7.08735181653708e-10
case O 0 7.268834423257431e-09
of O 0 1.8484319852518638e-08
maternal B-Disease 0 9.388948092237115e-05
disomy I-Disease 0 0.4296482801437378
15 I-Disease 0 9.593054528522771e-08
in O 0 5.345002662693332e-09
PWS B-Disease 1 1.0
that O 0 6.177693467890322e-09
is O 0 6.811290420571936e-10
most O 0 4.498089054005838e-11
consistent O 0 2.1615116641005017e-10
with O 0 3.791225666738285e-11
adjacent O 0 2.332059700904665e-08
- O 0 1.1112950915048714e-07
1 O 0 1.1538149102818807e-08
segregation O 0 2.3753161659811894e-09
of O 0 2.0290424895819115e-10
a O 0 5.869997266039206e-10
paternal O 0 2.7916955858131587e-08
t O 0 1.3281822752730932e-08
( O 0 4.3793019210980333e-10
3 O 0 3.565588269083264e-09
; O 0 3.736930764830504e-10
15 O 0 1.5346377502112318e-09
) O 0 2.768657803020602e-10
( O 0 6.498882543226614e-10
p25 O 0 9.71317106746028e-08
; O 0 8.604515433496829e-10
q11 O 0 8.258365369329113e-08
. O 0 2.0698907865490668e-10
2 O 0 1.8063767148746024e-09
) O 0 2.0352159194048092e-11
with O 0 2.9135392015655626e-11
simultaneous O 0 8.411017660137077e-09
maternal O 0 5.782662810815964e-07
meiotic O 0 4.454921872820705e-05
nondisjunction O 0 9.342878001916688e-06
for O 0 1.6768577637549242e-08
chromosome O 0 4.369519146507628e-08
15 O 0 3.393903469373072e-08
. O 0 6.21260127786627e-08

The O 0 7.179748422458943e-07
patient O 0 4.279377776583715e-07
( O 0 4.113998919308415e-09
J O 0 1.58257492444136e-07
. O 0 6.594002011084399e-10
B O 0 2.3996113540647457e-08
. O 0 1.3725000302944323e-10
) O 0 4.046298018867134e-11
, O 0 6.560954557421894e-11
a O 0 1.10742837122757e-09
17 O 0 7.95473908965505e-09
- O 0 4.825568566957372e-08
year O 0 1.1480238981675939e-08
- O 0 7.014988909759268e-07
old O 0 4.681881819124101e-06
white O 0 5.16293887642405e-08
male O 0 7.995653583670048e-10
with O 0 4.1638970049717727e-10
PWS B-Disease 1 1.0
, O 0 2.3414862937443104e-08
was O 0 6.248692585586468e-08
found O 0 8.773672344197792e-10
to O 0 7.369440613302913e-10
have O 0 6.927214912799684e-10
47 O 0 2.047155689410829e-08
chromosomes O 0 6.910376160185194e-10
with O 0 4.220636340424022e-10
a O 0 2.490346595607207e-08
supernumerary O 0 0.010619573295116425
, O 0 4.12867473542633e-09
paternal O 0 1.3312862847669749e-06
der O 0 0.000136001588543877
( O 0 4.161040401129412e-09
15 O 0 3.1003370981608214e-09
) O 0 5.666066921206081e-11
consisting O 0 2.619033601103382e-10
of O 0 2.1604742439507163e-09
the O 0 5.936181768362303e-09
short O 0 2.0184220517194262e-08
arm O 0 1.092695924853615e-07
and O 0 1.2266042626052354e-09
the O 0 1.1376222630588018e-08
proximal O 0 0.0007869296823628247
long O 0 1.4840824178463663e-06
arm O 0 1.7710881365928799e-06
of O 0 8.907682769176972e-08
chromosome O 0 2.3279534744347075e-08
15 O 0 7.529930456939837e-09
, O 0 4.725527191773438e-10
and O 0 1.1738573668651497e-08
distal O 1 0.5027298331260681
chromosome O 0 0.00016312743537127972
arm O 1 0.7100215554237366
3p O 1 0.9999825954437256
. O 0 8.29595865070587e-06

The O 0 3.878750703734113e-06
t O 0 5.6556456229373e-07
( O 0 4.900211347802497e-09
3 O 0 1.8224282527512514e-08
; O 0 1.3562622136475966e-09
15 O 0 7.929381595772611e-09
) O 0 7.68589913935358e-10
was O 0 6.608069202940214e-09
present O 0 1.6330744534442942e-09
in O 0 2.308108287829569e-10
the O 0 5.340984321478004e-10
balanced O 0 6.832239218823588e-10
state O 0 2.933748036171302e-11
in O 0 1.0688300938754836e-11
the O 0 1.1495127072436162e-10
patients O 0 4.0058087402705667e-10
father O 0 7.804618462614599e-08
and O 0 1.4329089026432484e-08
a O 0 2.697498473480664e-07
sister O 0 3.6742269003298134e-05
. O 0 1.8371758869761834e-06

Fluorescent O 0 2.0230516383890063e-05
in O 0 5.7805188191650814e-08
situ O 0 2.657775212355773e-06
hybridization O 0 3.917715574175418e-08
analysis O 0 1.2970357010644307e-09
demonstrated O 0 3.747846921697828e-09
that O 0 1.0332939365254035e-10
the O 0 1.8371457244370504e-08
PWS B-Disease 1 1.0
critical O 0 6.40615908196196e-05
region O 0 2.2219848005988752e-07
resided O 0 2.346462935065574e-07
on O 0 6.839909527656118e-09
the O 0 4.6341361303881e-10
derivative O 0 4.810440046298936e-09
chromosome O 0 1.5041000667181947e-09
3 O 0 1.4904832923434697e-09
and O 0 3.7395884999735785e-11
that O 0 1.6739793579079176e-11
there O 0 2.1657706184008418e-10
was O 0 1.5378969209223214e-08
no O 0 7.220440356725533e-10
deletion O 0 6.344514247302868e-09
of O 0 2.526134412761394e-09
the O 0 1.1285086642942588e-08
PWS B-Disease 1 1.0
region O 0 1.1179764669577708e-06
on O 0 5.7650048290724953e-08
the O 0 2.2834480972733218e-09
normal O 0 1.6135529579131003e-09
pair O 0 2.889865013955273e-09
of O 0 7.660039269552499e-10
15s O 0 6.034498483131756e-07
present O 0 2.2938472454825387e-08
in O 0 2.337965376852935e-08
J O 0 0.00010408004891360179
. O 0 9.695917242424912e-07

B O 0 0.0007013495196588337
. O 0 8.258148227469064e-06

Methylation O 0 2.365128693782026e-06
analysis O 0 1.4799014991240256e-07
at O 0 1.2869763565959147e-07
exon O 0 2.285057547624092e-07
alpha O 0 4.4948883726192435e-08
of O 0 5.351489917870822e-09
the O 0 4.776246953497321e-09
small O 0 3.4182443542363217e-09
nuclear O 0 4.948576020069595e-07
ribonucleoprotein O 0 6.654403023276245e-06
- O 0 1.4587958219181019e-07
associated O 0 1.6378947975681513e-08
polypeptide O 0 1.5912557671526883e-07
N O 0 4.502009787188399e-08
( O 0 6.866244239844832e-10
SNRPN O 0 1.1038438287869212e-06
) O 0 1.7482633396515013e-10
gene O 0 2.0287251045747468e-10
showed O 0 1.8095552833941042e-10
a O 0 9.517479165888076e-11
pattern O 0 8.576022114681336e-10
characteristic O 0 2.555360811840046e-09
of O 0 8.245078397806083e-09
only O 0 3.581515639616839e-10
the O 0 7.213599162447792e-10
maternal O 0 1.6132952751490848e-08
chromosome O 0 3.812345550358032e-09
15 O 0 1.9691575037228404e-09
in O 0 1.141969629969708e-09
J O 0 5.026671715313569e-05
. O 0 1.009444531518966e-06

B O 0 0.0006507029756903648
. O 0 1.2509626685641706e-05

Maternal B-Disease 0 9.817932732403278e-05
disomy I-Disease 0 0.00010064564412459731
was O 0 3.420418863697705e-07
confirmed O 0 9.915214427280716e-09
by O 0 3.5908453988042766e-10
polymerase O 0 1.56968127384971e-07
chain O 0 1.1111081832382297e-08
reaction O 0 8.071531776288055e-10
analysis O 0 1.055488696444229e-09
of O 0 5.212597908865746e-09
microsatellite O 0 5.345677891455125e-07
repeats O 0 1.307124364302581e-08
at O 0 1.5390112517721377e-09
the O 0 2.0633827979565922e-10
gamma O 0 6.453725553967615e-09
- O 0 2.1297083208082768e-08
aminobutyric O 0 2.9059660278107913e-07
acid O 0 1.849186404001557e-08
receptor O 0 9.16769593573008e-09
beta3 O 0 4.048891355523665e-07
subunit O 0 1.821653405897905e-08
( O 0 2.088307748948637e-09
GABRB3 O 0 5.624766345135868e-06
) O 0 8.090371039770616e-09
locus O 0 3.6872958730782557e-07
. O 0 2.6652829276940793e-08

A O 0 1.326925939793e-05
niece O 0 3.758759339689277e-05
( O 0 8.950955532327498e-09
B O 0 6.450147083114643e-08
. O 0 4.882091952929102e-10
B O 0 1.3139183074883931e-08
. O 0 1.1231949398338159e-10
) O 0 2.6721961449149845e-11
with O 0 2.1452544601840984e-11
45 O 0 1.0909289027694058e-09
chromosomes O 0 2.711629254470438e-10
and O 0 1.178857428341118e-10
the O 0 6.852820533254089e-10
derivative O 0 1.4162366390735315e-08
3 O 0 3.629448741548913e-09
but O 0 5.0546955510100133e-11
without O 0 2.825726874711165e-10
the O 0 1.4890229049768777e-09
der O 0 3.1277292578124616e-07
( O 0 3.739319409667985e-10
15 O 0 1.5451407930910932e-09
) O 0 4.2041495285083386e-10
demonstrated O 0 5.447450490692063e-09
a O 0 2.8965867482355634e-09
phenotype O 0 1.0160690955274276e-08
consistent O 0 1.780041114507469e-09
with O 0 2.2245167513590403e-11
that O 0 1.3363855161374616e-11
reported O 0 2.3298965534657157e-10
for O 0 2.2856300185836176e-10
haploinsufficiency O 0 3.856918624478567e-07
of O 0 6.327827861696278e-08
distal O 0 0.0015289655420929193
3 O 0 9.06564400793286e-06
p O 0 7.905938218755182e-06
. O 0 2.427860863463138e-07

Uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999998807907104
associated O 0 5.617379883915419e-06
with O 0 2.8156044606930664e-08
unbalanced O 0 3.353811962369946e-06
segregation O 0 8.027151920941833e-07
of O 0 6.876814495626604e-08
non O 0 9.465821335652436e-07
- O 0 4.12748295275378e-06
Robertsonian O 0 5.6720880820648745e-05
translocations O 0 1.684086100794957e-06
has O 0 1.9274899454302385e-09
been O 0 1.7359161330610107e-10
reported O 0 1.0563099006599685e-10
previously O 0 3.4043642904713067e-10
but O 0 7.499965232193873e-11
has O 0 2.0171602235774522e-11
not O 0 1.3561780171089666e-11
, O 0 4.221101246315584e-11
to O 0 8.061988576724133e-11
our O 0 1.3444556579145228e-09
knowledge O 0 5.042108242037102e-08
, O 0 3.202853537942474e-10
been O 0 1.1533120292117616e-10
observed O 0 1.396612825388388e-10
in O 0 2.269871443583149e-11
a O 0 9.430386471720453e-10
case O 0 4.5249951341475025e-08
of O 0 1.8458338217897108e-06
PWS B-Disease 1 1.0
. O 0 0.00022898890892975032

Furthermore O 0 3.423901944188401e-06
, O 0 2.1589428911283903e-08
our O 0 5.817613502046015e-09
findings O 0 2.1637196478963006e-09
are O 0 8.653508465350512e-11
best O 0 2.1250083914736706e-09
interpreted O 0 6.2994893745838e-09
as O 0 1.914249425638559e-09
true O 0 3.26641362846658e-08
gamete O 0 5.847631427968736e-07
complementation O 0 1.6156591300386935e-06
resulting O 0 3.7080869930150584e-08
in O 0 6.498713123193056e-09
maternal B-Disease 0 0.0001616801746422425
UPD I-Disease 1 1.0
15 I-Disease 0 1.1405275472498033e-05
and O 0 4.2609240153979044e-06
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9999456405639648
- I-Disease 1 0.9999932050704956
Jampel I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
type I-Disease 0 8.564850759285036e-06
2 I-Disease 0 1.4109191397437826e-06
and O 0 1.4242605317349444e-08
Stuve B-Disease 1 0.999967098236084
- I-Disease 1 0.9993976354598999
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 3.3462893567204333e-10
a O 0 5.372411959747581e-10
case O 0 2.483590666457758e-09
for O 0 5.156811644368986e-10
" O 0 5.826242155393402e-09
lumping O 0 4.603307601769302e-08
" O 0 2.6838259614692106e-08
. O 0 2.584887504042399e-08

Recent O 0 2.753764931640035e-07
studies O 0 1.8723872230452798e-08
demonstrated O 0 1.0839336539447686e-08
the O 0 9.4436525266417e-10
existence O 0 4.2483248030578125e-09
of O 0 7.643405020019145e-09
a O 0 1.753520773029038e-09
genetically O 0 6.5455121323054755e-09
distinct O 0 2.6205440040172334e-09
, O 0 1.1319718079549901e-10
usually O 0 7.71225375229001e-11
lethal O 0 1.4695407113407555e-09
form O 0 4.526889973988091e-10
of O 0 9.458691607733272e-09
the O 0 2.78163945210963e-08
Schwartz B-Disease 0 0.0013806622009724379
- I-Disease 0 0.03716167062520981
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 5.750321179220919e-07
SJS B-Disease 1 0.9999997615814209
) O 0 6.802997720711801e-09
of O 0 1.6976737526874786e-07
myotonia B-Disease 1 1.0
and O 0 1.1259048733336385e-05
skeletal B-Disease 1 0.9999953508377075
dysplasia I-Disease 1 1.0
, O 0 2.100080109812552e-08
which O 0 1.5537496844686416e-09
we O 0 3.923442015718592e-09
called O 0 1.3432598677809438e-07
SJS B-Disease 1 0.9989140033721924
type I-Disease 0 3.98658994527068e-06
2 I-Disease 0 3.77729770661972e-06
. O 0 1.5910462991541863e-07

This O 0 4.0935839251687867e-07
disorder O 0 0.003741257591173053
is O 0 7.930681888979052e-09
reminiscent O 0 3.682130454762955e-06
of O 0 6.444699351959571e-08
another O 0 1.5167239686419975e-09
rare O 0 1.1556958057212796e-08
condition O 0 8.017657364689512e-07
, O 0 1.3551451072402187e-09
the O 0 1.1914426778503184e-08
Stuve B-Disease 1 0.9996161460876465
- I-Disease 1 0.9999504089355469
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 9.552786650601774e-06
SWS B-Disease 1 0.99055016040802
) O 0 1.2309494534790133e-09
, O 0 1.915343994518537e-10
which O 0 1.8218077046938674e-10
comprises O 0 1.2740903887475952e-09
campomelia B-Disease 0 3.035563167941291e-06
at O 0 6.017782716583042e-09
birth O 0 1.585166309325814e-08
with O 0 3.408901383394891e-09
skeletal B-Disease 1 0.9999924898147583
dysplasia I-Disease 1 1.0
, O 0 3.333418874262861e-07
contractures B-Disease 1 0.9999992847442627
, O 0 1.4268271897321938e-08
and O 0 8.815747243318128e-09
early B-Disease 0 1.2838238490076037e-06
death I-Disease 0 4.6802883844065946e-06
. O 0 4.3065051613666583e-07

To O 0 7.900730736309924e-08
test O 0 1.4463553910104565e-08
for O 0 6.187560463999375e-10
possible O 0 2.0183295035280935e-08
nosologic O 0 0.00023865114781074226
identity O 0 1.5854777046797608e-08
between O 0 1.3299307211056544e-09
these O 0 6.111322004009878e-10
disorders O 0 5.739989319408778e-06
, O 0 2.1104377967429144e-10
we O 0 9.01500818439871e-11
reviewed O 0 1.0375840187037966e-09
the O 0 2.0848760218239448e-10
literature O 0 2.692518985547565e-10
and O 0 4.642148471178942e-11
obtained O 0 2.556617417770468e-10
a O 0 1.1770981411807213e-10
follow O 0 2.1619075973866586e-10
- O 0 9.107497866978065e-09
up O 0 5.334122588074308e-10
of O 0 6.177878764113132e-10
the O 0 5.027094296394807e-10
only O 0 9.950898438582101e-11
two O 0 7.857572925651368e-11
surviving O 0 1.8532122680881002e-07
patients O 0 5.497028165990514e-09
, O 0 2.93735508138937e-10
one O 0 2.5895183219937223e-10
with O 0 1.7849778322087673e-09
SJS B-Disease 1 0.9998437166213989
type I-Disease 0 3.447466588113457e-05
2 I-Disease 0 4.185753823549021e-06
at O 0 2.8588407197105425e-09
age O 0 2.1929098814599257e-10
10 O 0 8.186822747502376e-11
years O 0 1.0130454114465337e-10
and O 0 1.0957895701935172e-10
another O 0 4.860814528662161e-10
with O 0 8.761531500312003e-10
SWS B-Disease 0 0.026651468127965927
at O 0 3.710683316171526e-08
age O 0 4.157486355182982e-09
7 O 0 3.5306431556136886e-08
years O 0 1.4245049584360459e-08
. O 0 6.431596943912155e-08

Patients O 0 3.1990584830055013e-06
reported O 0 3.783624435982347e-08
as O 0 2.770381257732879e-09
having O 0 3.3602145510513992e-09
either O 0 2.7730692409022595e-07
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 0.005606576334685087
SWS B-Disease 0 0.017159296199679375
presented O 0 7.918498745596025e-09
a O 0 2.0788920584990933e-10
combination O 0 1.964659546160874e-09
of O 0 3.4336724574757227e-09
a O 0 2.8253777095699206e-09
severe O 0 8.726308806217276e-06
, O 0 1.4839258710708236e-08
prenatal O 0 0.0036896595265716314
- O 0 0.3468541204929352
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
( O 0 7.86443266065362e-09
with O 0 2.8113098515802903e-09
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 0.9999997615814209
respiratory O 1 1.0
and O 0 3.480782106635161e-05
feeding O 0 1.4050406207388733e-06
difficulties O 0 8.606810979472357e-07
, O 0 5.878602604703076e-10
tendency O 0 5.3336166594419865e-09
to O 0 4.186172297693247e-09
hyperthermia B-Disease 1 1.0
, O 0 5.2720814380791126e-09
and O 0 1.1079438477779036e-09
frequent O 0 4.645377416068186e-09
death O 0 2.818184157149517e-07
in O 0 1.8516914668254003e-09
infancy O 0 3.663345751192537e-06
) O 0 1.1614756378897084e-10
with O 0 3.066740264512369e-11
a O 0 1.8707762006187068e-09
distinct O 0 1.0794754246035154e-07
campomelic B-Disease 1 0.9999845027923584
- I-Disease 1 0.9994366765022278
metaphyseal I-Disease 1 0.9999841451644897
skeletal I-Disease 1 0.9999997615814209
dysplasia I-Disease 1 1.0
. O 0 8.171109948307276e-05

The O 0 9.735558137435874e-08
similarity O 0 2.6857290436055337e-07
of O 0 6.26775502610144e-08
the O 0 1.1758225504365782e-08
clinical O 0 8.92050167067282e-08
and O 0 1.7566408327951422e-09
radiographic O 0 0.00010288918565493077
findings O 0 6.493783644145878e-08
is O 0 8.320986122356544e-10
so O 0 1.1090362656007713e-10
extensive O 0 2.788288488986268e-09
that O 0 1.0943818073982925e-10
these O 0 3.246038993154343e-10
disorders O 0 1.2372181572573027e-06
appear O 0 8.325545586274075e-09
to O 0 6.582893674611512e-10
be O 0 6.774326655190066e-10
a O 0 2.458479197997576e-09
single O 0 7.176919503137924e-09
entity O 0 6.489388226782467e-08
. O 0 5.761645525126369e-07

The O 0 5.247504759609001e-07
follow O 0 9.60209760592079e-08
- O 0 6.139168817753671e-07
up O 0 5.0946944440966035e-09
observation O 0 2.8487342262906168e-08
of O 0 1.9704462506098253e-09
an O 0 4.370604225756303e-11
identical O 0 9.679910206727982e-10
and O 0 3.3353164674565505e-10
unique O 0 8.794481254348341e-10
pattern O 0 3.1191650151640715e-08
of O 0 1.6745458424338722e-06
progressive O 1 0.9999984502792358
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 1.0904821934332176e-08
the O 0 1.1908905861446328e-08
two O 0 8.382218252833695e-10
patients O 0 6.954805065184644e-10
( O 0 2.3673096816168027e-10
one O 0 3.089273836742734e-10
with O 0 8.833870301927504e-10
SJS B-Disease 1 0.9850335717201233
type I-Disease 0 1.4177414868754568e-06
2 I-Disease 0 6.420027034437226e-07
, O 0 2.0039046810804706e-10
one O 0 2.3480850597223935e-10
with O 0 3.6887828902543163e-10
SWS B-Disease 0 3.394428131286986e-05
) O 0 1.3048818692240616e-09
surviving O 0 8.069021077972138e-07
beyond O 0 3.334731957238546e-07
infancy O 0 1.7079252074836404e-06
adds O 0 3.4805145432414974e-09
to O 0 1.4076551035913099e-10
the O 0 2.155969847095207e-10
evidence O 0 1.5464438618550957e-09
in O 0 2.1223987844987136e-10
favor O 0 3.981921903317698e-09
of O 0 7.030564574961318e-09
identity O 0 3.337470744213533e-08
. O 0 8.19180101530037e-08

The O 0 8.809075779936393e-07
hypothesis O 0 1.3080755252303788e-06
that O 0 2.4656136687895014e-08
SWS B-Disease 0 0.03337772190570831
and O 0 2.4614607241346675e-07
SJS B-Disease 1 0.9999995231628418
type I-Disease 0 5.171087195776636e-06
2 I-Disease 0 1.7285771036767983e-07
are O 0 4.511450241162507e-11
the O 0 6.119136863880215e-10
same O 0 1.75817271852452e-09
disorder O 0 3.915445461188938e-07
should O 0 4.3199674393257226e-10
be O 0 1.0158762719925107e-10
testable O 0 2.4533781672886334e-09
by O 0 3.4345581934047686e-12
molecular O 0 1.2118277215034112e-10
methods O 0 1.3180567748349858e-09
. O 0 1.2183918318697806e-09
. O 0 1.6711297234905942e-08

A O 0 3.961885795433773e-06
mouse O 0 4.562961066767457e-07
model O 0 6.597465240787415e-09
of O 0 5.538567382501469e-09
severe O 1 0.9998315572738647
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9795753359794617
defects O 1 0.9999998807907104
in O 0 4.026648880994799e-08
hemostasis O 1 0.9997037053108215
and O 0 7.019057193247136e-07
thrombosis B-Disease 1 0.9999996423721313
. O 0 3.112333797616884e-05

von B-Disease 1 0.9999891519546509
Willebrand I-Disease 1 1.0
factor I-Disease 0 0.0004676203243434429
( I-Disease 0 2.3663924366701394e-06
vWf I-Disease 1 0.9976739287376404
) I-Disease 0 1.0255236020384473e-06
deficiency I-Disease 1 1.0
causes O 0 0.020568545907735825
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 7.508086127927527e-06
humans O 0 3.98459451389499e-06
. O 0 9.291382951914784e-08

We O 0 3.7423703247441154e-07
generated O 0 2.1054665566566655e-08
a O 0 6.668349872285262e-09
mouse O 0 1.5658143226460197e-08
model O 0 3.9546643737509157e-10
for O 0 4.7803067060314675e-11
this O 0 4.166309658382161e-11
disease O 0 1.571645036335667e-09
by O 0 4.8305706656925906e-11
using O 0 8.319272493118035e-10
gene O 0 3.2091780344245535e-09
targeting O 0 1.330735877047573e-08
. O 0 3.509386914402057e-08

vWf B-Disease 1 0.9945705533027649
- I-Disease 1 0.9999995231628418
deficient I-Disease 1 0.9999923706054688
mice O 0 3.3985625123023055e-06
appeared O 0 4.000109399271423e-08
normal O 0 7.0085941494824056e-09
at O 0 1.859953080440846e-09
birth O 0 2.282037447898233e-09
; O 0 3.4407182658569013e-10
they O 0 2.0707989489832102e-10
were O 0 2.316453917572403e-09
viable O 0 1.4999802715465194e-06
and O 0 3.847821972158272e-08
fertile O 0 2.4923649107222445e-05
. O 0 2.99266588399405e-07

Neither O 0 0.00010143106919713318
vWf O 0 0.0012820269912481308
nor O 0 9.512066753813997e-05
vWf O 0 0.00033053720835596323
propolypeptide O 0 0.00028015970019623637
( O 0 1.3356719819057616e-07
von B-Disease 0 0.008072828873991966
Willebrand I-Disease 1 0.9999896287918091
antigen O 0 0.00036464270669966936
II O 1 1.0
) O 0 1.9083955749010784e-08
were O 0 1.7785106720680233e-09
detectable O 0 1.8876592733363395e-08
in O 0 1.2227657775198963e-10
plasma O 0 3.2022504647954975e-09
, O 0 5.1861046707069036e-11
platelets O 0 5.529521729386033e-09
, O 0 7.025811876726351e-11
or O 0 3.060173781044284e-10
endothelial O 0 1.1734186067258179e-08
cells O 0 9.947317414216172e-10
of O 0 3.789768943107674e-09
the O 0 1.7372956406802587e-08
homozygous O 0 9.65469411084996e-08
mutant O 0 2.862375936274475e-07
mice O 0 2.1481919532106986e-07
. O 0 4.6029210665210485e-08

The O 0 1.3331118680071086e-05
mutant O 0 0.00010903614020207897
mice O 0 1.448733428333071e-06
exhibited O 0 1.2155611273101385e-07
defects O 0 0.00034652667818591
in O 0 4.794135755048501e-09
hemostasis O 0 0.001266029430553317
with O 0 1.933344373483692e-09
a O 0 1.5072481929223613e-08
highly O 0 1.0927913081104634e-06
prolonged O 1 0.9999970197677612
bleeding O 1 0.9962000250816345
time O 0 3.5524749364412855e-08
and O 0 3.3126403842231866e-09
spontaneous O 0 7.729978435122575e-09
bleeding O 0 7.587457417912447e-08
events O 0 4.8912141697998734e-11
in O 0 1.7678216529537494e-11
approximately O 0 2.8605121743519035e-11
10 O 0 6.929854606818608e-11
% O 0 1.3913747931582066e-10
of O 0 4.767436667663105e-09
neonates O 0 2.353931677134824e-06
. O 0 9.471627890889067e-07

As O 0 2.1044431264272134e-07
in O 0 2.451951308657385e-09
the O 0 2.384253683374027e-09
human O 0 4.334677949913157e-09
disease O 0 4.1463076172476576e-07
, O 0 4.225114702549604e-10
the O 0 1.4921816005042388e-09
factor O 0 9.512044485404658e-09
VIII O 1 1.0
level O 0 2.598774699436035e-05
in O 0 1.060970755695223e-09
these O 0 1.0744351935931817e-10
mice O 0 6.090457582708098e-10
was O 0 3.700572626108567e-10
reduced O 0 4.286071497716648e-10
strongly O 0 2.2370953700612262e-10
as O 0 8.60761392718068e-11
a O 0 1.1661638321669443e-10
result O 0 4.400049213870716e-10
of O 0 3.5938965137205514e-09
the O 0 2.3719388675402797e-09
lack O 0 2.368233253946528e-08
of O 0 1.9651915650342744e-09
protection O 0 1.5858134361224074e-08
provided O 0 1.690282691590994e-09
by O 0 4.251224650086982e-10
vWf O 0 3.894756446243264e-06
. O 0 4.2864931515396165e-07

Defective O 0 0.04613823443651199
thrombosis B-Disease 1 0.9999996423721313
in O 0 1.956081177922897e-06
mutant O 0 5.598115876637166e-06
mice O 0 1.1395902532740365e-07
was O 0 2.5152557370233808e-08
also O 0 2.752640337888579e-10
evident O 0 1.5382314089151805e-08
in O 0 1.6059101271004295e-10
an O 0 4.53034311453937e-11
in O 0 6.280359565735694e-11
vivo O 0 2.7411886094341753e-09
model O 0 8.711075194511864e-10
of O 0 7.007727731433988e-08
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 0 0.00019576482009142637

In O 0 5.232543287547742e-08
this O 0 1.6037774441812758e-09
model O 0 3.561231753934635e-09
, O 0 4.968706557306746e-10
the O 0 5.664711366648589e-09
exteriorized O 0 1.4233245565264951e-05
mesentery O 0 5.0998798542423174e-05
was O 0 1.3242417651326832e-07
superfused O 0 2.6765061988953676e-07
with O 0 2.811764432397723e-10
ferric O 0 0.0001284521713387221
chloride O 0 2.2785757209931035e-06
and O 0 1.6414725578783873e-08
the O 0 1.4028668005039435e-08
accumulation O 0 7.262130452545534e-08
of O 0 5.48682841383652e-08
fluorescently O 0 1.3725761164096184e-05
labeled O 0 1.6229809318701882e-07
platelets O 0 5.054548779526158e-08
was O 0 1.7925049888845024e-08
observed O 0 9.973096792847969e-10
by O 0 2.3971799545385863e-10
intravital O 0 7.047879648780508e-07
microscopy O 0 1.177986405309639e-06
. O 0 4.298098019717145e-07

We O 0 2.7824361836792377e-07
conclude O 0 2.3466307652597607e-07
that O 0 6.729625745549583e-10
these O 0 8.874114221235629e-10
mice O 0 1.805371852015014e-08
very O 0 4.934640474019147e-10
closely O 0 2.4478017390805462e-09
mimic O 0 4.731827516479825e-07
severe O 1 0.9723178148269653
human O 1 0.9922542572021484
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 1.6359457731596194e-05
will O 0 5.383161694183514e-10
be O 0 3.981226806559768e-11
very O 0 1.7853982181570416e-11
useful O 0 6.834412202838536e-11
for O 0 3.0688565837849735e-12
investigating O 0 1.8766856124674547e-11
the O 0 8.598588507879867e-11
role O 0 5.746259024164146e-10
of O 0 2.38845032640711e-09
vWf O 0 1.0701697874537786e-06
in O 0 4.5028469841668084e-10
normal O 0 3.802730130786358e-09
physiology O 0 1.2253702053044435e-08
and O 0 8.699779785459327e-11
in O 0 8.442464088931345e-11
disease O 0 8.537869078395488e-09
models O 0 5.009131331945582e-09
. O 0 2.3899779932889942e-08
. O 0 2.0219675889165956e-07

Oral O 0 0.00025192552129738033
contraceptives O 0 0.005491422023624182
and O 0 8.02416533218775e-09
the O 0 4.8243329331398854e-09
risk O 0 7.170791604949045e-08
of O 0 1.9102266378467903e-05
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 9.578631761542056e-06

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 0.999998927116394
Clinical O 0 1.562248326081317e-05
Study O 0 3.8155775428094785e-08
Group O 0 9.174097925779279e-09
. O 0 3.257634517694896e-08

BACKGROUND O 0 2.212099161624792e-06
Women O 0 8.920306715509696e-10
with O 0 5.836246069756967e-11
mutations O 0 3.0942862161431606e-10
in O 0 7.09540898258254e-11
either O 0 6.340156732953517e-10
the O 0 2.679630517476994e-09
BRCA1 O 0 4.422026744776986e-09
or O 0 7.510276289757201e-10
the O 0 1.7974340904558517e-09
BRCA2 O 0 4.022755017984991e-09
gene O 0 1.632466245515829e-10
have O 0 2.3532982854068685e-11
a O 0 3.1774860520528136e-10
high O 0 9.805981804333896e-09
lifetime O 0 2.8477996849574083e-08
risk O 0 4.938952997690649e-07
of O 0 0.08021634817123413
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 9.611036375645199e-07

Oral O 0 0.0959506407380104
contraceptives O 1 0.9999980926513672
protect O 0 0.18626801669597626
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 5.905915312354182e-09
general O 0 3.512929680482557e-08
, O 0 1.2808976102007819e-10
but O 0 4.035908066080118e-11
it O 0 1.0161101994532462e-11
is O 0 5.196062764084575e-12
not O 0 2.8597361024368384e-12
known O 0 7.513224070665458e-11
whether O 0 6.183675793636212e-11
they O 0 8.973338738726966e-11
also O 0 6.641234229221027e-10
protect O 0 1.7538620555868079e-09
against O 0 1.3839574819485279e-08
hereditary B-Disease 1 1.0
forms I-Disease 1 0.6329239010810852
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.153436611251891e-07

METHODS O 0 6.9355633058876265e-06
We O 0 3.5258448605191006e-08
enrolled O 0 1.927248405309001e-08
207 O 0 6.661650342465464e-09
women O 0 1.7730556606254666e-11
with O 0 1.062716581401446e-09
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 7.690203318588829e-08
161 O 0 1.2154122153162916e-08
of O 0 5.492752030988868e-09
their O 0 6.801090801644705e-09
sisters O 0 1.7247631376449135e-06
as O 0 4.772385597817674e-09
controls O 0 2.0084332419401107e-08
in O 0 1.9974633058694735e-10
a O 0 2.1469266364704254e-09
case O 0 5.585417994780073e-08
- O 0 3.528536751673528e-07
control O 0 3.8250643541459795e-08
study O 0 2.617142280669782e-09
. O 0 1.3342227767054737e-08

All O 0 7.322677220145124e-08
the O 0 1.5342930481665462e-08
patients O 0 5.2712967324453075e-09
carried O 0 5.609251951810279e-10
a O 0 3.4927424841235677e-10
pathogenic O 0 1.1596439364325306e-08
mutation O 0 3.468982434640111e-09
in O 0 3.357855382635222e-10
either O 0 1.6831118720972427e-09
BRCA1 O 0 9.800409372928698e-09
( O 0 6.733554824833732e-10
179 O 0 5.068960362564212e-09
women O 0 4.2876067279928876e-11
) O 0 2.814350419377831e-10
or O 0 1.670466964753814e-08
BRCA2 O 0 7.692277677051607e-07
( O 0 1.542394301168315e-08
28 O 0 1.2603243249031948e-07
women O 0 1.084619727365066e-09
) O 0 7.516671729490554e-09
. O 0 1.1489269269304714e-07

The O 0 1.5123907814995619e-06
control O 0 9.658899671194376e-07
women O 0 1.990655140726716e-10
were O 0 5.256194368641331e-10
enrolled O 0 3.546825333433645e-10
regardless O 0 3.00657665430748e-10
of O 0 3.6985262075184266e-10
whether O 0 1.27001853478248e-10
or O 0 2.985615366046801e-10
not O 0 5.2590497928717284e-11
they O 0 9.480410900764014e-11
had O 0 8.244507299082215e-10
either O 0 4.1148853213712755e-09
mutation O 0 2.4372836193720104e-08
. O 0 5.294172211733894e-08

Lifetime O 0 4.039028681290802e-06
histories O 0 1.925857759488281e-06
of O 0 1.2942815885708114e-07
oral O 0 2.182873140554875e-05
- O 0 8.608133157395059e-07
contraceptive O 0 2.0489180485583347e-07
use O 0 3.8872310925697207e-10
were O 0 4.953147961228588e-11
obtained O 0 8.156243042067857e-11
by O 0 2.126198175855798e-11
interview O 0 5.634084865313582e-10
or O 0 6.03909491858623e-11
by O 0 1.7935418775150147e-11
written O 0 1.6944912140104407e-10
questionnaire O 0 1.483502765076139e-10
and O 0 8.666243417332353e-11
were O 0 1.076160063839815e-10
compared O 0 3.552614036284041e-10
between O 0 2.4877151449942403e-09
patients O 0 2.991923508943728e-08
and O 0 1.3082967598165851e-08
control O 0 1.9272415840987378e-07
women O 0 4.496879604798387e-11
, O 0 2.3352878658622345e-11
after O 0 2.2393409349064086e-10
adjustment O 0 1.7190273648992616e-09
for O 0 3.095347589354702e-11
year O 0 8.915692489841476e-11
of O 0 1.7400739737993831e-09
birth O 0 8.703161569201256e-08
and O 0 1.1101337626939767e-08
parity O 0 7.768964565002534e-07
. O 0 1.0492871638234647e-07

RESULTS O 0 2.0208699424983934e-06
The O 0 2.3605898036294093e-07
adjusted O 0 1.2888814637790347e-07
odds O 0 5.896440598007757e-07
ratio O 0 1.8546268165664515e-07
for O 0 7.672195465602272e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 3.405601489703258e-08
with O 0 1.0771684239019308e-10
any O 0 3.2502642244303104e-10
past O 0 5.408551384533666e-10
use O 0 3.00929031693542e-10
of O 0 1.475796040928401e-09
oral O 0 1.5726661217740912e-07
contraceptives O 0 3.2260124953609193e-06
was O 0 7.096366516634589e-08
0 O 0 3.783862823070194e-08
. O 0 1.2749223898822493e-08

5 O 0 1.347264174000884e-06
( O 0 8.667194073552764e-09
95 O 0 2.794386944060534e-07
percent O 0 1.4319309293853166e-08
confidence O 0 4.26227124705747e-08
interval O 0 1.1883176220806035e-08
, O 0 6.964083199001436e-10
0 O 0 7.893432574235248e-10
. O 0 4.555271090889157e-11
3 O 0 7.107494592872854e-10
to O 0 2.1541488037790657e-10
0 O 0 3.572232287751831e-09
. O 0 5.281438619775258e-10
8 O 0 3.7369556338262555e-08
) O 0 8.08342992542066e-09
. O 0 1.0473915779130039e-07

The O 0 8.396185648962273e-07
risk O 0 1.6990017570606142e-07
decreased O 0 1.4152806926404082e-08
with O 0 1.3832909817601546e-10
increasing O 0 6.106905536817919e-10
duration O 0 1.4955217508827445e-08
of O 0 3.4088818434696577e-09
use O 0 1.9868782175080923e-09
( O 0 4.669876152441077e-10
P O 0 7.822398373491524e-08
for O 0 2.0795939970064126e-10
trend O 0 4.706323109004984e-10
, O 0 3.585088476087961e-11
< O 0 2.7108240097106773e-09
0 O 0 4.954190391259772e-10
. O 0 4.052523247533024e-11
001 O 0 8.140786711408055e-09
) O 0 8.66804024390877e-12
; O 0 7.669182996994373e-12
use O 0 2.1267590466500508e-10
for O 0 4.5681333715741346e-10
six O 0 1.1841222447017685e-09
or O 0 2.1935164795650053e-10
more O 0 1.4669935405331458e-11
years O 0 1.7261497786691393e-10
was O 0 5.764757005088939e-10
associated O 0 3.054593245011006e-10
with O 0 2.9403358220436715e-11
a O 0 6.626151849431494e-10
60 O 0 3.558651817670011e-09
percent O 0 6.323755963322242e-10
reduction O 0 1.914293967786307e-08
in O 0 6.175384648088311e-09
risk O 0 4.0344835383621103e-07
. O 0 5.464060564008832e-07

Oral O 0 0.00029423413798213005
- O 0 1.942266317200847e-05
contraceptive O 0 2.7234946173848584e-06
use O 0 1.5577951373302312e-08
protected O 0 8.999896817840636e-05
against O 1 0.9999879598617554
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 4.4587988856648053e-10
for O 0 2.8779039915050042e-11
carriers O 0 6.7713390450308e-11
of O 0 1.0907479364163919e-09
the O 0 2.987394331910309e-09
BRCA1 O 0 2.1195680766084024e-09
mutation O 0 1.1096922686304467e-10
( O 0 3.326858233343444e-11
odds O 0 4.170146006288178e-09
ratio O 0 3.727996522595589e-10
, O 0 4.1109744081113675e-11
0 O 0 1.7234388915987608e-10
. O 0 3.917934032759973e-11
5 O 0 5.268188107976357e-10
; O 0 1.4419550276034698e-10
95 O 0 4.2293599733511655e-08
percent O 0 3.3992662018533792e-09
confidence O 0 6.5047274233620556e-09
interval O 0 5.586533902146584e-09
, O 0 3.460469133464983e-10
0 O 0 6.089853621382701e-10
. O 0 6.329400198401558e-11
3 O 0 1.1031465740884983e-09
to O 0 2.436978951969593e-10
0 O 0 1.8446588700982147e-09
. O 0 8.783295618597364e-11
9 O 0 1.2951223427037917e-09
) O 0 1.6007320469135777e-11
and O 0 1.30407438320157e-11
for O 0 1.2533412675763689e-11
carriers O 0 2.928521869449696e-10
of O 0 4.5334069831426405e-09
the O 0 7.616119290787537e-09
BRCA2 O 0 1.1870626259735673e-08
mutation O 0 3.1198699179668665e-10
( O 0 4.5659791919616666e-11
odds O 0 4.9272030899771835e-09
ratio O 0 5.778462708327936e-10
, O 0 6.873775854066011e-11
0 O 0 4.390006413945713e-10
. O 0 8.58832796546416e-11
4 O 0 2.1516082249206647e-09
; O 0 4.017033095049527e-10
95 O 0 9.49147818118945e-08
percent O 0 5.357045917975256e-09
confidence O 0 2.1508869352260263e-08
interval O 0 7.678240265818204e-09
, O 0 2.903399465292722e-10
0 O 0 4.756943172701256e-10
. O 0 6.069846708589566e-11
2 O 0 1.0670631045428536e-09
to O 0 2.1019094798013782e-10
1 O 0 1.0849554143987916e-08
. O 0 1.2461437437494283e-09
1 O 0 5.501551214592837e-08
) O 0 1.2302575846945274e-08
. O 0 6.145705100379928e-08

CONCLUSIONS O 0 8.81739742908394e-06
Oral O 0 8.270321268355474e-05
- O 0 3.0938169857108733e-06
contraceptive O 0 6.308004572019854e-07
use O 0 1.4377045109981168e-09
may O 0 2.5121560387475483e-10
reduce O 0 5.053309992675281e-10
the O 0 3.277662585787766e-10
risk O 0 2.6634838334871347e-08
of O 1 0.9271067380905151
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.4536913339746604e-10
women O 0 1.295421886080006e-12
with O 0 1.896287380592776e-12
pathogenic O 0 1.6165873084617033e-09
mutations O 0 4.981327017539172e-10
in O 0 2.1204323019663462e-10
the O 0 4.558291522016589e-09
BRCA1 O 0 6.237939942366211e-08
or O 0 3.58488847496119e-08
BRCA2 O 0 3.0068320029386086e-06
gene O 0 1.8860038153434289e-06

A O 0 4.812205133930547e-06
Japanese O 0 8.512913154845592e-06
family O 0 6.886080683443652e-08
with O 0 6.161830157225268e-09
adrenoleukodystrophy B-Disease 1 1.0
with O 0 1.3471310289503435e-08
a O 0 2.5810988901753262e-08
codon O 0 2.977395574532693e-08
291 O 0 1.6462635699099337e-08
deletion O 0 1.5798418573353956e-08
: O 0 6.988043477207384e-11
a O 0 2.1015766904497468e-10
clinical O 0 1.2260247927997625e-08
, O 0 3.725181552116652e-10
biochemical O 0 3.924319855741487e-07
, O 0 4.108282602999225e-09
pathological O 0 2.038942966464674e-06
, O 0 1.4283022542471713e-09
and O 0 1.9536283701881985e-09
genetic O 0 1.0117144455534799e-07
report O 0 1.7300012089549455e-08
. O 0 9.441464499104768e-08

We O 0 1.055304394981249e-07
report O 0 6.843119404464915e-09
a O 0 8.324292366523878e-09
Japanese O 0 4.164989775290451e-07
family O 0 1.6962681925747347e-08
with O 0 1.1544797118290262e-08
adrenoleukodystrophy B-Disease 1 1.0
( O 0 0.09213610738515854
ALD B-Disease 1 1.0
) O 0 1.755871181785551e-08
with O 0 5.679356984700235e-10
a O 0 6.18374107475006e-09
three O 0 1.8898773657127776e-09
base O 0 1.4481848609193548e-07
pair O 0 5.50456391579246e-08
deletion O 0 7.516287325870508e-08
( O 0 1.7968891929953656e-09
delGAG O 0 3.2003902106225723e-07
291 O 0 4.019625965412388e-09
) O 0 2.2575757929743645e-10
in O 0 5.097063882075759e-10
the O 0 9.217582430665061e-08
ALD B-Disease 1 1.0
gene O 0 2.9587974495370872e-05
. O 0 1.7394861515640514e-06

A O 0 1.9001380451300065e-06
variety O 0 7.438715954322106e-08
of O 0 4.464862257691493e-08
phenotypes O 0 1.8705635795868147e-07
were O 0 2.9223743425177418e-09
observed O 0 1.1562818480470582e-09
within O 0 6.620669013024383e-10
this O 0 1.4931950120811166e-09
family O 0 5.296656624409479e-08
. O 0 6.670489227644794e-08

While O 0 2.0795054922473355e-07
the O 0 1.1658073617581977e-07
proband O 0 1.4088650459598284e-05
( O 0 1.4219858179842504e-08
patient O 0 3.580672682801378e-07
1 O 0 2.78342355386485e-07
) O 0 2.238453644665128e-09
was O 0 2.4719376767734502e-08
classified O 0 1.0666811434134615e-08
as O 0 7.273657232076403e-10
having O 0 9.035222570119572e-10
a O 0 1.4176142482114074e-09
rare O 0 3.899181422184483e-09
intermediate O 0 6.669217356147783e-08
type O 0 5.8188597051866964e-08
of O 0 5.285212623107327e-08
adult O 0 5.240563183406266e-08
cerebral O 0 7.908960810709686e-07
and O 0 4.642280160283008e-08
cerebello O 0 0.19423414766788483
- O 0 0.0002305755187990144
brain O 0 3.897704061728291e-07
stem O 0 2.425618816914721e-09
forms O 0 4.855384427848719e-10
, O 0 3.0169842318850115e-11
his O 0 7.460619344534791e-10
younger O 0 2.356850536955335e-08
brother O 0 1.1577607210710994e-06
( O 0 9.952574320237773e-10
patient O 0 3.1474566952738314e-08
2 O 0 4.23769321855616e-08
) O 0 1.950187511479129e-10
and O 0 1.1481678940938878e-09
nephew O 0 0.033402424305677414
( O 0 2.67140549681244e-08
patient O 0 1.2399133083818015e-05
3 O 0 9.11617178189772e-07
) O 0 9.396560196606174e-10
had O 0 1.2965763573902223e-08
a O 0 4.8766803928401714e-08
childhood O 0 0.0008699379395693541
ALD B-Disease 1 1.0
type O 1 0.9994421601295471
. O 0 9.173975740850437e-06

Another O 0 2.344539780096966e-06
nephew O 0 0.002591134514659643
( O 0 3.158799444236138e-08
patient O 0 3.2453991138936544e-07
4 O 0 1.480895548411354e-07
) O 0 5.129755509258871e-10
of O 0 1.1472665484291156e-08
patient O 0 1.3282516192703042e-05
1 O 0 1.521265289738949e-06
was O 0 6.674447661225713e-08
classified O 0 1.2760189571636715e-09
as O 0 3.083245880830532e-10
having O 0 4.4767622942032403e-10
an O 0 7.494502934912717e-11
adolescent O 0 1.065030286184765e-08
form O 0 1.813911154613379e-08
. O 0 7.813442266524362e-07

The O 0 5.93184859098983e-06
tau O 0 3.425528120715171e-06
level O 0 6.501505112055384e-08
in O 0 1.4927993285951402e-09
the O 0 2.6828932409017625e-09
cerebrospinal O 0 6.07896240012451e-08
fluid O 0 3.214987742694575e-08
( O 0 1.5563932365125766e-08
CSF O 0 0.0007657876121811569
) O 0 3.65928265466664e-09
in O 0 1.18807219617878e-09
patient O 0 1.1665596275634016e-06
1 O 0 1.9348117348272353e-06
was O 0 2.005823063200296e-07
as O 0 1.1054488435746634e-09
high O 0 5.63112267926158e-09
as O 0 3.3247904429600794e-11
that O 0 3.1884230498879784e-12
of O 0 4.819547538836844e-10
patients O 0 1.9377266458064923e-09
with O 0 3.735257880776999e-09
Alzheimers B-Disease 1 1.0
disease I-Disease 1 0.9989859461784363
( O 0 1.0448013121333588e-08
AD B-Disease 0 2.3862899070081767e-06
) O 0 2.6235360550685982e-08
. O 0 5.058763719034687e-08

His O 0 1.527605672890786e-05
brain O 0 1.6346746633644216e-05
magnetic O 0 3.1221823064697674e-06
resonance O 0 1.0002296448874404e-06
image O 0 5.014578050577256e-07
( O 0 6.345461400769636e-08
MRI O 0 0.00027213513385504484
) O 0 1.702303187300913e-08
showed O 0 7.323637696288188e-09
abnormalities B-Disease 0 1.222302671521902e-06
in I-Disease 0 4.247642515498029e-10
the I-Disease 0 9.377478349392732e-09
bilateral I-Disease 0 5.6880893680499867e-05
cerebellar I-Disease 1 1.0
hemispheres I-Disease 1 0.9999295473098755
and O 0 5.054355938227673e-07
brain O 0 5.063658363724244e-07
stem O 0 2.2294981860682128e-08
, O 0 7.913991684205257e-11
but O 0 3.703543374755647e-11
not O 0 5.8068105879272025e-11
in O 0 4.053608004817022e-10
the O 0 7.28201765554104e-09
cerebral O 0 4.325407644500956e-06
white O 0 2.936024934285797e-08
matter O 0 2.1279855655365054e-09
, O 0 1.7076598815557453e-11
where O 0 6.121430185662691e-12
marked O 0 2.3707436014319683e-10
reductions O 0 9.108922505163264e-09
of O 0 1.4542362869462977e-08
the O 0 1.400762617009832e-08
cerebral O 0 6.415498319256585e-07
blood O 0 1.1639028407728347e-08
flow O 0 5.098155231308965e-09
and O 0 8.71755778675265e-10
oxygen O 0 1.1026759061394387e-08
metabolism O 0 4.8498609572789064e-09
were O 0 3.9937628204533837e-10
clearly O 0 4.1360501135123684e-10
demonstrated O 0 2.118618169788533e-09
by O 0 1.027100487993593e-10
positron O 0 4.214783899669783e-08
emission O 0 1.6612652586900367e-08
tomography O 0 1.0791563909151591e-07
( O 0 7.688924164028776e-09
PET O 0 1.2345708455541171e-06
) O 0 5.224950694326935e-09
. O 0 5.1240697018783976e-08

In O 0 1.5459616520274722e-07
patients O 0 1.7433744403660967e-07
2 O 0 2.7967010396423575e-07
and O 0 4.891601346201924e-09
3 O 0 4.866366509759246e-08
, O 0 4.131886777170024e-10
the O 0 3.6491762944734774e-09
autopsy O 0 2.6482217663215124e-07
findings O 0 2.1867597510549786e-08
showed O 0 1.512760761102072e-08
massive O 0 1.8383257156528998e-06
demyelination B-Disease 1 1.0
of I-Disease 1 0.6639187335968018
the I-Disease 0 2.7987446173938224e-06
cerebral I-Disease 0 1.7199608919327147e-05
white I-Disease 0 8.229194214948166e-09
matter I-Disease 0 3.920679336744115e-10
with O 0 5.854583744885344e-12
sparing O 0 4.168650757918613e-09
of O 0 2.0217392204813223e-08
the O 0 1.1098757823901906e-07
U O 0 0.0039497436955571175
- O 0 4.161883225606289e-06
fibers O 0 2.1372613900894066e-07
, O 0 6.965796828239945e-10
compatible O 0 2.9068888807159965e-07
with O 0 1.419946243919057e-10
the O 0 2.190122749823331e-09
findings O 0 2.626518780246556e-09
of O 0 4.4169798485427236e-08
childhood O 0 0.0015137734590098262
ALD B-Disease 1 1.0
. O 0 2.1535450287046842e-05

Oleic O 0 0.006150619126856327
and O 0 1.9696992694662185e-06
erucic O 0 0.31031811237335205
acids O 0 7.183714387792861e-07
( O 0 9.37543997991952e-09
Lorenzos O 0 6.251593731576577e-06
Oil O 0 1.907846467474883e-07
) O 0 7.376791538726835e-11
were O 0 6.363584659219157e-11
administered O 0 3.4422081851559483e-10
to O 0 1.406501026757212e-10
patients O 0 2.3675770233211324e-09
1 O 0 2.344721927727278e-08
and O 0 2.4050950120368952e-09
4 O 0 2.8376495819770753e-08
, O 0 4.3344088734853514e-11
but O 0 3.630185735348235e-11
sufficient O 0 2.7438562533177446e-09
effectiveness O 0 1.8658239397950638e-08
was O 0 4.7332417985046504e-09
not O 0 1.2471228216792696e-10
obtained O 0 3.3014124767305475e-09
. O 0 1.4962834526954794e-08

The O 0 4.6816933263471583e-07
findings O 0 2.972549673074809e-08
in O 0 1.3152716693554112e-09
this O 0 5.243717682290594e-10
family O 0 1.3822684108433236e-09
suggest O 0 5.293944171924636e-10
that O 0 3.622169578165746e-11
delGAG291 O 0 4.484612503574681e-08
is O 0 1.0813141354537592e-10
part O 0 2.424567491221552e-10
of O 0 8.19720125111445e-10
the O 0 8.600856693519177e-10
cause O 0 1.329936427652001e-08
of O 0 1.424964608531809e-07
Japanese O 0 0.0012709686998277903
ALD B-Disease 1 1.0
with O 0 2.9026882231164564e-08
phenotypic O 0 2.4493640466971556e-06
variations O 0 7.664846179977758e-07
. O 0 2.6896736926573794e-07

Moreover O 0 1.535246610728791e-06
, O 0 6.367111282656879e-09
although O 0 2.018840650208631e-09
the O 0 1.0868023148091766e-09
scale O 0 8.58083737398374e-09
of O 0 1.2210625843778189e-09
the O 0 1.6971986316338672e-10
study O 0 1.9416275878758604e-11
is O 0 3.01414123694832e-12
limited O 0 2.6580444442703133e-11
, O 0 2.5586260540833017e-11
there O 0 1.645137151506937e-11
is O 0 1.94136477726925e-11
a O 0 9.635106601457721e-11
possibility O 0 1.7465945356676116e-09
that O 0 3.806864823374667e-10
PET O 0 5.870377890460077e-07
can O 0 6.567042465377426e-10
detect O 0 1.3575366608620243e-07
an O 0 1.938728511063914e-09
insidious B-Disease 0 1.3418758499028627e-05
lesion I-Disease 0 0.0005251223919913173
which O 0 1.1836525093400496e-09
is O 0 1.5323380064824477e-10
undetectable O 0 3.508301205101816e-09
by O 0 4.856381963236345e-11
computed O 0 3.4741076682109906e-09
tomogram O 0 7.263501515808457e-07
( O 0 1.5868534264384948e-09
CT O 0 2.0045194105478004e-05
) O 0 1.7244229377766374e-09
or O 0 6.532649421409076e-10
MRI O 0 7.971343052304292e-08
analysis O 0 1.136467919771178e-09
, O 0 6.810689512359858e-11
and O 0 2.8505994439931293e-11
that O 0 5.8901794032506505e-12
the O 0 3.240558099637525e-10
higher O 0 2.5281636784058037e-09
level O 0 3.993247066347294e-09
of O 0 1.2306535790429507e-09
tau O 0 1.9535986162111385e-09
reflects O 0 1.102100771754877e-10
the O 0 2.125030533484118e-11
process O 0 1.5563679511831907e-10
of O 0 1.2770147161944578e-09
neuronal B-Disease 0 3.0522196539095603e-06
degeneration I-Disease 1 0.9999997615814209
in O 0 1.6671573632720538e-07
ALD B-Disease 1 1.0
. O 0 8.207483915612102e-06

Lorenzos O 0 0.0006554651190526783
Oil O 0 1.8290833168066456e-06
should O 0 1.297213891859883e-09
be O 0 1.4590136043768354e-10
given O 0 1.403927946119765e-10
in O 0 1.5596544888918373e-10
the O 0 4.870735481610211e-10
early O 0 1.2642965785403248e-08
stage O 0 1.7085094228264097e-08
. O 0 1.5933770969311922e-09
. O 0 2.1612789780078856e-08

Nonsense O 0 2.0324343495303765e-05
mutation O 0 2.133660785830216e-07
in O 0 1.0539784156549103e-08
exon O 0 4.534698234692769e-07
4 O 0 6.05407279863357e-08
of O 0 4.329827163473965e-09
human O 0 3.737809617376797e-09
complement O 0 8.87087310275092e-08
C9 O 1 0.9891288876533508
gene O 0 1.7386282635811767e-08
is O 0 3.5241470852653833e-10
the O 0 2.2119940601417198e-10
major O 0 9.236035825033184e-10
cause O 0 3.2982843123363637e-09
of O 0 1.4469099696157173e-08
Japanese O 0 2.8506531180028105e-06
complement B-Disease 0 2.855063030438032e-06
C9 I-Disease 1 1.0
deficiency I-Disease 1 0.9999842643737793
. O 0 1.5196369531622622e-06

Deficiency B-Disease 1 0.999976396560669
of I-Disease 0 3.87432228308171e-05
the I-Disease 0 2.6435991458129138e-06
ninth I-Disease 0 0.0001804316561901942
component I-Disease 0 3.103818357885757e-07
of I-Disease 0 1.7082292913528363e-08
human I-Disease 0 3.1379603360193187e-09
complement I-Disease 0 4.718119939184362e-08
( O 0 2.151572253694667e-08
C9 O 1 0.9999978542327881
) O 0 3.2408813410711446e-09
is O 0 9.81939113353647e-11
the O 0 1.3254806974227762e-10
most O 0 5.931308916240496e-11
common O 0 5.5535384291260925e-08
complement B-Disease 1 0.9999996423721313
deficiency I-Disease 1 1.0
in O 0 4.318767121702649e-09
Japan O 0 1.8385163613743316e-08
but O 0 2.6408691899959535e-10
is O 0 8.74526492888883e-11
rare O 0 8.605155477070525e-10
in O 0 1.3483944516501367e-10
other O 0 1.2101324109448086e-10
countries O 0 6.813408726102921e-10
. O 0 1.4582505514226796e-07

We O 0 1.0138528949710235e-07
studied O 0 6.538176933190698e-08
the O 0 1.811054750611163e-09
molecular O 0 4.908144113358048e-09
basis O 0 7.579584959671593e-09
of O 0 2.459175334479369e-07
C9 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
in O 0 2.2144616806940576e-08
four O 0 5.478605569209094e-09
Japanese O 0 5.365581046135048e-07
C9 B-Disease 1 1.0
- I-Disease 1 0.9999785423278809
deficient I-Disease 1 0.9999936819076538
patients O 0 9.775704711501021e-06
who O 0 5.045879447607149e-08
had O 0 6.459442403183857e-08
suffered O 0 0.00013174139894545078
from O 0 6.503588565465179e-07
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 8.09173707239097e-06

Direct O 0 8.438690883849631e-07
sequencing O 0 1.3226921282694093e-06
of O 0 2.6698475608100125e-07
amplified O 0 2.303028622918646e-06
C9 O 0 0.00046814302913844585
cDNA O 0 1.8042620695268852e-06
and O 0 1.0048292864439645e-08
DNA O 0 3.4366617995829074e-08
revealed O 0 1.688572481839401e-08
a O 0 4.4019401457262575e-09
nonsense O 0 6.699279708755057e-08
substitution O 0 1.1063525562349241e-07
( O 0 7.911283184114382e-09
CGA O 0 1.3657530644195504e-06
- O 0 2.4745114046709205e-07
- O 0 2.1878888389892381e-07
> O 0 4.157806756666105e-07
TGA O 0 6.089202088332968e-06
) O 0 7.078515551484088e-10
at O 0 5.037441019872801e-10
codon O 0 3.7588196444282573e-10
95 O 0 8.257779349207794e-09
in O 0 4.724274305090148e-10
exon O 0 3.666871961627294e-08
4 O 0 1.1066370042556173e-08
in O 0 4.926045127362499e-10
the O 0 4.213849269518732e-09
four O 0 4.3946688066398565e-08
C9 B-Disease 1 1.0
- I-Disease 1 0.9526231288909912
deficient I-Disease 0 0.00048351133591495454
individuals O 0 6.764814042270473e-09
. O 0 1.640154039250774e-07

An O 0 3.543028626040723e-08
allele O 0 4.774154405140507e-08
- O 0 3.387371805274597e-08
specific O 0 1.6774039934830398e-09
polymerase O 0 1.8168009319197154e-06
chain O 0 7.539188828786791e-08
reaction O 0 5.340538677955919e-09
system O 0 3.2847317754658434e-08
designed O 0 2.9026496761730414e-08
to O 0 1.0281829831981781e-09
detect O 0 9.083002794341155e-09
exclusively O 0 6.935279017739049e-10
only O 0 3.354908711949989e-11
one O 0 3.2286371492995514e-11
of O 0 1.7303890265107924e-10
the O 0 2.1146728812482252e-10
normal O 0 5.106814415789529e-10
and O 0 7.41072203602755e-11
mutant O 0 1.0401673966597969e-10
alleles O 0 4.737290421052975e-12
indicated O 0 7.0559439367678944e-12
that O 0 2.2454375598474074e-12
all O 0 4.704030134167203e-12
the O 0 1.3371459495203908e-10
four O 0 1.0372629838384384e-10
patients O 0 1.2169142082907314e-10
were O 0 3.5907496420684026e-10
homozygous O 0 4.284878007965176e-10
for O 0 1.0576908099357851e-10
the O 0 5.002693259648083e-10
mutation O 0 2.3077738331434006e-10
in O 0 3.6003094949776937e-10
exon O 0 1.5025925392819772e-08
4 O 0 1.4871439635300021e-09
and O 0 3.165742668009841e-11
that O 0 4.3193205088998265e-12
the O 0 9.695388936137306e-11
parents O 0 1.1585572085026641e-10
of O 0 1.9492216729588563e-09
patient O 0 1.7973121657632873e-07
2 O 0 3.655162288396241e-07
were O 0 1.5721585810979377e-08
heterozygous O 0 2.620305394884781e-08
. O 0 2.312464353337873e-08

The O 0 3.4230424716952257e-07
common O 0 8.250462002479253e-08
mutation O 0 2.1802293304062914e-08
at O 0 7.953798508708587e-09
codon O 0 2.6027704436160093e-09
95 O 0 2.4038945056759076e-08
in O 0 1.8611384655642382e-09
exon O 0 2.011094295539806e-07
4 O 0 1.5008826181883705e-08
might O 0 7.139042690340602e-10
be O 0 1.0561326119207237e-10
responsible O 0 8.1246348537789e-10
for O 0 3.1154395729871e-10
most O 0 2.0427588509619454e-09
Japanese O 0 1.9265084119979292e-05
C9 B-Disease 1 1.0
deficiency I-Disease 1 0.9999997615814209
. O 0 7.40705843327305e-08
. O 0 9.831585856545644e-08

BRCA1 O 0 5.107321499053796e-07
required O 0 2.0907558351268563e-08
for O 0 1.278589856212875e-08
transcription O 0 3.6198280213284306e-06
- O 0 1.3299613783601671e-05
coupled O 0 4.150661879975814e-06
repair O 0 0.003866811515763402
of O 0 4.1562370256542636e-07
oxidative O 0 9.614001100999303e-06
DNA O 0 4.078245638083899e-06
damage O 0 2.7606416551861912e-05
. O 0 1.6173751760106825e-07

The O 0 6.599131666007452e-06
breast B-Disease 1 0.9999973773956299
and I-Disease 1 0.9305465221405029
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 0 1.5348661690950394e-05
gene O 0 8.355820035887973e-09
BRCA1 O 0 5.219034537873313e-09
encodes O 0 1.3736373150052827e-09
a O 0 1.3564898093676447e-09
zinc O 0 2.8560879172800924e-07
finger O 0 7.298470450223249e-08
protein O 0 4.7535806402265735e-09
of O 0 1.35131790202081e-08
unknown O 0 1.0098847980088976e-07
function O 0 3.138620030540551e-08
. O 0 8.636701664954671e-08

Association O 0 5.433225851447787e-07
of O 0 6.673180337202211e-07
the O 0 4.330928149443025e-08
BRCA1 O 0 8.884584623558567e-09
protein O 0 5.9413213238102e-10
with O 0 5.2938813055458667e-11
the O 0 9.545918500108996e-10
DNA O 0 6.000707486464307e-08
repair O 0 6.376536020979984e-06
protein O 0 2.449428393447306e-08
Rad51 O 0 8.354364240403811e-07
and O 0 1.2433938600953098e-10
changes O 0 1.0952566631416971e-10
in O 0 5.379094045188104e-11
the O 0 1.4843830331567887e-10
phosphorylation O 0 9.632483699562044e-10
and O 0 2.0633002251191357e-10
cellular O 0 5.045510675927289e-09
localization O 0 9.31196311171334e-08
of O 0 3.6170371142674185e-09
the O 0 1.905328561591091e-09
protein O 0 8.914863847131471e-10
after O 0 2.882400540471508e-09
exposure O 0 1.0637067227037278e-08
to O 0 5.690872773023159e-10
DNA O 0 3.36154045044168e-07
- O 0 7.772114258841611e-07
damaging O 0 9.172421755465621e-08
agents O 0 4.918506157913782e-10
are O 0 1.0339164420447577e-11
consistent O 0 4.742303216787036e-10
with O 0 3.4692967249005946e-11
a O 0 6.475707192699076e-10
role O 0 5.310705208927402e-09
for O 0 1.1841854163918697e-09
BRCA1 O 0 2.2121609433156664e-08
in O 0 2.21539009359617e-09
DNA O 0 7.107215651558363e-07
repair O 0 0.0001021075586322695
. O 0 5.537904144148342e-07

Here O 0 5.51316929886525e-07
, O 0 3.750006527525329e-09
it O 0 4.1107259263206686e-10
is O 0 2.3540447369185813e-10
shown O 0 4.4660930509365926e-10
that O 0 3.048109820102951e-10
mouse O 0 2.0935496536367282e-07
embryonic O 0 2.383568897812438e-07
stem O 0 1.6800535718175524e-07
cells O 0 1.1169539249067384e-07
deficient B-Disease 0 8.2877659224323e-06
in I-Disease 0 6.92515433886598e-10
BRCA1 I-Disease 0 5.774234868027861e-09
are O 0 3.618143978867394e-11
defective O 0 1.0279877216134992e-07
in O 0 9.308794846063506e-10
the O 0 1.475537025896756e-09
ability O 0 4.1476472256718466e-10
to O 0 7.114028810484285e-11
carry O 0 2.5721025309621837e-10
out O 0 9.045585391831423e-10
transcription O 0 1.504703988075562e-07
- O 0 5.184984956940752e-07
coupled O 0 7.07509343556012e-07
repair O 0 2.1602549168164842e-05
of O 0 3.8004987601425455e-08
oxidative O 0 2.3316044917010004e-07
DNA O 0 2.5558261995684006e-07
damage O 0 1.3426571285890532e-06
, O 0 5.872035635512418e-10
and O 0 6.433517607540296e-10
are O 0 1.49388654224758e-10
hypersensitive O 0 8.982339068097644e-07
to O 0 4.776174122866905e-09
ionizing O 0 0.00012175775191280991
radiation O 0 0.010480369441211224
and O 0 9.728927885532812e-09
hydrogen O 0 6.617569425770853e-08
peroxide O 0 2.235653028037632e-06
. O 0 1.675758767305524e-07

These O 0 2.7198680641049577e-08
results O 0 4.794282304487751e-09
suggest O 0 7.011923042199442e-09
that O 0 7.465914553250741e-10
BRCA1 O 0 2.5535205949722695e-08
participates O 0 4.829098787517694e-10
, O 0 4.4551071165521705e-11
directly O 0 5.3472809513621655e-11
or O 0 1.5169372702406037e-10
indirectly O 0 5.908097899798292e-10
, O 0 6.485172121539762e-11
in O 0 2.2136907584791032e-10
transcription O 0 2.306809392393916e-06
- O 0 5.2061073802178726e-05
coupled O 0 1.0250942978018429e-05
repair O 0 0.015851639211177826
of O 0 1.6774136213371094e-07
oxidative O 0 6.934491239007912e-07
DNA O 0 5.025291898164141e-07
damage O 0 9.402706382388715e-07
. O 0 5.208096176545496e-09
. O 0 3.2911408709423995e-08

Truncation O 0 0.00011153347440995276
mutations O 0 6.085587074267096e-07
in O 0 1.295721041572051e-08
the O 0 1.9997791866899206e-08
transactivation O 0 4.197385715087876e-05
region O 0 9.204388362604732e-08
of O 0 1.5879660963946662e-07
PAX6 O 1 0.9995922446250916
result O 0 1.946525713947267e-07
in O 0 1.1802669952487577e-08
dominant O 0 5.227862402534811e-06
- O 0 5.300072984937287e-07
negative O 0 1.202281474377287e-08
mutants O 0 2.066189637162097e-07
. O 0 3.3573144264664734e-08

PAX6 O 0 0.009726859629154205
is O 0 8.46527612452519e-08
a O 0 2.2288054069008467e-08
transcription O 0 5.398054980787492e-08
factor O 0 2.3517301439568428e-09
with O 0 1.297653651199937e-10
two O 0 3.451003927068541e-10
DNA O 0 1.9695116648676958e-08
- O 0 3.787400970622912e-08
binding O 0 6.0440443760967355e-09
domains O 0 6.644709227288104e-09
( O 0 1.711182029406899e-10
paired O 0 1.7657036943674598e-09
box O 0 2.4383622232448943e-08
and O 0 1.0408783834847668e-09
homeobox O 0 8.821871233521961e-07
) O 0 9.72677050015136e-10
and O 0 1.5535066566485511e-09
a O 0 1.2780753344543427e-08
proline O 0 5.768996516053448e-07
- O 0 4.541025191429071e-07
serine O 0 4.161202298291755e-07
- O 0 4.832273816646193e-07
threonine O 0 3.08806392013139e-07
( O 0 6.810034314241875e-09
PST O 0 0.000707445724401623
) O 0 8.842556908916777e-09
- O 0 1.4275381943207321e-07
rich O 0 1.100850255397745e-07
transactivation O 0 4.910600182483904e-05
domain O 0 1.3278787491799449e-07
. O 0 1.3358269157492941e-08

PAX6 O 1 0.9999991655349731
regulates O 0 1.4039480447536334e-05
eye O 0 0.0023127547465264797
development O 0 1.7018884079789132e-07
in O 0 1.8893944186970657e-09
animals O 0 6.386275952507958e-10
ranging O 0 8.535784523644452e-09
from O 0 6.522705042755206e-09
jellyfish O 0 2.5655300106564027e-08
to O 0 2.4863395786667297e-09
Drosophila O 0 5.998155216957457e-08
to O 0 1.2889663780768501e-09
humans O 0 9.203370154864388e-08
. O 0 8.675534246549432e-08

Heterozygous O 0 2.650030637596501e-06
mutations O 0 5.9287732057100584e-08
in O 0 1.445863762050692e-09
the O 0 2.39444841731995e-09
human O 0 1.1316513059966837e-08
PAX6 O 0 0.0063017988577485085
gene O 0 1.2908762059282708e-08
result O 0 1.6853026751917355e-09
in O 0 8.767261222564215e-11
various O 0 9.158319241864277e-11
phenotypes O 0 7.1283383640263764e-09
, O 0 4.291680899548567e-11
including O 0 3.934531034310851e-10
aniridia B-Disease 1 1.0
, O 0 4.254798469105481e-08
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.1575357561355304e-08
autosomal B-Disease 0 2.1537010979955085e-05
dominant I-Disease 1 0.9490991234779358
keratitis I-Disease 1 1.0
, O 0 1.5480981119253556e-07
and O 0 1.715115587330729e-07
familial B-Disease 1 0.9999995231628418
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.008130420930683613

It O 0 2.8128614104616645e-08
is O 0 1.2666444559883416e-09
believed O 0 2.6838145039675965e-09
that O 0 1.6787947768048816e-11
the O 0 3.1943001022050055e-10
mutated O 0 8.483715063789532e-09
allele O 0 1.0985111487116228e-08
of O 0 1.4698301242788148e-08
PAX6 O 0 0.00010043453221442178
produces O 0 2.5596877950562202e-09
an O 0 7.035131505128689e-11
inactive O 0 2.7702649063598983e-09
protein O 0 2.5435931139128343e-09
and O 0 6.268829011446542e-09
aniridia B-Disease 1 1.0
is O 0 5.7627920213576544e-09
caused O 0 3.247070523570983e-08
due O 0 2.0044269888330746e-07
to O 0 1.0560590624208999e-08
genetic O 0 1.1576282759051537e-06
haploinsufficiency O 0 5.136305117048323e-05
. O 0 6.715987979077909e-07

However O 0 7.504482937292778e-07
, O 0 1.0182671594805015e-08
several O 0 1.8623101949444276e-09
truncation O 0 1.0801052212627837e-06
mutations O 0 9.546687884665062e-09
have O 0 3.0201521838968404e-10
been O 0 2.3075361066382527e-10
found O 0 1.074013100677007e-10
to O 0 4.175983864262989e-11
occur O 0 1.3744437532547948e-10
in O 0 1.4155816796534992e-10
the O 0 1.4294223582567156e-09
C O 0 1.6227934338530758e-06
- O 0 5.177583375370887e-07
terminal O 0 3.9019477071633446e-07
half O 0 1.6376314748711707e-09
of O 0 2.2672776989196564e-09
PAX6 O 0 0.005758842919021845
in O 0 8.842485077487083e-10
patients O 0 3.76993591899577e-09
with O 0 1.1659864185276092e-09
Aniridia B-Disease 1 1.0
resulting O 0 7.145628160287743e-07
in O 0 4.275410248055778e-09
mutant O 0 3.970606510250718e-09
proteins O 0 2.1188302848362817e-11
that O 0 9.888305452232515e-12
retain O 0 2.7650388645383828e-09
the O 0 1.7370165306118679e-09
DNA O 0 1.650999159608091e-08
- O 0 8.704802212378127e-09
binding O 0 1.4697116856865478e-09
domains O 0 1.7388596118550481e-09
but O 0 3.30364069434097e-10
have O 0 2.852036662392976e-10
lost O 0 1.3183717229026115e-08
most O 0 1.055459955545679e-10
of O 0 1.7509006466909227e-09
the O 0 1.8657420497447674e-08
transactivation O 0 4.177738446742296e-05
domain O 0 1.170633026958967e-06
. O 0 1.6937407565364992e-07

It O 0 3.9234439697111156e-08
is O 0 1.3715664159974494e-09
not O 0 1.84945975201245e-10
clear O 0 3.273066484510423e-09
whether O 0 6.828760890087437e-10
such O 0 3.793746650160301e-09
mutants O 0 3.836840278381715e-06
really O 0 5.9401376262258054e-08
behave O 0 1.7185750600390293e-09
as O 0 1.0096721236863004e-09
loss O 0 1.6722713880312767e-08
- O 0 2.2948675848510902e-07
of O 0 4.81533561469405e-07
- O 0 1.6925311001614318e-06
function O 0 2.893836503758962e-09
mutants O 0 1.590657205952084e-08
as O 0 2.996260461962663e-10
predicted O 0 4.24495549822268e-09
by O 0 1.202173138814544e-09
haploinsufficiency O 0 5.1330924179637805e-05
. O 0 6.131743361947883e-07

Contrary O 0 8.248769063357031e-07
to O 0 5.570127026288674e-09
this O 0 4.872993675242299e-10
theory O 0 7.396495416145399e-09
, O 0 4.1990366739241836e-10
our O 0 1.648820524557948e-09
data O 0 9.147569368650466e-10
showed O 0 5.165582961375037e-10
that O 0 1.7894824511088814e-11
these O 0 1.3701720313896715e-10
mutants O 0 2.9909418941542754e-08
are O 0 4.223631722144461e-10
dominant O 0 6.330482733574172e-07
- O 0 8.089972425295855e-08
negative O 0 2.4074036097943008e-09
in O 0 5.219021881330832e-10
transient O 0 1.9783779947601943e-08
transfection O 0 2.3574244778501452e-07
assays O 0 8.701995568571874e-09
when O 0 3.2127284166350023e-10
they O 0 7.222365067116598e-11
are O 0 6.977361743931709e-11
coexpressed O 0 2.2190751280959375e-07
with O 0 1.6052740248184705e-09
wild O 0 3.4172560958722897e-07
- O 0 6.892886972309498e-07
type O 0 7.005781753832707e-06
PAX6 O 1 0.9999978542327881
. O 0 3.94048265661695e-06

We O 0 1.7690580023099756e-07
found O 0 8.821078978371588e-09
that O 0 4.801307684765277e-10
the O 0 1.4225445710280837e-08
dominant O 0 7.504347013309598e-05
- O 0 3.882362761942204e-06
negative O 0 4.6226973360319334e-09
effects O 0 5.448960038734185e-08
result O 0 1.4691426963864274e-09
from O 0 5.807322400741555e-10
the O 0 3.382384372585534e-10
enhanced O 0 3.6955098980939738e-09
DNA O 0 3.9431200526962584e-09
binding O 0 5.33613708775249e-10
ability O 0 7.931433287922118e-10
of O 0 1.051688625075542e-09
these O 0 9.395987321525467e-10
mutants O 0 2.2451430936598626e-07
. O 0 2.4713532553732875e-08

Kinetic O 0 2.9825505407643504e-06
studies O 0 8.331344503176297e-09
of O 0 5.9404632324344675e-09
binding O 0 6.028443966243913e-09
and O 0 1.6532482050024555e-09
dissociation O 0 4.954270593771071e-08
revealed O 0 1.725809006813961e-08
that O 0 5.757073637258081e-11
various O 0 1.7737169510922968e-09
truncation O 0 5.996691925247433e-07
mutants O 0 8.494551195781241e-08
have O 0 1.3014517241671797e-09
3 O 0 1.438185304181161e-08
- O 0 5.424487525829136e-08
5 O 0 3.423550865022662e-08
- O 0 8.80966624094981e-08
fold O 0 1.169019991920095e-08
higher O 0 6.7448313600948495e-09
affinity O 0 4.693898048024892e-10
to O 0 7.01043112449895e-11
various O 0 6.711586841845474e-11
DNA O 0 1.7842493038600082e-09
- O 0 1.2309939734223008e-09
binding O 0 2.188376424516747e-10
sites O 0 2.2218887840708135e-10
when O 0 3.724426669848846e-11
compared O 0 5.7763661909238095e-11
with O 0 1.6648344161596107e-11
the O 0 1.0322819266050942e-09
wild O 0 3.630212219718487e-08
- O 0 7.855786066102155e-08
type O 0 1.2121697636757744e-06
PAX6 O 1 0.9999724626541138
. O 0 8.878539574652677e-07

These O 0 1.5425031918425702e-08
results O 0 4.5524011227371375e-09
provide O 0 3.4755125444263513e-09
a O 0 2.910875540607094e-09
new O 0 4.899809891156792e-09
insight O 0 1.0305984510239341e-08
into O 0 7.231659715500882e-10
the O 0 2.603032234205216e-10
role O 0 1.073638844495406e-09
of O 0 9.47691258801342e-09
mutant O 0 3.645053254786035e-07
PAX6 O 0 0.29268819093704224
in O 0 1.627872414644571e-08
causing O 0 5.269947678243625e-07
aniridia B-Disease 1 1.0
. O 0 4.57923441388175e-08
. O 0 1.1343032468857928e-07

Reversal O 0 2.2144538888824172e-05
of O 0 3.2857801670616027e-06
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.9390476942062378
excellent O 0 0.0004028182302135974
neuropsychologic O 0 0.0005602059536613524
outcome O 0 5.967505103399162e-07
in O 0 5.561782590035591e-09
very B-Disease 0 7.855917694143955e-09
- I-Disease 0 1.0398871808092736e-07
long I-Disease 0 2.49711984423584e-08
- I-Disease 0 8.566401987764038e-08
chain I-Disease 0 2.6261895769152943e-08
acyl I-Disease 0 4.227795358247022e-08
- I-Disease 0 6.024170318141842e-08
coenzyme I-Disease 0 3.351344801671985e-08
A I-Disease 0 1.2320938367338385e-06
dehydrogenase I-Disease 0 4.558780346997082e-05
deficiency I-Disease 0 3.380743146408349e-05
. O 0 2.4921126851040754e-07

Very B-Disease 0 3.301224296592409e-06
- I-Disease 0 1.6027743185986765e-06
long I-Disease 0 1.7850577194167272e-07
- I-Disease 0 1.0571618958010731e-07
chain I-Disease 0 2.5371985401534403e-08
acyl I-Disease 0 2.117197261952697e-08
- I-Disease 0 1.3805669496491646e-08
coenzyme I-Disease 0 6.571832411594869e-09
A I-Disease 0 7.286800496331125e-08
dehydrogenase I-Disease 0 1.5357342419974884e-07
( I-Disease 0 2.5556241567414872e-09
VLCAD I-Disease 1 0.9055236577987671
) I-Disease 0 1.6817617520814565e-08
deficiency I-Disease 0 0.0005140752764418721
is O 0 1.126811088880686e-09
a O 0 9.956376167963299e-09
disorder O 0 2.7630533168121474e-06
of O 0 4.537112090474693e-07
fatty O 0 3.82740779514279e-07
acid O 0 9.742669782042412e-09
beta O 0 1.810909755484147e-09
oxidation O 0 5.088059418234536e-10
that O 0 7.952424829760218e-11
reportedly O 0 6.608560809695518e-09
has O 0 7.025610648803138e-11
high O 0 1.3753465033516932e-09
rates O 0 5.096597033293904e-10
of O 0 1.5624213034470813e-09
morbidity O 0 2.2100496153143467e-06
and O 0 1.195460441749674e-08
mortality O 0 9.965876870410284e-07
. O 0 3.200039486728201e-07

We O 0 1.4418043292607763e-07
describe O 0 7.498588416865459e-08
the O 0 1.971379504084325e-08
outcome O 0 6.808413388625922e-08
of O 0 4.351761617726879e-08
a O 0 1.2470479759940645e-08
5 O 0 1.1659470722236165e-08
- O 0 1.3355925254643353e-08
year O 0 2.966368928269958e-09
- O 0 8.838429721436114e-08
old O 0 4.763126639772963e-07
girl O 0 3.312692342660739e-08
with O 0 3.7215686088387656e-09
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 1.678658350101614e-06
was O 0 1.3787465036330104e-07
first O 0 1.5009704590340789e-09
seen O 0 1.3614717131460452e-09
at O 0 8.152607477995844e-10
5 O 0 3.7607483793777874e-10
months O 0 1.3554390942971395e-10
of O 0 3.9907929738625114e-10
age O 0 5.111628342824304e-10
with O 0 2.1665970406647972e-10
severe O 1 0.6828931570053101
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 0.9975171089172363
hepatomegaly B-Disease 1 1.0
, O 0 0.0017969973850995302
encephalopathy B-Disease 1 1.0
, O 0 7.878714569642398e-08
and O 0 1.0289032843502355e-06
hypotonia B-Disease 1 1.0
. O 0 0.00010108192509505898

Biochemical O 0 1.4679001651529688e-05
studies O 0 2.6982291956301196e-07
indicated O 0 0.00010028046381194144
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 0.00035958251100964844
by O 0 3.23482307607037e-09
a O 0 7.025309667341162e-09
stable O 0 1.6694563953478792e-07
yet O 0 1.8672409396458534e-08
inactive O 0 3.781619568599126e-07
enzyme O 0 4.0437319626107637e-07
. O 0 7.344105767970177e-08

Molecular O 0 8.189502977984375e-07
genetic O 0 1.0981176501445589e-07
analysis O 0 7.46899520009947e-09
of O 0 3.9459131073726894e-08
her O 0 2.036605373234579e-08
VLCAD O 0 0.03489825874567032
gene O 0 4.7858701890390876e-08
revealed O 0 6.397132779056847e-08
a O 0 1.1604891270167172e-08
T1372C O 0 4.876113735008403e-07
( O 0 1.6654269074933836e-09
F458L O 0 1.934644444645528e-07
) O 0 8.668181172843958e-10
missense O 0 6.62202594980954e-08
mutation O 0 3.6688712068411178e-09
and O 0 4.244469664627104e-09
a O 0 5.8400633662358814e-08
1668 O 0 0.0021581652108579874
ACAG O 1 0.9999475479125977
1669 O 0 0.002723505487665534
splice O 0 0.00027867371682077646
site O 0 1.9020308172912337e-06
mutation O 0 1.5419685439610475e-07
. O 0 1.2557126183310174e-07

After O 0 2.132578487135106e-07
initial O 0 6.422709475373267e-08
treatment O 0 1.3818676336541103e-07
with O 0 1.0914930070882178e-09
intravenous O 0 3.017294147866778e-07
glucose O 0 1.0626389439494233e-06
and O 0 5.461255447869462e-09
carnitine O 0 6.707923034809937e-07
, O 0 8.905211013043868e-10
the O 0 4.83302686760112e-09
patient O 0 2.46426736794092e-07
has O 0 4.013328336327504e-09
thrived O 0 1.2770890123192657e-07
on O 0 4.31947544399236e-09
a O 0 1.6514613010443213e-09
low O 0 1.4740814435754146e-07
- O 0 1.895123773465457e-07
fat O 0 7.259970402628824e-08
diet O 0 7.773105714647954e-09
supplemented O 0 1.5320349433523006e-09
with O 0 1.6196573249249724e-10
medium O 0 1.0871573294934933e-06
- O 0 1.3047576885583112e-06
chain O 0 1.8612249164107197e-07
triglyceride O 0 3.595324926664034e-07
oil O 0 9.640211828809697e-08
and O 0 1.6411054737375252e-09
carnitine O 0 2.0210364937156555e-07
and O 0 1.890338774401812e-09
avoidance O 0 1.8960904526466038e-06
of O 0 1.9594160960423324e-07
fasting O 0 7.718107553955633e-06
. O 0 5.034276568949281e-07

Her O 0 7.12924975232454e-06
ventricular O 1 0.9986953139305115
hypertrophy O 1 0.9981914162635803
resolved O 0 6.775357906008139e-05
significantly O 0 1.5941249387196876e-07
over O 0 4.072472581384545e-09
1 O 0 2.8678681651683746e-09
year O 0 1.3576745283572222e-10
, O 0 8.8017933219664e-11
and O 0 5.530341185000509e-10
cognitively O 0 1.3513250451069325e-05
, O 0 2.0006822865070717e-09
she O 0 1.1129820676192281e-10
is O 0 1.1992038438657371e-11
in O 0 1.4759521729801328e-11
the O 0 2.644523489081507e-10
superior O 0 4.863258595833031e-07
range O 0 1.0219410739864543e-07
for O 0 4.907582340507588e-09
age O 0 5.377748735213572e-08
. O 0 1.0047223497622326e-07

Clinical O 0 7.5647508310794365e-06
recognition O 0 2.7425048756413162e-05
of O 1 0.9999606609344482
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 1.6080274178875698e-07
important O 0 2.1658130844315338e-09
because O 0 4.616014168123961e-11
it O 0 6.807581841988819e-12
is O 0 4.59912099723403e-12
one O 0 4.766710897524673e-12
of O 0 1.1579364550540205e-10
the O 0 7.611801744467073e-10
few O 0 9.9008090614916e-10
directly O 0 3.0131974693148322e-09
treatable O 1 0.9503678679466248
causes O 0 7.075148289459321e-08
of O 0 8.974633601610549e-06
cardiomyopathy B-Disease 1 1.0
in O 0 1.9852242871820636e-07
children O 0 5.393266722109047e-09
. O 0 3.804050408007242e-09
. O 0 3.745154586454191e-08

Cloning O 0 3.44763748216792e-06
of O 0 1.4276797344336956e-07
a O 0 1.0443988784913927e-08
novel O 0 3.220591082708779e-08
member O 0 3.4670379900347825e-09
of O 0 9.058401140293881e-09
the O 0 2.0042277171228307e-08
low O 0 1.595691514921782e-06
- O 0 8.589946531856185e-08
density O 0 3.8707859140174605e-09
lipoprotein O 0 9.520676371721493e-07
receptor O 0 6.151498865847316e-08
family O 0 1.7305985977600358e-08
. O 0 2.2094157614560572e-08

A O 0 7.609252747897699e-07
gene O 0 1.317084841190308e-08
encoding O 0 7.747473063091093e-08
a O 0 2.061520198992639e-08
novel O 0 3.709628870751658e-08
transmembrane O 0 1.4731531550182808e-08
protein O 0 1.4168924922230985e-09
was O 0 1.2262439952337445e-09
identified O 0 1.5862473834449276e-10
by O 0 3.427830285243627e-12
DNA O 0 2.094150131082273e-10
sequence O 0 1.489265655241212e-11
analysis O 0 9.218004831668125e-12
within O 0 3.350866806250963e-11
the O 0 4.1865291788845127e-10
insulin B-Disease 0 1.79006365215173e-05
- I-Disease 0 3.311633918201551e-05
dependent I-Disease 0 0.0014179249992594123
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 3.714989702530147e-07
IDDM B-Disease 0 0.0004309058713261038
) O 0 4.767782169068369e-09
locus O 0 6.883914238642319e-08
IDDM4 O 0 5.653203970723553e-06
on O 0 6.22266966843199e-08
chromosome O 0 4.6592845137638506e-08
11q13 O 0 1.5347752650995972e-06
. O 0 1.1348247852538407e-07

Based O 0 7.846618927942473e-07
on O 0 8.430455977759266e-08
its O 0 7.607185992242194e-10
chromosomal O 0 8.14071299259922e-08
position O 0 7.19443704610967e-08
, O 0 2.207854871150161e-10
this O 0 6.101896071752932e-11
gene O 0 5.31403643311279e-10
is O 0 4.920943513786469e-11
a O 0 1.3857258396310357e-10
candidate O 0 5.574503081362536e-10
for O 0 3.0314292742694704e-10
conferring O 0 1.8743708096735645e-07
susceptibility O 0 9.597648386261426e-06
to O 0 1.0906303771207604e-07
diabetes B-Disease 1 1.0
. O 0 1.7826019757194445e-05

The O 0 3.8157159565344045e-07
gene O 0 2.7539032387835505e-08
, O 0 1.963767815027495e-09
termed O 0 1.4135601134057652e-07
low O 0 1.4222795243767905e-06
- O 0 1.1184121717633388e-07
density O 0 1.920946290923098e-09
lipoprotein O 0 1.0784218318349303e-07
receptor O 0 2.219788797219735e-09
related O 0 1.3234653373217498e-09
protein O 0 1.5537051645253541e-09
5 O 0 1.8676602486777938e-09
( O 0 1.918583486526515e-10
LRP5 O 0 7.20563662071072e-07
) O 0 2.3072191379647222e-10
, O 0 2.967786433272224e-11
encodes O 0 1.0844494746642397e-10
a O 0 8.211328145213415e-11
protein O 0 3.8642630761920316e-10
of O 0 1.2787841896511054e-09
1615 O 0 5.4413884953419256e-08
amino O 0 9.862284322537107e-10
acids O 0 3.37063099653534e-10
that O 0 1.1722379143763728e-11
contains O 0 7.929946976847901e-11
conserved O 0 1.192594800691893e-09
modules O 0 2.406783883301955e-09
which O 0 4.1959821034387446e-12
are O 0 9.11550891193047e-13
characteristic O 0 2.4204321880105795e-10
of O 0 1.0122964688719094e-09
the O 0 2.961422218561438e-09
low O 0 8.512522242654086e-08
- O 0 1.1744957006953882e-08
density O 0 3.724329178389496e-10
lipoprotein O 0 5.6617544430537237e-08
( O 0 1.0422134266718786e-09
LDL O 0 1.398008606656731e-07
) O 0 8.875417623066539e-10
receptor O 0 7.74758834864997e-09
family O 0 4.617568549747375e-09
. O 0 1.2517329395222987e-08

These O 0 1.1932466748021398e-07
modules O 0 5.732624686061172e-07
include O 0 9.50750944639367e-09
a O 0 6.239995631318607e-09
putative O 0 2.989277163578663e-07
signal O 0 5.520640655731768e-08
peptide O 0 3.9550736019577926e-09
for O 0 7.401723678412964e-11
protein O 0 2.0414335499818748e-10
export O 0 3.6033067640772742e-09
, O 0 3.0353983215825053e-10
four O 0 1.6259601443024962e-09
epidermal O 0 1.5147955423344683e-07
growth O 0 2.587120517816288e-09
factor O 0 6.138369368358099e-09
( O 0 1.8112620292498605e-09
EGF O 0 4.7629856680941884e-07
) O 0 3.950548221887118e-10
repeats O 0 9.70205360495413e-10
with O 0 2.211579704092248e-11
associated O 0 2.7417217385306003e-09
spacer O 0 1.3528477893487434e-07
domains O 0 3.7051155477030306e-09
, O 0 1.7842280430890867e-10
three O 0 4.1352851698484017e-10
LDL O 0 1.9700156883573072e-07
- O 0 2.6824346832654555e-07
receptor O 0 1.5788236495950514e-08
( O 0 2.4783757268664885e-09
LDLR O 0 3.1622644200979266e-06
) O 0 6.562409504695665e-10
repeats O 0 4.388568619617672e-09
, O 0 2.2144509836952153e-10
a O 0 7.196077622673158e-10
single O 0 4.258043695415381e-09
transmembrane O 0 9.702095127295252e-09
spanning O 0 3.4855767161445783e-09
domain O 0 3.191050090833869e-09
, O 0 1.6145125514288594e-10
and O 0 2.2986451631012983e-10
a O 0 4.9133328516859365e-09
cytoplasmic O 0 1.4627048017246125e-07
domain O 0 2.3744529187297303e-07
. O 0 7.288301873131786e-08

The O 0 6.030620625097072e-07
encoded O 0 5.285011184241739e-08
protein O 0 1.2378178482208568e-08
has O 0 3.676981497058307e-10
a O 0 3.314471475057701e-10
unique O 0 4.499138284153048e-10
organization O 0 3.803003745250777e-10
of O 0 1.1159633217516784e-08
EGF O 0 4.2089257476618513e-05
and O 0 1.4538757753257414e-08
LDLR O 0 0.00012494683323893696
repeats O 0 5.4661852821880075e-09
; O 0 1.0001398320635957e-10
therefore O 0 3.6906269706982187e-10
, O 0 1.7741356994616098e-10
LRP5 O 0 3.289199230493978e-05
likely O 0 1.1573281888388465e-08
represents O 0 8.122372774366227e-10
a O 0 3.4788139036123766e-10
new O 0 4.2627221197300003e-10
category O 0 1.151290618395251e-09
of O 0 4.438978518095382e-09
the O 0 2.1230325941701267e-08
LDLR O 1 0.9680297374725342
family O 0 3.221322799618065e-07
. O 0 1.01543783159741e-07

Both O 0 3.0146480867188075e-07
human O 0 1.4409658888325794e-07
and O 0 8.346776070311535e-08
mouse O 0 4.736871233035345e-06
LRP5 O 1 0.9823184013366699
cDNAs O 0 8.676615107106045e-05
have O 0 4.113708484965173e-09
been O 0 3.2818054940264574e-09
isolated O 0 1.4571016393460923e-08
and O 0 7.402659596422723e-10
the O 0 5.840892769448658e-10
encoded O 0 7.072901708760071e-10
mature O 0 4.3077899580801216e-10
proteins O 0 7.199338347696482e-12
are O 0 4.573664797585808e-12
95 O 0 1.4184959873375647e-09
% O 0 9.259207289780136e-11
identical O 0 4.967702360580972e-10
, O 0 1.1079537981517618e-10
indicating O 0 2.422682721103797e-09
a O 0 1.3189117575862497e-09
high O 0 1.108897773605122e-08
degree O 0 1.5441575129671037e-08
of O 0 1.9550299157344853e-09
evolutionary O 0 4.290555910557714e-09
conservation O 0 1.908423641339141e-09
. O 0 2.216775235597268e-10
. O 0 6.8064758274033466e-09

The O 0 1.5860605344641954e-06
APC B-Disease 0 1.3268779639474815e-06
variants O 0 5.651127139572054e-07
I1307K O 0 2.180447154387366e-06
and O 0 5.392762680855867e-09
E1317Q O 0 9.150823387926721e-08
are O 0 2.995196451971438e-11
associated O 0 1.9948304341710354e-08
with O 0 4.172223634668626e-05
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 4.1852561594168947e-07
but O 0 2.2773401220366196e-10
not O 0 4.007740320166597e-11
always O 0 1.9721597965816073e-10
with O 0 2.0716355714212042e-11
a O 0 9.42909195167374e-10
family O 0 4.174164569548111e-09
history O 0 3.5087914795894903e-08
. O 0 5.864564656121729e-08

Classical O 0 0.0020552414935082197
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 6.446003681048751e-05
FAP B-Disease 0 0.0009991612751036882
) O 0 8.782516935923468e-09
is O 0 1.0183405230179687e-09
a O 0 1.0537914540975635e-08
high O 0 0.0002428606676403433
- O 1 0.9999505281448364
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9996694326400757
that O 0 2.793201669959444e-09
predisposes O 0 4.6008500476091285e-07
to O 0 2.529871201417677e-09
hundreds O 0 2.7080333531159795e-09
or O 0 1.9990955557602774e-09
thousands O 0 4.687065402464441e-09
of O 0 3.0843995773466304e-05
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
and O 0 1.0136532502258433e-08
that O 0 1.581117528570708e-11
results O 0 4.719606649938868e-11
from O 0 3.483660859782134e-10
truncating O 0 5.7509474515882175e-08
mutations O 0 6.395418639115746e-10
in O 0 3.3550895395251246e-10
the O 0 9.728427841082521e-09
APC B-Disease 0 5.336285653356754e-07
gene O 0 1.5909978401396074e-07
. O 0 2.587320011571137e-07

A O 0 2.3196687379822833e-06
variant O 0 1.0956392543448601e-05
of O 0 1.3981581332700443e-06
FAP B-Disease 0 0.0001101017405744642
is O 0 3.495079283766245e-07
attenuated B-Disease 1 0.9999845027923584
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 3.817863358790419e-08
which O 0 2.568886492415601e-10
results O 0 2.2771316776637462e-10
from O 0 7.324723605428574e-10
germ O 0 0.07221638411283493
- O 0 8.388225978706032e-06
line O 0 1.685214243707378e-07
mutations O 0 1.094605628360057e-09
in O 0 2.3158076845053444e-10
the O 0 1.1583346504195902e-09
5 O 0 2.9914368759875742e-09
and O 0 6.236720584418265e-10
3 O 0 6.007816910624797e-09
regions O 0 1.6170343952737198e-09
of O 0 2.4437072809746496e-08
the O 0 1.5057203484047932e-07
APC B-Disease 0 5.247659942142491e-07
gene O 0 9.512882570561487e-08
. O 0 5.95664566560572e-08

Attenuated B-Disease 1 0.9999988079071045
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 0.011229646392166615
have O 0 6.734765634064388e-09
" O 0 1.3574377177860697e-08
multiple O 0 2.613323317746108e-07
" O 1 0.9998788833618164
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 8.136734841457383e-09
typically O 0 1.094674004220586e-10
fewer O 0 5.741764702582586e-11
than O 0 1.561094309376898e-11
100 O 0 6.524813328523393e-11
) O 0 1.0504406372513486e-11
without O 0 1.6539855596242603e-10
the O 0 6.946240249661173e-10
florid O 0 2.810961063914874e-07
phenotype O 0 7.318865158367771e-08
of O 0 7.904766619049042e-09
classical O 0 1.1887351547557046e-07
FAP B-Disease 0 3.09010124510678e-06
. O 0 1.217301246470015e-07

Another O 0 2.6742253567135776e-07
group O 0 3.648007007583942e-09
of O 0 9.850258386734367e-09
patients O 0 8.98391405712573e-09
with O 0 6.37289165883459e-10
multiple O 0 1.7066649888874963e-06
adenomas B-Disease 1 0.9999998807907104
has O 0 3.4701872486664342e-09
no O 0 4.344525295074675e-10
mutations O 0 8.085025010595714e-11
in O 0 2.0633463687635967e-11
the O 0 1.3184658920195602e-10
APC B-Disease 0 9.336658113312524e-10
gene O 0 8.595867073690755e-11
, O 0 1.870096612288652e-11
and O 0 5.257956570137168e-11
their O 0 1.279588796032627e-10
phenotype O 0 2.4906315232442466e-08
probably O 0 6.704489741160558e-10
results O 0 2.4010958152298478e-11
from O 0 6.591433648894807e-11
variation O 0 7.47646389243073e-09
at O 0 9.44572420280565e-10
a O 0 2.4974411427791665e-10
locus O 0 2.3972268614613768e-09
, O 0 5.216292675580547e-11
or O 0 3.449885377371231e-10
loci O 0 1.266579818803848e-08
, O 0 5.038391925893393e-10
elsewhere O 0 6.481629899468544e-09
in O 0 1.6731381835555226e-09
the O 0 3.503802048498983e-08
genome O 0 1.9309911181153439e-07
. O 0 1.0559527652276302e-07

Recently O 0 9.120936397266632e-07
, O 0 4.121279317814697e-09
however O 0 2.646008301354641e-09
, O 0 4.006442955173384e-10
a O 0 7.022010750645791e-10
missense O 0 6.480519942897445e-08
variant O 0 1.6858134586072993e-06
of O 0 6.653323907812592e-06
APC B-Disease 0 4.484318196773529e-06
( O 0 7.955103242807127e-09
I1307K O 0 2.4072423343568516e-07
) O 0 2.0030027636508407e-10
was O 0 1.2443743813150832e-09
described O 0 1.8433320148059096e-10
that O 0 5.229948418783437e-12
confers O 0 8.46662462361536e-10
an O 0 2.4649080519745237e-12
increased O 0 3.153021940760503e-11
risk O 0 9.596345051932076e-09
of O 1 0.9837320446968079
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 6.546900266357625e-08
including O 0 7.923389722108709e-10
multiple O 0 5.7274991860367663e-08
adenomas B-Disease 1 0.953211784362793
, O 0 4.024658384338409e-09
in O 0 1.5661576924230758e-08
Ashkenazim O 0 0.03782966732978821
. O 0 1.8546103319749818e-06

We O 0 1.2927100101478572e-07
have O 0 3.3853355674295926e-09
studied O 0 5.6924602809260705e-09
a O 0 6.553078635285203e-10
set O 0 8.323081668315524e-10
of O 0 8.012446262029016e-10
164 O 0 1.2217062028696546e-08
patients O 0 9.865972483424912e-10
with O 0 3.355985489505997e-10
multiple O 1 0.9999141693115234
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9994310736656189
/ I-Disease 1 1.0
or I-Disease 0 6.0910086176590994e-05
carcinoma I-Disease 1 1.0
and O 0 6.585421097327071e-09
analyzed O 0 3.066158216213921e-09
codons O 0 4.938154329892086e-09
1263 O 0 5.053315135228331e-07
- O 0 7.020142334113189e-08
1377 O 0 1.9987969608337153e-06
( O 0 7.522350742306116e-09
exon O 0 2.1905046310166654e-07
15G O 0 2.0846620429892937e-07
) O 0 6.505651573007754e-11
of O 0 8.241693993937815e-10
the O 0 2.31311614307117e-09
APC B-Disease 0 2.505416141218575e-08
gene O 0 1.6168586469689217e-09
for O 0 6.632626114999596e-10
germ O 1 0.5598918795585632
- O 0 2.4485781978000887e-05
line O 0 1.8778484900394687e-06
variants O 0 2.0478312308114255e-06
. O 0 3.477856012068514e-07

Three O 0 4.824749453291588e-07
patients O 0 3.108818447117301e-08
with O 0 1.4477540277724188e-09
the O 0 1.5045225509879856e-08
I1307K O 0 3.5865988934347115e-07
allele O 0 5.6381730395571594e-09
were O 0 7.263925017042538e-10
detected O 0 1.5992962509869812e-09
, O 0 1.527015493218986e-11
each O 0 1.471297562949392e-11
of O 0 3.851792218512173e-09
Ashkenazi O 0 5.958947440376505e-05
descent O 0 1.6240495824604295e-05
. O 0 8.55443886393914e-07

Four O 0 1.36278913487331e-06
patients O 0 2.702385586417222e-07
had O 0 6.277470276927488e-08
a O 0 2.377837837741481e-08
germ O 1 0.9963098168373108
- O 0 0.00027123396284878254
line O 0 4.895150595984887e-06
E1317Q O 0 1.8299941757504712e-06
missense O 0 1.5025014477032528e-07
variant O 0 1.3442748070247035e-07
of O 0 3.690539074341359e-08
APC O 0 3.151782124177771e-08
that O 0 1.6425732995983822e-10
was O 0 3.799714320962266e-09
not O 0 2.893988000629566e-11
present O 0 3.6444722240069893e-10
in O 0 6.541137076432335e-11
controls O 0 1.0137746198068953e-09
; O 0 7.957279973824782e-11
one O 0 7.691512010632451e-11
of O 0 1.8234347365364556e-10
these O 0 2.7000776614549693e-11
individuals O 0 2.308054268540527e-11
had O 0 3.3380229691459817e-09
an O 0 6.567514587718648e-11
unusually O 0 2.7289135395847097e-09
large O 0 2.3905047386030276e-10
number O 0 6.792708062697272e-11
of O 0 9.33098398547827e-09
metaplastic B-Disease 0 7.70069018471986e-05
polyps I-Disease 0 4.398284545459319e-06
of I-Disease 0 7.497087750607534e-08
the I-Disease 0 2.1731699462179677e-07
colorectum I-Disease 0 8.89532602741383e-05
. O 0 4.5416922489494027e-07

There O 0 8.331093681590573e-08
is O 0 3.058389763666014e-09
increasing O 0 9.618879026618288e-10
evidence O 0 2.102604090836735e-09
that O 0 2.6874997019477043e-11
there O 0 5.6975708873086006e-11
exist O 0 3.2023891871624244e-10
germ O 0 2.952514296339359e-05
- O 0 1.6856770912454522e-07
line O 0 9.237484555058018e-09
variants O 0 4.1732808320205095e-09
of O 0 6.071532165918825e-09
the O 0 3.1505784647833934e-09
APC B-Disease 0 5.710033335049047e-09
gene O 0 2.377599783720541e-10
that O 0 2.411192252804728e-11
predispose O 0 8.643553428555606e-09
to O 0 6.785473849468815e-10
the O 0 1.3492492678679469e-09
development O 0 6.803685170808649e-09
of O 0 2.7315081752021797e-08
multiple O 1 0.9991268515586853
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999946355819702
carcinoma I-Disease 1 1.0
, O 0 8.83732587109165e-10
but O 0 5.308086956090641e-11
without O 0 2.475454841111002e-10
the O 0 5.719731910325265e-10
florid O 0 1.1790097431685354e-07
phenotype O 0 8.131832096580638e-09
of O 0 9.92955606626822e-10
classical O 0 9.222028474198396e-09
FAP B-Disease 0 1.0519964632749179e-07
, O 0 7.147826774911437e-11
and O 0 4.720759200216307e-11
possibly O 0 3.3143449096328936e-10
with O 0 3.5972190504107715e-11
importance O 0 1.4041870599612594e-07
for O 0 6.463465979322791e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 1.834845716075506e-05
in O 0 1.511692021560762e-10
the O 0 1.7321059864183752e-10
general O 0 4.936871467187132e-10
population O 0 8.38144310899569e-12
. O 0 2.8206273428033057e-10
. O 0 1.0698454566693272e-08

Genomic O 0 8.247077403211733e-07
structure O 0 5.285011184241739e-08
of O 0 1.2052387532435205e-08
the O 0 5.444001693888367e-09
human O 0 2.356872073505656e-06
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9769754409790039
CLD B-Disease 1 1.0
) O 0 4.0391331168621036e-08
gene O 0 9.393199462692792e-08
. O 0 6.766842375327542e-08

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9995993971824646
CLD B-Disease 1 1.0
) O 0 1.9555978170160415e-08
is O 0 1.2836712248720517e-10
caused O 0 1.2195032761397329e-09
by O 0 9.844125514746338e-11
mutations O 0 2.2453972015057388e-10
in O 0 2.6975258138328684e-10
a O 0 9.889636887194797e-10
gene O 0 8.896908765265721e-10
which O 0 1.325885234937374e-10
encodes O 0 2.887584171773483e-09
an O 0 2.5474664044899953e-10
intestinal O 0 1.8378628965365351e-06
anion O 0 2.1362518509704387e-06
transporter O 0 3.1409101211465895e-05
. O 0 3.9155648323685455e-07

We O 0 2.5375814516337414e-07
report O 0 1.661563153732004e-08
here O 0 2.9827256220471554e-09
the O 0 1.574738672793785e-09
complete O 0 5.251587609222952e-09
genomic O 0 2.1329523036683895e-08
organization O 0 7.643138899560142e-10
of O 0 1.7633612348078032e-09
the O 0 2.623504524734699e-09
human O 0 2.212173555449226e-08
CLD B-Disease 1 0.999958872795105
gene O 0 2.388829756228006e-08
which O 0 8.203363544012632e-10
spans O 0 3.000562909249993e-09
approximately O 0 6.372450483960179e-11
39kb O 0 2.985197156135655e-08
, O 0 1.5229151273388197e-10
and O 0 4.922166008114459e-10
comprises O 0 1.74819092535472e-09
21 O 0 6.455094592183741e-08
exons O 0 1.2723185136565007e-05
. O 0 3.8574191307816363e-07

All O 0 3.70971133634157e-06
exon O 0 4.948357309331186e-05
/ O 0 6.594840670004487e-06
intron O 0 4.857603016716894e-06
boundaries O 0 2.8123251283318496e-08
conform O 0 1.5615432502613658e-08
to O 0 2.95310820241923e-09
the O 0 3.5323608926773886e-08
GT O 0 0.000191758488654159
/ O 0 0.016388576477766037
AG O 1 0.7643431425094604
rule O 0 3.5840387226926396e-06
. O 0 7.842070885999419e-07

An O 0 1.144567285393805e-08
analysis O 0 4.822474419796663e-09
of O 0 7.094766552029341e-09
the O 0 1.0952390105956056e-08
putative O 0 7.354137778747827e-06
promoter O 0 6.52645530863083e-06
region O 0 4.9147040215302695e-08
sequence O 0 5.385731416396311e-09
shows O 0 1.8282345637388175e-09
a O 0 4.807211517743326e-09
putative O 0 4.648961294151377e-06
TATA O 0 0.01218305341899395
box O 0 3.582763099529984e-07
and O 0 2.9395534895115816e-09
predicts O 0 1.5351011128927894e-08
multiple O 0 1.2179161679171102e-08
transcription O 0 4.2811572598111525e-07
factor O 0 1.1370256736142892e-08
binding O 0 2.9804866130689334e-08
sites O 0 1.366793753732054e-07
. O 0 9.759895647221128e-08

The O 0 1.1182324897163198e-06
genomic O 0 1.1828631159005454e-06
structure O 0 1.6350114151464368e-07
was O 0 4.1541593276406275e-08
determined O 0 3.3589184211813006e-10
using O 0 1.5373088912973287e-10
DNA O 0 2.0304760095513075e-09
from O 0 1.6304156635893463e-10
several O 0 2.031775615807252e-11
sources O 0 9.345940688021415e-10
including O 0 2.326180081890783e-10
multiple O 0 4.794885821723938e-09
large O 0 2.9002034551695033e-08
- O 0 4.1103467651737446e-07
insert O 0 2.381928254635568e-07
libaries O 0 6.124946025920508e-07
and O 0 4.2890643814352813e-10
genomic O 0 2.3147490590957887e-09
DNA O 0 4.440231737845579e-09
from O 0 9.832759051420226e-10
Finnish O 0 4.080128201167099e-05
CLD B-Disease 1 1.0
patients O 0 0.00010045100498246029
and O 0 1.6029440530473948e-07
controls O 0 2.9996085686434526e-06
. O 0 3.3118018905042845e-07

Exon O 0 2.718921678024344e-05
- O 0 5.906965725444024e-07
specific O 0 2.249848085611461e-09
primers O 0 8.58578630413831e-08
developed O 0 1.1618623396714156e-08
in O 0 3.354435479385742e-11
this O 0 7.391519687982573e-12
study O 0 7.749792994837801e-12
will O 0 1.1902796456797482e-12
facilitate O 0 2.9301241988299864e-11
mutation O 0 1.6449301989962528e-11
screening O 0 5.623196006054876e-11
studies O 0 4.0397416314896795e-12
of O 0 2.099111856557201e-11
patients O 0 6.766535942670515e-11
with O 0 4.3743241667781874e-11
the O 0 2.6873399505689122e-08
disease O 0 0.01907244510948658
. O 0 5.502721478478634e-07

Genomic O 0 2.7697017230821075e-06
sequencing O 0 6.215018402144779e-07
of O 0 3.0647103699266154e-07
a O 0 6.90728541030694e-07
BAC O 1 0.9999632835388184
clone O 1 0.9995657801628113
H O 1 1.0
_ O 0 9.26234349662991e-07
RG364P16 O 0 1.2247776339791017e-06
revealed O 0 1.0706619590905575e-08
the O 0 3.070018961270904e-10
presence O 0 4.0389136479745957e-10
of O 0 2.027960244177507e-09
another O 0 2.5391528879481484e-09
, O 0 1.8826881720279687e-10
highly O 0 7.781260635830733e-10
homologous O 0 2.7960853632436056e-09
gene O 0 2.3592960918250583e-09
3 O 0 4.6540598042099646e-09
of O 0 3.0227125247250797e-09
the O 0 9.78737002554908e-09
CLD B-Disease 1 0.8127077221870422
gene O 0 7.850196048764246e-09
, O 0 1.1825687651345618e-10
with O 0 8.613423342629378e-12
a O 0 1.737651827982134e-10
similar O 0 1.7744707092592904e-10
genomic O 0 7.863293127741144e-09
structure O 0 3.4869265252979176e-09
, O 0 6.208292213649713e-11
recently O 0 3.050605046350796e-10
identified O 0 3.6834182925993275e-10
as O 0 3.233827927662247e-10
the O 0 5.209668785255417e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 9.491964760854898e-07
( O 0 1.2936762772142174e-08
PDS B-Disease 0 0.00010266975732520223
) O 0 2.6158197830028485e-09
. O 0 4.9157793391430005e-09
. O 0 1.3130294007623888e-07

The O 0 1.3508472420653561e-06
APCI1307K O 0 0.0004603087727446109
allele O 0 8.233505468524527e-07
and O 0 3.4576487450976856e-08
cancer B-Disease 0 8.986321336124092e-05
risk O 0 1.323596592328613e-07
in O 0 2.305812651925976e-09
a O 0 4.947110276987132e-09
community O 0 8.538401652380401e-10
- O 0 1.8428829573480243e-09
based O 0 3.5659045161118286e-11
study O 0 1.1228173772692696e-11
of O 0 2.6673602215865344e-10
Ashkenazi O 0 9.253646453544206e-07
Jews O 0 1.2551726058518398e-07
. O 0 1.1380523545767574e-07

Mutations O 0 6.628350774917635e-07
in O 0 1.3776077167904077e-08
APC O 0 9.719138915897929e-08
are O 0 1.3387690955823928e-10
classically O 0 2.2259381182720972e-07
associated O 0 4.029191913446084e-08
with O 0 2.2243630937168746e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 2.9072152756270953e-05
FAP B-Disease 0 4.355980490799993e-05
) O 0 6.903314586637066e-10
, O 0 9.098009151609077e-11
a O 0 2.7327315965663956e-09
highly O 0 0.0004274594539310783
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 0.00045778436469845474
by O 0 1.7934411733477873e-09
multiple O 0 1.1249223774711936e-07
intestinal O 1 0.9999650716781616
polyps B-Disease 0 7.445681148965377e-06
and O 0 9.746976559199538e-10
, O 0 8.916219845778173e-11
without O 0 1.4994023800340983e-09
surgical O 0 0.03175754472613335
intervention O 0 3.300567186670378e-05
, O 0 1.0894588564624996e-09
the O 0 1.0652166926305995e-09
development O 0 2.243207575247652e-08
of O 0 0.0007248270558193326
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 3.1381409826281015e-06
CRC B-Disease 0 2.4641252821311355e-05
) O 0 7.335898555282938e-09
. O 0 8.194770373393112e-08

APC B-Disease 0 2.0663190298364498e-05
is O 0 9.113896481949268e-08
a O 0 1.6772423805377912e-07
tumour O 1 0.999996542930603
- O 0 2.4325709091499448e-06
suppressor O 0 3.2765353807917563e-07
gene O 0 1.1022296408924603e-09
, O 0 5.270567662862824e-11
and O 0 1.711142894045281e-10
somatic O 0 2.0037746253365185e-06
loss O 0 3.854650003631832e-07
occurs O 0 1.2161338247551612e-07
in O 0 2.7859297091481494e-08
tumours B-Disease 1 1.0
. O 0 1.3663080835613073e-06

The O 0 6.2901663113734685e-06
germline O 0 2.2078096662880853e-05
T O 0 2.719728627198492e-06
- O 0 8.762506809034676e-07
to O 0 1.850167308248274e-08
- O 0 1.7768304871879081e-07
A O 0 1.892699827976685e-07
transversion O 0 2.165154910471756e-06
responsible O 0 7.576983485080291e-09
for O 0 5.464201313643002e-10
the O 0 4.013022358861917e-09
APC O 0 3.655559410731257e-08
I1307K O 0 1.1679863121116796e-07
allele O 0 1.8294414871888875e-09
converts O 0 7.170187554805807e-09
the O 0 1.2543279748200575e-09
wild O 0 1.791984560739479e-09
- O 0 6.473447333732452e-10
type O 0 7.579624705655874e-10
sequence O 0 5.304759964630534e-10
to O 0 5.392224999845041e-10
a O 0 1.1480436157285112e-08
homopolymer O 0 0.0003480448795016855
tract O 0 8.087277819868177e-06
( O 0 5.981461548287825e-09
A8 O 0 3.8932088841647783e-07
) O 0 1.0430560581919934e-10
that O 0 1.0490211130309568e-11
is O 0 4.2465406191460886e-10
genetically O 0 9.83464332193762e-08
unstable O 0 0.0002696708543226123
and O 0 9.552720570127349e-08
prone O 0 1.560043529025279e-06
to O 0 6.54351461903957e-09
somatic O 0 6.594582828256534e-06
mutation O 0 1.1294285684471106e-07
. O 0 5.6008332194323884e-08

The O 0 3.872505203617038e-06
I1307K O 0 7.044472567940829e-06
allele O 0 2.302092525496846e-07
was O 0 9.248277166307162e-08
found O 0 3.601849929424361e-09
in O 0 4.826394839341219e-09
6 O 0 7.733505640317162e-07
. O 0 5.717195108445594e-07

1 O 0 6.062437932996545e-06
% O 0 4.302341949369293e-08
of O 0 5.758982268844193e-08
unselected O 0 0.00010575338819762692
Ashkenazi O 0 9.964560740627348e-05
Jews O 0 3.93761354189337e-07
and O 0 3.40930439435283e-09
higher O 0 8.751748659108216e-09
proportions O 0 1.6362772470301934e-08
of O 0 1.3283064426161673e-08
Ashkenazim O 0 5.2209570640116e-06
with O 0 5.298814165222154e-10
family O 0 1.1483064277229005e-08
or O 0 1.1927745457995798e-09
personal O 0 4.0173283366584656e-08
histories O 0 2.1892078905239032e-07
of O 0 3.913193268090254e-06
CRC B-Disease 1 0.9455496072769165
( O 0 4.2749395134933366e-08
ref O 0 0.0003400007262825966
. O 0 9.236427622738574e-09
2 O 0 1.4198994335856696e-07
) O 0 8.52213588586892e-09
. O 0 9.886439045203588e-08

To O 0 1.6951045722635172e-07
evaluate O 0 1.8325057737911266e-07
the O 0 2.9209324736712006e-08
role O 0 3.413913063354812e-08
of O 0 5.3053724968776805e-08
I1307K O 0 2.8496799586719135e-06
in O 0 2.27585617018633e-09
cancer B-Disease 0 3.7024582866251876e-07
, O 0 1.0158824892414486e-09
we O 0 1.188344200819813e-09
genotyped O 0 5.0238918447576e-06
5 O 0 7.706942994900601e-08
, O 0 4.994763269650093e-09
081 O 0 1.3893833056499716e-05
Ashkenazi O 0 2.2432486730394885e-05
volunteers O 0 2.396432563500639e-08
in O 0 1.088752532574233e-09
a O 0 5.3962714297028924e-09
community O 0 5.469230401899949e-09
survey O 0 2.63974730962957e-09
. O 0 9.56070067559267e-09

Risk O 0 2.1504044980247272e-06
of O 0 6.101882377151924e-07
developing O 1 0.9697680473327637
colorectal B-Disease 1 1.0
, I-Disease 0 0.0013498655753210187
breast I-Disease 1 0.9999997615814209
and I-Disease 0 4.620597451321373e-07
other I-Disease 0 4.818578602794332e-08
cancers I-Disease 1 0.9979767203330994
were O 0 2.1040213127321294e-08
compared O 0 1.4607413945100234e-08
between O 0 2.0663740940563002e-08
genotyped O 0 9.498189683654346e-06
I1307K O 0 2.9313423510757275e-07
carriers O 0 2.9909350551804437e-09
and O 0 9.074928586372266e-10
non O 0 1.5008625453560853e-08
- O 0 1.8304930904378125e-08
carriers O 0 1.6645312905794185e-09
and O 0 3.2710426034476825e-10
their O 0 2.4654608909990827e-10
first O 0 2.5162332217831818e-09
- O 0 1.4856166075105648e-08
degree O 0 1.071734914148692e-07
relatives O 0 1.085852261439868e-07
. O 0 4.389366026202879e-08

Sperm O 0 8.060646905505564e-08
DNA O 0 3.8169606142446355e-08
analysis O 0 3.4053400099764985e-09
in O 0 1.887755285423509e-09
a O 0 5.625157228905664e-08
Friedreich B-Disease 1 0.9999920129776001
ataxia I-Disease 1 1.0
premutation O 1 1.0
carrier O 0 4.606167567544617e-05
suggests O 0 6.350146719569238e-08
both O 0 2.275509114468832e-09
meiotic O 0 2.0627257981686853e-06
and O 0 1.874602517659696e-08
mitotic O 0 2.3310865060466313e-07
expansion O 0 1.7757903947313025e-07
in O 0 1.2387406655989253e-09
the O 0 1.4937798553660286e-08
FRDA B-Disease 0 0.00011028006701963022
gene O 0 1.174767234601859e-07
. O 0 7.763019738149524e-08

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 2.047009274974698e-06
usually O 0 1.4003637716086814e-07
caused O 0 7.601855855909889e-08
by O 0 2.0030943570503723e-10
an O 0 1.3694587130963498e-10
expansion O 0 9.863196481774139e-08
of O 0 3.134020687411976e-07
a O 0 6.031035013620567e-07
GAA O 0 5.3951673180563375e-05
trinucleotide O 0 0.0002473948406986892
repeat O 0 1.492271195502326e-07
in O 0 5.7195816971500335e-09
intron O 0 1.1057054507546127e-06
1 O 0 2.8888525349657357e-08
of O 0 6.508636740676366e-09
the O 0 4.408840581504592e-08
FRDA B-Disease 0 0.0011335205053910613
gene O 0 5.32831165855896e-07
. O 0 2.662600593339448e-07

Occasionally O 0 1.4659966609542607e-06
, O 0 2.0881454787513576e-08
a O 0 1.0242413139849305e-08
fully O 0 2.804803855838145e-08
expanded O 0 9.29724741638438e-09
allele O 0 2.435931101274491e-08
has O 0 5.171488237643018e-10
been O 0 1.4029430395190445e-10
found O 0 7.890087194706297e-11
to O 0 4.393296143545555e-11
arise O 0 3.437341744572109e-09
from O 0 3.1512032983016525e-09
a O 0 7.650552191762472e-09
premutation O 0 2.373679308220744e-06
of O 0 3.159944483854815e-08
100 O 0 1.9916130966635137e-09
or O 0 8.354381630937269e-10
less O 0 1.2015501482665059e-08
triplet O 0 8.771912689553574e-07
repeats O 0 5.587932037087739e-07
. O 0 1.763282284628076e-07

We O 0 4.6384917595787556e-07
have O 0 7.039313132395364e-09
examined O 0 2.771666984813237e-08
the O 0 1.6918536571708387e-09
sperm O 0 2.0224442121019592e-09
DNA O 0 6.132132579494964e-09
of O 0 9.435339620722516e-09
a O 0 3.7671274100148366e-08
premutation O 0 6.282500544330105e-05
carrier O 0 2.9612203888973454e-06
. O 0 4.3507577629497973e-07

This O 0 8.38071343878255e-07
mans O 0 1.7146512618637644e-05
leucocyte O 0 4.881361746811308e-06
DNA O 0 1.8657354416973249e-07
showed O 0 1.0109694414950354e-08
one O 0 2.911806906702452e-10
normal O 0 2.2577395508704967e-10
allele O 0 1.440943919739368e-09
and O 0 2.1966564678344014e-10
one O 0 7.504201426922208e-11
allele O 0 6.358988891008721e-10
of O 0 1.1395827614890663e-09
approximately O 0 1.8679728597259526e-10
100 O 0 1.647091796286304e-09
repeats O 0 1.6674173153319316e-08
. O 0 2.368386908813136e-08

His O 0 2.6854190764424857e-06
sperm O 0 1.317010003276664e-07
showed O 0 5.853129536603774e-09
an O 0 9.714454934917072e-11
expanded O 0 1.005261984765582e-09
allele O 0 7.629510356821356e-09
in O 0 5.931334867703697e-10
a O 0 7.873813601122492e-09
tight O 0 3.475836649613484e-07
range O 0 2.0786707466413645e-07
centering O 0 7.960780408211576e-07
on O 0 1.5279267628898197e-08
a O 0 7.08227032575337e-10
size O 0 1.2873987431660794e-09
of O 0 5.240520906113488e-09
approximately O 0 4.440536827132746e-09
320 O 0 4.078514592720239e-08
trinucleotide O 0 3.128820389974862e-05
repeats O 0 1.8507691947888816e-06
. O 0 4.2017168766506074e-07

His O 0 1.3909384506405331e-05
affected O 0 5.070111910754349e-06
son O 1 0.676278829574585
has O 0 4.428967415037732e-08
repeat O 0 2.40402311391108e-08
sizes O 0 7.950279545809735e-09
of O 0 1.491818046872595e-08
1040 O 0 1.1397656862754957e-06
and O 0 2.2955191525397822e-08
540 O 0 3.3588261771910766e-07
. O 0 5.9368527871583865e-08

These O 0 2.221852923867118e-08
data O 0 9.048799931576923e-09
suggest O 0 1.8943524526804367e-09
that O 0 8.476104540466878e-11
expansion O 0 1.1630906904258609e-08
occurs O 0 8.908200843649183e-10
in O 0 9.919725457718798e-11
two O 0 3.5349771720927237e-11
stages O 0 1.0633531832837662e-09
, O 0 6.028253590750765e-11
the O 0 1.3070682036708803e-10
first O 0 2.292830231231946e-10
during O 0 3.2410155115236705e-10
meiosis O 0 9.590813698778788e-10
followed O 0 8.556840791484888e-10
by O 0 3.875894397098456e-11
a O 0 1.1501712915418238e-09
second O 0 2.5374694345714488e-08
mitotic O 0 1.506185753896716e-07
expansion O 0 1.058921156982251e-06
. O 0 4.2361580199212767e-07

We O 0 5.929671829107974e-07
also O 0 1.3596974213214708e-08
show O 0 4.5060599696000736e-10
that O 0 1.760711194898068e-11
in O 0 3.9529428341733563e-11
all O 0 2.0341641565613244e-11
informative O 0 4.3032899466055596e-10
carrier O 0 2.2448327641200194e-09
father O 0 1.1595730597946385e-08
to O 0 4.948561560524922e-10
affected O 0 4.4024019985045015e-09
child O 0 3.2613151290661335e-08
transmissions O 0 5.7712867373993504e-08
, O 0 3.036763548958099e-11
with O 0 6.182799931753191e-12
the O 0 3.5083594362994575e-10
notable O 0 1.165672891545455e-09
exception O 0 2.453541814162463e-09
of O 0 3.911665658051788e-09
the O 0 6.476958525070131e-09
premutation O 0 4.6348301907528366e-07
carrier O 0 1.0370503567003198e-08
, O 0 3.774949242085768e-10
the O 0 1.5022192378921773e-09
expansion O 0 2.3898140355527175e-08
size O 0 5.357577048670237e-09
decreases O 0 8.80371597844487e-09
. O 0 1.4919823154713185e-09
. O 0 2.525591469293431e-08

The O 0 9.74313479673583e-07
R496H O 0 4.131712557864375e-06
mutation O 0 2.3721028696854773e-08
of O 0 3.91925532028381e-08
arylsulfatase O 0 1.4665988601336721e-05
A O 0 1.790212849073214e-07
does O 0 1.894103096589106e-09
not O 0 2.4896804617924317e-09
cause O 0 4.977548815077171e-05
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 3.77180094801588e-06

Deficiency B-Disease 1 0.9978961944580078
of I-Disease 0 3.170613490510732e-05
arylsulfatase I-Disease 1 0.6451810002326965
A I-Disease 0 6.874792597955093e-05
( O 0 3.5519542507245205e-07
ARSA O 1 0.5238436460494995
) O 0 2.6195745572721307e-09
enzyme O 0 8.710415499990631e-09
activity O 0 5.860893992348792e-09
causes O 0 2.3074289856594987e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 4.254670329828514e-06
MLD B-Disease 1 1.0
) O 0 2.93494537118022e-07
. O 0 1.7196161650190334e-07

A O 0 1.113040298150736e-06
number O 0 7.72412800387201e-09
of O 0 1.4969634776207386e-07
ARSA O 0 0.0012566037476062775
gene O 0 5.187715501620005e-08
mutations O 0 1.165818019899234e-08
responsible O 0 8.35508728869172e-09
for O 0 1.7802864960003717e-08
MLD B-Disease 1 1.0
have O 0 5.860270846369531e-08
been O 0 9.566957004381038e-09
identified O 0 4.078584581179712e-08
. O 0 5.897228305684621e-08

Recently O 0 8.370182513317559e-06
, O 0 4.465466929559625e-08
the O 0 2.5057458330479676e-08
R496H O 0 1.0465114428370725e-06
mutation O 0 2.9285528668765437e-08
of O 0 1.6425632054506423e-07
ARSA O 0 0.3719271123409271
was O 0 3.3145764177788806e-07
proposed O 0 1.2679140404259215e-08
to O 0 5.217956622338704e-10
be O 0 6.773809846372103e-10
a O 0 3.548856764012953e-09
cause O 0 2.1655421278410358e-07
of O 0 7.017008101684041e-06
MLD B-Disease 1 1.0
( O 0 5.741509880863305e-07
Draghia O 0 1.567324943607673e-05
et O 0 1.1816302247780186e-07
al O 0 9.752434237952912e-08
. O 0 1.8555797176578182e-10
, O 0 1.8233026199965252e-10
1997 O 0 3.948064541958729e-09
) O 0 4.437488598796335e-09
. O 0 2.596279955469072e-07

We O 0 1.5630577365755016e-07
have O 0 2.9204407780980546e-09
investigated O 0 5.268655911550013e-08
the O 0 4.566088396273926e-09
R496H O 0 7.234232413111386e-08
mutation O 0 5.172711148304643e-10
and O 0 7.669830742740302e-11
found O 0 4.612027773576166e-11
this O 0 2.443181594535826e-11
mutation O 0 4.599160774443334e-10
at O 0 1.0433272024101825e-09
a O 0 1.1439463265539018e-10
relatively O 0 1.3905876450337473e-09
high O 0 6.4772183172578934e-09
frequency O 0 3.509847301685909e-09
in O 0 1.2441482566405426e-10
an O 0 2.8620184347460942e-11
African O 0 1.9017150354461165e-10
American O 0 3.566804074317531e-10
population O 0 7.296243470511499e-12
( O 0 4.039473963657336e-11
f O 0 2.348444771982372e-09
= O 0 5.597540653212718e-09
0 O 0 2.4987765190331857e-09
. O 0 3.4728470099665287e-10
09 O 0 1.3511710861280335e-08
, O 0 7.911007404715065e-10
n O 0 8.518219019038042e-09
= O 0 4.654204133203166e-08
61 O 0 8.988974542489814e-08
subjects O 0 1.033305210285107e-07
) O 0 1.9902699932572432e-08
. O 0 1.382889251999586e-07

The O 0 1.8613063730299473e-05
ARSA O 0 0.14449822902679443
enzyme O 0 1.433059821920324e-07
activity O 0 1.2022969286817897e-09
in O 0 4.60681388869677e-11
subjects O 0 8.443804544455702e-10
with O 0 1.4796840835940017e-11
and O 0 4.808710374337721e-11
without O 0 5.685610870997948e-10
the O 0 1.5049838042457964e-09
R496H O 0 2.833755274878058e-08
mutation O 0 2.3965124329450305e-10
was O 0 1.8087142894529507e-09
determined O 0 4.216114402044724e-10
and O 0 1.8838877680060762e-10
found O 0 4.248031093556648e-10
to O 0 5.81091230689168e-10
be O 0 3.01988301032452e-09
normal O 0 1.2162128371073777e-07
. O 0 1.0678743933567603e-07

It O 0 4.958543797783932e-08
is O 0 3.4549445526721456e-09
therefore O 0 2.255777786785984e-09
concluded O 0 5.1456141569872216e-09
that O 0 7.481448793811296e-11
the O 0 1.790286474623315e-09
R496H O 0 1.460588805457519e-07
mutation O 0 5.7954192556053385e-09
of O 0 3.878000498502843e-08
ARSA O 1 0.9954549074172974
does O 0 3.869236042675084e-09
not O 0 3.0681340801308465e-10
negatively O 0 1.279428341049993e-09
influence O 0 1.2492947787379194e-09
the O 0 3.5849190282988275e-10
activity O 0 1.911511920971165e-10
of O 0 3.976571072428214e-09
ARSA O 0 0.11033489555120468
and O 0 8.271552331962084e-10
is O 0 4.5932497388934124e-11
not O 0 3.21636293987293e-11
a O 0 1.7373908978157715e-09
cause O 0 8.18705075289472e-07
of O 0 8.629449439467862e-05
MLD B-Disease 1 1.0

Down O 0 4.948980495100841e-05
- O 0 3.3073308713937877e-06
regulation O 0 1.7140722263775388e-07
of O 0 3.3224623052774405e-08
transmembrane O 0 1.7152561326838622e-07
carbonic O 0 0.00010611584002617747
anhydrases O 0 0.0002733567962422967
in O 0 8.144517238406479e-08
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 0 5.718325155612547e-06
lines O 0 2.1200896593853713e-09
by O 0 6.930885726452729e-11
wild O 0 6.520926465469756e-09
- O 0 7.69137376011031e-09
type O 0 3.2011288908506685e-07
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 0.9972935318946838
Lindau I-Disease 0 0.049928952008485794
transgenes O 0 8.27587500680238e-05
. O 0 3.819590119746863e-07

To O 0 3.493865960990661e-07
discover O 0 1.0817282714015164e-07
genes O 0 3.6428200456128934e-09
involved O 0 7.067534890659033e-10
in O 0 1.471043731271493e-09
von B-Disease 1 0.9122176766395569
Hippel I-Disease 1 1.0
- I-Disease 1 0.9999988079071045
Lindau I-Disease 1 0.9999986886978149
( O 0 2.1019941698341427e-07
VHL B-Disease 1 0.9999440908432007
) O 0 4.6781451601418667e-08
- O 0 6.958193807804491e-07
mediated O 0 5.746135502704419e-05
carcinogenesis O 1 0.996178150177002
, O 0 7.321092065915025e-10
we O 0 1.669153010253055e-10
used O 0 2.9010996271949807e-08
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 0 0.0015997650334611535
lines O 0 1.392970006008909e-07
stably O 0 3.363631435604475e-07
transfected O 0 1.4052334051939397e-07
with O 0 4.652752627620771e-10
wild O 0 4.781627183092496e-08
- O 0 2.0163177794074727e-07
type O 0 7.149662906158483e-06
VHL O 1 1.0
- O 0 0.015058738179504871
expressing O 0 1.0658899327609106e-06
transgenes O 0 5.8742760302266106e-05
. O 0 2.7231340027356055e-07

Large O 0 1.688352426754136e-06
- O 0 2.380094201726024e-06
scale O 0 1.2756662499668892e-06
RNA O 0 5.972276539978338e-07
differential O 0 8.739358747789083e-08
display O 0 3.979818696819848e-09
technology O 0 1.6290588433776065e-08
applied O 0 2.258257358889182e-09
to O 0 7.553312142416502e-11
these O 0 7.349209435458803e-11
cell O 0 4.95523222454608e-09
lines O 0 4.594084002107479e-10
identified O 0 1.5458474778018427e-10
several O 0 5.569494865298452e-11
differentially O 0 1.3281848509905103e-08
expressed O 0 2.0966001157418646e-10
genes O 0 1.304702040849648e-10
, O 0 2.304693588750517e-11
including O 0 5.406330938484416e-11
an O 0 1.6601929553328176e-10
alpha O 0 3.523935632188113e-08
carbonic O 0 2.0240947833372047e-06
anhydrase O 0 1.288293697143672e-05
gene O 0 1.9327112354972087e-08
, O 0 1.3899882356227522e-09
termed O 0 5.195726089368691e-07
CA12 O 0 0.0035846466198563576
. O 0 1.0414418056825525e-06

The O 0 2.5252478508264176e-07
deduced O 0 3.09597822933938e-07
protein O 0 2.998886250438204e-09
sequence O 0 6.35138885929365e-10
was O 0 3.294530870334711e-09
classified O 0 7.956934555686246e-10
as O 0 4.176495815855219e-10
a O 0 1.5772396722013582e-09
one O 0 3.4307787721843397e-09
- O 0 1.3484685723597067e-06
pass O 0 2.983509148180019e-06
transmembrane O 0 8.430711204709951e-07
CA O 0 6.007865636092902e-07
possessing O 0 1.7609186997447068e-08
an O 0 1.023225393304017e-09
apparently O 0 2.2426172918699194e-08
intact O 0 1.3568934775776142e-07
catalytic O 0 1.1078704176270548e-08
domain O 0 2.66601873910588e-09
in O 0 1.3688503108788552e-10
the O 0 2.1062847022079723e-09
extracellular O 0 6.852343403807026e-08
CA O 0 8.704622814548202e-06
module O 0 6.450682849390432e-05
. O 0 2.6857728130380565e-07

Reintroduced O 0 4.2887357267318293e-05
wild O 0 3.7473989777936367e-06
- O 0 6.925714615135803e-07
type O 0 3.434945483604679e-07
VHL B-Disease 1 0.9999685287475586
strongly O 0 1.377044753780865e-07
inhibited O 0 1.3598301507045107e-07
the O 0 4.084888427513533e-09
overexpression O 0 4.869709258059629e-08
of O 0 3.5772027562330777e-09
the O 0 3.187230035450739e-09
CA12 O 0 2.1799605747219175e-06
gene O 0 4.492158589552986e-10
in O 0 4.1273005846331756e-11
the O 0 7.519349032314437e-10
parental O 0 4.491666913963854e-06
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 0 0.18809092044830322
lines O 0 2.619611620957585e-07
. O 0 6.949665731781351e-08

Similar O 0 5.798927560363154e-08
results O 0 5.6906150902591435e-09
were O 0 9.383970267506925e-10
obtained O 0 1.395945026239076e-09
with O 0 2.0680360202085524e-10
CA9 O 0 0.00040140008786693215
, O 0 3.324628794487694e-09
encoding O 0 7.826457704140921e-08
another O 0 3.137626691795958e-08
transmembrane O 0 7.914968591649085e-08
CA O 0 4.958155841450207e-08
with O 0 1.0856580912044222e-10
an O 0 5.353110732464472e-10
intact O 0 3.0944491413720243e-07
catalytic O 0 1.793230524071987e-07
domain O 0 1.387563202115416e-07
. O 0 3.5286706889792185e-08

Although O 0 2.9850212968085543e-07
both O 0 3.124672787180316e-08
domains O 0 4.1975354747592064e-08
of O 0 1.0278269257923967e-07
the O 0 5.6643468582251444e-08
VHL B-Disease 0 0.002332985168322921
protein O 0 1.522446169133218e-08
contribute O 0 8.202049039951476e-10
to O 0 6.46436626450253e-10
regulation O 0 4.3581078301713205e-08
of O 0 2.06896917376298e-08
CA12 O 0 0.006732206791639328
expression O 0 1.6607392794298903e-08
, O 0 3.00552166487833e-10
the O 0 5.181065021453435e-10
elongin O 0 6.018807141572324e-08
binding O 0 4.376765172509067e-09
domain O 0 4.780968065887237e-09
alone O 0 7.700425852519288e-10
could O 0 7.788922840035184e-10
effectively O 0 5.694200666539473e-08
regulate O 0 8.218343339194689e-08
CA9 O 0 0.02583119459450245
expression O 0 1.725584183986939e-06
. O 0 8.764178573983372e-07

We O 0 2.5319445740024094e-06
mapped O 0 1.5481540685868822e-05
CA12 O 0 0.03299587219953537
and O 0 1.3465448773786193e-06
CA9 O 1 0.7533959150314331
loci O 0 1.9931817405449692e-06
to O 0 2.252623154674893e-08
chromosome O 0 1.2338555066548906e-08
bands O 0 4.823764854222645e-08
15q22 O 0 1.4808066453042557e-06
and O 0 2.285902667154005e-08
17q21 O 0 5.719094133382896e-06
. O 0 2.0214316975852853e-07

2 O 0 3.6307706068328116e-06
respectively O 0 1.2423430462149554e-07
, O 0 2.313874869486199e-09
regions O 0 1.1866595706067073e-08
prone O 0 1.3604025070890202e-06
to O 0 3.7015555065522676e-09
amplification O 0 0.0005123827140778303
in O 0 3.6779657097696372e-09
some O 0 5.188650065157674e-10
human O 0 2.0455241056538398e-08
cancers B-Disease 0 0.0029158703982830048
. O 0 3.384059823474672e-07

Additional O 0 1.5158981625518209e-07
experiments O 0 1.0763606894670374e-07
are O 0 3.199666365194531e-10
needed O 0 1.0650466286676874e-08
to O 0 4.139649179002447e-10
define O 0 6.193821899813656e-09
the O 0 4.895643002100769e-09
role O 0 1.4065347997416211e-08
of O 0 6.038872157887454e-08
CA O 0 1.6567266811762238e-06
IX O 1 0.9999998807907104
and O 0 1.6489746030856622e-06
CA O 0 2.42755140789086e-06
XII O 0 0.0002468931779731065
enzymes O 0 7.2511654458651265e-09
in O 0 1.1210739281342086e-10
the O 0 3.0070640422152906e-10
regulation O 0 8.63960958330523e-10
of O 0 2.765744577803986e-10
pH O 0 2.3014946393118407e-08
in O 0 1.853846104404866e-10
the O 0 1.713992170415679e-09
extracellular O 0 8.634919446137701e-09
microenvironment O 0 3.1316420745497453e-07
and O 0 7.224380538239927e-10
its O 0 1.8114063027319105e-10
potential O 0 3.497858003242982e-09
impact O 0 2.0921920196315114e-08
on O 0 1.0695968200025163e-07
cancer B-Disease 0 4.698158136307029e-06
cell O 0 1.8396444829704706e-06
growth O 0 2.7961561954725767e-08
. O 0 6.415289277583724e-08

A O 0 7.631614948877541e-07
gene O 0 1.5897533955921972e-08
encoding O 0 1.1453845161213394e-07
a O 0 1.7553990261376384e-08
transmembrane O 0 1.3441487034526745e-08
protein O 0 4.3276537908809587e-10
is O 0 1.3698786896498838e-11
mutated O 0 5.354152121661571e-10
in O 0 2.4768893533422265e-11
patients O 0 1.542249439268062e-09
with O 0 1.7234405902399885e-08
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 0 0.014626681804656982
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 6.967687316006277e-09
. O 0 1.411167360743093e-08

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 9.898174903355539e-05
WFS B-Disease 1 0.9999997615814209
; O 0 3.03298497783544e-06
OMIM O 1 0.9999040365219116
222300 O 0 5.7110912166535854e-05
) O 0 2.195208459454534e-09
is O 0 4.3977502195424734e-10
an O 0 1.1580738590311057e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 5.389371153796674e-07
by O 0 2.0488695184894823e-09
young O 0 1.0724134469342061e-08
- O 0 4.4727212866746413e-07
onset O 1 1.0
non O 1 1.0
- O 1 1.0
immune O 1 0.9999998807907104
insulin B-Disease 1 0.9999998807907104
- I-Disease 0 0.00026014004833996296
dependent I-Disease 0 1.2679023711825721e-05
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 0.017606642097234726
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 0 0.15581926703453064
. O 0 1.7882247220768477e-06

Linkage O 0 1.4593467312806752e-05
to O 0 6.719793788079187e-08
markers O 0 5.185934810469917e-07
on O 0 1.708572199277114e-07
chromosome O 0 2.6681320264287933e-07
4p O 1 0.7625191807746887
was O 0 5.413938310994126e-07
confirmed O 0 3.391483360815073e-08
in O 0 1.1631876573048316e-09
five O 0 3.101845447162077e-09
families O 0 6.403392482923209e-09
. O 0 1.057742764487557e-07

On O 0 5.919936256759684e-07
the O 0 1.0497512192841896e-08
basis O 0 2.4175786705882274e-08
of O 0 5.1823356272961973e-08
meiotic O 0 0.002919620368629694
recombinants O 1 0.9993001222610474
and O 0 6.349964820628884e-08
disease O 0 2.9311258913367055e-05
- O 0 1.6761136123477627e-07
associated O 0 1.8087979114511654e-08
haplotypes O 0 1.0436320962980972e-06
, O 0 1.2896351764268843e-09
the O 0 1.269334415354706e-08
WFS B-Disease 0 0.0027359973173588514
gene O 0 2.933382958758557e-08
was O 0 4.524857288856765e-08
localized O 0 4.917122709002797e-08
to O 0 5.977789818700785e-09
a O 0 1.3168141776986886e-07
BAC O 1 0.9998656511306763
/ O 0 0.0012988230446353555
P1 O 0 0.00010664606816135347
contig O 0 1.6322862848028308e-06
of O 0 7.144822067317591e-09
less O 0 1.5572060307889046e-09
than O 0 6.761714521630324e-10
250 O 0 7.63693464023163e-09
kb O 0 1.7890914705276373e-06
. O 0 1.4324585606573237e-07

Mutations O 0 2.799441460865637e-07
in O 0 8.200114365308764e-09
a O 0 4.80491957333129e-09
novel O 0 2.439748669758046e-08
gene O 0 4.598759151264176e-09
( O 0 2.882851513064111e-09
WFS1 O 0 3.803470826824196e-05
) O 0 2.2930717324953775e-09
encoding O 0 2.2962504786505633e-08
a O 0 1.1370495656137791e-08
putative O 0 5.197342147766904e-07
transmembrane O 0 5.267658309549006e-09
protein O 0 3.0119029492681193e-10
were O 0 5.2585279880501545e-11
found O 0 4.1824248925292906e-11
in O 0 3.162387365862607e-11
all O 0 7.26447582644063e-11
affected O 0 2.1618705436932117e-10
individuals O 0 2.803270116036316e-11
in O 0 7.504834531602e-10
six O 0 6.839530719560116e-09
WFS B-Disease 1 0.99951171875
families O 0 1.0248153436975826e-09
, O 0 2.013804401013175e-11
and O 0 6.56135128868085e-12
these O 0 3.8736162714936295e-12
mutations O 0 3.61344773547323e-11
were O 0 2.949018806930326e-11
associated O 0 3.6988437313034694e-10
with O 0 1.2915644942435023e-10
the O 0 4.092275673883705e-08
disease O 0 0.0037833291571587324
phenotype O 0 6.085631684982218e-05
. O 0 3.7200166502771026e-07

WFS1 O 0 0.01982216164469719
appears O 0 6.29868679880019e-07
to O 0 7.022576742343745e-09
function O 0 1.1800819210705527e-09
in O 0 1.4005053783350263e-09
survival O 0 5.919534487475175e-06
of O 0 2.1870479827157396e-07
islet O 0 9.943374607246369e-05
beta O 0 4.912135977974685e-07
- O 0 3.1654221288590634e-07
cells O 0 3.243725954504839e-09
and O 0 1.539956606677606e-09
neurons O 0 1.4064677422709337e-08
. O 0 2.7904165644798695e-09
. O 0 4.713946211154507e-08

Stable O 0 2.322904038010165e-05
interaction O 0 3.779880941578995e-08
between O 0 4.443714285429223e-09
the O 0 4.438620859747999e-10
products O 0 2.8788842421079153e-09
of O 0 3.5776122064845595e-09
the O 0 3.4778335766816326e-09
BRCA1 O 0 1.1522775622552217e-08
and O 0 3.737702591877223e-09
BRCA2 O 0 2.5706095030386678e-08
tumor B-Disease 0 8.796855155424055e-08
suppressor O 0 1.326587835137616e-07
genes O 0 2.6460370006198275e-10
in O 0 6.496388843535428e-11
mitotic O 0 8.665558048903677e-09
and O 0 3.0513396254150393e-09
meiotic O 0 1.0777699571917765e-05
cells O 0 1.423923094989732e-06
. O 0 2.07578835897948e-07

BRCA1 O 0 2.137071714969352e-05
and O 0 2.605728184335021e-07
BRCA2 O 0 2.430597021430003e-07
account O 0 3.521392066829776e-10
for O 0 7.630520520995887e-11
most O 0 2.4261575387596324e-11
cases O 0 5.3487495682569275e-11
of O 0 9.32798949193625e-10
familial O 0 2.6335436587032746e-07
, O 0 2.6320037815885655e-10
early O 0 2.0721364180076307e-08
onset O 1 0.9981694221496582
breast B-Disease 1 0.8744151592254639
and I-Disease 0 3.287051367806271e-05
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.6146476095334492e-09
encode O 0 2.504778051637402e-10
products O 0 8.535063766856865e-10
that O 0 1.050915604539071e-11
each O 0 1.532793336700422e-11
interact O 0 3.706836573802441e-11
with O 0 9.221420849137019e-11
hRAD51 O 0 7.193614237621659e-07
. O 0 6.717679212897565e-08

Results O 0 2.495611113317864e-07
presented O 0 7.049661121527606e-07
here O 0 1.79795609511757e-08
show O 0 1.2946332894614443e-09
that O 0 9.554237956344025e-11
BRCA1 O 0 2.7160162119344022e-08
and O 0 7.812404945184426e-09
BRCA2 O 0 6.497885465250874e-07
coexist O 0 8.511857174653414e-08
in O 0 2.5255503244281385e-10
a O 0 9.425459301937167e-10
biochemical O 0 5.512885437042314e-08
complex O 0 9.927480704163827e-08
and O 0 2.6941335828922774e-09
colocalize O 0 2.4200851385103306e-06
in O 0 1.4708277928932034e-09
subnuclear O 0 1.8049195205094293e-06
foci O 0 3.093558120781381e-07
in O 0 3.6542310843934445e-10
somatic O 0 3.653928004609952e-08
cells O 0 4.075145110249423e-09
and O 0 1.347952860442092e-09
on O 0 1.352320366798665e-09
the O 0 3.3559985346265364e-10
axial O 0 2.8931688156319524e-09
elements O 0 4.927504182461462e-09
of O 0 1.7328677159866857e-08
developing O 0 3.2778135050648416e-07
synaptonemal O 0 1.3735137144976761e-05
complexes O 0 5.067706752015511e-07
. O 0 7.552285552492322e-08

Like O 0 1.067951302502479e-06
BRCA1 O 0 2.031784561040695e-06
and O 0 1.9443031362698093e-07
RAD51 O 0 0.3550432026386261
, O 0 5.9519553730069674e-08
BRCA2 O 0 7.34613649910898e-07
relocates O 0 3.679020323943405e-07
to O 0 2.96244078157315e-08
PCNA O 0 8.819595677778125e-05
+ O 0 1.0194413135877767e-07
replication O 0 7.406434132661843e-09
sites O 0 4.679666654183734e-10
following O 0 2.1442161934892567e-10
exposure O 0 7.643434329906995e-09
of O 0 6.544014219400651e-09
S O 0 4.472439627534186e-07
phase O 0 1.2031537721668428e-07
cells O 0 5.0744062285446034e-09
to O 0 6.915096273374388e-10
hydroxyurea O 0 4.7290393467847025e-07
or O 0 8.937716344803448e-09
UV O 0 0.0022322607692331076
irradiation O 0 4.7940618969732895e-05
. O 0 2.4517052565897757e-07

Thus O 0 1.1980383760601399e-06
, O 0 9.069122341998082e-08
BRCA1 O 0 9.892738717098837e-08
and O 0 8.865659317791597e-09
BRCA2 O 0 2.2408940481000172e-08
participate O 0 3.6355854438063773e-10
, O 0 1.8084513053739926e-10
together O 0 1.6803460012315696e-10
, O 0 1.3552194089161418e-10
in O 0 2.6030175237501396e-10
a O 0 7.068778451468916e-09
pathway O 0 1.1066332206155494e-07
( O 0 1.5144923093401985e-09
s O 0 3.019855654429193e-08
) O 0 1.4699799710804484e-10
associated O 0 4.5198497722331865e-10
with O 0 7.234387394694508e-11
the O 0 1.8594423778495184e-09
activation O 0 1.4471584819375494e-08
of O 0 1.6848984429884695e-08
double O 0 1.4228594302778674e-08
- O 0 8.405616824802564e-08
strand O 0 3.7717718726071325e-08
break O 0 3.755562616447605e-08
repair O 0 1.6213672324738582e-06
and O 0 2.9459931383257754e-08
/ O 0 1.0670696610759478e-06
or O 0 1.3198762083277416e-08
homologous O 0 4.923354168795413e-08
recombination O 0 1.6949493897300272e-07
. O 0 6.771116289883139e-08

Dysfunction O 0 0.14383848011493683
of O 0 1.1028926110157045e-06
this O 0 7.842234417410054e-09
pathway O 0 1.8835596904409613e-07
may O 0 6.573884769878191e-10
be O 0 7.059716700119623e-11
a O 0 3.0187355393174187e-10
general O 0 2.928551401382151e-09
phenomenon O 0 2.7199600349803177e-09
in O 0 3.870117767923453e-11
the O 0 2.137755077125103e-11
majority O 0 8.103856127816833e-12
of O 0 2.6841084910245172e-11
cases O 0 5.281798956535688e-11
of O 0 3.0888098745407433e-09
hereditary B-Disease 1 1.0
breast I-Disease 1 0.9995918869972229
and I-Disease 0 4.556389831122942e-05
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.545127841813155e-08
. O 0 2.7310445460670962e-08

A O 0 4.5960528041177895e-06
novel O 0 9.160460763268929e-07
Arg362Ser O 0 1.078605873772176e-05
mutation O 0 1.518664127786451e-08
in O 0 1.7985589684244019e-09
the O 0 4.456182534084974e-09
sterol O 0 3.4374334063613787e-06
27 O 0 7.925193585833767e-07
- O 0 1.7024935914378148e-06
hydroxylase O 0 8.772138244239613e-05
gene O 0 9.99668259282771e-08
( O 0 9.140040724275877e-09
CYP27 O 0 0.00043925215140916407
) O 0 1.16679843564782e-09
: O 0 1.1069905409000214e-10
its O 0 3.239322143855361e-10
effects O 0 2.4190361713749553e-08
on O 0 1.3069423765443844e-08
pre O 0 1.7839549570908275e-07
- O 0 2.2313063396950383e-08
mRNA O 0 9.127827382826581e-09
splicing O 0 8.170139231822304e-09
and O 0 2.0141049938970923e-10
enzyme O 0 2.3256754300149396e-09
activity O 0 3.353689992380282e-09
. O 0 2.1669215755082405e-08

A O 0 6.698768402202404e-07
novel O 0 2.001313674782068e-07
C O 0 5.904205977458332e-07
to O 0 4.224826266607806e-09
A O 0 1.6112963407977077e-08
mutation O 0 2.5385478163997277e-09
in O 0 5.103990008414883e-10
the O 0 5.651135559503473e-09
sterol O 0 1.2669104307860835e-06
27 O 0 2.661592759523046e-07
- O 0 6.152109790491522e-07
hydroxylase O 0 1.892753061838448e-05
gene O 0 3.413874338775713e-08
( O 0 2.4020234690169673e-09
CYP27 O 0 2.0892484826617874e-05
) O 0 5.088447441181643e-10
was O 0 8.013272267959337e-10
identified O 0 7.074490299130431e-11
by O 0 2.1401293931466725e-11
sequencing O 0 5.341262099278765e-09
amplified O 0 1.3296397760598211e-08
CYP27 O 0 1.1178357226526714e-06
gene O 0 5.431439187297826e-10
products O 0 2.3051531794493485e-09
from O 0 5.010676873418163e-10
a O 0 1.4078921362070673e-09
patient O 0 2.01137364541637e-08
with O 0 8.83037198917691e-09
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 3.558375851753226e-07
CTX B-Disease 1 0.9875953197479248
) O 0 4.979223433565494e-08
. O 0 7.272929281043616e-08

The O 0 6.682255389023339e-07
mutation O 0 1.7159268850264198e-07
changed O 0 1.4086012356528954e-07
the O 0 2.5776500933716306e-08
adrenodoxin O 0 1.9935789623559685e-06
cofactor O 0 1.7474825142471673e-07
binding O 0 2.8284310005233237e-08
residue O 0 1.768992063944097e-07
362Arg O 0 1.5555330890038022e-07
to O 0 2.579399582813835e-09
362Ser O 0 1.299989548897429e-06
( O 0 2.8650486427750366e-08
CGT O 0 5.574041642830707e-05
362Arg O 0 4.629026989277918e-06
to O 0 9.93831790196964e-08
AGT O 0 0.003743906505405903
362Ser O 0 8.168496492544364e-07
) O 0 5.424368176853989e-10
, O 0 6.534702640115242e-11
and O 0 1.044921857373815e-10
was O 0 4.02986621850232e-09
responsible O 0 1.2453311715177051e-09
for O 0 1.0793200777570178e-09
deficiency O 0 6.374993972713128e-05
in O 0 8.615013591395382e-09
the O 0 3.6624893340331255e-08
sterol O 0 3.0828427952656057e-06
27 O 0 1.47921866755496e-07
- O 0 2.0587663129845168e-07
hydroxylase O 0 4.688230546889827e-06
activity O 0 1.2171817997952417e-09
, O 0 3.510580021126586e-11
as O 0 3.145843655016911e-11
confirmed O 0 2.634856777206096e-10
by O 0 5.0228075171299125e-11
expression O 0 2.3271176097239277e-09
of O 0 1.1112692099857213e-08
mutant O 0 4.684708088120715e-08
cDNA O 0 8.351776870085814e-08
into O 0 1.4844070861386172e-08
COS O 0 9.131362276093569e-06
- O 0 9.717180091683986e-07
1 O 0 9.913138399042509e-08
cells O 0 2.3926920889039138e-08
. O 0 3.159329509117015e-08

Quantitative O 0 7.906034511506732e-07
analysis O 0 2.6943611786123256e-08
showed O 0 3.633251477452859e-09
that O 0 3.103422380190679e-11
the O 0 2.6184143742113974e-10
expression O 0 1.7140836527929082e-09
of O 0 4.263455810615824e-09
CYP27 O 0 3.3262083434237866e-06
gene O 0 1.182334785632122e-09
mRNA O 0 5.748531428650949e-09
in O 0 2.006283472688608e-10
the O 0 7.784170530378276e-10
patient O 0 1.716718323052646e-08
represented O 0 1.879944910854192e-08
52 O 0 1.5183202322077705e-06
. O 0 4.852029178437078e-07

5 O 0 1.7020943232637364e-06
% O 0 2.6198357261364436e-08
of O 0 3.420965910549967e-08
the O 0 1.8561690851015555e-08
normal O 0 1.7432880383694283e-07
level O 0 8.159099706972484e-07
. O 0 1.0125194904730961e-07

As O 0 2.4484293703608273e-07
the O 0 4.738990000419108e-08
mutation O 0 1.28981803015904e-08
occurred O 0 5.723611806729423e-08
at O 0 3.4961502581865034e-09
the O 0 1.0694307661651692e-09
penultimate O 0 1.3934828757555806e-07
nucleotide O 0 2.9016753444466303e-08
of O 0 3.2021848284102816e-08
exon O 0 1.7218971493093704e-07
6 O 0 5.038089767595011e-08
( O 0 1.169130903200255e-09
- O 0 1.9330578027165757e-08
2 O 0 2.748309668731963e-08
position O 0 5.3756153306494525e-08
of O 0 6.238082761456099e-08
exon O 0 4.83572193843429e-07
6 O 0 1.10352004867309e-07
- O 0 1.71619532807199e-07
intron O 0 1.1077456747443648e-06
6 O 0 1.5783575690875296e-07
splice O 0 3.619054496084573e-07
site O 0 4.548703191886716e-09
) O 0 1.8053968042774926e-11
of O 0 1.2289946837995558e-10
the O 0 8.480572910585238e-10
gene O 0 1.8851324945501347e-09
, O 0 3.3442154601104335e-10
we O 0 9.771058268048805e-11
hypothesized O 0 1.1604382343932684e-08
that O 0 1.1199454558186162e-10
the O 0 1.8621396646878452e-09
mutation O 0 2.1495651925107495e-09
may O 0 2.400104559541205e-09
partially O 0 4.413021770233172e-08
affect O 0 1.2470188215374378e-09
the O 0 1.5335432923535564e-09
normal O 0 3.442610641002375e-09
splicing O 0 1.524291093346619e-08
efficiency O 0 2.4801916076455655e-09
in O 0 1.254497061786708e-10
exon O 0 1.724137810299453e-08
6 O 0 2.2860104920141566e-09
and O 0 4.648599213896709e-11
cause O 0 2.6495927674119457e-10
alternative O 0 1.3663057352175656e-08
splicing O 0 3.394939795953178e-08
elsewhere O 0 6.776446070944075e-10
, O 0 9.866452273243898e-12
which O 0 6.714284944003834e-12
resulted O 0 1.3284273681080094e-09
in O 0 1.6423665205600457e-10
decreased O 0 1.0671586947452738e-09
transcript O 0 2.1055146959270132e-08
in O 0 3.1663724420205597e-10
the O 0 1.604230193130718e-09
patient O 0 1.3573283297318994e-07
. O 0 9.105556131316916e-08

Transfection O 0 0.0006310617900453508
of O 0 2.150494765373878e-06
constructed O 0 7.731360710749868e-06
minigenes O 0 1.3284252418088727e-05
, O 0 6.377645633826035e-10
with O 0 2.8663559373254266e-11
or O 0 6.090504212075132e-10
without O 0 1.8170266402606217e-09
the O 0 3.181314323086326e-09
mutation O 0 6.889713244362383e-10
, O 0 1.5642276363081464e-10
into O 0 3.1961422397586148e-09
COS O 0 0.00018961560272146016
- O 0 1.616880012988986e-06
1 O 0 2.11112851644657e-08
cells O 0 5.130538771602744e-10
confirmed O 0 5.212505982399307e-10
that O 0 1.7159725029802786e-11
the O 0 4.268555509057137e-10
mutant O 0 7.005332314236057e-09
minigene O 0 1.6205557074044918e-07
was O 0 3.211027221894369e-09
responsible O 0 3.3100489016391066e-10
for O 0 7.743177626862163e-11
a O 0 6.738963831409706e-10
mRNA O 0 5.654563928203515e-09
species O 0 1.4218975996627137e-10
alternatively O 0 6.066831925721772e-09
spliced O 0 7.259347256649562e-08
at O 0 2.1469019895192787e-09
an O 0 1.2907468149858659e-10
activated O 0 3.466385578576592e-07
cryptic O 0 3.434432073845528e-06
5 O 0 2.3009816629837587e-07
splice O 0 1.286464339500526e-05
site O 0 5.300335601532424e-07
88 O 0 2.32705730240923e-07
bp O 0 3.859751984691684e-07
upstream O 0 1.5788597096388912e-08
from O 0 4.898676464470952e-10
the O 0 2.0607289208385282e-09
3 O 0 1.1432996771532089e-08
end O 0 5.041569295372028e-08
of O 0 6.01454956949965e-08
exon O 0 1.9998267362097977e-06
6 O 0 4.7672119762864895e-07
. O 0 5.180714524044561e-08

Our O 0 1.100486656469002e-06
data O 0 1.3931527931276833e-08
suggest O 0 1.0112467530021263e-09
that O 0 4.059362221364715e-11
the O 0 6.570462507404784e-10
C O 0 8.69524754421036e-08
to O 0 1.4883896337636315e-09
A O 0 4.005927323191827e-08
mutation O 0 4.125974673030441e-09
at O 0 3.3052685033396756e-09
the O 0 1.4526332359210414e-09
penultimate O 0 9.560996261370747e-08
nucleotide O 0 7.447031880047916e-09
of O 0 3.6262932656683233e-09
exon O 0 3.1191770943905794e-08
6 O 0 6.38893560278575e-09
of O 0 8.841085086253031e-10
the O 0 2.2583952485888403e-09
CYP27 O 0 2.6744937713374384e-05
gene O 0 2.2462978144233148e-09
not O 0 7.264281537411321e-11
only O 0 7.415119213094457e-11
causes O 0 1.5631337335619833e-09
the O 0 3.4142371152512396e-09
deficiency B-Disease 0 7.509805072913878e-06
in I-Disease 0 2.4362969419655656e-09
the I-Disease 0 5.051587148585668e-09
sterol I-Disease 0 5.91605385125149e-07
27 I-Disease 0 7.62525047548479e-08
- I-Disease 0 1.5785742846219364e-07
hydroxylase I-Disease 0 3.509847147142864e-06
activity I-Disease 0 2.695233369820471e-09
, O 0 2.584603919775219e-10
but O 0 1.5248508011822537e-10
also O 0 6.152185982877256e-10
partially O 0 4.031313594055064e-08
leads O 0 1.7209828007125338e-09
to O 0 1.408127781044044e-10
alternative O 0 1.4831477379573244e-08
pre O 0 2.29776716764718e-07
- O 0 1.528696280672648e-08
mRNA O 0 5.469897867982354e-09
splicing O 0 8.836959608515826e-09
of O 0 6.331612456556002e-10
the O 0 5.93801341430833e-10
gene O 0 8.257905470543392e-09
. O 0 3.384155888852547e-08

To O 0 2.513549191007769e-07
our O 0 9.529227185112177e-08
knowledge O 0 1.916481267016934e-07
, O 0 3.682245619529567e-10
this O 0 2.5427659977594885e-11
is O 0 1.8052488323649918e-11
the O 0 1.0617111356747699e-10
first O 0 7.850876893034098e-11
report O 0 3.047334953820702e-11
regarding O 0 4.799055597359825e-10
effects O 0 1.6036498351468254e-08
on O 0 1.1468290317395713e-08
pre O 0 1.3290038225477474e-07
- O 0 1.719185860338257e-08
mRNA O 0 5.631509480963359e-09
splicing O 0 3.4162435103013422e-09
of O 0 1.062790966344096e-10
a O 0 6.019865855799722e-11
mutation O 0 6.940621688489301e-11
at O 0 5.457910234873964e-10
the O 0 9.401490697058534e-10
- O 0 1.494250057021418e-08
2 O 0 2.9765267584025423e-08
position O 0 3.813111248973655e-08
of O 0 2.5185441288044785e-08
a O 0 1.0248944448676411e-07
5 O 0 2.6859160584535857e-07
splice O 0 1.8110638848156668e-05
site O 0 6.464550779128331e-07
. O 0 1.1974415770055202e-07

ATM O 0 0.0001732570817694068
germline O 0 1.4054122402740177e-05
mutations O 0 4.503014494616764e-08
in O 0 6.911117900187946e-09
classical O 0 0.00020679183944594115
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999997615814209
in O 0 1.0161698149602216e-08
the O 0 1.0803092642674983e-08
Dutch O 0 1.394016067024495e-06
population O 0 4.5843157048253147e-10
. O 0 1.971199026229442e-08

Germline O 0 2.640667480591219e-05
mutations O 0 5.045071205245222e-08
in O 0 1.0349019419209071e-09
the O 0 1.8637671406196432e-09
ATM O 0 7.666039181231099e-08
gene O 0 1.3728769510112926e-10
are O 0 2.0136266785930612e-12
responsible O 0 6.203214331090834e-11
for O 0 9.763978514598648e-11
the O 0 1.9230226655508886e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.003478313097730279
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.1378742733068066e-06
. O 0 1.4603537010771106e-06

In O 0 2.3397413428938307e-07
our O 0 3.816363403075229e-08
study O 0 1.9556716246427186e-09
, O 0 3.9738848323089826e-10
we O 0 1.1273866562522272e-10
have O 0 5.218372262083548e-11
determined O 0 2.686620925729244e-09
the O 0 4.285648724788871e-09
ATM O 0 2.1745195510902704e-07
mutation O 0 2.4244115603977434e-09
spectrum O 0 2.41405810896822e-08
in O 0 2.6672788977499806e-10
19 O 0 1.3665423237441132e-09
classical O 0 4.391602104192316e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 2.054213609881117e-06
, O 0 8.615431978942212e-11
including O 0 1.8929094403041802e-11
some O 0 3.922448303661508e-12
immigrant O 0 1.4238460410709308e-10
populations O 0 4.609995718496407e-11
, O 0 2.3621033948262316e-11
as O 0 4.374407086560339e-11
well O 0 3.7463868118869925e-10
as O 0 6.969279042756682e-10
12 O 0 1.577639796579433e-09
of O 0 2.721075587075461e-09
Dutch O 0 2.975324377985089e-07
ethnic O 0 1.7310797240099873e-09
origin O 0 2.5189285324245247e-08
. O 0 5.4617686373603647e-08

Both O 0 2.4360107886423066e-07
the O 0 5.6807820669746434e-08
protein O 0 1.1656045906249801e-08
truncation O 0 7.740264322819712e-07
test O 0 6.273735664308333e-08
( O 0 8.61415916375563e-09
PTT O 0 1.5230697272272664e-06
) O 0 4.237478701263342e-10
and O 0 5.202989705743732e-10
the O 0 6.0457621131604355e-09
restriction O 0 2.1609327660598865e-08
endonuclease O 0 8.090426604212553e-07
fingerprinting O 0 4.2657359244913096e-07
( O 0 3.349419852582969e-09
REF O 0 4.5933011278975755e-06
) O 0 1.1962232593365485e-10
method O 0 3.5473055048917956e-10
were O 0 5.518010701144327e-11
used O 0 2.751170402603975e-10
and O 0 1.7508529348564394e-10
compared O 0 3.89055426763818e-10
for O 0 4.76455888631655e-11
their O 0 1.2443499008973902e-10
detection O 0 5.382366197181909e-08
efficiency O 0 4.836900213689432e-09
, O 0 1.5597101735154162e-11
identifying O 0 9.34470625879591e-11
76 O 0 3.451611663152221e-09
% O 0 1.0475140199694977e-10
and O 0 1.6920076451043542e-10
60 O 0 3.7832528776426955e-10
% O 0 1.0616908741045705e-10
of O 0 5.714345108209784e-10
the O 0 1.211185929328451e-09
mutations O 0 1.0140706052652604e-09
, O 0 1.2612754174412544e-09
respectively O 0 2.866196524564657e-08
. O 0 1.2289963535749848e-07

Most O 0 2.2109001918124704e-07
patients O 0 5.969587846266222e-08
were O 0 3.6064007336022996e-09
found O 0 1.5323037283465624e-09
to O 0 5.812419989759121e-10
be O 0 6.309542666116386e-09
compound O 0 1.2487003004935104e-05
heterozygote O 0 0.0019387678476050496
. O 0 1.2577455663631554e-06

Seventeen O 0 2.2991882815404097e-06
mutations O 0 2.0053061433600305e-08
were O 0 7.851748695664185e-10
distinct O 0 4.3260939275313604e-10
, O 0 1.0761621455079862e-10
of O 0 7.392020884289252e-10
which O 0 2.2966116508538192e-10
10 O 0 6.040180577926435e-10
were O 0 3.098408474233594e-10
not O 0 2.9424634950814266e-10
reported O 0 1.0457802623875523e-08
previously O 0 1.2817035610623861e-07
. O 0 1.8254486633395572e-07

Mutations O 0 4.754353994940175e-07
are O 0 2.342820826228831e-09
small O 0 4.769255657066651e-09
deletions O 0 2.7881205255653185e-07
or O 0 4.4796880871444955e-08
point O 0 3.4748657640193414e-07
mutations O 0 1.283545092434224e-08
frequently O 0 6.315297174097623e-09
affecting O 0 1.4745728194043295e-08
splice O 0 1.937807428475935e-05
sites O 0 2.683703712591523e-07
. O 0 1.16926692328434e-07

Moreover O 0 6.6985526245844085e-06
, O 0 7.360246456755704e-08
a O 0 8.389343975068186e-08
16 O 0 9.37892821184505e-07
. O 0 8.327676255248662e-07

7 O 0 5.155983308213763e-05
- O 0 1.150902062363457e-05
kb O 0 6.855826995888492e-06
genomic O 0 3.231828031857731e-07
deletion O 0 8.341110913079319e-08
of O 0 1.2590072984153267e-08
the O 0 4.120540353369506e-09
3 O 0 7.345110741852068e-09
end O 0 5.7565303634987686e-09
of O 0 1.964674423149404e-09
the O 0 1.102292701560259e-09
gene O 0 5.200083141865264e-10
, O 0 5.1572225656659754e-11
most O 0 3.597129885624106e-11
likely O 0 4.1261849492713054e-10
a O 0 2.1456932064456424e-10
result O 0 5.332617125652916e-10
of O 0 1.8828758552302816e-09
recombination O 0 7.290380521496331e-10
between O 0 1.615270278643166e-10
two O 0 5.225125193630831e-11
LINE O 0 1.1864898397107027e-08
elements O 0 2.050386305185725e-09
, O 0 3.243025292753998e-10
was O 0 8.113627991690464e-09
identified O 0 1.3483700378458252e-08
. O 0 3.221979838485822e-08

The O 0 9.457114060751337e-07
most O 0 1.4554184524229186e-08
frequently O 0 1.5953751653086101e-09
found O 0 1.1136572913850173e-10
mutation O 0 1.3297804524192713e-10
, O 0 2.2507728320020348e-11
identified O 0 3.242981994056038e-10
in O 0 1.188921600059345e-10
three O 0 5.456931573277757e-10
unrelated O 0 3.7274453745794744e-08
Turkish O 0 1.4944965187169146e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
individuals O 0 7.263619705710767e-10
, O 0 7.131040757890617e-10
was O 0 9.045124649276204e-09
previously O 0 1.4565006978273232e-09
described O 0 5.039930139894011e-10
to O 0 3.4232061629779764e-11
be O 0 5.209223677415942e-11
a O 0 1.3517478247848658e-09
Turkish O 0 1.1226391052332474e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 0 0.019063850864768028
mutation O 0 2.9389337896645884e-07
. O 0 1.2477360655793746e-07

The O 0 2.483258754182316e-07
presence O 0 4.83293760566994e-08
of O 0 5.6723258978763624e-08
a O 0 3.8791618806044426e-08
founder O 0 1.7983707948587835e-05
mutation O 0 2.3531178783287032e-08
among O 0 1.2546006455949055e-09
relatively O 0 1.6326819896050893e-09
small O 0 1.7470734581248593e-10
ethnic O 0 2.60448624472831e-11
population O 0 1.7883146135808103e-12
groups O 0 1.505090648466767e-12
in O 0 1.4273204146375562e-11
Western O 0 9.938314171620277e-09
Europe O 0 7.818755420885282e-09
could O 0 6.529584650749598e-10
indicate O 0 1.9393857353389166e-10
a O 0 3.236024503916468e-10
high O 0 1.329114263093345e-09
carrier O 0 8.81419548459661e-10
frequency O 0 5.768419630847177e-10
in O 0 6.236384325619682e-11
such O 0 4.5145770455334855e-10
communities O 0 1.354143197573876e-08
. O 0 6.204027869216588e-08

In O 0 1.1263780663739453e-07
patients O 0 6.067540425647167e-08
of O 0 3.043076546305201e-08
Dutch O 0 1.078883201444114e-06
ethnic O 0 4.471437387021382e-10
origin O 0 9.924632227154007e-10
, O 0 3.943852883159238e-11
however O 0 1.7240373018090338e-10
, O 0 1.4654218810639108e-11
no O 0 4.586237292714124e-11
significant O 0 3.4614064392535226e-10
founder O 0 5.722966989196721e-07
effect O 0 2.5586091023654944e-09
could O 0 1.123283244197637e-09
be O 0 9.925428257062663e-10
identified O 0 1.779050862182885e-08
. O 0 3.518361424426075e-08

The O 0 2.837926444954064e-07
observed O 0 4.493233873859026e-08
genetic O 0 3.066312004307292e-08
heterogeneity O 0 2.3738869003864238e-07
including O 0 2.268203402877589e-09
the O 0 9.527406419351792e-09
relative O 0 2.5127774279098958e-06
high O 0 1.8212072063761298e-06
percentage O 0 7.942610125155625e-09
of O 0 1.6212228004519602e-08
splice O 0 2.386125925113447e-05
- O 0 8.11358290775388e-07
site O 0 7.334933105340724e-09
mutations O 0 2.646753927137979e-10
had O 0 5.73095737532725e-10
no O 0 4.4232983942293913e-10
reflection O 0 1.4638652068299507e-08
on O 0 1.3182912539377867e-08
the O 0 6.877113101211307e-09
phenotype O 0 7.881853321123344e-07
. O 0 8.167353371391073e-08

All O 0 1.2102863422569499e-07
patients O 0 3.550002958263576e-08
manifested O 0 3.82769194118282e-08
classical O 0 9.84642724688456e-07
A B-Disease 1 1.0
- I-Disease 1 0.9999994039535522
T I-Disease 1 1.0
and O 0 5.495790933451872e-09
increased O 0 1.4586163388230489e-09
cellular O 0 8.735671741533224e-09
radioresistant O 0 2.7392037083018295e-08
DNA O 0 4.437640921395314e-09
synthesis O 0 2.542148891393481e-08
. O 0 9.193366068416253e-09

Determination O 0 5.185210739000468e-06
of O 0 3.499134777484869e-07
the O 0 2.4258651976083456e-08
genomic O 0 2.98500353324016e-08
structure O 0 1.0407478434615314e-08
of O 0 6.391910112313326e-09
the O 0 2.1625357060628403e-09
COL4A4 O 0 3.6803644434257876e-06
gene O 0 8.206305635027888e-10
and O 0 1.1757361750852624e-10
of O 0 1.0630529789779075e-09
novel O 0 9.85356862770459e-08
mutations O 0 2.1228973423603748e-07
causing O 0 5.690791340384749e-07
autosomal B-Disease 1 0.9999997615814209
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 3.423017915338278e-05

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 2.1388570985436672e-06
a O 0 5.907962759010843e-07
progressive O 1 0.998492956161499
hematuric B-Disease 1 0.9999998807907104
glomerulonephritis I-Disease 1 1.0
characterized O 0 0.015651023015379906
by O 0 6.215481107574305e-08
glomerular B-Disease 1 1.0
basement I-Disease 1 0.9999983310699463
membrane I-Disease 0 3.972577815147815e-06
abnormalities I-Disease 0 8.237047381953744e-07
and O 0 3.0216446011976927e-10
associated O 0 4.172882928088484e-09
with O 0 1.7593700940565782e-09
mutations O 0 2.8984118216612842e-08
in O 0 2.64524135928923e-09
either O 0 5.464113073117005e-08
the O 0 1.0025744501263034e-07
COL4A3 O 0 0.003607493359595537
or O 0 4.976106637855082e-09
the O 0 3.7657033047366895e-09
COL4A4 O 0 1.1926701972697629e-06
gene O 0 2.8495408810336187e-10
, O 0 2.2685558292989683e-11
which O 0 8.156347992838153e-12
encode O 0 4.817213294927569e-10
the O 0 3.2905742575195518e-09
alpha3 O 0 1.927691755554406e-06
and O 0 4.26924184893096e-09
alpha4 O 0 1.4401293810806237e-06
type O 0 4.6322406888066325e-07
IV O 1 1.0
collagen O 1 0.9125861525535583
chains O 0 1.142958990385523e-05
, O 0 1.5209311143848936e-08
respectively O 0 5.7048108459412106e-08
. O 0 6.072229297160447e-08

To O 0 3.840277074118603e-08
date O 0 2.64601538901843e-07
, O 0 1.218396494806484e-09
mutation O 0 2.949537836194338e-10
screening O 0 1.934502558142981e-09
in O 0 1.184758680050635e-10
the O 0 3.881326371413252e-10
two O 0 2.1957852203158268e-10
genes O 0 7.118022282703862e-10
has O 0 1.598731147467447e-10
been O 0 4.1453065979801806e-10
hampered O 0 1.2712918078250368e-06
by O 0 1.981812908224967e-10
the O 0 1.137747562829361e-09
lack O 0 1.1695418855595108e-08
of O 0 3.854665475699903e-09
genomic O 0 2.6075820613868927e-08
structure O 0 8.760767222781851e-09
information O 0 9.434889314263728e-09
. O 0 1.8969856796502427e-08

We O 0 1.7884688929825643e-07
report O 0 1.342355115951932e-08
here O 0 2.41204101136816e-09
the O 0 1.2294429918568994e-09
complete O 0 4.296681677118386e-09
characterization O 0 8.685699981469952e-08
of O 0 1.1848118930402052e-08
the O 0 4.13015577294118e-09
48 O 0 1.675336136486294e-08
exons O 0 1.5029800692900608e-07
of O 0 7.936280965736842e-09
the O 0 4.565896993824481e-09
COL4A4 O 0 9.294711162510794e-06
gene O 0 2.3549708849657236e-09
, O 0 1.4884088406219576e-10
a O 0 4.0584355320838483e-10
comprehensive O 0 6.606443392342953e-09
gene O 0 2.392024578412588e-09
screen O 0 1.8872128748625983e-08
, O 0 9.690322849698063e-11
and O 0 6.801705726422469e-11
the O 0 6.002347230360527e-11
subsequent O 0 8.914761706613206e-10
detection O 0 5.070693731568099e-08
of O 0 4.181421875415481e-10
10 O 0 4.241689638417867e-11
novel O 0 1.275976824199887e-10
mutations O 0 2.5151079136032095e-11
in O 0 1.5426921892713885e-11
eight O 0 5.65204882896353e-10
patients O 0 8.21670997908086e-09
diagnosed O 0 3.0071244054852286e-06
with O 0 3.8827224102533364e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 6.200223288033158e-05

Furthermore O 0 9.342809335066704e-07
, O 0 6.104416971908222e-09
we O 0 4.136223863415722e-10
identified O 0 1.4659544689266113e-09
a O 0 8.927728001317803e-10
glycine O 0 5.300070160529913e-09
to O 0 3.449891761153623e-10
alanine O 0 1.3492035932927138e-08
substitution O 0 4.7908933709095436e-08
in O 0 1.4592869135299225e-09
the O 0 2.9312896554500867e-09
collagenous O 0 7.123609861992009e-07
domain O 0 6.563660726044418e-10
that O 0 4.417822010993611e-12
is O 0 1.3548128764695466e-11
apparently O 0 5.065140529225687e-10
silent O 0 8.193485001584122e-09
in O 0 9.063991224245171e-11
the O 0 4.864413316596483e-10
heterozygous O 0 3.875157417176922e-10
carriers O 0 5.812708092634011e-10
, O 0 2.999325510177897e-10
in O 0 1.2965186702018627e-09
11 O 0 1.9251108085427404e-07
. O 0 3.833361859051365e-07

5 O 0 2.6747812853500363e-07
% O 0 2.5793356339676166e-09
of O 0 3.2184461762341243e-09
all O 0 1.2512758884586361e-10
control O 0 1.7694324894179658e-09
individuals O 0 5.555212106295171e-12
, O 0 5.4923690595565233e-11
and O 0 1.389221515601946e-10
in O 0 2.0073935569353552e-10
one O 0 2.963127243571506e-10
control O 0 2.1523633986220148e-09
individual O 0 3.031439335665631e-11
homozygous O 0 3.61859486819327e-10
for O 0 2.892056732983761e-11
this O 0 6.461380042122045e-11
glycine O 0 2.742371485453532e-08
substitution O 0 2.398440699380444e-07
. O 0 2.1444070341658517e-07

There O 0 2.11354219459281e-07
has O 0 8.20590262406995e-09
been O 0 1.084661027661582e-09
no O 0 3.1767893871048614e-10
previous O 0 2.1025279295372457e-09
finding O 0 3.127098135990991e-09
of O 0 1.1676021260953462e-09
a O 0 7.042854632821616e-10
glycine O 0 1.9772039561161137e-09
substitution O 0 1.8136888657593886e-09
that O 0 1.722169629125858e-11
is O 0 4.621667631932169e-12
not O 0 1.488077998497428e-12
associated O 0 2.2122715118144676e-11
with O 0 3.895622106148133e-12
any O 0 1.9178773846828534e-10
obvious O 0 1.8887325481387052e-08
phenotype O 0 5.0270319462697444e-08
in O 0 2.047727681864231e-10
homozygous O 0 1.0442350317774185e-09
individuals O 0 1.5779609563448815e-10
. O 0 2.579366586985543e-08

Founder O 0 0.0011677868897095323
BRCA1 O 0 1.869380980679125e-06
and O 0 3.381587632134142e-08
BRCA2 O 0 2.926167042005545e-07
mutations O 0 3.6028944272459285e-09
in O 0 7.08587799547189e-10
French O 0 3.4797537296071823e-07
Canadian O 0 0.0003180726198479533
breast B-Disease 1 1.0
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.2391546988510527e-06
. O 0 2.186401530934745e-07

We O 0 1.1574235969646907e-07
have O 0 1.9061463518710298e-09
identified O 0 5.94599480763236e-09
four O 0 3.614648858007996e-10
mutations O 0 1.0156107899117472e-10
in O 0 3.002265797080739e-11
each O 0 8.204263657329847e-12
of O 0 7.802309021087694e-09
the O 0 3.6303234196566336e-07
breast B-Disease 1 0.9997896552085876
cancer I-Disease 1 0.5301811695098877
- O 0 4.6770041990384925e-06
susceptibility O 0 4.6954474441918137e-07
genes O 0 2.8982334310256874e-09
, O 0 2.6896856963887217e-10
BRCA1 O 0 7.468364815466089e-10
and O 0 1.4151226024328167e-10
BRCA2 O 0 3.6208125386849588e-09
, O 0 2.9883030078226014e-11
in O 0 4.38252489853852e-11
French O 0 3.4247459979042105e-08
Canadian O 0 9.696879033072037e-07
breast B-Disease 0 0.00011943263962166384
cancer I-Disease 0 3.6912952054990456e-05
and O 0 5.7028905757761095e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 6.934372720479587e-08
from O 0 3.8013254766156024e-08
Quebec O 0 8.023302484616579e-07
. O 0 8.851554866851075e-08

To O 0 4.427996600497863e-07
identify O 0 4.6657766006319434e-07
founder O 0 9.820028935791925e-05
effects O 0 4.501599323702976e-05
, O 0 1.069339461423624e-08
we O 0 5.711315864687094e-10
examined O 0 3.320275165918929e-09
independently O 0 3.6147315696233306e-10
ascertained O 0 2.3272518134831444e-08
French O 0 3.369233070316113e-08
Canadian O 0 1.4955651295167627e-07
cancer B-Disease 0 1.9458613564893312e-07
families O 0 2.1801439820112734e-10
for O 0 1.8696219919456247e-11
the O 0 3.862743111482381e-11
distribution O 0 8.546886115512464e-11
of O 0 1.879190136833131e-10
these O 0 1.0489535628988023e-10
eight O 0 3.4218974320765483e-09
mutations O 0 5.6542837079121e-09
. O 0 3.25637365961029e-08

Mutations O 0 4.877796868640871e-07
were O 0 1.0025932972723695e-08
found O 0 1.7721208944720956e-09
in O 0 7.585597705528357e-10
41 O 0 5.188823593016423e-08
of O 0 5.5854819436262915e-08
97 O 0 9.070452506421134e-06
families O 0 2.2306517166725826e-07
. O 0 3.5683189025803586e-07

Six O 0 4.425991448897548e-07
of O 0 6.389510787130348e-08
eight O 0 6.033356036994064e-09
mutations O 0 1.8714259031327174e-09
were O 0 1.6313186357308496e-09
observed O 0 4.218601912242548e-09
at O 0 5.811791048415671e-09
least O 0 5.136432945640479e-10
twice O 0 1.4753520183319324e-08
. O 0 5.448149309472683e-08

The O 0 3.0513929232256487e-06
BRCA1 O 0 1.9723815967154223e-06
C4446T O 0 1.5036639524623752e-06
mutation O 0 1.0256488991444712e-08
was O 0 1.0519640269990305e-08
the O 0 2.8963806353310417e-10
most O 0 5.0408791724132485e-11
common O 0 5.903659783257353e-10
mutation O 0 1.5179096868322972e-10
found O 0 1.0954050166933627e-10
, O 0 3.103896306644316e-11
followed O 0 6.774236172013559e-10
by O 0 5.651704104714383e-10
the O 0 4.4930366982498526e-08
BRCA2 O 0 3.4749493806884857e-06
8765delAG O 0 6.159639269753825e-06
mutation O 0 2.6753477300189843e-07
. O 0 1.879404152305142e-07

Together O 0 2.087552672946913e-07
, O 0 3.183754593294452e-09
these O 0 1.1069588995438195e-10
mutations O 0 4.018075316913894e-10
were O 0 2.1631615942929727e-10
found O 0 1.8217521935426362e-10
in O 0 1.2090457801594567e-10
28 O 0 7.05993974392527e-09
of O 0 9.513350995860037e-09
41 O 0 7.223532350053574e-08
families O 0 1.02057273743128e-09
identified O 0 3.0975590981086043e-09
to O 0 5.377578937704186e-10
have O 0 1.3902428097622987e-09
a O 0 2.3037696195160606e-08
mutation O 0 1.0522955307123993e-07
. O 0 1.5587349366796843e-07

The O 0 1.0729913810791913e-06
odds O 0 2.2485894533019746e-06
of O 0 5.0801613582507343e-08
detection O 0 1.397586174789467e-06
of O 0 1.6467565089328673e-08
any O 0 2.3263986292931804e-09
of O 0 1.0729126920239196e-08
the O 0 6.883701164639433e-09
four O 0 1.4660970215629732e-09
BRCA1 O 0 4.874520342923461e-09
mutations O 0 8.285321317913485e-10
was O 0 2.8434683940758987e-08
18 O 0 5.0344009849823124e-08
. O 0 8.062722400836719e-08

7x O 0 0.30513066053390503
greater O 0 1.7595089047972579e-06
if O 0 9.603375872302422e-09
one O 0 4.4777356822400805e-10
or O 0 6.23833554258546e-11
more O 0 3.1865688473325937e-12
cases O 0 1.634535146122218e-10
of O 0 3.848846063192468e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 3.5719548208135166e-08
also O 0 8.072343488096934e-11
present O 0 9.509259352169508e-11
in O 0 1.6771121991165927e-10
the O 0 2.568417256654243e-09
family O 0 3.5734537107146025e-08
. O 0 5.116003265470681e-08

The O 0 8.341379498233437e-07
odds O 0 1.415483893651981e-06
of O 0 1.0333166322595844e-08
detection O 0 6.126008997853205e-07
of O 0 5.707703198964964e-09
any O 0 1.6765243637806293e-09
of O 0 1.0137616079930467e-08
the O 0 7.561304471437325e-09
four O 0 1.5402210618020717e-09
BRCA2 O 0 2.8977593657941725e-08
mutations O 0 3.6125002988995902e-09
was O 0 8.107443250082724e-08
5 O 0 7.626719877862342e-08
. O 0 1.3526233999527904e-07

3x O 0 0.00012867651821579784
greater O 0 1.5696872424086905e-07
if O 0 1.9309343013418356e-09
there O 0 2.731677384293363e-10
were O 0 3.801364778510674e-10
at O 0 1.9962825836827847e-10
least O 0 2.6236408878776984e-12
five O 0 4.78115247046218e-12
cases O 0 3.314741536808441e-11
of O 0 1.3399863441065918e-08
breast B-Disease 1 0.9997013211250305
cancer I-Disease 0 0.005773654207587242
in O 0 5.956279025554068e-09
the O 0 7.288274161965091e-08
family O 0 3.016741629835451e-07
. O 0 8.382529870232247e-08

Interestingly O 0 3.4344780033279676e-06
, O 0 1.033809393646834e-08
the O 0 3.645030499654922e-09
presence O 0 3.2227465140977074e-09
of O 0 3.2581816356014315e-08
a O 0 8.823455743822706e-08
breast B-Disease 0 0.000167284335475415
cancer I-Disease 0 2.61684999713907e-06
case O 0 6.8832839872357e-08
< O 0 3.212239221284108e-07
36 O 0 5.261473035034214e-09
years O 0 2.546494681787692e-10
of O 0 3.2678562633670083e-10
age O 0 6.19744644492215e-10
was O 0 2.7215427689242233e-09
strongly O 0 1.8663987022549122e-10
predictive O 0 1.5807815056945174e-09
of O 0 1.4868772879594871e-09
the O 0 5.151011839288344e-10
presence O 0 2.671672882925691e-10
of O 0 6.835771948487945e-10
any O 0 6.340470926069486e-10
of O 0 3.6530760638697757e-09
the O 0 2.710658586480008e-09
eight O 0 1.7730236168134184e-09
mutations O 0 2.379710428712656e-09
screened O 0 6.58094094774242e-08
. O 0 2.658454079096373e-08

Carriers O 0 2.4282707045131247e-07
of O 0 7.878158925223033e-08
the O 0 5.928770363539115e-09
same O 0 3.57821772212219e-10
mutation O 0 3.249235602797995e-10
, O 0 1.2982274977257902e-11
from O 0 1.0382561130284351e-11
different O 0 1.2860378560686225e-11
families O 0 8.268519896548199e-11
, O 0 2.0882061704807775e-11
shared O 0 1.2899839529900703e-10
similar O 0 2.464765058718399e-10
haplotypes O 0 4.2609297423723547e-08
, O 0 9.411191964625587e-11
indicating O 0 1.6185587314865302e-09
that O 0 1.9366208636739657e-10
the O 0 2.6921815887703815e-09
mutant O 0 3.321598995853492e-09
alleles O 0 2.415971867009148e-10
were O 0 2.2321086645682442e-10
likely O 0 1.0557705820701813e-09
to O 0 7.550891856222819e-11
be O 0 3.0654184052236744e-11
identical O 0 2.4583374225173316e-10
by O 0 4.5196579118167435e-11
descent O 0 9.038587656107211e-09
for O 0 2.7310939620939223e-10
a O 0 9.593045247058285e-10
mutation O 0 3.5517874752422074e-10
in O 0 3.437890805368937e-10
the O 0 7.22680981724011e-09
founder O 0 1.2451225757104112e-06
population O 0 3.4942818083472105e-10
. O 0 1.5226202521034793e-08

The O 0 1.1185615278463956e-07
identification O 0 5.6280761384641664e-08
of O 0 3.690405137035668e-08
common O 0 1.1478726946734241e-06
BRCA1 O 0 6.135609851298796e-07
and O 0 1.8182133132427225e-08
BRCA2 O 0 5.3932591725924794e-08
mutations O 0 7.717231853554551e-10
will O 0 2.0131832312308973e-10
facilitate O 0 1.3164563883449887e-09
carrier O 0 8.141610052803117e-09
detection O 0 3.018554934897111e-07
in O 0 6.285683640250284e-10
French O 0 7.752468889066222e-08
Canadian O 0 5.969839094177587e-07
breast B-Disease 0 7.628837920492515e-06
cancer I-Disease 0 2.233274926766171e-06
and O 0 1.7740446764946682e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.3684528710200539e-07
. O 0 5.324542229345752e-08

Are O 0 9.484059404485379e-08
Dp71 O 0 0.00016755220713093877
and O 0 1.666063838001719e-07
Dp140 O 0 1.9003313354915008e-05
brain O 0 2.7868336474057287e-06
dystrophin O 0 2.4131022655637935e-06
isoforms O 0 1.1882998762757779e-07
related O 0 1.6555084414449084e-08
to O 0 1.9130921291576897e-09
cognitive B-Disease 0 5.337810216587968e-05
impairment I-Disease 1 0.9999974966049194
in O 0 2.58964082604507e-05
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9999990463256836

Molecular O 0 2.2121475922176614e-06
study O 0 2.302456003633324e-08
and O 0 1.6241004097139466e-09
neuropsychological O 0 4.279573317944596e-08
analysis O 0 2.2009940536804606e-09
were O 0 9.797936906252858e-10
performed O 0 1.9646359539216007e-10
concurrently O 0 5.489984022943872e-10
on O 0 2.1910335767927336e-09
49 O 0 7.735700968680703e-09
patients O 0 4.366309536152357e-09
with O 0 2.1951594320057666e-08
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999972581863403
DMD B-Disease 1 1.0
) O 0 2.4151163291463718e-09
in O 0 5.017617571434485e-11
order O 0 1.5439380329773655e-10
to O 0 6.68325395025704e-11
find O 0 2.6020743892907205e-10
a O 0 5.1387429034210896e-11
molecular O 0 3.260665071280755e-10
explanation O 0 2.902502682644581e-10
for O 0 4.7902463246041194e-11
the O 0 1.1214508210954932e-09
cognitive B-Disease 0 6.868083914923773e-07
impairment I-Disease 0 1.1497461400722386e-06
observed O 0 4.40131042722669e-09
in O 0 4.4826067857606233e-10
most O 0 8.147481800335754e-09
DMD B-Disease 1 1.0
patients O 0 2.0977553504053503e-05
. O 0 3.343938885791431e-07

Complete O 0 2.288867761990332e-07
analysis O 0 2.8013715791530558e-08
of O 0 1.779770464338526e-08
the O 0 1.0105183356756697e-08
dystrophin O 0 9.251264714293939e-07
gene O 0 2.662955722598781e-08
was O 0 5.195795793611069e-08
performed O 0 1.8643075971880307e-09
to O 0 1.7685611308770888e-10
define O 0 1.5841075118316894e-09
the O 0 7.068306384638845e-09
localization O 0 1.0372508768341504e-05
of O 0 3.7488209869707134e-08
deletions O 0 6.547124797862125e-08
and O 0 1.8763008924338465e-09
duplications O 0 2.386506992024806e-08
in O 0 6.347558589858693e-11
relation O 0 9.699204772672942e-10
to O 0 3.188310726542909e-10
the O 0 6.504441874000122e-09
different O 0 5.76222376480473e-08
DMD B-Disease 1 1.0
promoters O 0 0.0002397869830019772
. O 0 5.083462042421161e-07

Qualitative O 0 2.8033816761308117e-06
analysis O 0 8.033235587845411e-08
of O 0 7.045871086575062e-08
the O 0 1.7874725699584815e-08
Dp71 O 0 7.091825409588637e-06
transcript O 0 1.4218548471944814e-07
and O 0 3.8989414474777107e-10
testing O 0 1.4207915399744309e-10
for O 0 1.633384399957194e-11
the O 0 1.0731530941665568e-10
specific O 0 1.2142155336736238e-10
first O 0 1.765757540184154e-09
exon O 0 2.5800259706443285e-08
of O 0 5.898282751104489e-09
Dp140 O 0 1.6827523552365165e-07
were O 0 1.890151368755255e-09
also O 0 4.0532061040821077e-10
carried O 0 9.43211397874677e-10
out O 0 4.004687692571451e-09
. O 0 2.768882545467477e-08

Neuropsychological O 0 1.5261321095749736e-05
analysis O 0 1.1385603926328258e-07
assessed O 0 1.5112229334590666e-07
verbal O 0 2.4805578391351446e-07
and O 0 3.2602514465907007e-08
visuospatial O 0 1.1456632819317747e-05
intelligence O 0 4.233379229390266e-07
, O 0 1.5783953033476905e-09
verbal O 0 1.5121557339625724e-07
memory O 1 0.9999955892562866
, O 0 2.88612103105379e-08
and O 0 6.098644700358591e-09
reading O 0 2.691398037768522e-07
skills O 0 3.0219989639590494e-06
. O 0 2.8150896014267346e-07

Comparison O 0 1.0337009825889254e-06
of O 0 3.061788902414264e-07
molecular O 0 1.1435523674663273e-06
and O 0 5.455355633898762e-08
psychometric O 0 2.2174210243974812e-05
findings O 0 4.4129965459660525e-08
demonstrated O 0 1.5085742433029736e-08
that O 0 1.5550087606452934e-10
deletions O 0 3.2738856958758333e-08
and O 0 1.9423853636624244e-09
duplications O 0 6.264325236315926e-08
that O 0 1.1736815686003155e-10
were O 0 4.4626102813083435e-10
localized O 0 4.1051197996466726e-08
in O 0 3.2735641974923624e-10
the O 0 6.853526635097751e-10
distal O 0 1.477294404139684e-06
part O 0 6.1137157558732724e-09
of O 0 5.687142756727326e-09
the O 0 2.431932877300369e-09
gene O 0 1.0335565736596664e-09
seemed O 0 2.4323225655820124e-09
to O 0 1.2525144116315445e-11
be O 0 3.385648358888993e-11
preferentially O 0 1.414297789992247e-09
associated O 0 2.0249995014154365e-09
with O 0 8.235360726693841e-10
cognitive B-Disease 0 0.008998150937259197
impairment I-Disease 1 0.999902606010437
. O 0 6.5695930970832705e-06

Two O 0 5.475066586768662e-07
altered O 0 1.6412992636105628e-06
Dp71 O 0 3.7221900129225105e-05
transcripts O 0 3.8699249671481084e-07
and O 0 6.8340151315737785e-09
two O 0 1.182727249471327e-09
deleted O 0 9.541790468858835e-09
Dp140 O 0 1.972146712603262e-08
DNA O 0 1.2906293811454361e-09
sequences O 0 1.4319075092306122e-10
were O 0 5.1776638532174957e-11
found O 0 5.833052096892999e-11
in O 0 2.243469472695825e-11
four O 0 3.874432996653354e-10
patients O 0 2.600111015382822e-09
with O 0 3.697434802774069e-09
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 0 2.2984269890002906e-05

These O 0 2.558610390224203e-08
findings O 0 2.1640923719701277e-08
suggest O 0 1.2813943239819992e-09
that O 0 3.646236784726753e-11
some O 0 5.961614535365811e-11
sequences O 0 2.620222927518512e-10
located O 0 5.654626211715197e-10
in O 0 1.4609900095274853e-11
the O 0 2.735973947398662e-10
distal O 0 3.4991649044968653e-07
part O 0 2.429290324457156e-09
of O 0 1.7475909608322127e-09
the O 0 2.3827523287778263e-10
gene O 0 1.2709974739344432e-10
and O 0 1.1217198697677233e-10
, O 0 1.616255740355399e-11
in O 0 7.2496609410110935e-12
particular O 0 2.774134255645322e-10
, O 0 7.831867099294954e-11
some O 0 1.2824279138623496e-10
DMD B-Disease 1 1.0
isoforms O 0 4.5809292714693584e-07
expressed O 0 6.498118043651857e-09
in O 0 3.794743685947566e-10
the O 0 5.202178687824244e-09
brain O 0 1.0963555041598738e-07
may O 0 2.6927862717407436e-10
be O 0 2.658247233444655e-11
related O 0 6.477547942473905e-10
to O 0 3.341002197121412e-10
the O 0 8.519519312244483e-09
cognitive B-Disease 0 2.8978902264498174e-05
impairment I-Disease 0 0.0001275812101084739
associated O 0 2.70733806928547e-07
with O 0 3.159775374683704e-08
DMD B-Disease 1 1.0
. O 0 3.919936375496036e-07
. O 0 1.9341999291100365e-07

I1307K O 0 0.00012440969294402748
APC O 0 6.7149903770769015e-06
and O 0 7.125662904172714e-08
hMLH1 O 0 1.436967181689397e-06
mutations O 0 7.572822369183996e-09
in O 0 1.089608514526219e-09
a O 0 4.455859681229413e-09
non O 0 1.0526046878567286e-07
- O 0 4.1448134879829013e-07
Jewish O 0 1.0922099669130603e-08
family O 0 9.485768837080855e-10
with O 0 4.989692686807601e-11
hereditary B-Disease 1 0.9999998807907104
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.07725623995065689

We O 0 1.252771255622065e-07
describe O 0 9.3375028598075e-08
a O 0 3.2043356412714274e-08
French O 0 7.250905014188902e-07
Canadian O 0 4.42499640485039e-06
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.0002281474880874157
HNPCC B-Disease 1 1.0
) O 0 1.2682913386186101e-08
kindred O 0 2.1649011614499614e-06
which O 0 5.473714814741015e-10
carries O 0 3.4894747091840372e-09
a O 0 1.8525887490739024e-09
novel O 0 6.856262668719637e-09
truncating O 0 1.9908551962544152e-07
mutation O 0 5.695968585683886e-09
in O 0 2.4769486461906354e-09
hMLH1 O 0 2.33387436310295e-06
. O 0 2.0362213604130375e-07

Interestingly O 0 1.8860019963540253e-06
, O 0 1.4444449192296815e-08
the O 0 8.471491064199199e-09
I1307K O 0 7.607322913827375e-07
APC O 0 3.6238613887462634e-08
polymorphism O 0 2.0873292427836532e-08
, O 0 8.134461160214101e-11
associated O 0 1.2390496961778297e-10
with O 0 4.8029514393421735e-12
an O 0 6.823662728611124e-12
increased O 0 2.869552095940975e-10
risk O 0 1.1681245126737849e-07
of O 1 0.9999905824661255
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 2.5139128112527942e-08
is O 0 7.206252261582335e-11
also O 0 1.8102585402912652e-11
present O 0 3.662463041176345e-11
in O 0 6.39129374424563e-11
this O 0 2.9403710022357643e-10
family O 0 2.250887831678483e-08
. O 0 3.100551992929468e-08

The O 0 3.86307738153846e-06
I1307K O 0 1.893486114568077e-05
polymorphism O 0 1.8929285943158902e-06
has O 0 7.53122364471892e-09
previously O 0 3.0571651876698525e-09
only O 0 5.892148574604406e-11
been O 0 1.6559488502654318e-10
identified O 0 4.3733083820995944e-10
in O 0 2.253866017432049e-11
individuals O 0 1.476211167195096e-11
of O 0 2.1377745795803094e-08
self O 0 5.205683464737376e-06
- O 0 5.263390448817518e-06
reported O 0 1.1846243097579645e-08
Ashkenazi O 0 5.103557327856834e-07
Jewish O 0 2.1636299862848318e-08
origins O 0 1.4624635014115484e-07
. O 0 4.775939999035472e-08

In O 0 6.727783841142809e-08
addition O 0 5.492993171429816e-09
, O 0 6.094001969714213e-10
in O 0 1.2344850142120833e-10
this O 0 7.757161579746708e-11
family O 0 3.2813110006912893e-09
, O 0 9.374984122345609e-11
there O 0 5.405815378667356e-11
appears O 0 8.179553145915008e-10
to O 0 1.8412306401760503e-10
be O 0 5.24920162892073e-10
no O 0 2.2662138832174605e-09
relationship O 0 8.180336408258881e-09
between O 0 3.95709598421945e-09
the O 0 7.529758150326415e-09
I1307K O 0 3.7106691053168106e-08
polymorphism O 0 3.0294309283362963e-09
and O 0 5.431166974489976e-11
the O 0 3.488193414669105e-11
presence O 0 8.122290340306648e-11
or O 0 2.629625128758306e-10
absence O 0 7.993953232698914e-08
of O 0 2.5880157750179933e-07
cancer B-Disease 0 7.106886187102646e-05
. O 0 2.2194852178358815e-08
. O 0 1.2656674641675636e-07

Identification O 0 7.946581490614335e-07
of O 0 6.384065898146218e-08
a O 0 6.187268919433109e-09
novel O 0 1.1486788409342807e-08
mutation O 0 1.868957211215161e-09
of O 0 1.4561237549060024e-08
the O 0 2.289083411710635e-08
CPO O 0 1.8355017346038949e-06
gene O 0 3.27501492591864e-09
in O 0 5.863350360790776e-10
a O 0 1.009246997085711e-08
Japanese O 0 1.5653025911888108e-05
hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.9999982118606567
family O 0 5.629081442748429e-06
. O 0 2.7742012775888725e-07

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.999998927116394
( O 0 3.696964995469898e-06
HCP B-Disease 1 1.0
) O 0 1.232397206507585e-08
is O 0 9.882509255376704e-10
an O 0 1.6071824981978011e-09
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
characterized O 0 2.3839607820264064e-05
by O 0 2.236187901516473e-09
a O 0 1.2187853393186288e-08
deficiency B-Disease 0 0.02860654890537262
of I-Disease 0 0.00011626451305346563
coproporphyrinogen I-Disease 1 0.8885329961776733
oxidase I-Disease 0 5.001019758310576e-07
( O 0 3.658891634117367e-09
CPO O 0 6.796112757001538e-07
) O 0 2.76910133711894e-10
caused O 0 1.213722899962022e-09
by O 0 1.1502737651269968e-10
a O 0 8.941002938023246e-10
mutation O 0 8.277897256547817e-10
in O 0 4.928836228046407e-10
the O 0 1.534723459428733e-08
CPO O 0 5.0731059673125856e-06
gene O 0 1.1310432768141254e-07
. O 0 1.056464427051651e-07

Only O 0 7.214885044959374e-08
11 O 0 4.253995200542704e-08
mutations O 0 1.7022308007597076e-09
of O 0 4.406451203919914e-09
the O 0 4.017234545017345e-09
gene O 0 2.958768785532584e-09
have O 0 3.890057165278904e-10
been O 0 4.706224299155792e-10
reported O 0 7.810433966248809e-10
in O 0 1.7744953284548615e-09
HCP B-Disease 1 1.0
patients O 0 0.00037837756099179387
. O 0 2.607911028462695e-06

We O 0 8.661364603312904e-08
report O 0 6.019344578334085e-09
another O 0 1.934938209657844e-09
mutation O 0 1.878893707285556e-09
in O 0 1.106556291041727e-09
a O 0 1.2399515192385024e-08
Japanese O 0 6.292554189712973e-06
family O 0 4.1093508684753033e-07
. O 0 1.887472507178245e-07

Polymerase O 0 3.424085662118159e-05
chain O 0 4.4714931846101535e-07
reaction O 0 3.544509041830679e-08
- O 0 1.1697208179839436e-07
single O 0 3.625947542218455e-09
strand O 0 1.1512999442686578e-08
conformational O 0 3.3428126933188196e-10
polymorphism O 0 1.9139134721513074e-09
and O 0 8.100491805107524e-11
direct O 0 3.5833741529600616e-10
sequence O 0 2.2533599985941066e-10
analyses O 0 5.410780157255601e-10
demonstrated O 0 5.543902004134793e-10
a O 0 4.996437708015833e-10
C O 0 4.3524092774305245e-08
to O 0 1.1172960334704385e-09
T O 0 2.3817232630563012e-08
substitution O 0 1.584712805424715e-08
in O 0 9.358284147609197e-10
exon O 0 1.2014355732503645e-08
1 O 0 1.2119162340340495e-09
of O 0 4.3224238077677057e-10
the O 0 1.7160266541083047e-09
CPO O 0 1.3946767296602047e-07
gene O 0 1.907575875037537e-09
at O 0 1.1192050619612814e-09
nucleotide O 0 4.9009964975255116e-09
position O 0 1.572782437619935e-08
85 O 0 1.6916574807623874e-08
, O 0 4.915935991611775e-10
which O 0 4.331890124387172e-10
lies O 0 3.873165965728731e-08
in O 0 5.322475793434478e-10
the O 0 2.5305662010310925e-09
putative O 0 3.9441079024982173e-07
presequence O 0 7.934230552564259e-07
for O 0 4.832748090599637e-10
targeting O 0 4.388451380066272e-09
to O 0 4.737613856775624e-09
mitochondria O 0 2.1743007891927846e-06
. O 0 2.365394351500072e-07

This O 0 1.3941416021623354e-08
mutation O 0 5.7538738218454455e-09
changes O 0 1.1633961571888563e-09
the O 0 1.6545416148261438e-09
codon O 0 1.7404888641436855e-09
for O 0 2.2633532548166357e-10
glutamine O 0 4.30158531017355e-09
to O 0 1.789258186057907e-10
a O 0 7.115688038794588e-10
termination O 0 6.990799050754504e-08
codon O 0 1.4468659159661001e-08
at O 0 2.7332112129130337e-09
amino O 0 3.3979030700237445e-10
acid O 0 2.2140298483463994e-09
position O 0 2.8217922221074332e-08
29 O 0 2.535194312258682e-07
. O 0 1.4190628405685857e-07

MaeI O 0 0.00011583237210288644
restriction O 0 1.3838153734013758e-07
analysis O 0 9.769222764077767e-09
showed O 0 2.459379810915152e-09
two O 0 2.531491960500176e-10
other O 0 1.0619987528270869e-10
carriers O 0 1.029603735602791e-09
in O 0 7.662756540405269e-10
the O 0 3.4975926155311754e-08
family O 0 2.605787869924825e-07
. O 0 1.2253052261712583e-07

The O 0 1.6609094473096775e-06
C O 0 7.908078987384215e-05
- O 0 0.00013589917216449976
T O 0 2.4883631795091787e-06
mutation O 0 1.6343745912195118e-08
is O 0 6.895892745717447e-10
located O 0 1.0302068087497673e-09
within O 0 6.98087976314099e-10
a O 0 8.803913154054044e-10
recently O 0 1.8993560058078174e-09
proposed O 0 4.446401469238026e-09
putative O 0 6.646384775876868e-08
alternative O 0 3.504029422174426e-08
translation O 0 1.4637869583111751e-08
initiation O 0 8.311440424790817e-09
codon O 0 2.8538229557284467e-09
( O 0 3.1167710079493816e-10
TIC O 0 1.4877745257990682e-08
- O 0 2.1015186035810984e-08
1 O 0 8.115407901243543e-09
) O 0 1.7363796511737917e-10
, O 0 1.574269464788003e-10
supporting O 0 1.7279688790949876e-09
that O 0 6.269149088744541e-10
TIC O 0 5.521266643881972e-07
- O 0 8.609118253843917e-07
1 O 0 3.4715991859002315e-08
is O 0 3.2928582083258107e-10
the O 0 1.85737936142516e-09
real O 0 3.670671944178139e-08
TIC O 0 8.496382974954031e-08
rather O 0 2.084598715867969e-09
than O 0 6.263280449836373e-10
TIC O 0 1.623445342602281e-07
- O 0 1.6368305466585298e-07
2 O 0 3.226192291094776e-08
. O 0 3.001902282306901e-09
. O 0 3.4479548105537106e-08

Human B-Disease 0 1.5177555212630978e-07
complement I-Disease 0 4.120464609513874e-07
factor I-Disease 0 3.566369969121297e-06
H I-Disease 1 1.0
deficiency I-Disease 1 0.9983683228492737
associated O 0 8.028637239476666e-07
with O 0 2.948255314549897e-06
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999562501907349

This O 0 1.5356135918409564e-08
study O 0 2.9211539853690738e-09
reports O 0 3.032726070273384e-09
on O 0 2.1046142606451212e-09
six O 0 2.6093008309580057e-10
cases O 0 5.427990279471828e-10
of O 0 3.5908488627001134e-08
deficiency B-Disease 1 0.99998939037323
in I-Disease 0 1.385055892200171e-08
the I-Disease 0 7.279823410755171e-09
human I-Disease 0 5.727111562769949e-10
complement I-Disease 0 5.987954021513531e-10
regulatory I-Disease 0 1.4379136992204167e-08
protein I-Disease 0 9.640295228763307e-10
Factor I-Disease 0 3.3057601100949796e-09
H I-Disease 0 0.022793492302298546
( O 0 2.2120711928863557e-09
FH O 0 1.5771733785641118e-07
) O 0 1.3916342037068041e-11
in O 0 3.653670248293661e-12
the O 0 1.1569248163645351e-11
context O 0 1.0134590389121456e-10
of O 0 2.512711705371373e-10
an O 0 2.923582764768895e-10
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 2.8936397939105518e-05

Five O 0 1.5422538979237288e-07
of O 0 8.017190467057844e-09
the O 0 3.9026687437271335e-10
cases O 0 1.319502423990926e-10
were O 0 1.1686643319741563e-10
observed O 0 1.8259337097870088e-10
in O 0 1.1430579573146193e-11
children O 0 6.61013951908096e-12
presenting O 0 1.690465684101028e-10
with O 0 1.740077304468457e-09
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
HUS B-Disease 1 1.0
) O 0 1.1226541118958266e-06
. O 0 4.517691252203804e-07

Two O 0 1.0398395744459776e-07
of O 0 6.600954804980574e-08
the O 0 3.595049946625295e-08
children O 0 3.231289458227593e-09
exhibited O 0 9.277779433602973e-09
a O 0 5.6299445105878476e-08
homozygous O 0 5.960388989478815e-06
deficiency O 1 0.9905457496643066
characterized O 0 2.5955793603316124e-07
by O 0 2.1799912985898118e-09
the O 0 2.1748467915472247e-08
absence O 0 1.6414639958384214e-07
of O 0 1.0540511397039154e-07
the O 0 2.435824342228443e-08
150 O 0 2.069804994064839e-09
- O 0 3.254273517327988e-09
kD O 0 1.6874393438115476e-08
form O 0 3.6028649508246247e-10
of O 0 8.363761239138512e-09
Factor O 0 7.017906966666487e-08
H O 1 0.9999978542327881
and O 0 1.4219362354239706e-09
the O 0 4.17880646752522e-10
presence O 0 1.6257670210073627e-10
, O 0 4.265761702204607e-11
upon O 0 1.0604649380852038e-09
immunoblotting O 0 6.572386723746604e-08
, O 0 1.1427316731760229e-10
of O 0 9.795956268376926e-10
the O 0 3.2790274939742403e-09
42 O 0 2.969274426334323e-08
- O 0 4.026349387231676e-08
kD O 0 6.300339236986474e-07
Factor O 0 7.825263992344844e-08
H O 0 0.23195159435272217
- O 0 4.552029793103429e-07
like O 0 3.0570019848852326e-09
protein O 0 5.308051775898548e-09
1 O 0 1.4517254953716474e-08
( O 0 6.564037091649766e-10
FHL O 0 5.26763915331685e-06
- O 0 3.508490920012264e-07
1 O 0 4.364854433447363e-08
) O 0 1.6317781847963175e-10
and O 0 2.5531282643598274e-10
other O 0 5.362849608836484e-10
FH O 0 2.2833132788946386e-06
- O 0 3.930184888645272e-08
related O 0 1.3685122368656266e-08
protein O 0 1.4899270261992115e-08
( O 0 4.174387502331456e-09
FHR O 0 3.359359106980264e-05
) O 0 6.121696483063488e-09
bands O 0 2.4287686528623453e-07
. O 0 2.0826213642521907e-07

Southern O 0 2.1839143300894648e-05
blot O 0 2.9407039619400166e-05
and O 0 7.296657944522167e-09
PCR O 0 5.821001991535013e-08
analysis O 0 4.192626246179998e-10
of O 0 3.8515773903569084e-10
DNA O 0 4.225995109408132e-09
of O 0 2.2799664378680973e-09
one O 0 3.182235308596404e-10
patient O 0 4.787337637424116e-09
with O 0 7.6281958527602e-10
homozygous O 0 2.510116416942765e-07
deficiency O 1 0.808521032333374
ruled O 0 0.0001146662762039341
out O 0 5.0116923944187874e-09
the O 0 7.313248340246048e-10
presence O 0 1.0383991583262642e-10
of O 0 6.712012612375418e-10
a O 0 1.938328109130083e-10
large O 0 1.6408011060953243e-10
deletion O 0 2.2150519196628693e-09
of O 0 1.5730545754877312e-09
the O 0 4.18133616619798e-09
FH O 0 1.2939979114889866e-06
gene O 0 1.3865407710866862e-09
as O 0 2.65189814552258e-10
the O 0 6.056585233338296e-10
underlying O 0 1.5088323834788753e-06
defect O 0 5.270478141028434e-06
for O 0 7.646394628579856e-09
the O 0 3.4896569900411123e-07
deficiency O 1 0.9999951124191284
. O 0 3.277327778050676e-06

The O 0 2.954091087303823e-07
other O 0 3.284936989089715e-09
four O 0 1.0497727132019463e-09
children O 0 1.0331402400254319e-10
presented O 0 4.411126575121216e-09
with O 0 2.022359391062878e-09
heterozygous O 0 2.0877477879821527e-07
deficiency O 1 0.9999418258666992
and O 0 7.879631169771528e-08
exhibited O 0 2.706743629232733e-08
a O 0 2.021319112088804e-08
normal O 0 2.31014549711972e-08
immunoblotting O 0 1.0164939112655702e-07
pattern O 0 5.29706556395837e-10
of O 0 2.5990981589174567e-10
proteins O 0 2.5925712965335634e-11
of O 0 1.0875176315039425e-09
the O 0 9.11997943831011e-09
FH O 0 9.224863606505096e-05
family O 0 3.57337199829999e-08
. O 0 3.973396189849154e-08

Factor B-Disease 0 0.141923189163208
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 9.791440547246566e-09
the O 0 2.345100780232201e-09
only O 0 6.860942369790735e-10
complement B-Disease 0 0.37219560146331787
deficiency I-Disease 1 1.0
associated O 0 2.412964022369124e-06
with O 0 1.112346907916617e-07
HUS B-Disease 1 1.0
. O 0 3.089127494604327e-05

These O 0 6.595266199838079e-08
observations O 0 1.6481367026699445e-07
suggest O 0 1.1325344217993916e-08
a O 0 4.268647213478971e-09
role O 0 9.911395260076006e-09
for O 0 2.7190989460024184e-09
FH O 0 0.00011994875239906833
and O 0 6.733406365810879e-08
/ O 0 1.910507126012817e-05
or O 0 4.309668355517715e-08
FH O 0 6.3755874180060346e-06
receptors O 0 9.46664635570471e-10
in O 0 1.1861961933534726e-11
the O 0 6.975951760690435e-11
pathogenesis O 0 1.371829512208933e-06
of O 0 6.585587186691555e-08
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 0 9.395669735567935e-07
. O 0 2.1728033061663155e-07

Further O 0 6.432468069306196e-08
evidence O 0 5.1244995802335325e-08
for O 0 1.1338436856078715e-09
a O 0 1.906270030715973e-09
major O 0 1.661208237635492e-08
ancient O 0 1.8948034039567574e-06
mutation O 0 3.850281245831866e-06
underlying O 1 0.9999451637268066
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 1.2441054195733159e-06
linkage O 0 2.309276851519826e-06
disequilibrium O 0 1.8300762576473062e-06
studies O 0 1.3288632416674773e-09
in O 0 1.3613775384779814e-10
the O 0 1.3769528850460233e-09
Japanese O 0 1.842590791056864e-07
population O 0 6.459904278166562e-10
. O 0 3.6008625414751805e-08

The O 0 3.1843701435718685e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.044454049319028854
DM B-Disease 1 1.0
) O 0 4.992184443608494e-08
mutation O 0 5.244560785655494e-09
is O 0 4.632244865465651e-10
an O 0 1.764935142478663e-10
unstable O 0 1.1233352097406168e-06
( O 0 3.9220520164917616e-08
CTG O 0 4.998412259737961e-05
) O 0 1.8264501022713375e-09
n O 0 3.546319460312475e-09
repeat O 0 3.090972588992713e-09
, O 0 8.265366169268873e-11
present O 0 4.718204715814522e-10
at O 0 1.1596918980671944e-09
a O 0 1.0489995677653852e-10
copy O 0 5.4334803323286e-10
number O 0 3.3963332146669245e-11
of O 0 1.1266219068772898e-09
5 O 0 9.893452279641224e-09
- O 0 4.1467576039622145e-08
37 O 0 2.222090067505178e-08
repeats O 0 1.8638248278080027e-08
on O 0 5.151466364594626e-09
normal O 0 3.9132158624610724e-10
chromosomes O 0 3.1776015152473747e-10
but O 0 1.7060590440376444e-10
amplified O 0 9.353810170864563e-09
to O 0 7.605474028338222e-10
50 O 0 6.087626847062211e-09
- O 0 1.8345650332207697e-08
3000 O 0 4.58550708515304e-09
copies O 0 2.681532329518177e-09
on O 0 1.689378734681668e-07
DM B-Disease 1 0.9999998807907104
chromosomes O 0 3.851060057513678e-07
. O 0 2.8505803584266687e-07

Previous O 0 5.788892849523108e-07
findings O 0 2.7338487029737735e-08
in O 0 3.0727504984895404e-09
Caucasian O 0 5.746068509893121e-08
populations O 0 2.422701150806006e-09
of O 0 1.7160276755134873e-08
a O 0 1.0275559816363966e-06
DM B-Disease 1 1.0
founder O 1 0.9999853372573853
chromosome O 0 1.374671256826332e-07
raise O 0 1.065074473061145e-09
a O 0 2.875469307106471e-10
question O 0 4.1989087207205955e-10
about O 0 6.120005977688914e-12
the O 0 4.020403801541228e-11
molecular O 0 1.7563650533958253e-10
events O 0 7.75416970216769e-12
involved O 0 2.194695467028218e-11
in O 0 3.72525101044463e-11
the O 0 8.457053946031579e-10
expansion O 0 8.29530648616128e-08
mutation O 0 1.0430734675992426e-07
. O 0 1.0761348789856129e-07

To O 0 1.5186705581982096e-07
investigate O 0 5.439936145990032e-08
whether O 0 1.939084270929925e-08
a O 0 3.723139485600768e-08
founder O 0 1.0934251122307614e-06
chromosome O 0 1.6015222925602757e-08
for O 0 1.7816783604018838e-09
the O 0 5.625414800647377e-08
DM B-Disease 1 1.0
mutation O 0 3.678051285760375e-08
exists O 0 8.330673373357911e-10
in O 0 3.547317301011432e-11
the O 0 9.368459480407765e-11
Japanese O 0 3.755804112159922e-09
population O 0 2.378794643903559e-12
, O 0 2.0778522999420623e-11
we O 0 8.947327601038779e-11
genotyped O 0 2.6159065669162374e-07
families O 0 4.539703890582558e-10
using O 0 1.1989992332317456e-09
polymorphic O 0 5.05398034533755e-08
markers O 0 2.293733558644817e-08
near O 0 2.0992916915929527e-07
the O 0 2.2228489271469698e-08
( O 0 1.3366959983329707e-08
CTG O 0 2.615991616039537e-05
) O 0 4.0683580948552844e-09
n O 0 2.9943443280444626e-08
repeat O 0 2.1836005004161052e-08
region O 0 2.2654589315607154e-08
and O 0 6.583575018481724e-09
constructed O 0 3.780645556616946e-06
haplotypes O 0 4.679453468270367e-06
. O 0 2.194456527604416e-07

Six O 0 1.1885923356658168e-07
different O 0 1.2088641199170524e-09
haplotypes O 0 1.0620244950132474e-07
were O 0 1.58262469796e-09
found O 0 1.4901478939677304e-09
and O 0 7.996877826599302e-09
DM B-Disease 1 1.0
alleles O 0 1.4423820005049492e-07
were O 0 1.5425678512315244e-08
always O 0 3.478724153183066e-08
haplotype O 0 2.051656792900758e-06
A O 0 1.241229142578959e-06
. O 0 3.460869493210339e-07

To O 0 1.8004720914177597e-07
find O 0 3.337184395491022e-08
an O 0 1.1245453873653943e-10
origin O 0 1.4235453926758623e-09
of O 0 1.4693030792045647e-08
the O 0 9.679250290162145e-09
( O 0 4.028928746180327e-09
CTG O 0 7.456524144799914e-06
) O 0 9.041859483360781e-10
n O 0 3.4595470932430317e-09
repeat O 0 1.3104988205725476e-09
mutation O 0 2.195517240233258e-10
and O 0 1.005604835513374e-10
to O 0 8.4547431555837e-11
investigate O 0 8.344126500858806e-10
the O 0 8.541023999164565e-10
mechanism O 0 6.385281192677894e-09
of O 0 1.987696895966451e-09
the O 0 5.959275850564438e-10
expansion O 0 2.2478920946866765e-09
mutation O 0 8.701041276371058e-11
in O 0 1.716928682560237e-11
the O 0 1.1694069323997525e-10
Japanese O 0 4.439681511314575e-09
population O 0 2.8666279419664598e-12
we O 0 1.3168115903239297e-11
have O 0 1.2609207081237805e-11
studied O 0 1.4726102559592391e-09
90 O 0 3.1576592451898478e-09
Japanese O 0 5.84359497679543e-07
DM B-Disease 1 1.0
families O 0 1.7664321561028373e-08
comprising O 0 1.4457782748777959e-09
190 O 0 8.4668022592993e-10
affected O 0 3.554674332661989e-10
and O 0 7.739371921111626e-10
130 O 0 1.3671295207018375e-08
unaffected O 0 6.166912385197065e-07
members O 0 6.450095568766301e-09
. O 0 4.847338885838326e-08

The O 0 3.332986580062425e-07
results O 0 9.689371971433047e-09
suggest O 0 7.788837130817683e-09
that O 0 2.159418477365449e-10
a O 0 1.4644007118036484e-09
few O 0 1.2472947119590572e-09
common O 0 1.3791063402379677e-08
ancestral O 0 2.456344418533263e-06
mutations O 0 1.2197358678633918e-09
in O 0 7.204589008713569e-11
both O 0 3.101554013618113e-10
Caucasian O 0 9.188846661345451e-08
and O 0 1.0190540855603558e-08
Japanese O 0 6.839468369435053e-07
populations O 0 1.8231008369617996e-10
have O 0 3.0351998692168536e-11
originated O 0 1.3875479931702017e-10
by O 0 7.823905585901958e-12
expansion O 0 6.621376780202581e-10
of O 0 9.070048601067526e-10
an O 0 1.3695528044976868e-10
ancestral O 0 1.1320700821215723e-08
n O 0 1.676837779740481e-09
= O 0 1.160103457742423e-09
5 O 0 9.449850901788182e-10
repeat O 0 8.724693190131916e-10
to O 0 1.0454626053757465e-09
n O 0 1.8537136270424526e-08
= O 0 3.399708603524232e-08
19 O 0 3.7771858529822566e-08
- O 0 7.815419422740888e-08
37 O 0 4.3045254471962835e-08
copies O 0 2.4497461836858747e-08
. O 0 1.0122047200411544e-07

These O 0 4.300012435010103e-08
data O 0 3.586701069480114e-08
support O 0 6.950060971178118e-09
multistep O 0 7.026531534393143e-07
models O 0 3.707224038862478e-08
of O 0 8.218735558784829e-08
triplet O 0 2.9522534532588907e-06
repeat O 0 2.9746255236773322e-08
expansion O 0 1.4563181771620748e-08
that O 0 2.0162640654297626e-11
have O 0 7.957792411139586e-12
been O 0 1.7167125360151303e-11
proposed O 0 3.5553643362717935e-11
for O 0 9.850769505659329e-12
both O 0 9.297934644436623e-10
DM B-Disease 1 1.0
and O 0 5.007672712054045e-07
Friedreichs B-Disease 1 0.9679809212684631
ataxia I-Disease 1 0.9995410442352295
. O 0 8.797257322612495e-08
. O 0 1.9901035841485282e-07

The O 0 6.618351733322925e-08
molecular O 0 9.951025958798709e-08
basis O 0 2.353695407464329e-07
of O 0 0.0003171518037561327
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.1387967013831712e-08
the O 0 3.0090794300718926e-09
western O 0 1.8331169471252906e-08
Cape O 0 1.6015657422485674e-07
, O 0 3.609123833125949e-10
South O 0 6.4744143379869e-09
Africa O 0 1.0418044205096066e-08
. O 0 9.217019680818339e-08

Deficiency B-Disease 1 0.9987075328826904
of I-Disease 0 3.364305666764267e-05
the I-Disease 0 1.8683007283470943e-06
sixth I-Disease 0 1.1820211511803791e-05
component I-Disease 0 2.4858130132088263e-07
of I-Disease 0 8.869109890952132e-09
human I-Disease 0 2.6135158481821463e-09
complement I-Disease 0 3.954909644221516e-08
( O 0 5.8838804051219995e-08
C6 O 1 0.9996354579925537
) O 0 2.5873276854326832e-09
has O 0 1.9432735975932758e-10
been O 0 3.2124836124580725e-10
reported O 0 3.7024008858743684e-10
in O 0 7.256637651886777e-11
a O 0 2.6431265509607726e-10
number O 0 3.024797426420811e-11
of O 0 2.1199064725863082e-10
families O 0 1.684074268926139e-10
from O 0 1.3941137133599568e-10
the O 0 2.7497972787671188e-09
western O 0 5.10531990016716e-08
Cape O 0 1.6193891951843398e-06
, O 0 1.854695952374641e-09
South O 0 1.750060008021137e-08
Africa O 0 3.428085548762283e-08
. O 0 9.41993292258303e-08

Meningococcal B-Disease 1 1.0
disease I-Disease 1 0.9999994039535522
is O 0 3.4664576986642714e-08
endemic O 0 2.881544602928443e-08
in O 0 4.207245940524018e-10
the O 0 3.796193581706575e-09
Cape O 0 4.807292270925245e-07
and O 0 4.994151203696617e-10
almost O 0 1.3281910293816424e-10
all O 0 7.520235129065966e-11
pedigrees O 0 1.4942015624797023e-08
of O 0 8.19050072209393e-09
total O 0 5.996714236289336e-08
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 1.7440463295770314e-07
C6Q0 O 0 0.017349280416965485
) O 0 8.170291110332073e-10
have O 0 7.443729660439047e-11
been O 0 2.018443051587937e-10
ascertained O 0 2.2930423781986065e-08
because O 0 4.5837558748651475e-10
of O 0 5.166176375581699e-09
recurrent O 0 0.3478776216506958
disease O 1 0.9996684789657593
. O 0 6.840733703938895e-07

We O 0 7.385545330862442e-08
have O 0 1.635614976791544e-09
sequenced O 0 1.3399097831268136e-08
the O 0 2.800162768323844e-09
expressed O 0 8.699141851309378e-09
exons O 0 6.937692660358152e-07
of O 0 7.16748260742861e-08
the O 0 3.825531180723374e-08
C6 O 0 2.5929422918125056e-05
gene O 0 6.212689807050253e-10
from O 0 4.380970586304045e-11
selected O 0 3.241193424763367e-11
cases O 0 4.3111909875381826e-11
and O 0 7.05933991818064e-11
have O 0 3.297337403118661e-11
found O 0 1.8939903811965308e-10
three O 0 4.0551856317350143e-10
molecular O 0 1.8167233406529704e-07
defects O 0 0.0012757860822603106
leading O 0 6.192666290871784e-08
to O 0 1.232850266319474e-09
total O 0 3.9912970706268425e-09
deficiency O 1 0.99960857629776
879delG O 0 0.0007669941405765712
, O 0 1.4283186855479357e-09
which O 0 1.0063858080222587e-10
is O 0 7.943481289407472e-11
the O 0 2.7088223331084293e-10
common O 0 1.7438823718407548e-08
defect O 0 3.1754481710777327e-07
in O 0 8.645198446011193e-10
the O 0 1.0552456686241385e-08
Cape O 0 5.756450036642491e-07
and O 0 1.965619000898755e-09
hitherto O 0 3.485485677856559e-08
unreported O 0 1.5359679750304167e-08
, O 0 1.6887512221952505e-10
and O 0 4.10756734181561e-10
1195delC O 0 1.481316331819471e-07
and O 0 3.753369615111524e-09
1936delG O 0 4.1085985458266805e-07
, O 0 7.291909853712752e-10
which O 0 1.0567250546822393e-10
have O 0 1.4028304906599232e-10
been O 0 7.666762780189629e-10
previously O 0 2.1028245811294255e-09
reported O 0 3.3694158574348876e-10
in O 0 2.540585797294881e-10
African O 0 1.1503209940144643e-08
- O 0 4.1174163811774633e-07
Americans O 0 3.7744346315093935e-08
. O 0 2.512801415832655e-07

We O 0 6.669127401437436e-07
also O 0 1.41570186684703e-08
show O 0 4.935694630781029e-10
that O 0 2.0499307112897824e-11
the O 0 3.8459394002821057e-10
879delG O 0 1.2501372737006022e-07
and O 0 3.21139470571552e-09
1195delC O 0 1.8657866576177184e-06
defects O 0 9.79160972747195e-07
are O 0 2.6025893246073295e-11
associated O 0 1.8152082059685881e-09
with O 0 1.273215866071098e-09
characteristic O 0 0.009351192973554134
C6 O 1 1.0
/ O 1 0.9999535083770752
C7 O 0 0.00018821508274413645
region O 0 1.964840201651441e-08
DNA O 0 4.892640248499447e-08
marker O 0 2.0414082868569494e-08
haplotypes O 0 9.77069447571921e-09
, O 0 6.537195784694916e-11
although O 0 2.744419969058498e-10
small O 0 6.153769716021884e-10
variations O 0 4.00578770154425e-09
were O 0 6.918358330665342e-09
observed O 0 5.875503106267388e-08
. O 0 1.0361629421140606e-07

The O 0 1.644558437874366e-06
1936delG O 0 2.89278723357711e-05
defect O 0 3.316222864668816e-05
was O 0 2.2657793863345432e-07
observed O 0 3.799293768480538e-09
only O 0 3.0070584911001674e-10
once O 0 3.4366207657399173e-09
in O 0 1.3208016624854935e-10
the O 0 1.798891702264882e-09
Cape O 0 3.1028625357976125e-07
, O 0 4.8026423116187544e-11
but O 0 2.728572402743712e-11
its O 0 1.6473392094873418e-10
associated O 0 4.579834289586415e-09
haplotype O 0 1.0427208962937584e-06
could O 0 2.6506063122155865e-08
be O 0 1.245236891378454e-08
deduced O 0 1.8324933535041055e-06
. O 0 3.1682367307439563e-07

The O 0 3.7218478610157035e-07
data O 0 2.257268150174241e-08
from O 0 3.879692567210213e-09
the O 0 2.800846443662408e-09
haplotypes O 0 1.3396982012636727e-07
indicate O 0 9.468090755859748e-10
that O 0 3.3153799150476004e-11
these O 0 9.277451029632289e-11
three O 0 3.4907710055875896e-10
molecular O 0 1.3888547201190704e-08
defects O 0 7.451766492749812e-08
account O 0 1.0285472473725576e-10
for O 0 6.301649202455906e-10
the O 0 1.0259799410050618e-07
defects O 1 0.6049726009368896
in O 0 1.6028905980292052e-09
all O 0 1.332879029369849e-09
the O 0 2.0002322020928887e-09
38 O 0 5.230015975854485e-09
unrelated O 0 3.812898441424295e-09
C6Q0 O 0 9.08988295122981e-06
individuals O 0 2.3982121843957316e-11
we O 0 1.3906399642937828e-10
have O 0 4.900692698872611e-11
studied O 0 1.1693004342561153e-09
from O 0 3.6845637652049845e-10
the O 0 8.450672162041428e-09
Cape O 0 2.8738140827044845e-06
. O 0 8.631053560748114e-08

We O 0 2.1132217398189823e-07
have O 0 3.3342559824234286e-09
also O 0 1.2158521967009506e-09
observed O 0 1.167254737310941e-09
the O 0 1.4049199581478433e-09
879delG O 0 2.73441770559657e-07
defect O 0 2.1278368933508318e-07
in O 0 2.8618138969704887e-09
two O 0 1.9410677509767993e-08
Dutch O 1 0.9999996423721313
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 0.03657340630888939
, O 0 1.695038331916976e-09
but O 0 3.5464259307005364e-10
the O 0 1.4495389333291087e-09
879delG O 0 3.409076043681125e-07
defect O 0 4.0950558855001873e-07
in O 0 1.132356763910991e-09
the O 0 8.3925248972605e-09
Cape O 0 1.095824131880363e-06
probably O 0 1.1435133728809888e-08
did O 0 3.6196717845271564e-10
not O 0 3.821062563580391e-11
come O 0 1.7846432665002965e-10
from O 0 2.3976920449086947e-10
The O 0 4.091188721133676e-09
Netherlands O 0 1.642212339447724e-07
. O 0 1.2742076727079166e-08
. O 0 1.721401332588357e-07

Complement B-Disease 1 0.9999693632125854
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 4.403907283290209e-08
seven O 0 4.200608749727053e-09
further O 0 1.2926002490587507e-09
molecular O 0 9.733367534181525e-08
defects O 0 2.0448921986826463e-06
and O 0 4.3275877326109935e-10
their O 0 6.904842808630463e-10
associated O 0 2.6616893933351093e-07
marker O 0 1.2221359611430671e-05
haplotypes O 0 3.056495188502595e-05
. O 0 6.927841695869574e-07

Seven O 0 3.42948908382823e-07
further O 0 8.676490637071765e-09
molecular O 0 7.626603348853678e-08
bases O 0 3.871098783747584e-07
of O 0 2.4442619178444147e-05
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 3.832221295851923e-08
described O 0 3.3644013797129446e-07
. O 0 1.0437143060926246e-07

All O 0 1.7942015873018136e-08
these O 0 1.0421716822861526e-09
new O 0 3.854901287070334e-09
molecular O 0 3.276815974118108e-08
defects O 0 1.5925674290429015e-07
involve O 0 3.5040010892828377e-09
single O 0 2.0685982704549133e-08
- O 0 1.0719536902570326e-07
nucleotide O 0 1.265300131336744e-08
events O 0 1.9330265166317417e-10
, O 0 3.645207399816108e-11
deletions O 0 3.1492926044762726e-09
and O 0 2.8807117802287507e-10
substitutions O 0 4.497312744433657e-09
, O 0 1.663724297218394e-10
some O 0 1.751159287022297e-11
of O 0 1.1681146050435132e-09
which O 0 2.2044800707110568e-10
alter O 0 1.9572958365188242e-08
splice O 0 1.8607402125780936e-06
sites O 0 2.3863693243697526e-09
, O 0 1.1696345281198006e-10
and O 0 2.3487883860084935e-10
others O 0 5.393184565605225e-09
codons O 0 8.661246511110221e-07
. O 0 4.693463893090666e-07

They O 0 1.8072048746375913e-08
are O 0 4.1262795957841547e-10
distributed O 0 5.503802413819869e-10
along O 0 3.955481275852435e-09
the O 0 6.477032687968176e-09
C7 O 0 1.0421947081340477e-05
gene O 0 6.581164058161448e-09
, O 0 2.4037088985906507e-10
but O 0 6.550725933918145e-11
predominantly O 0 1.205032879036949e-10
towards O 0 4.5053405450801165e-09
the O 0 3.0365927550235483e-09
3 O 0 2.2003655786306808e-08
end O 0 2.0525439481389185e-07
. O 0 2.3264891524377163e-07

All O 0 8.116757754805803e-08
were O 0 9.944931989025463e-09
found O 0 3.3561535772719253e-09
in O 0 1.1172619496235825e-09
compound O 0 2.2711965641519782e-07
heterozygous O 0 2.5449288898471423e-08
individuals O 0 5.394529822844163e-10
. O 0 8.320882471934965e-08

The O 0 3.970305260736495e-05
C6 O 1 0.9999994039535522
/ O 1 0.6559718251228333
C7 O 0 0.0009153395076282322
marker O 0 1.2447189874364994e-06
haplotypes O 0 4.912511144539167e-07
associated O 0 1.9141625173801913e-08
with O 0 2.7613813458060577e-09
most O 0 1.9784288269875105e-06
C7 B-Disease 1 1.0
defects I-Disease 1 1.0
are O 0 1.7179859312932422e-08
tabulated O 0 2.9002319479332073e-07
. O 0 2.1471898037361825e-08
. O 0 1.2769865520567691e-07

A O 0 2.294752084708307e-05
genome O 0 1.1081809816460009e-06
- O 0 5.535760578823101e-07
wide O 0 2.173246116399241e-08
search O 0 6.053678003326013e-09
for O 0 1.9333103173924115e-10
chromosomal O 0 1.4215632404557255e-07
loci O 0 1.6794993484836596e-07
linked O 0 5.250748813523387e-07
to O 0 2.805692211893529e-08
mental O 1 0.9999998807907104
health O 0 0.003686283016577363
wellness O 0 9.211215910909232e-06
in O 0 1.9809816287352788e-10
relatives O 0 1.4320339358775414e-09
at O 0 8.626020731039574e-11
high O 0 3.691274230721575e-10
risk O 0 2.1629975588410844e-09
for O 0 1.747071820545898e-08
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 0 4.1927214624593034e-06
the O 0 1.7277432107221102e-07
Old O 0 1.7146147683888557e-06
Order O 0 1.3674848275968543e-07
Amish O 0 1.8988988585988409e-06
. O 0 5.9499235760540614e-08

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.999996542930603
BPAD B-Disease 1 1.0
; O 1 1.0
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 3.013411387087217e-08
is O 0 6.64723762144881e-11
characterized O 0 6.920162776147265e-10
by O 0 7.030369342242437e-11
episodes O 0 4.78792436808817e-08
of O 0 1.214208964483987e-07
mania B-Disease 0 0.11039292812347412
and O 0 8.463838696570747e-08
/ O 0 0.019693216308951378
or O 0 3.022344685632561e-08
hypomania B-Disease 0 0.03362303227186203
interspersed O 0 5.589347651380194e-09
with O 0 2.2587376413696347e-11
periods O 0 1.8378921495809664e-08
of O 0 3.4671323589918757e-08
depression B-Disease 0 0.00042626395588740706
. O 0 3.5709746271095355e-07

Compelling O 0 1.3778173979517305e-06
evidence O 0 1.1412455336312632e-07
supports O 0 4.2210668738107415e-08
a O 0 4.396494279745866e-09
significant O 0 2.1266222116622657e-09
genetic O 0 5.5934137321855815e-08
component O 0 8.887165137139164e-08
in O 0 1.76631009818351e-09
the O 0 9.503049902548355e-09
susceptibility O 0 2.682910235307645e-06
to O 0 7.630880816122954e-08
develop O 0 0.0036161711905151606
BPAD B-Disease 1 1.0
. O 0 6.372403731802478e-05

To O 0 7.113699496130721e-08
date O 0 5.057880798631231e-07
, O 0 1.4017240701491573e-09
however O 0 1.7517023387370045e-09
, O 0 1.9737667056318742e-10
linkage O 0 1.5280258836014582e-08
studies O 0 2.597111137259134e-10
have O 0 2.8171203217408625e-11
attempted O 0 1.1878507955032092e-08
only O 0 1.1489734857983436e-10
to O 0 1.9080623192557766e-10
identify O 0 5.794977386841538e-09
chromosomal O 0 1.6744149888836546e-06
loci O 0 3.6483575627244136e-07
that O 0 4.927671048982063e-10
cause O 0 5.8645756695341333e-08
or O 0 1.3058080172712039e-09
increase O 0 1.612949079854431e-10
the O 0 7.322404904641644e-10
risk O 0 2.2979360636554702e-09
of O 0 1.9429569064755015e-08
developing O 0 2.9817667382303625e-05
BPAD B-Disease 1 1.0
. O 0 2.7552173378353473e-06

To O 0 1.101305926454188e-07
determine O 0 4.566055977761607e-08
whether O 0 7.554126213449308e-09
there O 0 9.244530696506104e-10
could O 0 6.021592113825136e-10
be O 0 3.373158419250899e-10
protective O 0 6.483141135049664e-08
alleles O 0 9.126517319657523e-10
that O 0 1.535801694152461e-11
prevent O 0 4.756153804130747e-10
or O 0 4.5049342034531037e-10
reduce O 0 2.392914311144523e-09
the O 0 6.856233358831787e-10
risk O 0 2.2881130323781917e-09
of O 0 6.435226573842101e-09
developing O 0 9.125565156864468e-07
BPAD B-Disease 1 1.0
, O 0 7.166762322485809e-11
similar O 0 1.1516715532622346e-11
to O 0 1.1741018747513099e-11
what O 0 8.321326266935714e-12
is O 0 3.411523884569445e-12
observed O 0 2.2681231892640596e-11
in O 0 7.16022683852624e-12
other O 0 2.1983707909623007e-10
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 3.54757800913319e-09
we O 0 3.1993915849959365e-10
used O 0 5.044666906428574e-08
mental O 1 0.9999810457229614
health O 0 0.00011467775038909167
wellness O 0 1.4055436622584239e-05
( O 0 4.032632283657023e-10
absence O 0 6.477773872859416e-09
of O 0 1.4620794352993016e-08
any O 0 6.012083275663826e-08
psychiatric B-Disease 1 0.9999963045120239
disorder I-Disease 0 5.0127080612583086e-05
) O 0 4.1799544381326825e-10
as O 0 7.036758398193399e-10
the O 0 3.4951634919622165e-09
phenotype O 0 5.555000726076287e-08
in O 0 2.3088229106349445e-09
our O 0 4.1919346216445774e-08
genome O 0 3.592068154034678e-08
- O 0 6.253640805198302e-08
wide O 0 5.4091756851448736e-08
linkage O 0 5.401849421104998e-07
scan O 0 1.3742962323703978e-07
of O 0 6.20471141132839e-09
several O 0 8.825231656572896e-10
large O 0 1.157014151154101e-09
multigeneration O 0 5.11031771566195e-07
Old O 0 2.4363779971281474e-07
Order O 0 1.1445808212329212e-07
Amish O 0 8.710932206668076e-07
pedigrees O 0 6.612825131924183e-08
exhibiting O 0 5.864771446262296e-10
an O 0 5.96985308409792e-11
extremely O 0 4.282445509318222e-09
high O 0 4.419668186983472e-08
incidence O 0 2.519909685361199e-06
of O 0 5.990140834910562e-06
BPAD B-Disease 1 1.0
. O 0 2.536296051403042e-05

We O 0 3.6815683301938407e-07
have O 0 3.973477546992399e-09
found O 0 1.0099860947576644e-09
strong O 0 1.3852163860406108e-09
evidence O 0 1.221657353056571e-08
for O 0 1.4876885279235808e-09
a O 0 1.3513128394038176e-08
locus O 0 2.719223175517982e-07
on O 0 8.756561697964571e-08
chromosome O 0 1.967824374560223e-07
4p O 0 0.0011370773427188396
at O 0 1.7940686802830896e-07
D4S2949 O 0 4.754734561629448e-07
( O 0 2.2083572748243796e-09
maximum O 0 4.460495972580247e-08
GENEHUNTER O 0 2.0244642655598e-05
- O 0 3.1024688951220014e-07
PLUS O 0 1.6853798001648101e-07
nonparametric O 0 3.0708250164934725e-07
linkage O 0 3.53880764691894e-08
score O 0 4.8055337487085126e-09
= O 0 2.6155804189187393e-09
4 O 0 2.8406643703959844e-09
. O 0 1.6518542089727362e-10
05 O 0 1.6767531008099468e-07
, O 0 1.3769055895451743e-09
P O 0 3.1116366017158725e-07
= O 0 2.4913299867534988e-08
5 O 0 3.2532123661610512e-09
. O 0 2.6976595957073357e-10
22 O 0 1.7696146770163068e-09
x O 0 1.8402809942585918e-08
10 O 0 8.527078598774551e-09
( O 0 1.9021513253392186e-09
- O 0 5.093356492125167e-08
4 O 0 3.3391962972473266e-08
) O 0 1.213882550032963e-09
; O 0 3.269254200688465e-09
SIBPAL O 0 1.9377001081011258e-05
Pempirical O 0 1.441066501683963e-06
value O 0 8.141205043443733e-09
< O 0 3.399747683374699e-08
3 O 0 8.693916697666282e-09
x O 0 9.470552342349947e-09
10 O 0 1.3853511671158003e-09
( O 0 8.545081309208058e-10
- O 0 9.892584529325177e-09
5 O 0 4.118772434225093e-09
) O 0 1.5913870221595516e-10
) O 0 6.323656182027904e-11
and O 0 6.92452969963675e-11
suggestive O 0 2.04150074623044e-09
evidence O 0 4.575800627293347e-09
for O 0 5.351956655630374e-10
a O 0 4.561883759635066e-09
locus O 0 5.6781928492455336e-08
on O 0 1.9907407278196843e-08
chromosome O 0 1.684381167876836e-08
4q O 0 2.6344632715336047e-06
at O 0 5.377420109198283e-08
D4S397 O 0 4.5222603262118355e-07
( O 0 2.4352841965225025e-09
maximum O 0 6.013379305613853e-08
GENEHUNTER O 0 3.7380475987447426e-05
- O 0 6.300188601926493e-07
PLUS O 0 1.2157744322394137e-07
nonparametric O 0 2.555160847350635e-07
linkage O 0 5.752417564508505e-08
score O 0 9.089865748990178e-09
= O 0 4.6183967761237454e-09
3 O 0 1.5614918247308651e-09
. O 0 1.4048816276979181e-10
29 O 0 3.8673619862095165e-09
, O 0 2.4016924560221753e-10
P O 0 1.2424946760347666e-07
= O 0 1.7298560806011665e-08
2 O 0 4.3600509869179405e-09
. O 0 1.791429921071952e-10
57 O 0 3.1200262373687337e-09
x O 0 2.1621078261091498e-08
10 O 0 7.004677726740738e-09
( O 0 1.0770703218199174e-09
- O 0 3.425928696287883e-08
3 O 0 2.2562177903751035e-08
) O 0 4.73799055544788e-10
; O 0 2.776867180642739e-09
SIBPAL O 0 2.010066782531794e-05
Pempirical O 0 1.1287324923614506e-06
value O 0 1.252958359287959e-08
< O 0 1.4799658387687487e-08
1 O 0 3.3776152985609542e-09
x O 0 4.09470146678359e-09
10 O 0 1.4035325124339693e-09
( O 0 4.056856517387075e-10
- O 0 1.5444696188637863e-08
3 O 0 1.0032475294963206e-08
) O 0 7.735825868770974e-11
) O 0 1.5369122641217814e-11
that O 0 2.408557294580893e-12
are O 0 1.5599601471683044e-11
linked O 0 2.08237427301583e-08
to O 0 1.7647584726887544e-08
mental O 1 0.9999897480010986
health O 0 0.001740530482493341
wellness O 0 0.00021375238429754972
. O 0 1.3347170124689e-07

These O 0 1.3395494491419413e-08
findings O 0 6.851739176028104e-09
are O 0 4.652022864148897e-11
consistent O 0 1.6816806835961984e-09
with O 0 6.083674536361272e-11
the O 0 3.104063395209522e-10
hypothesis O 0 1.831375606720087e-09
that O 0 3.693975247215375e-12
certain O 0 3.015695332342361e-11
alleles O 0 2.6255658758245204e-10
could O 0 2.9390923028671523e-10
prevent O 0 8.411623619863917e-10
or O 0 2.267198651040303e-10
modify O 0 3.277870641582581e-09
the O 0 5.617902809618158e-10
clinical O 0 1.939519878035867e-09
manifestations O 0 2.502668223769433e-07
of O 0 3.9012033425933623e-07
BPAD B-Disease 1 1.0
and O 0 1.4996941466449698e-09
perhaps O 0 4.962626420912386e-10
other O 0 2.694738598929547e-10
related O 0 1.5913209381324123e-06
affective B-Disease 1 0.9999998807907104
disorders I-Disease 1 1.0
. O 0 6.715677591273561e-05

Segregation O 0 0.00018117694708053023
distortion O 0 0.0005255923606455326
in O 0 1.1884069408552023e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.0030644815415143967

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999727010726929
DM B-Disease 1 1.0
) O 0 1.9349526780843007e-07
is O 0 2.3406323546026897e-09
an O 0 3.6681135906491136e-10
autosomal B-Disease 1 0.9306050539016724
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
which O 0 1.6194025675986268e-08
, O 0 3.22835563837387e-10
in O 0 9.994877148145065e-11
the O 0 1.3537655441098195e-09
typical O 0 1.8395125422898673e-08
pedigree O 0 4.9072756524992656e-08
, O 0 1.2048330388925166e-10
shows O 0 1.0867043376272534e-10
a O 0 1.01931396656596e-09
three O 0 6.734251378759382e-09
generation O 0 6.469993422797415e-06
anticipation O 0 2.105120256601367e-05
cascade O 0 0.0004580137610901147
. O 0 1.7148191773230792e-06

This O 0 4.898800476382803e-09
results O 0 7.3693455782120054e-09
in O 0 3.88615850610563e-09
infertility B-Disease 1 0.9922229647636414
and O 0 6.45086111035198e-05
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.0001701578585198149
CDM B-Disease 0 0.0002203681506216526
) O 0 1.3511852747782882e-10
with O 0 2.016087123635213e-11
the O 0 3.138127757651432e-09
disappearance O 0 1.509264109245123e-07
of O 0 3.883288627548609e-06
DM B-Disease 1 1.0
in O 0 9.05738488654606e-08
that O 0 6.080258074803169e-09
pedigree O 0 8.691580433151103e-07
. O 0 8.144409235910643e-08

The O 0 4.4145292577013606e-07
concept O 0 3.803730237450509e-07
of O 0 5.977586425842674e-08
segregation O 0 2.0797037336706126e-07
distortion O 0 5.312734288054344e-07
, O 0 1.3884428329280496e-10
where O 0 4.323105762260582e-11
there O 0 7.2122577007838196e-12
is O 0 7.705604383734244e-12
preferential O 0 2.5453985585954797e-09
transmission O 0 4.136194053927511e-09
of O 0 1.806438776341679e-09
the O 0 1.5461254498916333e-09
larger O 0 2.0083863461195506e-09
allele O 0 2.5379474077880104e-09
at O 0 1.3291674427762246e-09
the O 0 6.278042530283301e-09
DM B-Disease 1 1.0
locus O 0 3.3718984582264966e-07
, O 0 1.3504953821907861e-09
has O 0 1.9959321695406373e-10
been O 0 5.038834349768706e-10
put O 0 1.871675703313258e-09
forward O 0 1.343190181302134e-08
to O 0 1.9958190655700037e-09
explain O 0 2.5991306884520782e-08
partially O 0 1.7535927554490627e-07
the O 0 5.748038489628016e-09
maintenance O 0 1.2828545550291892e-06
of O 0 5.356322958505189e-07
DM B-Disease 1 1.0
in O 0 2.6772713823675076e-08
the O 0 9.752969098997255e-09
population O 0 1.5355036686592882e-10
. O 0 1.514441017036461e-08

In O 0 2.7941416647081496e-07
a O 0 4.593589508772311e-08
survey O 0 2.1248542925178526e-09
of O 0 2.9087679820349877e-08
DM B-Disease 1 1.0
in O 0 5.57757218189181e-08
Northern O 0 3.2948912576102884e-07
Ireland O 0 9.348801199848822e-08
, O 0 3.1731210992091974e-09
59 O 0 4.153002919338178e-08
pedigrees O 0 2.493079875875992e-07
were O 0 1.6918027867518504e-08
ascertained O 0 1.9774515749304555e-06
. O 0 2.2590670312183647e-07

Sibships O 0 0.0004359990998636931
where O 0 4.708788026164257e-08
the O 0 9.704612224936682e-09
status O 0 1.8251554934067826e-08
of O 0 7.121583767144557e-09
all O 0 2.2806699584432266e-10
the O 0 5.588918217114269e-10
members O 0 4.0744883161858425e-11
had O 0 4.365083294821659e-10
been O 0 2.2306954894357744e-10
identified O 0 4.853643598146107e-10
were O 0 2.4902679918170634e-10
examined O 0 1.3969517764778061e-09
to O 0 9.784075633012534e-11
determine O 0 4.733032299419904e-10
the O 0 1.2267820093114779e-09
transmission O 0 1.4523237723551574e-08
of O 0 1.4145843607593633e-08
the O 0 8.779222326893432e-08
DM B-Disease 1 1.0
expansion O 0 2.6268592137057567e-06
from O 0 2.9941256141086114e-09
affected O 0 6.623738224575959e-10
parents O 0 1.8130690004891648e-10
to O 0 1.948766981119121e-10
their O 0 1.7572707733393145e-09
offspring O 0 1.7875687774449034e-07
. O 0 9.488274343993908e-08

Where O 0 2.5559867822266824e-07
the O 0 1.7801515639348509e-07
transmitting O 0 3.280629471191787e-06
parent O 0 1.3538054588480009e-07
was O 0 7.833432391635142e-08
male O 0 1.2227109991158613e-08
, O 0 2.6374373796045347e-09
58 O 0 3.8750917497054616e-07
. O 0 2.785733670407353e-07

3 O 0 8.620332323516777e-07
% O 0 9.02064201113717e-09
of O 0 1.1818754863668346e-08
the O 0 6.203682012539957e-09
offspring O 0 5.449635409604525e-08
were O 0 1.812513028554008e-09
affected O 0 7.08394565229753e-10
, O 0 9.748143958709932e-11
and O 0 6.4879927819117e-11
in O 0 2.7951547326710013e-11
the O 0 1.9926610361764574e-10
case O 0 8.455666722362309e-10
of O 0 8.876653301292947e-10
a O 0 1.047780306961954e-09
female O 0 1.0151736118402255e-09
transmitting O 0 2.426124368071214e-08
parent O 0 7.528379697419041e-09
, O 0 3.979469198611696e-09
68 O 0 2.0412114736245712e-06
. O 0 9.300102874476579e-07

7 O 0 1.1135086424474139e-05
% O 0 1.467578414349191e-07
were O 0 6.865792556709494e-08
affected O 0 2.241305026018381e-07
. O 0 7.180919965321664e-07

Studies O 0 4.3891736822843086e-07
on O 0 2.595906209990062e-07
meiotic O 0 8.63709738041507e-06
drive O 0 1.4449348100242787e-06
in O 0 5.4339423627425276e-08
DM B-Disease 1 1.0
have O 0 7.535734702912578e-09
shown O 0 3.886393429297641e-10
increased O 0 1.652358389003794e-10
transmission O 0 2.234861629091256e-09
of O 0 3.5934077935451114e-10
the O 0 4.522436591880563e-10
larger O 0 5.209186415555678e-10
allele O 0 2.167515722462099e-09
at O 0 3.777529400394997e-09
the O 0 5.794336122022514e-09
DM B-Disease 1 0.9999996423721313
locus O 0 1.815254506709607e-07
in O 0 1.8479903163282074e-09
non O 0 1.4162182537802437e-07
- O 0 9.16759017854929e-06
DM O 1 1.0
heterozygotes O 0 1.2260559742571786e-05
for O 0 3.879361543113191e-08
CTGn O 0 0.00010768975334940478
. O 0 2.579204760877474e-07

This O 0 1.8821513236844112e-08
study O 0 2.7489268639158126e-09
provides O 0 3.8102571098264093e-10
further O 0 1.1479439621098209e-10
evidence O 0 7.354429842898469e-10
that O 0 1.2467138432725733e-10
the O 0 3.631347667010232e-08
DM B-Disease 1 1.0
expansion O 0 1.686630093900021e-05
tends O 0 1.2477194388793578e-07
to O 0 1.5699941346980495e-09
be O 0 1.2840047913798003e-09
transmitted O 0 4.266891195925382e-08
preferentially O 0 8.398838247103413e-08
. O 0 4.280373389065062e-08

Diagnosis O 1 0.9999988079071045
of O 0 0.46793609857559204
hemochromatosis B-Disease 1 1.0
. O 0 0.0003916583373211324

If O 0 1.1062169505748898e-05
untreated O 1 1.0
, O 0 9.453080565435812e-06
hemochromatosis B-Disease 1 1.0
can O 0 1.316509383286757e-06
cause O 0 0.42495259642601013
serious O 1 0.6250787377357483
illness O 1 0.9997994303703308
and O 0 2.219238348644126e-09
early B-Disease 0 3.130202586021369e-08
death I-Disease 0 9.17991300752874e-08
, O 0 1.1260478660624074e-10
but O 0 5.75762250376588e-11
the O 0 1.284808370805024e-09
disease O 0 2.316487552889157e-06
is O 0 1.793063891808444e-10
still O 0 7.03172742255731e-10
substantially O 0 4.984658730222691e-08
under O 0 2.5657469450379722e-05
- O 1 0.9970117807388306
diagnosed O 1 0.8462961912155151
. O 0 1.4627901236963226e-06

The O 0 1.1611066383920843e-06
cornerstone O 0 5.500187398865819e-05
of O 0 5.8909328970457864e-08
screening O 0 2.8311243127632224e-08
and O 0 3.265413772712833e-10
case O 0 9.47864342570881e-10
detection O 0 1.3583499480773753e-07
is O 0 2.1414330031443995e-10
the O 0 2.543291133250136e-10
measurement O 0 3.713564922236401e-08
of O 0 1.6534825064695724e-08
serum O 0 9.093603807741601e-07
transferrin O 0 1.3915156159782782e-05
saturation O 0 1.8968016490816808e-07
and O 0 9.943503798126585e-10
the O 0 8.298670084450066e-10
serum O 0 8.809481499838512e-08
ferritin O 0 1.2648903066292405e-05
level O 0 3.638760119883955e-07
. O 0 6.938646635035184e-08

Once O 0 1.5329790130635956e-06
the O 0 2.821082034643041e-08
diagnosis O 0 1.8807910237228498e-05
is O 0 2.184365577306835e-09
suspected O 0 4.229468686389737e-07
, O 0 8.299524401067515e-10
physicians O 0 4.012073340220468e-09
must O 0 1.7257983930818455e-09
use O 0 2.160434142695067e-08
serum O 0 7.770315278321505e-06
ferritin O 0 0.02910720556974411
levels O 0 1.4775859824567306e-07
and O 0 4.8790994355840667e-08
hepatic O 1 0.9999977350234985
iron O 1 0.9999994039535522
stores O 0 1.4529199177104601e-07
on O 0 4.2471928196619047e-08
liver O 0 2.0107394504975673e-07
biopsy O 0 1.4032254469498184e-08
specimens O 0 1.8700546666750029e-10
to O 0 1.5107119721857742e-10
assess O 0 1.0860568444570617e-08
patients O 0 3.461885711431023e-08
for O 0 1.8244863397853806e-09
the O 0 1.0446359333116106e-08
presence O 0 1.634773738601325e-08
of O 0 1.0100839062943123e-06
iron B-Disease 1 1.0
overload I-Disease 0 0.002042629523202777
. O 0 2.5648850510151533e-07

Liver O 1 0.9999582767486572
biopsy O 0 0.001453103614039719
is O 0 1.5763260918788546e-08
also O 0 5.303343875162625e-10
used O 0 3.279432558844775e-10
to O 0 3.919400914931259e-10
establish O 0 7.928685263891566e-09
the O 0 3.560050254591829e-09
presence O 0 8.448154398266183e-10
or O 0 2.3562292117418338e-09
absence O 0 1.9683723451180413e-07
of O 0 4.627163150416891e-07
cirrhosis B-Disease 1 1.0
, O 0 6.040848932187259e-10
which O 0 3.881946500361444e-11
can O 0 6.984045980429343e-11
affect O 0 3.462596875891677e-09
prognosis O 1 0.9999983310699463
and O 0 1.2363200596610113e-07
management O 0 3.1145095817919355e-06
. O 0 1.5057288749176223e-07

A O 0 1.5904121255516657e-06
DNA O 0 8.976721233011631e-07
- O 0 2.2476002925486682e-07
based O 0 4.167744815930519e-09
test O 0 2.2359702978036466e-09
for O 0 6.355811987823756e-10
the O 0 4.2914725106868445e-09
HFE O 0 5.1920662372140214e-05
gene O 0 4.1735117584096315e-09
is O 0 6.93969534615313e-11
commercially O 0 2.149827871278376e-09
available O 0 6.952016046168907e-11
, O 0 1.569453594862935e-11
but O 0 1.5159705088474418e-11
its O 0 7.533744461607483e-11
place O 0 1.4818745119882237e-09
in O 0 3.1831138419535776e-11
the O 0 2.1473842148900246e-10
diagnosis O 0 3.691655592774623e-06
of O 0 1.1657889444904868e-06
hemochromatosis B-Disease 1 1.0
is O 0 3.216104005332454e-08
still O 0 1.651300651772658e-09
being O 0 1.6924925905215105e-09
evaluated O 0 1.904555624321347e-08
. O 0 4.045046608780467e-08

Currently O 0 2.031198107488308e-07
, O 0 9.243829701688355e-09
the O 0 3.8924192757860965e-09
most O 0 3.5631461670071474e-10
useful O 0 2.9325422090664688e-09
role O 0 2.8473310376142535e-09
for O 0 8.862878486670667e-11
this O 0 5.894587595811629e-11
test O 0 9.03835950527565e-10
is O 0 4.2739874139829936e-11
in O 0 3.4418124600366085e-11
the O 0 1.0119986793011293e-10
detection O 0 1.321231025031011e-06
of O 0 2.3137134519402025e-07
hemochromatosis B-Disease 1 1.0
in O 0 4.360916072698728e-09
the O 0 3.3045373104556575e-09
family O 0 4.1086092861242207e-10
members O 0 1.0278760481652327e-11
of O 0 1.1849711489819725e-10
patients O 0 2.188176029260802e-10
with O 0 6.881541170233874e-11
a O 0 4.558830646317347e-09
proven O 0 9.142377734860929e-07
case O 0 3.1713078385564586e-08
of O 0 6.061120672029574e-08
the O 0 6.281087649995243e-08
disease O 0 5.686147414962761e-05
. O 0 1.7454821943374554e-07

It O 0 3.7700601751566865e-08
is O 0 5.5998050640937436e-09
crucial O 0 1.8372233512309322e-07
to O 0 4.2609865857912155e-08
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 1.0
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 0.1379188746213913
because O 0 8.301557841150498e-08
phlebotomy O 1 0.8384109139442444
therapy O 0 3.0600131140090525e-06
can O 0 1.7409902408616063e-09
avert O 0 0.009923231787979603
serious O 1 0.9980766773223877
chronic O 1 1.0
disease O 1 1.0
and O 0 2.3856788544662777e-08
can O 0 4.3434980612211405e-10
even O 0 2.3549890926233275e-09
lead O 0 7.47275752388532e-09
to O 0 2.3377935698398744e-10
normal O 0 3.825485705988285e-09
life O 0 4.116510243790117e-09
expectancy O 0 4.753453630712556e-09
. O 0 9.808613921080678e-10
. O 0 1.3946390708952094e-08

Prevalence O 0 1.2857186447945423e-05
of O 0 1.3184064755478175e-06
the O 0 1.63113966777928e-07
I1307K O 0 3.6524691040540347e-06
APC B-Disease 0 9.63243707019501e-08
gene O 0 1.2590354314667707e-09
variant O 0 3.572036533228129e-08
in O 0 4.581492407673693e-10
Israeli O 0 2.4111960428285784e-08
Jews O 0 4.963537580948696e-09
of O 0 2.78106371265352e-10
differing O 0 1.0340767131467032e-10
ethnic O 0 9.715913837360368e-12
origin O 0 4.3180049813518195e-11
and O 0 6.193733026460535e-11
risk O 0 1.1111795927831736e-09
for O 0 3.9854114675108576e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.00020167800539638847

BACKGROUND O 0 0.00010214740177616477
& O 0 2.0056895664311014e-05
AIMS O 0 6.334837507893099e-07
Israeli O 0 2.1731844412897772e-07
Jews O 0 3.63040619788535e-08
of O 0 6.558884102503271e-09
European O 0 4.896082206329311e-09
birth O 0 5.348839593466437e-08
, O 0 1.1584517789486881e-09
i O 0 1.3943802779081693e-09
. O 0 9.192095001830936e-11
e O 0 2.2080529071821786e-10
. O 0 4.873651135439694e-11
, O 0 8.073036683597934e-11
Ashkenazim O 0 1.220164449478034e-06
, O 0 1.806940985726868e-10
have O 0 3.786514157777532e-11
the O 0 1.5582933832192225e-09
highest O 1 0.9992074370384216
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 1.1504919257276924e-06
of O 0 3.450420171802193e-09
any O 0 8.37676816800581e-10
Israeli O 0 5.592229612716437e-08
ethnic O 0 2.5036903661401766e-09
group O 0 1.757398115920239e-09
. O 0 1.5125529273518623e-08

The O 0 4.717517640528968e-06
I1307K O 0 1.6082211004686542e-05
APC B-Disease 0 4.2335852867836365e-07
gene O 0 4.820285948170522e-09
variant O 0 2.8510288530014805e-07
was O 0 1.1072371108866719e-07
found O 0 4.642507711594135e-09
in O 0 3.53746276715583e-09
6 O 0 6.364388696056267e-07
. O 0 3.12520398892957e-07

1 O 0 1.1135457498312462e-06
% O 0 3.86270260221977e-09
of O 0 5.238242284377748e-09
American O 0 4.080636717418429e-09
Jews O 0 8.860386202513837e-09
, O 0 3.8058919904493393e-10
28 O 0 2.532333454041691e-09
% O 0 1.6261204882628277e-10
of O 0 1.076988165316095e-09
their O 0 2.0608165840485526e-08
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 2.3640367885491287e-07
, O 0 1.2113378355937954e-10
but O 0 3.068671011741131e-11
not O 0 7.232235643694906e-11
in O 0 1.6905429833791175e-10
non O 0 2.6539552777649078e-08
- O 0 2.0998723471166159e-07
Jews O 0 8.552100894121395e-08
. O 0 1.2240414548614353e-07

We O 0 3.3845051916614466e-07
assessed O 0 8.640645319246687e-07
the O 0 4.226319560984848e-08
I1307K O 0 6.982031095503771e-07
prevalence O 0 6.309051769903817e-08
in O 0 2.4488558403312766e-10
Israeli O 0 4.867756420168234e-09
Jews O 0 2.1148471862630913e-09
of O 0 1.247622560818229e-10
differing O 0 3.575971463387617e-11
ethnic O 0 5.463278700962304e-12
origin O 0 5.772026606676306e-11
and O 0 5.071730882488801e-11
risk O 0 1.3696501710569464e-09
for O 0 5.148885762196187e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0001601218682480976

METHODS O 0 3.1379342999571236e-06
DNA O 0 3.459853132881108e-07
samples O 0 6.131863461433795e-09
from O 0 1.6719355899752486e-09
500 O 0 3.5151112576237153e-10
unrelated O 0 4.09920275501463e-09
Jews O 0 9.405638046189324e-09
of O 0 1.632505330917411e-08
European O 0 1.5483719195685808e-08
or O 0 4.5715609076069086e-09
non O 0 2.6512939399481184e-08
- O 0 4.066837089311548e-09
European O 0 2.6008439846236797e-10
origin O 0 1.429964202603884e-10
, O 0 1.397451338674971e-11
with O 0 1.7433068877359403e-12
or O 0 7.23270471292281e-11
without O 0 5.430061400524266e-10
a O 0 7.36419980551517e-10
personal O 0 3.644177226647116e-08
and O 0 4.3920206138636786e-08
/ O 1 0.6286329030990601
or O 0 6.028376731137541e-08
family O 0 7.355275499776326e-09
history O 0 4.280690024671685e-09
of O 0 3.1762215080277656e-09
neoplasia B-Disease 0 3.64134757546708e-05
, O 0 1.0721511456424082e-09
were O 0 1.1555917334149512e-09
examined O 0 8.285293340293265e-09
for O 0 5.57892787522718e-10
the O 0 3.3508447128127727e-09
I1307K O 0 9.526900868195298e-08
variant O 0 1.983739927879924e-08
by O 0 3.7266456587303765e-10
the O 0 1.5901497896209094e-09
allele O 0 8.993322198058706e-10
- O 0 2.273279342546175e-09
specific O 0 2.958394640373285e-10
oligonucleotide O 0 3.301672961697477e-07
( O 0 9.113388266257516e-09
ASO O 0 1.2272199455765076e-05
) O 0 1.565658158675376e-09
method O 0 7.052835826470982e-08
. O 0 5.056535457015343e-08

RESULTS O 0 6.145384077171911e-07
In O 0 1.1523940912638864e-08
persons O 0 2.2890558337707034e-09
at O 0 1.8260182255147583e-09
average O 0 9.913880133494146e-11
risk O 0 1.2489659306780254e-09
for O 0 6.532916785317866e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 5.208476636653359e-07
I1307K O 0 1.279138359677745e-06
was O 0 8.307764254311678e-09
found O 0 1.9449311605690411e-10
in O 0 2.529339515611184e-10
5 O 0 4.480687465502342e-08
. O 0 6.782542527616897e-08

0 O 0 1.0952055617963197e-06
% O 0 1.0494209057299031e-08
of O 0 1.2590696485403896e-08
120 O 0 1.2140476179922643e-08
European O 0 2.1945146144730643e-08
and O 0 3.184661068189598e-08
1 O 0 1.2427215096977307e-06
. O 0 5.388949944062915e-07

6 O 0 5.472203156386968e-06
% O 0 2.3822593675504322e-08
of O 0 3.293677863780431e-08
188 O 0 2.6888933746249677e-08
non O 0 1.7747872504969564e-08
- O 0 4.201027792305467e-08
European O 0 1.4726812658238941e-08
Jews O 0 4.116583340874058e-08
( O 0 2.4459023695300175e-09
P O 0 2.813570745274774e-07
= O 0 1.9422342845132334e-08
0 O 0 3.815153082342704e-09
. O 0 2.775081275885327e-10
08 O 0 1.9994091715602735e-08
) O 0 4.8253632201067376e-09
. O 0 4.877220050047981e-08

It O 0 7.478691799178705e-08
occurred O 0 4.190855804608873e-07
in O 0 4.654743257503924e-09
15 O 0 6.147358533326042e-08
. O 0 1.5112043172393896e-07

4 O 0 7.454750630131457e-07
% O 0 6.162006460641578e-09
of O 0 5.115864176730156e-09
52 O 0 3.328798925394949e-08
Ashkenazi O 0 7.251181841638754e-07
Israelis O 0 1.3013679911466625e-08
with O 0 2.5504220957373036e-10
familial O 0 4.335267647093133e-07
cancer B-Disease 0 9.237925041816197e-06
( O 0 3.0433300324261836e-09
P O 0 1.278579702557181e-06
= O 0 1.6455352636057796e-08
0 O 0 4.436862433010447e-09
. O 0 1.7297949184147399e-10
02 O 0 9.066178918715195e-09
) O 0 7.126346041053111e-11
and O 0 3.347080945736991e-10
was O 0 9.76246194994701e-09
not O 0 1.007219238569057e-10
detected O 0 6.600775481757637e-09
in O 0 3.831194250736303e-10
51 O 0 6.0459930395495576e-09
non O 0 1.956784423384761e-08
- O 0 1.4265148706726904e-07
European O 0 2.344476079940705e-08
Jews O 0 8.052717959117217e-08
at O 0 8.833825226872705e-09
increased O 0 1.139158989360567e-09
cancer B-Disease 0 1.5621829163592338e-07
risk O 0 3.9544872265651065e-08
. O 0 7.126438106297428e-08

Colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999996423721313
occurred O 0 0.00018059862486552447
personally O 0 4.038518000015756e-07
or O 0 2.9538407275708778e-09
in O 0 3.630914735541779e-10
the O 0 6.088343718069211e-10
families O 0 2.9952434976721065e-10
of O 0 2.482941630077562e-09
13 O 0 3.7369969341227716e-09
of O 0 7.392376932813249e-09
20 O 0 6.026995347241382e-09
Ashkenazi O 0 2.6752533699436754e-07
I1307K O 0 1.0657500837396583e-07
carriers O 0 1.1082248452254362e-09
, O 0 1.2906632707032628e-10
8 O 0 2.890901518171063e-09
of O 0 3.842744344950688e-09
whom O 0 2.641925505031395e-07
also O 0 9.802764822097743e-09
had O 0 1.829212159520921e-08
a O 0 4.590714031138532e-09
personal O 0 9.21879603765774e-08
or O 0 3.6511693224383635e-08
family O 0 8.86461126725635e-09
history O 0 9.708815085218703e-09
of O 0 6.174315103635308e-08
noncolonic O 0 0.00014094274956732988
neoplasia B-Disease 1 0.99064701795578
. O 0 6.7830087573383935e-06

CONCLUSIONS O 0 1.1469358469184954e-05
The O 0 1.5271364190994063e-06
I1307K O 0 1.0983259016938973e-05
APC O 0 7.724247552687302e-07
variant O 0 1.8347631112192175e-06
may O 0 1.263043181154444e-08
represent O 0 1.0364882285784915e-09
a O 0 2.269047172376304e-09
susceptibility O 0 1.434336809325032e-07
gene O 0 4.633643690965528e-09
for O 0 2.363890416745562e-09
colorectal B-Disease 1 1.0
, I-Disease 0 5.99102065734769e-08
or I-Disease 0 6.641975147658741e-08
other I-Disease 0 2.302042334534349e-09
, I-Disease 0 4.515972040763927e-10
cancers I-Disease 0 1.3300146974870586e-06
in O 0 1.6064156949102681e-10
Ashkenazi O 0 3.330865411044215e-06
Jews O 0 1.8540390556154307e-08
, O 0 1.2172995944581544e-10
and O 0 1.0906849728931078e-10
partially O 0 6.777690408910075e-09
explains O 0 4.029695188645377e-10
the O 0 4.121518751287745e-11
higher O 0 6.732501778294875e-10
incidence O 0 6.86484966649914e-08
of O 0 0.002029136288911104
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 2.3012356464846562e-08
European O 0 4.5867430742418946e-08
Israelis O 0 6.383955764022176e-08
. O 0 6.482139269792242e-08

Systematic O 0 6.924764051063903e-08
analysis O 0 1.4914709467461762e-08
of O 0 3.12139079028384e-08
coproporphyrinogen O 0 1.2853802218160126e-05
oxidase O 0 2.9970667583256727e-06
gene O 0 5.72522139918874e-07
defects O 0 3.8841291825519875e-05
in O 0 8.39447888978384e-09
hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.9999678134918213
and O 0 1.0006888118141433e-07
mutation O 0 4.233298156464116e-08
update O 0 1.198446284433885e-06
. O 0 4.956908128406212e-07

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.9999665021896362
( O 0 8.375352535949787e-07
HC B-Disease 1 0.9999960660934448
) O 0 4.228561323316171e-08
is O 0 1.9982566712428707e-09
an O 0 1.9803292339304335e-09
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 0 0.034469857811927795
autosomal O 1 1.0
dominant O 1 0.9999947547912598
inheritance O 0 0.03530672937631607
caused O 0 5.53157519789238e-07
by O 0 4.257749153246948e-10
deficient B-Disease 0 1.5468819469788286e-07
activity I-Disease 0 4.464006664317566e-10
of I-Disease 0 2.9590507821808387e-09
coproporphyrinogen I-Disease 0 6.427944754250348e-06
III I-Disease 1 1.0
oxidase I-Disease 0 1.495124365646916e-06
( O 0 1.363603452375628e-08
CPO O 0 2.173999973820173e-06
) O 0 6.115231432346491e-09
. O 0 4.452386903608385e-08

Clinical O 0 1.870077903731726e-05
manifestations O 0 0.18466728925704956
of O 0 1.6438683815067634e-05
the O 0 9.491230912317405e-07
disease O 0 0.0015590450493618846
are O 0 3.099636519676707e-11
characterized O 0 1.2404335336668737e-09
by O 0 8.099194231947493e-11
acute O 1 0.9461313486099243
attacks O 0 6.9545121732517146e-06
of O 1 0.9992308616638184
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 9.668990053057769e-09
precipitated O 0 1.7392784101843972e-08
by O 0 1.952926015347245e-11
drugs O 0 1.1804195398923412e-09
, O 0 2.828066947291319e-10
fasting O 0 4.948755076839007e-07
, O 0 1.476167632574743e-09
cyclical O 0 1.0024662060459377e-06
hormonal O 0 5.4645061027258635e-06
changes O 0 1.1605556515803528e-08
, O 0 1.5298505795513506e-09
or O 0 3.680086280155592e-08
infectious B-Disease 0 0.10109804570674896
diseases I-Disease 1 0.9988698363304138
. O 0 1.0629663620420615e-06

Skin O 1 1.0
photosensitivity O 1 1.0
may O 0 8.915345460991375e-06
also O 0 2.0220825902583783e-08
be O 0 1.7910823935096687e-09
present O 0 4.5737262865941375e-08
. O 0 3.25082623930939e-07

The O 0 3.410058752706391e-06
seven O 0 8.082197950898262e-07
exons O 0 3.7642546431015944e-06
, O 0 1.173767838480444e-08
the O 0 3.932494152536492e-08
exon O 0 2.3309560219786363e-06
/ O 0 1.5155512755882228e-06
intron O 0 1.840444724621193e-06
boundaries O 0 7.539041391169121e-09
and O 0 8.658581074350025e-10
part O 0 1.2748487820957166e-09
of O 0 5.1669157841160995e-09
3 O 0 8.038810506150185e-09
noncoding O 0 4.332812153506893e-08
sequence O 0 5.106385869702024e-10
of O 0 6.520238238216791e-10
the O 0 8.308837506909583e-10
CPO O 0 1.2770232160619344e-07
gene O 0 8.238581483688279e-10
were O 0 4.834407318909939e-10
systematically O 0 2.626156792029377e-10
analyzed O 0 1.755199735553603e-10
by O 0 5.1946679596737155e-11
an O 0 1.6023761484351695e-10
exon O 0 8.636833825903523e-08
- O 0 5.8305914762968314e-08
by O 0 6.174830868843628e-09
- O 0 1.096283995138947e-06
exon O 0 2.5557144454069203e-06
denaturing O 0 1.0164112609345466e-05
gradient O 0 7.118184157661744e-07
gel O 0 7.60762901563794e-08
electrophoresis O 0 5.153002291535813e-08
( O 0 3.6498306599241914e-09
DGGE O 0 6.01884676143527e-06
) O 0 2.991030201293654e-10
strategy O 0 2.443379942818069e-09
followed O 0 2.2434022695083655e-10
by O 0 9.79501289105622e-12
direct O 0 3.2742697442245117e-10
sequencing O 0 5.425788263124787e-09
in O 0 2.2223718698644035e-10
seven O 0 1.3744654303593506e-09
unrelated O 0 2.5496756705933876e-08
heterozygous O 0 9.8286010441484e-09
HC B-Disease 0 3.9568116335431114e-05
patients O 0 6.188297163589596e-08
from O 0 2.1237857694700324e-08
France O 0 3.2321171516969116e-08
, O 0 1.5634736838521235e-09
Holland O 0 6.975801056796627e-07
, O 0 2.3724955333648268e-09
and O 0 4.037621792463142e-09
Czech O 0 9.088539627555292e-06
Republic O 0 1.9439303287072107e-05
. O 0 6.149207183625549e-05

Seven O 0 4.5770687506774266e-07
novel O 0 9.258955202540164e-08
mutations O 0 3.3334293103592927e-09
and O 0 7.664686108022067e-10
two O 0 5.513510759058704e-10
new O 0 7.092682885456725e-09
polymorphisms O 0 4.3088013512715406e-07
were O 0 2.0560070979058764e-08
detected O 0 3.5547904531085806e-07
. O 0 1.1286017098655066e-07

Among O 0 5.889505771961012e-08
these O 0 1.717506803444735e-09
mutations O 0 3.136942927639552e-09
two O 0 6.358346071877463e-10
are O 0 1.938010169011406e-10
missense O 0 3.423760688292532e-07
( O 0 5.129699776063035e-09
G197W O 0 1.0580430398476892e-06
, O 0 2.1098554014997717e-09
W427R O 0 1.807243279472459e-07
) O 0 2.617210892452704e-10
, O 0 1.5078678583524407e-10
two O 0 1.8586258920816334e-10
are O 0 2.1750436174361454e-10
nonsense O 0 1.643920342075944e-07
( O 0 4.96497642998861e-09
Q306X O 0 2.8925310857630393e-07
, O 0 9.532526989985968e-10
Q385X O 0 1.1774444175216559e-07
) O 0 6.255878037819684e-10
, O 0 2.0321100357989508e-10
two O 0 3.689191174771622e-10
are O 0 1.702103319400905e-10
small O 0 1.2264592674782193e-09
deletions O 0 4.888190829888117e-08
( O 0 4.8929078566573025e-09
662de14bp O 0 3.8177145711415506e-07
; O 0 8.125878636633388e-09
1168del3bp O 0 1.3699809642275795e-06
removing O 0 1.0302529318551024e-07
a O 0 1.2435468654814485e-08
glycine O 0 2.5983425189224363e-08
at O 0 4.953606413948819e-09
position O 0 4.068605896634381e-09
390 O 0 4.962022792653897e-09
) O 0 3.845959661852305e-11
, O 0 3.567646178481709e-11
and O 0 2.040016627846697e-10
one O 0 2.445737778966617e-10
is O 0 1.3752565752866985e-10
a O 0 1.5713902401515156e-09
splicing O 0 4.01998043741969e-08
mutation O 0 1.3244957353109044e-09
( O 0 8.467625489672059e-10
IVS1 O 0 2.0282725472497987e-06
- O 0 7.861617490334538e-08
15c O 0 6.054142431821674e-07
- O 0 7.94238630419386e-08
- O 0 6.183884693200525e-08
> O 0 8.898105363641662e-08
g O 0 8.435663723105336e-09
) O 0 5.962433324846472e-11
which O 0 1.4693963060197213e-11
creates O 0 6.051758538738738e-10
a O 0 2.842402702096791e-10
new O 0 1.2826536499588315e-09
acceptor O 0 6.873493774151029e-09
splice O 0 4.855698989558732e-06
site O 0 2.7177944161849155e-07
. O 0 6.76276528110975e-08

The O 0 1.2546488505904563e-06
pathological O 0 3.8685629988322034e-06
significance O 0 6.104897352088301e-07
of O 0 2.1351792156565352e-07
the O 0 5.0275495766527456e-08
point O 0 7.407722790730986e-08
mutations O 0 3.1440110515035258e-09
G197W O 0 4.5721910169049806e-07
, O 0 1.8355440500883446e-09
W427R O 0 5.09730227804539e-07
, O 0 1.898027068847341e-09
and O 0 2.501151064038254e-09
the O 0 1.036463004311372e-08
in O 0 3.5424525535177054e-09
- O 0 9.83640617846504e-08
frame O 0 1.617165423795086e-07
deletion O 0 4.4742055393953706e-08
390delGly O 0 2.380805774748751e-08
were O 0 1.057124110470653e-10
assessed O 0 1.0409577644310275e-09
by O 0 1.508603658662011e-11
their O 0 1.2700476781368764e-10
respective O 0 6.425206144911044e-09
expression O 0 2.5975830375557507e-09
in O 0 1.9295380571104914e-10
a O 0 1.604186505854699e-10
prokaryotic O 0 3.508508594762816e-09
system O 0 7.657559031315486e-09
using O 0 3.6290057625620875e-09
site O 0 2.5454291119331174e-08
- O 0 3.759783950840756e-08
directed O 0 2.4608919346746916e-08
mutagenesis O 0 6.8828894654870965e-06
. O 0 1.336617430069964e-07

These O 0 3.6872950914812463e-08
mutations O 0 3.09792724806357e-08
resulted O 0 1.5453714752311498e-08
in O 0 7.87187259820854e-10
the O 0 1.1823934054078222e-09
absence O 0 8.117842043020573e-08
or O 0 5.155397886369428e-09
a O 0 3.6292688854189237e-09
dramatic O 0 1.7886423009372265e-08
decrease O 0 1.73027192573727e-08
of O 0 3.581058649615443e-07
CPO O 0 0.00012633511505555362
activity O 0 1.9334935075221438e-07
. O 0 1.9479408308598067e-07

The O 0 1.103260728996247e-06
two O 0 2.735100324002815e-08
polymorphisms O 0 2.9043172844467335e-07
were O 0 6.097272020610944e-09
localized O 0 9.155957059192588e-08
in O 0 2.458160341944904e-09
noncoding O 0 1.8799072449837695e-06
part O 0 6.489794479591637e-09
of O 0 5.550739867743459e-09
the O 0 2.4491373373791703e-09
gene O 0 2.762960416013982e-10
1 O 0 1.482140299380319e-09
) O 0 4.484596721754386e-11
a O 0 7.606663632309107e-10
C O 0 5.332368573363055e-07
/ O 0 5.626830557048379e-07
G O 0 3.4427574746587197e-07
polymorphism O 0 7.27618996165802e-08
in O 0 3.40437705803609e-10
the O 0 9.545335633021068e-10
promotor O 0 1.984313030334306e-06
region O 0 2.212502714371567e-08
, O 0 2.700976553526857e-09
142 O 0 4.312496670877408e-08
bp O 0 3.8467140939246747e-07
upstream O 0 1.5201132796960337e-08
from O 0 9.640203080252263e-10
the O 0 1.9348531665741575e-09
transcriptional O 0 4.0430641945476964e-08
initiation O 0 3.4826147299327204e-08
site O 0 9.509232512527888e-09
( O 0 1.9218834856893352e-10
- O 0 4.685939192228261e-09
142C O 0 1.6556133175527066e-07
/ O 0 2.483383276796758e-08
G O 0 3.8186129813766456e-08
) O 0 1.331364046786021e-10
, O 0 9.446080723174433e-11
and O 0 4.521134577828434e-10
2 O 0 1.988031606003915e-08
) O 0 4.0799033595995127e-10
a O 0 4.528032171435825e-09
6 O 0 9.676632828359288e-08
bp O 0 1.0021787488767586e-07
deletion O 0 5.295926808202012e-09
polymorphism O 0 4.909726403212744e-09
in O 0 5.7252733803858646e-11
the O 0 4.717305435164576e-10
3 O 0 8.843484167186944e-09
noncoding O 0 2.0762674068919296e-07
part O 0 4.088130722834649e-09
of O 0 1.370155100488546e-08
the O 0 2.1296148844385243e-08
CPO O 0 6.918268127265037e-07
gene O 0 8.06485722648631e-09
, O 0 1.5389495233719686e-09
574 O 0 1.877279487416672e-07
bp O 0 4.096489476523857e-07
downstream O 0 2.6447784406968822e-08
of O 0 2.126784304223861e-09
the O 0 2.4842348178566453e-09
last O 0 2.3333532883640373e-09
base O 0 2.1830839358472076e-08
of O 0 1.9558319408474745e-09
the O 0 1.0354687107749783e-09
normal O 0 1.570934715644512e-09
termination O 0 5.896475130384715e-08
codon O 0 1.1828181989415043e-08
( O 0 3.029037909385579e-09
+ O 0 5.2503683178883875e-08
574 O 0 3.283398370967916e-07
delATTCTT O 0 1.4264021501730895e-06
) O 0 9.821629731732173e-09
. O 0 7.652116806866616e-08

Five O 0 3.4220734050904866e-06
intragenic O 0 0.00017623775056563318
dimorphisms O 0 6.791853957111016e-05
are O 0 1.8373514931724344e-09
now O 0 2.104911356326511e-09
well O 0 4.052974067469961e-10
characterized O 0 4.850018164859193e-09
and O 0 3.821502003731325e-10
the O 0 5.107944067717085e-10
high O 0 7.1838490711684244e-09
degree O 0 2.6848807621604465e-08
of O 0 4.052249646946393e-09
allelic O 0 1.8362634079949203e-07
heterogeneity O 0 2.1185167042858666e-07
in O 0 2.5027258043763823e-09
HC B-Disease 0 0.010735359974205494
is O 0 2.920931052585729e-09
demonstrated O 0 1.9171213505586593e-09
with O 0 6.790117773602944e-11
seven O 0 4.956458576899081e-10
new O 0 8.41739664081409e-11
different O 0 1.3455163198894393e-11
mutations O 0 5.184492418708331e-11
making O 0 6.308333022619905e-11
a O 0 7.712033789353256e-11
total O 0 2.820109423762318e-11
of O 0 7.461857798318761e-10
nineteen O 0 4.9543839253374244e-08
CPO O 0 5.532068371394416e-06
gene B-Disease 0 1.5258626717695734e-07
defects I-Disease 0 8.298073908008519e-07
reported O 0 1.6165996319372766e-09
so O 0 4.686526722252893e-10
far O 0 3.4656228997675953e-09
. O 0 1.2720046127512319e-09
. O 0 1.8003721180548382e-08

Coincidence O 0 7.269791694852756e-06
of O 0 6.026538130754489e-07
two O 0 1.4176771756524431e-08
novel O 0 8.975405307865003e-08
arylsulfatase O 0 2.2486196940008085e-06
A O 0 4.489730187628993e-08
alleles O 0 2.139176613624727e-09
and O 0 6.256999918186068e-10
mutation O 0 2.250603481357416e-09
459 O 0 5.591632401547031e-08
+ O 0 9.264944367259886e-08
1G O 0 3.1676522667112295e-06
> O 0 1.1804431210293842e-07
A O 0 8.263009831921408e-09
within O 0 4.457795244050544e-10
a O 0 6.677510766550654e-10
family O 0 7.435956850265768e-10
with O 0 3.96080918063646e-10
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 6.346254077804758e-10
molecular O 0 4.112179041726449e-09
basis O 0 4.041882384342443e-09
of O 0 1.4714794716041979e-08
phenotypic O 0 1.3626591908177943e-06
heterogeneity O 0 1.8064356481772847e-05
. O 0 1.0118492355104536e-06

In O 0 5.8836786109850436e-08
a O 0 2.2120131504266283e-08
family O 0 4.368775119445445e-09
with O 0 1.1529205368177031e-10
three O 0 9.320235694332268e-10
siblings O 0 1.2587051401169447e-07
, O 0 2.4411378474198386e-10
one O 0 2.549930822048907e-10
developed O 0 6.711711364459916e-08
classical O 0 2.703163545447751e-06
late O 0 0.3292340934276581
infantile O 1 0.9999784231185913
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 1.5966674027367844e-07
MLD B-Disease 1 1.0
) O 0 7.826394643473122e-09
, O 0 6.536101659904148e-10
fatal O 0 1.6740017372285365e-07
at O 0 9.614409712810357e-09
age O 0 3.043852725426177e-09
5 O 0 7.2265615713718034e-09
years O 0 2.064013626679184e-09
, O 0 2.745739469123265e-10
with O 0 3.3448280256642704e-10
deficient O 0 0.01051977090537548
arylsulfatase O 0 0.02181624248623848
A O 0 5.558997600019211e-06
( O 0 4.569087508343728e-08
ARSA O 0 0.0008357843616977334
) O 0 8.407725626824458e-10
activity O 0 2.8455057754506186e-10
and O 0 9.964611774604393e-11
increased O 0 1.4505345813375925e-09
galactosylsulfatide O 0 1.8809851098922081e-06
( O 0 1.829351781168498e-08
GS O 1 0.9993565678596497
) O 0 1.0574901843085627e-08
excretion O 0 5.682537462803339e-08
. O 0 3.7207541936368216e-08

The O 0 5.362753086046723e-07
two O 0 1.0597415389668186e-08
other O 0 1.4380692192617062e-09
siblings O 0 3.15504252057508e-07
, O 0 3.9642347182677895e-09
apparently O 0 1.4581296170490532e-07
healthy O 0 6.127527996113713e-08
at O 0 1.6823424431322564e-08
12 O 0 2.450782243812455e-09
( O 0 5.656956569843885e-10
1 O 0 1.2573590879583207e-07
/ O 0 1.0750450201157946e-06
2 O 0 1.4344408327815472e-07
) O 0 5.406766701021581e-10
and O 0 6.079524661473101e-10
15 O 0 1.7773338356619206e-09
years O 0 8.068853918352659e-10
, O 0 6.646096867291007e-11
respectively O 0 2.4577140322890045e-10
, O 0 2.5085634958177394e-11
and O 0 4.0056770400642705e-11
their O 0 1.5517676033027783e-10
father O 0 3.486975685973448e-07
, O 0 1.4457837149706165e-09
apparently O 0 1.4616303722903012e-08
healthy O 0 1.5227241689785842e-09
as O 0 2.848828950519078e-10
well O 0 4.814237342110061e-10
, O 0 3.4292921280432154e-10
presented O 0 1.1754687534448749e-07
ARSA O 1 0.9999951124191284
and O 0 4.353198050921492e-07
GS O 1 1.0
values O 0 7.151475411859565e-09
within O 0 5.999511998311391e-10
the O 0 2.47832754318722e-10
range O 0 3.4355065459124035e-09
of O 0 1.5889622062559283e-08
MLD B-Disease 1 1.0
patients O 0 1.4710182767885271e-05
. O 0 1.4273393844632665e-07

Mutation O 0 1.655951251677834e-07
screening O 0 7.746527330709796e-08
and O 0 5.726171758979604e-10
sequence O 0 6.054965556723246e-11
analysis O 0 6.294966631292809e-11
disclosed O 0 2.029825418858877e-09
the O 0 2.0663169786327984e-10
involvement O 0 2.9460196504516034e-09
of O 0 2.7092008636486753e-09
three O 0 4.699326483503796e-10
different O 0 5.581290984935094e-10
ARSA O 0 0.00023032019089441746
mutations O 0 1.375976332873563e-09
being O 0 2.6140778430772116e-10
the O 0 6.554549958348588e-11
molecular O 0 3.7731351376635303e-10
basis O 0 6.924520401518919e-10
of O 0 9.056535077434091e-09
intrafamilial O 0 1.5436266039614566e-05
phenotypic O 0 1.5640762285329401e-06
heterogeneity O 0 8.072752279986162e-06
. O 0 4.160059745572653e-07

The O 0 1.9576264094212092e-06
late O 0 9.267353016184643e-05
infantile O 0 0.004226033575832844
patient O 0 5.895012236578623e-06
inherited O 0 0.0012811290798708797
from O 0 1.4095620315401902e-07
his O 0 2.2018230083631352e-07
mother O 0 2.374720082798376e-07
the O 0 1.119536463534132e-08
frequent O 0 1.3308982360626942e-08
0 O 0 8.960007846781082e-09
- O 0 6.0580211957983465e-09
type O 0 5.456664009528822e-09
mutation O 0 3.89356280550146e-09
459 O 0 1.4049340357757956e-08
+ O 0 1.4639377710068402e-08
1G O 0 3.090367499680724e-07
> O 0 7.768008458697295e-09
A O 0 3.683862992431841e-09
, O 0 5.855212148464517e-11
and O 0 9.047617516300122e-11
from O 0 4.2050798954029744e-10
his O 0 4.654405749704438e-09
father O 0 2.1899236202216343e-08
a O 0 1.7859994594360273e-09
novel O 0 5.316208362415864e-09
, O 0 2.0024643054838975e-10
single O 0 1.1558319856774801e-09
basepair O 0 9.57910060606082e-07
microdeletion O 0 1.2053453701810213e-06
of O 0 2.985795077847797e-08
guanine O 0 1.665587205934571e-07
at O 0 1.4465236120031477e-08
nucleotide O 0 4.109411033681454e-09
7 O 0 7.632507958987844e-09
in O 0 8.267703743847221e-10
exon O 0 7.557127190693791e-08
1 O 0 3.631181400010064e-08
( O 0 2.0344146367534677e-09
7delG O 0 6.353078561005532e-07
) O 0 1.1002892819078625e-08
. O 0 1.0539787353991414e-07

The O 0 7.341016612372187e-07
two O 0 8.479852908749308e-08
clinically O 0 0.00010866724915103987
unaffected O 0 3.6594636185327545e-05
siblings O 0 9.176951607514638e-07
carried O 0 4.32077751355564e-09
the O 0 1.5193007962821525e-09
maternal O 0 2.895858841611698e-08
mutation O 0 3.902335787842048e-09
459 O 0 2.9325548212000285e-08
+ O 0 1.546872496760443e-08
1G O 0 8.475759614157141e-07
> O 0 1.961170958963976e-08
A O 0 4.485225968409168e-09
and O 0 1.5618395465821777e-10
, O 0 3.523029784568976e-11
on O 0 2.6793939289504465e-10
their O 0 7.551295005958636e-11
paternal O 0 1.162367713192225e-08
allele O 0 1.9925023853062385e-09
, O 0 7.287374176323524e-11
a O 0 2.8026406195813536e-10
novel O 0 4.926883789835301e-09
cytosine O 0 6.33032612995521e-08
to O 0 4.4016292832793624e-09
thymidine O 0 3.4750487429846544e-06
transition O 0 9.07084938717162e-07
at O 0 3.857926245132148e-08
nucleotide O 0 5.354667820256509e-08
2435 O 0 3.390886831766693e-06
in O 0 1.4960572780609027e-09
exon O 0 6.930127938176156e-08
8 O 0 4.058800850970101e-09
, O 0 3.016431548985565e-11
resulting O 0 3.838976914138925e-10
in O 0 1.266834553925733e-10
substitution O 0 1.8631565623650204e-08
of O 0 2.586786251868034e-08
alanine O 0 9.315088789207948e-08
464 O 0 7.50833493157188e-08
by O 0 3.104763557360002e-09
valine O 0 1.3158290812498308e-06
( O 0 1.046352871014733e-08
A464V O 0 3.131205176032381e-06
) O 0 1.2734059140484533e-08
. O 0 1.1679440348189019e-07

The O 0 1.0514885389056872e-06
fathers O 0 3.931069727514114e-07
genotype O 0 7.751040698167344e-07
thus O 0 4.432703093470991e-08
was O 0 3.517113782436354e-07
7delG O 0 6.534601197927259e-06
/ O 0 1.4689531781186815e-05
A464V O 0 1.038577283907216e-05
. O 0 4.660529100419808e-07

Mutation O 0 1.0656988251867006e-06
A464V O 0 6.204990768310381e-06
was O 0 8.273485008203352e-08
not O 0 2.762180484339183e-10
found O 0 3.7174729961009234e-10
in O 0 2.298680273904452e-10
18 O 0 4.236301087701122e-09
unrelated O 0 2.5235412977053784e-06
MLD B-Disease 1 1.0
patients O 1 0.8709855079650879
and O 0 1.1713908065758005e-07
50 O 0 2.4024460643090606e-08
controls O 0 2.2426564783017966e-07
. O 0 1.7533152174564748e-07

A464V O 0 4.989658555132337e-05
, O 0 3.0122048855218964e-08
although O 0 1.1315930414923514e-08
clearly O 0 3.064604570113261e-08
modifying O 0 1.075738282452221e-06
ARSA O 1 0.9999996423721313
and O 0 1.2040552519465564e-06
GS O 1 1.0
levels O 0 8.04649999963658e-08
, O 0 7.701557169781381e-10
apparently O 0 7.204431717866555e-09
bears O 0 7.396439016815748e-09
little O 0 2.1298371954969753e-09
significance O 0 5.75374192735012e-09
for O 0 2.9571536885875105e-10
clinical O 0 2.4122034147922022e-08
manifestation O 0 0.0002087791363010183
of O 0 9.095743735088035e-05
MLD B-Disease 1 1.0
, O 0 4.989224677842685e-08
mimicking O 0 1.0060858102178827e-07
the O 0 1.3409196419900127e-08
frequent O 0 1.501177990803626e-07
ARSA O 0 0.004294895101338625
pseudodeficiency O 0 2.582725210231729e-05
allele O 0 1.6126203945532325e-06
. O 0 2.893634700740222e-07

Our O 0 3.0013341074663913e-06
results O 0 2.619126071579103e-08
demonstrate O 0 2.496719808675607e-08
that O 0 2.8096466819782506e-10
in O 0 2.660099640561242e-10
certain O 0 1.1595592264157517e-09
genetic O 0 5.190763729956416e-08
conditions O 0 1.7005041854645242e-06
MLD B-Disease 1 1.0
- O 1 0.9999520778656006
like O 0 2.493137003511947e-07
ARSA O 1 0.9999995231628418
and O 0 1.2483310740663e-07
GS O 1 0.9999998807907104
values O 0 1.1070628858078635e-09
need O 0 1.2061734944168734e-10
not O 0 3.7881303996400995e-12
be O 0 5.501634738058758e-12
paralleled O 0 2.6247046203131674e-10
by O 0 5.247954848464076e-12
clinical O 0 9.815917856315082e-09
disease O 0 2.5845972118077043e-07
, O 0 5.6541268195209327e-11
a O 0 1.4050209606875086e-10
finding O 0 9.778221565781564e-10
with O 0 8.797664680093575e-11
serious O 0 7.433298065961935e-08
diagnostic O 0 0.00021535229461733252
and O 0 2.3415985594965605e-07
prognostic O 1 0.9999903440475464
implications O 0 5.470032192533836e-05
. O 0 1.704365104160388e-06

Moreover O 0 2.350557679164922e-06
, O 0 3.4854188868393976e-08
further O 0 8.195051748316473e-08
ARSA O 0 0.000891739153303206
alleles O 0 3.008489812827975e-08
functionally O 0 5.660156432440999e-08
similar O 0 2.5060984398805886e-09
to O 0 2.3704826990211814e-09
A464V O 0 2.3607609023201803e-07
might O 0 1.296634910552541e-09
exist O 0 1.6463246044207125e-10
which O 0 6.680895420219102e-11
, O 0 7.591206309387477e-12
together O 0 8.53323141314366e-12
with O 0 1.528495732761037e-11
0 O 0 5.79064574068866e-09
- O 0 1.1506195107813255e-08
type O 0 8.583067767631292e-08
mutations O 0 2.621505146294112e-08
, O 0 6.613626868379185e-10
may O 0 5.937461633465091e-09
cause O 0 1.7878446669783443e-06
pathological O 0 0.3061220049858093
ARSA O 1 0.999984860420227
and O 0 5.006096515103309e-08
GS O 1 0.9999994039535522
levels O 0 2.105746466085634e-09
, O 0 1.3948097885019273e-11
but O 0 3.0312989531683376e-12
not O 0 2.6242263570508406e-12
clinical O 0 1.0040892561846704e-09
outbreak O 0 3.16794457333458e-09
of O 0 5.090712296151878e-09
the O 0 5.4059858811683625e-09
disease O 0 1.2740006241074298e-06
. O 0 4.365102057590775e-09
. O 0 4.9169635474299866e-08

Human O 0 0.005428355652838945
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 1 0.814939022064209
to O 0 1.0725565289249062e-06
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 0 2.776207111310214e-06
neurofibromatosis B-Disease 1 0.9999864101409912
type I-Disease 0 0.00037639093352481723
1 I-Disease 0 5.293183130561374e-05
. O 0 3.0121680083539104e-07

Heterozygous O 0 8.132787115755491e-06
germ O 0 0.00035640207352116704
- O 0 1.4693175216962118e-05
line O 0 2.872082802696241e-07
mutations O 0 3.960909378264432e-09
in O 0 3.8350103648276956e-10
the O 0 2.794336761979821e-09
DNA O 0 5.448491151582857e-07
mismatch O 0 0.0012022810988128185
repair O 0 0.001420220360159874
genes O 0 2.1929203342097026e-08
lead O 0 2.1952931916757734e-08
to O 0 8.924463834603102e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0004680743732023984

The O 0 1.2022766213704017e-06
disease O 0 2.2382459064829163e-05
susceptibility O 0 8.88695922185434e-06
of O 0 4.230888919209974e-07
individuals O 0 3.978998908138465e-09
who O 0 1.5721232671239704e-07
constitutionally O 0 2.049357135547325e-06
lack O 0 3.686466243379982e-06
both O 0 7.206712560048345e-09
wild O 0 1.4842231443878973e-08
- O 0 2.5707502793181902e-09
type O 0 2.364115792019561e-09
alleles O 0 1.3197144488330537e-09
is O 0 3.9806363760774843e-10
unknown O 0 2.8782816130501487e-08
. O 0 5.054992158193272e-08

We O 0 1.6275487269012956e-07
have O 0 4.454839608314387e-09
identified O 0 1.528562165731273e-08
three O 0 7.169568272402671e-10
offspring O 0 3.912695500929431e-09
in O 0 6.407430142019166e-11
a O 0 6.514946804259125e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.5126500129699707
who O 0 1.6907607758298582e-08
developed O 0 1.881081971077947e-06
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
at O 0 3.2621198897686554e-06
a O 0 2.6804942709901525e-09
very O 0 1.8334647688966754e-10
early O 0 5.2363442470948485e-09
age O 0 1.0780156767253857e-09
, O 0 1.005365027340055e-10
and O 0 1.9773652160104405e-10
at O 0 4.2019049351083027e-10
least O 0 7.75945193515204e-12
two O 0 1.4292164673967989e-11
of O 0 1.7432820464957643e-10
them O 0 1.1241979569476257e-10
displayed O 0 3.3462079773727282e-09
signs O 0 8.65500204838554e-09
of O 0 1.1823110668274239e-07
neurofibromatosis B-Disease 1 0.9926818013191223
type I-Disease 0 0.00020428533025551587
1 I-Disease 0 2.6665784389479086e-05
( O 0 2.371306884185742e-08
NF1 B-Disease 0 0.0010751893278211355
) O 0 3.097856193789994e-08
. O 0 5.785383194734095e-08

DNA O 0 3.901627394498064e-07
sequence O 0 7.150520620058387e-09
analysis O 0 1.597512677697921e-09
and O 0 2.4941659848565223e-10
allele O 0 9.822074265031233e-10
- O 0 6.956901166255136e-10
specific O 0 9.274638695933035e-11
amplification O 0 2.795148290601901e-08
in O 0 1.7718090883356297e-10
two O 0 4.3611469990878504e-10
siblings O 0 3.6607506359587205e-08
revealed O 0 2.7396948709679236e-08
a O 0 2.5347315357748812e-08
homozygous O 0 1.6314507433889958e-07
MLH1 O 0 0.00013866799417883158
mutation O 0 7.803532042771621e-08
( O 0 6.712707723011135e-09
C676T O 0 5.752811489401211e-07
- O 0 8.165591225406388e-07
- O 0 2.1146522612980334e-06
> O 0 4.480996722122654e-06
Arg226Stop O 0 3.7239726225379854e-05
) O 0 2.369511875599528e-08
. O 0 5.755764931336671e-08

Thus O 0 1.0015221505454974e-06
, O 0 3.329364517412614e-08
a O 0 2.810667965036373e-08
homozygous O 0 1.456024278922996e-07
germ O 1 0.9943650960922241
- O 0 0.0011877386132255197
line O 0 5.399421752372291e-06
MLH1 O 1 0.9996261596679688
mutation O 0 1.0136344030797773e-07
and O 0 2.2397137477980777e-09
consequent O 0 0.0009656850015744567
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 1.2712630059752428e-08
in O 0 7.745470931297405e-10
a O 0 2.428340417637287e-09
mutator O 0 4.536389678833075e-05
phenotype O 0 3.87866627704625e-08
characterized O 0 4.879466830587376e-10
by O 0 6.196403112834759e-11
leukemia B-Disease 1 0.9999970197677612
and O 0 8.921796688809991e-05
/ O 1 1.0
or O 1 0.9753079414367676
lymphoma B-Disease 1 1.0
associated O 0 1.0869845027627889e-05
with O 0 4.663736952181807e-09
neurofibromatosis B-Disease 0 0.0004865428782068193
type I-Disease 0 3.677634765608673e-07
1 I-Disease 0 1.4340660925427073e-07
. O 0 1.3655234720744147e-09
. O 0 1.592864329325039e-08

Missense O 0 0.00011268030357314274
mutations O 0 5.039204893364513e-07
in O 0 1.530254145620802e-08
the O 0 7.625378550812911e-09
most O 0 4.0161443615183146e-10
ancient O 0 3.032855033779924e-08
residues O 0 1.3181555402752565e-08
of O 0 6.858277057375517e-09
the O 0 1.3200978976612987e-08
PAX6 O 0 0.0018248455598950386
paired O 0 7.793224909846685e-08
domain O 0 1.8720836436614263e-08
underlie O 0 3.529990166839525e-08
a O 0 1.3320402558747446e-09
spectrum O 0 6.483734438234023e-08
of O 0 1.8341872021210293e-08
human O 0 0.005661266390234232
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 0 0.0030962079763412476

Mutations O 0 2.5757682919902436e-07
of O 0 8.619208813342993e-08
the O 0 2.7338067809523636e-08
human O 0 8.024337461165487e-08
PAX6 O 1 0.9975878000259399
gene O 0 6.301429948507575e-06
underlie O 1 0.9995880722999573
aniridia B-Disease 1 1.0
( O 0 0.004379520192742348
congenital B-Disease 1 1.0
absence I-Disease 1 0.6594854593276978
of I-Disease 0 0.011862858198583126
the I-Disease 0 1.7953367432710365e-06
iris I-Disease 0 0.0001980051602004096
) O 0 5.321744711572762e-10
, O 0 6.937895397074456e-11
a O 0 1.7938346363877145e-09
rare O 0 4.38072529505007e-05
dominant O 1 1.0
malformation B-Disease 1 1.0
of I-Disease 1 0.9999988079071045
the I-Disease 1 0.9773268103599548
eye I-Disease 1 1.0
. O 0 6.861694146209629e-06

The O 0 5.291628326631326e-07
spectrum O 0 2.9708744477829896e-06
of O 0 3.5015648336411687e-07
PAX6 O 1 0.9983296990394592
mutations O 0 5.979799198030378e-07
in O 0 3.5689311062014895e-08
aniridia B-Disease 1 1.0
patients O 0 7.025894888101902e-07
is O 0 3.3267902321831855e-10
highly O 0 7.334761686905722e-10
biased O 0 7.956676983944533e-10
, O 0 2.1132281688429622e-11
with O 0 4.567222468276899e-12
92 O 0 8.105477178332876e-09
% O 0 1.831766127668999e-10
of O 0 5.323572138671295e-10
all O 0 1.506712116183806e-10
reported O 0 6.049542533581587e-10
mutations O 0 1.9245466331696548e-10
leading O 0 1.0586177490168325e-09
to O 0 2.713181346258864e-10
premature O 0 1.0471758571384271e-07
truncation O 0 4.723162419395521e-06
of O 0 2.582360139058437e-07
the O 0 1.600297849790877e-08
protein O 0 2.617506877911069e-09
( O 0 1.627073059617956e-10
nonsense O 0 1.3587744263077184e-08
, O 0 1.187319548234811e-10
splicing O 0 1.1672954158825632e-08
, O 0 1.4069169440578122e-10
insertions O 0 4.1699070862932786e-09
and O 0 2.554882139182979e-10
deletions O 0 6.980283906443674e-09
) O 0 2.007117805291614e-10
and O 0 1.0007700224079485e-09
just O 0 3.0988356325423183e-09
2 O 0 3.046282159857583e-08
% O 0 4.284975985147099e-10
leading O 0 4.515421092587957e-10
to O 0 6.647161987505257e-11
substitution O 0 9.973101455784672e-09
of O 0 1.2321152098593302e-08
one O 0 2.624744588342054e-10
amino O 0 1.6624428222922205e-10
acid O 0 1.696874862844311e-10
by O 0 2.2169687960427176e-11
another O 0 7.283375569322459e-10
( O 0 1.0447928078249902e-09
missense O 0 4.5147362470743246e-07
) O 0 9.85258807872924e-09
. O 0 8.465696055282024e-08

The O 0 2.4052482672232145e-07
extraordinary O 0 8.448387944781643e-08
conservation O 0 6.467270452503726e-08
of O 0 1.2657659809178767e-08
the O 0 1.886500200498631e-08
PAX6 O 0 5.247617809800431e-05
protein O 0 1.584265518772554e-08
at O 0 1.1537922839366388e-09
the O 0 1.367086444048482e-10
amino O 0 2.0234860453882675e-09
acid O 0 1.5725273527777972e-08
level O 0 3.0405583828496674e-08
amongst O 0 3.6835839267723713e-08
vertebrates O 0 2.1194624366671633e-07
predicts O 0 7.174921101693599e-09
that O 0 1.4400558523419704e-10
pathological O 0 1.2924090242449893e-07
missense O 0 3.02398888152311e-07
mutations O 0 9.841052417414176e-10
should O 0 3.1755534313226974e-10
in O 0 6.275234498698268e-11
fact O 0 9.6544966465828e-11
be O 0 4.90402163322301e-11
common O 0 9.21154597044449e-10
even O 0 1.977380204021273e-10
though O 0 5.912829253995611e-11
they O 0 7.611285733621909e-12
are O 0 6.9896128815361e-12
hardly O 0 7.319001404937353e-09
ever O 0 4.98393326608948e-09
seen O 0 1.0801485039735326e-08
in O 0 7.383246014569522e-09
aniridia B-Disease 1 1.0
patients O 0 1.0100972758664284e-05
. O 0 5.818637305310403e-07

This O 0 1.7207867131219245e-08
indicates O 0 1.7002134811150427e-08
that O 0 2.148096839293956e-10
there O 0 3.780627477745213e-10
is O 0 2.1912582859329177e-10
a O 0 1.6953487502746611e-09
heavy O 0 1.6188364497793373e-06
ascertainment O 0 0.0007382082403637469
bias O 0 1.38879698852179e-07
in O 0 2.963183864945762e-10
the O 0 7.163482307337432e-11
selection O 0 2.372272378536877e-10
of O 0 3.925895164513804e-10
patients O 0 5.356378673937456e-10
for O 0 3.7799424701390194e-10
PAX6 O 0 7.832422852516174e-06
mutation O 0 1.0739952260863106e-09
analysis O 0 2.7890106890637867e-10
and O 0 5.525151516860838e-11
that O 0 2.220294781363208e-11
the O 0 4.895148286720996e-09
missing O 0 1.0490834938536864e-06
PAX6 O 1 0.9996485710144043
missense O 0 2.726360435190145e-05
mutations O 0 4.683082011069928e-08
frequently O 0 4.42861924909721e-09
may O 0 3.5337943682378636e-09
underlie O 0 1.0969407640004647e-06
phenotypes O 0 8.698015108166146e-07
distinct O 0 9.80579439868734e-09
from O 0 1.3588987712864764e-08
textbook O 0 2.175661393266637e-06
aniridia B-Disease 1 0.9999996423721313
. O 0 7.877270036260597e-07

Here O 0 3.892540405558975e-07
we O 0 2.895382600343055e-09
present O 0 5.953973314376526e-09
four O 0 5.1407775814027445e-09
novel O 0 1.1397946053648411e-07
PAX6 O 0 0.001054540858604014
missense O 0 3.6384863051353022e-06
mutations O 0 1.1727204984879336e-08
, O 0 7.064865914507834e-10
two O 0 1.833415919083592e-10
in O 0 2.267328269578428e-10
association O 0 4.037796763611823e-10
with O 0 1.6636544919457208e-10
atypical O 0 4.811553480976727e-06
phenotypes O 0 0.00039294440648518503
ectopia B-Disease 1 0.5573042631149292
pupillae I-Disease 0 0.00010966198169626296
( O 0 1.2206899935307547e-09
displaced B-Disease 0 1.0842411413136688e-09
pupils I-Disease 0 1.310633823692342e-09
) O 0 6.753053116703711e-10
and O 0 4.224586902523697e-08
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9999873638153076
( O 0 1.2176450070455758e-07
searching B-Disease 0 1.605626067657795e-07
gaze I-Disease 0 2.7538570179785893e-07
) O 0 1.3292934808450951e-10
, O 0 3.3558940348843436e-11
and O 0 1.2916630265369378e-10
two O 0 2.921330954919199e-10
in O 0 3.642984802709748e-10
association O 0 4.4592748937866133e-10
with O 0 1.5162604505292165e-10
more O 0 2.7262341273370794e-09
recognizable O 0 7.797327998559922e-05
aniridia B-Disease 1 1.0
phenotypes O 0 8.411738963332027e-05
. O 0 8.638972417429613e-07

Strikingly O 0 8.24698872747831e-06
, O 0 2.342509297648121e-08
all O 0 9.828295954861233e-10
four O 0 5.023307880769323e-10
mutations O 0 7.021448422683818e-10
are O 0 1.1588599524436916e-10
located O 0 3.3432925317100626e-09
within O 0 2.0187944649308065e-09
the O 0 5.687446513746863e-09
PAX6 O 0 0.00020652858074754477
paired O 0 2.77312111052197e-08
domain O 0 3.2969822427730833e-09
and O 0 9.284549518095986e-11
affect O 0 1.3831273626419005e-10
amino O 0 2.0735102523872229e-10
acids O 0 1.8731817486017377e-10
which O 0 1.8488944750205683e-11
are O 0 6.7829431307786514e-12
highly O 0 5.494100729919182e-10
conserved O 0 8.752278346513265e-10
in O 0 4.835696079674712e-11
all O 0 2.5332826114610185e-11
known O 0 7.24449888966916e-10
paired O 0 4.048572144199625e-09
domain O 0 6.825104925667347e-09
proteins O 0 8.659803429900137e-10
. O 0 1.1302599745022235e-08

Our O 0 1.9611882180470275e-06
results O 0 4.259320718347226e-08
support O 0 1.5210936510356987e-08
the O 0 2.422913647492919e-09
hypothesis O 0 4.1317944621255265e-09
that O 0 7.211253295891229e-12
the O 0 5.902463240392564e-11
under O 0 1.6470540487034668e-09
- O 0 2.9614675156608428e-09
representation O 0 8.596149903006278e-10
of O 0 2.2179775793773615e-09
missense O 0 1.2711423380551423e-07
mutations O 0 1.1131842114764368e-09
is O 0 4.8998981955206133e-11
caused O 0 7.30163818296603e-10
by O 0 1.2341083710509793e-10
ascertainment O 0 8.836964116198942e-05
bias O 0 1.0071686773471811e-07
and O 0 3.630803990795073e-10
suggest O 0 1.0315531762117303e-10
that O 0 7.1396348035046575e-12
a O 0 7.605659851916968e-11
substantial O 0 1.79059733707021e-09
burden O 0 2.543100379170937e-07
of O 0 1.87498926607077e-07
PAX6 B-Disease 1 1.0
- I-Disease 0 0.030121516436338425
related I-Disease 0 2.523122475395212e-06
disease I-Disease 1 0.9097962379455566
remains O 0 4.810002565136529e-07
to O 0 5.888365350870117e-10
be O 0 5.511849310302352e-10
uncovered O 0 1.283859063505588e-07
. O 0 3.618196187105127e-09
. O 0 2.316587632833489e-08

The O 0 2.895627915222576e-07
chromosomal O 0 6.957915275052073e-07
order O 0 9.972211501008132e-08
of O 0 1.993484630702369e-07
genes O 0 2.427161049922688e-08
controlling O 0 3.586680463740777e-08
the O 0 4.239220885438044e-08
major O 0 8.427520015175105e-07
histocompatibility O 1 0.9997187256813049
complex O 0 4.394754341774387e-06
, O 0 9.082997687315242e-10
properdin O 0 1.1454369541752385e-07
factor O 0 1.9928672045921303e-09
B O 0 6.430921928313182e-08
, O 0 1.9182029575848247e-10
and O 0 6.785150219457137e-10
deficiency B-Disease 0 0.0019450095715001225
of I-Disease 0 9.906784725899342e-06
the I-Disease 0 2.888707513193367e-07
second I-Disease 0 1.3492581274476834e-07
component I-Disease 0 3.571873108398904e-08
of I-Disease 0 5.6500466527609206e-09
complement I-Disease 0 7.245652255960522e-08
. O 0 2.4126640596477955e-07

The O 0 1.979420432007828e-07
relationship O 0 5.5503193152617314e-08
of O 0 4.078942339447167e-08
the O 0 9.63199298098516e-09
genes O 0 1.1062397664574064e-09
coding O 0 3.5911298823521065e-08
for O 0 1.335418664538679e-09
HLA O 0 1.8151369829411124e-07
to O 0 3.4995775721746725e-10
those O 0 4.3217149303664826e-10
coding O 0 2.6870630165376497e-08
for O 0 3.10253628343915e-10
properdin O 0 9.523049726567479e-08
Factor O 0 2.3098005730304294e-09
B O 0 6.058601087488569e-08
allotypes O 0 1.9354841640506493e-07
and O 0 2.1183543807978822e-10
for O 0 3.446163077125419e-10
deficiency B-Disease 0 6.010609922668664e-06
of I-Disease 0 2.969366050820099e-07
the I-Disease 0 2.9553412161931192e-08
second I-Disease 0 1.4221159361227365e-08
component I-Disease 0 6.854118161925271e-09
of I-Disease 0 2.849939173543703e-09
complement I-Disease 0 5.163763194815374e-09
( O 0 2.0338675188469324e-09
C2 O 0 4.700156353010243e-08
) O 0 1.1974879421394746e-10
was O 0 6.10146877466633e-10
studied O 0 2.937573517769465e-10
in O 0 7.850004500598029e-12
families O 0 2.249073496884968e-11
of O 0 2.424660194844108e-10
patients O 0 2.6247410911395264e-09
with O 0 1.2389823389469257e-08
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 0 8.653058102936484e-06

Patients O 0 2.840319211827591e-06
were O 0 2.2507592234433105e-08
selected O 0 1.89954096896372e-09
because O 0 3.219881583582662e-10
they O 0 1.2159977191839033e-10
were O 0 6.237648175755339e-10
heterozygous O 0 7.66772811910954e-10
or O 0 3.844032592237312e-10
homozygous O 0 2.661924725089193e-08
for O 0 3.709006080043764e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 4.3187545088585466e-05

12 O 0 1.5260037571351859e-06
families O 0 1.322164155936889e-08
with O 0 3.607542709005429e-09
15 O 0 4.1356759794553e-08
matings O 0 1.3342872762223124e-06
informative O 0 7.855876305029597e-08
for O 0 4.8449912526393746e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 7.588903372379718e-07
found O 0 6.190600032596194e-08
. O 0 4.5478813603949675e-08

Of O 0 6.680766091449186e-06
57 O 0 1.9862102362822043e-06
informative O 0 1.990031393006575e-07
meioses O 0 4.556783096631989e-06
, O 0 1.4560590511081273e-09
two O 0 4.860814528662161e-10
crossovers O 0 1.664646376298151e-08
were O 0 2.5365198830229474e-09
noted O 0 5.014886284016029e-09
between O 0 1.0290780672050914e-08
the O 0 7.035033604552154e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
gene O 0 8.877872326173986e-10
and O 0 1.5564807775980682e-10
the O 0 2.2389309850545658e-10
HLA O 0 1.6638908917343542e-08
- O 0 8.55305959390762e-09
B O 0 1.5186062185534865e-08
gene O 0 1.1488507367651835e-10
, O 0 6.482015878911396e-12
with O 0 3.729599962198904e-12
a O 0 1.8365624299132577e-10
recombinant O 0 4.996297153780915e-09
fraction O 0 7.296811155299565e-09
of O 0 2.4922901076251947e-08
0 O 0 1.440824348719616e-07
. O 0 8.819417729455381e-08

035 O 0 0.061894338577985764
. O 0 5.206067726248875e-05

A O 0 6.869400749565102e-06
lod O 0 0.00013877329183742404
score O 0 3.458632420461072e-07
of O 0 9.778455023479182e-08
13 O 0 3.624863609275053e-08
was O 0 2.0177676418597912e-08
calculated O 0 7.640456600732648e-10
for O 0 1.5413841036870934e-10
linkage O 0 4.803094384442375e-07
between O 0 4.877852575191355e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 6.317853973314413e-08
HLA O 0 2.950926045741653e-07
- O 0 2.0322591609556184e-08
B O 0 4.709326972829331e-08
at O 0 3.092923139824677e-10
a O 0 2.2061319784882905e-11
maximum O 0 7.549538078022167e-11
likelihood O 0 1.3254250474936669e-10
value O 0 1.1235784524998849e-10
of O 0 4.838853762123563e-10
the O 0 2.1611860911985303e-10
recombinant O 0 1.5901618910518778e-09
fraction O 0 1.6312843298393886e-09
of O 0 5.880713693784401e-09
0 O 0 7.614742258965634e-08
. O 0 4.163408462432017e-08

04 O 0 0.009610595181584358
. O 0 2.0648651116061956e-05

18 O 0 1.1739186902559595e-06
families O 0 2.038746771404476e-08
with O 0 2.9260833755984095e-09
21 O 0 4.0117541288964276e-08
informative O 0 1.1872459459993934e-08
matings O 0 1.0920895476829173e-07
for O 0 2.507551943864428e-09
both O 0 2.6896460614267426e-09
properdin O 0 1.7314920341959805e-06
Factor O 0 5.0359378889197615e-08
B O 0 1.9561525732569862e-07
allotype O 0 5.757740382250631e-07
and O 0 6.356530413142991e-09
HLA O 0 3.8594282614212716e-07
- O 0 1.6046968198679679e-07
B O 0 2.5704090944600466e-07
were O 0 2.706375790140214e-09
found O 0 2.1222135160314792e-09
. O 0 1.707222807567632e-08

Of O 0 1.2838243492296897e-05
72 O 0 4.7423309297300875e-06
informative O 0 3.3739024729584344e-07
meioses O 0 6.1980358623259235e-06
, O 0 3.922611124806963e-09
three O 0 9.5179930603706e-10
recombinants O 0 1.0845735687325941e-06
were O 0 1.888659229010159e-09
found O 0 4.4277809196913154e-10
, O 0 5.2521632876167956e-11
giving O 0 7.861425399546818e-11
a O 0 4.1220790669704854e-10
recombinant O 0 6.718881895295681e-09
fraction O 0 2.6094728156067504e-08
of O 0 1.7037835675637325e-07
0 O 0 4.931394528284727e-07
. O 0 2.727156811488385e-07

042 O 0 0.008119015954434872
. O 0 3.615286186686717e-05

A O 0 1.881092248368077e-05
lod O 0 0.00031659528031013906
score O 0 1.2298187357373536e-06
of O 0 2.479796421539504e-07
16 O 0 4.8844906785916464e-08
between O 0 1.168083851865731e-08
HLA O 0 7.358546554314671e-07
- O 0 5.7583672941063924e-08
B O 0 3.989609709265096e-08
and O 0 3.3761193840575743e-10
Factor O 0 1.0267092731552907e-09
B O 0 2.8288194897641006e-08
allotypes O 0 1.4851185881070705e-07
was O 0 3.762558264952531e-09
calculated O 0 2.2078043560025407e-10
at O 0 2.0021090341160175e-10
a O 0 4.179107754298528e-11
maximum O 0 3.3503319563088496e-10
likelihood O 0 5.28430021962123e-10
value O 0 5.116154166984188e-10
of O 0 4.024717781270226e-10
the O 0 1.5710957534942338e-10
recombinant O 0 1.0558349750056095e-09
fraction O 0 6.748906988818248e-10
of O 0 4.547957122014168e-09
0 O 0 3.909474699526072e-08
. O 0 2.6836108446559592e-08

04 O 0 0.008013904094696045
. O 0 4.07620427722577e-05

A O 0 6.3155557654681616e-06
crossover O 0 1.1253316642978461e-06
was O 0 1.3930949194218556e-07
shown O 0 1.2176670782793053e-09
to O 0 4.0186656780072383e-10
have O 0 2.0116018573101968e-10
occurred O 0 8.125351946830506e-09
between O 0 2.379940966523719e-10
genes O 0 4.683075108258272e-11
for O 0 2.8846196264975532e-11
Factor O 0 3.997176756254106e-10
B O 0 6.997733947855522e-09
and O 0 1.3317303926285717e-09
HLA O 0 1.7269657348606415e-07
- O 0 1.4604717080146656e-07
D O 0 1.9066533241129946e-07
, O 0 3.8501818400149546e-10
in O 0 2.2475181438164071e-10
which O 0 1.82441936558142e-10
HLA O 0 5.6438242523881854e-08
- O 0 2.914827312849866e-08
D O 0 8.944353879769551e-08
segregared O 0 1.2406192695380014e-07
with O 0 3.8345129849126636e-10
HLA O 0 2.7983816153209773e-07
- O 0 3.378261226316681e-08
A O 0 2.0524845822933457e-08
and O 0 1.0890480517389278e-08
B O 0 2.1747071059508016e-06
. O 0 9.835787295742193e-08

These O 0 1.1107267106069685e-08
studies O 0 2.203169868764121e-09
suggest O 0 3.6385128243665577e-10
that O 0 1.4511806686878792e-11
the O 0 1.4828945016365225e-10
genes O 0 1.38692349271885e-10
for O 0 9.823943047937433e-11
Factor O 0 1.2988857989171265e-08
B O 0 0.024896133691072464
and O 0 2.8101188945584e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 1.7273034114140273e-09
located O 0 2.1581596509889778e-09
outside O 0 2.995415027129411e-10
those O 0 9.865698535893586e-12
for O 0 8.075685259401055e-11
HLA O 0 1.5358163807377423e-07
, O 0 6.085717346726582e-11
that O 0 1.6630889373980828e-11
the O 0 4.506696127393184e-10
order O 0 3.244010615688353e-09
of O 0 1.8545907920497484e-08
genese O 0 6.93488800607156e-07
is O 0 1.072797517487345e-09
HLA O 0 2.2086824813527528e-08
- O 0 5.175457395978356e-09
A O 0 1.387570502942026e-08
, O 0 3.205114784687879e-10
- O 0 1.5074258508107619e-09
B O 0 1.498019663870309e-08
, O 0 2.562925427440632e-10
- O 0 8.425339537154741e-09
D O 0 3.4167406681717694e-08
, O 0 1.7569615207158051e-10
Factor O 0 2.4998825232103172e-09
B O 0 1.0487684676263598e-06
allotype O 0 0.0001866340753622353
, O 0 6.042398581485031e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 5.068483965864345e-10
that O 0 2.0406615633405956e-11
the O 0 3.910574364329733e-10
genes O 0 8.490121383708527e-10
coding O 0 3.917700652777967e-08
for O 0 3.143447502296226e-09
C2 B-Disease 1 0.9999990463256836
deficiency I-Disease 1 1.0
and O 0 2.517953312519694e-08
Factor O 0 1.874305866067516e-08
B O 0 9.080893192958683e-08
allotypes O 0 1.5344913606440969e-07
are O 0 6.193154322708949e-11
approximately O 0 1.6673935843147802e-10
3 O 0 1.8321302253099248e-09
- O 0 7.084354436415197e-09
- O 0 2.827050415987742e-08
5 O 0 2.3756799194529776e-08
centimorgans O 0 5.796914024358557e-07
from O 0 2.2356037021609154e-09
the O 0 4.884646465086462e-09
HLA O 0 6.817678155357498e-08
- O 0 1.5812133824510965e-08
A O 0 1.6621493514890062e-08
and O 0 2.080888350519672e-09
HLA O 0 1.0054891674826649e-07
- O 0 3.277734705875446e-08
B O 0 3.9245811933597e-08
loci O 0 1.7579143696266897e-09
, O 0 2.6939356995159258e-11
and O 0 8.434202988794048e-12
that O 0 6.731057117931316e-12
the O 0 5.440884964791337e-10
apparent O 0 4.0869167605706025e-08
lack O 0 4.499219841136437e-08
of O 0 4.638825323866058e-09
recombinants O 0 3.9598006651431206e-08
between O 0 1.636110275038405e-10
the O 0 1.6233314692470913e-10
Factor O 0 6.479203840115133e-10
B O 0 9.737378547924891e-08
gene O 0 2.353023553780531e-08
and O 0 7.849974537066373e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 4.338731152131459e-09
suggests O 0 8.177802185427296e-11
that O 0 9.089465833646282e-13
these O 0 4.668589299872128e-12
two O 0 4.9350613873233584e-11
genes O 0 2.408692967303949e-10
lie O 0 9.58741619427883e-09
in O 0 5.152662740925962e-10
close O 0 1.542356109496268e-08
proximity O 0 2.2535132870871166e-07
to O 0 3.936724723985208e-09
one O 0 5.4530642223937775e-09
another O 0 5.7128143993168123e-08
. O 0 2.491050565822661e-07

Distribution O 0 4.984140673514048e-07
of O 0 4.6105216711112007e-07
emerin O 0 8.191518281819299e-05
and O 0 6.34008969768729e-08
lamins O 0 0.0015314812771975994
in O 0 9.077425922043858e-09
the O 0 2.086660444433619e-08
heart O 0 1.7432460026611807e-06
and O 0 3.2649793979544484e-09
implications O 0 2.55804444293517e-08
for O 0 6.802517660275953e-09
Emery B-Disease 1 0.9999160766601562
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.0026841366197913885

Emerin O 0 0.0003453665704000741
is O 0 1.0809507244857741e-07
a O 0 4.4465480186772766e-08
nuclear O 0 8.678154586050368e-07
membrane O 0 2.875088433995643e-08
protein O 0 1.219982448397161e-09
which O 0 4.220939917032318e-11
is O 0 9.051655952552196e-11
missing O 0 5.361318056174014e-09
or O 0 2.3366668600033336e-09
defective O 0 4.304692083678674e-06
in O 0 4.225440974892081e-08
Emery B-Disease 1 0.9999995231628418
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.7792284488677979
EDMD B-Disease 1 1.0
) O 0 4.45949240202026e-07
. O 0 1.5955318133364926e-07

It O 0 2.998773496187823e-08
is O 0 2.8857012335237187e-09
one O 0 8.134123929970372e-10
member O 0 6.791507911607653e-10
of O 0 2.8884379332794197e-09
a O 0 6.059419632720164e-09
family O 0 1.511953051647197e-08
of O 0 1.5963925292794556e-08
lamina O 1 0.999995231628418
- O 0 9.475166734773666e-05
associated O 0 1.2123468451363806e-08
proteins O 0 8.183559385699368e-11
which O 0 3.038159654411565e-11
includes O 0 2.59878091268817e-10
LAP1 O 0 7.781869499012828e-06
, O 0 1.7396158957794228e-09
LAP2 O 0 5.059253817307763e-05
and O 0 4.554730637096327e-08
lamin O 0 5.7435117923887447e-05
B O 0 7.1368144745065365e-06
receptor O 0 1.332186343461217e-07
( O 0 5.152469118030467e-09
LBR O 0 2.028290691669099e-05
) O 0 3.712368368269381e-08
. O 0 1.4226590394628147e-07

A O 0 9.15843338589184e-06
panel O 0 5.266883249532839e-07
of O 0 6.954200415520972e-08
16 O 0 2.1637415414943462e-08
monoclonal O 0 1.0542582629113895e-07
antibodies O 0 5.3882416750639095e-08
( O 0 3.614900734305593e-08
mAbs O 0 5.0054845814884175e-06
) O 0 2.1539814376581035e-09
has O 0 2.3913251934182256e-10
been O 0 2.6196131375222365e-10
mapped O 0 2.1187676058076477e-09
to O 0 1.3929919717714512e-10
six O 0 1.722203352150231e-10
specific O 0 1.8311512028912347e-10
sites O 0 1.4667347336683179e-09
throughout O 0 8.378573390643851e-10
the O 0 1.1863466875539075e-09
emerin O 0 2.6811756370648254e-08
molecule O 0 4.784614926478525e-10
using O 0 4.6391415708946226e-10
phage O 0 5.671197733647659e-09
- O 0 9.574697479308725e-09
displayed O 0 6.025980825441479e-10
peptide O 0 2.2915283004465437e-09
libraries O 0 7.530644996478486e-10
and O 0 1.8476087326746438e-10
has O 0 2.7111779835053973e-11
been O 0 1.8140607072059112e-11
used O 0 1.2764150847388578e-10
to O 0 4.434457523405655e-10
localize O 0 9.341026725451229e-07
emerin O 0 1.3224312169768382e-05
in O 0 1.3714120949970265e-09
human O 0 5.654963164403171e-09
and O 0 2.0045870741114413e-08
rabbit O 0 6.77423449815251e-05
heart O 0 6.281008973019198e-05
. O 0 7.197923537205497e-07

Several O 0 5.913458949180495e-07
mAbs O 0 1.4827857739874162e-05
against O 0 7.000005552981747e-08
different O 0 1.070316901774504e-08
emerin O 0 2.032372503890656e-05
epitopes O 0 1.5060290934343357e-06
did O 0 3.890118449589863e-09
not O 0 2.5627006072781455e-10
recognize O 0 6.471352342884984e-09
intercalated O 0 7.435708084813086e-07
discs O 0 7.997550142135879e-07
in O 0 8.536284457072441e-10
the O 0 3.1505242858997917e-09
heart O 0 2.8659894724114565e-07
, O 0 2.027402273840906e-10
though O 0 2.131351900525047e-10
they O 0 3.593529293577369e-11
recognized O 0 9.636416109515267e-10
cardiomyocyte O 0 1.3543724719511374e-07
nuclei O 0 4.912501339049413e-08
strongly O 0 9.384045540627994e-09
, O 0 6.721082579375093e-10
both O 0 1.244652048093542e-09
at O 0 1.5862338997862935e-08
the O 0 8.171386234323563e-09
rim O 0 1.5921345948299859e-06
and O 0 5.53272894165957e-09
in O 0 3.718546137676526e-09
intranuclear O 0 4.271112265996635e-05
spots O 0 3.2081734957500885e-07
or O 0 6.048532696922848e-08
channels O 0 7.058762889755599e-07
. O 0 9.927063615577936e-08

A O 0 3.043516699108295e-05
polyclonal O 0 0.0005780066712759435
rabbit O 0 6.85401537339203e-05
antiserum O 0 1.9420127500779927e-05
against O 0 6.108158459028346e-07
emerin O 0 0.0003446991613600403
did O 0 5.265089697559233e-08
recognize O 0 2.740322102567916e-08
both O 0 5.149108694979532e-09
nuclear O 0 5.15381827881356e-07
membrane O 0 8.417244679037594e-09
and O 0 2.090665973675243e-10
intercalated O 0 9.256356570119806e-09
discs O 0 1.9607222512263434e-08
but O 0 1.638436747386507e-10
, O 0 6.70405120306583e-11
after O 0 5.475636055685129e-10
affinity O 0 2.4325359504473454e-09
purification O 0 9.292163127838649e-08
against O 0 1.3435642820525118e-08
a O 0 1.0423650387281214e-08
pure O 0 5.130377758177929e-07
- O 0 2.0100740982798015e-07
emerin O 0 1.1601591722865123e-06
band O 0 4.3679857952838574e-08
on O 0 2.613401273166005e-09
a O 0 2.937780851919314e-10
western O 0 1.426935991588607e-08
blot O 0 1.3339220004127128e-06
, O 0 1.475030542152922e-09
it O 0 1.7446624700490077e-10
stained O 0 2.3132333808462135e-06
only O 0 2.4116362240533817e-09
the O 0 1.98473522061704e-08
nuclear O 0 2.663814711922896e-06
membrane O 0 1.1548517022674787e-06
. O 0 1.6326974616731604e-07

These O 0 2.6623206750286954e-08
results O 0 2.911852980957974e-09
would O 0 7.164278059690332e-10
not O 0 2.1028356833596717e-10
be O 0 6.248389028407075e-10
expected O 0 5.1955448832075035e-09
if O 0 2.9342879237503894e-09
immunostaining O 0 1.4951536286389455e-05
at O 0 1.2611751643021307e-08
intercalated O 0 8.297489983988271e-08
discs O 0 7.191021467178871e-08
were O 0 1.5203038827849014e-09
due O 0 1.201431043540424e-08
to O 0 7.525934875296514e-10
a O 0 1.2068046562063728e-09
product O 0 1.4849727003607427e-09
of O 0 8.079854119102947e-09
the O 0 3.0744327084164524e-09
emerin O 0 8.304377274725994e-08
gene O 0 1.3633602580220838e-10
and O 0 5.608008502022699e-11
, O 0 1.513075949255427e-11
therefore O 0 2.591643288862855e-10
, O 0 9.407100098890453e-11
cast O 0 6.306290489810351e-10
some O 0 1.8557416020525963e-11
doubt O 0 4.555405830330983e-09
upon O 0 1.0770128122672418e-09
the O 0 3.1676528067237086e-10
hypothesis O 0 5.995716811924012e-09
that O 0 3.76531333889929e-10
cardiac B-Disease 1 0.7677311301231384
defects I-Disease 1 0.9867044687271118
in O 0 1.4597949871131277e-07
EDMD B-Disease 1 1.0
are O 0 2.503274920684362e-09
caused O 0 1.4842315820828844e-08
by O 0 3.605181708721261e-10
absence O 0 5.698133875853273e-08
of O 0 5.75225215015962e-07
emerin O 0 0.00015117191651370376
from O 0 3.697168793337369e-08
intercalated O 0 2.3203833734442014e-06
discs O 0 7.733337042736821e-06
. O 0 9.238789289156557e-07

Although O 0 1.4655940958618885e-06
emerin O 0 0.00018402164278086275
was O 0 3.877649987771292e-07
abundant O 0 1.1927937748623663e-07
in O 0 1.2125080939284771e-09
the O 0 1.6203255404079187e-09
membranes O 0 2.1371100444866897e-08
of O 0 2.082318673046757e-08
cardiomyocyte O 0 7.177044381023734e-07
nuclei O 0 1.1112738462770722e-07
, O 0 7.141807145671919e-10
it O 0 1.8938169088489332e-10
was O 0 3.721499552966634e-08
absent O 0 4.289036326099449e-08
from O 0 1.091876145054016e-09
many O 0 3.1119595789164123e-10
non O 0 8.611846880057783e-08
- O 0 7.124955914150632e-07
myocyte O 0 5.50021868548356e-05
cells O 0 1.144525807461605e-08
in O 0 4.855328916697488e-10
the O 0 8.267455164912008e-09
heart O 0 3.3740805065463064e-06
. O 0 2.7620393439065083e-07

This O 0 7.679147984163137e-09
distribution O 0 1.9456640742987474e-08
of O 0 2.1953937334728835e-08
emerin O 0 3.305357040517265e-06
was O 0 9.198031669654938e-09
similar O 0 1.0862339500095075e-10
to O 0 4.8990759365930003e-11
that O 0 2.1322818510860486e-11
of O 0 5.263510516329006e-09
lamin O 0 6.364215551002417e-06
A O 0 9.227608899209372e-08
, O 0 2.2886749440065302e-10
a O 0 2.428293122136438e-10
candidate O 0 5.921613199788567e-10
gene O 0 1.846280767159314e-10
for O 0 3.9613357732948273e-11
an O 0 4.2356503721086014e-11
autosomal O 0 6.727909340753513e-09
form O 0 2.295257104378834e-07
of O 1 0.9988534450531006
EDMD B-Disease 1 1.0
. O 0 9.290961315855384e-05

In O 0 1.3842326040958142e-07
contrast O 0 2.9205938290033373e-07
, O 0 9.013387369805059e-08
lamin O 0 0.0018530391389504075
B1 O 0 0.02410467155277729
was O 0 1.5037156799735385e-06
absent O 0 2.515208450404316e-07
from O 0 5.130051938806446e-09
cardiomyocyte O 0 3.5348148230696097e-07
nuclei O 0 1.4932165015579812e-07
, O 0 1.0049246990107008e-09
showing O 0 4.438834633191391e-09
that O 0 3.384786895210823e-09
lamin O 0 0.2747354805469513
B1 O 0 0.000534590391907841
is O 0 1.0282829032703944e-09
not O 0 1.1042491226964657e-10
essential O 0 1.5059716806931078e-09
for O 0 1.8383181088488243e-10
localization O 0 5.708054118258588e-07
of O 0 1.522452031110788e-08
emerin O 0 9.366557378598372e-07
to O 0 1.3536777254685717e-09
the O 0 6.172157895889541e-09
nuclear O 0 4.70395025331527e-06
lamina O 1 0.9953835606575012
. O 0 1.79205926542636e-06

Lamin O 1 0.9991185069084167
B1 O 1 0.9106655120849609
is O 0 6.123415374759134e-08
also O 0 7.952492886431628e-09
almost O 0 1.5565170263798223e-09
completely O 0 2.971030532705754e-08
absent O 0 4.0078998608805705e-07
from O 0 1.75210068675824e-08
skeletal O 0 1.0012260645453352e-05
muscle O 0 8.825094823805557e-07
nuclei O 0 0.00017714027490001172
. O 0 3.5622160794446245e-06

In O 0 1.8200316844740883e-06
EDMD B-Disease 1 1.0
, O 0 1.1884988104782224e-08
the O 0 2.4054438441112325e-09
additional O 0 7.465031925946164e-10
absence O 0 1.0676809125698128e-07
of O 0 5.53933034552756e-07
lamin O 1 0.9953846335411072
B1 O 1 0.9983106851577759
from O 0 2.478018359397538e-07
heart O 1 0.940056562423706
and O 0 6.340766844914469e-07
skeletal O 1 0.9919748902320862
muscle O 0 2.5464935333729954e-06
nuclei O 0 0.0002061366685666144
which O 0 7.327801032630532e-09
already O 0 5.062708918757153e-09
lack O 0 1.5898480398846004e-07
emerin O 0 1.304227680520853e-06
may O 0 9.275863410707075e-10
offer O 0 8.744002188976197e-10
an O 0 1.0922583150441145e-11
alternative O 0 8.191637368426541e-10
explanation O 0 9.562173275412533e-10
of O 0 8.390887984432993e-10
why O 0 9.482870044763558e-11
these O 0 4.240290063517449e-11
tissues O 0 6.741345703886736e-09
are O 0 3.439975040930854e-11
particularly O 0 5.272721703697414e-10
affected O 0 5.776853995165254e-10
. O 0 2.667330800676382e-09
. O 0 4.332927616701454e-08

Genetic O 0 3.218683332306682e-06
mapping O 0 6.986927019170253e-07
of O 0 3.171274727264972e-07
the O 0 4.1249941773457977e-07
copper B-Disease 0 0.001391656813211739
toxicosis I-Disease 1 0.9999915361404419
locus O 0 1.779721242201049e-05
in O 0 6.958287457337065e-08
Bedlington O 0 5.0629743782337755e-05
terriers O 0 3.7734992019977653e-06
to O 0 1.283885531222495e-08
dog O 0 8.402250983863269e-08
chromosome O 0 5.381890932909528e-09
10 O 0 1.9490877800620865e-09
, O 0 1.8363206788496456e-10
in O 0 2.691102063412387e-10
a O 0 7.178424965559316e-09
region O 0 1.2756952116887987e-07
syntenic O 0 8.916710066841915e-05
to O 0 5.210341047501288e-09
human O 0 1.7092526505280148e-08
chromosome O 0 3.958411198823342e-08
region O 0 5.666767677325879e-08
2p13 O 0 1.5063024875416886e-05
- O 0 3.5098537409794517e-06
p16 O 0 1.2675751577262417e-06
. O 0 1.3877273374873766e-07

Abnormal O 0 0.006551571190357208
hepatic B-Disease 1 1.0
copper I-Disease 0 0.10959504544734955
accumulation I-Disease 0 1.0904627743002493e-05
is O 0 3.299133854994807e-09
recognized O 0 5.441656014681939e-09
as O 0 2.046455893633947e-09
an O 0 7.952019043244718e-10
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 1.9362553302926244e-06
man O 0 5.3858852879784536e-06
, O 0 4.287610710917988e-09
mouse O 0 1.1151993248859071e-06
, O 0 1.2189736331436052e-08
rat O 0 0.013459540903568268
and O 0 2.1516814285860164e-07
dog O 0 0.00031963601941242814
. O 0 2.005173882935196e-06

The O 0 6.00419923557638e-07
major O 0 6.924922217876883e-07
cause O 0 5.146292551216902e-06
of O 0 2.0443234461708926e-05
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999790191650391
accumulation I-Disease 0 0.00012418899859767407
in O 0 2.345281124860321e-08
man O 0 2.1933767868631548e-07
is O 0 4.6565878930593385e-10
a O 0 3.807810511347043e-09
dysfunctional O 0 5.701872964891663e-07
ATP7B O 0 0.13023538887500763
gene O 0 2.9821126901197204e-08
, O 0 5.751567000444879e-10
causing O 0 2.7133499003184625e-08
Wilson B-Disease 0 3.084293712163344e-05
disease I-Disease 0 0.021251486614346504
( O 0 3.809869326687476e-07
WD B-Disease 1 1.0
) O 0 1.866436605268973e-07
. O 0 1.7518911477054644e-07

Mutations O 0 5.254556185718684e-07
in O 0 2.120952125039821e-08
the O 0 4.303007017369964e-08
ATP7B O 0 0.0328717902302742
genes O 0 2.184350300638016e-08
have O 0 1.9242649695883074e-09
also O 0 1.0283280893474966e-09
been O 0 1.5649593843036769e-09
demonstrated O 0 2.0856020910287043e-08
in O 0 7.0860846079767725e-09
mouse O 0 2.6335089842177695e-06
and O 0 1.3126188491696666e-07
rat O 0 0.00016104349924717098
. O 0 1.9652718208362785e-07

The O 0 4.41933298134245e-06
ATP7B O 0 0.00877315178513527
gene O 0 1.4138215931325249e-07
has O 0 3.122252678622317e-09
been O 0 9.804798084545041e-10
excluded O 0 2.1448596232431782e-09
in O 0 1.382249176229422e-10
the O 0 7.849892402767011e-10
much O 0 2.8651401251522657e-09
rarer O 0 0.0007703423616476357
human O 0 1.685164193077071e-06
copper B-Disease 1 0.9955390095710754
overload I-Disease 1 0.9037846922874451
disease O 0 0.1616208851337433
non B-Disease 0 2.1502160052477848e-06
- I-Disease 0 6.457619292632444e-07
Indian I-Disease 0 6.789790774064386e-08
childhood I-Disease 0 7.051778538880171e-06
cirrhosis I-Disease 1 0.9999998807907104
, O 0 1.266366567165278e-09
indicating O 0 8.88475426563673e-09
genetic O 0 1.0220970381169536e-07
heterogeneity O 0 2.6584978058963316e-06
. O 0 2.007802066827935e-07

By O 0 1.7012158792795162e-08
investigating O 0 3.689229899350721e-08
the O 0 1.950896333369201e-08
common O 0 2.049576096396777e-06
autosomal O 1 0.9712516069412231
recessive O 1 0.9998315572738647
copper B-Disease 1 1.0
toxicosis I-Disease 1 1.0
( O 0 7.804646884324029e-07
CT B-Disease 0 0.005347324535250664
) O 0 6.7386975999284005e-09
in O 0 3.2161144858378066e-09
Bedlington O 0 0.00010172087058890611
terriers O 0 3.0329995297506684e-06
, O 0 4.6421333443902313e-10
we O 0 1.1540360334016952e-10
have O 0 1.774199016868483e-11
identified O 0 2.2348435602115302e-10
a O 0 3.160718631267656e-10
new O 0 4.46055109515342e-10
locus O 0 3.39855299458236e-09
involved O 0 1.0528180410807053e-10
in O 0 5.172001160680395e-10
progressive O 1 0.9999980926513672
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 3.2712696338421665e-06

We O 0 1.354270295905735e-07
examined O 0 1.2228245793721726e-07
whether O 0 1.2074154120966796e-08
the O 0 3.5520887564644e-08
WD B-Disease 0 0.0008488499443046749
gene O 0 1.6496746013672237e-07
ATP7B O 0 0.0038831448182463646
was O 0 1.754767140482727e-07
also O 0 1.4863895669847693e-09
causative O 0 4.338054893082699e-08
for O 0 1.6959698090346365e-09
CT B-Disease 0 1.1089465260738507e-05
by O 0 1.4263911163325815e-09
investigating O 0 1.1929047971648288e-08
the O 0 1.5356867777427397e-08
chromosomal O 0 9.198173529512133e-07
co O 0 8.799354873190168e-06
- O 0 2.796497938106768e-06
localization O 0 0.0019112933659926057
of O 0 4.585256192513043e-07
ATP7B O 0 0.015851475298404694
and O 0 7.969286563991318e-09
C04107 O 0 7.545733637925878e-08
, O 0 5.256994145552696e-11
using O 0 2.2760722473424977e-10
fluorescence O 0 1.9176269461240736e-08
in O 0 1.4690866301236838e-09
situ O 0 2.722334215832234e-07
hybridization O 0 5.042242534614161e-08
( O 0 1.6885716158654418e-09
FISH O 0 1.8047717276203912e-07
) O 0 3.236298118380887e-09
. O 0 3.959000238751287e-08

C04107 O 0 7.377346628345549e-05
is O 0 2.7263187263315558e-08
an O 0 1.4406141835010544e-09
anonymous O 0 1.9215921298609828e-08
microsatellite O 0 2.907192993006902e-06
marker O 0 6.217805434971524e-07
closely O 0 1.3791246367134136e-08
linked O 0 4.779019491252257e-07
to O 0 2.906633937982406e-07
CT B-Disease 1 1.0
. O 0 5.2883293392369524e-05

However O 0 6.277778993535321e-06
, O 0 6.941921810721396e-07
BAC O 0 0.005821981932967901
clones O 0 2.1795200154883787e-05
containing O 0 1.1449651537986938e-07
ATP7B O 0 0.03218460828065872
and O 0 2.439627522221599e-08
C04107 O 0 6.63161983993632e-07
mapped O 0 5.510089451377098e-08
to O 0 1.5966719058013723e-09
the O 0 2.1904080327317388e-08
canine O 0 2.3289985620067455e-06
chromosome O 0 8.889453795291047e-08
regions O 0 1.1751768447254562e-08
CFA22q11 O 0 8.248593076132238e-06
and O 0 3.6922760404678456e-09
CFA10q26 O 0 4.420529876369983e-06
, O 0 5.342736808522375e-10
respectively O 0 9.955080093604352e-10
, O 0 1.469657590069673e-10
demonstrating O 0 3.3130320709062744e-09
that O 0 6.879182778973814e-10
WD B-Disease 0 0.00017249620577786118
cannot O 0 1.2091715184681107e-08
be O 0 4.766870231875941e-10
homologous O 0 1.8657411171574267e-09
to O 0 5.260209157142981e-09
CT B-Disease 0 0.00037126222741790116
. O 0 5.529012128135946e-07

The O 0 4.959838406648487e-06
copper O 0 2.24007399083348e-05
transport O 0 1.8266307506564772e-06
genes O 0 2.514062202862988e-07
CTR1 O 0 0.0019130426226183772
and O 0 6.624780723996082e-08
CTR2 O 1 0.9844251871109009
were O 0 2.2098836538475553e-08
also O 0 1.5908535599962192e-09
excluded O 0 4.2064294270005576e-09
as O 0 1.0612742906701556e-09
candidate O 0 1.3346751481790875e-09
genes O 0 4.990609037136551e-10
for O 0 3.653067293107881e-10
CT B-Disease 0 0.00036928110057488084
since O 0 1.1489878382064944e-08
they O 0 3.134549009242704e-10
both O 0 8.4872392447366e-10
mapped O 0 4.69250664991705e-08
to O 0 1.0041089737455877e-08
canine O 0 4.557251941150753e-06
chromosome O 0 5.06192009197548e-07
region O 0 4.642731425974489e-07
CFA11q22 O 0 0.0007155050989240408
. O 0 1.1024371815437917e-06

2 O 0 0.00014179143181536347
- O 0 4.477520997170359e-05
22 O 0 3.0925777991797077e-06
. O 0 1.257543999599875e-06

5 O 0 9.189052070723847e-05
. O 0 6.488648523372831e-06

A O 0 1.9580184016376734e-06
transcribed O 0 1.2454036379949684e-07
sequence O 0 2.549567446052947e-09
identified O 0 3.277645710397792e-09
from O 0 1.1153393764118391e-09
the O 0 5.131754576837011e-09
C04107 O 0 5.708733965548163e-07
- O 0 1.1544273803565375e-07
containing O 0 1.1661916765604019e-08
BAC O 0 0.002758238697424531
was O 0 3.287815530939042e-08
found O 0 2.3346966027126825e-10
to O 0 3.219229049999939e-11
be O 0 4.321234342574698e-11
homologous O 0 2.764320439219148e-10
to O 0 2.3386231839950256e-10
a O 0 1.4141844362214329e-09
gene O 0 2.3559862949440458e-09
expressed O 0 3.1364939534483938e-09
from O 0 4.201193615216425e-09
human O 0 4.33982361158769e-09
chromosome O 0 1.5144092202490356e-08
2p13 O 0 3.3189539294653514e-07
- O 0 5.287108351126335e-08
p16 O 0 9.53445944418263e-09
, O 0 1.9294311981443713e-10
a O 0 6.829437571020947e-10
region O 0 6.064634128222224e-09
devoid O 0 2.147597797375056e-07
of O 0 2.0382364684934373e-09
any O 0 1.112957170867901e-09
positional O 0 8.170389946826617e-07
candidate O 0 1.99465219452577e-07
genes O 0 3.823839023198161e-08
. O 0 8.890030045449748e-08

Molecular O 0 2.98898640949119e-07
analysis O 0 1.9468815892764724e-08
of O 0 4.1258587657466705e-08
the O 0 1.4347632415478984e-08
APC B-Disease 0 6.017900489041494e-08
gene O 0 2.165829515732298e-09
in O 0 3.651987323660677e-10
205 O 0 2.944895882706078e-09
families O 0 3.901946821205371e-10
: O 0 1.9485292546139732e-10
extended O 0 3.4923264280450894e-08
genotype O 0 3.5449461393000092e-06
- O 0 5.609107347481768e-07
phenotype O 0 5.577721040594952e-08
correlations O 0 1.2992450670878952e-08
in O 0 4.1544881423938307e-10
FAP B-Disease 0 8.446792065797126e-08
and O 0 1.0094655666925689e-10
evidence O 0 6.310357236749553e-10
for O 0 9.813604789910002e-11
the O 0 2.157582307260597e-10
role O 0 8.461377709600981e-10
of O 0 9.112844923109265e-10
APC B-Disease 0 7.45398054391444e-09
amino O 0 9.324698790891262e-10
acid O 0 1.518032033409611e-09
changes O 0 1.1688389145447786e-09
in O 0 2.105997225498868e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 0.9999979734420776
. O 0 2.826495119734318e-06

BACKGROUND O 0 2.8668733648373745e-05
/ O 0 6.175214366521686e-06
AIMS O 0 2.8558282849644456e-08
The O 0 1.1582949044353086e-09
development O 0 1.301790053531704e-08
of O 0 9.09919890546007e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 3.48186901533154e-09
a O 0 9.501917308529784e-11
variable O 0 5.498679636617432e-11
range O 0 5.802761049444882e-10
of O 0 2.5374875534112107e-09
extracolonic O 0 1.1416508414185955e-06
manifestations O 0 1.2274283562874189e-06
in O 0 3.926168545831388e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.9028203723792103e-07
FAP B-Disease 0 1.5478677823921316e-06
) O 0 1.787198028457837e-10
is O 0 2.23003941701716e-11
the O 0 7.951393710126098e-11
result O 0 6.2920413324008e-10
of O 0 1.0193145882908539e-08
the O 0 1.0544026096681591e-08
dominant O 0 8.816135732558905e-07
inheritance O 0 1.3058107697361265e-06
of O 0 8.73783903898584e-07
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999997615814209
( O 0 3.471314258263192e-08
APC B-Disease 0 8.339409163227174e-08
) O 0 8.863592082519745e-10
gene O 0 8.187642563939335e-09
mutations O 0 2.7320655959783835e-08
. O 0 1.5604661030010902e-07

In O 0 3.5580494994746914e-08
this O 0 3.612863896940155e-10
study O 0 1.1286216405892446e-10
, O 0 1.7237570745787245e-11
direct O 0 8.081694341521839e-11
mutation O 0 8.153536179555942e-11
analysis O 0 1.0084590107428681e-10
of O 0 1.5890916360561391e-09
the O 0 2.617257077730528e-09
APC B-Disease 0 1.8084771014059697e-08
gene O 0 1.6798245017213276e-09
was O 0 1.0183701881771867e-08
performed O 0 3.771696288623616e-10
to O 0 9.85652531815262e-11
determine O 0 3.1134452793679657e-09
genotype O 0 6.552672289217298e-07
- O 0 1.010412802315841e-07
phenotype O 0 1.3327779768701475e-08
correlations O 0 1.9932360206809108e-09
for O 0 1.7202007873695635e-10
nine O 0 1.1444030167950814e-09
extracolonic O 0 1.496135695333578e-07
manifestations O 0 8.929319506023603e-08
and O 0 1.0213380141621542e-09
to O 0 1.2828633988437588e-10
investigate O 0 7.729502593534221e-10
the O 0 1.8867214734985538e-10
incidence O 0 7.799689782927999e-09
of O 0 4.8727173407314694e-09
APC B-Disease 0 3.330291420411413e-08
mutations O 0 4.5921130786830133e-10
in O 0 3.9332326284835517e-10
non O 0 4.22964467361453e-06
- O 1 0.9978544116020203
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.274658229202032e-05

METHODS O 0 7.634004759893287e-06
The O 0 4.624807559139299e-07
APC B-Disease 0 2.2870632676585956e-07
gene O 0 7.62846230628611e-09
was O 0 2.3205014798577395e-08
analysed O 0 1.0733835154042026e-08
in O 0 2.754966810236681e-10
190 O 0 1.720063980137354e-09
unrelated O 0 1.4454756502857435e-08
FAP B-Disease 0 8.394432029490417e-07
and O 0 6.835449095632384e-09
15 O 0 5.246183931717496e-08
non O 0 0.00011048446322092786
- O 1 0.9999998807907104
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.158659506472759e-05
using O 0 2.2942190369690252e-08
denaturing O 0 2.6410289137857035e-06
gradient O 0 1.0235504532829509e-07
gel O 0 5.907120570469715e-09
electrophoresis O 0 1.8557256842299807e-09
, O 0 5.509303430129009e-11
the O 0 1.4703613326894072e-10
protein O 0 3.305317131108154e-10
truncation O 0 2.3402273896522274e-08
test O 0 5.1320583338565484e-09
, O 0 1.4599266240367115e-10
and O 0 1.6876822162004146e-10
direct O 0 3.901278855522605e-09
sequencing O 0 2.551257409777463e-07
. O 0 6.817015218985034e-08

RESULTS O 0 8.73239116572222e-07
Chain O 0 6.984848255342513e-07
terminating O 0 1.704178487216268e-07
signals O 0 2.480604521792884e-08
were O 0 4.984682111519589e-10
only O 0 2.100689934503297e-11
identified O 0 2.811501587096643e-10
in O 0 5.2090543684046864e-11
patients O 0 6.152783837976017e-10
belonging O 0 2.6937223562839563e-09
to O 0 8.249840810492515e-10
the O 0 2.1520440540712116e-08
FAP B-Disease 0 1.0203813872067258e-05
group O 0 2.122577891228161e-09
( O 0 1.277263184107369e-09
105 O 0 1.4662634839623934e-07
patients O 0 7.188073425368202e-08
) O 0 1.701494944938986e-08
. O 0 1.467547576794459e-07

Amino O 0 1.8317510352972022e-07
acid O 0 1.7037908861539108e-08
changes O 0 4.391061680930619e-10
were O 0 3.673392701131206e-10
identified O 0 4.2199602146020254e-10
in O 0 8.721112026988109e-11
four O 0 2.8556620956798895e-10
patients O 0 1.142061112346937e-09
, O 0 1.025569629220513e-10
three O 0 2.734466264531221e-10
of O 0 7.87088616505116e-09
whom O 0 5.8739907160543225e-08
belonged O 0 1.0148362434847513e-06
to O 0 2.121452791215006e-09
the O 0 1.1488189954889094e-08
non O 0 1.0366493086166884e-07
- O 0 1.350393574739428e-07
FAP O 0 9.478251286054729e-07
group O 0 1.569458230044063e-09
of O 0 0.0001312235981458798
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9471979737281799
. O 0 8.395040254072228e-07

Genotype O 0 0.0012971687829121947
- O 0 4.411041663843207e-05
phenotype O 0 7.233555265884206e-07
correlations O 0 4.4207979499333305e-08
identified O 0 3.1278495349340574e-09
significant O 0 9.51476231136894e-10
differences O 0 2.03261585340897e-08
in O 0 7.320896666662691e-10
the O 0 1.2949840089149234e-09
nature O 0 1.4697425498866323e-09
of O 0 1.1851434278398187e-09
certain O 0 1.4901819778145864e-09
extracolonic O 0 1.594579543962027e-06
manifestations O 0 3.0441654530477535e-07
in O 0 1.6838760386050922e-09
FAP B-Disease 0 2.3664705395276542e-07
patients O 0 1.1723420012543784e-09
belonging O 0 6.998744361830234e-10
to O 0 4.1464609523700346e-10
three O 0 1.6430503624320636e-09
mutation O 0 1.3448000046878406e-08
subgroups O 0 2.1275974404488807e-07
. O 0 1.0208695044866545e-07

CONCLUSIONS O 0 1.108902051782934e-05
Extended O 0 3.813020384768606e-06
genotype O 0 1.4675053535029292e-05
- O 0 1.9218471152271377e-06
phenotype O 0 7.446537608757353e-08
correlations O 0 1.916171754601237e-08
made O 0 2.3121191627950566e-09
in O 0 1.022339296552488e-10
this O 0 4.347059864850955e-11
study O 0 1.3673107090994563e-10
may O 0 4.0808603718467396e-10
have O 0 1.40290293271228e-10
the O 0 4.1838468800570183e-10
potential O 0 1.7816987885055369e-09
to O 0 1.177019592901729e-10
determine O 0 6.133977770161891e-10
the O 0 5.30652077834759e-10
most O 0 7.145196240232465e-11
appropriate O 0 1.3938431520088557e-09
surveillance O 0 9.386318389204007e-09
and O 0 1.2766829260435486e-10
prophylactic O 0 1.5263050556768576e-07
treatment O 0 5.595595098384365e-07
regimens O 0 7.202784786386474e-07
for O 0 1.7223741877181453e-10
those O 0 5.810289055441231e-11
patients O 0 1.3129500264774663e-10
with O 0 9.671189196702734e-12
mutations O 0 6.784344613874893e-11
associated O 0 4.714696966168219e-10
with O 0 2.1097576463624534e-10
life O 0 3.3763285500754137e-08
threatening O 0 5.63419746413274e-07
conditions O 0 2.658210178196896e-05
. O 0 8.127476576191839e-07

This O 0 1.0771079139715312e-08
study O 0 1.7810803942808207e-09
also O 0 1.241687586084339e-10
provided O 0 2.432033741062156e-10
evidence O 0 1.2426737416859623e-09
for O 0 1.8341783647457532e-10
the O 0 7.270550272941989e-10
pathological O 0 2.728092773907065e-08
nature O 0 8.591314326622523e-10
of O 0 1.295463292194654e-09
amino O 0 4.846686940673806e-10
acid O 0 4.25562168837601e-10
changes O 0 9.173196230394254e-11
in O 0 8.901843845388058e-11
APC O 0 2.255304609732889e-09
associated O 0 4.502709594067511e-10
with O 0 2.889718846155187e-11
both O 0 4.2948683498522655e-10
FAP B-Disease 0 2.734245470037422e-07
and O 0 2.986579650254839e-09
non O 0 7.421931513817981e-06
- O 1 0.9999254941940308
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 4.2042324821522925e-06
. O 0 5.2026947194860895e-09
. O 0 2.2215731476649125e-08

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.991678774356842
cancer B-Disease 1 0.9999954700469971
risk O 0 1.8382922917226097e-06
of O 0 1.0450185072841123e-06
the O 0 7.749333690298954e-07
APC O 0 8.75140176503919e-06
I1307K O 0 7.1596928137296345e-06
polymorphism O 0 3.422765530558536e-06
. O 0 2.4919864927142044e-07

Germ O 1 0.7572591304779053
- O 0 0.00017018901417031884
line O 0 1.3843938404534128e-06
and O 0 4.863487390593946e-09
somatic O 0 2.5095059186241997e-07
truncating O 0 1.2395842929890932e-07
mutations O 0 9.53823797722464e-10
of O 0 2.1445774045503185e-09
the O 0 2.9660294220690275e-09
APC B-Disease 0 1.2330390930515023e-08
gene O 0 3.1315730564251965e-10
are O 0 5.3565880030193025e-12
thought O 0 3.9107014848660526e-10
to O 0 4.375728113181765e-10
initiate O 0 7.041625167403254e-07
colorectal B-Disease 1 1.0
tumor I-Disease 0 2.5498187824268825e-05
formation O 0 8.368950688009136e-08
in O 0 1.0424644258932858e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 4.1600276290409965e-07
sporadic O 0 0.010385735891759396
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 6.248346551274153e-08
respectively O 0 3.8610406249972584e-07
. O 0 4.941685460835288e-07

Recently O 0 3.119711664112401e-06
, O 0 2.6797952301649275e-08
an O 0 3.1472631167872578e-09
isoleucine O 0 3.3512669688207097e-06
- O 0 1.9070466805715114e-05
- O 0 1.4093340723775327e-05
> O 0 9.88676674751332e-06
lysine O 0 9.150698474513774e-07
polymorphism O 0 5.674219494267163e-08
at O 0 2.080372540902431e-09
codon O 0 9.026971392600558e-10
1307 O 0 2.402337031526258e-07
( O 0 7.835053716931384e-10
I1307K O 0 4.064218117605378e-08
) O 0 1.2181171349379127e-10
of O 0 1.4645877843832977e-09
the O 0 5.717847528785569e-09
APC B-Disease 0 3.366464440546224e-08
gene O 0 3.1471250050429944e-09
has O 0 2.245054558924764e-10
been O 0 2.1414044149015155e-10
identified O 0 4.429706879083284e-10
in O 0 2.0728697924798922e-10
6 O 0 7.573891736001315e-09
% O 0 9.97661619983603e-10
- O 0 2.501405127475209e-08
7 O 0 1.2976896890393164e-08
% O 0 5.046048023871208e-10
of O 0 2.7036051175599596e-09
the O 0 5.433617999983653e-09
Ashkenazi O 0 6.616306791329407e-07
Jewish O 0 1.1817537171054937e-08
population O 0 2.0950650936324422e-10
. O 0 4.6514863072388835e-09

To O 0 9.166353009959494e-08
assess O 0 1.9695291086918587e-07
the O 0 1.5688932819557522e-08
risk O 0 9.306384107787835e-09
of O 0 3.0400870709712535e-09
this O 0 2.6262569896573495e-10
common O 0 8.308603582918295e-09
APC B-Disease 0 4.83411746188267e-08
allelic O 0 1.0441582531939275e-07
variant O 0 8.342875048583664e-07
in O 0 2.0660115396253786e-08
colorectal O 1 1.0
carcinogenesis O 1 0.9999998807907104
, O 0 3.5178782553657584e-08
we O 0 9.377403298316267e-10
have O 0 1.240842290028965e-10
analyzed O 0 3.1724478599670647e-10
a O 0 7.528400819412084e-11
large O 0 1.2973122576198648e-10
cohort O 0 1.433958818353176e-08
of O 0 7.012725511401641e-09
unselected O 0 1.921928378578741e-05
Ashkenazi O 0 3.4634588246262865e-06
Jewish O 0 2.5417319804432736e-08
subjects O 0 1.9198960643507235e-08
with O 0 1.0399635597124757e-09
adenomatous B-Disease 0 0.00010923128138529137
polyps I-Disease 0 3.802372157224454e-05
and O 0 3.0404931905536614e-09
. O 0 6.0941909296730046e-09
or O 1 0.9996542930603027
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 2.7279989822659445e-08
for O 0 7.763116260939285e-10
the O 0 4.116269280984852e-08
APC O 0 1.3156935665392666e-06
I1307K O 0 2.7545945613383083e-06
polymorphism O 0 6.522259923258389e-07
. O 0 1.279539247889261e-07

The O 0 5.951346793153789e-06
APC O 0 3.469237299214001e-06
I1307K O 0 1.7592186623005546e-06
allele O 0 2.956496913952833e-08
was O 0 1.1261714227828179e-08
identified O 0 1.419936057622806e-09
in O 0 2.938800869323188e-10
48 O 0 6.868225543854578e-09
( O 0 5.473193009919441e-10
10 O 0 1.102048785561749e-09
. O 0 1.9602938716722917e-10
1 O 0 1.092826806825542e-08
% O 0 3.1527647159634853e-10
) O 0 2.2346900718783758e-10
of O 0 3.948900317851667e-09
476 O 0 1.2943964975420386e-06
patients O 0 7.688412324569072e-07
. O 0 3.4545084304227203e-07

Compared O 0 1.3630643991291436e-07
with O 0 1.3944760901551945e-09
the O 0 1.7921862882630535e-09
frequency O 0 3.552453220478924e-09
in O 0 3.955039420966422e-11
two O 0 1.6213008366405823e-11
separate O 0 1.2857140699318315e-11
population O 0 1.0039307709805434e-12
control O 0 1.3652050323553766e-10
groups O 0 1.9883916561880266e-12
, O 0 3.445530319390322e-11
the O 0 3.9715206123780433e-10
APC O 0 4.9180417960315026e-08
I1307K O 0 7.944401403392476e-08
allele O 0 1.109722425063353e-09
is O 0 1.3688757592722478e-11
associated O 0 7.160913528814206e-11
with O 0 1.869233413887006e-11
an O 0 2.128421744407305e-11
estimated O 0 4.3454018161526164e-11
relative O 0 1.8479946461980035e-08
risk O 0 2.9102109166956325e-08
of O 0 5.242503107183438e-07
1 O 0 3.4072177186317276e-06
. O 0 3.340330749779241e-07

5 O 0 1.526711457700003e-05
- O 0 2.2166810595081188e-05
1 O 0 2.286819835717324e-06
. O 0 7.869033424867666e-07

7 O 0 1.2309556950640399e-05
for O 0 3.4691802852648834e-07
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999960660934448
( O 0 2.604851090381999e-07
both O 0 4.061521252651801e-08
P O 0 3.5412871511653066e-05
= O 0 7.486898567776734e-08
. O 0 2.3243185154342427e-09
01 O 0 7.384896605344693e-08
) O 0 2.1181454368246477e-09
. O 0 1.8377731336727265e-08

Furthermore O 0 1.0189198746957118e-06
, O 0 6.091552595677285e-09
compared O 0 2.394060283350541e-09
with O 0 3.532923398275045e-10
noncarriers O 0 1.0129681868420448e-05
, O 0 7.93924836983706e-09
APC O 0 2.990052792029019e-07
I1307K O 0 5.449042532745807e-07
carriers O 0 2.579325864005e-09
had O 0 9.754528296213039e-10
increased O 0 1.5296572342116121e-10
numbers O 0 7.572887456008814e-11
of O 0 5.713410633489957e-09
adenomas B-Disease 1 0.9999903440475464
and O 0 4.095069380127825e-05
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999628067016602
per O 0 2.7366187538291342e-08
patient O 0 1.830326112894909e-07
( O 0 1.5030130473547842e-09
P O 0 5.730307179874217e-07
= O 0 1.1736044136512191e-08
. O 0 3.051023877986836e-10
03 O 0 1.0434132668990515e-08
) O 0 4.1291116359420954e-11
, O 0 1.6413760975386715e-11
as O 0 8.840186915826109e-11
well O 0 1.3550359445613225e-10
as O 0 2.2247301223465854e-10
a O 0 5.179958129097884e-10
younger O 0 2.6439664679855923e-08
age O 0 6.475253666593517e-09
at O 0 1.5766810079753668e-08
diagnosis O 0 1.7031303514158935e-06
. O 0 1.5767628269713896e-07

We O 0 2.931275275841472e-07
conclude O 0 3.227023341878521e-07
that O 0 7.836473137068367e-10
the O 0 9.481577301073685e-09
APC O 0 1.9533281658823398e-07
I1307K O 0 7.382093940577761e-07
variant O 0 2.443885477987351e-06
leads O 0 5.309279771381625e-08
to O 0 2.1560613294724362e-09
increased O 0 6.312276923381432e-08
adenoma B-Disease 1 1.0
formation O 0 1.6877503412615624e-06
and O 0 1.610448308042578e-08
directly O 0 1.4590419983306901e-09
contributes O 0 9.240859466519424e-11
to O 0 5.376037462423433e-11
3 O 0 5.818698300963376e-10
% O 0 2.1025428620369269e-10
- O 0 3.5175813373200526e-09
4 O 0 1.4054747365932485e-09
% O 0 7.345719865714528e-11
of O 0 2.2770622887247072e-10
all O 0 2.6805235808780026e-10
Ashkenazi O 0 1.8032258594757877e-05
Jewish O 0 0.00012007818440906703
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.496601837265189e-06

The O 0 1.592379135217925e-07
estimated O 0 6.963250420710665e-09
relative O 0 6.464594548560854e-08
risk O 0 8.5168059271723e-09
for O 0 5.632075916750523e-10
carriers O 0 2.0016786006493703e-09
may O 0 7.837445137326426e-10
justify O 0 8.61327187351435e-09
specific O 0 6.707994160137787e-10
clinical O 0 3.498992207084939e-09
screening O 0 1.2640403168617809e-09
for O 0 4.517804880199705e-11
the O 0 3.301278417300324e-10
360 O 0 6.2627933949954695e-09
, O 0 9.476396750640603e-11
000 O 0 4.111314066967964e-10
Americans O 0 2.4974555756784866e-10
expected O 0 1.298456564491346e-09
to O 0 1.0797607252754915e-09
harbor O 0 8.79161063949141e-07
this O 0 6.24751569922033e-11
allele O 0 5.51547807425834e-10
, O 0 5.918900092272139e-11
and O 0 6.116730039140705e-11
genetic O 0 5.428922311701001e-10
testing O 0 3.7787098450259293e-10
in O 0 7.513453054164287e-11
the O 0 4.088144545111305e-10
setting O 0 3.5292342381865183e-09
of O 0 2.0582464621554664e-09
long O 0 5.937393243726774e-09
- O 0 1.6204809938358267e-08
term O 0 8.475454649214953e-08
- O 0 1.9490849823000644e-08
outcome O 0 1.7823922338067177e-09
studies O 0 6.761104870411927e-11
may O 0 3.0897968211762716e-11
impact O 0 4.813282550308884e-10
significantly O 0 3.1785500453906934e-08
on O 0 2.292420504090842e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 0.0021916369441896677
in O 0 7.112169880807429e-11
this O 0 1.1189669850419914e-11
population O 0 1.9454904701121656e-11
. O 0 3.2081621803570215e-09

Localization O 0 0.00025532295694574714
of O 0 8.022950623853831e-07
human O 0 1.8750037611425796e-07
BRCA1 O 0 1.8762843012609665e-07
and O 0 8.270341744776033e-09
its O 0 5.174568773469446e-09
loss O 0 1.1357905549402858e-07
in O 0 1.0202598765829407e-08
high O 0 2.9794289275741903e-06
- O 0 7.638481065441738e-07
grade O 0 1.8032351363217458e-06
, O 0 4.1704404374343085e-09
non B-Disease 0 2.2300334876490524e-06
- I-Disease 1 0.8456626534461975
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 4.2041483538923785e-06

Although O 0 1.0294770191876523e-07
the O 0 1.57686734780782e-08
link O 0 7.292320702845245e-08
between O 0 8.401622508813489e-09
the O 0 2.591028014364838e-08
BRCA1 O 0 6.267839012252807e-07
tumour B-Disease 1 1.0
- O 0 1.1430901167841512e-06
suppressor O 0 2.7475530828269257e-07
gene O 0 2.1556336715633506e-09
and O 0 2.1943042938232793e-09
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 1.0248426551839884e-09
established O 0 8.06420707988309e-10
, O 0 9.43001839809332e-12
the O 0 2.187089918892493e-11
role O 0 4.648814111440913e-10
, O 0 1.768465582308032e-11
if O 0 1.2565679399778595e-11
any O 0 2.062336273978005e-10
, O 0 1.2762835233104397e-10
of O 0 3.0812603579732922e-09
BRCA1 O 0 1.088312995278784e-08
in O 0 1.1341854122548511e-09
non B-Disease 0 6.391598162736045e-06
- I-Disease 0 0.004103300627321005
familial I-Disease 0 0.07262720167636871
cancers I-Disease 1 0.9999985694885254
is O 0 7.4232922031569615e-09
unclear O 0 1.7722916823004198e-07
. O 0 7.857839534608502e-08

BRCA1 O 0 2.400171069893986e-06
mutations O 0 2.67366875306152e-08
are O 0 1.359529988587127e-10
rare O 0 8.994167188802749e-09
in O 0 2.90484525322654e-10
sporadic B-Disease 0 2.627367848617723e-06
cancers I-Disease 1 1.0
, O 0 9.497500563782069e-10
but O 0 4.474918213759338e-10
loss O 0 8.889436742265389e-08
of O 0 8.769085297899437e-07
BRCA1 O 0 7.558857362255367e-08
resulting O 0 1.6138647751517965e-08
from O 0 7.116583433663948e-10
reduced O 0 1.4876319065493249e-09
expression O 0 1.8812630619979842e-10
or O 0 1.2665109239140548e-10
incorrect O 0 4.307529444247393e-09
subcellular O 0 5.440496408937179e-08
localization O 0 6.139074315569815e-08
is O 0 1.899510063130272e-11
postulated O 0 3.9038375310163076e-10
to O 0 1.8451953506803953e-11
be O 0 3.4352149597127735e-11
important O 0 5.331233787764234e-10
in O 0 2.408003796361413e-10
non B-Disease 0 6.734189810231328e-07
- I-Disease 0 0.00011213749530725181
familial I-Disease 1 0.999994158744812
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 5.364622211345704e-06

Epigenetic O 0 0.0018258335767313838
loss O 0 2.9925804483355023e-05
, O 0 1.0616129308971267e-08
however O 0 5.867784036439616e-09
, O 0 4.0730921413434373e-10
has O 0 4.095260242031884e-11
not O 0 7.2387451935385094e-12
received O 0 1.6989604167960692e-10
general O 0 1.1005573119504675e-09
acceptance O 0 1.0578532716465361e-08
due O 0 2.4601598980211747e-08
to O 0 8.788210159593746e-10
controversy O 0 4.810311704517289e-09
regarding O 0 3.169286388882142e-09
the O 0 2.8715463340489578e-09
subcellular O 0 2.1455976195738913e-07
localization O 0 4.7461134045079234e-07
of O 0 5.934166935617213e-09
BRCA1 O 0 9.53129131175956e-10
proteins O 0 1.8868644494074438e-11
, O 0 1.525711154637399e-11
reports O 0 3.483712276985962e-11
of O 0 1.2065054511012363e-09
which O 0 3.364624967527874e-10
have O 0 2.5489779731380224e-10
ranged O 0 3.024986128252749e-08
from O 0 1.418412054476903e-09
exclusively O 0 1.3205404547633748e-09
nuclear O 0 2.5687469928925566e-08
, O 0 1.235038599167737e-10
to O 0 2.220982009415451e-10
conditionally O 0 2.6738783276414324e-07
nuclear O 0 1.1604303153944784e-06
, O 0 4.723643698412161e-10
to O 0 5.634450128688684e-10
the O 0 2.6592756441345955e-08
ER O 1 0.7251143455505371
/ O 0 3.347963911437546e-06
golgi O 0 7.846268999855965e-06
, O 0 8.963695341535072e-10
to O 0 8.320795719107821e-10
cytoplasmic O 0 1.561186593335151e-07
invaginations O 0 1.3086507806292502e-06
into O 0 2.1485991652525627e-08
the O 0 1.676339778100555e-08
nucleus O 0 2.900646904890891e-07
. O 0 2.0254260846286343e-07

In O 0 2.3313243957545637e-07
an O 0 7.632435128357429e-09
attempt O 0 2.349311074567595e-07
to O 0 6.09722539124391e-09
resolve O 0 3.692912287078798e-07
this O 0 1.8368400134249896e-09
issue O 0 1.2182972852770035e-08
, O 0 5.291905247339912e-10
we O 0 2.596873271976108e-10
have O 0 1.9633360215376428e-10
comprehensively O 0 2.1088183643769298e-08
characterized O 0 1.63194489033458e-08
19 O 0 2.034120605287626e-08
anti O 0 3.5414217336438014e-07
- O 0 3.014175717908074e-06
BRCA1 O 0 6.190635559732982e-08
antibodies O 0 2.650323160935386e-08
. O 0 1.0355110191540007e-07

These O 0 1.173364196915827e-07
reagents O 0 1.8957433667310397e-06
detect O 0 1.161170871455397e-06
a O 0 6.748848591087153e-08
220 O 0 1.0961547758370216e-07
- O 0 1.294530846962516e-07
kD O 0 6.084159167585312e-07
protein O 0 3.313752383604651e-09
localized O 0 8.62713278593219e-09
in O 0 1.44939990565085e-10
discrete O 0 4.226954342101408e-09
nuclear O 0 1.1087290374689474e-07
foci O 0 6.238320082729842e-08
in O 0 6.59689247672901e-11
all O 0 6.138222569118668e-11
epithelial O 0 3.5189920311040623e-08
cell O 0 3.25470956852314e-08
lines O 0 4.1892050939296155e-10
, O 0 9.802974404449216e-12
including O 0 4.828781038218599e-12
those O 0 1.8147598007667298e-11
derived O 0 1.434894603136172e-08
from O 0 8.808422791162229e-08
breast B-Disease 0 0.0025765476748347282
malignancies I-Disease 0 0.00013760004367213696
. O 0 2.3410224514464062e-07

Immunohistochemical O 0 0.00022376724518835545
staining O 0 4.306638220441528e-05
of O 0 1.3229898740974022e-06
human O 0 2.92819066771699e-07
breast O 0 3.0224139209167333e-06
specimens O 0 5.277174608409041e-08
also O 0 8.141671337114076e-09
revealed O 0 9.021574243206487e-08
BRCA1 O 0 9.169675507791908e-08
nuclear O 0 7.342168828472495e-06
foci O 0 1.0358975487179123e-05
in O 0 9.200646466922535e-09
benign O 1 0.9999963045120239
breast O 1 1.0
, O 0 5.497365691553568e-07
invasive B-Disease 1 0.9999998807907104
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 5.794222943222849e-06
low B-Disease 1 0.9999978542327881
- I-Disease 1 0.999967098236084
grade I-Disease 1 0.9999943971633911
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 1.1976510450040223e-06

Conversely O 0 6.028939878888195e-06
, O 0 9.888607621633128e-08
BRCA1 O 0 6.494031623560659e-08
expression O 0 1.3984987390358583e-08
was O 0 1.9137354811959995e-08
reduced O 0 1.1434217128680757e-08
or O 0 1.618679190684702e-09
undetectable O 0 2.9556455061197084e-08
in O 0 1.6372216082860547e-10
the O 0 3.111188251470054e-10
majority O 0 2.0611211348775527e-10
of O 0 6.810657815492505e-09
high O 0 2.272930487379199e-06
- O 0 1.2226793160152738e-06
grade O 0 5.526715995074483e-06
, O 0 3.896833788985532e-08
ductal B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 3.5772826367796995e-10
suggesting O 0 4.910369888477817e-10
that O 0 2.4542977025698853e-11
absence O 0 6.393838702933863e-08
of O 0 2.619007091198e-07
BRCA1 O 0 3.138584503403763e-08
may O 0 5.404395264640982e-10
contribute O 0 6.976377114886745e-11
to O 0 8.593719486027496e-11
the O 0 6.16963535815529e-10
pathogenesis O 0 9.44217317737639e-05
of O 0 1.3030570400474062e-08
a O 0 1.3835133039208358e-09
significant O 0 1.0406878692137411e-09
percentage O 0 1.6444675621229976e-09
of O 0 1.5092612715150722e-09
sporadic B-Disease 0 6.624327397730667e-06
breast I-Disease 1 0.9999141693115234
cancers I-Disease 1 0.5522212386131287
. O 0 1.9586215316280686e-08
. O 0 1.321968028378251e-07

